PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kim, JK; Gabel, HW; Kamath, RS; Tewari, M; Pasquinelli, A; Rual, JF; Kennedy, S; Dybbs, M; Bertin, N; Kaplan, JM; Vidal, M; Ruvkun, G				Kim, JK; Gabel, HW; Kamath, RS; Tewari, M; Pasquinelli, A; Rual, JF; Kennedy, S; Dybbs, M; Bertin, N; Kaplan, JM; Vidal, M; Ruvkun, G			Functional genomic analysis of RNA interference in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GERMLINE; GENE; BETA; MAP	RNA interference (RNAi) of target genes is triggered by doubte-stranded RNAs (dsRNAs) processed by conserved nucleases and accessory factors. To identify the genetic components required for RNAi, we performed a genome-wide screen using an engineered RNAi sensor strain of Caenorhabditis elegans. The RNAi screen identified 90 genes. These included Piwi/PAZ proteins, DEAH helicases, RNA binding/processing factors, chromatin-associated factors, DNA recombination proteins, nuclear import/export factors, and 11 known components of the RNAi machinery. We demonstrate that some of these genes are also required for germline and somatic transgene silencing. Moreover, the physical interactions among these potential RNAi factors suggest links to other RNA-dependent gene regulatory pathways.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Bertin, Nicolas/O-9602-2019; Bertin, Nicolas/C-3025-2008	Kennedy, Scott/0000-0002-7974-8155; Rual, Jean-Francois/0000-0003-4465-8819; Bertin, Nicolas/0000-0002-9835-9606	NIA NIH HHS [K08-AG21613] Funding Source: Medline; NIGMS NIH HHS [GM44619] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG021613] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Dudley NR, 2002, P NATL ACAD SCI USA, V99, P4191, DOI 10.1073/pnas.062605199; Grishok A, 2002, ADV GENET, V46, P339; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 1997, GENETICS, V146, P227; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MELLO CC, COMMUNICATION; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Pirrotta V, 2002, CELL, V110, P661, DOI 10.1016/S0092-8674(02)00967-4; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Yochem J, 1998, GENETICS, V149, P1323	26	227	283	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1164	1167		10.1126/science.1109267	http://dx.doi.org/10.1126/science.1109267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15790806				2022-12-01	WOS:000229293400042
J	Stukel, TA; Lucas, FL; Wennberg, DE				Stukel, TA; Lucas, FL; Wennberg, DE			Long-term outcomes of regional variations in intensity of invasive vs medical management of medicare patients with acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIPID-LOWERING THERAPY; ELDERLY-PATIENTS; CORONARY-ANGIOGRAPHY; CARDIAC PROCEDURES; UNSTABLE ANGINA; UNITED-STATES; THROMBOLYTIC THERAPY; GEOGRAPHIC-VARIATION; PRIMARY ANGIOPLASTY; QUALITY	Context The health and policy implications of the marked regional variations in intensity of invasive compared with medical management of patients with acute myocardial infarction (AMI) are unknown. Objectives To evaluate patient clinical characteristics associated with receiving more intensive treatment; and to assess whether AMI patients residing in regions with more intensive invasive treatment and management strategies have better long-term survival than those residing in regions with more intensive medical management strategies. Design, Setting, and Patients National cohort study of 158 831 elderly Medicare patients hospitalized with first episode of confirmed AMI in 1994-1995, followed up for 7 years (mean, 3.6 years), according to the intensity of invasive management (performance of cardiac catheterization within 30 days) and medical management (prescription of beta-blockers to appropriate patients at discharge) in their region of residence. Baseline chart reviews were drawn from the Cooperative Cardiovascular Project and linked to Medicare health administrative data. Main Outcome Measure Long-term survival over 7 years of follow-up. Results Patient baseline AMI severity was similar across regions. In all regions, younger and healthier patients were more likely than older high-risk patients to receive invasive treatment and medical therapy. Regions with more invasive treatment practice styles had more cardiac catheterization laboratory capacity; patients in these regions were more likely to receive interventional treatment, regardless of age, clinical indication, or risk profile. The absolute unadjusted difference in 7-year survival between regions providing the highest rates of both invasive and medical management strategies and those providing the lowest rates of both was 6.2%. For both ST- and non-ST-segment elevation AMI patients, survival improved with regional intensity of both invasive and medical management. In areas with higher rates of medical management, there appeared to be little or no improvement in survival associated with increased invasive treatment. Conclusions In elderly Medicare patients with AMI, more intensive medical treatment provides population survival benefits. However, routine use of more costly and invasive treatment strategies may not be associated with an overall population benefit beyond that seen with excellent medical management. Efforts should focus on directing invasive clinical resources to patients with the greatest expected benefit.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA	University of Toronto; Dartmouth College; University of Toronto; Maine Medical Center	Stukel, TA (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	stukel@ices.on.ca		Stukel, Therese/0000-0002-2951-1360	NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER; NIA NIH HHS [1PO1-AG19783-01, P01 AG019783] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alter DA, 2001, JAMA-J AM MED ASSOC, V285, P2101, DOI 10.1001/jama.285.16.2101; Aronow HD, 2003, ARCH INTERN MED, V163, P2576, DOI 10.1001/archinte.163.21.2576; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; BLUSTEIN J, 1993, JAMA-J AM MED ASSOC, V270, P344, DOI 10.1001/jama.270.3.344; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Braunwald E, 2003, CIRCULATION, V108, P28; Brophy JM, 2004, ANN INTERN MED, V141, P292, DOI 10.7326/0003-4819-141-4-200408170-00009; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; Cox DR., 1984, ANAL SURVIVAL DATA; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Gattis WA, 2004, J AM COLL CARDIOL, V43, P1534, DOI 10.1016/j.jacc.2003.12.040; Guadagnoli E, 2000, NEW ENGL J MED, V343, P1460, DOI 10.1056/NEJM200011163432006; GUADAGNOLI E, 1995, NEW ENGL J MED, V333, P573, DOI 10.1056/NEJM199508313330908; Guadagnoli E, 2001, MED CARE, V39, P446, DOI 10.1097/00005650-200105000-00005; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Hlatky MA, 2004, NEW ENGL J MED, V350, P2126, DOI 10.1056/NEJMp048071; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kaul P, 2004, CIRCULATION, V110, P1754, DOI 10.1161/01.CIR.0000142671.06167.91; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2004, ANN INTERN MED, V141, P298, DOI 10.7326/0003-4819-141-4-200408170-00010; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Krumholz HM, 1999, ANN INTERN MED, V131, P648, DOI 10.7326/0003-4819-131-9-199911020-00003; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Krumholz HM, 1998, CIRCULATION, V98, P2010, DOI 10.1161/01.CIR.98.19.2010; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, NEW ENGL J MED, V331, P1130, DOI 10.1056/NEJM199410273311706; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Petersen LA, 2001, CIRCULATION, V104, P2898, DOI 10.1161/hc4901.100524; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907; Rosenbaum PR, 2002, OBSERVATIONAL STUDIE; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Solomon DH, 2001, J AM COLL CARDIOL, V38, P969, DOI 10.1016/S0735-1097(01)01503-0; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; Wennberg DE, 2004, JAMA-J AM MED ASSOC, V292, P1961, DOI 10.1001/jama.292.16.1961; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	52	109	125	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1329	1337		10.1001/jama.293.11.1329	http://dx.doi.org/10.1001/jama.293.11.1329			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769966	Green Accepted			2022-12-01	WOS:000227698600021
J	Cowan, ML; Bruner, BD; Huse, N; Dwyer, JR; Chugh, B; Nibbering, ETJ; Elsaesser, T; Miller, RJD				Cowan, ML; Bruner, BD; Huse, N; Dwyer, JR; Chugh, B; Nibbering, ETJ; Elsaesser, T; Miller, RJD			Ultrafast memory loss and energy redistribution in the hydrogen bond network of liquid H2O	NATURE			English	Article							INFRARED-SPECTROSCOPY; VIBRATIONAL-RELAXATION; ICE IH; WATER; DYNAMICS; SPECTRA	Many of the unusual properties of liquid water are attributed to its unique structure, comprised of a random and fluctuating three-dimensional network of hydrogen bonds that link the highly polar water molecules(1,2). One of the most direct probes of the dynamics of this network is the infrared spectrum of the OH stretching vibration(3-11), which reflects the distribution of hydrogen-bonded structures and the intermolecular forces controlling the structural dynamics of the liquid. Indeed, water dynamics has been studied in detail(5-14), most recently using multi-dimensional nonlinear infrared spectroscopy(15,16) for acquiring structural and dynamical information on femtosecond timescales. But owing to technical difficulties, only OH stretching vibrations in D2O or OD vibrations in H2O could be monitored. Here we show that using a specially designed, ultrathin sample cell allows us to observe OH stretching vibrations in H2O. Under these fully resonant conditions, we observe hydrogen bond network dynamics more than one order of magnitude faster than seen in earlier studies that include an extremely fast sweep in the OH frequencies on a 50-fs timescale and an equally fast disappearance of the initial inhomogeneous distribution of sites. Our results highlight the efficiency of energy redistribution within the hydrogen-bonded network, and that liquid water essentially loses the memory of persistent correlations in its structure within 50 fs.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada; Max Born Inst Nichtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany	University of Toronto; University of Toronto; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Miller, RJD (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	rjdmiller@lphys.chem.utoronto.ca	Elsaesser, Thomas/P-7608-2014; Huse, Nils/A-5712-2017	Elsaesser, Thomas/0000-0003-3056-6665; Huse, Nils/0000-0002-3281-7600; Dwyer, Jason/0000-0002-2938-2888; Bruner, Barry/0000-0003-3915-6304				Asbury JB, 2004, J PHYS CHEM A, V108, P1107, DOI 10.1021/jp036266k; Asplund MC, 2000, P NATL ACAD SCI USA, V97, P8219, DOI 10.1073/pnas.140227997; CASTNER EW, 1995, J CHEM PHYS, V102, P653, DOI 10.1063/1.469177; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; Eisenberg D., 2005, STRUCTURE PROPERTIES; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Franks F., 1972, WATER COMPREHENSIVE; Gale GM, 1999, PHYS REV LETT, V82, P1068, DOI 10.1103/PhysRevLett.82.1068; GRAENER H, 1991, PHYS REV LETT, V66, P2092, DOI 10.1103/PhysRevLett.66.2092; Hybl JD, 1998, CHEM PHYS LETT, V297, P307, DOI 10.1016/S0009-2614(98)01140-3; JIMENEZ R, 1994, NATURE, V369, P471, DOI 10.1038/369471a0; Lawrence CP, 2002, J CHEM PHYS, V117, P8847, DOI 10.1063/1.1514652; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Lock AJ, 2002, J CHEM PHYS, V117, P1708, DOI 10.1063/1.1485966; Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Moller KB, 2004, J PHYS CHEM A, V108, P1275, DOI 10.1021/jp035935r; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Pakoulev A, 2003, CHEM PHYS LETT, V371, P594, DOI 10.1016/S0009-2614(03)00314-2; POHORILLE A, 1987, J CHEM PHYS, V87, P6070, DOI 10.1063/1.453481; Poulsen JA, 2003, J PHYS CHEM A, V107, P8420, DOI 10.1021/jp0225469; RICE SA, 1983, J PHYS CHEM-US, V87, P4295, DOI 10.1021/j100244a061; Saito S, 1997, J CHEM PHYS, V106, P4889, DOI 10.1063/1.473538; Stenger J, 2002, J PHYS CHEM A, V106, P2341, DOI 10.1021/jp013104k; Stenger J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.027401; Torre R, 2004, NATURE, V428, P296, DOI 10.1038/nature02409; WOJCIK MJ, 1993, J CHEM PHYS, V99, P2332, DOI 10.1063/1.465248; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058	28	601	611	3	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					199	202		10.1038/nature03383	http://dx.doi.org/10.1038/nature03383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758995				2022-12-01	WOS:000227494500040
J	Enriquez-Sarano, M; Avierinos, JF; Messika-Zeitoun, D; Detaint, D; Capps, M; Nkomo, V; Scott, C; Schaff, HV; Tajik, AJ				Enriquez-Sarano, M; Avierinos, JF; Messika-Zeitoun, D; Detaint, D; Capps, M; Nkomo, V; Scott, C; Schaff, HV; Tajik, AJ			Quantitative determinants of the outcome of asymptomatic mitral regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOPPLER ASSESSMENT; NATURAL-HISTORY; ORIFICE AREA; VALVULAR REGURGITATION; AORTIC REGURGITATION; VALVE PROLAPSE; ECHOCARDIOGRAPHY; DISEASE; CARDIOLOGY; SEVERITY	BACKGROUND The clinical outcome of asymptomatic mitral regurgitation is poorly defined, and the treatment is uncertain. We studied the effect on the outcome of quantifying mitral regurgitation according to recent guidelines. METHODS We prospectively enrolled 456 patients (mean [+/-SD] age, 63+/-14 years; 63 percent men; ejection fraction, 70+/-8 percent) with asymptomatic organic mitral regurgitation, quantified according to current recommendations (regurgitant volume, 66+/-40 ml per beat; effective regurgitant orifice, 40+/-27 mm(sup 2)). RESULTS The estimated five-year rates (+/-SE) of death from any cause, death from cardiac causes, and cardiac events (death from cardiac causes, heart failure, or new atrial fibrillation) with medical management were 22+/-3 percent, 14+/-3 percent, and 33+/-3 percent, respectively. Independent determinants of survival were increasing age, the presence of diabetes, and increasing effective regurgitant orifice (adjusted risk ratio per 10-mm(sup 2) increment, 1.18; 95 percent confidence interval, 1.06 to 1.30; P<0.01), the predictive power of which superseded all other qualitative and quantitative measures of regurgitation. Patients with an effective regurgitant orifice of at least 40 mm(sup 2) had a five-year survival rate that was lower than expected on the basis of U.S. Census data (58+/-9 percent vs. 78 percent, P=0.03). As compared with patients with a regurgitant orifice of less than 20 mm(sup 2), those with an orifice of at least 40 mm(sup 2) had an increased risk of death from any cause (adjusted risk ratio, 2.90; 95 percent confidence interval, 1.33 to 6.32; P<0.01), death from cardiac causes (adjusted risk ratio, 5.21; 95 percent confidence interval, 1.98 to 14.40; P<0.01), and cardiac events (adjusted risk ratio, 5.66; 95 percent confidence interval, 3.07 to 10.56; P<0.01). Cardiac surgery was ultimately performed in 232 patients and was independently associated with improved survival (adjusted risk ratio, 0.28; 95 percent confidence interval, 0.14 to 0.55; P<0.01). CONCLUSIONS Quantitative grading of mitral regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation. Patients with an effective regurgitant orifice of at least 40 mm(sup 2) should promptly be considered for cardiac surgery.	Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin, Div Cardiac Surg, Rochester, MN 55905 USA; Mayo Clin, Biostat Sect, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Enriquez-Sarano, M (corresponding author), Mayo Clin, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu		Schaff, Hartzell/0000-0003-0994-027X; Scott, Christopher/0000-0003-1340-0647	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064928] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 64928] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; BLUMLEIN S, 1986, CIRCULATION, V74, P306, DOI 10.1161/01.CIR.74.2.306; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; Borer JS, 2003, CIRCULATION, V108, P2432, DOI 10.1161/01.CIR.0000096400.00562.A3; BRAUNWALD E, 1963, CIRCULATION, V27, P29, DOI 10.1161/01.CIR.27.1.29; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DELAHAYE JP, 1991, EUR HEART J, V12, P5, DOI 10.1093/eurheartj/12.suppl_B.5; Dujardin KS, 1997, CIRCULATION, V96, P3409; Enriquez-Sarano M, 1999, J AM COLL CARDIOL, V34, P1137, DOI 10.1016/S0735-1097(99)00313-7; Enriquez-Sarano R, 1999, J AM COLL CARDIOL, V34, P1129, DOI 10.1016/S0735-1097(99)00314-9; ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022, DOI 10.1161/01.CIR.91.4.1022; EnriquezSarano M, 1997, MAYO CLIN PROC, V72, P1034, DOI 10.4065/72.11.1034; ENRIQUEZSARANO M, 1995, J AM COLL CARDIOL, V25, P703, DOI 10.1016/0735-1097(94)00434-R; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V21, P1211, DOI 10.1016/0735-1097(93)90248-Y; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V22, P342; ENRIQUEZSARANO M, 1993, CIRCULATION, V87, P841, DOI 10.1161/01.CIR.87.3.841; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V23, P443, DOI 10.1016/0735-1097(94)90432-4; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; Ling LH, 1997, CIRCULATION, V96, P1819, DOI 10.1161/01.CIR.96.6.1819; MACISAAC AI, 1992, AUST NZ J MED, V22, P532, DOI 10.1111/j.1445-5994.1992.tb00473.x; MOHTY D, 2001, CIRCULATION S1, V104, P1, DOI 10.1161/hc37t1.094903; OTT DA, 1995, CIRCULATION, V91, P1264, DOI 10.1161/01.CIR.91.4.1264; REN JF, 1983, J AM COLL CARDIOL, V2, P729, DOI 10.1016/S0735-1097(83)80313-1; ROKEY R, 1986, J AM COLL CARDIOL, V7, P1273, DOI 10.1016/S0735-1097(86)80146-2; ROSEN SE, 1994, AM J CARDIOL, V74, P374, DOI 10.1016/0002-9149(94)90406-5; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SELLERS RD, 1964, AM J CARDIOL, V14, P437, DOI 10.1016/0002-9149(64)90027-X; SELZER A, 1972, MEDICINE, V51, P337, DOI 10.1097/00005792-197209000-00001; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Singh JP, 1999, AM J CARDIOL, V84, P1143; SPAIN MG, 1989, J AM COLL CARDIOL, V13, P585, DOI 10.1016/0735-1097(89)90597-4; Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400; VANDERVOORT PM, 1993, CIRCULATION, V88, P1150, DOI 10.1161/01.CIR.88.3.1150; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	39	740	772	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					875	883		10.1056/NEJMoa041451	http://dx.doi.org/10.1056/NEJMoa041451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745978				2022-12-01	WOS:000227310700006
J	Krylova, IN; Sablin, EP; Moore, J; Xu, RX; Waitt, GM; MacKay, JA; Juzumiene, D; Bynum, JM; Madauss, K; Montana, V; Lebedeva, L; Suzawa, M; Williams, JD; Williams, SP; Guy, RK; Thornton, JW; Fletterick, RJ; Willson, TM; Ingraham, HA				Krylova, IN; Sablin, EP; Moore, J; Xu, RX; Waitt, GM; MacKay, JA; Juzumiene, D; Bynum, JM; Madauss, K; Montana, V; Lebedeva, L; Suzawa, M; Williams, JD; Williams, SP; Guy, RK; Thornton, JW; Fletterick, RJ; Willson, TM; Ingraham, HA			Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1	CELL			English	Article							STEROIDOGENIC FACTOR-I; NUCLEAR-RECEPTOR; BINDING DOMAIN; CRYSTAL-STRUCTURE; TRANSFER PROTEIN; ACTIVATION; TRANSCRIPTION; CHOLESTEROL; INFERENCE; FACTOR-1	Vertebrate members of the nuclear receptor NR5A subfamily, which includes steroidogenic factor 1 (SF-1) and liver receptor homolog 1 (LRH-1), regulate crucial aspects of development, endocrine homeostasis, and metabolism. Mouse LRH-1 is believed to be a ligand-independent transcription factor with a large and empty hydrophobic pocket. Here we present structural and biochemical data for three other NR5A members-mouse and human SF-1 and human LRH-1-which reveal that these receptors bind phosphatidyl inositol second messengers and that ligand binding is required for maximal activity. Evolutionary analysis of structure-function relationships across the SF-1/LRH-1 subfamily indicates that ligand binding is the ancestral state of NR5A receptors and was uniquely diminished or altered in the rodent LRH-1 lineage. We propose that phospholipids regulate gene expression by directly binding to NR5A nuclear receptors.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Bioengn, San Francisco, CA 94143 USA; GlaxoSmithKline, Discovery Res, Res Triangle Pk, NC 27709 USA; Univ Oregon, Ctr Ecol & Evolut Biol, Eugene, OR 97403 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; GlaxoSmithKline; University of Oregon	Ingraham, HA (corresponding author), Univ Calif San Francisco, Dept Physiol, 1550 4th St,Miss Bay Campus, San Francisco, CA 94143 USA.	hollyi@itsa.ucsf.edu	Guy, Rodney/J-7107-2013; Thornton, Joseph/GSN-4190-2022; feinstein, doug/M-9414-2019	Guy, Rodney/0000-0002-9638-2060; Williams, Shawn/0000-0001-8311-2638	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072246, R01DK058080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM070792] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK058080, R01 DK058080-05, R01 DK072246] Funding Source: Medline; NIGMS NIH HHS [1R21-GM70792-1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacqueville D, 2001, J BIOL CHEM, V276, P22170, DOI 10.1074/jbc.M011572200; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Bland ML, 2000, P NATL ACAD SCI USA, V97, P14488, DOI 10.1073/pnas.97.26.14488; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Christenson LK, 1998, J BIOL CHEM, V273, P30729, DOI 10.1074/jbc.273.46.30729; DARIMONT BD, 1998, GENE DEV, V273, P30729; DEFIGUEIREDO BC, 2004, J CLIN ENDOCR METAB, V10, P2004; Deleris P, 2003, J BIOL CHEM, V278, P38884, DOI 10.1074/jbc.M300816200; Delerive P, 2004, MOL ENDOCRINOL, V18, P2378, DOI 10.1210/me.2004-0132; Desclozeaux M, 2002, MOL CELL BIOL, V22, P7193, DOI 10.1128/MCB.22.20.7193-7203.2002; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Escriva H, 2000, BIOESSAYS, V22, P717; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Hsuan J, 2001, GENOME BIOL, V2; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; IRVINE RF, 2002, SCI STKE; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Ledeen RW, 2004, J LIPID RES, V45, P1, DOI 10.1194/jlr.R300015-JLR200; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Lie J, 2002, J LIPID RES, V43, P1875, DOI 10.1194/jlr.M200166-JLR200; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ludbrook LM, 2004, TRENDS ENDOCRIN MET, V15, P116, DOI 10.1016/j.tem.2004.02.002; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Madauss K, 2004, ENDOCR RES, V30, P775, DOI 10.1081/ERC-200044038; Martelli AM, 2003, J CELL BIOCHEM, V88, P455, DOI 10.1002/jcb.10379; Mellon SH, 1998, ENDOCRINOLOGY, V139, P3026, DOI 10.1210/en.139.6.3026; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2000, SYST BIOL, V49, P183, DOI 10.1093/sysbio/49.2.183; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Weatherman RV, 1999, ANNU REV BIOCHEM, V68, P559, DOI 10.1146/annurev.biochem.68.1.559; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; YANG ZH, 1995, GENETICS, V141, P1641; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	50	319	339	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					343	355		10.1016/j.cell.2005.01.024	http://dx.doi.org/10.1016/j.cell.2005.01.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707893	Bronze			2022-12-01	WOS:000227028900010
J	Hill, WG				Hill, WG			A century of corn selection	SCIENCE			English	Editorial Material							ARTIFICIAL SELECTION; BODY-WEIGHT; TRAITS		Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Hill, WG (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland.	w.g.hill@ed.ac.uk						ANDERSSON L, COMMUNICATION; De Koning DJ, 2004, GENET RES, V83, P211, DOI 10.1017/S0016672304006846; Dudley J. W., 2004, Plant Breeding Reviews, V24, P79; Dunnington EA, 1996, POULTRY SCI, V75, P1168, DOI 10.3382/ps.0751168; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; HILL WG, 1982, GENET RES, V40, P255, DOI 10.1017/S0016672300019145; Janick J, 2003, PLANT BREEDING REV 1, V24; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; LYNCH M, 1998, INTRO QUANTITATIVE G; ROBERTSON A., 1960, PROC ROY SOC SER B BIOL SCI, V153, P234, DOI 10.1098/rspb.1960.0099; Sewalem A, 2002, POULTRY SCI, V81, P1775, DOI 10.1093/ps/81.12.1775; Walsh B., 2004, Plant Breeding Reviews, V24, P177	13	38	45	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					683	684		10.1126/science.1105459	http://dx.doi.org/10.1126/science.1105459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692038				2022-12-01	WOS:000226814900028
J	Kim, C; Xuong, NH; Taylor, SS				Kim, C; Xuong, NH; Taylor, SS			Crystal structure of a complex between the catalytic and regulatory (RI alpha) subunits of PKA	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CAMP-BINDING DOMAINS; AMIDE H/H-2 EXCHANGE; PHOSPHORYLASE-KINASE; MOLECULAR-BASIS; SITES; MONOPHOSPHATE; MECHANISM; CLASSIFICATION; RESOLUTION	The 2.0-angstrom structure of the cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) catalytic subunit bound to a deletion mutant of a regulatory subunit (Rlalpha) defines a previously unidentified extended interface. The complex provides a molecular mechanism for inhibition of PKA and suggests how CAMP binding leads to activation. The interface defines the large lobe of the catalytic subunit as a stable scaffold where Tyr(247) in the G helix and Trp(196) in the phosphorylated activation loop serve as anchor points for binding Rlalpha. These residues compete with CAMP for the phosphate binding cassette in Rlalpha. In contrast to the catalytic subunit, Rlalpha undergoes major conformational changes when the complex is compared with CAMP-bound Rlalpha. The inhibitor sequence docks to the active site, whereas the linker, also disordered in free Rlalpha, folds across the extended interface. The beta barrel of CAMP binding domain A, which is the docking site for CAMP, remains largely intact in the complex, whereas the helical subdomain undergoes major reorganization.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Phys & Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	staylor@ucsd.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019301, R01GM019301, R01GM034921] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07233] Funding Source: Medline; NIGMS NIH HHS [GM19301, GM34921] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*ACC, 2003, INS 2; ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Anand GS, 2003, P NATL ACAD SCI USA, V100, P13264, DOI 10.1073/pnas.2232255100; Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; Gibson RM, 1997, J BIOL CHEM, V272, P31998, DOI 10.1074/jbc.272.51.31998; GILL GN, 1971, P NATL ACAD SCI USA, V68, P786, DOI 10.1073/pnas.68.4.786; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hauer JA, 1999, PROTEIN SCI, V8, P545; Heller WT, 2004, J BIOL CHEM, V279, P19084, DOI 10.1074/jbc.M313405200; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IYER G, IN PRESS J BIOL CHEM; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kim C., UNPUB; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAW D, UNPUB; LEON DA, 1991, BIOCHEMISTRY-US, V30, P3035, DOI 10.1021/bi00226a008; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nayal M, 1999, PROTEIN SCI, V8, P676; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; OGREID D, 1981, FEBS LETT, V129, P287, DOI 10.1016/0014-5793(81)80185-8; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Stevenson LM, 2002, BIOCHEMISTRY-US, V41, P8528, DOI 10.1021/bi025812h; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Venien-Bryan C, 2002, STRUCTURE, V10, P33, DOI 10.1016/S0969-2126(01)00691-8; Walsh D.A., 2018, PEPT PROT PHOSPH, P43; WALSH DA, 1968, J BIOL CHEM, V243, P3763; YANG SMG, 2004, J MOL BIOL; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0	50	273	280	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					690	696		10.1126/science.1104607	http://dx.doi.org/10.1126/science.1104607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692043				2022-12-01	WOS:000226814900033
J	Nakagawa, T; Cheng, YF; Ramm, E; Sheng, M; Walz, T				Nakagawa, T; Cheng, YF; Ramm, E; Sheng, M; Walz, T			Structure and different conformational states of native AMPA receptor complexes	NATURE			English	Article							LIGAND-BINDING CORE; GLUTAMATE-RECEPTOR; ION-CHANNEL; KAINATE; DOMAIN; SELECTIVITY; MECHANISMS; TOPOLOGY; SYMMETRY; NEURONS	Ionotropic glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system(1,2). Their modulation is believed to affect learning and memory, and their dysfunction has been implicated in the pathogenesis of neurological and psychiatric diseases(1,2). Despite a wealth of functional data, little is known about the intact, three-dimensional structure of these ligand-gated ion channels. Here, we present the structure of native AMPA receptors (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; AMPA-Rs) purified from rat brain, as determined by single-particle electron microscopy. Unlike the homotetrameric recombinant GluR2 (ref. 3), the native heterotetrameric AMPA-R adopted various conformations, which reflect primarily a variable separation of the two dimeric extracellular amino-terminal domains. Members of the stargazin/ TARP family of transmembrane proteins co-purified with AMPA-Rs and contributed to the density representing the transmembrane region of the complex. Glutamate and cyclothiazide markedly altered the conformational equilibrium of the channel complex, suggesting that desensitization is related to separation of the N-terminal domains. These data provide a glimpse of the conformational changes of an important ligand-gated ion channel of the brain.	MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Harvard University; Harvard Medical School	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu; twalz@hms.harvard.edu		Sheng, Morgan/0000-0002-8703-5366; Cheng, Yifan/0000-0001-9535-0369; Walz, Thomas/0000-0003-2606-2835				Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; RANK J, 1996, 3 DIMENSIONAL ELECT; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005	30	211	217	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					545	549		10.1038/nature03328	http://dx.doi.org/10.1038/nature03328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690046				2022-12-01	WOS:000226727200054
J	Yeo, M; Lee, SK; Lee, B; Ruiz, EC; Pfaff, SL; Gill, GN				Yeo, M; Lee, SK; Lee, B; Ruiz, EC; Pfaff, SL; Gill, GN			Small CTD phosphatases function in silencing neuronal gene expression	SCIENCE			English	Article							TARGET GENES; TRANSCRIPTIONAL REPRESSION; DEACETYLASE COMPLEX; HISTONE H3; LYSINE 9; PROTEIN; DIFFERENTIATION; IDENTIFICATION; DOMAIN	Neuronal gene transcription is repressed in non-neuronal cells by the repressor element 1 (RE-1)-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) complex. To understand how this silencing is achieved, we examined a family of class-C RNA polymerase II (RNAPII) carboxyl-terminal domain (CTD) phosphatases [small CTD phosphatases (SCPs) 1 to 3], whose expression is restricted to non-neuronal tissues. We show that REST/NRSF recruits SCPs to neuronal genes that contain RE-1 elements, leading to neuronal gene silencing in non-neuronal cells. Phosphatase-inactive forms of SCP interfere with REST/NRSF function and promote neuronal. differentiation of P19 stem cells. Likewise, small interfering RNA directed to the single Drosophila SCP unmasks neuronal gene expression in S2 cells. Thus, SCP activity is an evolutionarily conserved transcriptional regulator that acts globally to silence neuronal genes.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Salk Institute	Gill, GN (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ggill@ucsd.edu			NIDDK NIH HHS [DK13149] Funding Source: Medline; NINDS NIH HHS [NS37116] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013149, R37DK013149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116, R37NS037116] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Bai G, 2003, J NEUROCHEM, V86, P992, DOI 10.1046/j.1471-4159.2003.01922.x; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Zohn IE, 2001, DEV BIOL, V239, P118, DOI 10.1006/dbio.2001.0420	23	170	184	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					596	600		10.1126/science.1100801	http://dx.doi.org/10.1126/science.1100801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681389				2022-12-01	WOS:000226694000052
J	Xing, HY; Wilkerson, DC; Mayhew, CN; Lubert, EJ; Skaggs, HS; Goodson, ML; Hong, YL; Park-Sarge, OK; Sarge, KD				Xing, HY; Wilkerson, DC; Mayhew, CN; Lubert, EJ; Skaggs, HS; Goodson, ML; Hong, YL; Park-Sarge, OK; Sarge, KD			Mechanism of hsp70i gene bookmarking	SCIENCE			English	Article							CHROMOSOME CONDENSATION; TRANSCRIPTION FACTORS; ACTIVATION; COMPLEXES; PROMOTER; PROTEIN; PHOSPHORYLATION	In contrast to most genomic DNA in mitotic cells, the promoter regions of some genes, such as the stress-inducible hsp70i gene that codes for a heat shock protein, remain uncompacted, a phenomenon called bookmarking. Here we show that hsp70i bookmarking is mediated by a transcription factor called HSF2, which binds this promoter in mitotic cells, recruits protein phosphatase 2A, and interacts with the CAP-G subunit of the condensin enzyme to promote efficient dephosphorylation and inactivation of condensin complexes in the vicinity, thereby preventing compaction at this site. Blocking HSF2-mediated bookmarking by HSF2 RNA interference decreases hsp70i induction and survival of stressed cells in the G, phase, which demonstrates the biological importance of gene bookmarking.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Albert B Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA; Univ Cincinnati, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Battelle Mem Inst, Columbus, OH 43201 USA; Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA	University of Kentucky; University of Kentucky; University System of Ohio; University of Cincinnati; Battelle Memorial Institute; University of California System; University of California Davis	Sarge, KD (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	kdsarge@uky.edu	Goodson, Michael L/G-4175-2010; Mayhew, Christopher N/AGB-4929-2022	Goodson, Michael/0000-0002-3464-490X	NICHD NIH HHS [HD41609, HD36879] Funding Source: Medline; NIGMS NIH HHS [GM64606, GM61053] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036879, R01HD041609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064606, R01GM061053] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Deroo BJ, 2001, MOL BIOL CELL, V12, P3365, DOI 10.1091/mbc.12.11.3365; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hirano T, 2004, CELL CYCLE, V3, P26; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hong YL, 1999, J BIOL CHEM, V274, P12967, DOI 10.1074/jbc.274.19.12967; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Li TH, 2000, NUCLEIC ACIDS RES, V28, P3031, DOI 10.1093/nar/28.16.3031; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Morano KA, 1999, GENE EXPRESSION, V7, P271; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; Strunnikov Alexander V, 2003, Prog Cell Cycle Res, V5, P361; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; Wang TY, 2002, J IMMUNOL, V169, P795, DOI 10.4049/jimmunol.169.2.795; Yokomori K, 2003, CURR TOP MICROBIOL, V274, P79	25	126	130	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					421	423		10.1126/science.1106478	http://dx.doi.org/10.1126/science.1106478			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662014				2022-12-01	WOS:000226492300046
J	Berwick, DM				Berwick, DM			My right knee	ANNALS OF INTERNAL MEDICINE			English	Article							REGIONAL-VARIATIONS; CARE	Despite some impressive recent gains, improving the glaring deficiencies in health care quality is proving to be very hard. Improvement is local, rather than system-wide, and is sustained with difficulty, rather than becoming an intrinsic feature of care. My right knee will probably need to be replaced soon. This has given me the opportunity to define, in very personal terms, 5 specific dimensions of "total quality" that I will require from the medical institution that does my surgery and that every patient has the right to require of their encounters with the health care system. Don't kill me (no needless deaths). Do help me, and don't hurt me (no needless pain). Don't make me feel helpless. Don't keep me waiting. And don't waste resources, mine or anyone else's. Given my requirements, it is not clear that any health care institution in the United States will want to take me on as a patient. Although at this point individual institutions can meet some of these requirements, no single institution can deliver on all of them. Generating the energy, insight, and courage we need to get to "total quality" may require those of us who work in health care to get much better at seeing images of ourselves in the people we help. As Gandhi said, "You must be the change you wish to see in the world."	Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	dberwick@ihi.org						Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; *I HLTH CAR IMPR, PRIM CAR ACC; Institute of Medicine, 2001, CROSSING QUALITY CHA; JULIUSSON R, 1984, ARCH ORTHOP TRAUM SU, V103, P42, DOI 10.1007/BF00451317; McManus ML, 2003, ANESTHESIOLOGY, V98, P1491, DOI 10.1097/00000542-200306000-00029; *PA HLTH CAR COST, 1999, TOT HIP KNEE REPL SU; Reinhardt UE, 2004, HEALTH AFFAIR, V23, P10, DOI 10.1377/hlthaff.23.3.10; SCHWARTZ DE, 1995, ANESTHESIOLOGY, V82, P367, DOI 10.1097/00000542-199502000-00007; *SWED BOARD HLTH, NAT REG KNEE INJ; Wennberg J.E., 1998, DARTMOUTH ATLAS HLTH; *WI COLL HEALTHC Q, 2003, PERF PROGR REP	12	19	20	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2005	142	2					121	125		10.7326/0003-4819-142-2-200501180-00011	http://dx.doi.org/10.7326/0003-4819-142-2-200501180-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915LQ	15657160				2022-12-01	WOS:000228306100006
J	Zeman, A				Zeman, A			Tales from the temporal lobe	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORIGIN		Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Zeman, A (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.			Zeman, Adam/0000-0003-4875-658X				BANCAUD J, 1994, BRAIN, V117, P71, DOI 10.1093/brain/117.1.71; Blanke O, 2004, BRAIN, V127, P719; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; JACKSON JH, 1880, BRAIN, V3, P206; Zeman AZJ, 1998, J NEUROL NEUROSUR PS, V64, P435, DOI 10.1136/jnnp.64.4.435	6	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2005	352	2					119	121		10.1056/NEJMp048219	http://dx.doi.org/10.1056/NEJMp048219			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886TG	15647573				2022-12-01	WOS:000226251700003
J	Okie, S				Okie, S			Safety in numbers - Monitoring risk in approved drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Dai CL, 2005, ARCH INTERN MED, V165, P171, DOI 10.1001/archinte.165.2.171; *GEN ACC OFF, 1990, GAOPEMD9015; HARRIS G, 2005, NY TIMES        0220, pA28; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622	4	46	48	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2005	352	12					1173	1176		10.1056/NEJMp058029	http://dx.doi.org/10.1056/NEJMp058029			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909AW	15788493				2022-12-01	WOS:000227832300002
J	Reyburn, H; Mbatia, R; Drakeley, C; Bruce, J; Carneiro, I; Olomi, R; Cox, J; Nkya, WMMM; Lemnge, M; Greenwood, BM; Riley, EM				Reyburn, H; Mbatia, R; Drakeley, C; Bruce, J; Carneiro, I; Olomi, R; Cox, J; Nkya, WMMM; Lemnge, M; Greenwood, BM; Riley, EM			Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TANZANIAN CHILDREN; SEVERE ANEMIA; RISK-FACTORS; 2 AREAS; MORTALITY; MORBIDITY; PARASITE; ADMISSION; ALTITUDE; INFANTS	Context There are concerns that malaria control measures such as use of insecticide-treated bed nets, by delaying acquisition of immunity, might result in an increase in the more severe manifestations of malaria. An understanding of the relationships among the level of exposure to Plasmodium falciparum, age, and severity of malaria can provide evidence of whether this is likely. Objective To describe the clinical manifestations and case fatality of severe P falciparum malaria at varying altitudes resulting in varying levels of transmission. Design, Setting, and Patients A total of 1984 patients admitted for severe malaria to 10 hospitals serving populations living at levels of transmission varying from very low (altitude >1200 m) to very high (altitude <600 m) in a defined area of northeastern Tanzania, studied prospectively from February 2002 to February 2003. Data were analyzed in a logistic regression model and adjusted for potential clustering within hospitals. Main Outcome Measures Specific syndromes of severe malaria; mortality. Results The median age of patients was 1 year in high transmission, 3 years in moderate transmission, and 5 years in low transmission areas. The odds of severe malarial anemia (hemoglobin <5 g/dL) peaked at 1 year of age at high transmission and at 2 years at moderate and low transmission intensities and then decreased with increasing age (P=.002). Odds were highest in infants (0-1 year: referent; 2-4 years: odds ratio [OR], 0.83; 95% confidence interval [0], 0.72-0.96), 5 to <15 years: OR, 0.44; 95% Cl, 0.27-0.72; >= 15 years: OR, 0.44; 95% Cl, 0.27-0.73; P<.001) and high transmission intensity areas (altitude <600 in: referent; 600 In to 1200 in: OR, 0.55; 95% Cl, 0.35-0.84; >1200 in: OR, 0.55; 95% Cl, 0.26-1.15; P for trend =.03). The odds of cerebral malaria were significantly higher in low transmission intensity areas (altitude of residence <600 in: referent; 600 in to 1200 m: OR, 3.17; 95% Cl, 1.32-7.60; >1200 in: OR, 3.76; 95% Cl, 1.96-7.18; P for trend=.003) and with age 5 years and older (0-1 year: referent; 2-4 years: OR, 1.57; 95% Cl, 0.82-2.99; 5 to <15 years: OR, 6.07; 95% Cl, 2.98-12.38; >= 15 years: OR, 6.24; 95% Cl, 3.47-11.21; P<.001). The overall case-fatality rate of 7% (139 deaths) was similar at high and moderate levels of transmission but increased to 13% in low transmission areas (P=.03), an increase explained by the increase in the proportion of cases with cerebral malaria. Conclusions Age and level of exposure independently influence the clinical presentation of severe malaria. Our study suggests that an increase in the proportion of cases with more fatal manifestations of severe malaria is likely to occur only after transmission has been reduced to low levels where the overall incidence is likely to be low.	Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Natl Inst Med Res, Amani, Tanzania	Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Reyburn, H (corresponding author), Kilimanjaro Christian Med Ctr, Joint Malaria Programme, POB 2228, Moshi, Tanzania.	hugh.reyburn@lshtm.ac.uk; eleanor.riley@lshtm.ac.uk	Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013	Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570				Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; DRAKELEY C, IN PRESS J INFECT DI; GREENBERG AE, 1990, ANN INTERN MED, V113, P326, DOI 10.7326/0003-4819-113-4-326; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Kahigwa E, 2002, TROP MED INT HEALTH, V7, P823, DOI 10.1046/j.1365-3156.2002.00938.x; Lengeler C, 1997, PARASITOL TODAY, V13, P123, DOI 10.1016/S0169-4758(97)84870-3; Lengeler C., 2004, COCHRANE DB SYST REV, V2; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Marsh K, 1997, PHILOS T R SOC B, V352, P1385, DOI 10.1098/rstb.1997.0124; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; *MIN HLTH, 2001, 16 HIVAIDSSTI MIN HL; Ministry of Health, 2000, NAT GUID MAL DIAGN T; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; Molineaux L, 1996, ANN TROP MED PARASIT, V90, P379, DOI 10.1080/00034983.1996.11813067; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Riley EM, 1999, IMMUNOL TODAY, V20, P228, DOI 10.1016/S0167-5699(99)01456-5; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; SNOW RW, 1994, INT J EPIDEMIOL, V23, P1013, DOI 10.1093/ije/23.5.1013; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; *WHO, 2003, PUBL WHO, P1093	40	211	212	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1461	1470		10.1001/jama.293.12.1461	http://dx.doi.org/10.1001/jama.293.12.1461			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784869	Bronze, Green Accepted			2022-12-01	WOS:000227784700025
J	Lai, ZC; Wei, XM; Shimizu, T; Ramos, E; Rohrbaugh, M; Nikolaidis, N; Ho, LL; Li, Y				Lai, ZC; Wei, XM; Shimizu, T; Ramos, E; Rohrbaugh, M; Nikolaidis, N; Ho, LL; Li, Y			Control of cell proliferation and apoptosis by Mob as tumor suppressor, Mats	CELL			English	Article							PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; PROMOTES APOPTOSIS; GENETIC MOSAICS; GROWTH-CONTROL; HUMAN HOMOLOG; CYCLE EXIT; HIPPO; DEATH; FAMILY	Appropriate cell number and organ size in a multicellular organism are determined by coordinated cell growth, proliferation, and apoptosis. Disruption of these processes can cause cancer. Recent studies have identified the Large tumor suppressor (Lats)/ Warts (Wts) protein kinase as a key component of a pathway that controls the coordination between cell proliferation and apoptosis. Here we describe growth inhibitory functions for a Mob superfamily protein, termed Mats (Mob as tumor suppressor), in Drosophila. Loss of Mats function results in increased cell proliferation, defective apoptosis, and induction of tissue overgrowth. We show that mats and wts function in a common pathway. Mats physically associates with Wts to stimulate the catalytic activity of the Wts kinase. A human Mats ortholog (Mats1) can rescue the lethality associated with loss of Mats function in Drosophila. As Mats1 is mutated in human tumors, Mats-mediated growth inhibition and tumor suppression is likely conserved in humans.	Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, Intercoll Program Genet, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Integrat Biosci Grad Degree Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lai, ZC (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	zcl1@psu.edu			NIGMS NIH HHS [GM20293] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020293] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen B, 1998, GENETICS, V149, P157; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Komarnitsky SI, 1998, MOL CELL BIOL, V18, P2100, DOI 10.1128/MCB.18.4.2100; Lee LA, 2003, ANNU REV GENET, V37, P545, DOI 10.1146/annurev.genet.37.110801.143149; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li YY, 2003, COMMUN PUR APPL ANAL, V2, P1; Luca FC, 1998, MOL BIOL CELL, V9, P29, DOI 10.1091/mbc.9.1.29; Macleod K, 2000, CURR OPIN GENET DEV, V10, P81, DOI 10.1016/S0959-437X(99)00041-6; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; Rothenberg ME, 2003, NATURE, V425, P469, DOI 10.1038/425469a; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stavridi ES, 2003, STRUCTURE, V11, P1163, DOI 10.1016/S0969-2126(03)00182-5; Stewart RA, 2003, ONCOGENE, V22, P6436, DOI 10.1038/sj.onc.1206820; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Wolff Tanya, 1993, P1277; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	47	431	458	1	50	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					675	685		10.1016/j.cell.2004.12.036	http://dx.doi.org/10.1016/j.cell.2004.12.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766530	Bronze			2022-12-01	WOS:000227771400013
J	Larson, G; Dobney, K; Albarella, U; Fang, MY; Matisoo-Smith, E; Robins, J; Lowden, S; Finlayson, H; Brand, T; Willerslev, E; Rowley-Conwy, P; Andersson, L; Cooper, A				Larson, G; Dobney, K; Albarella, U; Fang, MY; Matisoo-Smith, E; Robins, J; Lowden, S; Finlayson, H; Brand, T; Willerslev, E; Rowley-Conwy, P; Andersson, L; Cooper, A			Worldwide phylogeography of wild boar reveals multiple centers of pig domestication	SCIENCE			English	Article							MITOCHONDRIAL-DNA; GENETIC-EVIDENCE; ORIGINS; PHYLOGENIES; SULAWESI	Mitochondrial DNA (mtDNA) sequences from 686 wild and domestic pig specimens place the origin of wild boar in island Southeast Asia (ISEA), where they dispersed across Eurasia. Previous morphological and genetic evidence suggested pig domestication took place in a limited number of locations (principally the Near East and Far East). in contrast, new genetic data reveal multiple centers of domestication across Eurasia and that European, rather than Near Eastern, wild boar are the principal source of modern European domestic pigs.	Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Durham, Dept Archaeol, Durham DH1 3L, England; Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England; Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand; Jurox Pty Ltd, Rutherford, NSW 2320, Australia; Roslin Inst, Dept Genom & Bioinformat, Roslin EH25 9PS, Midlothian, Scotland; Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, DK-2100 Copenhagen O, Denmark	University of Oxford; Durham University; University of Sheffield; Uppsala University; Swedish University of Agricultural Sciences; University of Auckland; Massey University; University of Auckland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Copenhagen	Larson, G (corresponding author), Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	greger.larson@zoo.ox.ac.uk; alan.cooper@adelaide.edu.au	Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011; Cooper, Alan/E-8171-2012	Willerslev, Eske/0000-0002-7081-6748; Cooper, Alan/0000-0002-7738-7851; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Dobney, Keith/0000-0001-9036-4681				APOLLONIO M, 1988, B ZOOL, V3, P213; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benecke N, 1993, EXPLOITATION ANIMAUX, P233; Bokonyi S., 1974, HIST DOMESTIC MAMMAL; BULMER S, 1975, J SOC OCEANISTES, V31, P7, DOI DOI 10.3406/JSO.1975.2688; EPSTEIN J, 1984, EVOLUTION DOMESTICAT, P145; Ervynck A, 2002, PALEORIENT, V27, P47, DOI DOI 10.3406/paleo.2001.4731; Evans BJ, 1999, BIOL J LINN SOC, V66, P539, DOI 10.1111/j.1095-8312.1999.tb01925.x; Giuffra E, 2000, GENETICS, V154, P1785; Golson J., 1976, J SOC OCEAN, V36, P294; GROVES CP, 1981, TECH B DEP PREHISTOR, V3; Heise-Pavlov PM, 2003, WILDLIFE BIOL, V9, P21, DOI 10.2981/wlb.2003.060; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Jing Y, 2002, ANTIQUITY, V76, P724, DOI 10.1017/S0003598X00091171; KAKOI H, 1994, Z ZOOL SYST EVOL, V32, P1; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kirch P.V., 2017, ROAD WINDS ARCHAEOLO; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Peters Joris, 2000, Paleorient, V25, P27; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowley-Conwy P., 2003, WIDENING HARVEST NEO, P99; Ruedi M, 1996, BIOL J LINN SOC, V58, P197, DOI 10.1111/j.1095-8312.1996.tb01431.x; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; VIGNE JD, 1988, GALLIA PREHISTORIE S, V26	27	576	623	6	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1618	1621		10.1126/science.1106927	http://dx.doi.org/10.1126/science.1106927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761152				2022-12-01	WOS:000227622400046
J	Revankar, CM; Cimino, DF; Sklar, LA; Arterburn, JB; Prossnitz, ER				Revankar, CM; Cimino, DF; Sklar, LA; Arterburn, JB; Prossnitz, ER			A transmembrane intracellular estrogen receptor mediates rapid cell signaling	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; PLASMA-MEMBRANE; ACTIVATION; TRANSACTIVATION; MECHANISMS; GPR30	The steroid hormone estrogen regulates many functionally unrelated processes in numerous tissues. Although it is traditionally thought to control transcriptional activation through the classical nuclear estrogen receptors, it also initiates many rapid nongenomic signaling events. W. found that of all G protein-coupled receptors characterized to date, GPR30 is uniquely localized to the endoplasmic reticulum, where it specifically bind.,. estrogen and fluorescent estrogen derivatives. Activating GPR30 by estrogen resulted in intracellular calcium mobilization and synthesis of phosphatidylinositol 3,4,5-trisphosphate in the nucleus. Thus, GPR30 represents an intracellular transmembrane estrogen receptor that may contribute to normal estrogen physiology as well as pathophysiology.	Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; New Mexico State University	Prossnitz, ER (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA.	eprossnitz@salud.unm.edu	Prossnitz, Eric/I-4599-2019; Prossnitz, Eric R./B-4543-2008	Prossnitz, Eric/0000-0001-9190-8302; 	NATIONAL CANCER INSTITUTE [R24CA088339] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014668, P20RR011830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI036357, R01AI036357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R24EB000264] Funding Source: NIH RePORTER; NCI NIH HHS [R24 CA88339] Funding Source: Medline; NCRR NIH HHS [P20 RR11830, 1 S10 RR14668] Funding Source: Medline; NIAID NIH HHS [AI36357] Funding Source: Medline; NIBIB NIH HHS [EB00264] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Arterburn JB, 2000, TETRAHEDRON LETT, V41, P839, DOI 10.1016/S0040-4039(99)02205-4; Balla Tamas, 2002, Sci STKE, V2002, ppl3, DOI 10.1126/stke.2002.125.pl3; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Govind AP, 2003, MOL CELL BIOCHEM, V253, P233, DOI 10.1023/A:1026068017309; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Nicholson KM, 2003, BREAST CANCER RES TR, V81, P117, DOI 10.1023/A:1025765215765; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Prossnitz ER, 2004, LIFE SCI, V75, P893, DOI 10.1016/j.lfs.2004.04.003; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Shao WL, 2004, BREAST CANCER RES, V6, P39, DOI 10.1186/bcr742; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tsai EM, 2001, CANCER RES, V61, P8390; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	22	1731	1846	7	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1625	1630		10.1126/science.1106943	http://dx.doi.org/10.1126/science.1106943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15705806				2022-12-01	WOS:000227622400048
J	Levy, B; Gibot, S; Franck, P; Cravoisy, A; Bollaert, PE				Levy, B; Gibot, S; Franck, P; Cravoisy, A; Bollaert, PE			Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study	LANCET			English	Article							SKELETAL-MUSCLE; AEROBIC CONDITIONS; LACTIC-ACIDOSIS; HYPOXIA; TISSUE; MICRODIALYSIS; METABOLISM; GLYCOLYSIS; TRANSPORT; PERFUSION	Background Hyperlactataemia during septic shock is often viewed as evidence of tissue hypoxia. However this blood, disorder is not usually correlated with indicators of perfusion or diminished with increased oxygen delivery. Muscles can generate lactate under aerobic conditions in a process linking glycolytic ATP supply to stimulation of Na+K+ ATPase. Using in-vivo microdialysis, we tested whether inhibition of Na+K+ ATPase can reduce muscle lactate. Methods In 14 patients with septic shock, two microdialysis probes were inserted into the quadriceps muscles and infused with lactate-free Ringer's solution in the absence or presence of 10(-7) mol/L ouabain, a specific inhibitor of Na+K+ ATPase. We measured lactate and pyruvate concentrations in both the dialysate fluid and arterial blood samples. Findings All patients had increased blood lactate concentrations (mean 4.0 mmol/L; SD 2.1). Lactate and pyruvate concentrations were consistently higher in muscle than in arteries during the study period, with a mean positive gradient of 1.98 mmol/L (SD 0.2; p = 0.001) and 230 mumol/L (30; p = 0.01), respectively. Ouabain infusion stopped over production of muscle lactate and pyruvate (p = 0.0001). Muscle lactate to pyruvate ratios remained unchanged during ouabain infusion with no differences between blood and muscle. Interpretation Skeletal muscle could be a leading source of lactate formation as a result of exaggerated aerobic glycolysis through Na+K+ ATPase stimulation during septic shock. Lactate clearance as an end-point of resuscitation could therefore prove useful. Relevance to clinical practice In patients with septic shock, a high lactate concentration should be interpreted as a marker of disease, portending a bad outcome. The presence of hyperlactataemia in resuscitated septic patients should not be taken as proof of oxygen debt needing increases in systemic or regional oxygen transport to supranormal values. Lactate, instead of being regarded only as a marker of hypoxia, might be an important metabolic signal.	Hop Cent, Serv Reanimat Med, F-54035 Nancy, France; Hop Cent, Biochim Lab, F-54035 Nancy, France	CHU de Nancy; CHU de Nancy	Levy, B (corresponding author), Hop Cent, Serv Reanimat Med, F-54035 Nancy, France.	b.levy@chu-nancy.fr						Barron JT, 2000, AM J PHYSIOL-HEART C, V279, pH2872, DOI 10.1152/ajpheart.2000.279.6.H2872; Binnert C, 2002, CURR OPIN CLIN NUTR, V5, P185, DOI 10.1097/00075197-200203000-00011; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BROOKS GA, 1986, FASEB J, V45, P2924; Bundgaard H, 2003, AM J PHYSIOL-HEART C, V284, pH1028, DOI 10.1152/ajpheart.00639.2002; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; CLAUSEN T, 1980, BRIT J PHARMACOL, V68, P749, DOI 10.1111/j.1476-5381.1980.tb10868.x; CLUTTER WE, 1980, J CLIN INVEST, V66, P94, DOI 10.1172/JCI109840; DANIEL AM, 1978, SURG GYNECOL OBSTET, V147, P697; DIETZ MR, 1980, J BIOL CHEM, V255, P2301; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Gore DC, 1996, ANN SURG, V224, P97, DOI 10.1097/00000658-199607000-00015; GREEVER CJ, 1959, CIRC RES, V7, P192, DOI 10.1161/01.RES.7.2.192; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Henriksson J, 1999, P NUTR SOC, V58, P919, DOI 10.1017/S0029665199001226; HOTCHKISS RS, 1992, JAMA-J AM MED ASSOC, V267, P1503, DOI 10.1001/jama.267.11.1503; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; James JH, 1996, J CLIN INVEST, V98, P2388, DOI 10.1172/JCI119052; Kemper WF, 2001, P NATL ACAD SCI USA, V98, P723, DOI 10.1073/pnas.011387598; Kline JA, 2000, SHOCK, V14, P215, DOI 10.1097/00024382-200014020-00023; Leverve XM, 2002, CRIT CARE, V6, P284; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Luchette FA, 2002, J TRAUMA, V52, P415, DOI 10.1097/00005373-200203000-00001; MAZZEO RS, 1989, J APPL PHYSIOL, V67, P1319, DOI 10.1152/jappl.1989.67.4.1319; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; PISON CM, 1995, AM J PHYSIOL-ENDOC M, V268, pE965, DOI 10.1152/ajpendo.1995.268.5.E965; Rosdahl H, 1997, ACTA PHYSIOL SCAND, V159, P261, DOI 10.1046/j.1365-201X.1997.123358000.x; Sair M, 2001, CRIT CARE MED, V29, P1343, DOI 10.1097/00003246-200107000-00008; Schurr A, 1997, J NEUROCHEM, V69, P423	30	308	324	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					871	875		10.1016/S0140-6736(05)71045-X	http://dx.doi.org/10.1016/S0140-6736(05)71045-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752531				2022-12-01	WOS:000227444600029
J	Kinchen, JM; Cabello, J; Klingele, D; Wong, K; Feichtinger, R; Schnabel, H; Schnabel, R; Hengartner, MO				Kinchen, JM; Cabello, J; Klingele, D; Wong, K; Feichtinger, R; Schnabel, H; Schnabel, R; Hengartner, MO			Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C-elegans	NATURE			English	Article							PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; APOPTOTIC CELLS; CRKII/DOCK180/RAC PATHWAY; PROTEIN CED-6; ENGULFMENT; PHAGOCYTOSIS; MIGRATION; CLEARANCE; GENETICS	The removal of apoptotic cells is essential for the physiological well being of the organism(1-3). In Caenorhabditis elegans, two conserved, partially redundant genetic pathways regulate this process(4-6). In the first pathway, the proteins CED-2, CED-5 and CED-12 ( mammalian homologues CrkII, Dock180 and ELMO, respectively) function to activate CED-10 (Rac1)(7,8). In the second group, the candidate receptor CED-1 (CD91/LRP/SREC) probably recognizes an unknown ligand on the apoptotic cell(9) and signals via its cytoplasmic tail to the adaptor protein CED-6 (hCED-6/GULP)(10,11), whereas CED-7 (ABCA1) is thought to play a role in membrane dynamics(12). Molecular understanding of how the second pathway promotes engulfment of the apoptotic cell is lacking. Here, we show that CED-1, CED-6 and CED-7 are required for actin reorganization around the apoptotic cell corpse, and that CED-1 and CED-6 colocalize with each other and with actin around the dead cell. Furthermore, we find that the CED-10( Rac) GTPase acts genetically downstream of these proteins to mediate corpse removal, functionally linking the two engulfment pathways and identifying the CED-1, - 6 and - 7 signalling module as upstream regulators of Rac activation.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11743 USA; TU Braunschweig, Inst Genet, D-38106 Braunschweig, Germany	University of Zurich; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Braunschweig University of Technology	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Michael.Hengartner@molbio.unizh.ch	Cabello, Juan/AAM-1683-2020; Hengartner, Michael O/E-6235-2011; Hengartner, Michael O/A-7058-2008; Kinchen, Jason/ABC-5663-2021	Cabello, Juan/0000-0002-3835-0116; Kinchen, Jason/0000-0001-8430-2265; Hengartner, Michael/0000-0002-7584-596X				Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; BRENNER S, 1974, GENETICS, V77, P71; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Conradt B, 2001, DEV CELL, V1, P445, DOI 10.1016/S1534-5807(01)00065-X; ELLIS RE, 1991, GENETICS, V129, P79; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hamon Y, 2002, BBA-MOL CELL BIOL L, V1585, P64, DOI 10.1016/S1388-1981(02)00325-6; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Harris TW, 2003, NUCLEIC ACIDS RES, V31, P133, DOI 10.1093/nar/gkg053; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI13992; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Liu QA, 1999, CURR BIOL, V9, P1347, DOI 10.1016/S0960-9822(00)80061-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Praitis V, 2001, GENETICS, V157, P1217; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; STROME S, 1986, J CELL BIOL, V103, P2241, DOI 10.1083/jcb.103.6.2241; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Wu YC, 2000, GENE DEV, V14, P536; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	30	206	228	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					93	99		10.1038/nature03263	http://dx.doi.org/10.1038/nature03263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744306				2022-12-01	WOS:000227334600050
J	Schippers, A; Neretin, LN; Kallmeyer, J; Ferdelman, TG; Cragg, BA; Parkes, RJ; Jorgensen, BB				Schippers, A; Neretin, LN; Kallmeyer, J; Ferdelman, TG; Cragg, BA; Parkes, RJ; Jorgensen, BB			Prokaryotic cells of the deep sub-seafloor biosphere identified as living bacteria	NATURE			English	Article							IN-SITU HYBRIDIZATION; CATALYZED REPORTER DEPOSITION; SUBSEAFLOOR SEDIMENTS; MARINE-BACTERIA; METHANE HYDRATE; COPY NUMBER; COMMUNITY; OCEAN; QUANTIFICATION; DISSOCIATION	Chemical analyses of the pore waters from hundreds of deep ocean sediment cores have over decades provided evidence for ongoing processes that require biological catalysis by prokaryotes(1-3). This sub-seafloor activity of microorganisms may influence the surface Earth by changing the chemistry of the ocean and by triggering the emission of methane, with consequences for the marine carbon cycle and even the global climate(4-6). Despite the fact that only about 1% of the total marine primary production of organic carbon is available for deep-sea microorganisms(7,8), subseafloor sediments harbour over half of all prokaryotic cells on Earth(7). This estimation has been calculated from numerous microscopic cell counts in sediment cores of the Ocean Drilling Program(1,9). Because these counts cannot differentiate between dead and alive cells, the population size of living microorganisms is unknown(10,11). Here, using ribosomal RNA as a target for the technique known as catalysed reporter deposition-fluorescence in situ hybridization (CARD-FISH), we provide direct quantification of live cells as defined by the presence of ribosomes. We show that a large fraction of the sub-seafloor prokaryotes is alive, even in very old (16 million yr) and deep (>400 m) sediments. All detectable living cells belong to the Bacteria and have turnover times of 0.25-22 yr, comparable to surface sediments.	Fed Inst Geosci & Nat Resources, Sect Geomicrobiol, D-30655 Hannover, Germany; Max Planck Inst Marine Microbiol, Dept Biogeochem, D-28359 Bremen, Germany; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Univ Wales Coll Cardiff, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, S Glam, Wales	Max Planck Society; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Cardiff University	Schippers, A (corresponding author), Fed Inst Geosci & Nat Resources, Sect Geomicrobiol, Stilleweg 2, D-30655 Hannover, Germany.	a.schippers@bgr.de	Ferdelman, Timothy G/A-3758-2013; Jorgensen, Bo B/C-2214-2013; Parkes, Ronald/B-1731-2010; Schippers, Axel/AAB-3919-2021; Cragg, Barry/D-2690-2009; Kallmeyer, Jens/I-3554-2012; Kallmeyer, Jens/AAF-6906-2020	Ferdelman, Timothy G/0000-0002-9701-3793; Jorgensen, Bo B/0000-0001-9398-8027; Parkes, Ronald/0000-0001-9402-5943; Schippers, Axel/0000-0002-4469-9883; Kallmeyer, Jens/0000-0002-6440-1140; Kallmeyer, Jens/0000-0002-6440-1140				Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S. L., 2003, CONTROLS MICROBIAL C; DAVIS BD, 1986, J BACTERIOL, V166, P439, DOI 10.1128/jb.166.2.439-445.1986; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; HEDGES J, 1993, MAR CHEM, V39, P67; HEIJNEN JJ, 1992, BIOTECHNOL BIOENG, V39, P833, DOI 10.1002/bit.260390806; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Holland H. D., 1984, CHEM EVOLUTION ATMOS; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; KEPNER RL, 1994, MICROBIOL REV, V58, P603, DOI 10.1128/MMBR.58.4.603-615.1994; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Loferer-Krossbacher M, 1999, ARCH HYDROBIOL SPEC, V54, P185; Morita RY, 1997, BACTERIA OLIGOTROPHI; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Ravenschlag K, 2001, APPL ENVIRON MICROB, V67, P387, DOI 10.1128/AEM.67.1.387-395.2001; Sekar R, 2003, APPL ENVIRON MICROB, V69, P2928, DOI 10.1128/AEm.69.5.2928-2935.2003; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Webster G, 2003, J MICROBIOL METH, V55, P155, DOI 10.1016/S0167-7012(03)00140-4; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zubkov MV, 2001, APPL ENVIRON MICROB, V67, P5210, DOI 10.1128/AEM.67.11.5210-5218.2001	30	326	350	2	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					861	864		10.1038/nature03302	http://dx.doi.org/10.1038/nature03302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729341				2022-12-01	WOS:000227174600041
J	Claus, EB; Petruzella, S; Matloff, E; Carter, D				Claus, EB; Petruzella, S; Matloff, E; Carter, D			Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ONSET BREAST-CANCER; POPULATION-BASED SERIES; OVARIAN-CANCER; GERMLINE MUTATIONS; FAMILY-HISTORY; JEWISH WOMEN; CARRIER FREQUENCY; 185DELAG MUTATION; SEQUENCE-ANALYSIS; SINGLE-FAMILY	Context The distribution of BRCA1 and BRCA2 mutations in women diagnosed with noninvasive breast carcinoma is unknown. Objective To estimate the BRCA1 and BRCA2 mutation prevalence in women with ductal carcinoma in situ (DCIS), unselected for age, family history, or ethnicity. Design, Setting, and Participants The data were 369 DCIS cases diagnosed among female residents aged 20 to 79 years from the state of Connecticut between September 15,1994, and March 14, 1998. These women were participants in a large population-based case-control study of breast carcinoma in situ. Telephone interviews were used to collect risk factor information and blood or buccal specimens were collected for BRCA1 and BRCA2 mutation testing. Main Outcome Measures Prevalence of disease-associated mutations of BRCA1 and BRCA2 in women diagnosed with DCIS. Results Three (0.8%) and 9 (2.4%) of 369 DCIS cases had disease-associated mutations in BRCA1 or BRCA2, respectively. One woman had a mutation in both genes (BRCA1 W321X and BRCA2 3398del5). Carriers were significantly more likely than noncarriers to report a first-degree (mother, sister, or daughter) family history of breast cancer (odds ratio [OR], 3.7; 95% confidence interval [CI], 1.1 -12.4), as well as a personal history of ovarian cancer. In addition, carriers were more likely than noncarriers to be diagnosed at an early age (<50 years) (OR, 3.4; 95% Cl, 1.0-11.7), as well as to report at least 1 first-degree relative diagnosed with breast cancer before 50 years (OR, 10.6; 95% Cl, 3.0-37.0). Conclusions Ductal carcinoma in situ is a part of the breast/ovarian cancer syndromes defined by BRCA1 and BRCA2, with mutation rates similar to those found for invasive breast cancer. These findings suggest that patients with breast cancer with an appropriate personal or family history of breast and/or ovarian cancer should be screened and followed according to high-risk protocols, regardless of whether they are diagnosed with in situ or invasive breast cancer.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Yale Comprehens Canc Ctr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Brigham & Womens Hosp, Dept Neurosurg, Boston, MA USA	Yale University; Yale University; Harvard University; Brigham & Women's Hospital	Claus, EB (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Yale Comprehens Canc Ctr, 60 Coll St,POB 208034, New Haven, CT 06520 USA.	elizabeth.claus@yale.edu			NCI NIH HHS [R01-CA81393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adem C, 2003, CANCER, V97, P1, DOI 10.1002/cncr.11048; Anton-Culver H, 2000, EUR J CANCER, V36, P1200, DOI 10.1016/S0959-8049(00)00110-6; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Armes JE, 1998, CANCER-AM CANCER SOC, V83, P2335, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.3.CO;2-E; Armes JE, 2002, PATHOLOGY, V34, P309, DOI 10.1080/00313020220147113; Caldes T, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.8.e44; Claus EB, 2003, BREAST, V12, P451, DOI 10.1016/S0960-9776(03)00152-8; Claus EB, 2003, BREAST CANCER RES TR, V81, P129, DOI 10.1023/A:1025728524310; Claus EB, 2003, BREAST CANCER RES TR, V78, P7, DOI 10.1023/A:1022147920262; CLAUS EB, 1993, CANCER, V71, P147, DOI 10.1002/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO;2-V; Claus EB, 2001, J NATL CANCER I, V93, P1811, DOI 10.1093/jnci/93.23.1811; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FORD D, 1995, AM J HUM GENET, V57, P1457; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Friedman E, 1998, AM J HUM GENET, V63, P1224, DOI 10.1086/302040; Ganguly A, 2001, AM J MED GENET, V101, P146, DOI 10.1002/1096-8628(20010615)101:2<146::AID-AJMG1342>3.0.CO;2-E; Gershoni-Baruch R, 1997, EUR J CANCER, V33, P2283, DOI 10.1016/S0959-8049(97)00223-2; Hoogerbrugge N, 2003, J CLIN ONCOL, V21, P41, DOI 10.1200/JCO.2003.02.137; Jacquemier J, 1996, LANCET, V348, P1098, DOI 10.1016/S0140-6736(05)64441-8; Johannesdottir G, 1996, CANCER RES, V56, P3663; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Krainer M, 1997, NEW ENGL J MED, V336, P1416, DOI 10.1056/NEJM199705153362003; Lakhani SR, 1997, LANCET, V349, P1505; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; Liede A, 1998, AM J HUM GENET, V62, P1543, DOI 10.1086/301889; Loader S, 1998, GENET TEST, V2, P75, DOI 10.1089/gte.1998.2.75; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; Malone KE, 1998, JAMA-J AM MED ASSOC, V279, P922, DOI 10.1001/jama.279.12.922; Martin AM, 2001, J CLIN ONCOL, V19, P2247, DOI 10.1200/JCO.2001.19.8.2247; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Ramus SJ, 1997, NAT GENET, V15, P14, DOI 10.1038/ng0197-14; Randall TC, 1998, GYNECOL ONCOL, V70, P432, DOI 10.1006/gyno.1998.5081; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; StoppaLyonnet D, 1996, AM J HUM GENET, V59, P479; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Sun CC, 1996, LANCET, V348, P408, DOI 10.1016/S0140-6736(05)65027-1; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Tesoriero A, 1999, AM J HUM GENET, V65, P567, DOI 10.1086/302503; Thorlacius S, 1997, AM J HUM GENET, V60, P1079; Tsongalis GJ, 1998, ARCH PATHOL LAB MED, V122, P548; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7	51	65	66	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2005	293	8					964	969		10.1001/jama.293.8.964	http://dx.doi.org/10.1001/jama.293.8.964			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899LR	15728167	Bronze			2022-12-01	WOS:000227146400018
J	Wang, YX; Klijn, JGM; Zhang, Y; Sieuwerts, A; Look, MP; Yang, F; Talantov, D; Timmermans, M; Meijer-van Gelder, ME; Yu, J; Jatkoe, T; Berns, EMJJ; Atkins, D; Foekens, JA				Wang, YX; Klijn, JGM; Zhang, Y; Sieuwerts, A; Look, MP; Yang, F; Talantov, D; Timmermans, M; Meijer-van Gelder, ME; Yu, J; Jatkoe, T; Berns, EMJJ; Atkins, D; Foekens, JA			Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer	LANCET			English	Article							PROGNOSTIC VALUE; PROFILES; RECEPTORS; SIGNATURE; CONSENSUS; SURVIVAL; ESTROGEN; THERAPY	Background Genome-wide measures of gene expression can identify patterns of gene activity that subclassify tumours and might provide a better means than is currently available for individual risk assessment in patients with lymph-node-negative breast cancer. Methods We analysed, with Affymetrix Human U133a GeneChips, the expression of 22 000 transcripts from total RNA of frozen tumour samples from 286 lymph-node-negative patients who had not received adjuvant systemic treatment. Findings In a training set of 115 tumours, we identified a 76-gene signature consisting of 60 genes for patients positive for oestrogen receptors (ER) and 16 genes for ER-negative patients. This signature showed 93% sensitivity and 48% specificity in a subsequent independent testing set of 171 lymph-node-negative patients. The gene profile was highly informative in identifying patients who developed distant metastases within 5 years (hazard ratio 5.67 [95% CI 2.59-12.4]), even when corrected for traditional prognostic factors in multivariate analysis (5.55 [2.46-12.5]). The 76-gene profile also represented a strong prognostic factor for the development of metastasis in the subgroups of 84 premenopausal patients (9.60 [2.28-40.5]), 87 postmenopausal patients (4.04 [1.57-10.4]), and 79 patients with tumours of 10-20 mm (14.1 [3.34-59.2]), a group of patients for whom prediction of prognosis is especially difficult. Interpretation The identified signature provides a powerful tool for identification of patients at high risk of distant recurrence. The ability to identify patients who have a favourable prognosis could, after independent confirmation, allow clinicians to avoid adjuvant systemic therapy or to choose less aggressive therapeutic options.	Veridex LLC, San Diego, CA USA; Veridex LLC, Warren, NY USA; Erasmus MC Daniel den Hoed, Dept Med Oncol, Rotterdam, Netherlands	Johnson & Johnson; Johnson & Johnson USA; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Foekens, JA (corresponding author), Erasmus MC, Josephine Nefkens Inst, Rm BE-426,Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	j.foekens@erasmusmc.nl	li, jie/A-3133-2011					ABE O, 1995, NEW ENGL J MED, V333, P1444; Abe O, 1998, LANCET, V352, P930; Ahr A, 2002, LANCET, V359, P131, DOI 10.1016/S0140-6736(02)07337-3; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Clarke M, 1998, LANCET, V351, P1451; EFRON B, 1981, J AM STAT ASSOC, V76, P312, DOI 10.2307/2287832; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; FOEKENS JA, 1989, CANCER RES, V49, P5823; FOEKENS JA, 1989, CANCER RES, V49, P7002; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Gruvberger S, 2001, CANCER RES, V61, P5979; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Herrera-Gayol A, 1999, EXP MOL PATHOL, V66, P149, DOI 10.1006/exmp.1999.2251; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr433; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Woelfle U, 2003, CANCER RES, V63, P5679	30	2127	2265	3	133	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2005	365	9460					671	679		10.1016/S0140-6736(05)17947-1	http://dx.doi.org/10.1016/S0140-6736(05)17947-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15721472				2022-12-01	WOS:000227096800024
J	Collins, S; Ruina, A; Tedrake, R; Wisse, M				Collins, S; Ruina, A; Tedrake, R; Wisse, M			Efficient bipedal robots based on passive-dynamic walkers	SCIENCE			English	Article							WALKING; REINFORCEMENT; LOCOMOTION	Passive-dynamic walkers are simple mechanical devices, composed of solid parts connected by joints, that walk stably down a slope. They have no motors or controllers, yet can have remarkably humanlike motions. This suggests that these machines are useful models of human locomotion; however, they cannot walk on level. ground. Here we present three robots based on passive-dynamics, with small active power sources substituted for gravity, which can walk on level ground. These robots use less control and less energy than other powered robots, yet walk more naturally, further suggesting the importance of passive-dynamics in human locomotion.	Cornell Univ, Ithaca, NY 14853 USA; Univ Michigan, Ann Arbor, MI 48104 USA; MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; Delft Univ Technol, NL-2628 CD Delft, Netherlands	Cornell University; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Delft University of Technology	Ruina, A (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	ruina@cornell.edu	Ruina, Andy L/A-8725-2018	Ruina, Andy L/0000-0001-5493-6048; Collins, Steve/0000-0002-3997-3374				Atzler E, 1927, PFLUG ARCH GES PHYS, V215, P291, DOI 10.1007/BF01731318; Benbrahim H, 1997, ROBOT AUTON SYST, V22, P283, DOI 10.1016/S0921-8890(97)00043-2; Chevallereau C, 2003, IEEE CONTR SYST MAG, V23, P57, DOI 10.1109/MCS.2003.1234651; Collins SH, 2001, INT J ROBOT RES, V20, P607, DOI 10.1177/02783640122067561; Donelan JM, 2002, J EXP BIOL, V205, P3717; Garcia M, 2000, DYNAM STABIL SYST, V15, P75, DOI 10.1080/713603737; Kato I., 1973, P CISM IFTOMM S THEO, p[12, 12]; KUN A, 1996, P IEEE INT C ROB AUT; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; MCGEER T, 1993, J THEOR BIOL, V163, P277, DOI 10.1006/jtbi.1993.1121; MOLEN NH, 1972, P K NED AKAD C BIOL, V75, P305; Pfeiffer F, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P3129, DOI 10.1109/ROBOT.2002.1013708; RUINA A, IN PRESS J THEOR BIO; Sakagami Y, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2478, DOI 10.1109/IRDS.2002.1041641; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; TEDRAKE R, 2004, P IEEE INT C ROB AUT; Tedrake R., 2004, P IEEE RSJ INT C INT; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; WILSON JE, Patent No. 2140275; Winter DA., 2009, BIOMECHANICS MOTOR C; WISSE M, IN PRESS IEEE T ROBO; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; [No title captured]; [No title captured]	25	1249	1326	12	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1082	1085		10.1126/science.1107799	http://dx.doi.org/10.1126/science.1107799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718465				2022-12-01	WOS:000227197300040
J	Rouxel, OJ; Bekker, A; Edwards, KJ				Rouxel, OJ; Bekker, A; Edwards, KJ			Iron isotope constraints on the Archean and Paleoproterozoic ocean redox state	SCIENCE			English	Article							FE ISOTOPE; ATMOSPHERIC OXYGEN; REACTIVE IRON; BLACK-SEA; FRACTIONATION; SEDIMENTS; EARTH; CHEMISTRY; SULFUR; ADSORPTION	The response of the ocean redox state to the rise of atmospheric oxygen about 2.3 billion years ago (Ga) is a matter of controversy. Here we provide iron isotope evidence that the change in the ocean iron cycle occurred at the same time as the change in the atmospheric redox state. Variable and negative iron isotope values in pyrites older than about 2.3 Ga suggest that an iron-rich global ocean was strongly affected by the deposition of iron oxides. Between 2.3 and 1.8 Ga, positive iron isotope values of pyrite likely reflect an increase in the precipitation of iron sulfides relative to iron oxides in a redox stratified ocean.	Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Geomicrobiol Grp, Woods Hole, MA 02543 USA; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA	Woods Hole Oceanographic Institution; Carnegie Institution for Science	Rouxel, OJ (corresponding author), Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Geomicrobiol Grp, Mail Stop 8, Woods Hole, MA 02543 USA.	orouxel@whoi.edu	Rouxel, Olivier J/F-3954-2014	Rouxel, Olivier J/0000-0002-1431-222X; Bekker, Andrey/0000-0002-1154-0585				Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anderson TF, 2004, AM J SCI, V304, P203, DOI 10.2475/ajs.304.3.203; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Beard BL, 2004, REV MINERAL GEOCHEM, V55, P319, DOI 10.2138/gsrmg.55.1.319; Beard BL, 2003, GEOLOGY, V31, P629, DOI 10.1130/0091-7613(2003)031<0629:IICOFC>2.0.CO;2; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BEKKER A, IN PRESS PRECAMBRIAN; BEUKES NJ, 1990, ECON GEOL BULL SOC, V85, P663, DOI 10.2113/gsecongeo.85.4.663; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; BRATERMAN PS, 1983, NATURE, V303, P163, DOI 10.1038/303163a0; Bullen TD, 2001, GEOLOGY, V29, P699, DOI 10.1130/0091-7613(2001)029<0699:DOSAII>2.0.CO;2; Butler IB, 2003, GEOCHIM COSMOCHIM AC, V67, pA51; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Croal LR, 2004, GEOCHIM COSMOCHIM AC, V68, P1227, DOI 10.1016/j.gca.2003.09.011; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Holland H. D., 1984, CHEM EVOLUTION ATMOS; Icopini GA, 2004, GEOLOGY, V32, P205, DOI 10.1130/G20184.1; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Johnson CM, 2003, CONTRIB MINERAL PETR, V144, P523, DOI 10.1007/s00410-002-0418-x; Johnson CM, 2004, REV MINERAL GEOCHEM, V55, P359, DOI 10.2138/gsrmg.55.1.359; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; Levasseur S, 2004, EARTH PLANET SC LETT, V224, P91, DOI 10.1016/j.epsl.2004.05.010; Matthews A, 2004, GEOCHIM COSMOCHIM AC, V68, P3107, DOI 10.1016/j.gca.2004.01.019; Polyakov VB, 2000, GEOCHIM COSMOCHIM AC, V64, P849, DOI 10.1016/S0016-7037(99)00329-4; Rouxel O, 2004, GEOCHIM COSMOCHIM AC, V68, P2295, DOI 10.1016/j.gca.2003.11.029; Rouxel O, 2003, CHEM GEOL, V202, P155, DOI 10.1016/j.chemgeo.2003.08.011; SEVERMANN S, 2003, EOS S, V84; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Vargas M, 1998, NATURE, V395, P65, DOI 10.1038/25720; Welch SA, 2003, GEOCHIM COSMOCHIM AC, V67, P4231, DOI 10.1016/S0016-7037(03)00266-7; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; Wijsman JWM, 2001, MAR CHEM, V74, P261, DOI 10.1016/S0304-4203(01)00019-6	34	376	414	2	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2005	307	5712					1088	1091		10.1126/science.1105692	http://dx.doi.org/10.1126/science.1105692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718467	Green Published			2022-12-01	WOS:000227197300042
J	Conboy, IM; Conboy, MJ; Wagers, AJ; Girma, ER; Weissman, IL; Rando, TA				Conboy, IM; Conboy, MJ; Wagers, AJ; Girma, ER; Weissman, IL; Rando, TA			Rejuvenation of aged progenitor cells by exposure to a young systemic environment	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE; SATELLITE CELLS; C/EBP-ALPHA; OLD RATS; HETEROGENEITY; REGENERATION; PLASTICITY; PARABIOSIS; EXPRESSION	The decline of tissue regenerative potential is a hallmark of ageing and may be due to age-related changes in tissue-specific stem cells(1-5). A decline in skeletal muscle stem cell ( satellite cell) activity due to a loss of Notch signalling results in impaired regeneration of aged muscle(1,6). The decline in hepatic progenitor cell proliferation owing to the formation of a complex involving cEBP-alpha and the chromatin remodelling factor brahma (Brm) inhibits the regenerative capacity of aged liver(7). To examine the influence of systemic factors on aged progenitor cells from these tissues, we established parabiotic pairings ( that is, a shared circulatory system) between young and old mice (heterochronic parabioses), exposing old mice to factors present in young serum. Notably, heterochronic parabiosis restored the activation of Notch signalling as well as the proliferation and regenerative capacity of aged satellite cells. The exposure of satellite cells from old mice to young serum enhanced the expression of the Notch ligand ( Delta), increased Notch activation, and enhanced proliferation in vitro. Furthermore, heterochronic parabiosis increased aged hepatocyte proliferation and restored the cEBP-alpha complex to levels seen in young animals. These results suggest that the age-related decline of progenitor cell activity can be modulated by systemic factors that change with age.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	rando@stanford.edu	Ladoux, Benoit/A-9879-2013	Rando, Thomas/0000-0001-5843-8564				Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Carlson BM, 2001, J GERONTOL A-BIOL, V56, pB224, DOI 10.1093/gerona/56.5.B224; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; FINERTY JC, 1952, PHYSIOL REV, V32, P277, DOI 10.1152/physrev.1952.32.3.277; FULLER J, 2002, SCI AGING KNOWLEDGE, pE11; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Kuhn HG, 1996, J NEUROSCI, V16, P2027; MCCAY CM, 1957, GERONTOLOGY, V1, P7, DOI 10.1159/000210677; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Partridge TA, 2002, GENE THER, V9, P752, DOI 10.1038/sj.gt.3301764; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SIDORENKO AV, 1986, MECH AGEING DEV, V36, P41, DOI 10.1016/0047-6374(86)90137-5; SIGAL SH, 1992, AM J PHYSIOL, V263, P139; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; TAUCHI H, 1977, MECH AGEING DEV, V6, P333, DOI 10.1016/0047-6374(77)90034-3; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	26	1530	1622	11	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					760	764		10.1038/nature03260	http://dx.doi.org/10.1038/nature03260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716955				2022-12-01	WOS:000227039200043
J	Schumacher, B; Hanazawa, M; Lee, MH; Nayak, S; Volkmann, K; Hofmann, R; Hengartner, M; Schedl, T; Gartner, A				Schumacher, B; Hanazawa, M; Lee, MH; Nayak, S; Volkmann, K; Hofmann, R; Hengartner, M; Schedl, T; Gartner, A			Translational repression of C-elegans p53 by GLD-1 regulates DNA damage-induced apoptosis	CELL			English	Article							MESSENGER-RNA TARGETS; PROGRAMMED CELL-DEATH; TUMOR-SUPPRESSOR GENE; CAENORHABDITIS-ELEGANS; MEIOTIC RECOMBINATION; BINDING PROTEIN; T-REGION; CHECKPOINT; GERMLINE; ENCODES	p53 is a tumor suppressor gene whose regulation is crucial to maintaining genome stability and for the apoptotic elimination of abnormal, potentially cancer-predisposing cells. C. elegans contains a primordial p53 gene, cep-1, that acts as a transcription factor necessary for DNA damage-induced apoptosis. In a genetic screen for negative regulators of CEP-1, we identified a mutation in GLD-1, a translational repressor implicated in multiple C. elegans germ cell fate decisions and related to mammalian Quaking proteins. CEP-1-dependent transcription of proapoptotic genes is upregulated in the gld-1(op236) mutant and an elevation of p53-mediated germ cell apoptosis in response to DNA damage is observed. Further, we demonstrate that GLD-1 mediates its repressive effect by directly binding to the 3'UTR of cep-1/p53 mRNA and repressing its translation. This study reveals that the regulation of cep-1/p53 translation influences DNA damage-induced apoptosis and demonstrates the physiological importance of this mechanism.	Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	Max Planck Society; Washington University (WUSTL); University of Zurich	Gartner, A (corresponding author), Univ Dundee, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland.	a.gartner@dundee.ac.uk	Hengartner, Michael O/E-6235-2011; Schumacher, Björn/I-4829-2013; Hengartner, Michael O/A-7058-2008	Schumacher, Björn/0000-0001-6097-5238; Hengartner, Michael/0000-0002-7584-596X; Gartner, Anton/0000-0003-4639-9902	NIGMS NIH HHS [R01 GM063310, R01 GM63310] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063310] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BODE VC, 1984, GENETICS, V108, P457; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; FRANCIS R, 1995, GENETICS, V139, P579; FRANCIS R, 1995, GENETICS, V139, P607; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fu LN, 1997, EMBO J, V16, P4117, DOI 10.1093/emboj/16.13.4117; Fu LN, 1999, ONCOGENE, V18, P6419, DOI 10.1038/sj.onc.1203064; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gartner Anton, 2004, Methods Mol Biol, V280, P257; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hasegawa M, 1998, RADIAT RES, V149, P263, DOI 10.2307/3579959; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hofmann ER, 2000, COLD SPRING HARB SYM, V65, P467, DOI 10.1101/sqb.2000.65.467; Hubbard EJA, 2000, DEV DYNAM, V218, P2, DOI 10.1002/(SICI)1097-0177(200005)218:1<2::AID-DVDY2>3.0.CO;2-W; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; Kelly WG, 1997, GENETICS, V146, P227; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; Lee MH, 2004, GENE DEV, V18, P1047, DOI 10.1101/gad.1188404; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Marin VA, 2003, DEVELOPMENT, V130, P2623, DOI 10.1242/dev.00486; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Mootz D, 2004, DEVELOPMENT, V131, P3263, DOI 10.1242/dev.01196; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; PIEROTTI M A, 1992, Current Opinion in Oncology, V4, P127, DOI 10.1097/00001622-199202000-00017; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Roemer K, 1999, BIOL CHEM, V380, P879, DOI 10.1515/BC.1999.108; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; SAMORAJS.T, 1970, J NEUROPATH EXP NEUR, V29, P507, DOI 10.1097/00005072-197010000-00001; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Schwartz D, 1999, CELL GROWTH DIFFER, V10, P665; Seydoux G, 2001, INT REV CYTOL, V203, P139; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; SHEDLOVSKY A, 1988, P NATL ACAD SCI USA, V85, P180, DOI 10.1073/pnas.85.1.180; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Sjoblom T, 1996, ONCOGENE, V12, P2499; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WOOD WB, 1996, NEMATODE CAENORHABDI; Xu L, 2001, GENETICS, V159, P1007; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zaffran S, 1997, DEVELOPMENT, V124, P2087; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	63	168	177	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					357	368		10.1016/j.cell.2004.12.009	http://dx.doi.org/10.1016/j.cell.2004.12.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707894	Bronze			2022-12-01	WOS:000227028900011
J	de Duve, C				de Duve, C			The onset of selection	NATURE			English	Editorial Material							UNIVERSAL ANCESTOR		ICP, B-1200 Brussels, Belgium; Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	de Duve, C (corresponding author), ICP, B-1200 Brussels, Belgium.							DEDUVE C, 2002, SINGULARITIES; DEDUVE C, 2002, LIFE EVOLVING; Doolittle WF, 2000, CURR OPIN STRUC BIOL, V10, P355, DOI 10.1016/S0959-440X(00)00096-8; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1981, NATURWISSENSCHAFTEN, V68, P282, DOI 10.1007/BF01047470; Freeland SJ, 2003, ORIGINS LIFE EVOL B, V33, P457, DOI 10.1023/A:1025771327614; Morris S. Conway, 2003, LIFES SOLUTION; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854	8	40	41	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2005	433	7026					581	582		10.1038/433581a	http://dx.doi.org/10.1038/433581a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703726				2022-12-01	WOS:000226862000022
J	Blom, JW; Doggen, CJM; Osanto, S; Rosendaal, FR				Blom, JW; Doggen, CJM; Osanto, S; Rosendaal, FR			Malignancies, prothrombotic mutations, and the risk of venous thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEEP-VEIN THROMBOSIS; ACTIVATED PROTEIN-C; THROMBOEMBOLIC DISEASE; CANCER; GENE; THROMBOPHILIA; LEIDEN; BLOOD	Context Venous thrombosis is a common complication inpatients with cancer, leading to additional morbidity and compromising quality of life. Objective To identify individuals with cancer with an increased thrombotic risk, evaluating different tumor sites, the presence of distant metastases, and carrier status of prothrombotic mutations. Design, Setting, and Patients A large population-based, case-control (Multiple Environmental and Genetic Assessment [MEGA] of risk factors for venous thrombosis) study of 3220 consecutive patients aged 18 to 70 years, with a first deep venous thrombosis of the leg or pulmonary embolism, between March 1, 1999, and May 31, 2002, at 6 anticoagulation clinics in the Netherlands, and separate 2131 control participants (partners of the patients) reported via a questionnaire on acquired risk factors forvenous thrombosis. Three months after discontinuation of the anticoagulant therapy, all patients and controls were interviewed, a blood sample was taken, and DNA was isolated to ascertain the factor V Leiden and prothrombin 20210A mutations. Main Outcome Measure Risk of venous thrombosis. Results The overall risk of venous thrombosis was increased 7-fold in patients with a malignancy (odds ratio [OR], 6.7; 95% confidence interval [Cl], 5.2-8.6) vs persons without malignancy. Patients with hematological malignancies had the highest risk of venous thrombosis, adjusted for age and sex (adjusted OR, 28.0; 95% Cl, 4.0-199.7), followed by lung cancer and gastrointestinal cancer. The risk of venous thrombosis was highest in the first few months after the diagnosis of malignancy (adjusted OR, 53.5; 95% Cl, 8.6-334.3). Patients with cancer with distant metastases had a higher risk vs patients without distant metastases (adjusted OR, 19.8; 95% Cl, 2.6-149.1). Carriers of the factor V Leiden mutation who also had cancer had a 12-fold increased risk vs individuals without cancer and factor V Leiden (adjusted OR, 12.1; 95% Cl, 1.6-88.1). Similar results were indirectly calculated for the prothrombin 20210A mutation in patients with cancer. Conclusions Patients with cancer have a highly increased risk of venous thrombosis especially in the first few months after diagnosis and in the presence of distant metastases. Carriers of the factor V Leiden and prothrombin 20210A mutations appear to have an even higher risk.	Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Oncol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Hemostasis & Thrombosis Res, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, C9-P,POB 9600, NL-2300 RC Leiden, Netherlands.	f.r.rosendaal@lumc.nl	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Buller H R, 2000, Ned Tijdschr Geneeskd, V144, P1531; COGO A, 1994, ARCH INTERN MED, V154, P164, DOI 10.1001/archinte.154.2.164; Falanga A, 1999, SEMIN THROMB HEMOST, V25, P173, DOI 10.1055/s-2007-994919; Falanga A, 1998, HAEMOSTASIS, V28, P50; Francis JL, 1998, SEMIN THROMB HEMOST, V24, P93, DOI 10.1055/s-2007-995829; Gale AJ, 2001, ACTA HAEMATOL-BASEL, V106, P25, DOI 10.1159/000046586; Gomez E, 1998, BLOOD, V91, P2208, DOI 10.1182/blood.V91.6.2208.2208_2208_2209; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P651; Levitan N, 1999, MEDICINE, V78, P285, DOI 10.1097/00005792-199909000-00001; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monreal M, 1997, THROMB HAEMOSTASIS, V78, P1316; NORDSTROM M, 1994, BRIT MED J, V308, P891, DOI 10.1136/bmj.308.6933.891; Otterson GA, 1996, AM J MED, V101, P406, DOI 10.1016/S0002-9343(96)00235-5; Palareti G, 2000, THROMB HAEMOSTASIS, V84, P805; Pihusch R, 2002, CANCER, V94, P3120, DOI 10.1002/cncr.10590; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Sallah S, 2002, THROMB HAEMOSTASIS, V87, P575; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Thodiyil PA, 2001, ACTA HAEMATOL-BASEL, V106, P73, DOI 10.1159/000046592; TROUSSEAU A, 1868, PHLEGMASIA ALBA DOLE, V5, P281; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	27	1313	1435	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2005	293	6					715	722		10.1001/jama.293.6.715	http://dx.doi.org/10.1001/jama.293.6.715			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895DX	15701913	Green Published, Bronze			2022-12-01	WOS:000226842200025
J	Sanz, EJ; De-las-Cuevas, C; Kiuru, A; Bate, A; Edwards, R				Sanz, EJ; De-las-Cuevas, C; Kiuru, A; Bate, A; Edwards, R			Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis	LANCET			English	Article							ANTIDEPRESSANT WITHDRAWAL; DISCONTINUATION; SIGNALS	Background Selective serotonin reuptake inhibitors (SSRIs) have been associated with withdrawal symptoms. We investigated whether use of these drugs in pregnant women might cause neonatal withdrawal syndrome. Methods An association between paroxetine and neonatal convulsions was identified in December, 2001, by the data mining method routinely used to screen the WHO database of adverse drug reactions. An information component (IC) measure was used to screen for unexpected adverse reactions relative to the information in the database. We then assessed cases of neonatal convulsions and neonatal withdrawal syndrome associated with drugs included in the anatomical therapeutic chemical groups N06AB and N06AX. Findings By November, 2003, a total of 93 suspected cases of SSRI-induced neonatal withdrawal syndrome had been reported, and were regarded as enough information to confirm a possible causal relation. 64 of the cases were associated with paroxetine, 14 with fluoxetine, nine with sertraline, and seven with citalopram. The IC-2 SD for the group became greater than 0 in the first quarter of 1991, and the IC increased to 2.68 (IC-2 SD 0-32) by the second quarter of 2003. For each individual compound, the IC-2 SD was greater than 0. Interpretation SSRIs, especially paroxetine, should be cautiously managed in the treatment of pregnant women with a psychiatric disorder.	Univ La Laguna, Sch Med, Tenerife 38071, Spain; WHO, Collaborating Ctr Int Drug Monitoring, Uppsala Monitoring Ctr, Uppsala, Sweden	Universidad de la Laguna; World Health Organization	Sanz, EJ (corresponding author), Univ La Laguna, Sch Med, Tenerife 38071, Spain.	esanz@ull.es	De las Cuevas, Carlos/F-6423-2011; Sanz Alvarez, Emilio J/M-3535-2019; Sanz, Emilio J/C-9793-2009; Bate, Andrew/J-3799-2019	De las Cuevas, Carlos/0000-0001-5742-905X; Sanz Alvarez, Emilio J/0000-0001-6788-4435; Sanz, Emilio J/0000-0001-6788-4435; 				Bate A, 2002, EUR J CLIN PHARMACOL, V58, P483, DOI 10.1007/s00228-002-0484-x; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; BAUMAN HE, 1995, ADV MEAT RES, V10, P1; Benazzi F, 1996, CAN J PSYCHIAT, V41, P487, DOI 10.1177/070674379604100722; *BRIT MED ASS ROYA, 1990, BRIT NAT FORM; BROSEN K, 1993, CLIN INVESTIGATOR, V71, P1002; BRYOIS C, 1998, SCHWEIZERISCHE RUNDS, V87, P345; CECCHERININELLI A, 1993, AM J PSYCHIAT, V150, P165; *COMM SAF MED, 2003, SER MUST NOT BE US T; Dahl ML, 1997, BRIT J PSYCHIAT, V171, P391, DOI 10.1192/bjp.171.4.391c; DILSAVER SC, 1984, BIOL PSYCHIAT, V19, P237; Edwards I, 2002, PHARMACOVIGILANCE, P169; EDWARDS IR, 1994, DRUG SAFETY, V10, P93, DOI 10.2165/00002018-199410020-00001; Haddad P, 1998, BMJ-BRIT MED J, V316, P1105, DOI 10.1136/bmj.316.7138.1105; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Lejoyeux M, 1997, J CLIN PSYCHIAT, V58, P11; Lindquist M, 2000, DRUG SAFETY, V23, P533, DOI 10.2165/00002018-200023060-00004; Mareth TR, 1996, J CLIN PSYCHIAT, V57, P310; Mavissakalian MR, 1999, ARCH GEN PSYCHIAT, V56, P821, DOI 10.1001/archpsyc.56.9.821; Nijhuis IJM, 2001, ARCH DIS CHILD-FETAL, V84, pF77; Orre R, 2000, COMPUT STAT DATA AN, V34, P473, DOI 10.1016/S0167-9473(99)00114-0; Rosenbaum JF, 1998, BIOL PSYCHIAT, V44, P77, DOI 10.1016/S0006-3223(98)00126-7; SPENCER MJ, 1993, PEDIATRICS, V92, P721; Stahl MMS, 1997, EUR J CLIN PHARMACOL, V53, P163, DOI 10.1007/s002280050357; Stiskal JA, 2001, ARCH DIS CHILD-FETAL, V84, pF134, DOI 10.1136/fn.84.2.F134; VALDESSARINI RJ, 2001, PHARMACOL BASIS THER, P431; Young AH, 1997, BRIT J PSYCHIAT, V170, P288, DOI 10.1192/bjp.170.3.288a	27	257	260	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2005	365	9458					482	487		10.1016/S0140-6736(05)17865-9	http://dx.doi.org/10.1016/S0140-6736(05)17865-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894SS	15705457				2022-12-01	WOS:000226812500025
J	Jeong, PY; Jung, M; Yim, YH; Kim, H; Park, M; Hong, EM; Lee, W; Kim, YH; Kim, K; Paik, YK				Jeong, PY; Jung, M; Yim, YH; Kim, H; Park, M; Hong, EM; Lee, W; Kim, YH; Kim, K; Paik, YK			Chemical structure and biological activity of the Caenorhabditis elegans dauer-inducing pheromone	NATURE			English	Article							MULTIPLE-QUANTUM NMR; CHEMOSENSORY NEURONS; LARVAL DEVELOPMENT; SPECTROSCOPY; PARALLEL; FOOD	Pheromones are cell type-specific signals used for communication between individuals of the same species. When faced with overcrowding or starvation, Caenorhabditis elegans secrete the pheromone daumone, which facilitates communication between individuals for adaptation to adverse environmental stimuli(1-4). Daumone signals C. elegans to enter the dauer stage, an enduring and non-ageing stage of the nematode life cycle with distinctive adaptive features and extended life. Because daumone is a key regulator of chemosensory processes in development and ageing(5,6), the chemical identification of daumone is important for elucidating features of the daumone-mediated signalling pathway. Here we report the isolation of natural daumone from C. elegans by large-scale purification, as well as the total chemical synthesis of daumone. We present the stereospecific chemical structure of purified daumone, a fatty acid derivative. We demonstrate that both natural and chemically synthesized daumones equally induce dauer larva formation in C. elegans (N2 strain) and certain dauer mutants, and also result in competition between food and daumone. These results should help to elucidate the daumone-mediated signalling pathway, which might in turn influence ageing and obesity research and the development of antinematodal drugs.	Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; Yonsei Univ, Dept Chem, Seoul 120749, South Korea; Yonsei Univ, Bioprod Res Ctr, Seoul 120749, South Korea; Korea Res Inst Stand & Sci, Taejon 305600, South Korea; Korea Basic Sci Inst, Taejon 305333, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Korea Research Institute of Standards & Science (KRISS); Korea Basic Science Institute (KBSI)	Paik, YK (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021; Kim, Young Hwan/AAA-5484-2022	Kim, Young Hwan/0000-0003-3478-8839; Lee, Weontae/0000-0003-2347-1262				Antebi A, 1998, DEVELOPMENT, V125, P1191; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BAX A, 1986, J MAGN RESON, V67, P565, DOI 10.1016/0022-2364(86)90395-1; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Bird DM, 1998, J NEMATOL, V30, P299; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Choi BK, 2003, MOL CELL PROTEOMICS, V2, P1086, DOI 10.1074/mcp.M300036-MCP200; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Koga M, 1999, DEVELOPMENT, V126, P5387; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; REGNIER FE, 1968, J LIPID RES, V9, P541; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; THOMAS JH, 1993, GENETICS, V134, P1105; Viney ME, 2004, NATURWISSENSCHAFTEN, V91, P123, DOI 10.1007/s00114-004-0503-2; VOWELS JJ, 1994, GENETICS, V138, P303	25	271	287	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					541	545		10.1038/nature03201	http://dx.doi.org/10.1038/nature03201			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	893NT	15690045				2022-12-01	WOS:000226727200053
J	Lum, JJ; Bauer, DE; Kong, M; Harris, MH; Li, C; Lindsten, T; Thompson, CB				Lum, JJ; Bauer, DE; Kong, M; Harris, MH; Li, C; Lindsten, T; Thompson, CB			Growth factor regulation of autophagy and cell survival in the absence of apoptosis	CELL			English	Article							MALIGNANT GLIOMA-CELLS; DROSOPHILA FAT-BODY; SACCHAROMYCES-CEREVISIAE; DEATH; MUTANTS; MACROAUTOPHAGY; PATHWAY; YEAST; GENE; SIZE	In animals, cells are dependent on extracellular signals to prevent apoptosis. However, using growth factor-dependent cells from Bax/Bak-deficient mice, we demonstrate that apoptosis is not essential to limit cell autonomous survival. Following growth factor withdrawal, Bax(-/-)Bak(-/-) cells activate autophagy, undergo progressive atrophy, and ultimately succumb to death. These effects result from loss of the ability to take up sufficient nutrients to maintain cellular bioenergetics. Despite abundant extracellular nutrients, growth factor-deprived cells maintain ATP production from catabolism of intracellular substrates through autophagy. Autophagy is essential for maintaining cell survival following growth factor withdrawal and can sustain viability for several weeks. During this time, cells respond to growth factor readdition by rapid restoration of the ability to take up and metabolize glucose and by subsequent recovery of their original size and proliferative potential. Thus, growth factor signal transduction is required to direct the utilization of sufficient exogenous nutrients to maintain cell viability.	Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Thompson, CB (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.	craig@mail.upenn.edu		Lum, Julian/0000-0002-5624-3541				Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Aubert S, 1996, J CELL BIOL, V133, P1251, DOI 10.1083/jcb.133.6.1251; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KAN O, 1994, J EXP MED, V180, P917, DOI 10.1084/jem.180.3.917; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KUMA A, 2004, NATURE, V433, P1; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nelson DA, 2004, GENE DEV, V18, P1223, DOI 10.1101/gad.1212404; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Paglin S, 2001, CANCER RES, V61, P439; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 1997, ONCOGENE, V15, P971, DOI 10.1038/sj.onc.1201266	48	1206	1266	4	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					237	248		10.1016/j.cell.2004.11.046	http://dx.doi.org/10.1016/j.cell.2004.11.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680329	Bronze			2022-12-01	WOS:000226740000012
J	Cote, IM; Cheney, KL				Cote, IM; Cheney, KL			Animal mimicry: Choosing when to be a cleaner-fish mimic - A dangerous fish can discard a seemingly harmless disguise to suit its circumstances	NATURE			English	Editorial Material									Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Cote, IM (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	i.cote@uea.ac.uk	Cote, Isabelle/ABD-5898-2021; Cheney, Karen/L-3427-2018; Cheney, Karen L/A-6827-2013	Cheney, Karen/0000-0001-5622-9494; Cheney, Karen L/0000-0001-5622-9494				Cote IM, 2004, P ROY SOC B-BIOL SCI, V271, P2627, DOI 10.1098/rspb.2004.2904; Grutter AS, 1999, NATURE, V398, P672, DOI 10.1038/19443; Kuwamura T., 1981, Nanki Seibutu, V23, P61; Randall J.E., 1997, FISHES GREAT BARRIER; RUSSELL BC, 1976, J ZOOL, V180, P407; SMITHVANIZ WF, 1976, ACAD NAT SCI PHILADE, V19, P1	6	31	33	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2005	433	7023					211	212		10.1038/433211a	http://dx.doi.org/10.1038/433211a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662402				2022-12-01	WOS:000226381300028
J	Ahn, SH; Cheung, WL; Hsu, JY; Diaz, RL; Smith, MM; Allis, CD				Ahn, SH; Cheung, WL; Hsu, JY; Diaz, RL; Smith, MM; Allis, CD			Sterile 20 kinase phosphorylates histone H2B at serine 10 during hydrogen peroxide-induced apoptosis in S. cerevisiae	CELL			English	Article							PROGRAMMED CELL-DEATH; PROTEIN-KINASE; YEAST; DNA; PCR; PROLIFERATION; MODULES; STE20P; GROWTH; HIPPO	Apoptosis is a highly coordinated cell suicide mechanism in vertebrates. Phosphorylation of serine 14 of histone H2B, catalyzed by Mst1 kinase, has been linked to chromatin compaction during apoptosis. We extend these results to unicellular eukaryotes by demonstrating that H2B is specifically phosphorylated at serine 10 (S10) in a hydrogen peroxide-induced cell death pathway in S. cerevisiae. H2B S10A mutants are resistant to cell death elicited by H2O2 while H2B S10E phospho-site mimics promote cell death and induce the "constitutive" formation of condensed chromatin. Ste20 kinase, a yeast homolog of mammalian Mst1 kinase, translocates into the nucleus in a caspase-independent fashion and directly phosphorylates H2B at S10. Conservation of targeted H2B phosphorylation and the enzyme system responsible for the process point to an ancient mechanism of chromatin remodeling that likely plays an important role in governing cellular homeostasis in a wide range of organisms.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Univ Virginia, Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Syst, Dept Biochem, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Syst, Dept Mol Genet, Charlottesville, VA 22908 USA	Rockefeller University; University of Virginia; University of Virginia; University of Virginia	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, Box 78, New York, NY 10021 USA.	alliscd@rockefeller.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40922] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; de la Barre AE, 2001, EMBO J, V20, P6383, DOI 10.1093/emboj/20.22.6383; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; ROSE MD, 1990, METHODS YEAST GENETI; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; SIKORSKI RS, 1989, GENETICS, V122, P19; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang Z, 2003, BIOCHEM PHARMACOL, V65, P1767, DOI 10.1016/S0006-2952(03)00117-5; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200	37	198	212	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					25	36		10.1016/j.cell.2004.11.016	http://dx.doi.org/10.1016/j.cell.2004.11.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652479	Bronze			2022-12-01	WOS:000226365400008
J	Balmford, A; Bennun, L; ten Brink, B; Cooper, D; Cote, IM; Crane, P; Dobson, A; Dudley, N; Dutton, I; Green, RE; Gregory, RD; Harrison, J; Kennedy, ET; Kremen, C; Leader-Williams, N; Lovejoy, TE; Mace, G; May, R; Mayaux, P; Morling, P; Phillips, J; Redford, K; Ricketts, TH; Rodriguez, JP; Sanjayan, M; Schei, PJ; van Jaarsveld, AS; Walther, BA				Balmford, A; Bennun, L; ten Brink, B; Cooper, D; Cote, IM; Crane, P; Dobson, A; Dudley, N; Dutton, I; Green, RE; Gregory, RD; Harrison, J; Kennedy, ET; Kremen, C; Leader-Williams, N; Lovejoy, TE; Mace, G; May, R; Mayaux, P; Morling, P; Phillips, J; Redford, K; Ricketts, TH; Rodriguez, JP; Sanjayan, M; Schei, PJ; van Jaarsveld, AS; Walther, BA			The convention on biological diversity's 2010 target	SCIENCE			English	Article									Royal Bot Gardens, Richmond, England; Univ Cambridge, Cambridge CB2 1TN, England; Univ Cape Town, ZA-7700 Rondebosch, South Africa; BirdLife Int, Cambridge, England; RIVM, Bilthoven, Netherlands; Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; Princeton Univ, Princeton, NJ 08544 USA; Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; UN, Environm Program, World Conservat Monitoring Ctr, New York, NY USA; Conservat Int, Washington, DC USA; Univ Kent, Canterbury CT2 7NZ, Kent, England; Zool Soc London, London, England; Univ Oxford, Oxford OX1 2JD, England; Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy; Wildlife Conservat Soc, Bronx, NY USA; World Wildlife Fund, Washington, DC 20037 USA; Inst Venezolano Invest Cient, Caracas, Venezuela; Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa	Royal Botanic Gardens, Kew; University of Cambridge; University of Cape Town; BirdLife International; Netherlands National Institute for Public Health & the Environment; University of East Anglia; Princeton University; Royal Society for Protection of Birds; Conservation International; University of Kent; Zoological Society of London; University of Oxford; European Commission Joint Research Centre; EC JRC ISPRA Site; Wildlife Conservation Society; World Wildlife Fund; Venezuelan Institute Science Research; Stellenbosch University	Dobson, A (corresponding author), Royal Bot Gardens, Richmond, England.	dobber@prince-ton.edu	Rodriguez, Jon P/G-7224-2012; Rodriguez, Jon P/A-1491-2009; Cote, Isabelle/ABD-5898-2021; van Jaarsveld, Albert/H-5368-2013; Mace, Georgina M/I-3072-2016	Rodriguez, Jon P/0000-0001-5019-2870; Mace, Georgina M/0000-0001-8965-5211; Gregory, Richard/0000-0002-7419-5053; Balmford, Andrew/0000-0002-0144-3589; Crane, Peter/0000-0003-4331-6948; Cooper, David/0000-0003-4538-205X				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; [Anonymous], 1997, NATURES SERVICES; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; BUTCHART SHM, IN PRESS NATURE; CDB, 2002, CONTRIBUTION 6 NATL; COTE IM, IN PRESS PHILOS T B; Department of Environment Food and Rural Affairs (DEFRA), 2002, ACH BETT QUAL LIF RE; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; *EUR COUNC, 2001, SN200101 EC, P8; GREGORY RD, IN PRESS T R SOC L B; *HEINZ CTR, 2002, STAT NAT EC MEAS LAN; Homewood KM, 2004, ENVIRON SCI POLICY, V7, P125, DOI 10.1016/j.envsci.2003.12.006; HUTCHINGS JA, IN PRESS PHILOS T B; LOH J, IN PRESS PHILOS T B; MAYAUX P, IN PRESS PHILOS T B; Mea, 2003, ECOSYSTEMS HUMAN WEL; PAULY D, IN PRESS PHILOS T B; Ten Brink B J E, 2000, 402001014 RIVM NAT I; *UNEP, 2003, UNEPCCBDSBSTTA9INF26; *UNEP, 2004, C PART CONV BIOL DIV	20	299	319	5	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					212	213		10.1126/science.1106281	http://dx.doi.org/10.1126/science.1106281			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653489				2022-12-01	WOS:000226361900026
J	Evason, K; Huang, C; Yamben, I; Covey, DF; Kornfeld, K				Evason, K; Huang, C; Yamben, I; Covey, DF; Kornfeld, K			Anticonvulsant medications extend worm life-span	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; MUTANTS; ETHOSUXIMIDE; LONG	Genetic studies have elucidated mechanisms that regulate aging, but there has been little progress in identifying drugs that delay aging. Here, we report that ethosuximide, trimethadione, and 3,3-diethyl-2-pyrrolidinone increase mean and maximum life-span of Caenorhabditis elegans and delay age-related declines of physiological processes, indicating that these compounds retard the aging process. These compounds, two of which are approved for human use, are anticonvulsants that modulate neural activity. These compounds also regulated neuromuscular activity in nematodes. These findings suggest that the life-span-extending activity of these compounds is related to the anticonvulsant activity and implicate neural activity in the regulation of aging.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Kornfeld, K (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	kornfeid@molecool.wustl.edu	Evason, Kimberley/AAC-2506-2020		NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG05681] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; COULTER DA, 1989, ANN NEUROL, V25, P582, DOI 10.1002/ana.410250610; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2002, AGING CELL, V1, P1, DOI 10.1046/j.1474-9728.2002.00003.x; Gems D, 2000, GENETICS, V154, P1597; Gomora JC, 2001, MOL PHARMACOL, V60, P1121, DOI 10.1124/mol.60.5.1121; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; KATZUNG BG, 1998, BASIC CLIN PHARM; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Leresche N, 1998, J NEUROSCI, V18, P4842; Levy R.H., 2002, ANTIEPILEPTIC DRUGS, V5th ed.; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Reddy PA, 1996, J MED CHEM, V39, P1898, DOI 10.1021/jm9600196; Riddle D. L, 1997, COLD SPRING HARBOR M, V33; TRENT C, 1983, GENETICS, V104, P619	20	149	171	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					258	262		10.1126/science.1105299	http://dx.doi.org/10.1126/science.1105299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653505				2022-12-01	WOS:000226361900044
J	Kotwal, RS; Wenzel, RB; Sterling, RA; Porter, WD; Jordan, NN; Petruccelli, BP				Kotwal, RS; Wenzel, RB; Sterling, RA; Porter, WD; Jordan, NN; Petruccelli, BP			An outbreak of malaria in US Army Ranges returning from Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PLASMODIUM-VIVAX MALARIA; UNITED-STATES; PRIMAQUINE; WAR; CHEMOPROPHYLAXIS; RESISTANCE; SOLDIERS; VIETNAM; SOMALIA	Context With numerous US military personnel currently deployed throughout the world, military and civilian health care professionals may encounter imported malaria from this population. Objective To identify malaria in US Army personnel deployed to a combat zone. Design, Setting, and Patients Case series in the US Army health care system. A total of 38 cases of malaria were identified in a 725-man Ranger Task Force that deployed to eastern Afghanistan between June and September 2002. Main Outcome Measures Identification of malaria cases and soldiers' self-report of compliance with antimalarial measures. Results A total of 38 patients were infected with Plasmodium vivax, yielding an attack rate of 52.4 cases per 1000 soldiers. Diagnosis was confirmed a median of 233 days (range, 1-339 days) after return from the malaria endemic region, with additional laboratory findings noting anemia and thrombocytopenia. One case was complicated with acute respiratory distress syndrome during the patient's primary attack and a spontaneous pneumothorax during relapse. This case accounted for 1 of 2 relapse cases in the study population. From an anonymous postdeployment survey of 72% (521/725) of the task force, the self-reported compliance rate was 52% for weekly chemoprophylaxis, 41% for terminal (postdeployment) chemoprophylaxis, 31% for both weekly and terminal chemoprophylaxis, 82% for treating uniforms with permethrin, and 29% for application of insect repellent. Conclusions Delayed clinical presentation can occur with P vivax. Symptoms are often vague, but malaria should be included in the differential diagnosis for soldiers returning from an endemic region. Suboptimal compliance with preventive measures can result in a malaria outbreak.	Naval Operat Med Inst, Army Navy Aerosp Med Residency, Pensacola, FL 32508 USA; Univ Texas, Med Branch, Dept Prevent Med, Galveston, TX 77550 USA; Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA; 75th Ranger Regiment, Ft Benning, GA USA; 1st Cavalry Div, Div Prevent Med, Ft Hood, TX USA; USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA	University of Texas System; University of Texas Medical Branch Galveston; Uniformed Services University of the Health Sciences - USA	Kotwal, RS (corresponding author), Naval Operat Med Inst, Army Navy Aerosp Med Residency, Pensacola, FL 32508 USA.	russ.kotwal@us.army.mil						Addington W, 2003, ANN INTERN MED, V139, P305, DOI 10.7326/0003-4819-139-4-200308190-00024; *AFMIC, 2002, 05202 AFMIC; *AFMIC, 2002, 04002 AFMIC; *ARM MED SURV ACT, 2004, DEF MED EP DAT VERS; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; BARRETT O, 1969, AM J TROP MED HYG, V18, P495, DOI 10.4269/ajtmh.1969.18.495; BEADLE C, 1993, CLIN INFECT DIS, V16, P320, DOI 10.1093/clind/16.2.320; Carlini ME, 1999, CLIN INFECT DIS, V28, P1182, DOI 10.1086/517779; *CDCP, 2001, MAL SURV US 2001; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P22; *CDCP, 2003, HLTH INF INT TRAV 20; Chin J, 2001, CONTROL COMMUNICABLE, P310; COATES JB, 1963, PREVENTIVE MED WORLD; Collins WE, 1996, AM J TROP MED HYG, V55, P243, DOI 10.4269/ajtmh.1996.55.243; Curlin ME, 1999, CLIN INFECT DIS, V28, P1166, DOI 10.1086/517767; Gambel JM, 1998, J TRAVEL MED, V5, P217, DOI 10.1111/j.1708-8305.1998.tb00511.x; ISLAM N, 1995, TROP GEOGR MED, V47, P141; Joy RJT, 1999, MED HIST, V43, P192, DOI 10.1017/S002572730006508X; NEWTON JA, 1994, JAMA-J AM MED ASSOC, V272, P397, DOI 10.1001/jama.272.5.397; PUKRITTAYAKAMEE S, 1994, J INFECT DIS, V169, P932, DOI 10.1093/infdis/169.4.932; Robert L L, 2001, Med Trop (Mars), V61, P67; SHANKS GD, 1991, MIL MED, V156, P684, DOI 10.1093/milmed/156.12.684; Shanks GD, 2001, CLIN INFECT DIS, V33, P381, DOI 10.1086/321866; SHANKS GD, 1995, MED J AUSTRALIA, V162, P306, DOI 10.5694/j.1326-5377.1995.tb139906.x; Smoak BL, 1997, AM J TROP MED HYG, V56, P231, DOI 10.4269/ajtmh.1997.56.231; Tanios MA, 2001, CRIT CARE MED, V29, P665, DOI 10.1097/00003246-200103000-00037; *US DEP ARM, 2000, FIELD MAN 4 02 17 PR; *WHO EXP COMM MAL, 1998, WHO TECHN REP SER, V892	28	83	86	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					212	216		10.1001/jama.293.2.212	http://dx.doi.org/10.1001/jama.293.2.212			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644548	Bronze			2022-12-01	WOS:000226171000037
J	Pereira, MA; Kartashov, AI; Ebbeling, CB; Van Horn, L; Slattery, M; Jacobs, DR; Ludwig, DS				Pereira, MA; Kartashov, AI; Ebbeling, CB; Van Horn, L; Slattery, M; Jacobs, DR; Ludwig, DS			Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; GLYCEMIC INDEX; DIABETES-MELLITUS; DIETARY FIBER; OBESITY; CHILDREN; WOMEN; RISK; PREVALENCE	Background Fast-food consumption has increased greatly in the USA during the past three decades. However, the effect of fast food on risk of obesity and type 2 diabetes has received little attention. We aimed to investigate the association between reported fast-food habits and changes in bodyweight and insulin resistance over a 15-year period in the USA. Methods Participants for the CARDIA study included 3031 young (age 18-30 years in 1985-86) black and white adults who were followed up with repeated dietary assessment. We used multiple linear regression models to investigate the association of frequency of fast-food restaurant visits (fast-food frequency) at baseline and follow-up with 15-year changes in bodyweight and the homoeostasis model (HOMA) for insulin resistance. Findings Fast-food frequency was lowest for white women (about 1.3 times per week) compared with the other ethnic-sex groups (about twice a week). After adjustment for lifestyle factors, baseline fast-food frequency was directly associated with changes in bodyweight in both black (p=0.0050) and white people (p=0.0013). Change in fast-food frequency over 15 years was directly associated with changes in bodyweight in white individuals (p<0.0001), with a weaker association recorded in black people (p=0.1004). Changes were also directly associated with insulin resistance in both ethnic groups (p=0.0015 in black people, p<0.0001 in white people). By comparison with the average 15-year weight gain in participants with infrequent (less than once a week) fast-food restaurant use at baseline and follow-up (n=203), those with frequent (more than twice a week) visits to fast-food restaurants at baseline and follow-up (n=87) gained an extra 4.5 kg of bodyweight (p=0.0054) and had a two-fold greater increase in insulin resistance (p=0.0083). Interpretation Fast-food consumption has strong positive associations with weight gain and insulin resistance, suggesting that fast food increases the risk of obesity and type 2 diabetes.	Childrens Hosp, Dept Med, Boston, MA 02115 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; Childrens Hosp, Clin Res Program, Boston, MA 02115 USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL USA; Univ Utah, Sch Med, Salt Lake City, UT USA; Univ Oslo, Dept Nutr, Oslo, Norway	Harvard University; Boston Children's Hospital; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Boston Children's Hospital; Northwestern University; Utah System of Higher Education; University of Utah; University of Oslo	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Jacobs, David/0000-0002-7232-0543; Pereira, Mark/0000-0002-6704-5276; Ludwig, David/0000-0003-3307-8544	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095, N01HC048049, N01HC048047, N01HC048048, N01HC048050] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR02172] Funding Source: Medline; NHLBI NIH HHS [N01-HC-48050, N01-HC-95095, N01-HC-48049, N01-HC-48048, N01-HC-48047] Funding Source: Medline; NIDDK NIH HHS [1R01DK59240] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; American Diabetes Association, 2002, DIABETES CARE, V25, pS50, DOI DOI 10.2337/DIACARE.25.2007.S50; BIINGHWAN L, 1997, FOOD REV, P33; Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429; FRENCH SA, 1994, INT J OBESITY, V18, P145; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Frost G, 1998, METABOLISM, V47, P1245, DOI 10.1016/S0026-0495(98)90331-6; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Jarvi AE, 1999, DIABETES CARE, V22, P10, DOI 10.2337/diacare.22.1.10; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; *TECN INF SERV, 2002, US FOODS IND FOR; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; *USDA, 1997, CONT SURV FOOD INT I	33	851	871	3	143	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					36	42		10.1016/S0140-6736(04)17663-0	http://dx.doi.org/10.1016/S0140-6736(04)17663-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639678				2022-12-01	WOS:000226213100026
J	Eccles, SA; Paon, L				Eccles, SA; Paon, L			Breast cancer metastasis: when, where, how?	LANCET			English	Editorial Material									Inst Canc Res, Canc Res UK Ctr Canc Therapeut, McElwain Labs, Sutton SM2 5NG, Surrey, England	Cancer Research UK; University of London; Institute of Cancer Research - UK	Eccles, SA (corresponding author), Inst Canc Res, Canc Res UK Ctr Canc Therapeut, McElwain Labs, Sutton SM2 5NG, Surrey, England.	Sue.Eccles@icr.ac.uk						Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Brandt B, 1998, INT J CANCER, V76, P824, DOI 10.1002/(SICI)1097-0215(19980610)76:6<824::AID-IJC10>3.0.CO;2-2; EPSTEIN RJ, 2004, NAT REV CANCER, P1; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Zeelenberg IS, 2003, CANCER RES, V63, P3833	8	14	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1006	1007		10.1016/S0140-6736(05)71116-8	http://dx.doi.org/10.1016/S0140-6736(05)71116-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781080				2022-12-01	WOS:000227731800005
J	MacMahon, S; Neal, B; Rodgers, A				MacMahon, S; Neal, B; Rodgers, A			Hypertension - time to move on	LANCET			English	Editorial Material							BLOOD-PRESSURE; DISEASE		Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand	University of Sydney; University of Auckland	MacMahon, S (corresponding author), Royal Prince Alfred Hosp, George Inst Int Hlth, POB M201, Sydney, NSW 2050, Australia.	smacmahon@thegeorgeinstitute.org		MacMahon, Stephen/0000-0003-2064-7699; Rodgers, Anthony/0000-0003-1282-1896; Neal, Bruce/0000-0002-0490-7465				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], WORLD HLTH REP 2002; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Fox KM, 2003, LANCET, V362, P782; HARINGTON M, 1959, BRIT MED J, V2, P969, DOI 10.1136/bmj.2.5158.969; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1994, HYPERTENS RES, V17, P23; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; *NZ GUID GROUP, 2003, GUID DET MAN CARD DI; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; *REUT BUS INS HEAL, 2003, CARD MARK OUTL 2008; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Turnbull F, 2003, LANCET, V362, P1527; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Yusuf S, 2000, NEW ENGL J MED, V342, P145	17	44	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1108	1109						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781107				2022-12-01	WOS:000227731800036
J	Murray, JB; Muller, JP; Neukum, G; Werner, SC; van Gasselt, S; Hauber, E; Markiewicz, WJ; Head, JW; Foing, BH; Page, D; Mitchell, KL; Portyankina, G				Murray, JB; Muller, JP; Neukum, G; Werner, SC; van Gasselt, S; Hauber, E; Markiewicz, WJ; Head, JW; Foing, BH; Page, D; Mitchell, KL; Portyankina, G		HRSC Co-Investigator Team	Evidence from the Mars Express High Resolution Stereo Camera for a frozen sea close to Mars' equator	NATURE			English	Article							CERBERUS FOSSAE; WATER; PLAINS; FATE; GROUNDWATER; VOLCANISM; STABILITY; EVOLUTION; FLOODS; MODEL	It is thought that the Cerberus Fossae fissures on Mars were the source of both lava and water floods(1,2-4) two to ten million years ago(1,2,5). Evidence for the resulting lava plains has been identified in eastern Elysium(1,2,4,6 - 8), but seas and lakes from these fissures and previous water flooding events were presumed to have evaporated and sublimed away(9-11). Here we present High Resolution Stereo Camera images from the European Space Agency Mars Express spacecraft that indicate that such lakes may still exist. We infer that the evidence is consistent with a frozen body of water, with surface pack-ice, around 5 degrees north latitude and 150 degrees east longitude in southern Elysium. The frozen lake measures about 800 x 900 km in lateral extent and may be up to 45 metres deep - similar in size and depth to the North Sea. From crater counts, we determined its age to be 5 +/- 2 million years old. If our interpretation is confirmed, this is a place that might preserve evidence of primitive life, if it has ever developed on Mars.	Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; UCL, Dept Geomat Engn, London WC1E 6BT, England; Free Univ Berlin, Inst Geosci, D-12249 Berlin, Germany; DLR, Inst Planetenforsch, D-12489 Berlin, Germany; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; European Space Agcy, Res & Sci Support Dept, ESTEC, SCISR, NL-2200 AG Noordwijk, Netherlands; Nat Hist Museum, Dept Mineral, London SW7 5PB, England; Univ Lancaster, Dept Environm Sci, Lancaster LA1 4YQ, England	Open University - UK; University of London; University College London; Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society; Brown University; European Space Agency; Natural History Museum London; Lancaster University	Murray, JB (corresponding author), Open Univ, Dept Earth Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	J.B.Murray@open.ac.uk	van Gasselt, Stephan/L-9762-2013; Mitchell, Karl Leon/AAG-3821-2020; Werner, Stephanie C/A-6438-2012; Mitchell, Karl Leon/AGL-9516-2022; Muller, Jan-Peter/Q-8886-2019; Hauber, Ernst/U-2521-2018	van Gasselt, Stephan/0000-0003-2130-6343; Mitchell, Karl Leon/0000-0003-1093-8441; Werner, Stephanie C/0000-0001-5704-0909; Muller, Jan-Peter/0000-0002-5077-3736; Hauber, Ernst/0000-0002-1375-304X				Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Berman DC, 2002, ICARUS, V159, P1, DOI 10.1006/icar.2002.6920; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; CARR MH, 1983, ICARUS, V56, P476, DOI 10.1016/0019-1035(83)90168-9; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; Fuller ER, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001842; Garvin J.B., 2003, 6 INT C MARS; Greenberg R, 2000, J GEOPHYS RES-PLANET, V105, P17551, DOI 10.1029/1999JE001147; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Head JW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017135; HUMPRHIS SE, 1995, AM GEOPHYS UNION MON, V91, P1; Keszthelyi L, 2000, J GEOPHYS RES-PLANET, V105, P15027, DOI 10.1029/1999JE001191; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; LANAGAN P, 2003, 6 INT C MARS; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LASKAR J, 2004, LUNAR PLANET SCI, V35; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Patrick MR, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002537; Plescia JB, 2003, ICARUS, V164, P79, DOI 10.1016/S0019-1035(03)00139-8; RICE JW, 2002, LUNAR PLANET SCI, V33; Skinner B.J., 1966, HDB PHYS CONSTANTS G, P75, DOI [rg/10.1130/MEM97-p75, 10.1130/MEM97-p75, DOI 10.1130/MEM97-P75]; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; WALLACE D, 1983, ICARUS, V39, P476; Werner SC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002020	28	135	138	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					352	356		10.1038/nature03379	http://dx.doi.org/10.1038/nature03379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772653				2022-12-01	WOS:000227715100043
J	Herman, WH; Hoerger, TJ; Brandle, M; Hicks, K; Sorensen, S; Zhang, P; Hamman, RF; Ackermann, RT; Engelgau, MM; Ratner, RE				Herman, WH; Hoerger, TJ; Brandle, M; Hicks, K; Sorensen, S; Zhang, P; Hamman, RF; Ackermann, RT; Engelgau, MM; Ratner, RE		Diabetes Prevention Program Res Gr	The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance	ANNALS OF INTERNAL MEDICINE			English	Article							MELLITUS; RISK; DISEASE; NIDDM; PREVALENCE; INFARCTION; DIAGNOSIS; THERAPY; OBESITY; STROKE	Background: The Diabetes Prevention Program (DPP) demonstrated that interventions can delay or prevent the development of type 2 diabetes. Objective: To estimate the lifetime cost-utility of the DPP interventions. Design: Markov simulation model to estimate progression of disease, costs, and quality of life. Data Sources: The DPP and published reports. Target Population: Members of the DPP cohort 25 years of age or older with impaired glucose tolerance. Time Horizon: Lifetime. Perspectives: Health system and societal. Interventions: intensive lifestyle, metformin, and placebo interventions as implemented in the DPP. Outcome Measures: Cumulative incidence of diabetes, microvascular and neuropathic complications, cardiovascular complications, survival, direct medical and direct nonmedical costs, quality-adjusted life-years (QALYs), and cost per QALY. Results of Base-Case Analysis: Compared with the placebo intervention, the lifestyle and metformin interventions were estimated to delay the development of type 2 diabetes by 11 and 3 years, respectively, and to reduce the absolute incidence of diabetes by 20% and 8%, respectively. The cumulative incidence of microvascular, neuropathic, and cardiovascular complications were reduced and survival was improved by 0.5 and 0.2 years. Compared with the placebo intervention, the cost per QALY was approximately $1100 for the lifestyle intervention and $31300 for the metformin intervention. From a societal perspective, the interventions cost approximately $8800 and $29 900 per QALY, respectively. From both perspectives, the lifestyle intervention dominated the metformin intervention. Results of Sensitivity Analysis: Cost-effectiveness improved when the interventions were implemented as they might be in routine clinical practice. The lifestyle intervention was cost-effective in all age groups. The metformin intervention did not represent good use of resources for persons older than 65 years of age. Limitations: Simulation results depend on the accuracy of the underlying assumptions, including participant adherence. Conclusions: Health policy should promote diabetes prevention in high-risk individuals.	RTI Int, Res Triangle Pk, NC USA; Univ Michigan, Hlth Syst, Ann Arbor, MI USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Medstar Res Inst, Hyattsville, MD USA	Research Triangle Institute; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Indiana University System; Indiana University-Purdue University Indianapolis	Herman, WH (corresponding author), George Washington Univ, Ctr Biostat, Diabet Prevent Program Coordinating Ctr, 6100 Execut Blvd,Suite 750, Rockville, MD 20852 USA.	dppmail@biostat.bsc.gwu.edu		Hicks, Katherine/0000-0002-1058-3401; Hoerger, Thomas/0000-0003-4154-7806	NIDDK NIH HHS [U01 DK048489, U01 DK048489-06] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048489] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Barzilay JI, 2001, DIABETES CARE, V24, P1233, DOI 10.2337/diacare.24.7.1233; Brandle M, 2003, DIABETES CARE, V26, P2300, DOI 10.2337/diacare.26.8.2300; Bray GA, 1999, DIABETES CARE, V22, P623; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Diabet Prevention Program Res Grp, 2003, DIABETES CARE, V26, P2518, DOI 10.2337/diacare.26.9.2518; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Gold MR., 1996, COST EFFECTIVENESS H; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Herman WH, 2003, DIABETES CARE, V26, P3182, DOI 10.2337/diacare.26.11.3182; Herman WH, 2003, DIABETES CARE, V26, P683, DOI 10.2337/diacare.26.3.683; Herman WH, 2003, DIABETES CARE, V26, P36; Herman WH, 1998, DIABETIC MED, V15, P1045, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L; *HLTH CAR FIN ADM, 1998, 1999 MED CLIN DIAGN; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; KINGSLEY RG, 1977, J CONSULT CLIN PSYCH, V45, P288, DOI 10.1037/0022-006X.45.2.288; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kohner EM, 1998, ARCH OPHTHALMOL-CHIC, V116, P297, DOI 10.1001/archopht.116.3.297; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; MOSS SE, 1992, ARCH INTERN MED, V152, P610, DOI 10.1001/archinte.152.3.610; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Qureshi AI, 1998, STROKE, V29, P1329, DOI 10.1161/01.STR.29.7.1329; REIBER GE, 1995, NIH PUBLICATION, P409; Renjilian DA, 2001, J CONSULT CLIN PSYCH, V69, P717, DOI 10.1037//0022-006X.69.4.717; Rodby RA, 1996, DIABETES CARE, V19, P1051, DOI 10.2337/diacare.19.10.1051; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; SCHEFFLER RM, 1992, AM J PUBLIC HEALTH, V82, P168, DOI 10.2105/AJPH.82.2.168; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Thompson TJ, 1996, DIABETIC MED, V13, P337, DOI 10.1002/(SICI)1096-9136(199604)13:4<337::AID-DIA71>3.0.CO;2-A; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637	41	476	486	0	65	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					323	332		10.7326/0003-4819-142-5-200503010-00007	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738451	Green Accepted			2022-12-01	WOS:000227325100002
J	Bellafiore, S; Barneche, F; Peltier, G; Rochaix, JD				Bellafiore, S; Barneche, F; Peltier, G; Rochaix, JD			State transitions and light adaptation require chloroplast thylakoid protein kinase STN7	NATURE			English	Article							COMPLEX-II LHCII; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-II; ENERGY-DISTRIBUTION; PHOSPHORYLATION; PHOTOSYNTHESIS; XANTHOPHYLL; FLUORESCENCE; CHLOROPHYLL; MUTANTS	Photosynthetic organisms are able to adjust to changing light conditions through state transitions, a process that involves the redistribution of light excitation energy between photosystem II (PSII) and photosystem I (PSI)(1,2). Balancing of the light absorption capacity of these two photosystems is achieved through the reversible association of the major antenna complex (LHCII) between PSII and PSI (ref. 3). Excess stimulation of PSII relative to PSI leads to the reduction of the plastoquinone pool and the activation of a kinase(4,5); the phosphorylation of LHCII; and the displacement of LHCII from PSII to PSI ( state 2). Oxidation of the plastoquinone pool by excess stimulation of PSI reverses this process ( state 1). The Chlamydomonas thylakoid-associated Ser-Thr kinase Stt7, which is required for state transitions, has an orthologue named STN7 in Arabidopsis(6). Here we show that loss of STN7 blocks state transitions and LHCII phosphorylation. In stn7 mutant plants the plastoquinone pool is more reduced and growth is impaired under changing light conditions, indicating that STN7, and probably state transitions, have an important role in response to environmental changes.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Dept Plant Biol, CH-1211 Geneva, Switzerland; CEA Cadarache, DSV,DEVM, Lab Ecophysiol Photosynth, UMR 6191,CNRS CEA, F-3108 St Paul Les Durance, France	University of Geneva; University of Geneva; CEA	Rochaix, JD (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	jean-david.rochaix@molbio.unige.ch	BARNECHE, Fredy/AAB-5054-2019; PELTIER, Gilles/ABD-4484-2021; Bellafiore, stephane/J-4756-2014; Bellafiore, stephane/AFS-1835-2022; Rochaix, Jean-David/ABC-5243-2020; Barneche, Fredy/M-4228-2015	BARNECHE, Fredy/0000-0002-7014-7097; Bellafiore, stephane/0000-0002-4394-0866; Bellafiore, stephane/0000-0002-4394-0866; Barneche, Fredy/0000-0002-7014-7097; Peltier, Gilles/0000-0002-2226-3931				ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Baroli I, 2000, PHILOS T R SOC B, V355, P1385, DOI 10.1098/rstb.2000.0700; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V935, P152, DOI 10.1016/0005-2728(88)90212-5; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; BENNETT J, 1979, EUR J BIOCHEM, V99, P133, DOI 10.1111/j.1432-1033.1979.tb13239.x; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Li XP, 2002, J BIOL CHEM, V277, P33590, DOI 10.1074/jbc.M204797200; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Lunde C, 2003, PLANT CELL PHYSIOL, V44, P44, DOI 10.1093/pcp/pcg012; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Race HL, 1996, BIOCHEMISTRY-US, V35, P13006, DOI 10.1021/bi961809k; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; ROBINSON HH, 1980, BIOCHIM BIOPHYS ACTA, V590, P97, DOI 10.1016/0005-2728(80)90149-8; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; SOKOLENKO A, 1995, FEBS LETT, V371, P176, DOI 10.1016/0014-5793(95)00892-D; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Vink M, 2004, BIOCHEMISTRY-US, V43, P7824, DOI 10.1021/bi030267l; WEIS E, 1985, PHOTOSYNTH RES, V6, P73, DOI 10.1007/BF00029047; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Zer H, 2003, BIOCHEMISTRY-US, V42, P728, DOI 10.1021/bi020451r; Zhang SP, 2004, J BIOL CHEM, V279, P3180, DOI 10.1074/jbc.M311640200; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	30	544	575	3	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					892	895		10.1038/nature03286	http://dx.doi.org/10.1038/nature03286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729347				2022-12-01	WOS:000227174600049
J	Lucas, MES; Deen, JL; von Seidlein, L; Wang, XY; Ampuero, J; Puri, M; Ali, M; Ansaruzzaman, M; Amos, J; Macuamule, A; Cavailler, P; Guerin, PJ; Mahoudeau, C; Kahozi-Sangwa, P; Chaignat, C; Barreto, A; Songane, FF; Clemens, JD				Lucas, MES; Deen, JL; von Seidlein, L; Wang, XY; Ampuero, J; Puri, M; Ali, M; Ansaruzzaman, M; Amos, J; Macuamule, A; Cavailler, P; Guerin, PJ; Mahoudeau, C; Kahozi-Sangwa, P; Chaignat, C; Barreto, A; Songane, FF; Clemens, JD			Effectiveness of mass oral cholera vaccination in Beira, Mozambique	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-SUBUNIT; FIELD TRIAL; VACCINES; EFFICACY; BANGLADESH; DIARRHEA	BACKGROUND: New-generation, orally administered cholera vaccines offer the promise of improved control of cholera in sub-Saharan Africa. However, the high prevalence of human immunodeficiency virus (HIV) infection in many cholera-affected African populations has raised doubts about the level of protection possible with vaccination. We evaluated a mass immunization program with recombinant cholera-toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in Beira, Mozambique, a city where the seroprevalence of HIV is 20 to 30 percent. METHODS: From December 2003 to January 2004, we undertook mass immunization of nonpregnant persons at least two years of age, using a two-dose regimen of rBS-WC vaccine in Esturro, Beira (population 21,818). We then assessed vaccine protection in a case-control study during an outbreak of El Tor Ogawa cholera in Beira between January and May 2004. To estimate the level of vaccine protection, antecedent rates of vaccination were compared between persons with culture-confirmed cholera severe enough to have prompted them to seek treatment and age- and sex-matched neighborhood controls without treated diarrhea. RESULTS: We assessed the effectiveness of the vaccine in 43 persons with cholera and 172 controls. Receipt of one or more doses of rBS-WC vaccine was associated with 78 percent protection (95 percent confidence interval, 39 to 92 percent; P=0.004). The vaccine was equally effective in children younger than five years of age and in older persons. A concurrently conducted case-control study designed to detect bias compared persons with treated, noncholeraic diarrhea and controls without diarrhea in the same population and found no protection associated with receipt of the rBS-WC vaccine. CONCLUSIONS: The rBS-WC vaccine was highly effective against clinically significant cholera in an urban sub-Saharan African population with a high prevalence of HIV infection.	Int Vaccine Inst, Seoul 151600, South Korea; Minist Hlth, Maputo, Mozambique; Ctr Hlth & Populat Res, Dhaka, Bangladesh; Epicentre, Paris, France; Med Sans Frontieres, Geneva, Switzerland; WHO, Maputo, Mozambique; NICHHD, Bethesda, MD 20892 USA	International Vaccine Institute; Doctors Without Borders; World Health Organization; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Deen, JL (corresponding author), Int Vaccine Inst, POB 14, Seoul 151600, South Korea.	jdeen@ivi.int	Guerin, Philippe/AAH-8873-2021; Ali, Mohammad/E-2365-2017; Cavailler, Philippe/G-4138-2017	Ali, Mohammad/0000-0003-1410-388X; Ampuero, Julia/0000-0001-5486-1656; Guerin, Philippe/0000-0002-6008-2963				Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Clemens J, 1996, JAMA-J AM MED ASSOC, V275, P390, DOI 10.1001/jama.275.5.390; CLEMENS JD, 1986, LANCET, V2, P124; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; CLEMENS JD, 1990, AM J EPIDEMIOL, V131, P400, DOI 10.1093/oxfordjournals.aje.a115515; CLEMENS JD, 1988, J INFECT DIS, V158, P372, DOI 10.1093/infdis/158.2.372; Dorlencourt F, 1999, B WORLD HEALTH ORGAN, V77, P949; ERIKSSON K, 1993, AIDS, V7, P1087, DOI 10.1097/00002030-199308000-00010; HOLMGREN J, 2004, NEW GENERATION VACCI, P499; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; LEWIS DJM, 1994, AIDS, V8, P779, DOI 10.1097/00002030-199406000-00009; MONSUR K. A., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P440, DOI 10.1016/0035-9203(61)90090-6; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Ortigao-deo-Sampaio MB, 1998, AIDS, V12, pF145, DOI 10.1097/00002030-199814000-00001; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PELTOLA H, 1991, LANCET, V338, P1285, DOI 10.1016/0140-6736(91)92590-X; SANCHEZ JL, 1994, LANCET, V344, P1273, DOI 10.1016/S0140-6736(94)90755-2; Shapiro ED, 2004, PEDIATR INFECT DIS J, V23, P127, DOI 10.1097/01.inf.0000109248.32907.1d; Stolley PD, 1982, CASE CONTROL STUDIES, P69; *WHO, 1990, WHOCDDSER802; *WHO, MOZ SUMM COUNTR PROF; *WHO GLOB TASK FOR, 2003, REP CHOL CONTR PROGR; *WHO GLOB TASK FOR, 2004, WHOCDSCPEZFK20045 WH	23	185	198	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2005	352	8					757	767		10.1056/NEJMoa043323	http://dx.doi.org/10.1056/NEJMoa043323			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899MC	15728808	Green Accepted			2022-12-01	WOS:000227147500005
J	Pasupathy, A; Miller, EK				Pasupathy, A; Miller, EK			Different time courses of learning-related activity in the prefrontal cortex and striatum	NATURE			English	Article							BASAL-GANGLIA; NEURONAL-ACTIVITY	To navigate our complex world, our brains have evolved a sophisticated ability to quickly learn arbitrary rules such as 'stop at red'. Studies in monkeys using a laboratory test of this capacity-conditional association learning-have revealed that frontal lobe structures ( including the prefrontal cortex) as well as subcortical nuclei of the basal ganglia are involved in such learning(1-5). Neural correlates of associative learning have been observed in both brain regions(6-14), but whether or not these regions have unique functions is unclear, as they have typically been studied separately using different tasks. Here we show that during associative learning in monkeys, neural activity in these areas changes at different rates: the striatum ( an input structure of the basal ganglia) showed rapid, almost bistable, changes compared with a slower trend in the prefrontal cortex that was more in accordance with slow improvements in behavioural performance. Also, pre-saccadic activity began progressively earlier in the striatum but not in the prefrontal cortex as learning took place. These results support the hypothesis that rewarded associations are first identified by the basal ganglia, the output of which 'trains' slower learning mechanisms in the frontal cortex(15).	MIT, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Pasupathy, A (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	anitha@mit.edu	Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; DeLong M. R., 1981, HDB PHYSL NERVOUS SY, P1017; Fuster J., 2015, PREFRONTAL CORTEX; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GRAYBIEL AM, 1990, REV NEUROL, V146, P570; Hadj-Bouziane F, 2003, EXP BRAIN RES, V153, P190, DOI 10.1007/s00221-003-1592-4; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; PASSINGHAM RE, 1995, FRONTAL LOEBS VOLUNT; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY, P59; Reilly R. O., 2000, COMPUTATIONAL EXPLOR; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schumacher EH, 2003, J COGNITIVE NEUROSCI, V15, P1111, DOI 10.1162/089892903322598085; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	30	527	535	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					873	876		10.1038/nature03287	http://dx.doi.org/10.1038/nature03287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729344				2022-12-01	WOS:000227174600044
J	Wainberg, MA				Wainberg, MA			Generic HIV drugs - Enlightened policy for global health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE		McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada	McGill University	Wainberg, MA (corresponding author), McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada.							*GLOB HIV AIDS PRO, 2004, AIDS S, V18, pS1; Kuritzkes DR, 1996, AIDS, V10, P975, DOI 10.1097/00002030-199610090-00007; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2004, 3 AIDS MED REM PREQ	5	17	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2005	352	8					747	750		10.1056/NEJMp048356	http://dx.doi.org/10.1056/NEJMp048356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899MC	15728804				2022-12-01	WOS:000227147500001
J	Hendrix, SL; Cochrane, BB; Nygaard, IE; Handa, VL; Barnabei, VM; Iglesia, C; Aragaki, A; Naughton, MJ; Wallace, RB; McNeeley, SG				Hendrix, SL; Cochrane, BB; Nygaard, IE; Handa, VL; Barnabei, VM; Iglesia, C; Aragaki, A; Naughton, MJ; Wallace, RB; McNeeley, SG			Effects of estrogen with and without progestin on urinary incontinence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; STRESS-INCONTINENCE; RISK-FACTORS; RECEPTORS; SYMPTOMS; PREVALENCE; MANAGEMENT; SUPPLEMENTATION; ESTRADIOL; HORMONES	Context Menopausal hormone therapy has long been credited with many benefits beyond the indications of relieving hot flashes, night sweats, and vaginal dryness, and it is often prescribed to treat urinary incontinence (UI). Objective To assess the effects of menopausal hormone therapy on the incidence and severity of symptoms of stress, urge, and mixed UI in healthy postmenopausal women. Design, Setting, and Participants Women's Health Initiative multicenter double-blind, placebo-controlled, randomized clinical trials of menopausal hormone therapy in 27347 postmenopausal women aged 50 to 79 years enrolled between 1993 and 1998, for whom UI symptoms were known in 23 296 participants at baseline and 1 year. Interventions Women were randomized based on hysterectomy status to active treatment or placebo in either the estrogen plus progestin (E + P) or estrogen alone trials. The E + P hormones were 0.625 mg/d of conjugated equine estrogen plus 2.5 mg/d of medroxyprogesterone acetate (CEE + MPA); estrogen alone consisted of 0.625 mg/d of conjugated equine estrogen (CEE). There were 8506 participants who received CEE + MPA (8102 who received placebo) and 5310 who received CEE alone (5429 who received placebo). Main Outcome Measures Incident UI at 1 year among women without UI at baseline and severity of UI at 1 year among women who had UI at baseline. Results Menopausal hormone therapy increased the incidence of all types of UI at 1 year among women who were continent at baseline. The risk was highest for stress UI (CEE + MPA: relative risk [RR], 1.87 [95% confidence interval {CI}, 1.61-2.18]; CEE alone: RR, 2.15 [95% CI, 1.77-2.62]), followed by mixed UI (CEE + MPA: RR, 1.49 [95% Cl, 1.10-2.01]; CEE alone: RR, 1.79 [95% Cl, 1.26-2.53]). The combination of CEE + MPA had no significant effect on developing urge UI (RR, 1.15; 95% Cl, 0.99-1.34), but CEE alone increased the risk (RR, 1.32; 95% Cl, 1.10-1.58). Among women experiencing UI at baseline, frequency worsened in both trials (CEE + MPA: RR, 1.38 [95% Cl, 1.28-1.49]; CEE alone: RR, 1.47 [95% Cl, 1.35-1.61]). Amount of UI worsened at 1 year in both trials (CEE + MPA: RR, 1.20 [95% Cl, 1.06-1.36]; CEE alone: RR, 1.59 [95% Cl, 1.39-1.82]). Women receiving menopausal hormone therapy were more likely to report that UI limited their daily activities (CEE + MPA: RR, 1.18 [95% Cl, 1.06-1.32]; CEE alone: RR, 1.29 [95% Cl, 1.15-1.45]) and bothered or disturbed them (CEE + MPA: RR, 1.22 [95% Cl, 1.13-1.32]; CEE alone: RR, 1.50 [95% Cl, 1.37-1.65]) at 1 year. Conclusions Conjugated equine estrogen alone and CEE + MPA increased the risk of UI among continent women and worsened the characteristics of UI among symptomatic women after 1 year. Conjugated equine estrogen with or without progestin should not be prescribed for the prevention or relief of UI.	Wayne State Univ, Sch Med, Hutzel Womens Hosp, Dept Obstet & Gynecol, Detroit, MI 48201 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Univ Iowa, Carver Coll Med, Dept Obstet & Gynecol, Iowa City, IA USA; Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; Washington Hosp Ctr, Dept Obstet & Gynecol, Washington, DC 20010 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA	Wayne State University; Fred Hutchinson Cancer Center; University of Iowa; University of Iowa; Johns Hopkins University; Medical College of Wisconsin; MedStar Washington Hospital Center; Wake Forest University; Wake Forest Baptist Medical Center	Hendrix, SL (corresponding author), Wayne State Univ, Sch Med, Hutzel Womens Hosp, Dept Obstet & Gynecol, Detroit, MI 48201 USA.	shendrix@med.wayne.edu						*1 DATABANK INC, 2000, MDDB PROD LIN DOC MA; AHLSTROM K, 1990, GYNECOL OBSTET INVES, V30, P37, DOI 10.1159/000293211; *AM COLL OBST GYN, 2003, RESP WOM HLTH IN RES; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Andersson KE, 1999, BJU INT, V84, P923; BATRA SC, 1987, J UROLOGY, V138, P1301, DOI 10.1016/S0022-5347(17)43588-9; Brown JS, 1996, OBSTET GYNECOL, V87, P715, DOI 10.1016/0029-7844(96)00013-0; Brown JS, 1999, OBSTET GYNECOL, V94, P66, DOI 10.1016/S0029-7844(99)00263-X; Butler RN, 1999, GERIATRICS, V54, P31; Fantl JA, 1996, OBSTET GYNECOL, V88, P745; FANTL JA, 1994, OBSTET GYNECOL, V83, P12; Fornell EU, 2004, ACTA OBSTET GYN SCAN, V83, P383, DOI 10.1111/j.0001-6349.2004.00367.x; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; Griebling TL, 1997, ENDOCRIN METAB CLIN, V26, P347, DOI 10.1016/S0889-8529(05)70251-6; Grodstein F, 2003, AM J OBSTET GYNECOL, V189, P428, DOI 10.1067/S0002-9378(03)00361-2; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hunskaar S, 2003, UROLOGY, V62, P16, DOI 10.1016/S0090-4295(03)00755-6; IOSIF CS, 1981, AM J OBSTET GYNECOL, V141, P817, DOI 10.1016/0002-9378(81)90710-9; IOSIF CS, 1984, ACTA OBSTET GYN SCAN, V63, P257, DOI 10.3109/00016348409155509; Jackson S, 2002, BJOG-INT J OBSTET GY, V109, P339; Jackson S, 1999, BRIT J OBSTET GYNAEC, V106, P711, DOI 10.1111/j.1471-0528.1999.tb08372.x; JUDGE TG, 1969, GERONTOL CLIN, V11, P159, DOI 10.1159/000245230; Moehrer B, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001405; Muscatello DJ, 2001, INTERN MED J, V31, P151, DOI 10.1046/j.1445-5994.2001.00035.x; Novielli Karen D., 2003, International Urology and Nephrology, V35, P423, DOI 10.1023/B:UROL.0000022868.73066.9a; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; RESNICK NM, 1994, J AM GERIATR SOC, V42, P202, DOI 10.1111/j.1532-5415.1994.tb04953.x; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rufford J, 2003, INT UROGYNECOL J, V14, P78, DOI 10.1007/s00192-003-1054-3; SAEZ S, 1981, J STEROID BIOCHEM, V15, P317, DOI 10.1016/0022-4731(81)90291-0; Sampselle CM, 2002, OBSTET GYNECOL, V100, P1230, DOI 10.1016/S0029-7844(02)02241-X; Sarkar PK, 2000, J CLIN PHARM THER, V25, P251; SCHREITER F, 1976, UROL INT, V31, P13, DOI 10.1159/000280026; Swithinbank LV, 1999, BRIT J GEN PRACT, V49, P897; Thom DH, 1998, J AM GERIATR SOC, V46, P1411; WILSON PD, 1987, BRIT J OBSTET GYNAEC, V94, P568, DOI 10.1111/j.1471-0528.1987.tb03152.x	37	329	335	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2005	293	8					935	948		10.1001/jama.293.8.935	http://dx.doi.org/10.1001/jama.293.8.935			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899LR	15728164	Bronze			2022-12-01	WOS:000227146400015
J	Nojima, S; Schal, C; Webster, FX; Santangelo, RG; Roelofs, WL				Nojima, S; Schal, C; Webster, FX; Santangelo, RG; Roelofs, WL			Identification of the sex pheromone of the German cockroach, Blattella germanica	SCIENCE			English	Article							CALLING BEHAVIOR; LOW-INCOME; ALLERGEN; ABATEMENT; BLA-G-1	The sex pheromone of the German cockroach, Blattella germanica, has been characterized as gentisyl quinone isovalerate. This cockroach is a major cause of allergic disease and serves as a mechanical vector of pathogens, making it one of the most important residential and food-associated pests worldwide. The sex pheromone-producing gland in adult females was identified in 1993, but thermal instability of the pheromone made characterization difficult. Now, using a new preparative gas chromatography approach coupled with electro-, antennographic detection, we have isolated and characterized the pheromone, which we term btattellaquinone, and confirmed the identification by chemical synthesis. The synthetic pheromone was active in behavioral assays and highly effective in field trapping tests, which suggest that it may provide a new tool in cockroach population detection, monitoring, and control.	Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA	Cornell University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Roelofs, WL (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	wlr1@cornell.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358				Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V113, P109, DOI 10.1016/j.jaci.2003.10.042; Arbes SJ, 2003, J ALLERGY CLIN IMMUN, V112, P339, DOI 10.1067/mai.2003.1597; Brenner Richard J., 1995, P77; BROSSUT R, 1983, J CHEM ECOL, V9, P143, DOI 10.1007/BF00987778; Eisner T, 2004, J EXP BIOL, V207, P1313, DOI 10.1242/jeb.00849; LIANG D, 1993, EXPERIENTIA, V49, P324, DOI 10.1007/BF01923412; LIANG D, 1993, TISSUE CELL, V25, P763, DOI 10.1016/0040-8166(93)90057-R; LIANG DS, 1994, J INSECT PHYSIOL, V40, P251, DOI 10.1016/0022-1910(94)90048-5; LIANG DS, 1993, J INSECT BEHAV, V6, P603, DOI 10.1007/BF01048126; McConnell R, 2003, ANN ALLERG ASTHMA IM, V91, P546, DOI 10.1016/S1081-1206(10)61532-3; Nishida R., 1983, Memoirs of the College of Agriculture, Kyoto University, P1; Nojima S, 2004, J CHEM ECOL, V30, P2153, DOI 10.1023/B:JOEC.0000048780.26118.c0; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; SCHAL C, 1990, ANNU REV ENTOMOL, V35, P521, DOI 10.1146/annurev.en.35.010190.002513; Zurek L, 2004, VET MICROBIOL, V101, P263, DOI 10.1016/j.vetmic.2004.04.011	15	94	104	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1104	1106		10.1126/science.1107163	http://dx.doi.org/10.1126/science.1107163			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	900ED	15718472				2022-12-01	WOS:000227197300047
J	Opferman, JT; Iwasaki, H; Ong, CC; Suh, H; Mizuno, S; Akashi, K; Korsmeyer, SJ				Opferman, JT; Iwasaki, H; Ong, CC; Suh, H; Mizuno, S; Akashi, K; Korsmeyer, SJ			Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells	SCIENCE			English	Article							PROGENITORS; LINEAGES; DEATH; MICE; BAX; BCL-2	Apoptosis is important in controlling hematopoietic stem cell (HSC) numbers. However, the specific BCL-2 family member(s) that regulate HSC homeostasis are not precisely defined. We tested myeloid Leukemia-1 (MCL-1) as an attractive candidate that is highly expressed in HSCs and regulated by growth factor signals. Inducible deletion of Mcl-1 in mice resulted in ablation of bone marrow. This resulted in the Loss of early bone marrow progenitor populations, including HSCs. Moreover, growth factors including stem cell factor increased transcription of the Mcl-1 gene and required MCL-1 to augment survival of purified bone marrow progenitors. Deletion of Mcl-1 in other tissues, including liver, did not impair survival. Thus, MCL-1 is a critical and specific regulator essential for ensuring the homeostasis of early hematopoietic progenitors.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS Pathol & Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Akashi, K (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS Pathol & Med, 44 Binney St, Boston, MA 02115 USA.	Koichi_Akashi@dfci.harvard.edu; Stanley_Korsmeyer@dfci.harvard.edu	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621	NCI NIH HHS [R37CA50239, CA072009] Funding Source: Medline; NIDDK NIH HHS [DK061320] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA050239, P01CA072009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061320] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 2001, APOPTOSIS, V6, P239, DOI 10.1023/A:1011347623402; Huang HM, 2000, BLOOD, V96, P1764, DOI 10.1182/blood.V96.5.1764.h8001764_1764_1771; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; OPFERMAN JT, UNPUB; Rinkenberger JL, 2000, GENE DEV, V14, P23; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	20	440	461	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1101	1104		10.1126/science.1106114	http://dx.doi.org/10.1126/science.1106114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718471				2022-12-01	WOS:000227197300046
J	Rich, TH; Hopson, JA; Musser, AM; Flannery, TF; Vickers-Rich, P				Rich, TH; Hopson, JA; Musser, AM; Flannery, TF; Vickers-Rich, P			Independent origins of middle ear bones in Monotremes and Therians	SCIENCE			English	Article							OSSIFIED MECKELS CARTILAGE; MAMMALIAN EVOLUTION; MESOZOIC MAMMALS; PLATYPUS	A dentary of the oldest known monotreme, the Early Cretaceous Teinolophos trusleri, has an internal mandibular trough, which in outgroups to mammals houses accessory jaw bones, and probable contact facets for angular, coronoid, and splenial bones. Certain of these accessory bones were detached from the mandible to become middle ear bones in mammals. Evidence that the angular (homologous with the mammalian ectotympanic) and the articular and prearticular (homologous with the mammalian malleus) bones retained attachment to the lower jaw in a basal monotreme indicates that the definitive mammalian middle ear evolved independently in living monotremes and therians (marsupials and placentals).	Museum Victoria, Melbourne, Vic 3001, Australia; Monash Univ, Sch Geosci, Melbourne, Vic 3800, Australia; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Australian Museum, Sydney, NSW 2010, Australia; S Australian Museum, Adelaide, SA 5000, Australia	Museum Victoria; Monash University; University of Chicago; Australian Museum	Rich, TH (corresponding author), Museum Victoria, POB 666E, Melbourne, Vic 3001, Australia.	trich@museum.vic.gov.au						ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; CHOW M, 1982, Australian Mammalogy, V5, P127; FLEISCHER G, 1973, Saeugetierkundliche Mitteilungen, V21, P131; Forasiepi A, 2004, J VERTEBR PALEONTOL, V24, p59A; FOURIE S, 1974, Annals of the South African Museum, V65, P337; HOPSON JA, 1966, AM ZOOL, V6, P437; HOPSON JA, 2000, ENCY PALEONTOLOGY, P691; HOPSON JA, 1994, MAJOR FEATURES VERTE, P190; Janke A, 1997, P NATL ACAD SCI USA, V94, P1276, DOI 10.1073/pnas.94.4.1276; JENKINS FA, 1983, SCIENCE, V222, P1233, DOI 10.1126/science.222.4629.1233; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; Ji Q, 1999, NATURE, V398, P326; KEMP TS, 1983, ZOOL J LINN SOC-LOND, V77, P353, DOI 10.1111/j.1096-3642.1983.tb00859.x; KERMACK DM, 1968, J LINN SOC ZOOLOGY, V47, P312; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELANJAWOROWSKA Z, 1987, NATURE, V326, P871, DOI 10.1038/326871a0; Krusat G., 1980, MEMORIAS SERVICOS GE, V27, P1; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; MENG J, 1995, NATURE, V377, P141, DOI 10.1038/377141a0; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Musser AM, 2003, COMP BIOCHEM PHYS A, V136, P927, DOI 10.1016/S1095-6433(03)00275-7; Musser AM, 1998, PHILOS T R SOC B, V353, P1063, DOI 10.1098/rstb.1998.0266; NOVACEK MJ, 1993, SKULL, V2, P438; PARRINGTON FR, 1971, PHILOS T R SOC B, V261, P231, DOI 10.1098/rstb.1971.0055; PATTERSON BRUAN, 1956, FIELDIANA GEOL, V13, P1; PATTERSON C, 1980, VICARIANCE BIOGEOGRA, P446; Penny D, 1997, NATURE, V387, P549, DOI 10.1038/42352; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Prothero DR, 1981, B AM MUS NAT HIST, V167, P277; Rauhut OWM, 2002, NATURE, V416, P165, DOI 10.1038/416165a; REICHERT C, 1837, MULLERS ARCH ANAT PH, P120; Rich TH, 2001, ACTA PALAEONTOL POL, V46, P113; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Romer A.S., 1956, OSTEOLOGY REPTILES; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Wible John R., 1995, American Museum Novitates, V3149, P1; WIBLE JR, 1993, MAMMAL PHYLOGENY, V1, P45; Woodburne Michael O., 2003, Journal of Mammalian Evolution, V10, P195, DOI 10.1023/B:JOMM.0000015104.29857.f0; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; Zeller U., 1993, MAMMAL PHYLOGENY, P95; [No title captured]; [No title captured]	48	84	88	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					910	914		10.1126/science.1105717	http://dx.doi.org/10.1126/science.1105717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705848				2022-12-01	WOS:000226985100049
J	Dragun, D; Muller, DN; Brasen, JH; Fritsche, L; Nieminen-Kelha, M; Dechend, R; Kintscher, U; Rudolph, B; Hoebeke, J; Eckert, D; Mazak, I; Plehm, R; Schonemann, C; Unger, T; Budde, K; Neumayer, HH; Luft, FC; Wallukat, G				Dragun, D; Muller, DN; Brasen, JH; Fritsche, L; Nieminen-Kelha, M; Dechend, R; Kintscher, U; Rudolph, B; Hoebeke, J; Eckert, D; Mazak, I; Plehm, R; Schonemann, C; Unger, T; Budde, K; Neumayer, HH; Luft, FC; Wallukat, G			Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE FACTOR; DILATED CARDIOMYOPATHY; AGONISTIC ANTIBODIES; VASCULAR REJECTION; ENDOTHELIAL-CELLS; C4D DEPOSITION; AT(1) RECEPTOR; TRANSPLANTATION; CLASSIFICATION; INJURY	BACKGROUND Antibodies against HLA antigens cause refractory allograft rejection with vasculopathy in some, but not all, patients. METHODS We studied 33 kidney-transplant recipients who had refractory vascular rejection. Thirteen had donor-specific anti-HLA antibodies, whereas 20 did not. Malignant hypertension was present in 16 of the patients without anti- HLA antibodies, 4 of whom had seizures. The remaining 17 patients had no malignant hypertension. We hypothesized that activating antibodies targeting the angiotensin II type 1 (AT(1)) receptor might be involved. RESULTS Activating IgG antibodies targeting the AT(1) receptor were detected in serum from all 16 patients with malignant hypertension and without anti- HLA antibodies, but in no other patients. These receptor-activating antibodies are subclass IgG1 and IgG3 antibodies that bind to two different epitopes on the second extracellular loop of the AT(1) receptor. Tissue factor expression was increased in renal-biopsy specimens from patients with these antibodies. In vitro stimulation of vascular cells with an AT(1)-receptor-activating antibody induced phosphorylation of ERK 1/2 kinase and increased the DNA binding activity of the transcription factors activator protein 1 (AP-1) and nuclear factor-kappaB. The AT(1) antagonist losartan blocked agonistic AT(1) - receptor antibody - mediated effects, and passive antibody transfer induced vasculopathy and hypertension in a rat kidney-transplantation model. CONCLUSIONS A non-HLA, AT(1) - receptor - mediated pathway may contribute to refractory vascular rejection, and affected patients might benefit from removal of AT(1) - receptor antibodies or from pharmacologic blockade of AT(1) receptors.	Charite, Dept Nephrol, D-10117 Berlin, Germany; Charite, Dept Pathol, D-10117 Berlin, Germany; Charite, Cardiovasc Res Ctr, D-10117 Berlin, Germany; Franz Volhard Clin, Berlin, Germany; HELIOS Klin, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; HLA Lab, Berlin, Germany; CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Franz-Volhard Clinical Research Center; Helios Kliniken; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dragun, D (corresponding author), Charite, Dept Nephrol & Transplantat, Campus Mitte,Schumannstr 20-21, D-10117 Berlin, Germany.	duska.dragun@charite.de	Budde, Klemens/AAD-2170-2020	Budde, Klemens/0000-0002-7929-5942; Nieminen-Kelha, Melina/0000-0002-7577-8058; Kintscher, Ulrich/0000-0001-7386-0990; Luft, Friedrich/0000-0002-8635-1199; Dragun, Duska/0000-0002-0310-9269; Muller, Dominik N/0000-0003-3650-5644				AHERN AT, 1982, TRANSPLANTATION, V33, P103, DOI 10.1097/00007890-198201000-00023; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Dobado-Berrios PM, 2001, ARTHRITIS RHEUM-US, V44, P2467, DOI 10.1002/1529-0131(200111)44:11<2467::AID-ART426>3.0.CO;2-U; Dragun D, 2003, TRANSPLANT P, V35, P2104, DOI 10.1016/S0041-1345(03)00680-8; Dragun D, 2000, KIDNEY INT, V58, P2166, DOI 10.1111/j.1523-1755.2000.00390.x; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; Heidenreich S, 1998, J AM SOC NEPHROL, V9, P1309; Hisada Y, 1999, J CLIN INVEST, V103, P627, DOI 10.1172/JCI2454; Holschermann H, 1999, AM J PATHOL, V154, P211, DOI 10.1016/S0002-9440(10)65267-4; JEANNET M, 1970, NEW ENGL J MED, V282, P111, DOI 10.1056/NEJM197001152820301; Le Bas-Bernardet S, 2003, AM J TRANSPLANT, V3, P167, DOI 10.1034/j.1600-6143.2003.00021.x; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; Masuda MO, 1998, FASEB J, V12, P1551, DOI 10.1096/fasebj.12.14.1551; Mauiyyedi S, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133779; Mellor AL, 2000, ANNU REV IMMUNOL, V18, P367, DOI 10.1146/annurev.immunol.18.1.367; Miller JA, 1999, KIDNEY INT, V56, P2173, DOI 10.1046/j.1523-1755.1999.00770.x; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nataraj C, 1999, J CLIN INVEST, V104, P1693, DOI 10.1172/JCI7451; PAUL LC, 1985, TRANSPLANTATION, V40, P117, DOI 10.1097/00007890-198508000-00001; Praprotnik S, 2001, ARTHRITIS RHEUM-US, V44, P1484, DOI 10.1002/1529-0131(200107)44:7<1484::AID-ART269>3.0.CO;2-Q; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rapoport B, 2001, J CLIN INVEST, V108, P1253, DOI 10.1172/JCI14321; Regele H, 2001, NEPHROL DIAL TRANSPL, V16, P2058, DOI 10.1093/ndt/16.10.2058; Remuzzi G, 2002, CURR OPIN NEPHROL HY, V11, P1, DOI 10.1097/00041552-200201000-00001; Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005; SCHWIMMBECK PL, 1989, J CLIN INVEST, V84, P1174, DOI 10.1172/JCI114282; SHIMADA K, 1978, J BIOCHEM-TOKYO, V84, P1013, DOI 10.1093/oxfordjournals.jbchem.a132183; Thway TM, 2004, CIRCULATION, V110, P1612, DOI 10.1161/01.CIR.0000142855.68398.3A; VANDERWOUDE FJ, 1995, KIDNEY INT, V48, pS11; VANSAASE JLCM, 1995, TRANSPLANTATION, V59, P1280, DOI 10.1097/00007890-199505000-00010; Vos IHC, 2000, FASEB J, V14, P815, DOI 10.1096/fasebj.14.5.815; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P397, DOI 10.1016/S0022-2828(08)80036-3; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P2529; YARD B, 1993, TRANSPLANTATION, V55, P1287, DOI 10.1097/00007890-199306000-00015	39	616	647	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2005	352	6					558	569		10.1056/NEJMoa035717	http://dx.doi.org/10.1056/NEJMoa035717			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895KY	15703421	Green Accepted			2022-12-01	WOS:000226862100006
J	Randau, L; Munch, R; Hohn, MJ; Jahn, D; Soll, D				Randau, L; Munch, R; Hohn, MJ; Jahn, D; Soll, D			Nanoarchaeum equitans creates functional tRNAs from separate genes for their 5 '- and 3 '-halves	NATURE			English	Article							ESCHERICHIA-COLI; ARCHAEAL; RECOGNITION; ENDONUCLEASE; 3'-TERMINUS; SYNTHETASE; SEQUENCES; INVITRO; ORIGIN	Analysis of the genome sequence of the small hyperthermophilic archaeal parasite Nanoarchaeum equitans(1,2) has not revealed genes encoding the glutamate, histidine, tryptophan and initiator methionine transfer RNA species. Here we develop a computational approach to genome analysis that searches for widely separated genes encoding tRNA halves that, on the basis of structural prediction, could form intact tRNA molecules. A search of the N. equitans genome reveals nine genes that encode tRNA halves; together they account for the missing tRNA genes. The tRNA sequences are split after the anticodon-adjacent position 37, the normal location of tRNA introns. The terminal sequences can be accommodated in an intervening sequence that includes a 12 - 14-nucleotide GC-rich RNA duplex between the end of the 50 tRNA half and the beginning of the 30 tRNA half. Reverse transcriptase polymerase chain reaction and amino-acylation experiments of N. equitans tRNA demonstrated maturation to full-size tRNA and acceptor activity of the tRNA His and tRNA(Glu) species predicted in silico. As the joining mechanism possibly involves tRNA trans-splicing, the presence of an intron might have been required for early tRNA synthesis.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38023 Braunschweig, Germany; Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany; Univ Regensburg, Archaeenzentrum, D-93053 Regensburg, Germany; Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Braunschweig University of Technology; University of Regensburg; University of Regensburg; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	soll@trna.chem.yale.edu		Jahn, Dieter/0000-0002-4064-9205; Randau, Lennart/0000-0002-2780-2076				Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Boucher Y, 2002, NATURE, V417, P27, DOI 10.1038/417027a; Connolly SA, 2004, BIOCHEMISTRY-US, V43, P962, DOI 10.1021/bi035708f; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Di Giulio M, 1999, J THEOR BIOL, V197, P403, DOI 10.1006/jtbi.1998.0882; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Fabbri S, 1998, SCIENCE, V280, P284, DOI 10.1126/science.280.5361.284; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; HAIN J, 1992, NUCLEIC ACIDS RES, V20, P5423, DOI 10.1093/nar/20.20.5423; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; KlemanLeyer K, 1997, CELL, V89, P839, DOI 10.1016/S0092-8674(00)80269-X; KONARSKA MM, 1985, CELL, V42, P165, DOI 10.1016/S0092-8674(85)80112-4; Li H, 2000, J MOL BIOL, V302, P639, DOI 10.1006/jmbi.2000.3941; Lohan Amanda J, 2004, Methods Mol Biol, V265, P315; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Marck C, 2003, RNA, V9, P1516, DOI 10.1261/rna.5132503; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Nagaswamy U, 2003, ORIGINS LIFE EVOL B, V33, P199, DOI 10.1023/A:1024658727570; Salgia SR, 2003, RNA, V9, P319, DOI 10.1261/rna.2118203; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144; Sekine S, 1996, J MOL BIOL, V256, P685, DOI 10.1006/jmbi.1996.0118; SOLNICK D, 1986, CELL, V44, P211, DOI 10.1016/0092-8674(86)90752-X; Tanaka T., 2001, VIVA ORIGINO, V29, P134; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Williams MA, 2000, NUCLEIC ACIDS RES, V28, P4444, DOI 10.1093/nar/28.22.4444; WISSINGER B, 1991, CELL, V65, P473, DOI 10.1016/0092-8674(91)90465-B; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4	30	149	160	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					537	541		10.1038/nature03233	http://dx.doi.org/10.1038/nature03233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690044				2022-12-01	WOS:000226727200052
J	Rosen, S; Sanne, I; Collier, A; Simon, JL				Rosen, S; Sanne, I; Collier, A; Simon, JL			Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa	LANCET			English	Editorial Material							HIV; AIDS		Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA; Univ Witwatersrand, Clin HIV Res Unit, Johannesburg, South Africa	Boston University; University of Witwatersrand	Rosen, S (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA.	sbrosen@bu.edu	Sanne, Ian/ABH-2231-2020	Simon, Jonathon/0000-0001-6740-549X; Rosen, Sydney/0000-0002-6560-2964				ATTAWELL K, 2003, PROVISION ANTIRETROV; Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Fleck F, 2004, BRIT MED J, V328, P1151, DOI 10.1136/bmj.328.7449.1151; *JICC, 2002, KENY NAT PROP ADDR R; KOMBE G, 2004, 29 ABT ASS INC; Loewenson R, 2004, BMJ-BRIT MED J, V328, P241, DOI 10.1136/bmj.328.7434.241; Mitka M, 2002, JAMA-J AM MED ASSOC, V288, P153, DOI 10.1001/jama.288.2.153; SAKYIADDO K, 2004, GHANA GIVES FREE ANT; STIGLITZ JE, 2004, EC PUBLIC SECTOR; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; World Health Organization, 2002, SCAL ANT THER RES LT; 2004, IRINPLUS NEWS   0305; 2004, IRINPLUS NEWS   0506; 2004, THIS DAY        0616; 2004, IRINPLUS NEWS   0128	15	37	38	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 22	2005	365	9456					354	356						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664233				2022-12-01	WOS:000226449600041
J	Rhodes, CJ				Rhodes, CJ			Type 2 diabetes - A matter of beta-cell life and death?	SCIENCE			English	Editorial Material							INSULIN-RECEPTOR SUBSTRATE-1; TYROSINE PHOSPHORYLATION; OXIDATIVE STRESS; FATTY-ACID; RESISTANCE; APOPTOSIS; KINASE; GROWTH; FAILURE; MASS	In type 2 diabetes, the beta cells of the pancreas fail to produce enough insulin to meet the body's demand, in part because of an acquired decrease in beta-cell mass. In adults, pancreatic beta-cell mass is controlled by several mechanisms, including beta-cell replication, neogenesis, hypertrophy, and survival. Here, I discuss evidence supporting the notion that increased beta-cell apoptosis is an important factor contributing to beta-cell loss and the onset of type 2 diabetes. Interestingly, a key signaling molecule that promotes beta-cell growth and survival, insulin receptor substrate 2 (IRS-2), is a member of a family of proteins whose inhibition contributes to the development of insulin resistance in the liver and other insulin-responsive tissues. Thus, the IRS-2 pathway appears to be a crucial participant in the tenuous balance between effective pancreatic beta-cell mass and insulin resistance.	Pacific NW Res Inst, Seattle, WA 98122 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle	Rhodes, CJ (corresponding author), Pacific NW Res Inst, 720 Broadway, Seattle, WA 98122 USA.	cjr@pnri.org	Northe, Hilda/I-1916-2012	Northe, Hilda/0000-0002-8873-5014	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055267] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-55267] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Borge PD, 2003, J BIOL CHEM, V278, P11359, DOI 10.1074/jbc.M209521200; Bouwens L, 1996, VIRCHOWS ARCH, V427, P553; BRIAUD I, 2004, J BIOL CHEM     1109; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Greene MW, 2004, BIOCHEM J, V378, P105, DOI 10.1042/BJ20031493; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; LEAHY JL, 1990, DIABETES CARE, V13, P992, DOI 10.2337/diacare.13.9.992; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; MCLEAN N, 1955, DIABETES, V4, P367; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Rajagopal J, 2003, SCIENCE, V299, P363; Rhodes CJ, 2002, EUR J CLIN INVEST, V32, P3, DOI 10.1046/j.1365-2362.32.s3.2.x; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Willaime-Morawek S, 2003, NEUROSCIENCE, V119, P387, DOI 10.1016/S0306-4522(02)00996-X; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wrede CE, 2003, J MOL ENDOCRINOL, V30, P271, DOI 10.1677/jme.0.0300271; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)81297-6; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	55	684	755	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					380	384		10.1126/science.1104345	http://dx.doi.org/10.1126/science.1104345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662003				2022-12-01	WOS:000226492300033
J	Niess, JH; Brand, S; Gu, XB; Landsman, L; Jung, S; McCormick, BA; Vyas, JM; Boes, M; Ploegh, HL; Fox, JG; Littman, DR; Reinecker, HC				Niess, JH; Brand, S; Gu, XB; Landsman, L; Jung, S; McCormick, BA; Vyas, JM; Boes, M; Ploegh, HL; Fox, JG; Littman, DR; Reinecker, HC			CX(3)CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance	SCIENCE			English	Article							PEYERS PATCH; IMMUNE-RESPONSES; FRACTALKINE; EPITHELIUM; LOCALIZATION; CHEMOKINE; SUBSETS; GUT	Dendritic cells (DCs) and macrophages are critical to innate and adaptive immunity to the intestinal bacterial microbiota. Here, we identify a myeloid-derived mucosal DC in mice, which populates the entire lamina propria of the small intestine. Lamina propria DCs were found to depend on the chemokine receptor CX(3)CR1 to form transepithelial dendrites, which enable the cells to directly sample luminal antigens. CX(3)CR1 was also found to control the clearance of entero-invasive pathogens by DCs. Thus, CX(3)C1-dependent processes, which control host interactions of specialized DCs with commensal and pathogenic bacteria, may regulate immunological tolerance and inflammation.	Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat Gastroenterol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; NYU, Sch Med, Howard Hughes Med Inst, Mol Pathogenesis Program,Skirball Inst Biomol Med, New York, NY 10016 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; MIT, Div Comparat Med, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Weizmann Institute of Science; Howard Hughes Medical Institute; New York University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Reinecker, HC (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, 55 Fruit St, Boston, MA 02114 USA.	hans-christian-reinecker@hms.harvard.edu	Vyas, Jatin/Q-1627-2016; Niess, Jan/E-8361-2017; Jung, Steffen/K-1409-2012; Landsman, Limor/AAT-5982-2020	Vyas, Jatin/0000-0002-9985-9565; Niess, Jan/0000-0001-6902-5650; Jung, Steffen/0000-0003-4290-5716; Landsman, Limor/0000-0002-8974-1344; Boes, Marianne/0000-0003-2590-1692	NIAID NIH HHS [AI33856] Funding Source: Medline; NIDDK NIH HHS [DK33506, DK54427] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK054427] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banchereau J, 2003, ANN NY ACAD SCI, V987, P180, DOI 10.1111/j.1749-6632.2003.tb06047.x; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kelsall BL, 2002, NAT IMMUNOL, V3, P699, DOI 10.1038/ni0802-699; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Maric I, 1996, J IMMUNOL, V156, P1408; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Uhlig HH, 2003, J CLIN INVEST, V112, P648, DOI 10.1172/JC1200319545; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	18	1177	1222	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					254	258		10.1126/science.1102901	http://dx.doi.org/10.1126/science.1102901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653504				2022-12-01	WOS:000226361900043
J	Yoshimura, T; Kawano, Y; Arimura, N; Kawabata, S; Kikuchi, A; Kaibuchi, K				Yoshimura, T; Kawano, Y; Arimura, N; Kawabata, S; Kikuchi, A; Kaibuchi, K			GSK-3 beta regulates phosphorylation of CRMP-2 and neuronal polarity	CELL			English	Article							RESPONSE MEDIATOR PROTEIN-2; ADENOMATOUS POLYPOSIS-COLI; SYNTHASE KINASE 3-BETA; HIPPOCAMPAL-NEURONS; LIGHT-CHAIN; MICROTUBULE STABILITY; NEURITE OUTGROWTH; SENSORY NEURONS; RHO-KINASE; GROWTH	Neurons are highly polarized and comprised of two structurally and functionally distinct parts, an axon and dendrites. We previously showed that collapsin response mediator protein-2 (CRMP-2) is critical for specifying axon/dendrite fate, possibly by promoting neurite elongation via microtubule assembly. Here, we showed that glycogen synthase kinase-3beta (GSK-3beta) phosphorylated CRMP-2 at Thr-514 and inactivated it. The expression of the nonphosphorylated form of CRMP-2 or inhibition of GSK-3beta induced the formation of multiple axon-like neurites in hippocampal neurons. The expression of constitutively active GSK-3beta impaired neuronal polarization, whereas the nonphosphorylated form of CRMP-2 counteracted the inhibitory effects of GSK-3beta, indicating that GSK-3beta regulates neuronal polarity through the phosphorylation of CRMP-2. Treatment of hippocampal neurons with neurotrophin-3 (NT-3) induced inactivation of GSK-3beta and dephosphorylation of CRMP-2. Knockdown of CRMP-2 inhibited NT-3-induced axon outgrowth. These results suggest that NT-3 decreases phosphorylated CRMP-2 and increases nonphosphorylated active CRMP-2, thereby promoting axon outgrowth.	Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; Hiroshima Univ, Dept Biochem, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348551, Japan	Nagoya University; Hiroshima University	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	kaibuchi@med.nagoya-u.ac.jp	Yoshimura, Takeshi/F-3817-2012; Kawano, Yoji/C-7484-2011	Kawano, Yoji/0000-0003-0687-2777; Yoshimura, Takeshi/0000-0002-0316-8082				Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; BRESNICK AR, 1995, BIOCHEMISTRY-US, V34, P12576, DOI 10.1021/bi00039a012; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goold RG, 1999, J CELL SCI, V112, P3373; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; IP NY, 1993, J NEUROSCI, V13, P3394; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x; KAMISOYAMA H, 1994, BIOCHEMISTRY-US, V33, P840, DOI 10.1021/bi00169a027; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; MORFINI G, 1994, J NEUROSCI RES, V39, P219, DOI 10.1002/jnr.490390212; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SWEENEY HL, 1994, P NATL ACAD SCI USA, V91, P1490, DOI 10.1073/pnas.91.4.1490; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tucker KL, 2002, PANMINERVA MED, V44, P325; UCHIDA Y, IN PRESS GENES CELLS; Yu JY, 2003, MOL THER, V7, P228, DOI 10.1016/S1525-0016(02)00037-0; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	45	721	750	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					137	149		10.1016/j.cell.2004.11.012	http://dx.doi.org/10.1016/j.cell.2004.11.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652488	Bronze			2022-12-01	WOS:000226365400017
J	Dunavan, CP				Dunavan, CP			Jambo, Jahi	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												cpanosian@mednet.ucla.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1430	1431						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784849				2022-12-01	WOS:000227784700001
J	Janssen, EM; Droin, NM; Lemmens, EE; Pinkoski, MJ; Bensinger, SJ; Ehst, BD; Griffith, TS; Green, DR; Schoenberger, SP				Janssen, EM; Droin, NM; Lemmens, EE; Pinkoski, MJ; Bensinger, SJ; Ehst, BD; Griffith, TS; Green, DR; Schoenberger, SP			CD4(+) T-cell help controls CD8(+) T-cell memory via TRAIL-mediated activation-induced cell death	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; CD8-T-CELL MEMORY; CD4-T-CELL HELP; ACUTE INFECTION; LIGAND TRAIL; FAS-LIGAND; APOPTOSIS; EXPRESSION; RECEPTOR; FAMILY	The 'help' provided by CD4(+) T lymphocytes during the priming of CD8(+) T lymphocytes confers a key feature of immune memory: the capacity for autonomous secondary expansion following re-encounter with antigen(1-4). Once primed in the presence of CD4(+) T cells, 'helped' CD8(+) T cells acquire the ability to undergo a second round of clonal expansion upon restimulation in the absence of T-cell help. 'Helpless' CD8(+) T cells that are primed in the absence of CD4(+) T cells, in contrast, can mediate effector functions such as cytotoxicity and cytokine secretion upon restimulation, but do not undergo a second round of clonal expansion. These disparate responses have features of being 'programmed', that is, guided by signals that are transmitted to naive CD8(+) T cells during priming, which encode specific fates for their clonal progeny. Here we explore the instructional programme that governs the secondary response of CD8(+) T cells and find that helpless cells undergo death by activation-induced cell death upon secondary stimulation. This death is mediated by tumour-necrosis factor (TNF)- related apoptosis-inducing ligand ( TRAIL). Regulation of Trail expression can therefore account for the role of CD4(+) T cells in the generation of CD8(+) T cell memory and represents a novel mechanism for controlling adaptive immune responses.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Iowa, Dept Urol, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	La Jolla Institute for Immunology; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	doug@liai.org; sps@liai.org	Griffith, Thomas/ABF-8225-2020; Droin, Nathalie M/Y-5506-2018; Green, Douglas R/N-8083-2018	Droin, Nathalie M/0000-0002-6099-5324; Green, Douglas R/0000-0002-7332-1417				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Martinez-Lorenzo MJ, 1998, EUR J IMMUNOL, V28, P2714, DOI 10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pinkoski MJ, 2002, J BIOL CHEM, V277, P42380, DOI 10.1074/jbc.M208167200; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zhang XR, 2003, CELL DEATH DIFFER, V10, P203, DOI 10.1038/sj.cdd.4401138	26	477	499	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					88	93		10.1038/nature03337	http://dx.doi.org/10.1038/nature03337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744305				2022-12-01	WOS:000227334600049
J	Christopherson, KS; Ullian, EM; Stokes, CCA; Mullowney, CE; Hell, JW; Agah, A; Lawler, J; Mosher, DF; Bornstein, P; Barres, BA				Christopherson, KS; Ullian, EM; Stokes, CCA; Mullowney, CE; Hell, JW; Agah, A; Lawler, J; Mosher, DF; Bornstein, P; Barres, BA			Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis	CELL			English	Article							RETINAL GANGLION-CELLS; INDUCE SYNAPSE FORMATION; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; SILENT SYNAPSES; GLIAL-CELLS; NEURONS; SPECIALIZATIONS; EXPRESSION; CULTURE	The establishment of neural circuitry requires vast numbers of synapses to be generated during a specific window of brain development, but it is not known why the developing mammalian brain has a much greater capacity to generate new synapses than the adult brain. Here we report that immature but not mature astrocytes express thrombospondins (TSPs)-1 and -2 and that these TSPs promote CNS synaptogenesis in vitro and in vivo. TSPs induce ultrastructurally normal synapses that are presynaptically active but postsynaptically silent and work in concert with other, as yet unidentified, astrocyte-derived signals to produce functional synapses. These studies identify TSPs as CNS synaptogenic proteins, provide evidence that astrocytes are important contributors to synaptogenesis within the developing CNS, and suggest that TSP-1 and -2 act as a permissive switch that times CNS synaptogenesis by enabling neuronal molecules to assemble into synapses within a specific window of CNS development.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Wisconsin, Med Sci Ctr, Dept Med, Madison, WI 53706 USA	Stanford University; University of Iowa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison	Christopherson, KS (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	ksc@stanford.edu	Hell, Johannes W./P-5085-2019; Ritter, Stefanie L/D-9312-2012; Lawler, Jack/AAJ-1379-2020		NEI NIH HHS [EY07033] Funding Source: Medline; NHLBI NIH HHS [HL68003] Funding Source: Medline; NIAMS NIH HHS [AR45418] Funding Source: Medline; NIDA NIH HHS [DA15043] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams JC, 2000, DEV DYNAM, V218, P280; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; CHIH B, 2005, IN PRESS SCIENCE; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hayashi K, 1999, J CELL SCI, V112, P1149; IRUELAARISPE ML, 1993, DEV DYNAM, V197, P40, DOI 10.1002/aja.1001970105; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Moller JC, 1996, GLIA, V17, P121; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; ScottDrew S, 1997, J NEUROSCI RES, V50, P202, DOI 10.1002/(SICI)1097-4547(19971015)50:2<202::AID-JNR9>3.0.CO;2-J; Tooney PA, 1998, MATRIX BIOL, V17, P131, DOI 10.1016/S0945-053X(98)90026-9; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025	37	1118	1167	0	67	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 11	2005	120	3					421	433		10.1016/j.cell.2004.12.020	http://dx.doi.org/10.1016/j.cell.2004.12.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707899	Bronze			2022-12-01	WOS:000227028900016
J	MacLean, JA; Chen, MGA; Wayne, CM; Bruce, SR; Rao, M; Meistrich, ML; Macleod, C; Wilkinson, MF				MacLean, JA; Chen, MGA; Wayne, CM; Bruce, SR; Rao, M; Meistrich, ML; Macleod, C; Wilkinson, MF			Rhox: A new homeobox gene cluster	CELL			English	Article							RAPID EVOLUTION; CELL-DEATH; EXPRESSION; SEX; HOX; HOMEODOMAIN; TESTIS; TRANSCRIPTION; TESTOSTERONE; HIERARCHY	Homeobox genes encode transcription factors notable for their ability to regulate embryogenesis. Here, we report the discovery of a cluster of 12 related homeobox genes on the X chromosome expressed in male and female reproductive tissues in adult mice. These reproductive homeobox on the X chromosome (Rhox) genes are expressed in a cell type-specific manner; several are hormonally regulated, and their expression pattern during postnatal testis development corresponds to their chromosomal position. Most of the Rhox genes are expressed in Sertoli cells, the nurse cells in direct contact with developing male germ cells, suggesting that they regulate the expression of somatic-cell gene products critical for germ cell development. In support of this, targeted disruption of Rhox5 increased male germ cell apoptosis and reduced sperm production, sperm motility, and fertility. Identification of this family of homeobox genes provides an opportunity to study colinear gene regulation and the transcriptional control of reproduction.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; Univ Calif San Diego, Sch Med, Dept Med, Ctr Canc, La Jolla, CA 92093 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	Wilkinson, MF (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mwilkins@mdanderson.org						Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Charlesworth B, 2002, NOVART FDN SYMP, V244, P207; Chun JY, 1999, DEV DYNAM, V216, P257, DOI 10.1002/(SICI)1097-0177(199911)216:3<257::AID-DVDY4>3.0.CO;2-0; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; DUBOULE D, 1994, GUIDEBOOK HOMEBOX GE; DYM M, 1971, BIOL REPROD, V4, P195, DOI 10.1093/biolreprod/4.2.195; Gall H, 1999, HAUTARZT, V50, P186, DOI 10.1007/s001050050887; Geserick C, 2002, BIOCHEM J, V366, P367, DOI 10.1042/bj20020399; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Hasegawa M, 1997, RADIAT RES, V147, P457, DOI 10.2307/3579503; Hikim APS, 2003, ENDOCRINOLOGY, V144, P3167, DOI 10.1210/en.2003-0175; Hurst LD, 2001, NATURE, V411, P149, DOI 10.1038/35075697; Jackson M, 2002, J BIOL CHEM, V277, P38683, DOI 10.1074/jbc.M203459200; Kang YL, 2004, BIOL REPROD, V70, P828, DOI 10.1095/biolreprod.103.021048; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Kouprina N, 2004, P NATL ACAD SCI USA, V101, P3077, DOI 10.1073/pnas.0308532100; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kumar TR, 2001, ENDOCRINOLOGY, V142, P3512, DOI 10.1210/en.142.8.3512; Lane RP, 2002, P NATL ACAD SCI USA, V99, P291, DOI 10.1073/pnas.012608399; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIM K, 1994, J ANDROL, V15, P543; Lue YH, 2000, ENDOCRINOLOGY, V141, P1414, DOI 10.1210/en.141.4.1414; Lysiak JJ, 2001, BIOL REPROD, V65, P718, DOI 10.1095/biolreprod65.3.718; Maiti S, 1996, GENOMICS, V34, P304, DOI 10.1006/geno.1996.0291; Martinez P, 2002, COMP BIOCHEM PHYS B, V133, P571, DOI 10.1016/S1096-4959(02)00121-5; MEISTRICH ML, 1993, EUR UROL, V23, P136; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Peterson KJ, 2004, MOL PHYLOGENET EVOL, V31, P1208, DOI 10.1016/j.ympev.2003.10.007; Pitman JL, 1998, DEV BIOL, V202, P196, DOI 10.1006/dbio.1998.8978; Pollard SL, 2000, CURR BIOL, V10, P1059, DOI 10.1016/S0960-9822(00)00676-X; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Rao MK, 2002, J BIOL CHEM, V277, P48771, DOI 10.1074/jbc.M209417200; Rao MK, 2002, J BIOL CHEM, V277, P26036, DOI 10.1074/jbc.M203374200; Reed RR, 2004, CELL, V116, P329, DOI 10.1016/S0092-8674(04)00047-9; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; RUSSELL R, 1993, SERTOLI CELL; Soares MJ, 2001, ENDOCRIN UPDAT, V12, P139; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Sun S, 2004, SCIENCE, V305, P81, DOI 10.1126/science.1093904; Sutton KA, 1997, GENOMICS, V45, P447, DOI 10.1006/geno.1997.4946; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Takasaki N, 2000, DEV BIOL, V223, P181, DOI 10.1006/dbio.2000.9741; TREISMAN J, 1989, CELL, V59, P553; Vallender EJ, 2004, BIOESSAYS, V26, P159, DOI 10.1002/bies.10393; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wayne CM, 2002, GENE, V301, P1, DOI 10.1016/S0378-1119(02)01087-9; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001	55	157	164	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					369	382		10.1016/j.cell.2004.12.022	http://dx.doi.org/10.1016/j.cell.2004.12.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707895	Bronze			2022-12-01	WOS:000227028900012
J	Sezen, UU; Chazdon, RL; Holsinger, KE				Sezen, UU; Chazdon, RL; Holsinger, KE			Genetic consequences of tropical second-growth forest regeneration	SCIENCE			English	Article									Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Sezen, UU (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	uzay.sezen@huskymail.uconn.edu	Holsinger, Kent/A-7435-2009; Sezen, Uğur Uzay/V-1186-2019	Holsinger, Kent/0000-0003-4312-3804; Sezen, Uğur Uzay/0000-0002-2988-8790				Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Cespedes M, 2003, MOL ECOL, V12, P3201, DOI 10.1046/j.1365-294X.2003.01986.x; Chase MR, 1996, NATURE, V383, P398, DOI 10.1038/383398a0; *FAO UN, 2001, 140 FAO UN; HENDESON A, 1990, FLORA NEOTROP MONOGR, V53; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607	6	78	83	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					891	891		10.1126/science.1105034	http://dx.doi.org/10.1126/science.1105034			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705843	Green Submitted			2022-12-01	WOS:000226985100043
J	Panda, S; Nayak, SK; Campo, B; Walker, JR; Hogenesch, JB; Jegla, T				Panda, S; Nayak, SK; Campo, B; Walker, JR; Hogenesch, JB; Jegla, T			Illumination of the melanopsin signaling pathway	SCIENCE			English	Article							RETINAL GANGLION-CELLS; LIGHT; PHOTOTRANSDUCTION; DROSOPHILA; RESPONSES; MELANOPHORES; EXPRESSION; PROTEIN; SYSTEM; GENE	In mammals, a small population of intrinsically photosensitive retinal ganglion cells (ipRGCs) plays a key role in the regulation of nonvisual photic responses, such as behavioral responses to tight, pineal melatonin synthesis, pupillary light reflex, and steep latency. These ipRGCs also express melanopsin (Opn4), a putative opsin-family photopigment that has been shown to play a rote in mediating these nonvisual photic responses. Melanopsin is required for the function of this inner retinal pathway, but its precise role in generating photic responses has not yet been determined. We found that expression of melanopsin in Xenopus oocytes results in light-dependent activation of membrane currents through the Galpha(q)/Galpha(11) G protein pathway, with an action spectrum closely matching that of melanopsin-expressing ipRGCs and of behavioral responses to light in mice lacking rods and cones. When coexpressed with arrestins, melanopsin could use all-trans-retinaldehyde as a chromophore, which suggests that it may function as a bireactive opsin. We also found that melanopsin could activate the cation channel TRPC3, a mammalian homolog of the Drosophila phototransduction channels TRP and TRPL. Melanopsin therefore signals more like an invertebrate opsin than like a classical vertebrate rod-and-cone opsin.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Novartis	Panda, S (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	satchin@salk.edu; tjegta@gnf.org	Panda, Satchidananda/J-6891-2012	Jegla, Timothy/0000-0001-8616-2390				Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; Kiselev A, 1997, BIOCHEMISTRY-US, V36, P2188, DOI 10.1021/bi9621268; Knox BE, 2000, METHOD ENZYMOL, V316, P41; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MEYLAN Z, 2005, IN PRESS NATURE 0126, DOI DOI 10.1038/NATURE03344; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; QIU X, 2005, NATURE          0126, DOI DOI 10.1038/NATURE03345; Rollag MD, 2000, METHOD ENZYMOL, V316, P291; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	29	356	408	4	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					600	604		10.1126/science.1105121	http://dx.doi.org/10.1126/science.1105121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681390				2022-12-01	WOS:000226694000053
J	Waters, AP; Mota, MM; van Dijk, MR; Janse, CJ				Waters, AP; Mota, MM; van Dijk, MR; Janse, CJ			Parasitology - Malaria vaccines: Back to the future?	SCIENCE			English	Editorial Material							PLASMODIUM-FALCIPARUM; PROTECTIVE IMMUNITY; IRRADIATED SPOROZOITES; GENOME SEQUENCE		Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands; Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Instituto Gulbenkian de Ciencia	Waters, AP (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands.	a.p.waters@lumc.nl	Waters, Andy P/C-9377-2009; Mota, Maria/AAF-2048-2019	Waters, Andy P/0000-0001-8900-2982; Janse, Chris J/0000-0002-6410-6205; Mota, Maria Manuel/0000-0002-2858-1041				Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; LEIRIAO P, IN PRESS CELL MICROB; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Morrot A, 2004, IMMUNOL REV, V201, P291, DOI 10.1111/j.0105-2896.2004.00175.x; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; MUELLER AK, 2004, MOL PAR M WOODS HOL; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; VANDIJK MR, UNPUB; ZAVALA F, 1991, RES IMMUNOL, V142, P654, DOI 10.1016/0923-2494(91)90144-8	15	24	35	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2005	307	5709					528	530		10.1126/science.1108598	http://dx.doi.org/10.1126/science.1108598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681372				2022-12-01	WOS:000226694000032
J	Petkova, AT; Leapman, RD; Guo, ZH; Yau, WM; Mattson, MP; Tycko, R				Petkova, AT; Leapman, RD; Guo, ZH; Yau, WM; Mattson, MP; Tycko, R			Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; STRUCTURAL MODEL; COMMON MECHANISM; PRION PROTEIN; PEPTIDE; STATE; PROTOFIBRILS; CONSTRAINTS; MICROSCOPY; NANOWIRES	Amyloid fibrils commonly exhibit multiple distinct morphologies in electron microscope and atomic force microscope images, often within a single image field. By using electron microscopy and solid-state nuclear magnetic resonance measurements on fibrils formed by the 40-residue beta-amyloid peptide of Alzheimer's disease (Abeta(1-40)), we show that different fibril morphologies have different underlying molecular structures, that the predominant structure can be controlled by subtle variations in fibril growth conditions, and that both morphology and molecular structure are self-propagating when fibrils grow from preformed seeds. Different Abeta(1-40) fibril morphologies also have significantly different toxicities in neuronal cell cultures. These results have implications for the mechanism of amyloid formation, the phenomenon of strains in prion diseases, the role of amyloid fibrils in amyloid diseases, and the development of amyloid-based nanomaterials.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; NIH, Div Bioengn & Phys Sci, Off Res Serv, Bethesda, MD 20892 USA; NIA, Neurosci Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tycko, R (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	rt46d@nih.gov	Mattson, Mark P/F-6038-2012	Leapman, Richard/0000-0002-8575-4084	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029029, ZIADK029029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000312, Z01AG000312] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [Z01OD011017] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Burkoth TS, 2000, J AM CHEM SOC, V122, P7883, DOI 10.1021/ja000645z; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Wishart DS, 2001, METHOD ENZYMOL, V338, P3	30	1357	1378	3	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					262	265		10.1126/science.1105850	http://dx.doi.org/10.1126/science.1105850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653506				2022-12-01	WOS:000226361900045
J	Herr, AJ; Jensen, MB; Dalmay, T; Baulcombe, DC				Herr, AJ; Jensen, MB; Dalmay, T; Baulcombe, DC			RNA polymerase IV directs silencing of endogenous DNA	SCIENCE			English	Article							METHYLATION; ARABIDOPSIS; ARGONAUTE4	Plants encode subunits for a fourth RNA polymerase (Pot IV) in addition to the well-known DNA-dependent RNA polymerases I, II, and III. By mutation of the two largest subunits (NRPD1a and NRPD2), we show that Pot IV silences certain transposons and repetitive DNA in a short interfering RNA pathway involving RNA-dependent RNA polymerase-2 and Dicer-like 3. The existence of this distinct silencing polymerase may explain the paradoxical involvement of an RNA silencing pathway in maintenance of transcriptional silencing.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@sainsbury-laboratory.ac.uk	Dalmay, Tamas/E-1377-2011	Dalmay, Tamas/0000-0003-1492-5429; Baulcombe, David/0000-0003-0780-6878; Herr, Alan/0000-0002-9498-0972				Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bellaoui M, 2004, PLANTA, V219, P819, DOI 10.1007/s00425-004-1295-5; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Myouga F, 2001, GENES GENET SYST, V76, P169, DOI 10.1266/ggs.76.169; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	14	518	547	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					118	120		10.1126/science.1106910	http://dx.doi.org/10.1126/science.1106910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15692015				2022-12-01	WOS:000228221500046
J	Elefteriou, F; Ahn, JD; Takeda, S; Starbuck, M; Yang, XL; Liu, XY; Kondo, H; Richards, WG; Bannon, TW; Noda, M; Clement, K; Vaisse, C; Karsenty, G				Elefteriou, F; Ahn, JD; Takeda, S; Starbuck, M; Yang, XL; Liu, XY; Kondo, H; Richards, WG; Bannon, TW; Noda, M; Clement, K; Vaisse, C; Karsenty, G			Leptin regulation of bone resorption by the sympathetic nervous system and CART	NATURE			English	Article							TARGETED DISRUPTION; MICE; ACTIVATION; ELEMENTS; OBESITY; CELLS; GENE	Bone remodelling, the mechanism by which vertebrates regulate bone mass, comprises two phases, namely resorption by osteoclasts and formation by osteoblasts; osteoblasts are multifunctional cells also controlling osteoclast differentiation. Sympathetic signalling via beta 2-adrenergic receptors (Adrb2) present on osteoblasts controls bone formation downstream of leptin(1). Here we show, by analysing Adrb2-deficient mice, that the sympathetic nervous system favours bone resorption by increasing expression in osteoblast progenitor cells of the osteoclast differentiation factor Rankl. This sympathetic function requires phosphorylation ( by protein kinase A) of ATF4, a cell-specific CREB-related transcription factor essential for osteoblast differentiation and function(2). That bone resorption cannot increase in gonadectomized Adrb2-deficient mice highlights the biological importance of this regulation, but also contrasts sharply with the increase in bone resorption characterizing another hypogonadic mouse with low sympathetic tone, the ob/ob mouse(3). This discrepancy is explained, in part, by the fact that CART ('cocaine amphetamine regulated transcript'), a neuropeptide whose expression is controlled by leptin and nearly abolished in ob/ob mice(4), inhibits bone resorption by modulating Rankl expression. Our study establishes that leptin-regulated neural pathways control both aspects of bone remodelling, and demonstrates that integrity of sympathetic signalling is necessary for the increase in bone resorption caused by gonadal failure.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Bone Dis Program Texas, Houston, TX 77030 USA; Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Tokyo Med & Dent Univ, Dept Orthoped, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, Tokyo 1010062, Japan; Amgen Inc, Neurosci, Thousand Oaks, CA 91320 USA; CHRU Pitie Salpetriere, Hotel Dieu, Dept Nutr, F-75004 Paris, France; Univ Paris 06, INSERM, Avenir Team, EA3502, F-75004 Paris, France; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Amgen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Karsenty, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	karsenty@bcm.tmc.edu	Elefteriou, Florent/P-2586-2017; Clément, karine/R-1120-2017; Elefteriou, Florent/GMW-8429-2022; takeda, shu/B-5195-2012; Vaisse, Christian/F-1067-2011	Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Xiangli/0000-0002-2333-8747	NIDDK NIH HHS [R01 DK060540] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060540] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; ORWOLL B, 2004, ORS AAOS PRESENTATIO; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Satoh N, 1999, DIABETES, V48, P1787, DOI 10.2337/diabetes.48.9.1787; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	18	889	958	7	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					514	520		10.1038/nature03398	http://dx.doi.org/10.1038/nature03398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15724149				2022-12-01	WOS:000227836000044
J	Lin, DY; Zhang, SZ; Block, E; Katz, LC				Lin, DY; Zhang, SZ; Block, E; Katz, LC			Encoding social signals in the mouse main olfactory bulb	NATURE			English	Article							GAS-CHROMATOGRAPHY; ODORANT RECEPTORS; HOUSE MOUSE; VOLATILE COMPOUNDS; MASS-SPECTROMETRY; FEMALE MICE; BODY ODORS; PHEROMONE; URINE; DISCRIMINATION	Mammalian urine releases complex mixtures of volatile compounds that are used in reproduction, territoriality and conspecific recognition. To understand how such complex mixtures are represented in the main olfactory bulb, we analysed the electrophysiological responses of individual mitral cells to volatile compounds in mouse urine. In both males and females, urine volatile compounds evoke robust responses in a small subset of mitral cells. Fractionation of the volatile compounds using gas chromatography showed that out of the hundreds of compounds present, mitral cells are activated by single compounds. One cohort of mitral cells responded exclusively to male urine; these neurons were activated by ( methylthio) methanethiol, a potent, previously unknown semiochemical present only in male urine. When added to urine, synthetic ( methylthio) methanethiol significantly enhances urine attractiveness to female mice. We conclude that mitral cells represent natural odorant stimuli by acting as selective feature detectors, and that their activation is largely independent of the presence of other components in the olfactory stimulus.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; SUNY Albany, Dept Chem, Albany, NY 12222 USA	Duke University; Howard Hughes Medical Institute; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Lin, DY (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3209, Durham, NC 27710 USA.	dayulin@neuro.duke.edu	Block, Eric/D-3989-2014	Block, Eric/0000-0002-4668-1687; Lin, Dayu/0000-0003-2006-0791				ANDREOLINI F, 1987, EXPERIENTIA, V43, P998, DOI 10.1007/BF01952217; Baek HH, 2004, FOOD SCI BIOTECHNOL, V13, P90; BALDWIN BA, 1974, ANIM BEHAV, V22, P220, DOI 10.1016/S0003-3472(74)80072-2; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Bocchini P, 1999, RAPID COMMUN MASS SP, V13, P2133, DOI 10.1002/(SICI)1097-0231(19991115)13:21<2133::AID-RCM764>3.0.CO;2-J; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Contarini G, 2002, J AGR FOOD CHEM, V50, P7350, DOI 10.1021/jf025713a; DOTY RL, 1982, HORM BEHAV, V16, P13, DOI 10.1016/0018-506X(82)90002-2; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Fu SG, 2002, J AGR FOOD CHEM, V50, P549, DOI 10.1021/jf010883t; GALEF BG, 1988, PHYSIOL BEHAV, V42, P119, DOI 10.1016/0031-9384(88)90285-5; HARVEY S, 1989, J CHEM ECOL, V15, P2061, DOI 10.1007/BF01207438; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; JEMIOLO B, 1991, J CHEM ECOL, V17, P353, DOI 10.1007/BF00994338; Kayali-Sayadi MN, 2003, J CHROMATOGR B, V796, P55, DOI 10.1016/j.jchromb.2003.08.001; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lee SN, 2003, ANAL BIOANAL CHEM, V377, P749, DOI 10.1007/s00216-003-2163-z; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Lodovichi C, 2003, NEURON, V38, P265, DOI 10.1016/S0896-6273(03)00194-6; LOUCH D, 1992, ANAL CHEM, V64, P1187, DOI 10.1021/ac00034a020; MIYASHITA K, 1980, MECH AGEING DEV, V13, P177, DOI 10.1016/0047-6374(80)90060-3; MORI K, 1995, CURR OPIN NEUROBIOL, V5, P467, DOI 10.1016/0959-4388(95)80007-7; Motokizawa F, 1996, EXP BRAIN RES, V112, P24; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; NOVOTNY M, 1984, EXPERIENTIA, V40, P217, DOI 10.1007/BF01963608; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; Schaefer ML, 2002, J NEUROSCI, V22, P9513; SCHUTTE L, 1971, TETRAHEDRON LETT, P2321; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; SCOTT JW, 1970, PHYSIOL BEHAV, V5, P407, DOI 10.1016/0031-9384(70)90243-X; SHINODA K, 1989, J COMP NEUROL, V284, P362, DOI 10.1002/cne.902840304; SINGER AG, 1976, SCIENCE, V191, P948, DOI 10.1126/science.1251205; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; Torrens J, 2004, J CHROMATOGR SCI, V42, P310, DOI 10.1093/chromsci/42.6.310; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WADHAMS LJ, 1982, Z NATURFORSCH C, V37, P947; WALLACE P, 1977, PHYSIOL BEHAV, V19, P577, DOI 10.1016/0031-9384(77)90238-4; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Weruaga E, 2001, CHEM SENSES, V26, P7, DOI 10.1093/chemse/26.1.7; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817	50	314	326	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					470	477		10.1038/nature03414	http://dx.doi.org/10.1038/nature03414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15724148				2022-12-01	WOS:000227836000033
J	Liu, XG; Zhang, Y; Goswami, DK; Okasinski, JS; Salaita, K; Sun, P; Bedzyk, MJ; Mirkin, CA				Liu, XG; Zhang, Y; Goswami, DK; Okasinski, JS; Salaita, K; Sun, P; Bedzyk, MJ; Mirkin, CA			The controlled evolution of a polymer single crystal	SCIENCE			English	Article							DIP-PEN NANOLITHOGRAPHY; ATOMIC-FORCE MICROSCOPY; X-RAY-DIFFRACTION; ELECTROCHEMICAL NUCLEATION; GROWTH; MONOLAYERS; CRYSTALLIZATION; SURFACES; PARALLEL; PROBE	We present a method for controlling the initiation and kinetics of polymer crystal growth using dip-pen nanolithography and an atomic force microscope tip coated with poly-DL-lysine hydrobromide. Triangular prisms of the polymer epitaxially grow on freshly cleaved mica substrates, and their in-plane and out-of-plane growth rates can be controlled by raster scanning the coated tip across the substrate. Atomic force microscope images were concomitantly recorded, providing a set of photographic images of the process as it spans the nanometer-to micrometer-length scales as a function of environmental conditions.	Northwestern Univ, Dept Mat Sci & Engn, Inst Nanotechnol, Evanston, IL 60208 USA; Northwestern Univ, Nanoscale Sci & Engn Ctr, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Inst Nanotechnol, Evanston, IL 60208 USA.	camirkin@chem.northwestern.edu	Bedzyk, Michael J/K-6903-2013; Bedzyk, Michael J/B-7503-2009; salaita, khalid/C-4414-2008; Mirkin, Chad A/E-3911-2010; Goswami, Dipak Kumar/AAR-4656-2021; LIU, XIAOGANG/A-8038-2011; Goswami, Dipak K/E-8186-2011	Goswami, Dipak Kumar/0000-0002-5891-6172; LIU, XIAOGANG/0000-0003-2517-5790; Goswami, Dipak K/0000-0002-5891-6172; Mirkin, Chad/0000-0002-6634-7627	NIGMS NIH HHS [GM62109-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062109] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal G, 2003, J AM CHEM SOC, V125, P580, DOI 10.1021/ja020471g; Barsotti RJ, 2004, LANGMUIR, V20, P4795, DOI 10.1021/la049763g; Bullen D, 2004, APPL PHYS LETT, V84, P789, DOI 10.1063/1.1644317; Dzwolak W, 2004, J AM CHEM SOC, V126, P3762, DOI 10.1021/ja039138i; Empedocles SA, 1997, SCIENCE, V278, P2114, DOI 10.1126/science.278.5346.2114; Fransaer JL, 1999, J PHYS CHEM B, V103, P7643, DOI 10.1021/jp990622a; Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608; HILLIER AC, 1994, SCIENCE, V263, P1261, DOI 10.1126/science.263.5151.1261; Hobbs JK, 2001, MACROMOLECULES, V34, P353, DOI 10.1021/ma001697b; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Hooks DE, 1998, J PHYS CHEM B, V102, P9958, DOI 10.1021/jp982851n; Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410; JACOBSON BS, 1977, SCIENCE, V195, P302, DOI 10.1126/science.831278; KERN R, 1989, NATO ADV SCI I B-PHY, P143; LAND TA, 1995, PHYS REV LETT, V75, P2774, DOI 10.1103/PhysRevLett.75.2774; LANDAU EM, 1985, NATURE, V318, P353, DOI 10.1038/318353a0; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Maynor BW, 2004, J AM CHEM SOC, V126, P6409, DOI 10.1021/ja0317832; McCrone WC., 1965, PHYSICS CHEM ORGANIC, P726; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Pluth JJ, 1997, P NATL ACAD SCI USA, V94, P12263, DOI 10.1073/pnas.94.23.12263; RATNER B, 1998, ACS S SERIES; Sanz N, 2004, LANGMUIR, V20, P5989, DOI 10.1021/la036385r; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Walko DA, 2004, AIP CONF PROC, V705, P1166, DOI 10.1063/1.1758007; Ward MD, 2001, CHEM REV, V101, P1697, DOI 10.1021/cr000020j; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566	27	91	94	4	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1763	1766		10.1126/science.1109487	http://dx.doi.org/10.1126/science.1109487			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774755				2022-12-01	WOS:000227883900041
J	Jing, Q; Huang, S; Guth, S; Zarubin, T; Motoyama, A; Chen, JM; Di Padova, F; Lin, SC; Gram, H; Han, JH				Jing, Q; Huang, S; Guth, S; Zarubin, T; Motoyama, A; Chen, JM; Di Padova, F; Lin, SC; Gram, H; Han, JH			Involvement of MicroRNA in AU-rich element-mediated mRNA instability	CELL			English	Article							BINDING-PROTEIN; INTERFERENCE; SEQUENCE; CLONING; EXOSOME; HUR; TRISTETRAPROLIN; IDENTIFICATION; DEADENYLATION; TRANSLATION	AU-rich elements (AREs) in the 3' untranslated region (UTR) of unstable mRNAs dictate their degradation. An RNAi-based screen performed in Drosophila S2 cells has revealed that Dicer1, Argonaute1 (Ago1) and Ago2, components involved in microRNA (miRNA) processing and function, are required for the rapid decay of mRNA containing AREs of tumor necrosis factor-a. The requirement for Dicer in the instability of ARE-containing mRNA (ARE-RNA) was confirmed in HeLa cells. We further observed that miR16, a human miRNA containing an UAAAUAUU sequence that is complementary to the ARE sequence, is required for ARE-RNA turnover. The role of miR16 in ARE-RNA decay is sequence-specific and requires the ARE binding protein tristetraprolin (TTP). TTP does not directly bind to miR16 but interacts through association with Ago/eiF2C family members to complex with miR16 and assists in the targeting of ARE. miRNA targeting of ARE, therefore, appears to be an essential step in ARE-mediated mRNA degradation.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Scripps Research Institute; Novartis; Hong Kong University of Science & Technology	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jhan@scripps.edu	Lin, SC/G-4666-2010; Jing, Qing/F-6752-2016; Han, J/G-4671-2010; Motoyama, Andrea/AAB-9362-2019	Jing, Qing/0000-0001-9834-1214; Guth-Gundel, Sabine/0000-0001-9115-1397	NATIONAL CANCER INSTITUTE [R01CA093926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054796, R01AI041637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101] Funding Source: NIH RePORTER; NCI NIH HHS [CA93926] Funding Source: Medline; NIAID NIH HHS [AI41637, AI054796] Funding Source: Medline; NIGMS NIH HHS [GM67101] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	45	668	735	4	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					623	634		10.1016/j.cell.2004.12.038	http://dx.doi.org/10.1016/j.cell.2004.12.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766526	Bronze			2022-12-01	WOS:000227771400009
J	Hessa, T; White, SH; von Heijne, G				Hessa, T; White, SH; von Heijne, G			Membrane insertion of a potassium-channel voltage sensor	SCIENCE			English	Article							DEPENDENT K+ CHANNEL		Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Program Macromol Struct, Irvine, CA 92697 USA	Stockholm University; University of California System; University of California Irvine; University of California System; University of California Irvine	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	White, Stephen/N-1507-2019; von Heijne, Gunnar/AAH-9389-2019; White, Stephen H/B-1053-2009; von Heijne, Gunnar/F-5576-2011	White, Stephen H/0000-0001-8540-7907; von Heijne, Gunnar/0000-0002-4490-8569	NIGMS NIH HHS [GM46823, GM68002] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046823, R01GM068002] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		FREITES JA, UNPUB; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; MacKinnon R, 2004, SCIENCE, V306, P1304, DOI 10.1126/science.1105528; Tu L, 2000, BIOCHEMISTRY-US, V39, P824, DOI 10.1021/bi991740r	7	160	162	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1427	1427		10.1126/science.1109176	http://dx.doi.org/10.1126/science.1109176			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15681341				2022-12-01	WOS:000227503100035
J	Su, H; Bidere, N; Zheng, LX; Cubre, A; Sakai, K; Dale, J; Salmena, L; Hakem, R; Straus, S; Lenardo, M				Su, H; Bidere, N; Zheng, LX; Cubre, A; Sakai, K; Dale, J; Salmena, L; Hakem, R; Straus, S; Lenardo, M			Requirement for caspase-8 in NF-kappa B activation by antigen receptor	SCIENCE			English	Article							MALT1; BCL10; THETA	Caspase-8, a proapoptotic protease, has an essential role in lymphocyte activation and protective immunity. We show that caspase-8 deficiency (CED) in humans and mice specifically abolishes activation of the transcription factor nuclear factor kappaB (NF-kappaB) after stimulation through antigen receptors, Fc receptors, or Toll-like receptor 4 in T, B, and natural killer cells. Caspase-8 also causes the up complex of the inhibitor of NF-kappaB kinase (IKK) to associate with the upstream Bcl10-MALT1 (mucosa-associated lymphatic tissue) adapter complex. Recruitment of the IKKalpha,beta complex, its activation, and the nuclear translocation of NF-kappaB require enzyme activity of full-length caspase-8. These findings thus explain the paradoxical association of defective apoptosis and combined immunodeficiency in human CED.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lenardo, M (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov	Su, Helen C/H-9541-2015; sakai, Keiko/F-5807-2013; Bidère, Nicolas/K-8887-2015	Su, Helen C/0000-0002-5582-9110; Bidère, Nicolas/0000-0001-9177-0008; Hakem, Razqallah/0000-0001-5948-7931; Salmena, Leonardo/0000-0003-4023-658X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000732, ZIAAI000565, Z01AI000732, ZIAAI000769, Z01AI000769, Z01AI000565] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yu L, 2003, SCIENCE, V302, P1515, DOI 10.1126/science.1092951; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	21	338	363	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1465	1468		10.1126/science.1104765	http://dx.doi.org/10.1126/science.1104765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746428	Green Published			2022-12-01	WOS:000227503100047
J	Bertram, L; Hiltunen, M; Parkinson, M; Ingelsson, M; Lange, C; Ramasamy, K; Mullin, K; Menon, R; Sampson, AJ; Hsiao, MY; Elliott, KJ; Velicelebi, G; Moscarillo, T; Hyman, BT; Wagner, SL; Becker, KD; Blacker, D; Tanzi, RE				Bertram, L; Hiltunen, M; Parkinson, M; Ingelsson, M; Lange, C; Ramasamy, K; Mullin, K; Menon, R; Sampson, AJ; Hsiao, MY; Elliott, KJ; Velicelebi, G; Moscarillo, T; Hyman, BT; Wagner, SL; Becker, KD; Blacker, D; Tanzi, RE			Family-based association between Alzheimer's disease and variants in UBQLN1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-E; LINKAGE; PROTEIN; ALLELE; TESTS; ONSET; UBIQUILIN; AGE; UBIQUITINATION; ACCUMULATION	BACKGROUND Recent analyses suggest that the known Alzheimer's disease genes account for less than half the genetic variance in this disease. The gene encoding ubiquilin 1 (UBQLN1) is one of several candidate genes for Alzheimer's disease located near a well-established linkage peak on chromosome 9q22. METHODS We evaluated 19 single-nucleotide polymorphisms in three genes within the chromosome 9q linkage region in 437 multiplex families with Alzheimer's disease from the National Institute of Mental Health (NIMH) sample (1439 subjects). We then tested the single-nucleotide polymorphisms showing a positive result in an independently identified set of 217 sibships discordant for Alzheimer's disease (Consortium on Alzheimer's Genetics [CAG] sample; 489 subjects) and assessed the functional effect of an implicated single-nucleotide polymorphism in brain tissue from 25 patients with Alzheimer's disease and 17 controls. RESULTS In the NIMH sample, we observed a significant association between Alzheimer's disease and various single-nucleotide polymorphisms in UBQLN1. We confirmed these associations in the CAG sample. The risk-conferring haplotype in both samples was defined by a single intronic single-nucleotide polymorphism located downstream of exon 8. The risk allele was associated with a dose-dependent increase in an alternatively spliced UBQLN1 (lacking exon 8) transcript in RNA extracted from brain samples of patients with Alzheimer's disease. CONCLUSIONS Our findings suggest that genetic variants in UBQLN1 on chromosome 9q22 substantially increase the risk of Alzheimer's disease, possibly by influencing alternative splicing of this gene in the brain.	Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA; Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimer Dis Res Unit, Charlestown, MA USA; Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; Massachusetts Gen Hosp, Dept Psychiat, Gerontol Res Unit, Charlestown, MA USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Neurogenetics, La Jolla, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Tanzi, RE (corresponding author), MGH E, MIND, Genet & Aging Res Unit, 114 16th St, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Elliott, Kathryn/0000-0002-4926-1215				Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; BLACKER D, 1994, ARCH NEUROL-CHICAGO, V51, P1198, DOI 10.1001/archneur.1994.00540240042014; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; MARTIN ER, 2003, J BIOINFORM COMPUT B, V1, P1; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Pfeiffer RM, 2003, GENET EPIDEMIOL, V25, P136, DOI 10.1002/gepi.10245; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tanzi RE, 1999, J CLIN INVEST, V104, P1175, DOI 10.1172/JCI8593; Witte JS, 1999, AM J EPIDEMIOL, V149, P693; Wollmer MA, 2003, NEUROBIOL AGING, V24, P421, DOI 10.1016/S0197-4580(02)00094-5; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Wu SL, 2002, BBA-MOL CELL RES, V1542, P41, DOI 10.1016/S0167-4889(01)00164-1	30	196	204	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					884	894		10.1056/NEJMoa042765	http://dx.doi.org/10.1056/NEJMoa042765			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745979				2022-12-01	WOS:000227310700007
J	Gill, SS; Rochon, PA; Herrmann, N; Lee, PE; Sykora, K; Gunraj, N; Normand, SLT; Gurwitz, JH; Marras, C; Wodchis, WP; Mamdani, M				Gill, SS; Rochon, PA; Herrmann, N; Lee, PE; Sykora, K; Gunraj, N; Normand, SLT; Gurwitz, JH; Marras, C; Wodchis, WP; Mamdani, M			Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CEREBROVASCULAR EVENTS; DEMENTIA; RISPERIDONE; MANAGEMENT; SYMPTOMS; ATTACK; TRIAL	Objective To compare the incidence of admissions to hospital for stroke among older adults with dementia,receiving atypical or typical ancipsychotics. Design Population based retrospective cohort study. Setting Ontario, Canada. Patients 32 7 10 older adults 65 years) with dementia (17 845 dispensed an atypical antipsychotic and 14 865 dispensed a typical antipsychotic). Main outcome measures Admission to hospital with the most responsible diagnosis (single most important condition responsible for the patients admission) of ischaemic stroke. Observation of patients until they were either admitted to hospital with ischaemic stroke, stopped taking antipsychotics, died, or the study ended. Results After adjustment for potential confounders, participants receiving atypical antipsychotics showed no significant increase in risk of ischaemic stroke compared with those receiving typical antipsychotics (adjusted hazard ratio 1.01, 95% confidence interval 0.81 to 1.26). This finding was consistent in a series of subgroup analyses, including ones of individual atypical antipsychotic drugs (risperidone, olanzapine, and quetiapine) and selected subpopulations of the main cohorts. Conclusion Older adults with dementia who take atypical antipsychotics have a similar risk of ischaemic stroke to those taking typical antipsychotics.	Inst Clin Evaluat Sci, Toronto, ON, Canada; Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Div Geriatr Psychiat, Toronto, ON, Canada; Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada; Toronto Rehabil Inst, Toronto, ON, Canada; Univ British Columbia, Div Geriatr Med, Vancouver, BC V5Z 1M9, Canada; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of British Columbia; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Gill, SS (corresponding author), St Marys Lake Hosp, Chapel Wing, Room 1-152,340 Union St, Kingston, ON K7L 5A2, Canada.	gills@pccchealth.org	Rochon, Paula A/J-2918-2016; Greiver, Michelle/N-8764-2015	Rochon, Paula A/0000-0002-5973-4151; Greiver, Michelle/0000-0001-8957-0285; wodchis, walter/0000-0003-2494-7031; Normand, Sharon-Lise/0000-0001-7027-4769				Brodaty H, 2003, J CLIN PSYCHIAT, V64, P134, DOI 10.4088/JCP.v64n0205; Brown TM, 2002, BMJ-BRIT MED J, V325, P644, DOI 10.1136/bmj.325.7365.644; *CALM AD, CALM AD TRIAL RAND C; *CEM CMO, CEMCMO20041; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COHEN CA, 1993, GERONTOLOGIST, V33, P714, DOI 10.1093/geront/33.6.714; Cohen-Mansfield J, 1998, J AM GERIATR SOC, V36, P7; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Gladstone DJ, 2004, CAN MED ASSOC J, V170, P1099, DOI 10.1503/cmaj.1031349; Harrison-Woolrych M, 2004, BRIT MED J, V328, P1416, DOI 10.1136/bmj.328.7453.1416; Health Canada, IMP DRUG SAF INF RIS; Herrmann N, 2004, AM J PSYCHIAT, V161, P1113, DOI 10.1176/appi.ajp.161.6.1113; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2F; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; KOZMA CM, 2003 M INT COLL GER; Lee PE, 2004, BMJ-BRIT MED J, V329, P75, DOI 10.1136/bmj.38125.465579.55; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liperoti R, 2003, J CLIN PSYCHIAT, V64, P1106, DOI 10.4088/JCP.v64n0918; LIPEROTI R, 2004 ANN M AM GER SO; LIPEROTI R, 200J ANN M AM GER SO; Mayo N E, 1994, Health Rep, V6, P62; Mowat D, 2004, BRIT MED J, V328, P1262, DOI 10.1136/bmj.328.7450.1262-b; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider LS, 2001, AM J GERIAT PSYCHIAT, V9, P346, DOI 10.1176/appi.ajgp.9.4.346; Smith David A, 2004, J Am Med Dir Assoc, V5, P129, DOI 10.1097/01.JAM.0000113432.52383.E0; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1388, DOI 10.1001/jama.288.11.1388; Tariot PN, 2001, CLIN GERIATR MED, V17, P359, DOI 10.1016/S0749-0690(05)70073-2; Teri L, 2002, MED CLIN N AM, V86, P641, DOI 10.1016/S0025-7125(02)00006-8; *US FDA, 2004, 2003 SAF AL RISPERDA; Wallaschofski H, 2001, J CLIN ENDOCR METAB, V86, P5912, DOI 10.1210/jc.86.12.5912; Wooltorton E, 2002, CAN MED ASSOC J, V167, P1269; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1395, DOI 10.1503/cmaj.1040539; *WORK GROUP FAC OL, GUID MAN BEH PSYCH S; Zornberg GL, 2000, LANCET, V356, P1219, DOI 10.1016/S0140-6736(00)02784-7; WUETIAPINE EVALUATED	37	221	225	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2005	330	7489					445	448B		10.1136/bmj.38330.470486.8F	http://dx.doi.org/10.1136/bmj.38330.470486.8F			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15668211	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000227315400016
J	Zhu, GP; Golding, GB; Dean, AM				Zhu, GP; Golding, GB; Dean, AM			The selective cause of an ancient adaptation	SCIENCE			English	Article							ISOCITRATE DEHYDROGENASE; ESCHERICHIA-COLI; 3-ISOPROPYLMALATE DEHYDROGENASE; DECARBOXYLATING DEHYDROGENASE; COFACTOR SPECIFICITY; NUCLEOTIDE-SEQUENCE; ADAPTIVE EVOLUTION; NATURAL-SELECTION; CRYSTAL-STRUCTURE; BRANCH POINT	Phylogenetic analysis reveals that the use of nicotinamide adenine dinucleotide phosphate (NADP) by prokaryotic isocitrate dehydrogenase (IDH) arose around the time eukaryotic mitochondria first appeared, about 3.5 billion years ago. We replaced the wild-type gene that encodes the NADP-dependent IDH of Escherichia coli with an engineered gene that possesses the ancestral NAD-dependent phenotype. The engineered enzyme is disfavored during competition for acetate. The selection intensifies in genetic backgrounds where other sources of reduced NADP have been removed. A survey of sequenced prokaryotic genomes reveals that those genomes that encode isocitrate lyase, which is essential for growth on acetate, always have an NADP-dependent IDH. Those with only an NAD-dependent IDH never have isocitrate lyase. Hence, the NADP dependence of prokaryotic IDH is an ancient adaptation to anabolic demand for reduced NADP during growth on acetate.	Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; McMaster University	Dean, AM (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.	adean@biosci.umn.edu		Zhu, Guo-ping/0000-0002-1877-4501	NIGMS NIH HHS [GM060611] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060611] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; CLARKE B, 1975, GENETICS, V79, P101; CLARKE DM, 1986, EUR J BIOCHEM, V158, P647, DOI 10.1111/j.1432-1033.1986.tb09802.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; DYKHUIZEN DE, 1993, METHOD ENZYMOL, V224, P613, DOI 10.1016/0076-6879(93)24046-W; FELSENSTEIN J, 1994, PHYLIP VER 3 5; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Hurley JH, 1996, BIOCHEMISTRY-US, V35, P5670, DOI 10.1021/bi953001q; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1994, STRUCTURE, V2, P1007, DOI 10.1016/S0969-2126(94)00104-9; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; KIRINO H, 1991, J BIOCHEM-TOKYO, V109, P852, DOI 10.1093/oxfordjournals.jbchem.a123470; Lunzer M, 2002, GENETICS, V162, P485; Madigan M., 2000, BROCK BIOL MICROORGA, V9th; Miller SP, 2000, J BIOL CHEM, V275, P833, DOI 10.1074/jbc.275.2.833; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Neidhardt F.C., 1990, PHYSL BACTERIAL CELL; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Shi YS, 2003, P NATL ACAD SCI USA, V100, P8308, DOI 10.1073/pnas.1532535100; Sivaraman J, 2003, J BIOL CHEM, V278, P43682, DOI 10.1074/jbc.M306344200; Suiter AM, 2003, P NATL ACAD SCI USA, V100, P12782, DOI 10.1073/pnas.2134994100; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; TIPTON PA, 1994, ARCH BIOCHEM BIOPHYS, V313, P15, DOI 10.1006/abbi.1994.1352; Voet D., 2004, BIOCHEMISTRY-US; WALSH K, 1984, J BIOL CHEM, V259, P9646; WALSH K, 1985, J BIOL CHEM, V260, P8430; Yasutake Y, 2003, J BIOL CHEM, V278, P36897, DOI 10.1074/jbc.M304091200; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4; Zhu G., UNPUB	32	109	118	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1279	1282		10.1126/science.1106974	http://dx.doi.org/10.1126/science.1106974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15653464				2022-12-01	WOS:000227313200050
J	Yamagishi, K; Onuma, K; Suzuki, T; Okada, F; Tagami, J; Otsuki, M; Senawangse, P				Yamagishi, K; Onuma, K; Suzuki, T; Okada, F; Tagami, J; Otsuki, M; Senawangse, P			A synthetic enamel for rapid tooth repair	NATURE			English	Article							GROWTH		FAP Dent Inst, Meguro Ku, Tokyo 1520022, Japan; Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; Univ Yamanashi, Fac Engn, Dept Appl Chem & Biotechnol, Yamanashi 4008511, Japan; Tokyo Med & Dent Univ, Grad Sch, Dept Restorat Sci, Bunkyo Ku, Tokyo 1138549, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Yamanashi; Tokyo Medical & Dental University (TMDU)	Yamagishi, K (corresponding author), FAP Dent Inst, Meguro Ku, 3-2-1 Kakinokizaka,502, Tokyo 1520022, Japan.	FZT02705@nifty.com	Onuma, Kazuo/L-8736-2018					[Anonymous], 1994, STRUCTURE CHEM APATI; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Carvalho RM, 1996, OPER DENT, V21, P17; Duschner H, 1997, EUR J ORAL SCI, V105, P466, DOI 10.1111/j.1600-0722.1997.tb00232.x; FRANK RM, 1966, ARCH ORAL BIOL, V11, P883, DOI 10.1016/0003-9969(66)90080-X; GEROULD CH, 1945, J DENT RES, V24, P223, DOI 10.1177/00220345450240050201; Hilton TJ, 2002, AM J DENT, V15, P198; JOHNSON N. W., 1967, CARIES RES, V1, P356; Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c; Raskin A, 1999, J DENT, V27, P13, DOI 10.1016/S0300-5712(98)00026-8; Wilson NHF, 2000, J DENT, V28, P15, DOI 10.1016/S0300-5712(99)00055-X; YAMAGISHI K, 1995, ESTHETIC DENT, V7, P78	12	184	201	7	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					819	819		10.1038/433819a	http://dx.doi.org/10.1038/433819a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729330				2022-12-01	WOS:000227174600030
J	Li, Y; Di Naro, E; Vitucci, A; Zimmermann, B; Holzgreve, W; Hahn, S				Li, Y; Di Naro, E; Vitucci, A; Zimmermann, B; Holzgreve, W; Hahn, S			Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TIME QUANTITATIVE PCR; PRENATAL-DIAGNOSIS; CYSTIC-FIBROSIS; BLOOD; ANEMIA	Context Currently, fetal point mutations cannot be reliably analyzed from circulatory fetal DNA in maternal plasma, due to the predominance of maternal DNA sequences. However, analysis of circulatory fetal DNA sequences in maternal plasma have been shown to selectively enrich for fetal DNA molecules on the basis of a smaller molecular size than maternal DNA. Objective To examine the prenatal analysis of 4 common beta-thalassemia point mutations: IVSI-1, IVSI-6, 1VSI-110, and codon 39. Design, Setting, and Patients A total of 32 maternal blood samples were collected at 10 to 12 weeks of gestation (mean, 10.7 weeks) between February 15, 2003, and February 25, 2004, in Bari, Italy, from women with risk for beta-thalassemia in their newborns immediately prior to chorionic villous sampling. Samples in which the father and mother did not carry the same mutation were examined. Circulatory DNA was size-fractionated by gel electrophoresis and polymerase chain reaction (PCR) amplified with a peptide-nucleic-acid clamp, which suppresses amplification of the normal maternal allele. Presence of the paternal mutant allele was detected by allele-specific real-time PCR. Main Outcome Measure Detection of paternally inherited p-globin gene point mutations. Results Presence or absence of the paternal mutant allele was correctly determined in 6 (86%) of 7 cases with the IVSI-1 mutation, 4 (100%) of 4 with the IVSI-6 mutation, 5 (100%) of 5 with the IVSI-110 mutation, and 13 (81%) of 16 with the codon 39 mutation. One false-positive test result was scored for the IVSI-1 mutation. Two cases with the codon 39 mutation were classified as uncertain and 1 case was excluded due to lack of a diagnostic. test result,at the time of analysis. These results yielded an overall sensitivity of 100% and specificity of 93.8%, with classified cases removed. Conclusion Our recently described technique of the size-fractionation of circulatory DNA in maternal plasma may be potentially useful for the noninvasive prenatal determination of fetal point mutations.	Univ Basel Hosp, Univ Womens Hosp, Dept Res, Lab Prenatal Med, CH-4013 Basel, Switzerland; Univ Bari, Dept Obstet & Gynecol, Bari, Italy; Univ Bari, Div Hematol 2, Bari, Italy	University of Basel; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Hahn, S (corresponding author), Univ Basel Hosp, Univ Womens Hosp, Dept Res, Lab Prenatal Med, Spitalstr 21, CH-4013 Basel, Switzerland.	shahn@uhbs.ch		di naro, edoardo/0000-0001-7675-7171; Zimmermann, Bernhard/0000-0002-5275-4571				Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; Chiu Rossa W K, 2002, Expert Rev Mol Diagn, V2, P32, DOI 10.1586/14737159.2.1.32; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; Di Naro E, 2000, MOL HUM REPROD, V6, P571, DOI 10.1093/molehr/6.6.571; Ding CM, 2004, P NATL ACAD SCI USA, V101, P10762, DOI 10.1073/pnas.0403962101; Hahn S, 2000, ANN NY ACAD SCI, V906, P148; Hahn S, 2002, CLIN OBSTET GYNECOL, V45, P649, DOI 10.1097/00003081-200209000-00008; JACKSON LG, 1992, NEW ENGL J MED, V327, P594, DOI 10.1056/NEJM199208273270903; KAZAZIAN HH, 1988, BLOOD, V72, P1107; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Nasis O, 2004, CLIN CHEM, V50, P694, DOI 10.1373/clinchem.2003.025981; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; Simpson JL, 2004, JAMA-J AM MED ASSOC, V291, P1135, DOI 10.1001/jama.291.9.1135; Strom CM, 2004, GENET MED, V6, P136, DOI 10.1097/01.GIM.0000127268.65149.69; Swinkels DW, 2003, CLIN CHEM, V49, P525, DOI 10.1373/49.3.525; TABOR A, 1986, LANCET, V1, P1287; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Weatherall DJ, 2004, NAT REV GENET, V5, P625, DOI 10.1038/nrg1406; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; Zhong XY, 2001, LANCET, V357, P310, DOI 10.1016/S0140-6736(05)71754-2; Zimmermann B, 2002, CLIN CHEM, V48, P362	24	171	241	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2005	293	7					843	849		10.1001/jama.293.7.843	http://dx.doi.org/10.1001/jama.293.7.843			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DQ	15713774	Bronze			2022-12-01	WOS:000226984600026
J	Kay, B; Nam, VS				Kay, B; Nam, VS			New strategy against Aedes aegypti in Vietnam	LANCET			English	Article							MESOCYCLOPS COPEPODA; FUNNEL TRAP; DENGUE; ALBOPICTUS; CULICIDAE; DIPTERA; MOSQUITOS; LARVAE	The container-breeding mosquito, Aedes aegypti, is the major global vector of dengue viruses, causing around 50 million infections annually. We have developed-a mosquito control strategy, incorporating four elements: (1) a combined vertical and horizontal approach that depends on community understanding; (2) prioritised control according to the larval productivity of major habitat types; (3) use of predacious copepods of the genus Mesocyclops as a biological control agent; delivered by (4) community activities of health volunteers, schools, and the public.. We have previously reported that, from 1998 to 2003, community-based vector control had resulted in A aegypti elimination in six of nine communes, with only small numbers of larvae detected in the others. Here, we report eradication in two further communes and, as a result of local expansion after the project in three northern provinces, elimination from 32 of 37 communes (309 730 people). As a result, no dengue cases have been detected in any commune since 2002. These findings suggest that this strategy is sustainable in Vietnam and applicable where the major sources of A aegypti are large water storage containers.	Queensland Inst Med Res, Australian Ctr Int & Trop Hlth & Nutr, Brisbane, Qld 4006, Australia; Minist Hlth, Gen Dept Prevent Med & HIV AIDS Control, Hanoi, Vietnam	QIMR Berghofer Medical Research Institute	Kay, B (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	brianK@qimr.edu.au						Almond Jeffrey, 2002, Vaccine, V20, P3043, DOI 10.1016/S0264-410X(02)00246-3; BRETEAU H, 1954, Bull World Health Organ, V11, P453; Dieng H, 2002, MED VET ENTOMOL, V16, P285, DOI 10.1046/j.1365-2915.2002.00377.x; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; HALSTEAD SB, 1987, ARBOVIRUS RES AUSTR, V4, P30; Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292; KAY BH, 1992, J AM MOSQUITO CONTR, V8, P372; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; Kay BH, 2002, J MED ENTOMOL, V39, P469, DOI 10.1603/0022-2585-39.3.469; KAY BH, 2001, ARBOVIRUS RES AUST, V8, P187; LARDEUX F, 1992, J MED ENTOMOL, V29, P571, DOI 10.1093/jmedent/29.4.571; Lifson AR, 1996, LANCET, V347, P1201, DOI 10.1016/S0140-6736(96)90730-8; MARTEN GG, 1990, J AM MOSQUITO CONTR, V6, P681; Marten GG, 2000, J VECTOR ECOL, V25, P1; MARTEN GG, 1994, HYDROBIOLOGIA, V293, P491, DOI 10.1007/BF00229976; MARTEN GG, 1990, J AM MOSQUITO CONTR, V6, P689; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Nam VS, 2003, J AM MOSQUITO CONTR, V19, P220; Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657; Nam VS, 2000, AM J TROP MED HYG, V62, P5, DOI 10.4269/ajtmh.2000.62.5; Russell BM, 1999, J MED ENTOMOL, V36, P851, DOI 10.1093/jmedent/36.6.851; *SECR 55 WORLD HLT, 2002, DENGUE B, V26, P218; THAN PV, 2004, J PRACTICE MED, V477, P89; TUNLIN W, 1994, J AM MOSQUITO CONTR, V10, P390; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; United Nations, 2003, WAT PEOPL WAT LIF; *WHO, 1972, WKLY EPIDEMIOL REC, V47, P73; ZHEN TM, 1993, J AM MOSQUITO CONTR, V9, P316	30	158	165	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					613	617		10.1016/S0140-6736(05)17913-6	http://dx.doi.org/10.1016/S0140-6736(05)17913-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708107				2022-12-01	WOS:000226984300036
J	Martis, L; Patel, M; Giertych, J; Mongoven, J; Taminne, M; Perrier, MA; Mendoza, O; Goud, N; Costigan, A; Denjoy, N; Verger, C; Owen, WF				Martis, L; Patel, M; Giertych, J; Mongoven, J; Taminne, M; Perrier, MA; Mendoza, O; Goud, N; Costigan, A; Denjoy, N; Verger, C; Owen, WF			Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution	LANCET			English	Article							CHEMICAL PERITONITIS; STERILE PERITONITIS; CYTOKINE RELEASE; ICODEXTRIN; ENDOTOXIN; PYROGENS; ASSAY; CAPD	Background Manufacturers of parenteral solutions adhere to European and US Pharmacopoeia standards to define safety and sterility. In response to excess cases of aseptic peritonitis in peritonea,l dialysis patients using icodextrin-containing dialysate that met all Pharmacopoeia standards, a global recall was issued in May, 2002. We aimed to establish the cause of aseptic peritonitis. Methods We analysed 186 reports of aseptic peritonitis between September, 2001, and January, 2003. Extensive physical, chemical, and microbiological investigations of recalled dialysate were done. We calculated dose-response curves for peptidoglycan-induced interleukin 6 elaboration in peripheral blood mononuclear cells (PBMCs) from healthy donors and for sterile peritonitis in rats. Findings Although its chemical constituents and concentrations of endotoxin were within pharmacopoeia specifications, the dialysis solution elicited an interlukin 6 response in vivo and in vitro. We identified peptidoglycan from thermophilic acidophilic bacteria (Aticyclobacillus acidocaidarius) as the contaminating proinflammatory substance. In the PBMC assay, strong dose-response relations were noted between peptidoglycan concentrations and interleukin 6. in rats injected with peptidoglycan, dose-dependent increases of intraperitoneal neutrophils and pyrogenic cytokines were recorded. We measured a positive relation between peptidoglycan concentrations in recalled dialysate and reports of aseptic peritonitis. After implementation of corrective actions, the rate of peritonitis returned to baseline. Interpretation Excess cases of aseptic peritonitis in peritoneal dialysis patients were due to peptidoglycan contamination of dialysate by Alicyclobacillus. This outbreak serves as an example of how contemporary parenteral products with microbial contaminants can be considered safe under current Pharmacopoeia tests, but provoke adverse clinical effects.	Baxter Healthcare Corp, Mcgaw Pk, IL USA; Hosp Pontoise, Serv Nephrol, Pontoise, France; Duke Univ, Med Ctr, Sch Med, Dept Med, Durham, NC 27710 USA	Baxter International Inc; Duke University	Owen, WF (corresponding author), 1620 Waukegan Rd, Mcgaw Pk, IL 60085 USA.	william_owen@baxter.com	Verger, Christian/T-5139-2019; Verger, Christian/GQA-4459-2022	Verger, Christian/0000-0002-8009-5366; 				BENEVENT D, 1984, PRESSE MED, V13, P1844; Burke RA, 1997, J CHROMATOGR B, V693, P353, DOI 10.1016/S0378-4347(97)00073-X; Fennrich S, 1999, Dev Biol Stand, V101, P131; Garner RE, 1996, INFECT IMMUN, V64, P4561, DOI 10.1128/IAI.64.11.4561-4566.1996; GOKAL R, 1981, CLIN NEPHROL, V15, P328; Gokal R, 2002, PERITON DIALYSIS INT, V22, P445; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; KARANICOLAS S, 1977, NEW ENGL J MED, V296, P1336, DOI 10.1056/NEJM197706092962309; Mangram AJ, 1998, KIDNEY INT, V54, P1367, DOI 10.1046/j.1523-1755.1998.00110.x; Mascoli C C, 1979, J Parenter Drug Assoc, V33, P81; Matsubara H, 2002, INT J SYST EVOL MICR, V52, P1681, DOI [10.1099/ijs.0.02169-0, 10.1099/00207713-52-5-1681]; MISTRY CD, 1987, LANCET, V2, P178; Nakagawa Y, 2002, CLIN DIAGN LAB IMMUN, V9, P588, DOI 10.1128/CDLI.9.3.588-597.2002; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Pool EJ, 1999, J IMMUNOASSAY, V20, P79, DOI 10.1080/01971529909349315; POOLE S, 1988, LANCET, V1, P130; RAY A, 1991, FEMS MICROBIOL LETT, V79, P211, DOI 10.1016/0378-1097(91)90088-R; Royce CL, 1996, J ENDOTOXIN RES, V3, P437, DOI 10.1177/096805199600300601; SCHWAB JH, 1993, INFECT IMMUN, V61, P4535, DOI 10.1128/IAI.61.11.4535-4539.1993; SMITH TA, 1991, DICP ANN PHARMAC, V25, P602, DOI 10.1177/106002809102500607; SRISKANDAN S, 1999, BACTERIAL SEPSIS SEP, P397; TAKTAK YS, 1991, J PHARM PHARMACOL, V43, P578, DOI 10.1111/j.2042-7158.1991.tb03540.x; Tintillier M, 2002, PERITON DIALYSIS INT, V22, P534; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1111/j.1574-695X.1996.tb00063.x; Tuncer H, 2000, NEPHROL DIAL TRANSPL, V15, P2037, DOI 10.1093/ndt/15.12.2037; Vas SI, 1989, PERITONEAL DIALYSIS, V3rd, P261; WEARY M, 1987, DETECTION BACTERIAL, P307; Williams PF, 2002, PERITON DIALYSIS INT, V22, P89; Wolfson M, 2002, AM J KIDNEY DIS, V40, P1055, DOI 10.1053/ajkd.2002.36344; 2002, EUROPEAN PHARMACOPOE, P131	30	66	71	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					588	594						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708102				2022-12-01	WOS:000226984300031
J	Peake, JB				Peake, JB			Beyond the purple heart - Continuity of care for the wounded in Iraq.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											Peake, JB (corresponding author), Project HOPE, Millwood, VA USA.								0	35	36	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2005	352	3					219	222		10.1056/NEJMp048312	http://dx.doi.org/10.1056/NEJMp048312			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888JP	15659720				2022-12-01	WOS:000226370500001
J	Choudhry, NK; Detsky, AS				Choudhry, NK; Detsky, AS			A perspective on US drug reimportation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEVELOPMENT COSTS; PRICES; MEDICARE; BENEFITS; MARKET; PAY		Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Hlth Network, Toronto, ON, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	choudhry@fas.harvard.edu						ALEXANDER D, 2004, VANCOUVER SUN   0825, pA1; BAKER C, 2004, WORLD PRESCRIPTION D; Bartlett Donald L., 2004, TIME            0920, P51; COHEN JC, 2003, GLOBE MAIL      0826, pA17; CONNOLLY C, 2004, WASHINGTON POST 0219, pA10; CONNOLLY C, 2004, WASHINGTON POST 0423; Danzon PM, 1998, PHARMACOECONOMICS, V13, P293, DOI 10.2165/00019053-199813030-00004; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Frank RG, 2004, NEW ENGL J MED, V351, P1375, DOI 10.1056/NEJMp048158; Frank RG, 2003, HEALTH AFFAIR, V22, P46, DOI 10.1377/hlthaff.22.3.46; Frank RG, 2003, J HEALTH ECON, V22, P325, DOI 10.1016/S0167-6296(03)00002-X; Frank RG, 2001, HEALTH AFFAIR, V20, P115, DOI 10.1377/hlthaff.20.2.115; FRIESEN J, 2004, GLOBE MAIL      1111; Gibbons Moira, 2004, Manag Care, V13, P21; *HLTH CAN HLTH PRO, SUMM REP COMPL INSP; HUBBARD WK, 2003, CANADIAN PRESCRIPTIO; Huskamp HA, 2003, HEALTH AFFAIR, V22, P149, DOI 10.1377/hlthaff.22.3.149; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; KAMATH R, 2003, REPORT FEASIBILITY E; Kanavos P, 2003, HEALTH AFFAIR, V22, P16, DOI 10.1377/hlthaff.22.3.16; LESTER W, 3 AM SAY PAYING DRUG; LUECK S, 2004, WALL ST J       0108, pA4; MAJESKI T, 2004, ST PAUL PIONEER 0520, pB8; MARIMOW AE, 2004, CONTRA COSIA TI 0826; Maynard A, 2003, HEALTH AFFAIR, V22, P31, DOI 10.1377/hlthaff.22.3.31; Menon D, 2001, HEALTH AFFAIR, V20, P92, DOI 10.1377/hlthaff.20.3.92; Newhouse JP, 2004, HEALTH AFFAIR, V23, P89, DOI 10.1377/hlthaff.23.1.89; *NIH, 2000, NIH CONTR PHARM DEV; NITKIN D, 2004, BALTIMORE SUN   0331, pB1; PEAR R, 2004, NY TIMES        0422, pA23; *PUBL CIT C WATCH, AM OTH DRUG PROBL BN; Rector TS, 2004, HEALTH AFFAIR, V23, P213, DOI 10.1377/hlthaff.23.4.213; RICHER S, 2004, GLOBE MAIL      0517, pA1; Saatsoglou Paul, 2004, Manag Care, V13, P7; SAGER A, 2000, PRESCRIPTION DRUG PE; SAGER A, 2004, DO DRUG MAKERS LOSE; SANDERS B, 2003, INT PRESCRIPTION DRU; Scherer FM, 2004, NEW ENGL J MED, V351, P927, DOI 10.1056/NEJMhpr040117; Scherer FM, 2001, HEALTH AFFAIR, V20, P216, DOI 10.1377/hlthaff.20.5.216; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Soumerai SB, 2004, HEALTH AFFAIR, V23, P135, DOI 10.1377/hlthaff.23.1.135; STRAHINICH J, 2004, BOSTON HERALD   1118, P46; *US C OFF TECHN AS, 1993, OTAH522; *US DEP HHS, PRESCR DRUG COV SPEN; *US FDA, FDA US CUST IMP BLIT; *US GEN ACC OFF, 2003, NIH PRIV SECT PARTN; *US GEN ACC OFF, 2004, INT PHARM SOM POS SA; Wagner JL, 2004, ANNU REV PUBL HEALTH, V25, P475, DOI 10.1146/annurev.publhealth.25.101802.123042; Ward Christopher, 2004, Manag Care, V13, P17; Wilson JF, 2004, ANN INTERN MED, V140, P677, DOI 10.7326/0003-4819-140-8-200404200-00044; Wolfe W., 2004, MINNEAPOLIS STA 0514, p1B; WALL STREET U; 2004, AARP             JUL	53	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2005	293	3					358	362		10.1001/jama.293.3.358	http://dx.doi.org/10.1001/jama.293.3.358			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888FA	15657329				2022-12-01	WOS:000226358400030
J	Kusserow, A; Pang, K; Sturm, C; Hrouda, M; Lentfer, J; Schmidt, HA; Technau, U; von Haeseler, A; Hobmayer, B; Martindale, MQ; Holstein, TW				Kusserow, A; Pang, K; Sturm, C; Hrouda, M; Lentfer, J; Schmidt, HA; Technau, U; von Haeseler, A; Hobmayer, B; Martindale, MQ; Holstein, TW			Unexpected complexity of the Wnt gene family in a sea anemone	NATURE			English	Article							NEMATOSTELLA-VECTENSIS; EVOLUTION; ORIGINS; EXPRESSION; BRAIN; MESODERM; CNIDARIA; EMBRYOS; SYSTEM; PHYLUM	The Wnt gene family encodes secreted signalling molecules that control cell fate in animal development and human diseases(1). Despite its significance, the evolution of this metazoan-specific protein family is unclear. In vertebrates, twelve Wnt subfamilies were defined, of which only six have counterparts in Ecdysozoa (for example, Drosophila and Caenorhabditis)(2). Here, we report the isolation of twelve Wnt genes from the sea anemone Nematostella vectensis(3), a species representing the basal group(4) within cnidarians. Cnidarians are diploblastic animals and the sister-group to bilaterian metazoans(5). Phylogenetic analyses of N. vectensis Wnt genes reveal a thus far unpredicted ancestral diversity within the Wnt family(2,6,7). Cnidarians and bilaterians have at least eleven of the twelve known Wnt gene subfamilies in common; five subfamilies appear to be lost in the protostome lineage. Expression patterns of Wnt genes during N. vectensis embryogenesis indicate distinct roles of Wnts in gastrulation, resulting in serial overlapping expression domains along the primary axis of the planula larva. This unexpectedly complex inventory of Wnt family signalling factors evolved in early multicellular animals about 650 million years (Myr) ago, predating the Cambrian explosion by at least 100 Myr (refs 5, 8). It emphasizes the crucial function of Wnt genes in the diversification of eumetazoan body plans(9).	Univ Hawaii, Kewalo Marine Lab PBRC, Honolulu, HI 96813 USA; Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany; Univ Innsbruck, Inst Zool & Limnol, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; Forschungszentrum Julich, John von Neumann Inst Comp, D-52425 Julich, Germany; Univ Dusseldorf, Inst Bioinformat, D-40225 Dusseldorf, Germany; Univ Heidelberg, Dept Mol Evolut & genom, D-69120 Heidelberg, Germany	University of Hawaii System; Technical University of Darmstadt; University of Innsbruck; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg	Martindale, MQ (corresponding author), Univ Hawaii, Kewalo Marine Lab PBRC, 41 Ahui St, Honolulu, HI 96813 USA.	mqmartin@hawaii.edu; holstein@uni-hd.de	von Haeseler, Arndt/HCI-9958-2022; Schmidt, Heiko A/AAC-4650-2022	von Haeseler, Arndt/0000-0002-3366-4458; Schmidt, Heiko A/0000-0002-2311-8592; Technau, Ulrich/0000-0003-4472-8258; Holstein, Thomas/0000-0003-0480-4674				Angerer LM, 2003, CURR TOP DEV BIOL, V53, P159, DOI 10.1016/S0070-2153(03)53005-8; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Christenson JC, 2001, J TRAVEL MED, V8, P1; Davidson B, 2003, P NATL ACAD SCI USA, V100, P11469, DOI 10.1073/pnas.1634991100; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Fritzenwanker JH, 2004, DEV BIOL, V275, P389, DOI 10.1016/j.ydbio.2004.08.014; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holland LZ, 2002, DEV BIOL, V241, P209, DOI 10.1006/dbio.2001.0503; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Landesman Y, 1997, MECH DEVELOP, V63, P199, DOI 10.1016/S0925-4773(97)00041-5; Le Gouar M, 2004, DEV GENES EVOL, V214, P250, DOI 10.1007/s00427-004-0399-z; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Marsal M, 2003, GENE EXPR PATTERNS, V3, P489, DOI 10.1016/S1567-133X(03)00058-9; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; MCGREW LL, 1992, DEVELOPMENT, V115, P463; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Nusse R, 2001, TRENDS GENET, V17, P443, DOI 10.1016/S0168-9525(01)02349-6; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Primus A, 2004, BIOESSAYS, V26, P474, DOI 10.1002/bies.20031; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; SALVINIPLAWEN LV, 1978, Z ZOOL SYST EVOL, V16, P40; Technau U, 2003, INT J DEV BIOL, V47, P531; Vinh LS, 2004, MOL BIOL EVOL, V21, P1565, DOI 10.1093/molbev/msh176	30	437	455	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					156	160		10.1038/nature03158	http://dx.doi.org/10.1038/nature03158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650739				2022-12-01	WOS:000226252200037
J	Shahinian, VB; Kuo, Y; Freeman, JL; Goodwin, JS				Shahinian, VB; Kuo, Y; Freeman, JL; Goodwin, JS			Risk of fracture after androgen deprivation for prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENT BONE LOSS; HORMONAL-THERAPY; OSTEOPOROSIS; MEDICARE; MEN; CARCINOMA; CLAIMS; SUPPRESSION; PATTERNS; SURVIVAL	Background: The use of androgen-deprivation therapy for prostate cancer has increased substantially over the past 15 years. This treatment is associated with a loss of bone-mineral density, but the risk of fracture after androgen-deprivation therapy has not been well studied. Methods: We studied the records of 50,613 men who were listed in the linked database of the Surveillance, Epidemiology, and End Results program and Medicare as having received a diagnosis of prostate cancer in the period from 1992 through 1997. The primary outcomes were the occurrence of any fracture and the occurrence of a fracture resulting in hospitalization. Cox proportional-hazards analyses were adjusted for characteristics of the patients and the cancer, other cancer treatment received, and the occurrence of a fracture or the diagnosis of osteoporosis during the 12 months preceding the diagnosis of cancer. Results: Of men surviving at least five years after diagnosis, 19.4 percent of those who received androgen-deprivation therapy had a fracture, as compared with 12.6 percent of those not receiving androgen-deprivation therapy (P<0.001). In the Cox proportional-hazards analyses, adjusted for characteristics of the patient and the tumor, there was a statistically significant relation between the number of doses of gonadotropin-releasing hormone received during the 12 months after diagnosis and the subsequent risk of fracture. Conclusions: Androgen-deprivation therapy for prostate cancer increases the risk of fracture.	Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Shahinian, VB (corresponding author), Univ Texas, Med Branch, Dept Internal Med, John Sealy Annex,Rm 4-200,301 Univ Blvd, Galveston, TX 77555 USA.	vbshahin@utmb.edu			NATIONAL CANCER INSTITUTE [P50CA105631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER; AHRQ HHS [R24HS51161] Funding Source: Medline; NCI NIH HHS [P50CA12385, P50 CA105631-01] Funding Source: Medline; NIA NIH HHS [P30 AG024832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Awodipe A, 2004, J AM GERIATR SOC, V52, pS162; Beahrs OH, 1988, MANUAL STAGING CANC, P177; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chodak GW, 2002, UROLOGY, V60, P201, DOI 10.1016/S0090-4295(02)01677-1; Cooper GS, 2000, MED CARE, V38, P411, DOI 10.1097/00005650-200004000-00008; Cooperberg MR, 2003, J NATL CANCER I, V95, P981, DOI 10.1093/jnci/95.13.981; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Daniell HW, 2000, J UROLOGY, V163, P181, DOI 10.1016/S0022-5347(05)68000-7; Diamond TH, 2004, CANCER-AM CANCER SOC, V100, P892, DOI 10.1002/cncr.20056; Du XL, 1999, J CLIN EPIDEMIOL, V52, P463, DOI 10.1016/S0895-4356(99)00011-6; Flemming ID, 1997, AJCC CANC STAGING MA, P219; Fowler FJ, 2002, CANCER-AM CANCER SOC, V95, P287, DOI 10.1002/cncr.10656; GREENE FL, 2002, AJCC CANC STAGING MA, P310; Harlan LC, 2001, J NATL CANCER I, V93, P1864, DOI 10.1093/jnci/93.24.1864; Huggins C, 1941, CANCER RES, V1, P293; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lamont EB, 2002, MED CARE, V40, P201, DOI 10.1097/00005650-200203000-00004; Melton LJ, 2003, J UROLOGY, V169, P1747, DOI 10.1097/01.ju.0000059281.67667.97; Meng MV, 2002, UROLOGY, V60, P7, DOI 10.1016/S0090-4295(02)01560-1; Milbank AJ, 2002, UROLOGY, V60, P738, DOI 10.1016/S0090-4295(02)01867-8; Mittan D, 2002, J CLIN ENDOCR METAB, V87, P3656, DOI 10.1210/jc.87.8.3656; Morote J, 2003, EUR UROL, V44, P661, DOI 10.1016/S0302-2838(03)00379-8; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1016/S0022-5347(05)64561-2; Oefelein MG, 2001, J UROLOGY, V166, P1724, DOI 10.1016/S0022-5347(05)65661-3; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; Ross RW, 2002, J UROLOGY, V167, P1952, DOI 10.1016/S0022-5347(05)65060-4; Smith MR, 2002, UROLOGY, V60, P79, DOI 10.1016/S0090-4295(02)01579-0; Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Smith MR, 2001, NEW ENGL J MED, V345, P948, DOI 10.1056/NEJMoa010845; Soloway MS, 2002, UROLOGY, V60, P735, DOI 10.1016/S0090-4295(02)01964-7; Townsend MF, 1997, CANCER, V79, P545, DOI 10.1002/(SICI)1097-0142(19970201)79:3<545::AID-CNCR17>3.0.CO;2-3; Virnig BA, 2002, MED CARE, V40, P49; Warren JL, 2002, MED CARE, V40, P3; Wei JT, 1999, UROLOGY, V54, P607, DOI 10.1016/S0090-4295(99)00301-5	35	964	980	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2005	352	2					154	164		10.1056/NEJMoa041943	http://dx.doi.org/10.1056/NEJMoa041943			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886TG	15647578	Bronze			2022-12-01	WOS:000226251700008
J	Walsh, B; Steiner, A; Pickering, RM; Ward-Basu, J				Walsh, B; Steiner, A; Pickering, RM; Ward-Basu, J			Economic evaluation of nurse led intermediate care versus standard acute care for post-acute medical patients: cost minimisation analysis of data from a randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							INPATIENT UNIT	Objective To undertake an economic evaluation of nurse led intermediate care compared with standard hospital care for post-acute medical patients. Design Cost minimisation analysis from an NHS perspective, comprising secondary care, primary care, and community care, using data from a pragmatic randomised controlled trial. Setting Nurse led unit and acute general medical wards in large, urban, UK teaching hospital. Participants 238 patients. Outcome measure Costs to acute hospital trusts and to the NHS over six months. Results On an intention to treat basis, nurse led care was associated with higher costs during the initial admission period (nurse led care 7892 pound ($14 970; E11 503), standard care 4810 pound, difference 3082 pound (95% confidence interval 1161 pound to 5002 pound)) pound. During the readmission period, costs were similar (nurse led care 1444 pound, standard care 1879 pound, difference - 435 pound, - 1406 pound to 536 pound) pound. Total costs at six months were significantly higher (nurse led care 10 529 pound, standard care 7819 pound, difference 2710 pound, 518 pound to 4903 pound). Sensitivity analyses suggested that the trend for nurse led care to be more expensive was maintained even with substantial cost reductions, although differences were no longer significant. Conclusion Acute hospitals may not be cost effective settings for nurse led intermediate care. Both inpatient and total costs were significantly higher for nurse led care than for standard care of post-acute medical patients, suggesting that this model of care should not be pursued unless clinical or organisational benefits justify the increased investment.	Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England; Univ Southampton, Dept Geriatr Med, Southampton SO9 5NH, Hants, England; Southampton Gen Hosp, Med Stat Grp, Hlth Care Res Unit, Southampton SO16 6YD, Hants, England; Southampton Gen Hosp, Dept Geriatr Med, Elderly Care Res Unit, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton	Walsh, B (corresponding author), Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England.	b.m.walsh@soton.ac.uk		Walsh, Bronagh/0000-0003-1008-0545				Coast J, 1998, BRIT MED J, V316, P1802, DOI 10.1136/bmj.316.7147.1802; *DEP HLTH, 2001, HLTH SERV CIRC 2001; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2000, SHAP FUT NHS LONG TE; Griffiths P, 2001, AGE AGEING, V30, P483, DOI 10.1093/ageing/30.6.483; Griffiths P, 2000, INT J NURS STUD, V37, P153, DOI 10.1016/S0020-7489(99)00061-9; GRIFFITHS P, 1995, EVALUATING NURSE LED; NETTEN A, 1999, UNIT COSTS COMMUNITY; PEARSON A, 1992, NURSING BEDS EVALUAT; Stein RL, 2004, J PALESTINE STUD, V33, P5, DOI 10.1525/jps.2004.33.4.005; Steiner A, 2001, AGE AGEING, V30, P433, DOI 10.1093/ageing/30.6.433; Steiner A, 2001, BRIT MED J, V322, P453, DOI 10.1136/bmj.322.7284.453; Walsh B, 2003, INT J NURS STUD, V40, P307, DOI 10.1016/S0020-7489(02)00091-3; Wiles R, 2001, J ADV NURS, V34, P813, DOI 10.1046/j.1365-2648.2001.01812.x	15	24	24	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 26	2005	330	7493					699	702		10.1136/bmj.38397.633588.8F	http://dx.doi.org/10.1136/bmj.38397.633588.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	912IT	15757959	Green Published, Bronze			2022-12-01	WOS:000228071900015
J	Vezzi, A; Campanaro, S; D'Angelo, M; Simonato, F; Vitulo, N; Lauro, FM; Cestaro, A; Malacrida, G; Simionati, B; Cannata, N; Romualdi, C; Bartlett, DH; Valle, G				Vezzi, A; Campanaro, S; D'Angelo, M; Simonato, F; Vitulo, N; Lauro, FM; Cestaro, A; Malacrida, G; Simionati, B; Cannata, N; Romualdi, C; Bartlett, DH; Valle, G			Life at depth: Photobacterium profundum genome sequence and expression analysis	SCIENCE			English	Article							VIBRIO-CHOLERAE; PRESSURE; CHROMOSOMES; PATHOGEN; BACTERIA; DISTINCT; STRESS; GROWTH	Deep-sea life requires adaptation to high pressure, an extreme yet common condition given that oceans cover 70% of Earth's surface and have an average depth of 3800 meters. Survival at such depths requires specific adaptation but, compared with other extreme conditions, high pressure has received little attention. Recently, Photobacterium profundum strain SS9 has been adopted as a model for piezophily. Here we report its genome sequence (6.4 megabase pairs) and transcriptome analysis. The results provide a first glimpse into the. molecular basis for life in the largest portion of the biosphere, revealing high metabolic versatility.	Univ Padua, CRIBI Biotechnol Ctr, I-35131 Padua, Italy; Univ Padua, Dept Biol, I-35131 Padua, Italy; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Padua; University of Padua; University of California System; University of California San Diego; Scripps Institution of Oceanography	Valle, G (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Via Bassi 58-B, I-35131 Padua, Italy.	giorgio.valle@unipd.it	Campanaro, Stefano/I-5657-2019; VEZZI, ALESSANDRO/AAB-7686-2022; Vitulo, Nicola/GVT-2319-2022; Lauro, Federico/X-2420-2019; Romualdi, Chiara/K-1132-2016	VEZZI, ALESSANDRO/0000-0002-8629-6644; Lauro, Federico/0000-0002-8373-1014; Romualdi, Chiara/0000-0003-4792-9047; VALLE, GIORGIO/0000-0003-4377-5685; Vitulo, Nicola/0000-0002-9571-0747; simionati, barbara/0000-0002-0522-0737; Cestaro, Alessandro/0000-0003-1439-5165; CAMPANARO, STEFANO/0000-0002-9431-1648				Abe F, 2000, MOL CELL BIOL, V20, P8093, DOI 10.1128/MCB.20.21.8093-8102.2000; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Egan ES, 2003, CELL, V114, P521, DOI 10.1016/S0092-8674(03)00611-1; Graentzdoerffer A, 2001, ARCH MICROBIOL, V175, P8, DOI 10.1007/s002030000232; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawano H, 2003, BIOSCI BIOTECH BIOCH, V67, P1983, DOI 10.1271/bbb.67.1983; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Nogi Y, 1998, EXTREMOPHILES, V2, P1, DOI 10.1007/s007920050036; Pruss BM, 1999, J BACTERIOL, V181, P2624; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Varela C, 2003, APPL MICROBIOL BIOT, V60, P547, DOI 10.1007/s00253-002-1120-7; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; YAYANOS AA, 1986, P NATL ACAD SCI USA, V83, P9542, DOI 10.1073/pnas.83.24.9542	18	204	824	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1459	1461		10.1126/science.1103341	http://dx.doi.org/10.1126/science.1103341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746425				2022-12-01	WOS:000227503100044
J	He, X; He, X; Dave, VP; Zhang, Y; Hua, X; Nicolas, E; Xu, WH; Roe, BA; Kappes, DJ				He, X; He, X; Dave, VP; Zhang, Y; Hua, X; Nicolas, E; Xu, WH; Roe, BA; Kappes, DJ			The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment	NATURE			English	Article							GENE-EXPRESSION; FACTOR GATA-3; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; TRANSGENIC MICE; SELECTION; DIFFERENTIATION; DNA; PROTEINS; DURATION	Development of immature T-cell precursors (thymocytes) to either the CD4 helper or CD8 killer T-cell lineages correlates precisely with their T-cell receptor specificity for major histocompatibility complex class II or class I molecules, respectively, indicating that the process is carefully regulated. Although intensively studied owing to its importance in determining the composition of the mature T-cell compartment and as a general model of binary lineage decisions, the underlying molecular pathways remain obscure. We have previously reported a spontaneous mouse mutant (HD ( helper deficient) mice) in which lineage commitment is specifically perturbed without affecting positive selection. Here we show that a point mutation in the zinc finger transcription factor Th-POK (T-helper-inducing POZ/Kruppel-like factor) is responsible for redirection of class-II-restricted thymocytes to the CD8 lineage in HD mice. Furthermore, we demonstrate that constitutive expression of this factor during thymic development leads to redirection of class-I-restricted thymocytes to the CD4 lineage, indicating that Th-POK is a master regulator of lineage commitment.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Fox Chase Cancer Center; University of Oklahoma System; University of Oklahoma - Norman	Kappes, DJ (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	dj_kappes@fccc.edu	He, Xi/GXH-3286-2022	He, Xi/0000-0002-4383-0157; He, Xiao/0000-0002-9286-9859				Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; BLOBEL GA, 1995, MOL CELL BIOL, V15, P626; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KLEVIT RE, 1991, SCIENCE, V253, P1367, DOI 10.1126/science.1896847; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Singer A, 2004, ADV IMMUNOL, V83, P91; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Widom RL, 2001, MATRIX BIOL, V20, P451, DOI 10.1016/S0945-053X(01)00167-6; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	32	302	311	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					826	833		10.1038/nature03338	http://dx.doi.org/10.1038/nature03338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729333	Bronze			2022-12-01	WOS:000227174600033
J	Goossens, H; Ferech, M; Stichele, RV; Elseviers, M				Goossens, H; Ferech, M; Stichele, RV; Elseviers, M		ESAC Project Grp	Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.	LANCET			English	Article							STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL CONSUMPTION; ESCHERICHIA-COLI; TRENDS	Background Resistance to antibiotics is a major public-health problem and antibiotic use is being increasingly recognised as the main selective pressure driving this resistance. Our aim was to assess outpatient use of antibiotics and the association with resistance. Methods We, investigated outpatient antibiotic use in 26 countries in Europe that provided. internationally M comparable distribution or reimbursement data, between Jan 1, 1997, and Dec 31, 2002; by calculating the number R of defined daily doses (DDD) per 1000 inhabitants per day, according to WHO anatomic therapeutic chemical M classification and DDD measurement methodology. We assessed the ecological association between antibiotic use and antibiotic resistance rates using Spearman's correlation coefficients. Findings Prescription of antibiotics in primary care in Europe varied greatly; the highest rate was in France (32.2 DDD per 1000 inhabitants daily) and the lowest was in the Netherlands (10.0 DDD per 1000 inhabitants daily). We noted a shift from the old narrow-spectrum antibiotics to the new broad-spectrum antibiotics. We also recorded striking seasonal fluctuations with heightened winter peaks in countries with high yearly use of antibiotics. We showed higher rates of antibiotic resistance in high consuming countries, probably related, to the higher consumption in southern and eastern Europe than in northern Europe. Interpretation These data might provide a useful method for assessing public-health strategies that aim to reduce antibiotic use and resistance levels.	Univ Antwerp, Dept Microbiol, ESAC Management Team, B-2610 Antwerp, Belgium; Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RA Leiden, Netherlands	University of Antwerp; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goossens, H (corresponding author), Univ Antwerp, Dept Microbiol, ESAC Management Team, B-2610 Antwerp, Belgium.	Herman.Goossens@uza.be	Stichele, Robert Vander/K-7203-2015	Stichele, Robert Vander/0000-0001-9118-9651; Elseviers, Monique/0000-0001-9415-6900				Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Bergman M, 2004, CLIN INFECT DIS, V38, P1251, DOI 10.1086/383309; BRONZWAER S, 2003, THESIS RIJKSUNIVERSI; Bronzwaer SL, 2000, EMERG INFECT DIS, V3, P278; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Chow KM, 2003, ARCH INTERN MED, V163, P1617, DOI 10.1001/archinte.163.13.1617-a; *DAN VET LAB, 2001, DANMAP 2000 CONS ANT; De Laat E., 2002, DOES PHARM MARKETING; DESCHEPPER R, 2002, PATIENT EDUC COUNS, V1590, P1; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Garcia-Rey C, 2004, J ANTIMICROB CHEMOTH, V54, P465, DOI 10.1093/jac/dkh375; GARCIAREY C, IMPORTANCE LOCAL VAR; Goossens H, 1998, BRIT MED J, V317, P654, DOI 10.1136/bmj.317.7159.654; GOOSSENS H, 2003, CORRELATION MACROLID, P111; Guillemot D, 1998, J INFECT DIS, V177, P492, DOI 10.1086/517384; Ho PL, 2001, J ANTIMICROB CHEMOTH, V48, P659, DOI 10.1093/jac/48.5.659; Hooper DC, 2002, LANCET INFECT DIS, V2, P530, DOI 10.1016/S1473-3099(02)00369-9; Hutchinson JM, 2001, CAN FAM PHYSICIAN, V47, P1217; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P1005, DOI 10.1093/jac/dkg488; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; McCormick AW, 2003, NAT MED, V9, P424, DOI 10.1038/nm839; Monnet DL, 2004, J ANTIMICROB CHEMOTH, V53, P1109, DOI 10.1093/jac/dkh230; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; Orero A, 1997, MED CLIN-BARCELONA, V109, P782; Price DB, 2004, RESP MED, V98, P17, DOI 10.1016/j.rmed.2003.08.011; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Van Zuijlen DA, 2001, PEDIATR INFECT DIS J, V20, P140, DOI 10.1097/00006454-200102000-00004; Vander Stichele RH, 2004, BRIT J CLIN PHARMACO, V58, P419, DOI 10.1111/j.1365-2125.2004.02164.x; World Health Organization (WHO), 2004, AN THER CHEM CLASS S; WORLD HEALTH ORGANIZATION (WHO) REGIONAL OFFICE FOR EUROPE, 2003, EUR HLTH ALL DAT	31	2085	2154	11	283	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					579	587		10.1016/S0140-6736(05)17907-0	http://dx.doi.org/10.1016/S0140-6736(05)17907-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708101				2022-12-01	WOS:000226984300030
J	Remuzzi, G; Weening, JJ				Remuzzi, G; Weening, JJ			Albuminuria as early test for vascular disease	LANCET			English	Editorial Material							STAGE RENAL-DISEASE		Mario Negri Inst Pharmacol Res, Lab Negri Bergamo, Bergamo, Italy; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Weening, JJ (corresponding author), Mario Negri Inst Pharmacol Res, Lab Negri Bergamo, Bergamo, Italy.	j.j.weening@amc.uva.nl	Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; Brenner Barry M, 2003, Kidney Int Suppl, pS77; Brenner BM, 2003, KIDNEY INT, V64, P370, DOI 10.1046/j.1523-1755.2003.t01-2-00052.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Moeller S, 2002, NEPHROL DIAL TRANSPL, V17, P2071, DOI 10.1093/ndt/17.12.2071; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 1997, LANCET, V349, P1857; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; Wild SH, 2004, DIABETES CARE, V27, P2569, DOI 10.2337/diacare.27.10.2569-a; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	12	38	46	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					556	557						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708086				2022-12-01	WOS:000226984300009
J	Sustar, A; Schubiger, G				Sustar, A; Schubiger, G			A transient cell cycle shift in Drosophila imaginal disc cells precedes multipotency	CELL			English	Article							ADULT STEM-CELLS; ECTOPIC EXPRESSION; CLONAL ANALYSIS; WING FORMATION; LEG DISKS; MELANOGASTER; GENE; TRANSDETERMINATION; REGENERATION; GROWTH	When Drosophila imaginal discs regenerate, specific groups of cells can switch disc identity so that, for example, cells determined for leg identity switch to wing. Such switches in cell determination are known as transdetermination. We have developed a system by which individual cells are marked and monitored in vivo as they transdetermine so that their proliferation, cell sizes, and differentiation are accurately traced. Here, we document that when cells transdetermine, they do not convert to a younger cell cycle. Instead, cell cycle changes precede transdetermination and are different from those observed at any time in normal development. We propose that it is not a younger but a unique cell cycle progression and a big cell size that conditions the cells for developmental plasticity.	Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schubiger, G (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	gerold@u.washington.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058282] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58282] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M., 1989, DROSOPHILA LAB HDB M; Avots A, 2002, IMMUNOL REV, V187, P9, DOI 10.1034/j.1600-065X.2002.18702.x; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brumby AM, 2002, EMBO J, V21, P3377, DOI 10.1093/emboj/cdf334; BRYANT PJ, 1975, J EXP ZOOL, V193, P49, DOI 10.1002/jez.1401930106; del Alamo D, 2002, DEVELOPMENT, V129, P1975; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Edgar Bruce A., 2004, VVolume 42, P23; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; GEHRING W, 1968, J EMBRYOL EXP MORPH, V20, P307; GEHRING W, 1967, DEV BIOL, V16, P438, DOI 10.1016/0012-1606(67)90058-9; GEHRING W, 1966, J EMBRYOL EXP MORPH, V15, P77; Gehring W., 1972, BIOL IMAGINAL DISKS, P35; GIRTON JR, 1980, DEV BIOL, V77, P1, DOI 10.1016/0012-1606(80)90453-4; GRAVES BJ, 1982, DEV BIOL, V93, P104, DOI 10.1016/0012-1606(82)90243-3; HADORN E, 1970, P NATL ACAD SCI USA, V65, P633, DOI 10.1073/pnas.65.3.633; HADORN E, 1978, GENET BIOL DROSOPHIL, P555; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; JAN YN, 1985, J NEUROSCI, V5, P2453; Johnston LA, 1996, DEVELOPMENT, V122, P3519; Johnston LA, 2003, NAT CELL BIOL, V5, P827, DOI 10.1038/ncb1041; KIEHLE CP, 1985, DEV BIOL, V109, P336, DOI 10.1016/0012-1606(85)90460-9; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; LOOSLI R, 1959, DEV BIOL, V1, P24, DOI 10.1016/0012-1606(59)90040-5; Maves L, 1998, DEVELOPMENT, V125, P115; Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006; MAVES L, 1995, DEVELOPMENT, V121, P1263; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MINDEK G, 1968, Wilhelm Roux' Archiv fuer Entwicklungsmechanik der Organismen, V161, P249, DOI 10.1007/BF00573805; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Oldham S, 2002, DEVELOPMENT, V129, P4103; Popperl H, 2000, MOL CELL, V6, P255, DOI 10.1016/s1097-2765(00)00027-7; Priller J, 2001, J CELL BIOL, V155, P733, DOI 10.1083/jcb.200105103; Quesenberry PJ, 2002, BLOOD, V100, P4266, DOI 10.1182/blood-2002-04-1246; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SCHUBIGE.G, 1973, EXPERIENTIA, V29, P631, DOI 10.1007/BF01926712; Schubiger G., 1968, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V160, P9, DOI 10.1007/BF00573645; SCHUBIGER G, 1971, DEV BIOL, V26, P277, DOI 10.1016/0012-1606(71)90127-8; Serrano N, 1997, CURR BIOL, V7, pR186, DOI 10.1016/S0960-9822(97)70085-X; Spemann H., 1938, EMBRYONIC DEV INDUCT; Tanaka EM, 2003, CURR OPIN GENET DEV, V13, P497, DOI 10.1016/j.gde.2003.08.003; TOBLER H, 1966, J EMBRYOL EXP MORPH, V16, P609; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Voncken JW, 1999, J CELL SCI, V112, P4627; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; WILDERMU.H, 1968, DEV BIOL, V18, P1, DOI 10.1016/0012-1606(68)90019-5; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0	51	57	60	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					383	393		10.1016/j.cell.2004.12.008	http://dx.doi.org/10.1016/j.cell.2004.12.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707896	Bronze			2022-12-01	WOS:000227028900013
J	Teuten, EL; Xu, L; Reddy, CM				Teuten, EL; Xu, L; Reddy, CM			Two abundant bioaccumulated halogenated compounds are natural products	SCIENCE			English	Article							POLYBROMINATED DIPHENYL ETHERS; SPONGE DYSIDEA-HERBACEA; MARINE SPONGE; RADIOCARBON; DERIVATIVES; CONGENERS	Methoxylated polybrominated diphenyl ethers (MeO-PBDEs) have been found bioaccumulated in the tissues of a variety of aquatic animals and at concentrations comparable to those of anthropogenic halogenated organic compounds, including polychlorinated biphenyls (PCBs). The origin of the MeO-PBDEs has been uncertain; circumstantial evidence supports a natural and/or an industrial source. By analyzing the natural abundance radiocarbon content of two MeO-PBDEs isolated from a True's beaked whale (Mesoplodon mirus), we show that these compounds were naturally produced.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Reddy, CM (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	creddy@whoi.edu		Reddy, Christopher/0000-0002-7814-2071				Anjaneyulu V, 1996, INDIAN J CHEM B, V35, P89; CAPON R, 1981, J CHEM SOC PERK T 1, P2464, DOI 10.1039/p19810002464; CARTE B, 1981, TETRAHEDRON, V37, P2335, DOI 10.1016/S0040-4020(01)88886-4; Eriksson J, 2004, ENVIRON SCI TECHNOL, V38, P3119, DOI 10.1021/es049830t; FU XO, 1995, J NAT PROD, V58, P1384, DOI 10.1021/np50123a008; Haglund PS, 1997, ENVIRON SCI TECHNOL, V31, P3281, DOI 10.1021/es9702834; Hakk H, 2003, ENVIRON INT, V29, P801, DOI 10.1016/S0160-4120(03)00109-0; Handayani D, 1997, J NAT PROD, V60, P1313, DOI 10.1021/np970271w; HIGA T, 1977, MARINE NATURAL PRODU, P35; Hundt K, 2000, APPL ENVIRON MICROB, V66, P4157, DOI 10.1128/AEM.66.9.4157-4160.2000; Kierkegaard A, 1999, ENVIRON SCI TECHNOL, V33, P1612, DOI 10.1021/es9807082; Kierkegaard A, 2004, ENVIRON POLLUT, V130, P187, DOI 10.1016/j.envpol.2003.12.011; KUNIYOSHI M, 1985, EXPERIENTIA, V41, P523, DOI 10.1007/BF01966182; LETCHER RJ, 2003, ORGANOHALOGEN COMPD, V61, P29; Liu HW, 2004, J NAT PROD, V67, P472, DOI 10.1021/np0304621; Mead J.G., 1989, P349; MEIRONYTE D, 2003, J TOXICOL ENV HLTH, V58, P329; Nydal R, 2000, RADIOCARBON, V42, P81; PEARSON A, 2000, THESIS WOODS HOLE OC; Reddy CM, 2004, ENVIRON SCI TECHNOL, V38, P1992, DOI 10.1021/es030568i; Reddy CM, 2002, ENVIRON POLLUT, V120, P163, DOI 10.1016/S0269-7491(02)00162-8; SCHMIDT S, 1992, APPL ENVIRON MICROB, V58, P2744, DOI 10.1128/AEM.58.9.2744-2750.1992; Stapleton HM, 2004, ENVIRON SCI TECHNOL, V38, P1054, DOI 10.1021/es0348804; Stegeman JJ, 1993, AQUATIC TOXICOLOGY M, P87; Stringer R, 2001, CHLORINE ENV OVERVIE; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; Utkina NK, 2002, J NAT PROD, V65, P1213, DOI 10.1021/np0106438; Vetter W, 2002, ENVIRON TOXICOL CHEM, V21, P2014, DOI 10.1897/1551-5028(2002)021<2014:SHNPFA>2.0.CO;2; Vetter W, 2001, ARCH ENVIRON CON TOX, V41, P221; *VIRG MAR SCI MUS, 2003, NECR EX REP	30	278	293	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					917	920		10.1126/science.1106882	http://dx.doi.org/10.1126/science.1106882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705850				2022-12-01	WOS:000226985100051
J	Grice, K; Cao, CQ; Love, GD; Bottcher, ME; Twitchett, RJ; Grosjean, E; Summons, RE; Turgeon, SC; Dunning, W; Jin, YG				Grice, K; Cao, CQ; Love, GD; Bottcher, ME; Twitchett, RJ; Grosjean, E; Summons, RE; Turgeon, SC; Dunning, W; Jin, YG			Photic zone euxinia during the Permian-Triassic superanoxic event	SCIENCE			English	Article							MOLECULAR INDICATORS; MASS EXTINCTION; ORGANIC GEOCHEMISTRY; BOUNDARY; SULFUR; ANOXIA; CARBON; ENRICHMENT; ISOTOPE; SULFATE	Carbon and sulfur isotopic data, together with biomarker and iron speciation analyses of the Hovea-3 core that was drilled in the Perth Basin, Western Australia, indicate that euxinic conditions prevailed in the paleowater column during the Permian-Triassic superanoxic event. Biomarkers diagnostic for anoxygenic photosynthesis, by Chlorobiaceae are particularly abundant at the boundary and into the Early Triassic. Similar conditions prevailed in the contemporaneous seas off South China. Our evidence for widespread photic-zone euxinic conditions suggests that sulfide toxicity was a driver of the extinction and a factor in the protracted recovery.	Curtin Univ Technol, Perth, WA 6001, Australia; MIT, Cambridge, MA 02139 USA; Nanjing Inst Geol & Palaeontol, Nanjing, Peoples R China; Max Planck Inst Marine Microbiol, Bremen, Germany; Univ Plymouth, Plymouth PL4 8AA, Devon, England; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	Curtin University; Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Max Planck Society; University of Plymouth; United States Department of Energy (DOE); Oak Ridge National Laboratory	Grice, K (corresponding author), Curtin Univ Technol, Perth, WA 6001, Australia.	K.Grice@curtin.edu.au	Summons, Roger Everett/AAL-3789-2020; Böttcher, Michael/A-6746-2013	Grice, Kliti/0000-0003-2136-3508; Bottcher, Michael Ernst/0000-0002-8877-0303				Anderson TF, 2004, AM J SCI, V304, P203, DOI 10.2475/ajs.304.3.203; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Foster C.B., 1997, APPEA J, V37, P472; Grice K, 1996, ORG GEOCHEM, V25, P131, DOI 10.1016/S0146-6380(96)00130-1; Grice K, 1996, GEOCHIM COSMOCHIM AC, V60, P3913, DOI 10.1016/0016-7037(96)00199-8; GRICE K, UNPUB; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; KAJIWARA Y, 1994, PALAEOGEOGR PALAEOCL, V111, P367, DOI 10.1016/0031-0182(94)90072-8; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Koopmans MP, 1996, GEOCHIM COSMOCHIM AC, V60, P4467, DOI 10.1016/S0016-7037(96)00238-4; Korte C, 2004, INT J EARTH SCI, V93, P565, DOI 10.1007/s00531-004-0406-7; KUMP LR, 2003, GSA ANN M GEOL SOC A; LEWAN MD, 1982, GEOCHIM COSMOCHIM AC, V46, P2547, DOI 10.1016/0016-7037(82)90377-5; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Newton RJ, 2004, EARTH PLANET SC LETT, V218, P331, DOI 10.1016/S0012-821X(03)00676-9; Pancost RD, 2004, J GEOL SOC LONDON, V161, P353, DOI 10.1144/0016764903-059; Passier HF, 1999, NATURE, V397, P146, DOI 10.1038/16441; Schouten S, 1998, GEOCHIM COSMOCHIM AC, V62, P1397, DOI 10.1016/S0016-7037(98)00076-3; Schwab V, 2004, APPL GEOCHEM, V19, P55, DOI 10.1016/S0883-2927(03)00127-6; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P557, DOI 10.1016/0016-7037(87)90069-X; Thomas BM, 2004, AUST J EARTH SCI, V51, P423, DOI 10.1111/j.1400-0952.2004.01066.x; TRULL TW, 2001, EOS T AM GEOPHYS UN, V82, P306; WIGNALL PB, 1992, PALAEOGEOGR PALAEOCL, V93, P21, DOI 10.1016/0031-0182(92)90182-5; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155	28	590	649	4	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2005	307	5710					706	709		10.1126/science.1104323	http://dx.doi.org/10.1126/science.1104323			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15661975	Green Submitted			2022-12-01	WOS:000226814900038
J	Fan, QR; Hendrickson, WA				Fan, QR; Hendrickson, WA			Structure of human follicle-stimulating hormone in complex with its receptor	NATURE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; LEUCINE-RICH REPEATS; ALPHA-SUBUNIT; LUTEINIZING-HORMONE; HUMAN FOLLITROPIN; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; BINDING DOMAIN; BETA-SUBUNIT; REGION	Follicle-stimulating hormone (FSH) is central to reproduction in mammals. It acts through a G-protein-coupled receptor on the surface of target cells to stimulate testicular and ovarian functions. We present here the 2.9-Angstrom-resolution structure of a partially deglycosylated complex of human FSH bound to the extracellular hormone-binding domain of its receptor (FSHRHB). The hormone is bound in a hand-clasp fashion to an elongated, curved receptor. The buried interface of the complex is large (2,600 Angstrom(2)) and has a high charge density. Our analysis suggests that all glycoprotein hormones bind to their receptors in this mode and that binding specificity is mediated by key interaction sites involving both the common alpha- and hormone-specific beta-subunits. On binding, FSH undergoes a concerted conformational change that affects protruding loops implicated in receptor activation. The FSH-FSHRHB complexes form dimers in the crystal and at high concentrations in solution. Such dimers may participate in transmembrane signal transduction.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068671] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068671] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold CJ, 1998, BIOCHEMISTRY-US, V37, P1762, DOI 10.1021/bi971816o; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN F, 1992, MOL ENDOCRINOL, V6, P914, DOI 10.1210/me.6.6.914; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; Dias JA, 2002, VITAM HORM, V64, P249, DOI 10.1016/S0083-6729(02)64008-7; DIAS JA, 1994, J BIOL CHEM, V269, P25289; ERICKSON LD, 1990, ENDOCRINOLOGY, V126, P2555, DOI 10.1210/endo-126-5-2555; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Grossmann M, 1997, J BIOL CHEM, V272, P15532, DOI 10.1074/jbc.272.24.15532; Heikoop JC, 1998, EUR J BIOCHEM, V253, P354, DOI 10.1046/j.1432-1327.1998.2530354.x; Hsu SYT, 2003, TRENDS ENDOCRIN MET, V14, P303, DOI 10.1016/S1043-2760(03)00106-1; Ji I, 2004, MOL ENDOCRINOL, V18, P968, DOI 10.1210/me.2003-0443; JI IH, 1993, J BIOL CHEM, V268, P22971; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEUTMANN HT, 1989, MOL ENDOCRINOL, V3, P526, DOI 10.1210/mend-3-3-526; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90, DOI DOI 10.1007/S00249-009-0425-1; LEINUNG MC, 1991, P NATL ACAD SCI USA, V88, P9707, DOI 10.1073/pnas.88.21.9707; Liu C, 1996, ARCH BIOCHEM BIOPHYS, V329, P127, DOI 10.1006/abbi.1996.0200; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; NARAYAN P, 1995, MOL ENDOCRINOL, V9, P1720, DOI 10.1210/me.9.12.1720; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Osuga Y, 1997, J BIOL CHEM, V272, P25006, DOI 10.1074/jbc.272.40.25006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Remy JJ, 1996, MOL CELL ENDOCRINOL, V125, P79, DOI 10.1016/S0303-7207(96)03955-X; Roess DA, 2003, BIOL REPROD, V69, P1765, DOI 10.1095/biolreprod.103.018846; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; SUGAHARA T, 1995, P NATL ACAD SCI USA, V92, P2041, DOI 10.1073/pnas.92.6.2041; Szkudlinski MW, 1996, NAT BIOTECHNOL, V14, P1257, DOI 10.1038/nbt1096-1257; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tao YX, 2004, J BIOL CHEM, V279, P5904, DOI 10.1074/jbc.M311162200; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vischer HF, 2003, MOL ENDOCRINOL, V17, P1972, DOI 10.1210/me.2003-0172; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X	50	429	453	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					269	277		10.1038/nature03206	http://dx.doi.org/10.1038/nature03206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662415	Green Accepted			2022-12-01	WOS:000226381300045
J	Forman, JP; Rimm, EB; Stampfer, MJ; Curhan, GC				Forman, JP; Rimm, EB; Stampfer, MJ; Curhan, GC			Folate intake and the risk of incident hypertension among US women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVES ENDOTHELIAL FUNCTION; CORONARY-ARTERY DISEASE; BLOOD-PRESSURE CHANGE; MIDDLE-AGED MEN; FOLIC-ACID; DEPENDENT VASODILATION; NUTRITIONAL FACTORS; MILD HYPERTENSION; DIETARY FACTORS; CLINICAL-TRIAL	Context Folate has important beneficial effects on endothelial function, but there is limited information about folate intake and risk of incident hypertension. Objective To determine whether higher folate intake is associated with a lower risk of incident hypertension. Design, Setting, and Participants Two prospective cohort studies of 93803 younger women aged 27 to 44 years in the Nurses' Health Study II (1991-1999) and 62260 older women aged 43 to 70 years in the Nurses' Health Study I (1990-1998), who did not have a history of hypertension. Baseline information on dietary folate and supplemental folic acid intake was derived from semiquantitative food frequency questionnaires and was updated every 4 years. Main Outcome Measure Relative risk of incident self-reported hypertension during 8 years of follow-up. Results We identified 7373 incident cases of hypertension in younger women and 12347 cases in older women. After adjusting for multiple potential confounders, younger women who consumed at least 1000 mug/d of total folate (dietary plus supplemental) had a decreased risk of hypertension (relative risk [RR], 0.54; 95% confidence interval [CI], 0.45-0.66; P for trend <.001) compared with those who consumed less than 200 mu g/d. Younger women's absolute risk reduction (ARR) was approximately 8 cases per,1000 person-years (6.7 vs 14.8 cases). The multivariable RR for the same comparison in older women was 0.82 (95% CI, 0.69-0.97; P for trend =.05). Older women's ARR was approximately 6 cases per 1000 person-years (34.7 vs 40.4 cases). When the analysis was restricted to women with low dietary folate intake (<200 mug/d), the multivariable RR for younger women with total folate intake at least 800 mug/d compared with less than 200 mug/d was 0.55 (95% CI, 0.32-0.94; P for trend =.03), and 0.61 (95% CI, 0.34-1.11; P for trend =.05) in the older cohort. Among women who did not take folic acid-containing supplements, dietary folate intake of 400 mug/d or more was not significantly associated with risk of hypertension. Conclusion Higher total folate intake was associated with a decreased risk of incident hypertension, particularly in younger women.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Forman, JP (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 3rd Floor,181 Longwood Ave, Boston, MA 02115 USA.	jforman@partners.org			NATIONAL CANCER INSTITUTE [P01CA087969, R01CA050385] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL078093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052866] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allender PS, 1996, ANN INTERN MED, V124, P825, DOI 10.7326/0003-4819-124-9-199605010-00007; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Curhan GC, 2002, ARCH INTERN MED, V162, P2204, DOI 10.1001/archinte.162.19.2204; Dedier J, 2002, HYPERTENSION, V40, P604, DOI 10.1161/01.HYP.0000035856.77718.DA; Doshi SN, 2002, CIRCULATION, V105, P22, DOI 10.1161/hc0102.101388; Doshi SN, 2001, ARTERIOSCL THROM VAS, V21, P1196, DOI 10.1161/hq0701.092000; ELIASSON K, 1992, J HYPERTENS, V10, P195, DOI 10.1097/00004872-199202000-00014; FIEBACH NH, 1989, AM J EPIDEMIOL, V130, P646; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; He J, 2004, J HYPERTENS, V22, P73, DOI 10.1097/00004872-200401000-00015; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Johnson W. J., 1998, NUTR EPIDEMIOLOGY, P22, DOI [DOI 10.1093/ACPROF:OSO/9780195122978.003.11, 10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001]; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mangoni AA, 2002, J INTERN MED, V252, P497, DOI 10.1046/j.1365-2796.2002.01059.x; MARGETTS BM, 1986, BRIT MED J, V293, P1468, DOI 10.1136/bmj.293.6560.1468; Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Stamler J, 2003, J HUM HYPERTENS, V17, P655, DOI 10.1038/sj.jhh.1001608; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; Stroes ESG, 2000, CIRC RES, V86, P1129; Suitor CW, 2000, J AM DIET ASSOC, V100, P88, DOI 10.1016/S0002-8223(00)00027-4; Sundstrom J, 2003, HYPERTENSION, V42, P1100, DOI 10.1161/01.HYP.0000101690.58391.13; van Dijk RAJM, 2001, ARTERIOSCL THROM VAS, V21, P2072, DOI 10.1161/hq1201.100223; van Etten RW, 2002, DIABETOLOGIA, V45, P1004, DOI 10.1007/s00125-002-0862-1; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Verhaar MC, 1999, CIRCULATION, V100, P335, DOI 10.1161/01.CIR.100.4.335; Verhaar MC, 1998, CIRCULATION, V97, P237, DOI 10.1161/01.CIR.97.3.237; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; WALKER WG, 1993, AM J KIDNEY DIS, V22, P164; WALL RT, 1980, THROMB RES, V18, P113, DOI 10.1016/0049-3848(80)90175-9; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; WHELTON PK, 1989, AM J CARDIOL, V63, pG26, DOI 10.1016/0002-9149(89)90215-4; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc	48	93	100	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2005	293	3					320	329		10.1001/jama.293.3.320	http://dx.doi.org/10.1001/jama.293.3.320			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888FA	15657325				2022-12-01	WOS:000226358400026
J	Sanchez, PA; Swaminathan, MS				Sanchez, PA; Swaminathan, MS			Hunger in Africa: the link between unhealthy people and unhealthy soils	LANCET			English	Article									Columbia Univ, Earth Inst, Palisades, NY 10964 USA; MS Swaminathan Res Fdn, Madras, Tamil Nadu, India	Columbia University	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, Lamont Doherty Campus,61 Route 9W,POB 1000,Lamont, Palisades, NY 10964 USA.	sanchez@iri.columbia.edu						[Anonymous], 2001, STAT FOOD INS WORLD; [Anonymous], 2003, CROP VARIETY IMPROVE; De Onis M., 2003, WHO GLOBAL DATABASE; KADIYALA S, 2003, 159 INT FOOD POL RES; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; SANCHEZ PA, IN PRESS SCIENCE; *UN, SECR GEN CALLS UN AF; *UN ACC SCN, 2000, 4 UN ACCSCN IFPRI; *UN MILL PROJ TASK, 2005, INV DEV PRACT GUID A; [No title captured]; [No title captured]	12	104	111	0	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2005	365	9457					442	444						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680461				2022-12-01	WOS:000226610900033
J	Coaker, G; Falick, A; Staskawicz, B				Coaker, G; Falick, A; Staskawicz, B			Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin	SCIENCE			English	Article							III EFFECTOR; SACCHAROMYCES-CEREVISIAE; DISEASE RESISTANCE; INNATE IMMUNITY; AVRRPT2; ARABIDOPSIS; RIN4; SECRETION; CLEAVAGE; PROTEASES	Innate immunity in higher plants invokes a sophisticated surveillance system capable of recognizing bacterial effector proteins. In Arabidopsis, resistance to infection by strains of Pseudomonas syringae expressing the effector AvrRpt2 requires the plant resistance protein RPS2. AvrRpt2 was identified as a putative cysteine protease that results in the elimination of the Arabidopsis protein RIN4. RIN4 cleavage serves as a signal to activate RP52-mediated resistance. AvrRpt2 is delivered into the plant cell, where it is activated by a eukaryotic factor that we identify as cyclophilin. This activation of AvrRpt2 is necessary for protease activity. Active AvrRpt2 can then directly cleave RIN4.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Staskawicz, B (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	stask@nature.berkeley.edu			PHS HHS [R01-FM069680-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; COAKER, UNPUB; CORCORAN ML, 1995, ADV EXP MED BIOL, V385, P151; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; WANDERSMAN C, 1989, MOL MICROBIOL, V3, P1825, DOI 10.1111/j.1365-2958.1989.tb00169.x	22	185	198	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					548	550		10.1126/science.1108633	http://dx.doi.org/10.1126/science.1108633			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15746386				2022-12-01	WOS:000228810500051
J	Quill, TE				Quill, TE			Terri Schiavo - A tragedy compounded	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Rochester, Med Ctr, Ctr Palliat Care & Clin Eth, Rochester, NY 14642 USA	University of Rochester	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Ctr Palliat Care & Clin Eth, Rochester, NY 14642 USA.							ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ganzini L, 2003, NEW ENGL J MED, V349, P359, DOI 10.1056/NEJMsa035086; Gostin L, 1991, Law Med Health Care, V19, P9; JENNETT B, 2002, VEGETATIVE STATE MED; *MULT TASK FORC PV, 1995, NEW ENGL J MED, V333, P130	5	77	80	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1630	+		10.1056/NEJMp058062	http://dx.doi.org/10.1056/NEJMp058062			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15784658				2022-12-01	WOS:000228515200002
J	Rumpel, S; LeDoux, J; Zador, A; Malinow, R				Rumpel, S; LeDoux, J; Zador, A; Malinow, R			Postsynaptic receptor trafficking underlying a form of associative learning	SCIENCE			English	Article							LONG-TERM POTENTIATION; DRIVING AMPA RECEPTORS; SYNAPTIC PLASTICITY; SPATIAL MEMORY; FEAR; LTP; HIPPOCAMPUS; EXPRESSION; SYNAPSES; AMYGDALA	To elucidate molecular, cellular, and circuit changes that occur in the brain during learning, we investigated the rote of a glutamate receptor subtype in fear conditioning. In this form of learning, animals associate two stimuli, such as a tone and a shock. Here we report that fear conditioning drives AMPA-type glutamate receptors into the synapse of a large fraction of postsynaptic neurons in the lateral amygdala, a brain structure essential for this learning process. Furthermore, memory was reduced if AMPA receptor synaptic incorporation was blocked in as few as 10 to 20% of lateral amygdala neurons. Thus, the encoding of memories in the lateral amygdala is mediated by AMPA receptor trafficking, is widely distributed, and displays little redundancy.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NYU, New York, NY 10003 USA	Cold Spring Harbor Laboratory; New York University	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.edu		Zador, Anthony/0000-0002-8431-9136				Andersen P, 2003, PHILOS T R SOC B, V358, P613, DOI 10.1098/rstb.2002.1232; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; ANDERSEN P, 1995, J NEUROBIOL, V26, P396, DOI 10.1002/neu.480260311; Bahi A, 2004, EUR J NEUROSCI, V19, P1621, DOI 10.1111/j.1460-9568.2004.03260.x; Bellgowan PSF, 1996, BEHAV NEUROSCI, V110, P727; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Dong ZZ, 2003, P NATL ACAD SCI USA, V100, P12438, DOI 10.1073/pnas.2132992100; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; FREUD S, 1895, ORIGINS PSYCHOANALYS, P356; GOOD MA, 2004, ANN M SOC NEUR SAN D; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Goss James R, 2004, Methods Mol Biol, V246, P309; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hebb D.O., 2002, CLIN PSYCHOL; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lynch G, 2003, PHILOS T ROY SOC B, V358, P625, DOI 10.1098/rstb.2002.1253; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McNaughton BL, 2003, PHILOS T ROY SOC B, V358, P629, DOI 10.1098/rstb.2002.1231; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Moser MB, 1998, J NEUROSCI, V18, P7535; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Neve R L, 1999, Adv Neurol, V79, P1027; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; SANANES CB, 1992, BEHAV NEUROSCI, V106, P72, DOI 10.1037/0735-7044.106.1.72; Sandler VM, 2002, J NEUROSCI METH, V121, P211, DOI 10.1016/S0165-0270(02)00262-5; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	52	545	559	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					83	88		10.1126/science.1103944	http://dx.doi.org/10.1126/science.1103944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15746389	Bronze			2022-12-01	WOS:000228221500037
J	Ong, BN; Evans, D; Bartlam, A				Ong, BN; Evans, D; Bartlam, A			A patient's journey with myalgic encephalomyelitis	BRITISH MEDICAL JOURNAL			English	Review							CHRONIC ILLNESS; CHRONIC PAIN		Keele Univ, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England; Light Oaks, Stoke On Trent ST2 7DE, Staffs, England; Keele Med Sch, Keele ST5 5BG, Staffs, England	Keele University; Keele University	Ong, BN (corresponding author), Keele Univ, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England.	b.n.ong@kcele.ac.uk						Barry CA, 2001, SOC SCI MED, V53, P487, DOI 10.1016/S0277-9536(00)00351-8; BENDELOW GA, 1995, SOCIOL HEALTH ILL, V17, P139, DOI 10.1111/1467-9566.ep10933376; COMAROFF J, 1981, SOC SCI MED-MED ANTH, V15, P115, DOI 10.1016/0160-7987(81)90034-X; HUTCHINSON A, 2002, REPORT CHIEF MED OFF; Hyden LC, 2002, HEALTH, V6, P325, DOI 10.1177/136345930200600305; May C, 2004, SOCIOL HEALTH ILL, V26, P135, DOI 10.1111/j.1467-9566.2004.00384.x; POLANYI M, 1997, MEANING; Risdon A, 2003, SOC SCI MED, V56, P375, DOI 10.1016/S0277-9536(02)00043-6; Smith M., 1998, PERSPECTIVES PAIN MA, P26; Werner A, 2004, SOC SCI MED, V59, P1035, DOI 10.1016/j.socscimed.2003.12.001; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191	11	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					648	650		10.1136/bmj.330.7492.648	http://dx.doi.org/10.1136/bmj.330.7492.648			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774997	Green Published			2022-12-01	WOS:000227861700027
J	Hauber, E; van Gasselt, S; Ivanov, B; Werner, S; Head, JW; Neukum, G; Jaumann, R; Greeley, R; Mitchell, KL; Muller, P				Hauber, E; van Gasselt, S; Ivanov, B; Werner, S; Head, JW; Neukum, G; Jaumann, R; Greeley, R; Mitchell, KL; Muller, P		HRSC Co-Investigator Team	Discovery of a flank caldera and very young glacial activity at Hecates Tholus, Mars	NATURE			English	Article							GROUND ICE; SUBLIMATION; VOLCANISM; EVOLUTION; WATER; DEPOSITS	The majority of volcanic products on Mars are thought to be mafic and effusive(1,2). Explosive eruptions of basic to ultrabasic chemistry are expected to be common(3,4), but evidence for them is rare and mostly confined to very old surface features(5). Here we present new image and topographic data from the High Resolution Stereo Camera that reveal previously unknown traces of an explosive eruption at 30 degrees N and 149 degrees E on the northwestern flank of the shield volcano Hecates Tholus. The eruption created a large, 10-km-diameter caldera similar to 350 million years ago. We interpret these observations to mean that large-scale explosive volcanism on Mars was not confined to the planet's early evolution. We also show that glacial deposits partly fill the caldera and an adjacent depression. Their age, derived from crater counts, is about 5 to 24 million years. Climate models predict that near-surface ice is not stable at mid-latitudes today(6), assuming a thermo-dynamic steady state. Therefore, the discovery of very young glacial features at Hecates Tholus suggests recent climate changes. We show that the absolute ages of these very recent glacial deposits correspond very well to a period of increased obliquity of the planet's rotational axis(7).	DLR, German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; FU Berlin, Inst Geosci, D-12249 Berlin, Germany; Russian Acad Sci, Inst Dynam Geospheres, Moscow 117334, Russia; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Univ Lancaster, Dept Environm Sci, Lancaster LA1 4YQ, England; UCL, Dept Geomat Engn, London WC1E 6BT, England	Helmholtz Association; German Aerospace Centre (DLR); Free University of Berlin; Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Brown University; Arizona State University; Arizona State University-Tempe; Lancaster University; University of London; University College London	Hauber, E (corresponding author), DLR, German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany.	Ernst.Hauber@dlr.de	Mitchell, Karl Leon/AGL-9516-2022; Werner, Stephanie C/A-6438-2012; Jaumann, Ralf/N-1001-2018; van Gasselt, Stephan/L-9762-2013; Hauber, Ernst/U-2521-2018; Muller, Jan-Peter/Q-8886-2019; Mitchell, Karl Leon/AAG-3821-2020	Werner, Stephanie C/0000-0001-5704-0909; Jaumann, Ralf/0000-0002-9759-6597; van Gasselt, Stephan/0000-0003-2130-6343; Hauber, Ernst/0000-0002-1375-304X; Muller, Jan-Peter/0000-0002-5077-3736; Mitchell, Karl Leon/0000-0003-1093-8441				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; FRANCIS PW, 1982, J GEOPHYS RES, V87, P9881, DOI 10.1029/JB087iB12p09881; GREELEY R, 1990, J GEOPHYS RES-SOLID, V95, P7133, DOI 10.1029/JB095iB05p07133; GREELEY R, 1981, REV GEOPHYS, V19, P13, DOI 10.1029/RG019i001p00013; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Head JW, 2003, GEOLOGY, V31, P641, DOI 10.1130/0091-7613(2003)031<0641:CMGOMW>2.0.CO;2; HELBERT J, 2003, 6 INT C MARS LUN PLA; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; Mangold N, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001885; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P19357, DOI 10.1029/97JE01346; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mouginis-Mark P.J., 1992, MARS PP, P424; MOUGINISMARK PJ, 1982, J GEOPHYS RES, V87, P9890, DOI 10.1029/JB087iB12p09890; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Neukum G., 2004, MARS EXPRESS SCI PAY, V1240, P17; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; SQUYRES SW, 1978, ICARUS, V34, P600, DOI 10.1016/0019-1035(78)90048-9; WALL SD, 1981, ICARUS, V47, P173, DOI 10.1016/0019-1035(81)90165-2; WERNER SC, 2004, LUNAR PLANET SCI, V35; Wewel F., 2000, Canadian Journal of Remote Sensing, V26, P466; WILSON L, 1994, REV GEOPHYS, V32, P221, DOI 10.1029/94RG01113	30	66	66	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					356	361		10.1038/nature03423	http://dx.doi.org/10.1038/nature03423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772654				2022-12-01	WOS:000227715100044
J	Anderson, BL; Winawer, J				Anderson, BL; Winawer, J			Image segmentation and lightness perception	NATURE			English	Article							ILLUMINATION; ORGANIZATION; DEPENDS	The perception of surface albedo ( lightness) is one of the most basic aspects of visual awareness. It is well known that the apparent lightness of a target depends on the context in which it is embedded(1-6), but there is extensive debate about the computations and representations underlying perceived lightness. One view asserts that the visual system explicitly separates surface reflectance from the prevailing illumination and atmospheric conditions in which it is embedded(7-10), generating layered image representations. Some recent theory has challenged this view and asserted that the human visual system derives surface lightness without explicitly segmenting images into multiple layers(11,12). Here we present new lightness illusions - the largest reported to date - that unequivocally demonstrate the effect that layered image representations can have in lightness perception. We show that the computations that underlie the decomposition of luminance into multiple layers under conditions of transparency can induce dramatic lightness illusions, causing identical texture patches to appear either black or white. These results indicate that mechanisms involved in decomposing images into layered representations can play a decisive role in the perception of surface lightness.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; MIT, Cambridge, MA 02139 USA	University of New South Wales Sydney; Massachusetts Institute of Technology (MIT)	Anderson, BL (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	bart.a@unsw.edu.au	Winawer, Jonathan/AFQ-2476-2022	Winawer, Jonathan/0000-0001-7475-5586; Anderson, Barton/0000-0003-0313-4285				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; ADELSON EH, 1999, NEW COGNITIVE NEUROS, P339; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anderson BL, 2003, PSYCHOL REV, V110, P785, DOI 10.1037/0033-295X.110.4.785; Anderson BL, 2003, PERCEPTION, V32, P269, DOI 10.1068/p3216; Anderson BL, 1999, NEURON, V24, P919, DOI 10.1016/S0896-6273(00)81039-9; Barrow H., 1978, COMPUTER VISION SYST, V2, P2; BERGSTROM SS, 1977, SCAND J PSYCHOL, V18, P180, DOI 10.1111/j.1467-9450.1977.tb00275.x; Boyaci H, 2003, J VISION, V3, P541, DOI 10.1167/3.8.2; Eagleman DM, 2004, NATURE, V428, P854, DOI 10.1038/nature02467; Gilchrist A, 1999, PSYCHOL REV, V106, P795, DOI 10.1037/0033-295X.106.4.795; GILCHRIST AL, 1980, PERCEPT PSYCHOPHYS, V28, P527, DOI 10.3758/BF03198821; GILCHRIST AL, 1979, SCI AM, V240, P112, DOI 10.1038/scientificamerican0379-112; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; Koffka K, 1935, PRINCIPLES GESTALT P; Rutherford MD, 2002, PSYCHOL SCI, V13, P142, DOI 10.1111/1467-9280.00426; Singh M, 2002, PSYCHOL REV, V109, P492, DOI 10.1037//0033-295X.109.3.492	18	115	117	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					79	83		10.1038/nature03271	http://dx.doi.org/10.1038/nature03271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744303				2022-12-01	WOS:000227334600047
J	Krakauer, AH				Krakauer, AH			Kin selection and cooperative courtship in wild turkeys	NATURE			English	Article							MELEAGRIS-GALLOPAVO; NATURAL-POPULATIONS; LEK; EVOLUTION; ORNAMENTATION; RELATEDNESS; VERTEBRATES; PATERNITY; MARKERS; MALES	In the few species of birds in which males form display partnerships to attract females, one male secures most or all of the copulations(1,2). This leads to the question of why subordinate males help in the absence of observable reproductive benefits. Hamilton's concept of kin selection(3), whereby individuals can benefit indirectly by helping a relative, was a crucial breakthrough for understanding apparently altruistic systems. However in the only direct test of kin selection in coordinated display partnerships, partners were unrelated(1), discounting kin selection as an explanation for the evolution of cooperation. Here I show, using genetic measures of relatedness and reproductive success, that kin selection can explain the evolution of cooperative courtship in wild turkeys. Subordinate ( helper) males do not themselves reproduce, but their indirect fitness as calculated by Hamilton's rule(3,4) more than offsets the cost of helping. This result confirms a textbook example of kin selection(2) that until now has been controversial(5) and also extends recent findings(6-8) of male relatedness on avian leks by quantifying the kin-selected benefits gained by non-reproducing males.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krakauer, AH (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	krakauer@berkeley.edu		Krakauer, Alan/0000-0001-9177-7963				BALPH DF, 1980, AUK, V97, P854; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Brown J. L., 1987, HELPING COMMUNAL BRE; Buchholz R, 1997, J AVIAN BIOL, V28, P223, DOI 10.2307/3676973; BUCHHOLZ R, 1995, ANIM BEHAV, V50, P929, DOI 10.1016/0003-3472(95)80095-6; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Donoghue AM, 1999, BIOL REPROD, V61, P422, DOI 10.1095/biolreprod61.2.422; EMLEN ST, 1994, TRENDS ECOL EVOL, V9, P282, DOI 10.1016/0169-5347(94)90030-2; GOODENOUGH J, 2001, PERSPECTIVES ANIMAL; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Healy W., 1992, WILD TURKEY BIOL MAN, P46; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Hoglund J, 2003, ANN ZOOL FENN, V40, P249; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P919, DOI 10.1098/rspb.1996.0136; Lank DB, 2002, BEHAV ECOL, V13, P209, DOI 10.1093/beheco/13.2.209; Lucas JR, 1996, ANIM BEHAV, V51, P225, DOI 10.1006/anbe.1996.0019; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; Mock KE, 2002, MOL ECOL, V11, P643, DOI 10.1046/j.1365-294X.2002.01467.x; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed KM, 2000, ANIM GENET, V31, P140, DOI 10.1046/j.1365-2052.2000.00571.x; Shorey L, 2000, NATURE, V408, P352, DOI 10.1038/35042562; WATTS CR, 1971, SCI AM, V224, P112; Wilson E.O., 1975, P1	27	138	140	2	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					69	72		10.1038/nature03325	http://dx.doi.org/10.1038/nature03325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744300				2022-12-01	WOS:000227334600044
J	Hinds, DA; Stuve, LL; Nilsen, GB; Halperin, E; Eskin, E; Ballinger, DG; Frazer, KA; Cox, DR				Hinds, DA; Stuve, LL; Nilsen, GB; Halperin, E; Eskin, E; Ballinger, DG; Frazer, KA; Cox, DR			Whole-genome patterns of common DNA variation in three human populations	SCIENCE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE-DISEQUILIBRIUM; HAPLOTYPE; ASSOCIATION; DISEASE; ADMIXTURE; SELECTION; MAP; SUSCEPTIBILITY; DIVERSITY	Individual differences in DNA sequence are the genetic basis of human variability. We have characterized whole-genome patterns of common human DNA variation by genotyping 1,586,383 single-nucleotide polymorphisms (SNPs) in 71 Americans of European, African, and Asian ancestry. Our results indicate that these SNPs capture most common genetic variation as a result of linkage disequilibrium, the correlation among common SNP alleles. We observe a strong correlation between extended regions of linkage disequilibrium and functional genomic elements. Our data provide a toot for exploring many questions that remain regarding the causal role of common human DNA variation in complex human traits and for investigating the nature of genetic variation within and between human populations.	Perlegen Sci Inc, Mountain View, CA 94043 USA; Int Comp Sci Inst, Berkeley, CA 94704 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Cox, DR (corresponding author), Perlegen Sci Inc, 2021 Stierlin Court, Mountain View, CA 94043 USA.	david_cox@perlegen.com	Eskin, Eleazar/J-9187-2012	Eskin, Eleazar/0000-0003-1149-4758; Frazer, Kelly/0000-0002-6060-8902; Hinds, David/0000-0002-4911-803X				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Duggal P, 2003, GENES IMMUN, V4, P245, DOI 10.1038/sj.gene.6363950; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hinds David A., 2004, Human Genomics, V1, P421; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huttley GA, 1999, GENETICS, V152, P1711; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Nakayama K, 2002, J HUM GENET, V47, P92, DOI 10.1007/s100380200007; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Roses AD, 1997, NEUROGENETICS, V1, P3, DOI 10.1007/s100480050001; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; *U WASH FRED HUTCH, SEATTLESNPS; Van Gassen G, 2003, NEUROSCIENTIST, V9, P117, DOI 10.1177/1073858403252227; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Xiao Q, 1996, J CLIN INVEST, V98, P2027, DOI 10.1172/JCI119007	38	890	958	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1072	1079		10.1126/science.1105436	http://dx.doi.org/10.1126/science.1105436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718463				2022-12-01	WOS:000227197300038
J	Sarbassov, DD; Guertin, DA; Ali, SM; Sabatini, DM				Sarbassov, DD; Guertin, DA; Ali, SM; Sabatini, DM			Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex	SCIENCE			English	Article							PROTEIN-KINASE-B; INTEGRIN-LINKED KINASE; INSULIN-RESISTANCE; BINDING PARTNER; S6 KINASE; DNA-PK; RAPAMYCIN; ACTIVATION; MECHANISM; GROWTH	Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes. Akt/PKB activation requires the phosphorylation of Thr(308) in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser(473) within the carboxyl-terminal hydrophobic motif by an unknown kinase. We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its associated protein rictor are necessary for Ser(473) phosphorylation and that a reduction in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector. The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser(473) in vitro and facilitated Thr(308) phosphorylation by PDK1. Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Broad Inst, Cambridge, MA 02141 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Ali, Siraj/AAE-2958-2019; Sarbassov, Dos/AAS-4950-2020	/0000-0002-1446-7256	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI47389] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dore AS, 2004, DNA REPAIR, V3, P33, DOI 10.1016/j.dnarep.2003.09.003; Edinger AL, 2003, CANCER RES, V63, P8451; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6	29	4991	5210	17	610	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1098	1101		10.1126/science.1106148	http://dx.doi.org/10.1126/science.1106148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718470				2022-12-01	WOS:000227197300045
J	Begovac, J; Lukas, D				Begovac, J; Lukas, D			Condylomata lata of secondary syphilis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Zagreb, Univ Hosp Infect Dis, Zagreb 10000, Croatia	University of Zagreb; University of Zagreb, School of Dental Medicine	Begovac, J (corresponding author), Univ Zagreb, Univ Hosp Infect Dis, Zagreb 10000, Croatia.		Begovac, Josip/AAI-5672-2021	Begovac, Josip/0000-0003-2641-4327					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2005	352	7					708	708		10.1056/NEJMicm040514	http://dx.doi.org/10.1056/NEJMicm040514			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897UO	15716565				2022-12-01	WOS:000227031100010
J	Miller, WC				Miller, WC			Screening for chlamydial infection: are we doing enough?	LANCET			English	Editorial Material							BARRIERS; WOMEN		Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Miller, WC (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA.	bill_miller@unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827				Andersen B, 2002, J INFECT DIS, V185, P252, DOI 10.1086/338268; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; *CDCP, 2002, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P983; Cook RL, 2001, J ADOLESCENT HEALTH, V28, P204, DOI 10.1016/S1054-139X(00)00152-X; Idahl A, 2004, HUM REPROD, V19, P1121, DOI 10.1093/humrep/deh155; La Montagne DS, 2004, SEX TRANSM DIS, V31, P283, DOI 10.1097/01.OLQ.0000124613.85111.6B; LaMontagne DS, 2004, SEX TRANSM INFECT, V80, P335, DOI 10.1136/sti.2004.012856; Low N, 2002, INT J EPIDEMIOL, V31, P891, DOI 10.1093/ije/31.5.891; Low N, 2004, SEX TRANSM INFECT, V80, P342, DOI 10.1136/sti.2003.006197; McNulty CAM, 2004, BRIT J GEN PRACT, V54, P508; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; QUINN K, 2000, THEIR OWN YOUNG ADUL; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Sandman D., 2000, OUT TOUCH AM MEN HLT; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103	16	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2005	365	9458					456	458						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894SS	15705443				2022-12-01	WOS:000226812500007
J	Pease, PJ; Levy, O; Cost, GJ; Gore, J; Ptacin, JL; Sherratt, D; Bustamante, C; Cozzarelli, NR				Pease, PJ; Levy, O; Cost, GJ; Gore, J; Ptacin, JL; Sherratt, D; Bustamante, C; Cozzarelli, NR			Sequence-directed DNA translocation by purified FtsK	SCIENCE			English	Article							ESCHERICHIA-COLI CHROMOSOME; CELL-DIVISION; SINGLE-MOLECULE; RNA-POLYMERASE; RECOMBINATION; REPLICATION; HELICASE; PROTEIN; FORCE; XERC	DNA translocases are molecular motors that move rapidly along DNA using adenosine triphosphate as the source of energy. We directly observed the movement of purified FtsK, an Escherichia coli translocase, on single DNA molecules. The protein moves at 5 kilobases per second and against forces up to 60 piconewtons, and locally reverses direction without dissociation. On three natural substrates, independent of its initial binding position, FtsK efficiently translocates over long distances to the terminal region of the E. coli chromosome, as it does in vivo. Our results imply that FtsK is a bidirectional motor that changes direction in response to short, asymmetric directing DNA sequences.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Oxford	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	carios@alice.berkeley.edu; ncozzare@socrates.berkeley.edu		Cost, Gregory/0000-0002-8509-4653; Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031657, R01GM032543, R01GM031657, R37GM032543] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08295-15, GM07232-27, GM32543, GM31657] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BLAKELY G, 1991, NEW BIOL, V3, P789; Corre J, 2002, J BACTERIOL, V184, P3801, DOI 10.1128/JB.184.14.3801-3807.2002; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Espeli O, 2003, J BIOL CHEM, V278, P44639, DOI 10.1074/jbc.M308926200; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Liu GW, 1998, MOL MICROBIOL, V29, P893, DOI 10.1046/j.1365-2958.1998.00986.x; LOUARN J, 1994, J BACTERIOL, V176, P7524, DOI 10.1128/JB.176.24.7524-7531.1994; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Saleh OA, 2004, EMBO J, V23, P2430, DOI 10.1038/sj.emboj.7600242; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; Singleton MR, 2003, EMBO J, V22, P4579, DOI 10.1093/emboj/cdg441; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614	27	152	155	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					586	590		10.1126/science.1104885	http://dx.doi.org/10.1126/science.1104885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681387				2022-12-01	WOS:000226694000049
J	Miller, TM; Cleveland, DW				Miller, TM; Cleveland, DW			Treating neurodegenerative diseases with antibiotics	SCIENCE			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; MECHANISMS; UPDATE; ALS		Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med & Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Miller, TM (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS027036] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; ROTHSTEIN JD, 1991, ANN NEUROL, V30, P224, DOI 10.1002/ana.410300223; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286	8	45	49	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					361	362		10.1126/science.1109027	http://dx.doi.org/10.1126/science.1109027			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15661995				2022-12-01	WOS:000226492300024
J	Nadel, MR; Shapiro, JA; Klabunde, CN; Seeff, LC; Uhler, R; Smith, RA; Ransohoff, DF				Nadel, MR; Shapiro, JA; Klabunde, CN; Seeff, LC; Uhler, R; Smith, RA; Ransohoff, DF			A national survey of primary care physicians' methods for screening for fecal occult blood	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER-SOCIETY GUIDELINES; COLORECTAL-CANCER; CLINICAL GUIDELINES; SELF-REPORT; FOLLOW-UP; SURVEILLANCE; UPDATE; SIGMOIDOSCOPY; MORTALITY; PROSTATE	Background: Screening with the fecal occult blood test (FOBT) has been shown to reduce colorectal cancer incidence and mortality in randomized, controlled trials. Although the test is simple, implementation requires adherence to specific techniques of testing and follow-up of abnormal results. Objective: To examine how FOBT and follow-up are conducted in community practice across the United States. Design: Cross-sectional national surveys of primary care physicians and the public. Setting: The Survey of Colorectal Cancer Screening Practices in Health Care Organizations and the 2000 National Health Interview Survey. Participants: 1147 primary care physicians who ordered or performed FOBT and 11 365 adults 50 years of age or older who responded to questions about FOBT use. Measurements: Self-reported data on details of FOBT implementation and follow-up of positive results. Results: Although screening guidelines recommend home tests, 32.5% (95% Cl, 29.8% to 35.3%) of physicians used only the less accurate method of single-sample in-office testing; another 41.2% (Cl, 38.3% to 44.0%) used both types of test. Follow-up of positive test results showed considerable nonadherence to guidelines, with 29.7% (Cl, 27.1% to 32.4%) of physicians recommending repeating FOBT. Furthermore, sigmoidoscopy, rather than total colon examination, was commonly recommended to work up abnormal findings. Nearly one third of adults who reported having FOBT said they had only an in-office test, and nearly one third of those who reported abnormal FOBT results reported no follow-up diagnostic procedures. Limitations: The study was based on self-reports. Data from the National Health Interview Survey may underestimate the prevalence of in-office testing and inadequate follow-up. Conclusions: mortality reductions demonstrated with FOBT in clinical trials may not be realized in community practice because of the common use of in-office tests and inappropriate follow-up of positive results. Education of providers and system-level interventions are needed to improve the quality of screening implementation.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; Amer Canc Soc, Atlanta, GA 30329 USA; NCI, Bethesda, MD 20892 USA; Univ N Carolina, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Nadel, MR (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway,Mailstop K-55, Atlanta, GA 30341 USA.	mrn1@cdc.gov			DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC085169] Funding Source: NIH RePORTER; NCI NIH HHS [N01-PC-85169] Funding Source: Medline; PHS HHS [99FED06571] Funding Source: Medline	DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baig N, 2003, AM J GASTROENTEROL, V98, P2078, DOI 10.1016/S0002-9270(03)00424-6; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; *GUID COMM PREV SE, IMPR US BREAST CERV; Hall HI, 2004, PREV MED, V39, P27, DOI 10.1016/j.ypmed.2004.02.024; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Klabunde CN, 2003, PREV MED, V36, P352, DOI 10.1016/S0091-7435(02)00066-X; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Levin B, 1997, ARCH INTERN MED, V157, P970, DOI 10.1001/archinte.157.9.970; Levin B, 2003, CA-CANCER J CLIN, V53, P44, DOI 10.3322/canjclin.53.1.44; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Lurie JD, 1999, J NATL CANCER I, V91, P1641, DOI 10.1093/jnci/91.19.1641; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; MYERS RE, 1993, AM J PUBLIC HEALTH, V83, P1620, DOI 10.2105/AJPH.83.11.1620; Nadel MR, 2002, PREV MED, V35, P199, DOI 10.1006/pmed.2002.1070; NASH C, 2003, GASTROENTEROLOGY S1, V124, pW1053; *NAT CTR HLTH STAT, 2000, NAT HLTH INT SURV; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Peterson SK., 2000, SEMIN COLON RECTAL S, V11, P58; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; Ransohoff DF, 1997, ANN INTERN MED, V126, P808, DOI 10.7326/0003-4819-126-10-199705150-00014; *RES TRIANGL I, 2001, SUDAAN US MAN REL 8; SAS Institute, 2002, SAS PROC GUID VERS 9; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; STARFIELD B, 1998, PRIMARY CARE BALANCI, P154; *US PREV SERV TASK, 2002, SCREEN COL CANC; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; Yabroff KR, 2003, MED CARE RES REV, V60, P294, DOI 10.1177/1077558703254698; Yamamoto M, 2000, HEPATO-GASTROENTEROL, V47, P396; YOUNG GP, 1996, PREVENTION EARLY DET, P241; 1996, US PREVENTIVE TASK F	39	143	145	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2005	142	2					86	94		10.7326/0003-4819-142-2-200501180-00007	http://dx.doi.org/10.7326/0003-4819-142-2-200501180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915LQ	15657156				2022-12-01	WOS:000228306100002
J	Kearney, PM; Whelton, M; Reynolds, K; Muntner, P; Whelton, PK; He, J				Kearney, PM; Whelton, M; Reynolds, K; Muntner, P; Whelton, PK; He, J			Global burden of hypertension: analysis of worldwide data	LANCET			English	Article							BLOOD-PRESSURE LEVELS; CARDIOVASCULAR-DISEASE; HEALTH SURVEY; RISK-FACTORS; DEVELOPING-COUNTRIES; RURAL-POPULATION; URBAN-POPULATION; PREVALENCE; AWARENESS; EPIDEMIOLOGY	Background Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition. We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025. Methods We searched the published literature from Jan 1, 1980, to Dec 31, 2002, using MEDLINE, supplemented by a manual search of bibliographies of retrieved articles. We included studies that reported sex-specific and age-specific prevalence of hypertension in representative population samples. All data were obtained independently, by two investigators with a standardised protocol and data-collection form. Results Overall, 26.4% (95% CI 26.0-26.8%) of the adult population in 2000 had hypertension (26.6% of men [26.0-27.2%] and 26.1% of women [25.5-26.6%]), and 29.2% (28.8-29.7%) were projected to have this condition by 2025 (29.0% of men [28.6-29.4%] and 29.5% of women [29.1-29.9%]). The estimated total number of adults with hypertension in 2000 was 972 million (957-987 million); 333 million (329-336 million) in economically developed countries and 639 million (625-654 million) in economically developing countries. The number of adults with hypertension in 2025 was predicted to increase by about 60% to a total of 1.56 billion (1.54-1.58 billion). Interpretation Hypertension is an important public-health challenge worldwide. Prevention, detection, treatment, and control of this condition should receive high priority.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Dept Med, New Orleans, LA 70112 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England	Tulane University; Tulane University; Tulane University; Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave,SL18, New Orleans, LA 70112 USA.	jhe@tulane.edu	Kearney, Patricia M/AAE-8501-2020; He, Jiang/AAF-5303-2020; Reynolds, Kristi/AAN-1434-2021	He, Jiang/0000-0002-8286-9652; Reynolds, Kristi/0000-0001-7619-1649; Kearney, Patricia/0000-0001-9599-3540	NHLBI NIH HHS [R01 HL68057] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068057] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], NATL CARDIOVASCULAR; Arroyo P, 1999, J HUM HYPERTENS, V13, P671, DOI 10.1038/sj.jhh.1000909; BABA S, 1991, J HUM HYPERTENS, V5, P317; Banegas JR, 1998, HYPERTENSION, V32, P998, DOI 10.1161/01.HYP.32.6.998; BENNETT SA, 1994, MED J AUSTRALIA, V161, P519, DOI 10.5694/j.1326-5377.1994.tb127594.x; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Forrester T, 1996, CIBA F SYMP, V201, P17; Fuentes R, 2000, J HYPERTENS, V18, P521, DOI 10.1097/00004872-200018050-00003; Giampaoli S, 2001, Ital Heart J Suppl, V2, P294; Gordis L., 2000, EPIDEMIOLOGY, V2; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2003, EUR J CARDIOV PREV R, V10, P249, DOI 10.1097/01.hjr.0000085254.65733.21; GUPTA R, 1994, J HUM HYPERTENS, V8, P823; GUPTA R, 1995, J HYPERTENS, V13, P1193, DOI 10.1097/00004872-199510000-00014; Gupta R, 1999, J Indian Med Assoc, V97, P74; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Halberstein RA, 1999, HUM BIOL, V71, P659; Hamet P, 2000, CAN J CARDIOL, V16, P1483; He J, 1997, MED CLIN N AM, V81, P1077, DOI 10.1016/S0025-7125(05)70568-X; Hernandez-Hernandez R, 2000, J HUM HYPERTENS, V14, pS2, DOI 10.1038/sj.jhh.1000978; IBRAHIM MM, 1995, HYPERTENSION, V26, P886, DOI 10.1161/01.HYP.26.6.886; Joffres MR, 1997, AM J HYPERTENS, V10, P1097; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; KIM JS, 1994, AM J PREV MED, V10, P200, DOI 10.1016/S0749-3797(18)30591-9; Levenson James W, 2002, Prev Cardiol, V5, P188, DOI 10.1111/j.1520-037X.2002.00564.x; Malhotra P, 1999, J HUM HYPERTENS, V13, P467, DOI 10.1038/sj.jhh.1000864; Mbanya JCN, 1998, INT J EPIDEMIOL, V27, P181, DOI 10.1093/ije/27.2.181; Mufunda T, 2000, J HUM HYPERTENS, V14, P65, DOI 10.1038/sj.jhh.1000886; Murray C.J, 1994, GLOBAL COMP ASSESSME; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Pan WH, 2001, J HUM HYPERTENS, V15, P793, DOI 10.1038/sj.jhh.1001268; Pearson TA, 1999, CARDIOVASC DRUG THER, V13, P95, DOI 10.1023/A:1007727924276; POULTER N, 2003, HEART, V89, P2; Primatesta P, 2001, HYPERTENSION, V38, P827, DOI 10.1161/hyp.38.4.827; RAMIREZ MOA, 1995, J HUM HYPERTENS, V9, P891; Riecansky I, 1991, Bratisl Lek Listy, V92, P203; Seedat YK, 2000, J HUM HYPERTENS, V14, P739, DOI 10.1038/sj.jhh.1001059; Singh RB, 2000, J HUM HYPERTENS, V14, P749, DOI 10.1038/sj.jhh.1001057; Singh RB, 1997, J HUM HYPERTENS, V11, P679, DOI 10.1038/sj.jhh.1000511; Singh RB, 1997, J HUM HYPERTENS, V11, P51, DOI 10.1038/sj.jhh.1000384; Sonmez HM, 1999, J HUM HYPERTENS, V13, P399, DOI 10.1038/sj.jhh.1000824; STATA, 2001, STAT STAT SOFTW REL; Stegmayr B, 1996, CEREBROVASC DIS, V6, P80, DOI 10.1159/000108002; Stergiou GS, 1999, AM J HYPERTENS, V12, P959, DOI 10.1016/S0895-7061(99)00136-3; Steyn K, 2001, J HYPERTENS, V19, P1717, DOI 10.1097/00004872-200110000-00004; Sulbaran T, 2000, J HUM HYPERTENS, V14, pS6, DOI 10.1038/sj.jhh.1000979; THAMM M, 1999, GESUNDHEITSWESEN; THOM TJ, 1989, INT J EPIDEMIOL, V18, pS20; Ueshima H, 2000, J HUM HYPERTENS, V14, P765, DOI 10.1038/sj.jhh.1001054; United Nations Secretariat Department of Economic and Social Affairs Population Division, 2001, WORLD POP PROSP 2000; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; *WHO, WHOMNCCCH02012002; *WHO, 2001, WORLD HLTH REP 2001, P144; *WHO COLL CTR SURV, 2001, GLOB CARD INFOBASE; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wolz M, 2000, AM J HYPERTENS, V13, P103, DOI 10.1016/S0895-7061(99)00241-1; World Bank, 1993, WORLD DEV REP 1993 I, V1; *WORLD BANK GROUP, WORLD DEV IND 2003 C; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	64	5145	5492	17	543	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2005	365	9455					217	223		10.1016/S0140-6736(05)17741-1	http://dx.doi.org/10.1016/S0140-6736(05)17741-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887MG	15652604				2022-12-01	WOS:000226309600027
J	Yuan, ZL; Guan, YJ; Chatterjee, D; Chin, YE				Yuan, ZL; Guan, YJ; Chatterjee, D; Chin, YE			Stat3 dimerization regulated by reversible acetylation of a single lysine residue	SCIENCE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; SH2 DOMAIN; TRANSCRIPTION; DNA; ACTIVATION; CBP/P300; P300/CBP; PEPTIDE; PROTEIN	Upon cytokine treatment, members of the signal transducers and activators of transcription (STAT) family of proteins are phosphorytated on tyrosine and serine sites within the carboxyl-terminal region in cells. We show that in response to cytokine treatment, Stat3 is also acetylated on a single lysine residue, Lys(685). Histone acetyltransferase p300-mediated Stat3 acetylation on Lys(685) was reversible by type I histone deacetylase (HDAC). Use of a prostate cancer cell line (PC3) that lacks Stat3 and PC3 cells expressing wildtype Stat3 or a Stat3 mutant containing a Lys(685)-to-Arg substitution revealed that Lys(685) acetylation was critical for Stat3 to form stable dimers required for cytokine-stimulated DNA binding and transcriptional regulation, to enhance transcription of cell growth-related genes, and to promote cell cycle progression in response to treatment with oncostatin M.	Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med, Providence, RI 02903 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Chin, YE (corresponding author), Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA.	y_eugene_chin@brown.edu						Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Clark J, 2003, ONCOGENE, V22, P1247, DOI 10.1038/sj.onc.1206247; Gao Q, 2004, MOL CELL PROTEOMICS, V3, P704, DOI 10.1074/mcp.M300131-MCP200; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matsui T, 2002, J BIOL CHEM, V277, P36167, DOI 10.1074/jbc.M203184200; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; YUAN PZ, UNPUB; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhukovskaya NV, 2004, DEVELOPMENT, V131, P447, DOI 10.1242/dev.00927	27	590	618	4	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					269	273		10.1126/science.1105166	http://dx.doi.org/10.1126/science.1105166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653507				2022-12-01	WOS:000226361900047
J	Ross, MT; Grafham, DV; Coffey, AJ; Scherer, S; McLay, K; Muzny, D; Platzer, M; Howell, GR; Burrows, C; Bird, CP; Frankish, A; Lovell, FL; Howe, KL; Ashurst, JL; Fulton, RS; Sudbrak, R; Wen, GP; Jones, MC; Hurles, ME; Andrews, TD; Scott, CE; Searle, S; Ramser, J; Whittaker, A; Deadman, R; Carter, NP; Hunt, SE; Chen, R; Cree, A; Gunaratne, P; Havlak, P; Hodgson, A; Metzker, ML; Richards, S; Scott, G; Steffen, D; Sodergren, E; Wheeler, DA; Worley, KC; Ainscough, R; Ambrose, KD; Ansari-Lari, MA; Aradhya, S; Ashwell, RIS; Babbage, AK; Bagguley, CL; Ballabio, A; Banerjee, R; Barker, GE; Barlow, KF; Barrett, IP; Bates, KN; Beare, DM; Beasley, H; Beasley, O; Beck, A; Bethel, G; Blechschmidt, K; Brady, N; Bray-Allen, S; Bridgeman, AM; Brown, AJ; Brown, MJ; Bonnin, D; Bruford, EA; Buhay, C; Burch, P; Burford, D; Burgess, J; Burrill, W; Burton, J; Bye, JM; Carder, C; Carrel, L; Chako, J; Chapman, JC; Chavez, D; Chen, E; Chen, G; Chen, Y; Chen, ZJ; Chinault, C; Ciccodicola, A; Clark, SY; Clarke, G; Clee, CM; Clegg, S; Clerc-Blankenburg, K; Clifford, K; Cobley, V; Cole, CG; Conquer, JS; Corby, N; Connor, RE; David, R; Davies, J; Davis, C; Davis, J; Delgado, O; DeShazo, D; Dhami, P; Ding, Y; Dinh, H; Dodsworth, S; Draper, H; Dugan-Rocha, S; Dunham, A; Dunn, M; Durbin, KJ; Dutta, I; Eades, T; Ellwood, M; Emery-Cohen, A; Errington, H; Evans, KL; Faulkner, L; Francis, F; Frankland, J; Fraser, AE; Galgoczy, P; Gilbert, J; Gill, R; Glockner, G; Gregory, SG; Gribble, S; Griffiths, C; Grocock, R; Gu, YH; Gwilliam, R; Hamilton, C; Hart, EA; Hawes, A; Heath, PD; Heitmann, K; Hennig, S; Hernandez, J; Hinzmann, B; Ho, S; Hoffs, M; Howden, PJ; Huckle, EJ; Hume, J; Hunt, PJ; Hunt, AR; Isherwood, J; Jacob, L; Johnson, D; Jones, S; de Jong, PJ; Joseph, SS; Keenan, S; Kelly, S; Kershaw, JK; Khan, Z; Kioschis, P; Klages, S; Knights, AJ; Kosiura, A; Kovar-Smith, C; Laird, GK; Langford, C; Lawlor, S; Leversha, M; Lewis, L; Liu, W; Lloyd, C; Lloyd, DM; Loulseged, H; Loveland, JE; Lovell, JD; Lozado, R; Lu, J; Lyne, R; Ma, J; Maheshwari, M; Matthews, LH; McDowall, J; McLaren, S; McMurray, A; Meidl, P; Meitinger, T; Milne, S; Miner, G; Mistry, SL; Morgan, M; Morris, S; Muller, I; Mullikin, JC; Nguyen, N; Nordsiek, G; Nyakatura, G; O'Dell, CN; Okwuonu, G; Palmer, S; Pandian, R; Parker, D; Parrish, J; Pasternak, S; Patel, D; Pearce, AV; Pearson, DM; Pelan, SE; Perez, L; Porter, KM; Ramsey, Y; Reichwald, K; Rhodes, S; Ridler, KA; Schlessinger, D; Schueler, MG; Sehra, HK; Shaw-Smith, C; Shen, H; Sheridan, EM; Shownkeen, R; Skuce, CD; Smith, ML; Sotheran, EC; Steingruber, HE; Steward, CA; Storey, R; Swann, RM; Swarbreck, D; Tabor, PE; Taudien, S; Taylor, T; Teague, B; Thomas, K; Thorpe, A; Timms, K; Tracey, A; Trevanion, S; Tromans, AC; d'Urso, M; Verduzco, D; Villasana, D; Waldron, L; Wall, M; Wang, QY; Warren, J; Warry, GL; Wei, XH; West, A; Whitehead, SL; Whiteley, MN; Wilkinson, JE; Willey, DL; Williams, G; Williams, L; Williamson, A; Williamson, H; Wilming, L; Woodmansey, RL; Wray, PW; Yen, J; Zhang, JK; Zhou, JL; Zoghbi, H; Zorilla, S; Buck, D; Reinhardt, R; Poustka, A; Rosenthal, A; Lehrach, H; Meindl, A; Minx, PJ; Hillier, LW; Willard, HF; Wilson, RK; Waterston, RH; Rice, CM; Vaudin, M; Coulson, A; Nelson, DL; Weinstock, G; Sulston, JE; Durbin, R; Hubbard, T; Gibbs, RA; Beck, S; Rogers, J; Bentley, DR				Ross, MT; Grafham, DV; Coffey, AJ; Scherer, S; McLay, K; Muzny, D; Platzer, M; Howell, GR; Burrows, C; Bird, CP; Frankish, A; Lovell, FL; Howe, KL; Ashurst, JL; Fulton, RS; Sudbrak, R; Wen, GP; Jones, MC; Hurles, ME; Andrews, TD; Scott, CE; Searle, S; Ramser, J; Whittaker, A; Deadman, R; Carter, NP; Hunt, SE; Chen, R; Cree, A; Gunaratne, P; Havlak, P; Hodgson, A; Metzker, ML; Richards, S; Scott, G; Steffen, D; Sodergren, E; Wheeler, DA; Worley, KC; Ainscough, R; Ambrose, KD; Ansari-Lari, MA; Aradhya, S; Ashwell, RIS; Babbage, AK; Bagguley, CL; Ballabio, A; Banerjee, R; Barker, GE; Barlow, KF; Barrett, IP; Bates, KN; Beare, DM; Beasley, H; Beasley, O; Beck, A; Bethel, G; Blechschmidt, K; Brady, N; Bray-Allen, S; Bridgeman, AM; Brown, AJ; Brown, MJ; Bonnin, D; Bruford, EA; Buhay, C; Burch, P; Burford, D; Burgess, J; Burrill, W; Burton, J; Bye, JM; Carder, C; Carrel, L; Chako, J; Chapman, JC; Chavez, D; Chen, E; Chen, G; Chen, Y; Chen, ZJ; Chinault, C; Ciccodicola, A; Clark, SY; Clarke, G; Clee, CM; Clegg, S; Clerc-Blankenburg, K; Clifford, K; Cobley, V; Cole, CG; Conquer, JS; Corby, N; Connor, RE; David, R; Davies, J; Davis, C; Davis, J; Delgado, O; DeShazo, D; Dhami, P; Ding, Y; Dinh, H; Dodsworth, S; Draper, H; Dugan-Rocha, S; Dunham, A; Dunn, M; Durbin, KJ; Dutta, I; Eades, T; Ellwood, M; Emery-Cohen, A; Errington, H; Evans, KL; Faulkner, L; Francis, F; Frankland, J; Fraser, AE; Galgoczy, P; Gilbert, J; Gill, R; Glockner, G; Gregory, SG; Gribble, S; Griffiths, C; Grocock, R; Gu, YH; Gwilliam, R; Hamilton, C; Hart, EA; Hawes, A; Heath, PD; Heitmann, K; Hennig, S; Hernandez, J; Hinzmann, B; Ho, S; Hoffs, M; Howden, PJ; Huckle, EJ; Hume, J; Hunt, PJ; Hunt, AR; Isherwood, J; Jacob, L; Johnson, D; Jones, S; de Jong, PJ; Joseph, SS; Keenan, S; Kelly, S; Kershaw, JK; Khan, Z; Kioschis, P; Klages, S; Knights, AJ; Kosiura, A; Kovar-Smith, C; Laird, GK; Langford, C; Lawlor, S; Leversha, M; Lewis, L; Liu, W; Lloyd, C; Lloyd, DM; Loulseged, H; Loveland, JE; Lovell, JD; Lozado, R; Lu, J; Lyne, R; Ma, J; Maheshwari, M; Matthews, LH; McDowall, J; McLaren, S; McMurray, A; Meidl, P; Meitinger, T; Milne, S; Miner, G; Mistry, SL; Morgan, M; Morris, S; Muller, I; Mullikin, JC; Nguyen, N; Nordsiek, G; Nyakatura, G; O'Dell, CN; Okwuonu, G; Palmer, S; Pandian, R; Parker, D; Parrish, J; Pasternak, S; Patel, D; Pearce, AV; Pearson, DM; Pelan, SE; Perez, L; Porter, KM; Ramsey, Y; Reichwald, K; Rhodes, S; Ridler, KA; Schlessinger, D; Schueler, MG; Sehra, HK; Shaw-Smith, C; Shen, H; Sheridan, EM; Shownkeen, R; Skuce, CD; Smith, ML; Sotheran, EC; Steingruber, HE; Steward, CA; Storey, R; Swann, RM; Swarbreck, D; Tabor, PE; Taudien, S; Taylor, T; Teague, B; Thomas, K; Thorpe, A; Timms, K; Tracey, A; Trevanion, S; Tromans, AC; d'Urso, M; Verduzco, D; Villasana, D; Waldron, L; Wall, M; Wang, QY; Warren, J; Warry, GL; Wei, XH; West, A; Whitehead, SL; Whiteley, MN; Wilkinson, JE; Willey, DL; Williams, G; Williams, L; Williamson, A; Williamson, H; Wilming, L; Woodmansey, RL; Wray, PW; Yen, J; Zhang, JK; Zhou, JL; Zoghbi, H; Zorilla, S; Buck, D; Reinhardt, R; Poustka, A; Rosenthal, A; Lehrach, H; Meindl, A; Minx, PJ; Hillier, LW; Willard, HF; Wilson, RK; Waterston, RH; Rice, CM; Vaudin, M; Coulson, A; Nelson, DL; Weinstock, G; Sulston, JE; Durbin, R; Hubbard, T; Gibbs, RA; Beck, S; Rogers, J; Bentley, DR			The DNA sequence of the human X chromosome	NATURE			English	Article							LINKED MENTAL-RETARDATION; MAMMALIAN Y-CHROMOSOME; HUMAN GENOME SEQUENCE; INACTIVATION CENTER; REPEAT HYPOTHESIS; GENE FAMILY; EVOLUTION; MUTATIONS; REGION; RNA	The human X chromosome has a unique biology that was shaped by its evolution as the sex chromosome shared by males and females. We have determined 99.3% of the euchromatic sequence of the X chromosome. Our analysis illustrates the autosomal origin of the mammalian sex chromosomes, the stepwise process that led to the progressive loss of recombination between X and Y, and the extent of subsequent degradation of the Y chromosome. LINE1 repeat elements cover one-third of the X chromosome, with a distribution that is consistent with their proposed role as way stations in the process of X-chromosome inactivation. We found 1,098 genes in the sequence, of which 99 encode proteins expressed in testis and in various tumour types. A disproportionately high number of mendelian diseases are documented for the X chromosome. Of this number, 168 have been explained by mutations in 113 X-linked genes, which in many cases were characterized with the aid of the DNA sequence.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; Inst Mol Biotechnol, D-07745 Jena, Germany; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Munich, D-80336 Munich, Germany; UCL, Galton Lab, HUGO Gen Nomenclature Comm, Dept Biol, London NW1 2HE, England; Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; PE Appl Biosyst, Adv Ctr Genet Technol, Foster City, CA 94404 USA; European Bioinformat Inst, Cambridge CB10 1SD, England; Inst Genet & Biophys, I-80100 Naples, Italy; Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Paris 05, INSERM, U567,Inst Cochin, Lab Genet & Physiopathol Retards Mentaux, F-75014 Paris, France; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; GSF, Natl Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; RZPD Resource Ctr Genome Res, D-14059 Berlin, Germany; NHGRI, NIH, Bethesda, MD 20892 USA; NIA, Genet Lab, Baltimore, MD 21224 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Wellcome Trust Sanger Institute; Baylor College of Medicine; Washington University (WUSTL); Max Planck Society; University of Kiel; University of Munich; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Thermo Fisher Scientific; Applied Biosystems; European Molecular Biology Laboratory (EMBL); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Duke University	Ross, MT (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mtr@sanger.ac.uk	Francis, Fiona/B-5854-2016; Lyne, Rachel/AAE-2189-2020; Johnson, David/A-3907-2011; Hubbard, Tim J/C-2567-2008; Norouzi, Neil/H-2530-2012; Frankish, Adam/G-6545-2011; BALLABIO, Andrea/AAL-2672-2020; Glöckner, Gernot/A-7800-2010; Meitinger, Thomas/O-1318-2015; Bruford, Elspeth/AAU-4961-2020; Durbin, Richard/AAE-7178-2019; Wheeler, David A/M-9740-2018; Driemeier, David/H-3461-2012; Andrews, Dan/ABG-4815-2020; Wilson, Richard K./AAF-4139-2019; Evans, Kathryn KL/I-5910-2012; Hubbard, Tim J.P./AAT-4571-2020; Weinstock, George M/C-6314-2013	Lyne, Rachel/0000-0001-8050-402X; Johnson, David/0000-0003-0887-3343; Hubbard, Tim J/0000-0002-1767-9318; BALLABIO, Andrea/0000-0003-1381-4604; Glöckner, Gernot/0000-0002-9061-1061; Bruford, Elspeth/0000-0002-8380-5247; Durbin, Richard/0000-0002-9130-1006; Wheeler, David A/0000-0002-9056-6299; Driemeier, David/0000-0003-3766-0654; Wilson, Richard K./0000-0002-1992-1358; Hubbard, Tim J.P./0000-0002-1767-9318; Weinstock, George M/0000-0002-2997-4592; Hunt, Sarah/0000-0002-8350-1235; Bridgeman, Anne/0000-0002-9478-6125; Zoghbi, Huda/0000-0002-0700-3349; Howe, Kevin/0000-0002-1751-9226; Meitinger, Thomas/0000-0002-8838-8403; Wilming, Laurens/0000-0002-4154-7358; Swarbreck, David/0000-0002-5453-1013; Fosker, Christine/0000-0002-3799-9474; Wass, Elizabeth/0000-0002-8605-9921; Andrews, Dan/0000-0003-3922-6376; Keenan, Stephen/0000-0002-9141-7690; Worley, Kim/0000-0002-0282-1000; Frankish, Adam/0000-0002-4333-628X; Storey, Roy/0000-0003-1375-7136; Evans, Kathryn/0000-0002-7884-5877; Steward, Charles/0000-0001-8829-5349; Trevanion, Stephen/0000-0002-4862-3333; Delgado, Oliver/0000-0003-2547-5857; /0000-0002-9833-2817; Loveland, Jane/0000-0002-7669-2934; Gilbert, James/0000-0001-8079-3159; Ciccodicola, Alfredo/0000-0002-9924-1482; Davidson, Claire/0000-0002-4910-8202; Francis, Fiona/0000-0001-8542-7537; ARADHYA, SWAROOP/0000-0001-6219-2931; Hunt, Adrienne/0000-0002-1227-0310; Reinhardt, Richard/0000-0001-9376-2132; Gregory, Simon/0000-0002-7805-1743	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000647] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Bourque G, 2002, GENOME RES, V12, P26; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Chomez P, 2001, CANCER RES, V61, P5544; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Humphray SJ, 2004, NATURE, V429, P369, DOI 10.1038/nature02465; Hurst LD, 2001, NATURE, V411, P149, DOI 10.1038/35075697; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; *J HOPK U NAT CTR, 2000, OMIM ONL MEND INH MA; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2000, HUM MOL GENET, V9, P311, DOI 10.1093/hmg/9.2.311; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Migeon BR, 2001, AM J HUM GENET, V69, P951, DOI 10.1086/324022; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ohno S., 1967, SEX CHROMOSOMES SEX; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sargent CA, 1996, GENOMICS, V32, P200, DOI 10.1006/geno.1996.0106; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Schmid M, 2000, CYTOGENET CELL GENET, V90, P169, DOI 10.1159/000056772; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Toder R, 2000, CYTOGENET CELL GENET, V91, P285, DOI 10.1159/000056858	67	761	1542	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					325	337		10.1038/nature03440	http://dx.doi.org/10.1038/nature03440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772651	Bronze, Green Accepted			2022-12-01	WOS:000227715100040
J	Rathore, SS; Epstein, AJ; Volpp, KGM; Krumholz, HM				Rathore, SS; Epstein, AJ; Volpp, KGM; Krumholz, HM			Regionalization of care for acute coronary syndromes - More evidence is needed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; IMMEDIATE THROMBOLYSIS; FIBRINOLYTIC THERAPY; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; VOLUME; MORTALITY; INTERVENTION; SPECIALTY		Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & EValuat, New Haven, CT 06504 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Vet Affairs Ctr Hlth Equity Res & Promot, Philadelphia, PA USA	Yale University; Yale University; Yale University; Yale University; University of Pennsylvania	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, Room I-456 SHM,333 Cedar St,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Epstein, Andrew/0000-0001-5078-6564; Volpp, Kevin/0000-0003-1423-4599	NIGMS NIH HHS [T32 GM007205, T32 GM007205-35, GM07205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agency for Healthcare Research and Quality U.S. Department of Health & Human Services, HEALTHC COST UT PROJ; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Armstrong PW, 2003, NEW ENGL J MED, V349, P2168; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Bogaty P, 2003, LANCET, V361, P1813, DOI 10.1016/S0140-6736(03)13407-1; Califf RM, 2003, CIRCULATION, V107, P1467, DOI 10.1161/01.CIR.0000065160.19016.26; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Dalby M, 2003, CIRCULATION, V108, P1809, DOI 10.1161/01.CIR.0000091088.63921.8C; DEVERS KJ, 2003, SPECIALTY HOSP FOCUS; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Epstein AJ, 2004, J AM COLL CARDIOL, V43, P1755, DOI 10.1016/j.jacc.2003.09.070; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Frances CD, 1999, ARCH INTERN MED, V159, P1429, DOI 10.1001/archinte.159.13.1429; *GEN ACC OFF, 2003, PUBL GEN ACC OFF; Gibson CM, 2004, EUR HEART J, V25, P1001, DOI 10.1016/j.ehj.2004.04.029; Go AS, 2000, AM J MED, V108, P216, DOI 10.1016/S0002-9343(99)00430-1; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; Ho V, 2000, CIRCULATION, V101, P1806, DOI 10.1161/01.CIR.101.15.1806; Ho V, 2002, J HEALTH ECON, V21, P873, DOI 10.1016/S0167-6296(02)00057-7; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Kansagra SM, 2004, JAMA-J AM MED ASSOC, V292, P1717, DOI 10.1001/jama.292.14.1717; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2004, ANN INTERN MED, V141, P298, DOI 10.7326/0003-4819-141-4-200408170-00010; Kent DM, 2002, J GEN INTERN MED, V17, P887, DOI 10.1046/j.1525-1497.2002.11232.x; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Nallamothu BK, 2003, AM J CARDIOL, V92, P824, DOI 10.1016/S0002-9149(03)00891-9; NALLAMOTHU BK, IN PRESS CIRCULATION; *NAT HEART ATT AL, 1998, J THROMB THROMBOLYS, V6, P19; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Shahian DM, 2003, ANN THORAC SURG, V75, P1048, DOI 10.1016/S0003-4975(02)04308-4; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; Topol EJ, 2003, CIRCULATION, V107, P1463, DOI 10.1161/01.CIR.0000063680.45780.A0; Vermeer F, 1999, HEART, V82, P426, DOI 10.1136/hrt.82.4.426; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Williams DO, 2004, CIRCULATION, V109, P1806, DOI 10.1161/01.CIR.0000126892.17646.83	40	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1383	1387		10.1001/jama.293.11.1383	http://dx.doi.org/10.1001/jama.293.11.1383			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769973	Green Accepted			2022-12-01	WOS:000227698600028
J	Bibring, JP; Langevin, Y; Gendrin, A; Gondet, B; Poulet, F; Berthe, M; Soufflot, A; Arvidson, R; Mangold, N; Mustard, J; Drossart, P				Bibring, JP; Langevin, Y; Gendrin, A; Gondet, B; Poulet, F; Berthe, M; Soufflot, A; Arvidson, R; Mangold, N; Mustard, J; Drossart, P		OMEGA Team	Mars surface diversity as revealed by the OMEGA/Mars Express observations	SCIENCE			English	Article							MGS-TES; CAP; WATER; SOIL	The Observatoire pour [a Mineralogie, l'Eau, les Glaces, et I'Activite (OMEGA) investigation, on board the European Space Agency Mars Express mission, is mapping the surface composition of Mars at a 0.3- to 5-kilometer resolution by means of visible-near-infrared hyperspectral reflectance imagery. The data acquired during, the first 9 months of the mission already reveal a diverse and complex surface mineralogy, offering key insights into the evolution of Mars. OMEGA has identified and mapped mafic iron-bearing silicates of both the northern and southern crust, localized concentrations of hydrated phyllosilicates and sulfates but nocarbonates, and ices and frosts with a water-ice composition of the north polar perennial cap, as for the south cap, covered by a thin carbon dioxide-ice veneer.	Inst Astrophys Spatiale, F-91405 Orsay, France; Washington Univ, St Louis, MO 63130 USA; IDES, F-91405 Orsay, France; Brown Univ, Providence, RI 02912 USA; Observ Paris, LESIA, F-92195 Meudon, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Washington University (WUSTL); Brown University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Bibring, JP (corresponding author), Inst Astrophys Spatiale, Batiment 121,Orsay Campus, F-91405 Orsay, France.	bibring@ias.u-psud.fr	Schmitt, Bernard/A-1064-2009; Drossart, Pierre/H-8670-2013; Bellucci, Giancarlo/ABA-9201-2020; Fouchet, Thierry/C-6374-2017	Schmitt, Bernard/0000-0002-1230-6627; Bellucci, Giancarlo/0000-0003-0867-8679; Erard, Stephane/0000-0002-9099-8366; Fouchet, Thierry/0000-0001-9040-8285; Ignatiev, Nikolay/0000-0002-6358-7094; Altieri, Francesca/0000-0002-6338-8300; Capaccioni, Fabrizio/0000-0003-1631-4314; Cerroni, Priscilla/0000-0003-0239-2741				Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001469; Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, P37; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Bibring JP, 2001, SPACE SCI REV, V96, P293, DOI 10.1023/A:1011909708806; Byrne S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017597; CHICARRO A, 2004, ESA SPEC PUBL, V1240, P00003; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Hamilton VE, 2003, METEORIT PLANET SCI, V38, P871, DOI 10.1111/j.1945-5100.2003.tb00284.x; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Kieffer HH, 2001, ICARUS, V154, P162, DOI 10.1006/icar.2001.6670; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Langevin Y, 2005, SCIENCE, V307, P1581, DOI 10.1126/science.1109438; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; MILLIKEN MS, 2003, LUNAR PLANET SCI C, V34, P1345; MINITTI ME, 2002, J GEOPHYS RES, V107, pE5, DOI DOI 10.1029/2001JE001518; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Mustard JF, 1997, J GEOPHYS RES-PLANET, V102, P25605, DOI 10.1029/97JE02354; Poulet F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002179; Ruff SW, 2001, J GEOPHYS RES-PLANET, V106, P23921, DOI 10.1029/2000JE001329; Schultz PH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2002JE002025; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; Tosca NJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002218; Vaniman DT, 2004, NATURE, V431, P663, DOI 10.1038/nature02973; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a; Yen AS, 2000, SCIENCE, V289, P1909, DOI 10.1126/science.289.5486.1909	29	738	749	4	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1576	1581		10.1126/science.1108806	http://dx.doi.org/10.1126/science.1108806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718430				2022-12-01	WOS:000227622400034
J	Delamarre, L; Pack, M; Chang, H; Mellman, I; Trombetta, ES				Delamarre, L; Pack, M; Chang, H; Mellman, I; Trombetta, ES			Differential lysosomal proteolysis in antigen-presenting CeRs determines antigen fate	SCIENCE			English	Article							CLASS-II COMPLEXES; DENDRITIC CELLS; PROTEIN ANTIGENS; TRANSPORT; IMMUNITY; HIV	Antigen-presenting cells (APCs) internalize antigens and present antigen-derived peptides to T cells. Although APCs have been thought to exhibit a well-developed capacity for lysosomal proteolysis, here we found that they can exhibit two distinct strategies upon antigen encounter. Whereas macrophages contained high levels of lysosomal proteases and rapidly degraded internalized proteins, dendritic cells (DCs) and B lymphocytes were protease-poor, resulting in a limited capacity for lysosomal degradation. Consistent with these findings, DCs in vivo degraded internalized antigens slowly and thus retained antigen in lymphoid organs for extended periods. Limited lysosomal proteolysis also favored antigen presentation. These results help explain why DCs are able to efficiently accumulate, process, and disseminate antigens and microbes systemically for purposes of tolerance and immunity.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.	ira.mellman@yale.edu; sergio.trombetta@yale.edu	Mellman, Ira/ABG-5896-2020		NIAID NIH HHS [R37-AI34098] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara A, 2003, J CELL BIOL, V162, P371, DOI 10.1083/jcb.200307062; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; KIM EE, 1992, BIOCHEMISTRY-US, V31, P12304, DOI 10.1021/bi00164a004; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Niedergang F, 2004, TRENDS MICROBIOL, V12, P79, DOI 10.1016/j.tim.2003.12.011; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RICHARDS FM, 1971, BOVINE PANCREATIC RI, V4; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; TROMBETTA ES, UNPUB; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522	21	539	561	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1630	1634		10.1126/science.1108003	http://dx.doi.org/10.1126/science.1108003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761154				2022-12-01	WOS:000227622400049
J	Matsuo, Y; Imagawa, H; Nishizawa, M; Shizuri, Y				Matsuo, Y; Imagawa, H; Nishizawa, M; Shizuri, Y			Isolation of an algal morphogenesis inducer from a marine bacterium	SCIENCE			English	Article							AXENIC CULTURE; MONOSTROMA-OXYSPERMUM; ULVA; CHLOROPHYCEAE		Marine Biotechnol Inst Co Ltd, Kamaishi, Iwate 0260001, Japan; Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan	Japanese Society of Marine Biotechnology; Tokushima Bunri University	Matsuo, Y (corresponding author), Marine Biotechnol Inst Co Ltd, 3-75-1 Heita, Kamaishi, Iwate 0260001, Japan.	yoshihide.matsuo@mbio.jp						BONNEAU ER, 1977, J PHYCOL, V13, P133, DOI 10.1111/j.1529-8817.1977.tb00569.x; FRIES L, 1975, BOT MAR, V18, P251, DOI 10.1515/botm.1975.18.4.251; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; MATSUO Y, UNPUB; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; PROVASOLI L, 1958, BIOL BULL, V114, P375, DOI 10.2307/1538992; PROVASOLI L, 1980, J PHYCOL, V16, P196, DOI 10.1111/j.1529-8817.1980.tb03019.x; PROVASOLI L, 1963, P INT SEAWEED S, V4, P1; TATEWAKI M, 1983, J PHYCOL, V19, P409, DOI 10.1111/j.0022-3646.1983.00409.x	9	161	167	8	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1598	1598		10.1126/science.1105486	http://dx.doi.org/10.1126/science.1105486			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	906ED	15761147				2022-12-01	WOS:000227622400040
J	Inoue, N; Ikawa, M; Isotani, A; Okabe, M				Inoue, N; Ikawa, M; Isotani, A; Okabe, M			The immunoglobulin superfamily protein Izumo is required for sperm to fuse with eggs	NATURE			English	Article							PLASMA-MEMBRANE; CD9-DEFICIENT MICE; ACROSOME REACTION; HUMAN-SPERMATOZOA; GAMETE FUSION; FERTILIN-BETA; MOUSE; BINDING; RECEPTORS; CALMEGIN	Representing the 60 trillion cells that build a human body, a sperm and an egg meet, recognize each other, and fuse to form a new generation of life. The factors involved in this important membrane fusion event, fertilization, have been sought for a long time(1). Recently, CD9 on the egg membrane was found to be essential for fusion(2-4), but sperm-related fusion factors remain unknown. Here, by using a fusion-inhibiting monoclonal antibody(5) and gene cloning, we identify a mouse sperm fusion-related antigen and show that the antigen is a novel immunoglobulin superfamily protein. We have termed the gene Izumo and produced a gene-disrupted mouse line. Izumo(-/-) mice were healthy but males were sterile. They produced normal-looking sperm that bound to and penetrated the zona pellucida but were incapable of fusing with eggs. Human sperm also contain Izumo and addition of the antibody against human Izumo left the sperm unable to fuse with zona-free hamster eggs.	Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Pharmaceut Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Okabe, M (corresponding author), Osaka Univ, Genome Informat Res Ctr, Yamadaoka 3-1, Suita, Osaka 5650871, Japan.	okabe@gen-info.osaka-u.ac.jp	Isotani, Ayako/D-4564-2017; Inoue, Naokazu/A-9911-2009; ikawa, masahito/A-5315-2009; Isotani, Ayako/A-9929-2009; Okabe, Masaru/B-6917-2015	Isotani, Ayako/0000-0002-4720-2318; ikawa, masahito/0000-0001-9859-6217; Isotani, Ayako/0000-0002-4720-2318; Inoue, Naokazu/0000-0002-6187-8293; Okabe, Masaru/0000-0002-0803-9044				ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Ellerman DA, 2003, MOL BIOL CELL, V14, P5098, DOI 10.1091/mbc.E03-04-0244; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hao ZL, 2002, BIOL REPROD, V66, P735, DOI 10.1095/biolreprod66.3.735; He ZY, 2003, DEV BIOL, V254, P226, DOI 10.1016/S0012-1606(02)00043-X; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ilayperuma I, 2002, J EXP ZOOL, V293, P617, DOI 10.1002/jez.10182; Inoue N, 2003, MOL CELL BIOL, V23, P2614, DOI 10.1128/MCB.23.7.2614-2622.2003; Inoue N, 2001, J IMMUNOL, V166, P424, DOI 10.4049/jimmunol.166.1.424; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Manandhar G, 2001, BIOL REPROD, V65, P1425, DOI 10.1095/biolreprod65.5.1425; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; OKABE M, 1990, FERTIL STERIL, V54, P1121; OKABE M, 1987, J REPROD IMMUNOL, V11, P91, DOI 10.1016/0165-0378(87)90014-3; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; OVERSTREET JW, 1980, FERTIL STERIL, V33, P534; ROCHWERGER L, 1992, DEV BIOL, V153, P83, DOI 10.1016/0012-1606(92)90093-V; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; Stein KK, 2004, J CELL SCI, V117, P6269, DOI 10.1242/jcs.01598; Yamagata K, 2002, DEV BIOL, V250, P348, DOI 10.1006/dbio.2002.0803; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [10.1262/jrd1955.16.147, DOI 10.1262/JRD1955.16.147]	31	526	570	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					234	238		10.1038/nature03362	http://dx.doi.org/10.1038/nature03362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759005				2022-12-01	WOS:000227494500050
J	Andersen, JB; Rourke, BC; Caiozzo, VJ; Bennett, AF; Hicks, JW				Andersen, JB; Rourke, BC; Caiozzo, VJ; Bennett, AF; Hicks, JW			Postprandial cardiac hypertrophy in pythons	NATURE			English	Editorial Material							HEART; MODEL		Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Orthopaed, Irvine, CA 92697 USA; Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; California State University System; California State University Long Beach	Andersen, JB (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	jhicks@uci.edu						COOPER G, 1987, ANNU REV PHYSIOL, V49, P501, DOI 10.1146/annurev.ph.49.030187.002441; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; Quinn KE, 1998, BIOPHYS J, V74, pA355; Richey PA, 1998, J SPORT SCI, V16, P129; Secor SM, 1997, AM J PHYSIOL-REG I, V272, pR902, DOI 10.1152/ajpregu.1997.272.3.R902; Secor SM, 2000, J EXP BIOL, V203, P2447; Secor SM, 1998, NATURE, V395, P659, DOI 10.1038/27131; Starck JM, 2001, J EXP BIOL, V204, P325; VLIEGEN HW, 1990, COMP BIOCHEM PHYS A, V95, P109, DOI 10.1016/0300-9629(90)90017-M	9	84	88	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					37	38		10.1038/434037a	http://dx.doi.org/10.1038/434037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744290				2022-12-01	WOS:000227334600034
J	Boxma, B; de Graaf, RM; van der Staay, GWM; van Alen, TA; Ricard, G; Gabaldon, T; van Hoek, AHAM; Moon-van der Staay, SY; Koopman, WJH; van Hellemond, JJ; Tielens, AGM; Friedrich, T; Veenhuis, M; Huynen, MA; Hackstein, JHP				Boxma, B; de Graaf, RM; van der Staay, GWM; van Alen, TA; Ricard, G; Gabaldon, T; van Hoek, AHAM; Moon-van der Staay, SY; Koopman, WJH; van Hellemond, JJ; Tielens, AGM; Friedrich, T; Veenhuis, M; Huynen, MA; Hackstein, JHP			An anaerobic mitochondrion that produces hydrogen	NATURE			English	Article							CHYTRID NEOCALLIMASTIX SP; PYRUVATE-FORMATE-LYASE; COMPLEX-I; ORGANELLES; GENOME; EVOLUTION; EUKARYOTE; MEMBRANE; SEQUENCE; ORIGINS	Hydrogenosomes are organelles that produce ATP and hydrogen(1), and are found in various unrelated eukaryotes, such as anaerobic flagellates, chytridiomycete fungi and ciliates(2). Although all of these organelles generate hydrogen, the hydrogenosomes from these organisms are structurally and metabolically quite different, just like mitochondria where large differences also exist(3). These differences have led to a continuing debate about the evolutionary origin of hydrogenosomes(4,5). Here we show that the hydrogenosomes of the anaerobic ciliate Nyctotherus ovalis, which thrives in the hindgut of cockroaches, have retained a rudimentary genome encoding components of a mitochondrial electron transport chain. Phylogenetic analyses reveal that those proteins cluster with their homologues from aerobic ciliates. In addition, several nucleus-encoded components of the mitochondrial proteome, such as pyruvate dehydrogenase and complex II, were identified. The N. ovalis hydrogenosome is sensitive to inhibitors of mitochondrial complex I and produces succinate as a major metabolic end product - biochemical traits typical of anaerobic mitochondria(3). The production of hydrogen, together with the presence of a genome encoding respiratory chain components, and biochemical features characteristic of anaerobic mitochondria, identify the N. ovalis organelle as a missing link between mitochondria and hydrogenosomes.	Radboud Univ Nijmegen, Fac Sci, Dept Evolutionary Microbiol, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, NCMLS, Microscop Imaging Ctr, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3508 TD Utrecht, Netherlands; Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany; Univ Groningen, Dept Eukaryot Microbiol, NL-9750 AA Haren, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; University of Freiburg; University of Groningen	Hackstein, JHP (corresponding author), Radboud Univ Nijmegen, Fac Sci, Dept Evolutionary Microbiol, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	j.hackstein@science.ru.nl	van Hellemond, Jaap/T-7555-2019; Gabaldón, Toni/A-7336-2008; Koopman, Werner J.H./D-3592-2009; Huynen, Martijn A/A-1530-2014; Koopman, Werner J.H./AAC-9668-2020; de Graaf, Rob/E-7665-2012; Huijnen, M.A./H-8051-2014	van Hellemond, Jaap/0000-0003-4862-7796; Gabaldón, Toni/0000-0003-0019-1735; Koopman, Werner J.H./0000-0002-5340-6747; Huynen, Martijn A/0000-0001-6189-5491; Koopman, Werner J.H./0000-0002-5340-6747; de Graaf, Rob/0000-0001-9143-8961				Akhmanova A, 1999, MOL MICROBIOL, V32, P1103, DOI 10.1046/j.1365-2958.1999.01434.x; Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023; Boxma B, 2004, MOL MICROBIOL, V51, P1389, DOI 10.1046/j.1365-2958.2003.03912.x; Brunk CF, 2003, NUCLEIC ACIDS RES, V31, P1673, DOI 10.1093/nar/gkg270; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Clemens DL, 2000, MOL BIOCHEM PARASIT, V106, P307, DOI 10.1016/S0166-6851(99)00220-0; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Curtis EA, 1999, ANN NY ACAD SCI, V870, P349, DOI 10.1111/j.1749-6632.1999.tb08900.x; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Embley TM, 1997, TRENDS ECOL EVOL, V12, P437, DOI 10.1016/S0169-5347(97)01208-1; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Koopman WJH, 2001, BIOPHYS J, V81, P57, DOI 10.1016/S0006-3495(01)75679-2; Leon-Avila G, 2004, MICROBIOL-SGM, V150, P1245, DOI 10.1099/mic.0.26923-0; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; Roger AJ, 1999, AM NAT, V154, pS146, DOI 10.1086/303290; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Van Hoek AHAM, 1999, J EUKARYOT MICROBIOL, V46, P427, DOI 10.1111/j.1550-7408.1999.tb04623.x; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251, DOI 10.1093/oxfordjournals.molbev.a026304; vanderGiezen M, 1997, FEBS LETT, V408, P147, DOI 10.1016/S0014-5793(97)00409-2; VanHellemond JJ, 1995, J BIOL CHEM, V270, P31065, DOI 10.1074/jbc.270.52.31065; Voncken F, 2002, MOL MICROBIOL, V44, P1441, DOI 10.1046/j.1365-2958.2002.02959.x; Voncken FGJ, 2002, GENE, V284, P103, DOI 10.1016/S0378-1119(02)00388-8	30	156	166	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					74	79		10.1038/nature03343	http://dx.doi.org/10.1038/nature03343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744302	Green Published, Green Submitted			2022-12-01	WOS:000227334600046
J	Carreira, S; Goodall, J; Aksan, I; La Rocca, SA; Galibert, MD; Denat, L; Larue, L; Goding, CR				Carreira, S; Goodall, J; Aksan, I; La Rocca, SA; Galibert, MD; Denat, L; Larue, L; Goding, CR			Mitf cooperates with Rb1 and activates p21(Cip1) expression to regulate cell cycle progression	NATURE			English	Article							MICROPHTHALMIA GENE-PRODUCT; DEPENDENT KINASE INHIBITOR; TRANSCRIPTION FACTOR; MELANOCYTE DEVELOPMENT; FACTOR TBX2; IN-VITRO; S PHASE; PROMOTER; TARGET; DIFFERENTIATION	The controls that enable melanoblasts and melanoma cells to proliferate are likely to be related, but so far no key regulator of cell cycle progression specific to the melanocyte lineage has been identified. The microphthalmia-associated transcription factor Mitf has a crucial but poorly defined role in melanoblast and melanocyte survival and in differentiation(1). Here we show that Mitf can act as a novel anti-proliferative transcription factor able to induce a G1 cell-cycle arrest that is dependent on Mitf-mediated activation of the p21(Cip1) (CDKN1A) cyclin-dependent kinase inhibitor gene. Moreover, cooperation between Mitf and the retinoblastoma protein Rb1 potentiates the ability of Mitf to activate transcription. The results indicate that Mitf-mediated activation of p21(Cip1) expression and consequent hypophosphorylation of Rb1 will contribute to cell cycle exit and activation of the differentiation programme. The mutation of genes associated with melanoma, such as INK4a or BRAF that would affect either Mitf cooperation with Rb1 or Mitf stability respectively, would impair Mitf-mediated cell cycle control.	Inst Curie, CNRS, UMR146, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Goding, CR (corresponding author), Marie Curie Res Inst, Signalling & Dev Lab, The Chart, Oxted RH8 OTL, Surrey, England.	c.goding@mcri.ac.uk	Carreira, Suzanne/C-8445-2012; Larue, Lionel/F-7355-2013; Larue, Lionel/I-6532-2016; KURNAZ, ISIL/GXG-5616-2022; la rocca, severina anna/D-8028-2011	Carreira, Suzanne/0000-0002-5077-5379; Goding, Colin/0000-0002-1614-3909				Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Halaban R, 1998, ONCOGENE, V16, P2489, DOI 10.1038/sj.onc.1201773; HIRST K, 1994, EMBO J, V13, P5410, DOI 10.1002/j.1460-2075.1994.tb06876.x; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; JIANG HP, 1995, ONCOGENE, V10, P1855; KONYUKHOV BV, 1966, FOLIA BIOL-PRAGUE, V12, P116; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; OKURA M, 1995, J INVEST DERMATOL, V105, P322, DOI 10.1111/1523-1747.ep12319939; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1995, ONCOGENE, V11, P635; Takahashi Y, 2000, GENE DEV, V14, P804; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Vigo E, 1999, MOL CELL BIOL, V19, P6379; YAVUZER U, 1995, ONCOGENE, V10, P123; Yu BD, 2003, P NATL ACAD SCI USA, V100, P14881, DOI 10.1073/pnas.2431391100	30	299	308	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					764	769		10.1038/nature03269	http://dx.doi.org/10.1038/nature03269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716956				2022-12-01	WOS:000227039200044
J	Boyce, M; Bryant, KF; Jousse, C; Long, K; Harding, HP; Scheuner, D; Kaufman, RJ; Ma, DW; Coen, DM; Ron, D; Yuan, JY				Boyce, M; Bryant, KF; Jousse, C; Long, K; Harding, HP; Scheuner, D; Kaufman, RJ; Ma, DW; Coen, DM; Ron, D; Yuan, JY			A selective inhibitor-of eIF2 alpha dephosphorylation protects cells from ER stress	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSLATIONAL CONTROL; PHOSPHORYLATION; IRE1; INTEGRATION; INFECTION; SURVIVAL; MUTANTS; SHUTOFF; GROWTH	Most protein phosphatases have little intrinsic substrate specificity, making selective pharmacological inhibition of specific dephosphorylation reactions a challenging problem. In a screen for small molecules that protect cells from endoplasmic reticulum (ER) stress, we,identified salubrinal, a selective inhibitor of cellular complexes that dephosphorylate eukaryotic translation initiation factor 2 subunit alpha (eIF2alpha). Salubrinal also blocks eIF2alpha dephosphorylation mediated by a herpes simplex virus protein and inhibits viral replication. These results suggest that selective chemical inhibitors of eIF2a dephosphorylation may be useful in diseases involving ER stress or viral infection. More broadly, salubrinal demonstrates the feasibility of selective pharmacological targeting of cellular dephosphorylation events.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Comm Virol, Boston, MA 02115 USA; NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; Shanghai Inst Organ Chem, Shanghai, Peoples R China; Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; New York University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu		Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974; Boyce, Michael/0000-0002-2729-4876	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026077, R56AI026077, R01AI019838, U01AI026077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R37DK047119, R01DK047119, R29DK047119, R01DK042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19838, AI26077] Funding Source: Medline; NIA NIH HHS [R37-AG012859] Funding Source: Medline; NIDDK NIH HHS [DDK42394, DK47119] Funding Source: Medline; NIEHS NIH HHS [ES08681] Funding Source: Medline; NIGMS NIH HHS [GM64703] Funding Source: Medline; NINDS NIH HHS [NS35138] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; BOYCE MC, UNPUB; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; CHOU J, 1995, P NATL ACAD SCI USA, V92, P10516, DOI 10.1073/pnas.92.23.10516; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sood R, 2000, GENETICS, V154, P787; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	30	1141	1207	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					935	939		10.1126/science.1101902	http://dx.doi.org/10.1126/science.1101902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705855				2022-12-01	WOS:000226985100057
J	Griffitts, JS; Haslam, SM; Yang, TL; Garczynski, SF; Mulloy, B; Morris, H; Cremer, PS; Dell, A; Adang, MJ; Aroian, RV				Griffitts, JS; Haslam, SM; Yang, TL; Garczynski, SF; Mulloy, B; Morris, H; Cremer, PS; Dell, A; Adang, MJ; Aroian, RV			Glycolipids as receptors for Bacillus thuringiensis crystal toxin	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HELIOTHIS-VIRESCENS; PINK-BOLLWORM; RESISTANCE; BINDING; IDENTIFICATION; GLYCOSYLATION; ENDOTOXIN; PROTEINS	The development of pest resistance threatens the effectiveness of Bacillus thuringiensis (Bt) toxins used in transgenic and organic farming. Here, we demonstrate that (i) the major mechanism for Bt toxin resistance in Caenorhabditis elegans entails a loss of glycolipid carbohydrates; (ii) Bt toxin directly and specifically binds glycotipids; and (iii) this binding is carbohydrate-dependent and relevant for toxin action in vivo. These carbohydrates contain the arthroseries core conserved in insects and nematodes but lacking in vertebrates. We present evidence that insect glycolipids are also receptors for Bt toxin.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; Univ Georgia, Dept Entomol, Athens, GA 30602 USA; Natl Inst Biol Stand & Controls, Mol Struct Lab, Potters Bar EN6 3QG, Herts, England; MSCAN Mass Spectrometry Res & Training Ctr, Ascot SL5 7PZ, Berks, England	University of California System; University of California San Diego; Imperial College London; Texas A&M University System; Texas A&M University College Station; University System of Georgia; University of Georgia; National Institute for Biological Standards & Control	Aroian, RV (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	raroian@ucsd.edu	Yang, Tinglu/N-3569-2013	Yang, Tinglu/0000-0003-0872-8218				Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Dennis R D, 1986, Biomed Chromatogr, V1, P31, DOI 10.1002/bmc.1130010108; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; GARCZYNSKI SF, 2000, ENTOMOPATHOGENIC BAC, P181; Gerdt S, 1999, EUR J BIOCHEM, V266, P952, DOI 10.1046/j.1432-1327.1999.00937.x; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Heckel DG, 1997, J ECON ENTOMOL, V90, P75, DOI 10.1093/jee/90.1.75; James C, 2002, ISAAA BRIEFS, V27, P1; Jurat-Fuentes JL, 2002, APPL ENVIRON MICROB, V68, P5711, DOI 10.1128/AEM.68.11.5711-5717.2002; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; Kumaraswami NS, 2001, COMP BIOCHEM PHYS B, V129, P173, DOI 10.1016/S1096-4959(01)00327-X; LEE MK, 1995, APPL ENVIRON MICROB, V61, P3836, DOI 10.1128/AEM.61.11.3836-3842.1995; Marroquin LD, 2000, GENETICS, V155, P1693; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Mucha J, 2004, BIOCHEM J, V382, P67, DOI 10.1042/BJ20040535; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Yang TL, 2003, J AM CHEM SOC, V125, P4779, DOI 10.1021/ja029469f	26	261	309	5	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					922	925		10.1126/science.1104444	http://dx.doi.org/10.1126/science.1104444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705852				2022-12-01	WOS:000226985100053
J	Nakata, K; Abrams, B; Grill, B; Goncharov, A; Huang, X; Chisholm, AD; Jin, YS				Nakata, K; Abrams, B; Grill, B; Goncharov, A; Huang, X; Chisholm, AD; Jin, YS			Regulation of a DLK-1 and p38 MAP kinase pathway by the ubiquitin ligase RPM-1 is required for presynaptic development	CELL			English	Article							ZIPPER-BEARING KINASE; AMPA RECEPTOR TRAFFICKING; CAENORHABDITIS-ELEGANS; C-ELEGANS; SYNAPTIC GROWTH; PROTEIN-KINASE; ACTIVE ZONES; IN-VIVO; SYNAPSES; LINEAGE	Synapses display a stereotyped ultrastructural organization, commonly containing a single electron-dense presynaptic density surrounded by a cluster of synaptic vesicles. The mechanism controlling subsynaptic proportion is not understood. Loss of function in the C. elegans rpm-1 gene, a putative RING finger/E3 ubiquitin ligase, causes disorganized presynaptic cytoarchitecture. RPM-1 is localized to the presynaptic periactive zone. We report that RPM-1 negatively regulates a p38 MAP kinase pathway composed of the dual leucine zipper-bearing MAPKKK DLK-1, the MAPKK MKK-4, and the p38 MAP kinase PMK-3. Inactivation of this pathway suppresses rpm-1 loss of function phenotypes, whereas overexpression or constitutive activation of this pathway causes synaptic defects resembling rpm-1(lf) mutants. DLK-1, like RPM-1, is localized to the periactive zone. DLK-1 protein levels are elevated in rpm-1 mutants. The RPM-1 RING finger can stimulate ubiquitination of DLK-1. Our data reveal a presynaptic role of a previously unknown p38 MAP kinase cascade.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Jin, YS (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	jin@biology.ucsc.edu		Huang, Xun/0000-0002-2653-8293; Grill, Brock/0000-0002-0379-3267; Chisholm, Andrew/0000-0001-5091-0537; Jin, Yishi/0000-0002-9371-9860				Acsady L, 1998, J NEUROSCI, V18, P3386; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Berman Kevin, 2001, Molecular Cell Biology Research Communications, V4, P337, DOI 10.1006/mcbr.2001.0300; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; BRENNER S, 1974, GENETICS, V77, P71; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; Fan G, 1996, J BIOL CHEM, V271, P24788, DOI 10.1074/jbc.271.40.24788; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Guan ZH, 2003, J NEUROSCI, V23, P7317; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Nihalani D, 2003, J BIOL CHEM, V278, P28694, DOI 10.1074/jbc.M304212200; Nonet ML, 1997, J NEUROSCI, V17, P8061; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 1997, J NEUROSCI, V17, P5858; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sone M, 2000, DEVELOPMENT, V127, P4157; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	55	249	263	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					407	420		10.1016/j.cell.2004.12.017	http://dx.doi.org/10.1016/j.cell.2004.12.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707898	Bronze			2022-12-01	WOS:000227028900015
J	Yang, HJ; Li, QB; Fan, J; Holloman, WK; Pavletich, NP				Yang, HJ; Li, QB; Fan, J; Holloman, WK; Pavletich, NP			The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction	NATURE			English	Article							REPLICATION PROTEIN-A; DNA STRAND EXCHANGE; PRESYNAPTIC COMPLEX-FORMATION; BREAST-CANCER SUSCEPTIBILITY; RAD51-MEDIATED RECOMBINATION; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; DIRECTED REPAIR; USTILAGO-MAYDIS; BINDING PROTEIN	The BRCA2 tumour suppressor(1) is essential for the error- free repair of double- strand breaks ( DSBs) in DNA by homologous recombination(2,3). This is mediated by RAD51, which forms a nucleoprotein filament with the 30 overhanging single- stranded DNA ( ssDNA) of the resected DSB, searches for a homologous donor sequence, and catalyses strand exchange with the donor DNA(4). The 3,418- amino- acid BRCA2 contains eight similar to 30- amino-acid BRC repeats that bind RAD51 ( refs 5, 6) and a similar to 700- amino-acid DBD domain that binds ssDNA(7). The isolated BRC and DBD domains have the opposing effects of inhibiting(8,9) and stimulating recombination(7), respectively, and the role of BRCA2 in repair has been unclear. Here we show that a full- length BRCA2 homologue ( Brh2) stimulates Rad51- mediated recombination at substoichiometric concentrations relative to Rad51. Brh2 recruits Rad51 to DNA and facilitates the nucleation of the filament, which is then elongated by the pool of free Rad51. Brh2 acts preferentially at a junction between double- stranded DNA ( dsDNA) and ssDNA, with strict specificity for the 30 overhang polarity of a resected DSB. These results establish a BRCA2 function in RAD51- mediated DSB repair and explain the loss of this repair capacity in BRCA2- associated cancers.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Hearst Microbiol Res Ctr, Dept Microbiol & Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	nikola@xray2.mskcc.org	fan, jie/A-3922-2012					Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Gupta RC, 1999, MOL CELL, V4, P705, DOI 10.1016/S1097-2765(00)80381-0; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Kojic M, 2003, MOL CELL, V12, P1043, DOI 10.1016/S1097-2765(03)00367-8; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lo T, 2003, DNA REPAIR, V2, P1015, DOI 10.1016/S1568-7864(03)00097-1; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	30	244	249	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					653	657		10.1038/nature03234	http://dx.doi.org/10.1038/nature03234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703751				2022-12-01	WOS:000226862000049
J	Hoebe, K; Georgel, P; Rutschmann, S; Du, X; Mudd, S; Crozat, K; Sovath, S; Shamel, L; Hartung, T; Zahringer, U; Beutler, B				Hoebe, K; Georgel, P; Rutschmann, S; Du, X; Mudd, S; Crozat, K; Sovath, S; Shamel, L; Hartung, T; Zahringer, U; Beutler, B			CD36 is a sensor of diacylglycerides	NATURE			English	Article							TOLL-LIKE RECEPTOR-2; PATTERN-RECOGNITION; LIPOTEICHOIC ACID; IMMUNE-RESPONSE; FATTY-ACID; LIPOPOLYSACCHARIDE; IDENTIFICATION; GENE; LIPOPROTEINS; METABOLISM	Toll-like receptor 2 (TLR2) is required for the recognition of numerous molecular components of bacteria(1-8), fungi(9,10) and protozoa(11). The breadth of the ligand repertoire seems unusual, even if one considers that TLR2 may form heteromers with TLRs 1 and 6 (ref. 12), and it is likely that additional proteins serve as adapters for TLR2 activation. Here we show that an N-ethyl-N-nitrosourea-induced nonsense mutation of Cd36 ( oblivious) causes a recessive immunodeficiency phenotype in which macrophages are insensitive to the R-enantiomer of MALP-2 ( a diacylated bacterial lipopeptide) and to lipoteichoic acid. Homozygous mice are hypersusceptible to Staphylococcus aureus infection. Cd36(obl) macrophages readily detect S-MALP-2, PAM(2)CSK(4), PAM(3)CSK(4) and zymosan, revealing that some - but not all TLR2 ligands are dependent on CD36. Already known as a receptor for endogenous molecules, CD36 is also a selective and nonredundant sensor of microbial diacylglycerides that signal via the TLR2/6 heterodimer.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; EU Joint Res Ctr, ECVAM, I-21020 Ispra, Italy; Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Scripps Research Institute; Forschungszentrum Borstel	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	georgel, philippe/P-5676-2016; Crozat, Karine/L-7297-2019; Eckhardt, Erik/G-1567-2010	georgel, philippe/0000-0001-6853-7080; Crozat, Karine/0000-0003-4761-3675; Hoebe, Kasper/0000-0002-3626-8098; Rutschmann, Sophie/0000-0003-3932-1162				Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; CALVO D, 1995, GENOMICS, V25, P100, DOI 10.1016/0888-7543(95)80114-2; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Glazier AN, 2002, MAMM GENOME, V13, P108, DOI 10.1007/s00335-001-2132-9; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Means TK, 1999, J IMMUNOL, V163, P3920; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(200212)32:12<3337::AID-IMMU3337>3.0.CO;2-#; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	24	643	666	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					523	527		10.1038/nature03253	http://dx.doi.org/10.1038/nature03253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690042				2022-12-01	WOS:000226727200049
J	Heaton, T; Rowe, J; Turner, S; Aalberse, RC; de Klerk, N; Suriyaarachchi, D; Serralha, M; Holt, BJ; Hollams, E; Yerkovich, S; Holt, K; Sly, PD; Goldblatt, J; Le Souef, P; Holt, PG				Heaton, T; Rowe, J; Turner, S; Aalberse, RC; de Klerk, N; Suriyaarachchi, D; Serralha, M; Holt, BJ; Hollams, E; Yerkovich, S; Holt, K; Sly, PD; Goldblatt, J; Le Souef, P; Holt, PG			An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children	LANCET			English	Article							AIRWAY HYPERRESPONSIVENESS; BRONCHIAL RESPONSIVENESS; RESPIRATORY SYMPTOMS; ATOPIC-DERMATITIS; IMMUNE-RESPONSE; 2 POPULATIONS; ALLERGEN; TH1; INTERLEUKIN-10; EOSINOPHILS	Background Increasing evidence suggests that patterns of T-cell immunity to inhalant allergens in genetically diverse human populations are more heterogeneous than previously assumed, and that covert differences in expression patterns might underlie variations in airway disease phenotypes. We tested this proposition in a community sample of children Methods We analysed data from 172 individuals who had been recruited antenatally to a longitudinal birth cohort study. Of the 194 birth cohort participants, data from the 147 probands (age range 8.6-13.5 years) who consented to blood collection were included along with data from 25 consenting siblings (mean age 11 years [range 7.4-17.4]). We ascertained clinical phenotypes related to asthma and allergy. We measured T-cell responses to allergens and mitogens, together with blood eosinophils and IgE/IgG antibodies, and assessed associations between these indices and clinical phenotypes. Findings Atopy was associated with allergen-specific T-helper (Th)2 responses dominated by interleukin 4, interleukin 5, interleukin 9, interleukin 13, whereas interleukin 10, tumour necrosis factor a, and interferon gamma responses were common to both atopics and non-atopics. The wheal size from skin prick with allergen was positively associated with in-vitro interleukin 5 and interferon gamma responses, and negatively associated with interleukin 10. Asthma, especially in atopics, was strongly associated with eosinophilia/interleukin 5, and bronchial hyperresponsiveness (BHR) was associated with eosinophilia plus polyclonal interferon gamma production. BHR in non-atopics was associated with elevated allergen-specific and polyclonal interleukin 10 production. Interpretation Parallel immunological and clinical profiling of children identified distinctive immune response patterns related to asthma and wheeze compared with BHR, in atopics non-atopics. Immunological hyperresponsiveness, including within the Th1 cytokine compartment, is identified as a hallmark of BHR. Relevance to practice These findings highlight the heterogeneity of immune response patterns in asthmatic children, including those with seemingly homogeneous Th2-driven atopic asthma. Further elucidation of the covert relationships between wheezing phenotypes and underlying immunophenotypes in this age group will potentially lead to more effective treatments for what is an unexpectedly heterogeneous collection of disease subtypes.	Univ Western Australia, Fac Med & Dent, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; Univ Western Australia, Fac Med & Dent, Dept Paediat, Perth, WA 6009, Australia; CLB, Sanquin Res Labs, Amsterdam, Netherlands	Telethon Kids Institute; University of Western Australia; University of Western Australia	Holt, PG (corresponding author), Telethon Inst Child Hlth Res, Div Cell Biol, POB 855, Perth, WA 6872, Australia.	patrick@ichr.uwa.edu.au	de Klerk, Nicholas H/D-8388-2016; Holt, Patrick G/H-1548-2011; Sly, Peter D/F-1486-2010; Holt, Kathryn E/A-8108-2012; Le Souef, Peter N/H-5256-2014; Serralha, Michael/CAA-0940-2022	de Klerk, Nicholas H/0000-0001-9223-0767; Holt, Patrick G/0000-0003-1193-0935; Sly, Peter D/0000-0001-6305-2201; Holt, Kathryn E/0000-0003-3949-2471; Serralha, Michael/0000-0002-0121-2879; Hollams, Elysia/0000-0002-3481-6396; Yerkovich, Stephanie/0000-0003-4163-4782				AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Boushey HA, 2000, LANCET, V356, P2114, DOI 10.1016/S0140-6736(00)03486-3; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; BURROWS B, 1995, J ALLERGY CLIN IMMUN, V95, P548, DOI 10.1016/S0091-6749(95)70317-9; Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033; CALHOUN W J, 1992, American Review of Respiratory Disease, V145, pA638; Castro M, 2000, AM J RESP CELL MOL, V22, P143, DOI 10.1165/ajrcmb.22.2.f174; Colavita AM, 2000, J ALLERGY CLIN IMMUN, V106, P880, DOI 10.1067/mai.2000.110475; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; DEL PG, 1993, J IMMUNOL, V150, P353; Essayan DM, 1996, J ALLERGY CLIN IMMUN, V98, P1035, DOI 10.1016/S0091-6749(96)80188-6; Glass DC, 2001, ANN OCCUP HYG, V45, P275, DOI 10.1016/S0003-4878(01)00022-9; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Grunstein MM, 2001, AM J PHYSIOL-LUNG C, V281, pL1130, DOI 10.1152/ajplung.2001.281.5.L1130; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hartmann M, 2004, J CANCER RES CLIN, V130, P93, DOI 10.1007/s00432-003-0513-z; Holgate ST, 1999, J ALLERGY CLIN IMMUN, V104, P1139, DOI 10.1016/S0091-6749(99)70005-9; Holt PG, 2000, J ALLERGY CLIN IMMUN, V105, P1117, DOI 10.1067/mai.2000.105804; HOLT PG, 1992, CLIN EXP ALLERGY, V22, P1093, DOI 10.1111/j.1365-2222.1992.tb00135.x; Holt PG, 2000, THORAX, V55, P700, DOI 10.1136/thorax.55.8.700; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Li XM, 1996, J IMMUNOL, V157, P3216; Macaubas C, 1999, CLIN EXP ALLERGY, V29, P1223; Magnan AO, 2000, AM J RESP CRIT CARE, V161, P1790, DOI 10.1164/ajrccm.161.6.9906130; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; O'Sullivan S, 2001, AM J RESP CRIT CARE, V164, P560, DOI 10.1164/ajrccm.164.4.2102018; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Postma DS, 2000, AM J RESP CRIT CARE, V162, pS118, DOI 10.1164/ajrccm.162.supplement_2.ras-13; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; ROMAGNANI S, 1992, IMMUNOL TODAY, V13, P379, DOI 10.1016/0167-5699(92)90083-J; SALOME CM, 1987, CLIN ALLERGY, V17, P271, DOI 10.1111/j.1365-2222.1987.tb02015.x; Sharp MJ, 2003, CLIN EXP ALLERGY, V33, P435, DOI 10.1046/j.1365-2222.2003.01627.x; Smart JM, 2002, CLIN EXP ALLERGY, V32, P796, DOI 10.1046/j.1365-2222.2002.01391.x; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; TURNER SW, 2004, IN PRESS AM J RESP C, V169; Umetsu DT, 1999, AM J RESP CELL MOL, V21, P562, DOI 10.1165/ajrcmb.21.5.f171; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; Woolcock AJ, 1995, ALLERGY, V50, P935, DOI 10.1111/j.1398-9995.1995.tb02504.x; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760; YOUNG S, 1991, NEW ENGL J MED, V324, P1168, DOI 10.1056/NEJM199104253241704	44	185	205	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					142	149		10.1016/S0140-6736(05)17704-6	http://dx.doi.org/10.1016/S0140-6736(05)17704-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639296				2022-12-01	WOS:000226170700029
J	Zohrabian, A				Zohrabian, A			The long-term effects and economic consequences of treatments for obesity: work in progress	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Div Adult & Community Hlth, Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Zohrabian, A (corresponding author), Ctr Dis Control & Prevent, Div Adult & Community Hlth, Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.	Abz8@cdc.gov						Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; LADDAWALLA D, 2002, 8946 NAT BUR EC RES; PHILIPSON T, 2004, 04004 USDA EFAN EC R; PHILIPSON TJ, 1999, 7423 NAT BUR EC RES; Services U.S. Department of Health and Human, 2001, SURG GEN CALL ACT PR; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; STURM R, 2004, RAND REV         SPR, P24	9	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					104	105		10.1016/S0140-6736(05)17718-6	http://dx.doi.org/10.1016/S0140-6736(05)17718-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639278				2022-12-01	WOS:000226170700007
J	Mahadevan, L; Rica, S				Mahadevan, L; Rica, S			Self-organized origami	SCIENCE			English	Article							CONVECTION		Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Chile, Dept Fis, Santiago, Chile	Harvard University; Harvard University; Universidad de Chile	Mahadevan, L (corresponding author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@deas.harvard.edu	Rica, Sergio/G-9865-2011					Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Haas F, 1996, P ROY SOC B-BIOL SCI, V263, P1651, DOI 10.1098/rspb.1996.0241; Kobayashi H, 1998, P ROY SOC B-BIOL SCI, V265, P147, DOI 10.1098/rspb.1998.0276; Kresling Biruta, 1995, Biomimetics, V3, P105; Miura K., 1980, P 31 C INT ASTRONAUT, P1; NEWELL AC, 1969, J FLUID MECH, V38, P279, DOI 10.1017/S0022112069000176; RIZZIERI R, COMMUNICATION; SEGEL LA, 1969, J FLUID MECH, V38, P203, DOI 10.1017/S0022112069000127	8	171	175	8	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1740	1740		10.1126/science.1105169	http://dx.doi.org/10.1126/science.1105169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774751				2022-12-01	WOS:000227883900035
J	Shen, J; Dahmann, C				Shen, J; Dahmann, C			Extrusion of cells with inappropriate Dpp signaling from Drosophila wing disc epithelia	SCIENCE			English	Article							TGF-BETA; APOPTOSIS; MORPHOGENESIS; SURVIVAL; ROLES; JNK	Decapentaplegic (Dpp) is a signaling molecule that controls growth and patterning of the developing Drosophila wing. Mutant cells lacking Dpp signal transduction have been shown to activate c-Jun amino-terminal kinase (JNK)-dependent apoptosis and to be lost from the wing disc epithelium. These observations have led to the hypothesis that Dpp promotes cell survival by preventing apoptosis. Here, we show that in the absence of JNK-dependent apoptosis, mutant cells tacking Dpp signal transduction can survive; however, they are still lost from the wing disc epithelium. This loss correlates with extensive cytoskeletal changes followed by basal epithelial extrusion. We propose that Dpp promotes cell survival within disc epithelia by affecting cytoskeletal organization.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Dahmann, C (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	dahmann@mpi-cbg.de	shen, jie/W-9807-2019; Dahmann, Christian/B-5841-2017; shen, jie/H-9087-2016	shen, jie/0000-0002-6021-7151; 				Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; BRYANT PJ, 1988, DEV BIOL, V128, P386, DOI 10.1016/0012-1606(88)90300-4; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ricos MG, 1999, J CELL SCI, V112, P1225; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208	13	127	130	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1789	1790		10.1126/science.1104784	http://dx.doi.org/10.1126/science.1104784			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774763				2022-12-01	WOS:000227883900049
J	Boccaccio, C; Sabatino, G; Medico, E; Girolami, F; Follenzi, A; Reato, G; Sottile, A; Naldini, L; Comoglio, PM				Boccaccio, C; Sabatino, G; Medico, E; Girolami, F; Follenzi, A; Reato, G; Sottile, A; Naldini, L; Comoglio, PM			The MET oncogene drives a genetic programme linking cancer to haemostasis	NATURE			English	Article							LENTIVIRAL VECTORS; EXPRESSION; GROWTH; RECEPTORS; CYCLOOXYGENASE-2; MOUSE; CELLS	The close relationship between activation of blood coagulation and cancer is an old enigma. In 1865, migrans trombophlebitis ('a condition of the blood that predisposes it to spontaneous coagulation') was described as a forewarning of occult malignancy ( Trousseau's sign(1)). This pioneering observation emphasized the existence of haemostasis disorders associated with cancer onset; this phenomenon has since been extensively reported in clinical and epidemiological studies(2-4), but has so far resisted a mechanistic explanation. Here we report a mouse model of sporadic tumorigenesis based on genetic manipulation of somatic cells. Targeting the activated, human MET oncogene to adult liver caused slowly progressing hepatocarcinogenesis. This was preceded and accompanied by a syndrome manifesting first with blood hypercoagulation ( venous thromboses), and then evolving towards fatal internal haemorrhages. The pathogenesis of this syndrome is driven by the transcriptional response to the oncogene, including prominent upregulation of plasminogen activator inhibitor type 1 (PAI-1) and cyclooxygenase-2 (COX-2) genes. In vivo analysis showed that both proteins support the thrombohaemorrhagic phenotype, thus providing direct genetic evidence for the long-sought-after link between oncogene activation and haemostasis.	Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, I-10060 Turin, Italy	University of Turin	Boccaccio, C (corresponding author), Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, Str Prov 142, I-10060 Turin, Italy.	carla.boccaccio@ircc.it	Girolami, Flavia/K-6304-2013; Boccaccio, Carla/AHE-7875-2022; Medico, Enzo/AAC-3185-2021; Naldini, Luigi/E-9083-2012	Girolami, Flavia/0000-0001-9005-5301; Boccaccio, Carla/0000-0003-2620-9083; Medico, Enzo/0000-0002-3917-2438; REATO, GIGLIOLA/0000-0003-3463-2930; Follenzi, Antonia/0000-0001-9780-300X; Comoglio, Paolo/0000-0002-7056-5328; sottile, antonino/0000-0003-4252-3240; NALDINI, Luigi/0000-0002-7835-527X	Telethon [TGT03D03, TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; DIRENZO MF, 1991, ONCOGENE, V6, P1997; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Friederich PW, 1997, CIRCULATION, V96, P916; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Muller-Berghaus G, 1999, THROMB HAEMOSTASIS, V82, P706; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Oshima M, 2001, CANCER RES, V61, P1733; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; Rickles FR, 2001, ACTA HAEMATOL-BASEL, V106, P6, DOI 10.1159/000046583; Rickles FR, 2000, HEMOSTASIS THROMBOSI, P1132; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Trousseau A., 1865, CLIN MED HOTEL DIEU, V3, P654; Trusolino L, 1998, FASEB J, V12, P1267, DOI 10.1096/fasebj.12.13.1267; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vigna E, 2000, J GENE MED, V2, P308; Zeng QH, 2002, J BIOL CHEM, V277, P50137, DOI 10.1074/jbc.M208952200	30	200	219	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					396	400		10.1038/nature03357	http://dx.doi.org/10.1038/nature03357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772665				2022-12-01	WOS:000227715100055
J	Reynolds, R				Reynolds, R			The evolution of sensibility	NATURE			English	Article									Univ Calif San Diego, Dept Mus, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Reynolds, R (corresponding author), Univ Calif San Diego, Dept Mus, La Jolla, CA 92037 USA.							Levitin DJ, 2004, MUSIC PERCEPT, V22, P167, DOI 10.1525/mp.2004.22.2.167; MCADAMS S, IN PRESS PERCEPTION	2	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					316	319		10.1038/434316a	http://dx.doi.org/10.1038/434316a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772649				2022-12-01	WOS:000227715100038
J	Sellal, F; Stoll-Keller, F				Sellal, F; Stoll-Keller, F			Rabies: ancient yet contemporary cause of encephalitis	LANCET			English	Editorial Material									Hop Univ Strasbourg, Dept Neurol, F-67091 Strasbourg, France; Hop Univ Strasbourg, Inst Virol, F-67091 Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sellal, F (corresponding author), Hop Univ Strasbourg, Dept Neurol, F-67091 Strasbourg, France.	Francois.Sellal@chru-strasbourg.fr						Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Coleman PG, 2004, EMERG INFECT DIS, V10, P140, DOI 10.3201/eid1001.020744; Dietzschold B, 2004, LANCET, V364, P648, DOI 10.1016/S0140-6736(04)16912-2; Galperine T, 2004, PRESSE MED, V33, P791, DOI 10.1016/S0755-4982(04)98745-3; Hemachudha T, 2004, CLIN INFECT DIS, V39, P1085, DOI 10.1086/423813; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Laothamatas J, 2003, AM J NEURORADIOL, V24, P1102; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nathwani D, 2003, CLIN INFECT DIS, V37, P598, DOI 10.1086/376641; RAY NB, 1995, J VIROL, V69, P764, DOI 10.1128/JVI.69.2.764-772.1995; Schankin CJ, 2005, LANCET, V365, P358; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					921	923		10.1016/S0140-6736(05)71060-6	http://dx.doi.org/10.1016/S0140-6736(05)71060-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766980	Green Published, Bronze			2022-12-01	WOS:000227559800008
J	Kamata, H; Honda, S; Maeda, S; Chang, LF; Hirata, H; Karin, M				Kamata, H; Honda, S; Maeda, S; Chang, LF; Hirata, H; Karin, M			Reactive oxygen species promote TNF alpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; NECROTIC CELL-DEATH; INDUCED APOPTOSIS; REDOX REGULATION; CYTOCHROME-C; LIVER-REGENERATION; FACTOR RECEPTOR; IKK-BETA; PROTEIN	TNF alpha is a pleiotropic cytokine that induces either cell proliferation or cell death. Inhibition of NF-kappa B activation increases susceptibility to TNF alpha-induced death, concurrent with sustained JNK activation, an important contributor to the death response. Sustained JNK activation in NF-kappa B-deficient cells was suggested to depend on reactive oxygen species (ROS), but how RIDS affect JNK activation was unclear. We now show that TNF alpha-induced ROS, whose accumulation is suppressed by mitochondrial superoxide dismutase, cause oxidation and inhibition of JNK-inactivating phosphatases by converting their catalytic cysteine to sulfenic acid. This results in sustained JNK activation, which is required for cytochrome c release and caspase 3 cleavage, as well as necrotic cell death. Treatment of cells or experimental animals with an antioxidant prevents H(2)O(2) accumulation, JNK phosphatase oxidation, sustained JNK activity, and both forms of cell death. Antioxidant treatment also prevents TNF alpha-mediated fulminant liver failure without affecting liver regeneration.	Univ Calif San Diego, Sch Med, Lab Gene Regulat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Hyogo	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Kamata, Hideaki/N-3907-2017		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004151, R01ES006376, P42ES010337, R37ES004151] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477] Funding Source: Medline; NIEHS NIH HHS [ES06376, ES04151, 5P42 ES10337] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amanullah A, 2003, NATURE, V424, P741, DOI 10.1038/424741b; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Perfettini JL, 2003, NAT IMMUNOL, V4, P308, DOI 10.1038/ni0403-308; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Smith ML, 1996, ONCOGENE, V13, P2255; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441	52	1419	1472	3	145	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					649	661		10.1016/j.cell.2004.12.041	http://dx.doi.org/10.1016/j.cell.2004.12.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766528	Bronze			2022-12-01	WOS:000227771400011
J	Okajima, T; Xu, AG; Lei, L; Irvine, KD				Okajima, T; Xu, AG; Lei, L; Irvine, KD			Chaperone activity of protein O-fucosyltransferase 1 promotes Notch receptor folding	SCIENCE			English	Article							FUCOSYL-TRANSFERASE; ENDOPLASMIC-RETICULUM; DELTA INTERACTIONS; SIGNALING PATHWAY; C-MANNOSYLATION; QUALITY-CONTROL; IDENTIFICATION; GLYCOSYLATION; DROSOPHILA; ENCODES	Notch proteins are receptors for a conserved signaling pathway that affects numerous cell fate decisions. We found that in, Drosophila, Protein O-fucosyltransferase 1 (OFUT1), an enzyme that glycosylates epidermal growth factor-like domains of Notch, also has a distinct Notch chaperone activity. OFUT1 is an endoplasmic reticulum protein, and its localization was essential for function in vivo. OFUT1 could bind to Notch, was required for the trafficking of wild-type Notch out of the endoplasmic reticulum, and could partially rescue defects in secretion and ligand binding associated with Notch. point mutations. This ability of OFUT1 to facilitate folding of Notch did not require its fucosyltransferase activity. Thus, a glycosyltransferase can bind its substrate in the endoplasmic reticulum to facilitate normal folding.	Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu	Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X	NIGMS NIH HHS [R01-GM54594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chazalet V, 2001, J BACTERIOL, V183, P7067, DOI 10.1128/JB.183.24.7067-7075.2001; Chen DP, 2004, ANN CLIN LAB SCI, V34, P314; Culi J, 2004, EMBO J, V23, P1372, DOI 10.1038/sj.emboj.7600132; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; HALTIWANGER R, COMMUNICATION; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1998, SEMIN CELL DEV BIOL, V9, P619, DOI 10.1006/scdb.1998.0261; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Perez-Vilar J, 2004, GLYCOBIOLOGY, V14, P325, DOI 10.1093/glycob/cwh041; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112	32	188	193	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1599	1603		10.1126/science.1108995	http://dx.doi.org/10.1126/science.1108995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15692013				2022-12-01	WOS:000227622400041
J	Tobler, PN; Fiorillo, CD; Schultz, W				Tobler, PN; Fiorillo, CD; Schultz, W			Adaptive coding of reward value by dopamine neurons	SCIENCE			English	Article							NEURAL BASIS; PREDICTION; MOTIVATION; MECHANISMS; CONTRAST	It is important for animals to estimate the value of rewards as accurately as, possible. Because the number of potential reward values is very large, it is necessary that the brain's limited resources be allocated so as to discriminate! better among more likely reward outcomes at the expense of less likely outcomes. We found that midbrain dopamine neurons rapidly adapted to the information provided by reward-predicting stimuli. Responses shifted relative to the expected reward value, and the gain adjusted to the variance of reward value. In this way, dopamine neurons maintained their reward sensitivity over a large range of reward values.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland	University of Cambridge; University of Fribourg	Schultz, W (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	ws234@cam.ac.uk	Fiorillo, Christopher Dante/C-1718-2011; schultz, wolfram/H-8958-2016	Fiorillo, Christopher/0000-0002-7232-9505; schultz, wolfram/0000-0002-8530-4518; Tobler, Philippe/0000-0002-4915-9448	Wellcome Trust [095495] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arnauld A., 1662, LOGIQUE LHRT PENSER; Barlow H.B., 1961, SENSORY COMMUNICATIO; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Glimcher PW, 2003, BRADFORD BOOKS, P1; Kawakami D, 2004, COMP EXPTL METHODS, V10, P13; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Leon MI, 1998, J EXP PSYCHOL ANIM B, V24, P265, DOI 10.1037/0097-7403.24.3.265; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Pavlov IP, 1927, CONDITIONAL REFLEXES; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1177/0269881120954052, DOI 10.1101/GR.110528.110]; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Thorndike EL, 1911, ANIMAL INTELLIGENCE; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; [No title captured]	25	839	850	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1642	1645		10.1126/science.1105370	http://dx.doi.org/10.1126/science.1105370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761155	Green Submitted			2022-12-01	WOS:000227622400052
J	Cranmer, HH				Cranmer, HH			The public health emergency in Indonesia - One patient at a time	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Emergency Med, Div Int Hlth & Humanitarian Programs, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Cranmer, HH (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, Div Int Hlth & Humanitarian Programs, 75 Francis St, Boston, MA 02115 USA.							TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381	1	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					965	965		10.1056/NEJMp058045	http://dx.doi.org/10.1056/NEJMp058045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904JC	15758005				2022-12-01	WOS:000227491200003
J	Lieberman, RL; Rosenzweig, AC				Lieberman, RL; Rosenzweig, AC			Crystal structure of a membrane-bound metalloenzyme that catalyses the biological oxidation of methane	NATURE			English	Article							METHYLOCOCCUS-CAPSULATUS BATH; CYTOCHROME-C-OXIDASE; MONOOXYGENASE; COPPER; ACTIVATION; HYDROXYLATION; SPECTROSCOPY; BIOCHEMISTRY; PARAMETERS; PROTEINS	Particulate methane monooxygenase ( pMMO) is an integral membrane metalloenzyme that catalyses the conversion of methane to methanol. Knowledge of how pMMO performs this extremely challenging chemistry may have an impact on the use of methane as an alternative energy source by facilitating the development of new synthetic catalysts. We have determined the structure of pMMO from the methanotroph Methylococcus capsulatus ( Bath) to a resolution of 2.8 Angstrom. The enzyme is a trimer with an alpha(3)beta(3)gamma(3) polypeptide arrangement. Two metal centres, modelled as mononuclear copper and dinuclear copper, are located in soluble regions of each pmoB subunit, which resembles cytochrome c oxidase subunit II. A third metal centre, occupied by zinc in the crystal, is located within the membrane. The structure provides new insight into the molecular details of biological methane oxidation.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	amyr@northwestern.edu						Arp DJ, 2002, ARCH MICROBIOL, V178, P250, DOI 10.1007/s00203-002-0452-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barondeau DP, 2004, BIOCHEMISTRY-US, V43, P8038, DOI 10.1021/bi0496081; Basu P, 2003, BIOCHEM J, V369, P417, DOI 10.1042/BJ20020823; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan SI, 2004, BIOCHEMISTRY-US, V43, P4421, DOI 10.1021/bi0497603; Chen P, 2004, P NATL ACAD SCI USA, V101, P13105, DOI 10.1073/pnas.0402114101; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Cook SA, 2002, ARCH BIOCHEM BIOPHYS, V398, P32, DOI 10.1006/abbi.2001.2628; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Elliott SJ, 1998, J AM CHEM SOC, V120, P3247, DOI 10.1021/ja972968+; George SD, 2001, J AM CHEM SOC, V123, P5757, DOI 10.1021/ja004109i; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Harford C, 1997, ACCOUNTS CHEM RES, V30, P123, DOI 10.1021/ar9501535; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lemos S. S., 2002, CURR TOP BIOPHYS, V26, P43; Lieberman RL, 2004, CRIT REV BIOCHEM MOL, V39, P147, DOI 10.1080/10409230490475507; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Mirica LM, 2004, CHEM REV, V104, P1013, DOI 10.1021/cr020632z; Nguyen HHT, 1998, J BIOL CHEM, V273, P7957, DOI 10.1074/jbc.273.14.7957; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; Park S, 2002, WASTE MANAGE RES, V20, P434, DOI 10.1177/0734242X0202000507; Periana RA, 2004, J MOL CATAL A-CHEM, V220, P7, DOI 10.1016/j.molcata.2004.05.036; PERIANA RA, 1993, SCIENCE, V259, P340, DOI 10.1126/science.259.5093.340; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; SEMRAU JD, 1995, J BACTERIOL, V177, P3071, DOI 10.1128/jb.177.11.3071-3079.1995; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stolyar S, 1999, MICROBIOL-UK, V145, P1235, DOI 10.1099/13500872-145-5-1235; Sullivan JP, 1998, CRIT REV MICROBIOL, V24, P335, DOI 10.1080/10408419891294217; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TSUPRUN VL, 1987, DOKL AKAD NAUK SSSR+, V292, P490; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Yu SSF, 2003, J BACTERIOL, V185, P5915, DOI 10.1128/JB.185.20.5915-5924.2003	48	477	492	8	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					177	182		10.1038/nature03311	http://dx.doi.org/10.1038/nature03311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15674245				2022-12-01	WOS:000227494500036
J	Waite, JH; Cravens, TE; Ip, WH; Kasprzak, WT; Luhmann, JG; McNutt, RL; Niemann, HB; Yelle, RV; Mueller-Wodarg, I; Ledvina, SA; Scherer, S				Waite, JH; Cravens, TE; Ip, WH; Kasprzak, WT; Luhmann, JG; McNutt, RL; Niemann, HB; Yelle, RV; Mueller-Wodarg, I; Ledvina, SA; Scherer, S			Oxygen ions observed near Saturn's A ring	SCIENCE			English	Article								Ions were detected in the vicinity of Saturn's A ring by the Ion and Neutral Mass Spectrometer (INMS) instrument onboard the Cassini Orbiter during the spacecraft's passage over the rings. The INMS saw signatures of molecular and atomic oxygen ions and of protons, thus demonstrating the existence of an ionosphere associated with the A ring. A likely explanation for these ions is photoionization by solar ultraviolet radiation of neutral O-2 molecules associated with a tenuous ring atmosphere. INMS neutral measurements made during the ring encounter are dominated by a background signal.	Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ London Imperial Coll Sci Technol & Med, Space & Atmospher Phys Grp, London SW7 2BW, England	University of Kansas; University of Michigan System; University of Michigan; National Central University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; Imperial College London	Cravens, TE (corresponding author), Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA.	cravens@ku.edu	Mueller-Wodarg, Ingo C. F./M-9945-2014; McNutt, Ralph L/E-8006-2010	Mueller-Wodarg, Ingo C. F./0000-0001-6308-7826; McNutt, Ralph L/0000-0002-4722-9166				[Anonymous], 1984, SATURN; COATES AJ, 1991, GEOPHYS MONOGR SER, V61, P301; CONNERNEY JEP, 1984, SATURN, P354; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; HUEBNER WF, 1980, ASTROPHYS J, V238, P753, DOI 10.1086/158033; IP WH, 1995, ICARUS, V115, P295, DOI 10.1006/icar.1995.1098; IP WH, 1983, NATURE, V302, P599, DOI 10.1038/302599a0; Johnson RE, 2003, ASTROBIOLOGY, V3, P823, DOI 10.1089/153110703322736123; Johnson RE., 1990, ENERGETIC CHARGED PA, DOI 10.1007/978-3-642-48375-2; Kasprzak W, 1996, P SOC PHOTO-OPT INS, V2803, P129, DOI 10.1117/12.253413; Kliore AJ, 1997, SCIENCE, V277, P355, DOI 10.1126/science.277.5324.355; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; LUHMANN JG, 1991, GEOPHYS MONOGR, V61, P5; WAITE JH, IN PRESS SPACE SCI R; WILSON GR, 1989, J GEOPHYS RES, P17287; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	16	54	54	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1260	1262		10.1126/science.1105734	http://dx.doi.org/10.1126/science.1105734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731442				2022-12-01	WOS:000227313200044
J	Kishi, M; Pan, YA; Crump, JG; Sanes, JR				Kishi, M; Pan, YA; Crump, JG; Sanes, JR			Mammalian SAD kinases are required for neuronal polarization	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; PROTEIN-KINASE; TAU-PROTEIN; PHOSPHORYLATION; POLARITY; ESTABLISHMENT; PAR-1	Electrical activity in neurons is generally initiated in dendritic processes then propagated along axons to synapses, where it is passed to other neurons. Major structural features of neurons-their dendrites and axons-are thus related to their fundamental functions: the receipt and transmission of information. The acquisition of these distinct properties by dendrites and axons, called polarization, is a critical step in neuronat differentiation. We show here that SAD-A and SAD-B, mammalian orthologs of a kinase needed for presynaptic differentiation in Caenorhabditis elegans, are required for neuronal polarization. These kinases will provide entry points for unraveling signaling mechanisms that polarize neurons.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Washington University (WUSTL); Harvard University; University of California System; University of California San Francisco	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	sanesj@mcb.harvard.edu	Kishi, Masashi/GLU-0437-2022					Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Goslin K., 1998, CULTURING NERVE CELL, P339; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Mandell JW, 1996, J NEUROSCI, V16, P5727; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Molnar Z, 1998, J NEUROSCI, V18, P5723; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Pan Y., UNPUB; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sasakura Y, 1998, MECH DEVELOP, V76, P161, DOI 10.1016/S0925-4773(98)00100-2; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Silverman MA, 2001, P NATL ACAD SCI USA, V98, P7051, DOI 10.1073/pnas.111146198; Spicer J, 2004, CURR BIOL, V14, pR383, DOI 10.1016/j.cub.2004.05.012; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	25	255	269	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					929	932		10.1126/science.1107403	http://dx.doi.org/10.1126/science.1107403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705853				2022-12-01	WOS:000226985100055
J	de la Sierra-Gallay, IL; Pellegrini, O; Condon, C				de la Sierra-Gallay, IL; Pellegrini, O; Condon, C			Structural basis for substrate binding, cleavage and allostery in the tRNA maturase RNase Z	NATURE			English	Article							BETA-LACTAMASE; END MATURATION; PRECURSOR; CCA; ENZYME; GENE	Transfer RNAs ( tRNAs) are synthesized as part of longer primary transcripts that require processing of both their 30 and 50 extremities in every living organism known. The 50 side is processed ( matured) by the ubiquitously conserved endonucleolytic ribozyme, RNase P-1, whereas removal of the 30 tails can be either exonucleolytic(2,3) or endonucleolytic(4). The endonucleolytic pathway is catalysed by an enzyme known as RNase Z, or 3' tRNase(5,6). RNase Z cleaves precursor tRNAs immediately after the discriminator base ( the unpaired nucleotide 30 to the last base pair of the acceptor stem, used as an identity determinant by many aminoacyl- tRNA synthetases) in most cases(6 - 8), yielding a tRNA primed for addition of the CCA motif by nucleotidyl transferase. Here we report the crystal structure of Bacillus subtilis RNase Z at 2.1 Angstrom resolution, and propose a mechanism for tRNA recognition and cleavage. The structure explains the allosteric properties of the enzyme, and also sheds light on the mechanisms of inhibition by the CCA motif and long 50 extensions. Finally, it highlights the extraordinary adaptability of the metallo- hydrolase domain of the beta- lactamase family for the hydrolysis of covalent bonds.	Univ Paris 07, CNRS, UPR 9073, F-75221 Paris 05, France; Inst Biol Physicochim, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Condon, C (corresponding author), Univ Paris 07, CNRS, UPR 9073, F-75221 Paris 05, France.	condon@ibpc.fr	Condon, Ciaran/F-6798-2011	Condon, Ciaran/0000-0002-2199-9621; Li de la Sierra-Gallay, Ines/0000-0003-2770-7439				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; GARBER RL, 1979, CELL, V18, P817, DOI 10.1016/0092-8674(79)90134-X; GARBER RL, 1979, CELL, V17, P389, DOI 10.1016/0092-8674(79)90165-X; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; Kunzmann A, 1998, P NATL ACAD SCI USA, V95, P108, DOI 10.1073/pnas.95.1.108; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Lu GG, 1999, J APPL CRYSTALLOGR, V32, P365, DOI 10.1107/S0021889898015052; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Mohan A, 1999, RNA, V5, P245, DOI 10.1017/S1355838299981256; Nashimoto M, 1997, NUCLEIC ACIDS RES, V25, P1148, DOI 10.1093/nar/25.6.1148; Nashimoto M, 1999, NUCLEIC ACIDS RES, V27, P2770, DOI 10.1093/nar/27.13.2770; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schiffer S, 2001, BIOCHEMISTRY-US, V40, P8264, DOI 10.1021/bi0101953; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200	29	126	130	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					657	661		10.1038/nature03284	http://dx.doi.org/10.1038/nature03284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15654328				2022-12-01	WOS:000226862000050
J	Bano, D; Young, KW; Guerin, CJ; LeFeuvre, R; Rothwell, NJ; Naldini, L; Rizzuto, R; Carafoli, E; Nicotera, P				Bano, D; Young, KW; Guerin, CJ; LeFeuvre, R; Rothwell, NJ; Naldini, L; Rizzuto, R; Carafoli, E; Nicotera, P			Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity	CELL			English	Article							EXCITATORY AMINO-ACIDS; CARDIAC NA+-CA2+ EXCHANGER; CEREBELLAR GRANULE CELLS; ISCHEMIC BRAIN-INJURY; GLUTAMATE EXCITOTOXICITY; PERMEABILITY TRANSITION; CA2+-BINDING DOMAIN; NEURONAL APOPTOSIS; PROTEOLYTIC SYSTEM; NMDA RECEPTOR	In brain ischemia, gating of postsynaptic glutamate receptors and other membrane channels triggers intracellular Ca2+ overload and cell death. In excitotoxic settings, the initial Ca2+ influx through glutamate receptors is followed by a second uncontrolled Ca2+ increase that leads to neuronal demise. Here we report that the major plasma membrane Ca2+ extruding system, the Na+/Ca2+ exchanger (NCX), is cleaved during brain ischemia and in neurons undergoing excitotoxicity. Inhibition of Ca2+-activated proteases (calpains) by overexpressing their endogenous inhibitor protein, calpastatin or the expression of an NCX isoform not cleaved by calpains, prevented Ca2+ overload and rescued neurons from excitotoxic death. Conversely, down-regulation of NCX by siRNA compromised neuronal Ca2+ handling, transforming the Ca2+ transient elicited by non-excitotoxic glutamate concentrations into a lethal Ca2+ overload. Thus, proteolytic in,activation of NCX-driven neuronal Ca2+ extrusion is responsible for the delayed excitotoxic Ca2+ deregulation and neuronal death.	Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England; Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Padua, Dept Biochem, I-35121 Padua, Italy; VIMM, I-35129 Padua, Italy	University of Leicester; University of Leicester; University of Manchester; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of Padua; Veneto Institute Molecular Medicine	Nicotera, P (corresponding author), Univ Leicester, MRC Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	pn10@le.ac.uk	Carafoli, Ernesto/K-5192-2016; Guerin, Christopher/AAM-3233-2020; Bano, Daniele/AAZ-9371-2020; Naldini, Luigi/E-9083-2012; Rizzuto, Rosario/B-6312-2008; Le Feuvre, Rosalind/A-7034-2013	Carafoli, Ernesto/0000-0002-7826-0094; NALDINI, Luigi/0000-0002-7835-527X; Rizzuto, Rosario/0000-0001-7044-5097	MRC [G19/24] Funding Source: UKRI; Medical Research Council [G19/24] Funding Source: Medline; Telethon [TGT06S01, TGT03D01] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon)		Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BINDOKAS VP, 1995, J NEUROSCI, V15, P6999; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Brini M, 2002, J BIOL CHEM, V277, P38693, DOI 10.1074/jbc.M206075200; Budd SL, 1996, J NEUROCHEM, V67, P2282; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; EMORI Y, 1988, J BIOL CHEM, V263, P2364; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Fryer HJL, 1999, J NEUROCHEM, V72, P500, DOI 10.1046/j.1471-4159.1999.0720500.x; Guerini D, 2003, J BIOL CHEM, V278, P38141, DOI 10.1074/jbc.M302400200; Han BH, 2002, J BIOL CHEM, V277, P30128, DOI 10.1074/jbc.M202931200; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Leist M, 1997, MOL MED, V3, P750, DOI 10.1007/BF03401713; Leist M, 1998, MOL PHARMACOL, V54, P789, DOI 10.1124/mol.54.5.789; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Li L, 2000, J BIOL CHEM, V275, P20903, DOI 10.1074/jbc.M000995200; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MELLGREN RL, 1989, RBC-CELL BIOL REV, V20, P139; Murachi T, 1987, NEUROPEPTIDES THEIR, P202; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOTERA P, 1986, J BIOL CHEM, V261, P4628; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reynolds IJ, 1999, ANN NY ACAD SCI, V893, P33, DOI 10.1111/j.1749-6632.1999.tb07816.x; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; ROTHMAN SM, 1987, NEUROSCIENCE, V22, P471, DOI 10.1016/0306-4522(87)90347-2; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schwab BL, 2002, CELL DEATH DIFFER, V9, P818, DOI 10.1038/sj.cdd.4401042; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; THUMEYSEN T, 2002, BRAIN RES MOL BRAIN, V107, P145; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; TYMIANSKI M, 1993, BRAIN RES, V607, P319, DOI 10.1016/0006-8993(93)91523-U; Ward MW, 2000, J NEUROSCI, V20, P7208; Waterhouse NJ, 1998, CELL DEATH DIFFER, V5, P1051, DOI 10.1038/sj.cdd.4400425; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	55	427	444	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					275	285		10.1016/j.cell.2004.11.049	http://dx.doi.org/10.1016/j.cell.2004.11.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680332	Bronze			2022-12-01	WOS:000226740000015
J	Amonlirdviman, K; Khare, NA; Tree, DRP; Chen, WS; Axelrod, JD; Tomlin, CJ				Amonlirdviman, K; Khare, NA; Tree, DRP; Chen, WS; Axelrod, JD; Tomlin, CJ			Mathematical modeling of planar cell polarity to understand domineering nonautonomy	SCIENCE			English	Article							DROSOPHILA EYE; ASYMMETRIC LOCALIZATION; TISSUE POLARITY; VAN-GOGH; PRICKLE; ABDOMEN; GENE; MELANOGASTER; STRABISMUS; AUTONOMY	Planar cell polarity (PCP) signaling generates subcellular asymmetry along an axis orthogonal to the epithelia[ apical-basal axis. Through a poorly understood mechanism, cell clones that have mutations in some PCP signaling components, including some, but not all, alleles of the receptor frizzled, cause polarity disruptions of neighboring wild-type cells, a phenomenon referred to as domineering nonautonomy. Here, a contact-dependent signaling hypothesis, derived from experimental results, is shown by reaction-diffusion, partial differential equation modeling and simulation to fully reproduce PCP phenotypes, including domineering nonautonomy, in the Drosophila wing. The sufficiency of this model and the experimental validation of model predictions reveal how specific protein-protein interactions produce autonomy or domineering nonautonomy.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Aeronaut & Astronaut, Stanford, CA 94305 USA	Stanford University; Stanford University	Axelrod, JD (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	jaxetrod@stanford.edu; tomlin@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059823] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM59823] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER PM, COMMUNICATION; Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; AMONLIRDVIMAN K, UNPUB; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Hannus M, 2002, DEVELOPMENT, V129, P3493; Jones KH, 1996, GENETICS, V142, P205; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Struhl G, 1997, DEVELOPMENT, V124, P2155; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Taylor J, 1998, GENETICS, V150, P199; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wehrli M, 1998, DEVELOPMENT, V125, P1421; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342	31	215	218	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					423	426		10.1126/science.1105471	http://dx.doi.org/10.1126/science.1105471			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662015				2022-12-01	WOS:000226492300047
J	O'Rahilly, S; Barroso, I; Wareham, NJ				O'Rahilly, S; Barroso, I; Wareham, NJ			Genetic factors in type 2 diabetes: The end of the beginning?	SCIENCE			English	Editorial Material							NUCLEAR FACTOR-4-ALPHA GENE; INSULIN-RESISTANCE; ASSOCIATION; POLYMORPHISM; MELLITUS; OBESITY; RISK; SUSCEPTIBILITY; CONTRIBUTE; MUTATIONS	The intensive search for genetic variants that predispose to type 2 diabetes was launched with optimism, but progress has been slower than was hoped. Even so, major advances have been made in the understanding of monogenic forms of the disease which together represent a substantial health burden, and a few common gene variants that influence susceptibility have now been unequivocally identified. Armed with a better understanding of the tools needed to detect such genes, it seems inevitable that the rate of progress will increase and the relevance of genetic information to the diagnosis, treatment, and prevention of diabetes will become increasingly tangible.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; MRC, Epidemiol Unit, Elsie Widdowson Lab, Cambridge CB1 9NL, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	O'Rahilly, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England.	so104@medscht.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Barroso, Ines/0000-0001-5800-4520				Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Beck-Nielsen H, 2003, BEST PRACT RES CL EN, V17, P445, DOI 10.1016/S1521-690X(03)00041-1; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hegele RA, 1999, DIABETES CARE, V22, P524, DOI 10.2337/diacare.22.3.524b; Horikawa Y, 2000, NAT GENET, V26, P502; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Love-Gregory L, 2003, DIABETOLOGIA, V46, P136, DOI 10.1007/s00125-002-0947-x; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; McCarthy MI, 2002, AM J PHYSIOL-ENDOC M, V283, pE217, DOI 10.1152/ajpendo.00099.2002; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; O'Rahilly S, 2002, EUR J ENDOCRINOL, V147, P435, DOI 10.1530/eje.0.1470435; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Sargeant LA, 2000, INT J OBESITY, V24, P1333, DOI 10.1038/sj.ijo.0801383; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Stride A, 2002, ANN MED, V34, P207, DOI 10.1080/713782136; 't Hart LM, 1999, J CLIN ENDOCR METAB, V84, P1002, DOI 10.1210/jc.84.3.1002; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Zhu Q, 2003, DIABETOLOGIA, V46, P567, DOI 10.1007/s00125-003-1067-y	27	198	204	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					370	373		10.1126/science.1104346	http://dx.doi.org/10.1126/science.1104346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662000				2022-12-01	WOS:000226492300030
J	Saez, AG; Lozano, E				Saez, AG; Lozano, E			Body doubles	NATURE			English	Editorial Material									Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, Madrid 28006, Spain; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Imperial College London	Saez, AG (corresponding author), Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, Madrid 28006, Spain.		Lozano, Encarnacion/C-5161-2008; Sáez, Alberto García/B-5018-2008	Sáez, Alberto García/0000-0003-0209-7179; Lozano, Encarnacion/0000-0003-0254-0935				Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Thierstein HR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P455; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x	5	159	163	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					111	111		10.1038/433111a	http://dx.doi.org/10.1038/433111a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650721	Bronze			2022-12-01	WOS:000226252200018
J	van Gils, CH; Peeters, PHT; Bueno-De-Mesquita, HB; Boshuizen, HC; Lahmann, PH; Clavel-Chapelon, F; Thiebaut, A; Kesse, E; Sieri, S; Palli, D; Tumino, R; Panico, S; Vineis, P; Gonzalez, CA; Ardanaz, E; Sanchez, MJ; Amiano, P; Navarro, C; Quiros, JR; Key, TJ; Allen, N; Khaw, KT; Bingham, SA; Psaltopoulou, T; Koliva, M; Trichopoulou, A; Nagel, G; Linseisen, J; Boeing, H; Berglund, G; Wirfalt, E; Hallmans, G; Lenner, P; Overvad, K; Tjonneland, A; Olsen, A; Lund, E; Engeset, D; Alsaker, E; Norat, TA; Kaaks, R; Slimani, N; Riboli, E				van Gils, CH; Peeters, PHT; Bueno-De-Mesquita, HB; Boshuizen, HC; Lahmann, PH; Clavel-Chapelon, F; Thiebaut, A; Kesse, E; Sieri, S; Palli, D; Tumino, R; Panico, S; Vineis, P; Gonzalez, CA; Ardanaz, E; Sanchez, MJ; Amiano, P; Navarro, C; Quiros, JR; Key, TJ; Allen, N; Khaw, KT; Bingham, SA; Psaltopoulou, T; Koliva, M; Trichopoulou, A; Nagel, G; Linseisen, J; Boeing, H; Berglund, G; Wirfalt, E; Hallmans, G; Lenner, P; Overvad, K; Tjonneland, A; Olsen, A; Lund, E; Engeset, D; Alsaker, E; Norat, TA; Kaaks, R; Slimani, N; Riboli, E			Consumption of vegetables and fruits and risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							24-HOUR DIET RECALL; CALIBRATION; FOOD; QUESTIONNAIRES; VALIDITY; NITROGEN	Context The intake of vegetables and fruits has been thought to protect against breast cancer. Most of the evidence comes from case-control studies, but a recent pooled analysis of the relatively few published cohort studies suggests no significantly reduced breast cancer risk is associated with vegetable and fruit consumption. Objective To examine the relation between total and specific vegetable and fruit intake and the incidence of breast cancer. Design, Setting, and Participants Prospective study of 285526 women between the ages of 25 and 70 years, participating in the European Prospective Investigation Into Cancer and Nutrition (EPIC) study, recruited from 8 of the 10 participating European countries. Participants completed a dietary questionnaire in 1992-1998 and were followed up for incidence of cancer until 2002. Main Outcome Measures Relative risks for breast cancer by total and specific vegetable and fruit intake. Analyses were stratified by age at recruitment and study center. Relative risks were adjusted for established breast cancer risk factors. Results During 1486402 person-years (median duration of follow-up, 5.4 years), 3659 invasive incident breast cancer cases were reported. No significant associations between vegetable or fruit intake and breast cancer risk were observed. Relative risks for the highest vs the lowest quintile were 0.98 (95% confidence interval [CI], 0.84-1.14) for total vegetables, 1.09 (95% Cl, 0.94-1.25) for total fruit, and 1.05 (95% Cl, 0.92-1.20) for fruit and vegetable juices. For 6 specific vegetable subgroups no associations with breast cancer risk were observed either. Conclusion Although the period of follow-up is limited for now, the results suggest that total or specific vegetable and fruit intake is not associated with risk for breast cancer.	Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; Natl Inst Publ Hlth & Environm, Ctr Nutr & Hlth, NL-3720 BA Bilthoven, Netherlands; Natl Inst Publ Hlth & Environm, Ctr Informat Technol & Methodol, NL-3720 BA Bilthoven, Netherlands; German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany; Inst Gustave Roussy, INSERM, Equipe Nutr Hormones & Canc, F-94805 Villejuif, France; Ist Nazl Tumori, Epidemiol Unit, I-20133 Milan, Italy; Sci Inst Tuscany, CSPO, Mol & Nutr Epidemiol Unit, Florence, Italy; Azienda Osped Civile MP Arezzo, Canc Registry, Ragusa, Italy; Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; Univ Turin, I-10124 Turin, Italy; Univ London Imperial Coll Sci Technol & Med, London, England; Catalan Inst Oncol, Dept Epidemiol, Barcelona, Spain; Inst Publ Hlth, Navarra, Spain; Andalusian Sch Publ Hlth, Granada, Spain; Hlth Dept Basque Country, Publ Hlth Div Gipuzkoa, San Sebastian, Spain; Murcia Hlth Council, Dept Epidemiol, Murcia, Spain; Principal Asturias, Hlth & Hlth Serv Council, Publ Hlth & Planning Directorate, Hlth Informat Unit, Oviedo, Spain; Univ Oxford, Canc Res UK Epidemiol Unit, Oxford OX1 2JD, England; Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England; MRC, Dunn Human Nutr Unit, Cambridge, England; Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-10679 Athens, Greece; Deutsch Krebsforschungszentrum, Div Clin Epidemiol, D-6900 Heidelberg, Germany; Lund Univ, Malmo Univ Hosp, Dept Med, Malmo, Sweden; Umea Univ, Unit Nutr Res, S-90187 Umea, Sweden; Umea Univ, Unit Oncol, S-90187 Umea, Sweden; Umea Univ, Dept Radiat Sci, S-90187 Umea, Sweden; Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Epidemiol, Aalborg, Denmark; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; Univ Tromso, Inst Community Med, Tromso, Norway; WHO, Int Agcy Res Canc, Lyon, France	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; University of Naples Federico II; University of Turin; Imperial College London; Catalan Institute of Oncology; Public Health Institute of Navarra; Escuela Andaluza de Salud Publica; Murcia Regional Health Council; Cancer Research UK; University of Oxford; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Athens Medical School; National & Kapodistrian University of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Skane University Hospital; Umea University; Umea University; Umea University; Aalborg University; Aalborg University Hospital; Aarhus University; Danish Cancer Society; UiT The Arctic University of Tromso; World Health Organization; International Agency for Research on Cancer (IARC)	Peeters, PHT (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Room Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	P.H.M.Peeters@umcutrecht.nl	TRICHOPOULOU, ANTONIA/ABF-8727-2021; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Engeset, Dagrun/A-4508-2008; Linseisen, Jakob/B-5353-2014; Thiébaut, Anne C.M./O-1788-2018; Clavel-Chapelon, Francoise/G-6733-2014; Khaw, Kay-Tee/AAZ-3209-2021; Psaltopoulou, Theodora/AAA-6878-2020; Panico, Salvatore/K-6506-2016; Sieri, Sabina/K-4667-2016; Kesse-Guyot, Emmanuelle/F-2692-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Sánchez, Maria-José/D-1087-2011; Boshuizen, Hendriek C/B-3718-2014; Nagel, Gabriele/C-3635-2012; Boshuizen, Hendriek/M-3415-2014	TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Linseisen, Jakob/0000-0002-9386-382X; Thiébaut, Anne C.M./0000-0003-2651-2795; Psaltopoulou, Theodora/0000-0002-1404-9716; Panico, Salvatore/0000-0002-5498-8312; Sieri, Sabina/0000-0001-5201-172X; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Sánchez, Maria-José/0000-0003-4817-0757; Nagel, Gabriele/0000-0001-6185-8535; Boshuizen, Hendriek/0000-0002-3916-9095; Olsen, Anja/0000-0003-4788-503X; Navarro, Carmen/0000-0001-8896-7483; Lund, Eiliv/0000-0002-8071-8711; tumino, rosario/0000-0003-2666-414X; LAHMANN, Petra/0000-0002-9563-1635; Overvad, Kim/0000-0001-6429-7921; PALLI, Domenico/0000-0002-5558-2437; Riboli, Elio/0000-0001-6795-6080; Tjonneland, Anne/0000-0003-4385-2097				Agudo A, 2002, PUBLIC HEALTH NUTR, V5, P1179, DOI 10.1079/PHN2002398; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409; Gandini S, 2000, EUR J CANCER, V36, P636, DOI 10.1016/S0959-8049(00)00022-8; Gaudet MM, 2004, CANCER EPIDEM BIOMAR, V13, P1485; *IARC WORK GROUP E, 2003, IARC WORK GROUP EV C, V8; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; KAAKS R, 1995, AM J EPIDEMIOL, V142, P548, DOI 10.1093/oxfordjournals.aje.a117673; Kipnis V, 2001, AM J EPIDEMIOL, V153, P394, DOI 10.1093/aje/153.4.394; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Margetts BM, 1997, INT J EPIDEMIOL, V26, pS1, DOI 10.1093/ije/26.suppl_1.S1; Miller AB, 2004, INT J CANCER, V108, P269, DOI 10.1002/ijc.11559; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 2003, CANCER EPIDEM BIOMAR, V12, P784; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Smith-Warner SA, 2001, JAMA-J AM MED ASSOC, V285, P769, DOI 10.1001/jama.285.6.769; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; *WHO, 1997, FOOD NUTR PREV CANC; Zhang SM, 1999, JNCI-J NATL CANCER I, V91, P547, DOI 10.1093/jnci/91.6.547	24	188	192	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					183	193		10.1001/jama.293.2.183	http://dx.doi.org/10.1001/jama.293.2.183			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644545	Green Published, Bronze			2022-12-01	WOS:000226171000034
J	Gami, AS; Howard, DE; Olson, EJ; Somers, VK				Gami, AS; Howard, DE; Olson, EJ; Somers, VK			Day-night pattern of sudden death in obstructive sleep apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; CERTIFICATE DIAGNOSIS; CARDIAC DEATH; ATRIOVENTRICULAR-CONDUCTION; MYOCARDIAL-INFARCTION; BREATHING DISORDERS; QT INTERVAL; VALIDATION; POPULATION; DISTURBANCES	BACKGROUND: The risk of sudden death from cardiac causes in the general population peaks from 6 a.m. to noon and has a nadir from midnight to 6 a.m. Obstructive sleep apnea is highly prevalent and associated with neurohormonal and electrophysiological abnormalities that may increase the risk of sudden death from cardiac causes, especially during sleep. METHODS: We reviewed polysomnograms and the death certificates of 112 Minnesota residents who had undergone polysomnography and had died suddenly from cardiac causes between July 1987 and July 2003. For four intervals of the day, we compared the rates of sudden death from cardiac causes among people with obstructive sleep apnea and the following: the rates among people without obstructive sleep apnea, the rates in the general population, and the expectations according to chance. For each interval, we assessed the median apnea-hypopnea index and the relative risk of sudden death from cardiac causes. We similarly analyzed sudden death from cardiac causes during three time intervals that correlate with usual sleep-wake cycles. RESULTS: From midnight to 6 a.m., sudden death from cardiac causes occurred in 46 percent of people with obstructive sleep apnea, as compared with 21 percent of people without obstructive sleep apnea (P=0.01), 16 percent of the general population (P<0.001), and the 25 percent expected by chance (P<0.001). People with sudden death from cardiac causes from midnight to 6 a.m. had a significantly higher apnea-hypopnea index than those with sudden death from cardiac causes during other intervals, and the apnea-hypopnea index correlated directly with the relative risk of sudden death from cardiac causes from midnight to 6 a.m. For people with obstructive sleep apnea, the relative risk of sudden death from cardiac causes from midnight to 6 a.m. was 2.57 (95 percent confidence interval, 1.87 to 3.52). The analysis of usual sleep-wake cycles showed similar results. CONCLUSIONS: People with obstructive sleep apnea have a peak in sudden death from cardiac causes during the sleeping hours, which contrasts strikingly with the nadir of sudden death from cardiac causes during this period in people without obstructive sleep apnea and in the general population.	Mayo Clin & Mayo Fdn, Coll Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Div Hypertens, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Somers, VK (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	somers.virend@mayo.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073211, R01HL061560, R01HL065176] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREOTTI F, 1988, AM J CARDIOL, V62, P635, DOI 10.1016/0002-9149(88)90669-8; BECKER H, 1995, AM J RESP CRIT CARE, V151, P215, DOI 10.1164/ajrccm.151.1.7812557; BEXTON RS, 1986, BRIT HEART J, V55, P253; CLARKE JM, 1976, LANCET, V2, P508, DOI 10.1016/S0140-6736(76)90801-1; Coady SA, 2001, J CLIN EPIDEMIOL, V54, P40, DOI 10.1016/S0895-4356(00)00272-9; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; Fichter J, 2002, CHEST, V122, P558, DOI 10.1378/chest.122.2.558; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FOLSOM AR, 1987, AM J EPIDEMIOL, V125, P1012, DOI 10.1093/oxfordjournals.aje.a114617; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Fries R, 1999, PACE, V22, P223, DOI 10.1111/j.1540-8159.1999.tb00337.x; GILLIS AM, 1991, SLEEP, V14, P346, DOI 10.1093/sleep/14.4.346; GONZALEZROTHI RJ, 1988, CHEST, V94, P531, DOI 10.1378/chest.94.3.531; Goraya TY, 2000, MAYO CLIN PROC, V75, P681; Goraya TY, 2003, AM J EPIDEMIOL, V157, P763, DOI 10.1093/aje/kwg057; Grimm W, 1996, AM J CARDIOL, V77, P1310, DOI 10.1016/S0002-9149(96)00197-X; GUILLEMINAULT C, 1983, AM J CARDIOL, V52, P490, DOI 10.1016/0002-9149(83)90013-9; Harbison J, 2000, CHEST, V118, P591, DOI 10.1378/chest.118.3.591; HUIKURI HV, 1994, CIRCULATION, V90, P121, DOI 10.1161/01.CIR.90.1.121; HUIKURI HV, 1995, PACE, V18, P1362, DOI 10.1111/j.1540-8159.1995.tb02597.x; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Koehler U, 1998, EUR RESPIR J, V11, P434, DOI 10.1183/09031936.98.11020434; Legramante JM, 2003, J HYPERTENS, V21, P1555, DOI 10.1097/00004872-200308000-00021; MOSER DK, 1994, J AM COLL CARDIOL, V24, P963, DOI 10.1016/0735-1097(94)90856-7; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Priori SG, 2002, EUR HEART J, V23, P257; Sanner BM, 2000, EUR RESPIR J, V16, P648, DOI 10.1034/j.1399-3003.2000.16d14.x; Schafer H, 1997, CHEST, V111, P387, DOI 10.1378/chest.111.2.387; SEPPALA T, 1991, J INTERN MED, V229, P23, DOI 10.1111/j.1365-2796.1991.tb00301.x; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; SHEPARD JW, 1985, CHEST, V88, P335, DOI 10.1378/chest.88.3.335; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; TILKIAN AG, 1977, AM J MED, V63, P348, DOI 10.1016/0002-9343(77)90272-8; VIROLAINEN J, 1995, J APPL PHYSIOL, V79, P455, DOI 10.1152/jappl.1995.79.2.455; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; ZWILLICH C, 1982, J CLIN INVEST, V69, P1286, DOI 10.1172/JCI110568; [No title captured]	41	639	687	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2005	352	12					1206	1214		10.1056/NEJMoa041832	http://dx.doi.org/10.1056/NEJMoa041832			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909AW	15788497				2022-12-01	WOS:000227832300007
J	Riskin, DK; Hermanson, JW				Riskin, DK; Hermanson, JW			Biomechanics - Independent evolution of running in vampire bats	NATURE			English	Editorial Material							BODY SIZE; LOCOMOTION; MECHANICS; SPEED		Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University	Riskin, DK (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	dkr8@cornell.edu		Riskin, Daniel K./0000-0001-8742-8509				ALTENBACH JS, 1979, SPEC PUBL ANN SOC MA, V6, P137; Gambaryan PP, 2002, ZH OBSHCH BIOL, V63, P426; Greenhall A. M., 1988, NATURAL HIST VAMPIRE; HEGLUND NC, 1988, J EXP BIOL, V138, P301; Hildebrand M., 1985, P38; Parchman AJ, 2003, J EXP BIOL, V206, P1379, DOI 10.1242/jeb.00267; RISKIN DK, IN PRESS J EXP BIOL; Schutt WA, 1997, J EXP BIOL, V200, P3003; TAYLOR CR, 1982, J EXP BIOL, V97, P1; VAUGHAN TERRY A., 1959, UNIV KANSAS PUBL MUS NAT HIST, V12, P1	11	32	32	5	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					292	292		10.1038/434292a	http://dx.doi.org/10.1038/434292a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772640	Bronze			2022-12-01	WOS:000227715100029
J	Back, AL; Arnold, RM				Back, AL; Arnold, RM			Dealing with conflict in caring for the seriously ill - "It was just out of the question"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; DOCTOR-NURSE GAME; INTERPERSONAL CONFLICTS; PROLONGED STAY; CRITICALLY-ILL; FOLLOW-UP; COMMUNICATION; LIFE; PHYSICIANS; END	Physicians often assume that conflict is undesirable and destructive, yet conflict handled Well can be productive, and the clarity that results can lead to clearer decision making and greater family, patient, and clinician satisfaction. We review the course of Mrs B, an 84-year-old woman with advanced dementia and an advance directive stating no artificial hydration or nutrition. Over the course of her illness, her family and physicians had conflicting opinions about the use of short-term tube feeding and intravenous hydration in her care. We describe the conflicts that arose between her physicians and family and a typology of conflicts common in care of patients who are seriously ill (family vs team, team member vs team member). Drawing from the business, psychology, and mediation literature, we describe useful communication tools and common pitfalls. We outline a step-wise approach that physicians can use to deal with conflicts and the use of treatment trials as a strategy to address conflicts about the use of life-sustaining medical interventions.	Univ Washington, Dept Med, Seattle, WA USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Back, AL (corresponding author), Seattle Canc Care Alliance, 825 Eastlake Ave E,POB 19023, Seattle, WA 98109 USA.	tonyback@u.washington.edu			PHS HHS [R25 92055] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM MED ASS, 2004, END PAT PHYS REL; Andrew L B, 1999, Physician Exec, V25, P38; Aschenbrener C A, 1999, Physician Exec, V25, P44; Aulisio MP, 2004, CRIT CARE CLIN, V20, P505, DOI 10.1016/j.ccc.2004.03.006; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Bowman KW, 2000, J PALLIATIVE CARE, V16, pS17, DOI 10.1177/082585970001601S05; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; Brett AS, 2003, ARCH INTERN MED, V163, P1645, DOI 10.1001/archinte.163.14.1645; Burns JP, 2003, CRIT CARE MED, V31, P2107, DOI 10.1097/01.CCM.0000069732.65524.72; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; Dowdy MD, 1998, CRIT CARE MED, V26, P252, DOI 10.1097/00003246-199802000-00020; DUBLER N, 2003, BIOETHICS MED GUIDE; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; FARBER NJ, 1990, ACAD MED, V65, P713, DOI 10.1097/00001888-199011000-00019; Fetters MD, 2001, CRIT CARE MED, V29, P921, DOI 10.1097/00003246-200105000-00001; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Fisher R., 1991, GETTING YES NEGOTIAT; Frederich Michael E, 2002, J Palliat Med, V5, P155; GABBARD GO, 1985, JAMA-J AM MED ASSOC, V254, P2926, DOI 10.1001/jama.254.20.2926; Goleman D., 2002, PRIMAL LEADERSHIP RE; Goold SD, 2000, JAMA-J AM MED ASSOC, V283, P909, DOI 10.1001/jama.283.7.909; Green P, 2004, AM J DRUG ALCOHOL AB, V30, P489, DOI 10.1081/ADA-120037390; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Jain A, 1999, BRIT MED J, V318, P1596, DOI 10.1136/bmj.318.7198.1596; Jameson JK, 2003, J HEALTH COMMUN, V8, P563, DOI 10.1080/716100415; Kalisch B J, 1977, J Nurs Adm, V7, P50, DOI 10.1097/00005110-197701000-00014; Kressel Kenneth, 2002, J Health Care Law Policy, V5, P364; Kristjanson L, 1997, J PALLIATIVE CARE, V13, P5; LEVENSON RW, 1994, J PERS SOC PSYCHOL, V67, P56, DOI 10.1037/0022-3514.67.1.56; Levine C, 1999, Trustee, V52, P24; Levine C, 2004, CLIN MED, V4, P244, DOI 10.7861/clinmedicine.4-3-244; Levinson W, 1999, JAMA-J AM MED ASSOC, V282, P1477, DOI 10.1001/jama.282.15.1477; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Lilly CM, 2003, CRIT CARE MED, V31, pS394, DOI 10.1097/01.CCM.0000065279.77449.B4; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Orr Robert D., 2001, American Journal of Bioethics, V1, P45, DOI 10.1162/152651601317139397; PORTER S, 1991, J ADV NURS, V16, P728, DOI 10.1111/j.1365-2648.1991.tb01731.x; Prendergast TJ, 2000, JAMA-J AM MED ASSOC, V283, P3200; PRESCOTT PA, 1985, ANN INTERN MED, V103, P127, DOI 10.7326/0003-4819-103-1-127; Rabeneck L, 1997, LANCET, V349, P496, DOI 10.1016/S0140-6736(96)07369-2; Rosenbaum JR, 2004, AM J MED, V116, P402, DOI 10.1016/j.amjmed.2003.09.044; Rosenstein AH, 2002, AM J NURS, V102, P26, DOI 10.1097/00000446-200206000-00040; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; STEIN LI, 1967, ARCH GEN PSYCHIAT, V16, P699; STEIN LI, 1990, NEW ENGL J MED, V322, P546, DOI 10.1056/NEJM199002223220810; Stone D, 1999, DIFFICULT CONVERSATI; Studdert DM, 2003, INTENS CARE MED, V29, P1489, DOI 10.1007/s00134-003-1853-5; Studdert DM, 2003, PEDIATRICS, V112, P553, DOI 10.1542/peds.112.3.553; TANNEN D, 2000, YOU JUST DONT UNDERS; Taylor SR, 2004, BMJ-BRIT MED J, V329, P233, DOI 10.1136/bmj.329.7459.233; The AM, 2002, BRIT MED J, V325, P1326, DOI 10.1136/bmj.325.7376.1326; Thomas EJ, 2003, CRIT CARE MED, V31, P956, DOI 10.1097/01.CCM.0000056183.89175.76; TOMLINSON T, 1990, GERONTOLOGIST, V30, P54, DOI 10.1093/geront/30.1.54; Ury W., 1991, GETTING PAST NO NEGO; VAILLANT GE, 1972, NEW ENGL J MED, V287, P372, DOI 10.1056/NEJM197208242870802; Valdimarsdottir U, 2004, PALLIATIVE MED, V18, P432, DOI 10.1191/0269216304pm891oa; Weitzman PF, 2003, CLIN PSYCHOL REV, V23, P523, DOI 10.1016/S0272-7358(02)00209-X; Weitzman PF, 2001, INT J AGING HUM DEV, V52, P281, DOI 10.2190/H3LH-59KQ-8WJP-ULM5	62	83	85	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1374	1381		10.1001/jama.293.11.1374	http://dx.doi.org/10.1001/jama.293.11.1374			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	907EP	15769971				2022-12-01	WOS:000227698600026
J	Lemoine, FJ; Degtyareva, NP; Lobachev, K; Petes, TD				Lemoine, FJ; Degtyareva, NP; Lobachev, K; Petes, TD			Chromosomal translocations in yeast induced by low levels of DNA polymerase: A model for chromosome fragile sites	CELL			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; GENOMIC INSTABILITY; GENETIC INSTABILITY; REARRANGEMENTS; RECOMBINATION; COMMON; REPLICATION; REPAIR; PALINDROMES	In the yeast Saccharomyces cerevisiae, reduced levels of the replicative a DNA polymerase result in greatly elevated frequencies of chromosome translocations and chromosome loss. We selected translocations in a small region of chromosome III and found that they involve homologous recombination events between yeast retrotransposons (Ty elements) on chromosome III and retrotransposons located on other chromosomes. One of the two preferred sites of these translocations on chromosome III involve two Ty elements arrayed head-to-head; disruption of this site substantially reduces the rate of translocations. We demonstrate that this pair of T elements constitutes a preferred site for double-strand DNA breaks when DNA replication is compromised, analogous to the fragile sites observed in mammalian chromosomes.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Georgia Inst Technol, Sch Biol, Inst Bioengn & Biosci, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia Institute of Technology	Petes, TD (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	tompetes@duke.edu	Degtyareva, Natalya/AAI-5500-2021	Degtyareva, Natalya/0000-0002-7141-6308	NCI NIH HHS [CA09156] Funding Source: Medline; NIGMS NIH HHS [GM52319] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GLOVER TW, 1988, AM J HUM GENET, V43, P265; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; GORDENIN DA, 1991, YEAST, V7, P37, DOI 10.1002/yea.320070105; Gotter AL, 2004, HUM MOL GENET, V13, P103, DOI 10.1093/hmg/ddh004; Guthrie C, 1991, GUIDE YEAST GENETICS; HAWTHORNE DC, 1963, GENETICS, V48, P1721; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Kokoska RJ, 2000, MOL CELL BIOL, V20, P7490, DOI 10.1128/MCB.20.20.7490-7504.2000; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lobachev KS, 1998, GENETICS, V148, P1507; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; MCCUSKER JH, 1981, GENETICS, V99, P383; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROEDER GS, 1980, CELL, V21, P239, DOI 10.1016/0092-8674(80)90131-2; RUSKIN B, 1993, GENETICS, V134, P43; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; Umezu K, 2002, GENETICS, V160, P97; Wang L, 1997, GENOMICS, V41, P485, DOI 10.1006/geno.1997.4690; WICKSTEED BL, 1994, YEAST, V10, P39, DOI 10.1002/yea.320100105; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	33	247	251	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					587	598		10.1016/j.cell.2004.12.039	http://dx.doi.org/10.1016/j.cell.2004.12.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766523	Bronze			2022-12-01	WOS:000227771400006
J	Onodera, Y; Haag, JR; Ream, T; Nunes, PC; Pontes, O; Pikaard, CS				Onodera, Y; Haag, JR; Ream, T; Nunes, PC; Pontes, O; Pikaard, CS			Plant nuclear RNA polymerase IV mediates siRNA and DNA methylation-dependent heterochromatin formation	CELL			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION; METHYLTRANSFERASES; PURIFICATION; CHROMOSOMES; ARGONAUTE4; HOLOENZYME; RESOLUTION; GENES; DRM	All eukaryotes have three nuclear DNA-dependent RNA polymerases, namely, Pol I, II, and III. Interestingly, plants have catalytic subunits for a fourth nuclear polymerase, Pol IV. Genetic and biochemical evidence indicates that Pol IV does not functionally overlap with Pol I, II, or III and is nonessential for viability. However, disruption of the Pol IV catalytic subunit genes NRPD1 or NRPD2 inhibits heterochromatin association into chromocenters, coincident with losses in cytosine methylation at pericentromeric 5S gene clusters and AtSN1 retroelements. Loss of CG, CNG, and CNN methylation in Pol IV mutants implicates a partnership between Pol IV and the methyltransferase responsible for RNA-directed de novo methylation. Consistent with this hypothesis, 5S gene and AtSN1 siRNAs are essentially eliminated in Pol IV mutants. The data suggest that Pol IV helps produce siRNAs that target de novo cytosine methylation events required for facultative heterochromatin formation and higher-order heterochromatin associations.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Hokkaido Univ, Fac Agr, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; Inst Super Agron, Ctr Bot & Engn Biol, Seccao Genet, P-1349017 Lisbon, Portugal	Washington University (WUSTL); Hokkaido University; Universidade de Lisboa	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pontes, Olga MF/F-9768-2011; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Pikaard, Craig S/0000-0001-8204-7459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM60380] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; CAMPELL BR, 1992, GENE, V112, P225, DOI 10.1016/0378-1119(92)90380-8; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; HERR A, 2005, IN PRESS SCIENC 0203, DOI DOI 10.1126/SCIENCE.1106910; Houben A, 1996, CHROMOSOME RES, V4, P191, DOI 10.1007/BF02254958; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Larkin RM, 1999, GENE, V231, P41, DOI 10.1016/S0378-1119(99)00090-6; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Saez-Vasquez J, 2000, J BIOL CHEM, V275, P37173, DOI 10.1074/jbc.M006057200; SaezVasquez J, 1997, P NATL ACAD SCI USA, V94, P11869, DOI 10.1073/pnas.94.22.11869; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5898; Schwarzacher HG, 2000, CYTOGENET CELL GENET, V91, P243, DOI 10.1159/000056853; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	36	485	510	4	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					613	622		10.1016/j.cell.2005.02.007	http://dx.doi.org/10.1016/j.cell.2005.02.007			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766525	Bronze			2022-12-01	WOS:000227771400008
J	Takaoka, A; Yanai, H; Kondo, S; Duncan, G; Negishi, H; Mizutani, T; Kano, S; Honda, K; Ohba, Y; Mak, TW; Taniguchi, T				Takaoka, A; Yanai, H; Kondo, S; Duncan, G; Negishi, H; Mizutani, T; Kano, S; Honda, K; Ohba, Y; Mak, TW; Taniguchi, T			Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; DIFFERENTIAL REGULATION; HOST-DEFENSE; STRANDED-RNA; CPG MOTIFS; KAPPA-B; MYD88; DNA; IMMUNITY; INNATE	The activation of Toll-like receptors (TLRs) is central to innate and adaptive immunity(1-3). All TLRs use the adaptor MyD88 for signalling(4), but the mechanisms underlying the MyD88-mediated gene induction programme are as yet not fully understood. Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-alpha. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5(-/-) mice), the induction of these cytokines by various TLR ligands is severely impaired, whereas interferon-alpha induction is normal. We also provide evidence that IRF-5 interacts with and is activated by MyD88 and TRAF6, and that TLR activation results in the nuclear translocation of IRF-5 to activate cytokine gene transcription. Consistently, Irf5(-/-) mice show resistance to lethal shock induced by either unmethylated DNA or lipopolysaccharide, which correlates with a marked decrease in the serum levels of proinflammatory cytokines. Thus, our study identifies IRF-5 as a new, principal downstream regulator of the TLR-MyD88 signalling pathway and a potential target of therapeutic intervention to control harmful immune responses.	Univ Toronto, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; JST, PRESTO, Informat & Cell Funct, Kawaguchi, Saitama 3320012, Japan	University of Toronto; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Mak, TW (corresponding author), Univ Toronto, Campbell Family Inst Breast Canc Res, 610 Univ Ave,Room 7-411, Toronto, ON M5G 2M9, Canada.	tmak@uhnres.utroronto.ca; tada@m.u-tokyo.ac.jp	Mizutani, Tatsuaki/AAA-5044-2021; Kano, Shinichi/F-4144-2015; Honda, Kenya/N-5297-2015; Yanai, Hideyuki/AGK-5933-2022; Ohba, Yusuke/E-7944-2011	Mizutani, Tatsuaki/0000-0002-4323-4347; Kano, Shinichi/0000-0002-5171-3436; Yanai, Hideyuki/0000-0002-0115-9000; 				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alvarez M, 2003, GENE, V313, P43, DOI 10.1016/S0378-1119(03)00627-9; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Cowdery JS, 1999, J IMMUNOL, V162, P6770; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; LIN R, IN PRESS J BIOL CHEM; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738	30	742	783	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					243	249		10.1038/nature03308	http://dx.doi.org/10.1038/nature03308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15665823				2022-12-01	WOS:000227494500052
J	Cerdeno-Tarraga, AM; Patrick, S; Crossman, LC; Blakely, G; Abratt, V; Lennard, N; Poxton, I; Duerden, B; Harris, B; Quail, MA; Barron, A; Clark, L; Corton, C; Doggett, J; Holden, MTG; Larke, N; Line, A; Lord, A; Norbertczak, H; Ormond, D; Price, C; Rabbinowitsch, E; Woodward, J; Barrell, B; Parkhill, J				Cerdeno-Tarraga, AM; Patrick, S; Crossman, LC; Blakely, G; Abratt, V; Lennard, N; Poxton, I; Duerden, B; Harris, B; Quail, MA; Barron, A; Clark, L; Corton, C; Doggett, J; Holden, MTG; Larke, N; Line, A; Lord, A; Norbertczak, H; Ormond, D; Price, C; Rabbinowitsch, E; Woodward, J; Barrell, B; Parkhill, J			Extensive DNA inversions in the B. fragilis genome control variable gene expression	SCIENCE			English	Article							BACTEROIDES-FRAGILIS; ANTIGENIC VARIATION; POLYSACCHARIDES; SALMONELLA	The obligately anaerobic bacterium Bacteroides fragilis, an opportunistic pathogen and inhabitant,of the normal human colonic microbiota, exhibits considerable within-strain phase and antigenic variation of surface components. The complete genome sequence has revealed an unusual breadth (in number and in effect) of DNA inversion events that potentially control expression of man different components, including surface and secreted components, regulatory molecules, and restriction-modification proteins. Invertible promoters of two different types (12 group 1 and 11 group 2) were identified. One group has inversion crossover (fix) sites similar to the hix sites of Salmonella typhimurium. There are also four independent intergenic shufflons that potentially alter the expression and function of varied genes. The composition of the 10 different polysaccharide biosynthesis gene clusters identified (7 with associated invertible promoters) suggests a mechanism of synthesis similar to the O-antigen capsules of Escherichia coli.	Queens Univ Belfast, Sch Med, Dept Microbiol & Immunobiol, Belfast BT12 6BN, Antrim, North Ireland; Sanger Inst, Cambridge CB10 1SA, England; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Cape Town, Dept Mol & Cell Biol, ZA-7701 Rondebosch, South Africa; Univ Edinburgh, Sch Med, Div Med Microbiol, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Wales Coll Med, Dept Med Microbiol, Cardiff CF14 4XN, S Glam, Wales	Queens University Belfast; Wellcome Trust Sanger Institute; University of Edinburgh; University of Cape Town; University of Edinburgh; Cardiff University	Patrick, S (corresponding author), Queens Univ Belfast, Sch Med, Dept Microbiol & Immunobiol, Grosvenor Rd, Belfast BT12 6BN, Antrim, North Ireland.	s.patrick@qub.ac.uk; parkhill@sanger.ac.uk	Quail, michael/ABE-6131-2020; Parkhill, Julian/G-4703-2011; Holden, Matthew TG/K-6449-2014	Parkhill, Julian/0000-0002-7069-5958; Holden, Matthew TG/0000-0002-4958-2166; Crossman, Lisa/0000-0003-2390-4750; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237				Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Gyohda A, 2004, ADV BIOPHYS, V38, P183, DOI 10.1016/S0065-227X(04)80166-7; Horino A, 2003, J BACTERIOL, V185, P231, DOI 10.1128/JB.185.1.231-242.2003; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; LINDBERG AA, 1990, REV INFECT DIS, V12, P133; LUTTON DA, 1991, J MED MICROBIOL, V35, P229, DOI 10.1099/00222615-35-4-229; Patrick S., 2002, Molecular medical microbiology: Volumes 1-3, P1921; Patrick S, 1999, INFECT IMMUN, V67, P4346, DOI 10.1128/IAI.67.9.4346-4351.1999; PATRICK S, 1986, J GEN MICROBIOL, V132, P1099; Patrick S, 2003, MICROBIOL-SGM, V149, P915, DOI 10.1099/mic.0.26166-0; POXTON IR, 1986, J GEN MICROBIOL, V132, P2475; SILVERMAN M, 1979, P NATL ACAD SCI USA, V76, P391, DOI 10.1073/pnas.76.1.391; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	18	205	530	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1463	1465		10.1126/science.1107008	http://dx.doi.org/10.1126/science.1107008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746427	Green Submitted			2022-12-01	WOS:000227503100046
J	Gombosi, TI; Hansen, KC				Gombosi, TI; Hansen, KC			Viewpoint - Saturn's variabie magnetosphere	SCIENCE			English	Editorial Material								Since the Cassini spacecraft reached Saturn's orbit in 2004, its instruments have been sending back a wealth of data on the planet's magnetosphere (the region dominated by the magnetic field of the planet). In this Viewpoint, we discuss some of these results, which are reported in a collection of reports in this issue. The magnetosphere is shown to be highly variable and influenced by the planet's rotation, sources of plasma within the planetary system, and the solar wind. New insights are also gained into the chemical composition of the magnetosphere, with surprising results. These early results from Cassini's first orbit around Saturn bode well for the future as the spacecraft continues to orbit the planet.	Univ Michigan, Dept Atmospher Ocean & Space Sci, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Gombosi, TI (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA.	tamas@umich.edu; kenhan@umich.edu	Hansen, Kenneth C/F-3693-2011; Gombosi, Tamas I/G-4238-2011	Hansen, Kenneth C/0000-0002-8502-1980; Gombosi, Tamas I/0000-0001-9360-4951				Blanc M, 2002, SPACE SCI REV, V104, P253, DOI 10.1023/A:1023605110711; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; JURAC S, IN PRESS J GEOPHYS R; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; Powell KG, 1999, J COMPUT PHYS, V154, P284, DOI 10.1006/jcph.1999.6299; Sanchez-Lavega A, 2005, SCIENCE, V307, P1223, DOI 10.1126/science.1104956; Waite JH, 2005, SCIENCE, V307, P1260, DOI 10.1126/science.1105734; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	10	10	10	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1224	1226		10.1126/science.1108226	http://dx.doi.org/10.1126/science.1108226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731438				2022-12-01	WOS:000227313200037
J	Kelly, JW				Kelly, JW			Attacking amyloid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE; INHIBITORS		Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.							Findeis MA, 2000, BBA-MOL BASIS DIS, V1502, P76, DOI 10.1016/S0925-4439(00)00034-X; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a	5	21	21	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2005	352	7					722	723		10.1056/NEJMcibr044231	http://dx.doi.org/10.1056/NEJMcibr044231			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897UO	15716569				2022-12-01	WOS:000227031100015
J	McGhee, SM; Ho, SY; Schooling, M; Ho, LM; Thomas, GN; Hedley, AJ; Mak, KH; Peto, R; Lam, TH				McGhee, SM; Ho, SY; Schooling, M; Ho, LM; Thomas, GN; Hedley, AJ; Mak, KH; Peto, R; Lam, TH			Mortality associated with passive smoking in Hong Kong	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STROKE; COHORT; RISK		Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Student Hlth Serv, Kowloon, Hong Kong, Peoples R China; Univ Oxford, Nuffield Dept Clin Med, Oxford OX2 6HE, England	University of Hong Kong; University of Oxford	Lam, TH (corresponding author), Univ Hong Kong, Dept Community Med, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Hedley, Anthony J/A-9113-2013; Thomas, G. Neil/A-1879-2013; McGhee, Sarah M/A-6460-2013; McGhee, Sarah/C-4367-2009; Hedley, Anthony/C-4305-2009; Schooling, Catherine Mary/C-4386-2009; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Thomas, G. Neil/0000-0002-2777-1847; McGhee, Sarah M/0000-0003-1025-5915; ho, lm/0000-0002-2709-927X; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971; Ho, Daniel Sai Yin/0000-0001-9485-0273				Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; Hill SE, 2004, BMJ-BRIT MED J, V328, P988, DOI 10.1136/bmj.38070.503009.EE; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; KAY R, 1992, NEUROLOGY, V42, P985, DOI 10.1212/WNL.42.5.985; Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361	5	50	53	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2005	330	7486					287	288		10.1136/bmj.38342.706748.47	http://dx.doi.org/10.1136/bmj.38342.706748.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895EM	15677632	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000226843700016
J	Reimann, S; Manning, AJ; Simmonds, PG; Cunnold, DM; Wang, RHJ; Li, JL; McCulloch, A; Prinn, RG; Huang, J; Weiss, RF; Fraser, PJ; O'Doherty, S; Greally, BR; Stemmler, K; Hill, M; Folini, D				Reimann, S; Manning, AJ; Simmonds, PG; Cunnold, DM; Wang, RHJ; Li, JL; McCulloch, A; Prinn, RG; Huang, J; Weiss, RF; Fraser, PJ; O'Doherty, S; Greally, BR; Stemmler, K; Hill, M; Folini, D			Low European methyl chloroform emissions inferred from long-term atmospheric measurements	NATURE			English	Article							TROPOSPHERIC OH; TRACE GASES; VARIABILITY; HYDROXYL; HISTORY; TRENDS	Methyl chloroform (CH3CCl3, 1,1,1,-trichloroethane) was used widely as a solvent before it was recognized to be an ozone-depleting substance and its phase-out was introduced under the Montreal Protocol(1). Subsequently, its atmospheric concentration has declined steadily(2-4) and recent European methyl chloroform consumption and emissions were estimated to be less than 0.1 gigagrams per year(1,5). However, data from a short-term tropospheric measurement campaign ( EXPORT) indicated that European methyl chloroform emissions could have been over 20 gigagrams in 2000 (ref. 6), almost doubling previously estimated global emissions(1,4). Such enhanced emissions would significantly affect results from the CH3CCl3 method of deriving global abundances of hydroxyl radicals ( OH) (refs 7 - 12) - the dominant reactive atmospheric chemical for removing trace gases related to air pollution, ozone depletion and the greenhouse effect. Here we use long-term, high-frequency data from MaceHead, Ireland and Jungfraujoch, Switzerland, to infer European methyl chloroform emissions. We find that European emission estimates declined from about 60 gigagrams per year in the mid-1990s to 0.3 - 1.4 and 1.9 - 3.4 gigagrams per year in 2000 - 03, based on Mace Head and Jungfraujoch data, respectively. Our European methyl chloroform emission estimates are therefore higher than calculated from consumption data(1,5), but are considerably lower than those derived from the EXPORT campaign in 2000 ( ref. 6).	Empa, Inst Mat Sci & Technol, CH-8600 Dubendorf, Switzerland; Met Off, Exeter EX1 3PB, Devon, England; Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; CSIRO, PMBI, Aspendale, Vic 3195, Australia	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Met Office - UK; University of Bristol; University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Scripps Institution of Oceanography; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Reimann, S (corresponding author), Empa, Inst Mat Sci & Technol, Ueberlandstr 129, CH-8600 Dubendorf, Switzerland.	stefan.reimann@empa.ch	Reimann, Stefan/A-2327-2009; Fraser, Paul J. B./D-1755-2012	Reimann, Stefan/0000-0002-9885-7138; 				Cunnold DM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001226; Forrer J, 2000, J GEOPHYS RES-ATMOS, V105, P12241, DOI 10.1029/1999JD901178; Gros V, 2003, ATMOS CHEM PHYS, V3, P1223, DOI 10.5194/acp-3-1223-2003; Krol M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002423; Krol M, 1998, J GEOPHYS RES-ATMOS, V103, P10697, DOI 10.1029/98JD00459; Krol MC, 2003, NATURE, V421, P131, DOI 10.1038/nature01311; Manning AJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002312; McCulloch A, 2001, ATMOS ENVIRON, V35, P5311, DOI 10.1016/S1352-2310(01)00306-5; MIDGLEY PM, 1995, ATMOS ENVIRON, V29, P1601, DOI 10.1016/1352-2310(95)00078-D; Montzka SA, 1999, NATURE, V398, P690, DOI 10.1038/19499; Montzka SA, 2000, SCIENCE, V288, P500, DOI 10.1126/science.288.5465.500; MONTZKA SA, 2003, 47 WMO GLOB OZ RES M; O'Doherty S, 2001, J GEOPHYS RES-ATMOS, V106, P20429, DOI 10.1029/2000JD900792; Prinn RG, 2001, SCIENCE, V292, P1882, DOI 10.1126/science.1058673; PRINN RG, 1995, SCIENCE, V269, P187, DOI 10.1126/science.269.5221.187; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Reimann S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003923; Ryall DB, 2001, ATMOS ENVIRON, V35, P2507, DOI 10.1016/S1352-2310(00)00433-7; Spivakovsky CM, 2000, J GEOPHYS RES-ATMOS, V105, P8931, DOI 10.1029/1999JD901006; UNEP, 2003, 15 M PART MONTR PROT; UNEP ( United Nations Environment Programme), 2002, PROD CONS OZ DEPL SU; VESTRENG V, 2004, 12004 EMEPEEA EMEPMS	22	47	51	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					506	508		10.1038/nature03220	http://dx.doi.org/10.1038/nature03220			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690037				2022-12-01	WOS:000226727200044
J	Kern, LM; Powe, NR; Levine, MA; Fitzpatrick, AL; Harris, TB; Robbins, J; Fried, LP				Kern, LM; Powe, NR; Levine, MA; Fitzpatrick, AL; Harris, TB; Robbins, J; Fried, LP			Association between screening for osteoporosis and the incidence of hip fracture	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	25th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 01-05, 2002	ATLANTA, GA	Soc Gen Internal Med			POSTMENOPAUSAL OSTEOPOROSIS; BONE-DENSITY; VITAMIN-D; NONVERTEBRAL FRACTURES; RISK; WOMEN; ALENDRONATE; RISEDRONATE; PREVENTION; OUTCOMES	Background: Because direct evidence for the effectiveness of screening is lacking, guidelines disagree on whether people should be screened for osteoporosis. Objective: To determine whether population-based screening for osteoporosis in older adults is associated with fewer incident hip fractures than usual medical care. Design: Nonconcurrent cohort study. Setting: Population-based cohort enrolled in the Cardiovascular Health Study (CHS) from 4 states (California, Pennsylvania, Maryland, and North Carolina). Patients: 3107 adults 65 years of age and older who attended their CHS study visits in 1994-1995. Measurements: 31 participant characteristics (including demographic characteristics, medical histories, medications, and physical examination findings) and incident hip fractures over 6 years of follow-up. Intervention: Bone density scans (dual-energy x-ray absorptiometry [DEXA] at the hip) for participants in California and Pennsylvania (n = 1422) and usual care for participants in Maryland and North Carolina (n = 1685). Results: The incidence of hip fractures per 1000 person-years was 4.8 in the screened group and 8.2 in the usual care group. Screening was associated with a statistically significant lower hazard of hip fracture than usual care after adjustment for sex and propensity to be screened (Cox proportional hazard ratio, 0.64 [95% CI, 0.41 to 0.99]). Limitations: The mechanism of the association was unclear. A small unmeasured confounder that decreased the hazard of hip fracture could diminish or erase the observed association. Conclusions: Use of hip DEXA scans to screen for osteoporosis in older adults was associated with 36% fewer incident hip fractures over 6 years compared with usual medical care. Further research is needed to explore the mechanism of this association.	Johns Hopkins Bloomberg Sch Publ Hlth, Sch Med, Robert Wood Johnson Clin Scholars Program, Baltimore, MD USA; Univ Washington, Seattle, WA 98195 USA; Univ Calif Davis, Sacramento, CA 95817 USA; NIA, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kern, LM (corresponding author), Cornell Univ, Weill Med Coll, Dept Publ Hlth, 411 E 69th St,Room KB-311, New York, NY 10021 USA.	lmk2003@med.cornell.edu	Kern, Lisa/AAI-9781-2021	Kern, Lisa/0000-0003-1191-8100; Levine, Michael/0000-0003-0036-7809	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085080, N01HC085081, N01HC035129, N01HC085079, N01HC085084, N01HC085083, N01HC085085, N01HC015103, N01HC085086, N01HC085082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002643] Funding Source: NIH RePORTER; NHLBI NIH HHS [1-Y02-HC-40205, N01-HC-85086, N01-HC-85085, N01-HC-15103, N01-HC-35129, N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-HC-85082, N01-HC-85083, N01-HC-85084] Funding Source: Medline; NIA NIH HHS [Y02-AG-4-0251] Funding Source: Medline; NIDDK NIH HHS [K24DK02643] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Carlin JB, 2003, STATA J, V3, P226, DOI 10.1177/1536867X0300300302; *CTR DRUG EV RES F, 2004, EL OR BOOK APPR DRUG; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gillespie LD, 2002, COCHRANE LIB; Guo ZC, 1998, AM J EPIDEMIOL, V148, P887; Guyatt GH, 2002, ENDOCRIN METAB CLIN, V31, P659, DOI 10.1016/S0889-8529(02)00024-5; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HONAKER J, 2001, AMELIA PROGR MISSING; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MCPHILLIPS JB, 1989, AM J PREV MED, V5, P65, DOI 10.1016/S0749-3797(18)31107-3; *MED PREV SERV, 2004, OST DIAB PROST CANC; *NAT OS FDN, 2003, PHYS GUID PREV TREAT; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Rodriguez-Martinez MA, 2002, PHARMACOL THERAPEUT, V93, P37, DOI 10.1016/S0163-7258(02)00164-X; Rosenbaum PR, 1998, ENCY BIOSTATISTICS, V5, P3551; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Stevens JA, 2000, MMWR-MORBID MORTAL W, V49, P1; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; *U CAL CHS BON DEN, 1994, CARD HLTH STUD DXA Q; van Staa TP, 2001, JAMA-J AM MED ASSOC, V285, P1850, DOI 10.1001/jama.285.14.1850; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211	42	71	72	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2005	142	3					173	181		10.7326/0003-4819-142-3-200502010-00007	http://dx.doi.org/10.7326/0003-4819-142-3-200502010-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	900UH	15684205				2022-12-01	WOS:000227239300003
J	Ellman, T; Culbert, H; Torres-Feced, V				Ellman, T; Culbert, H; Torres-Feced, V			Treatment of AIDS in conflict-affected settings: a failure of imagination	LANCET			English	Editorial Material									Med Sans Frontieres, London WC1R 5DJ, England	Doctors Without Borders	Ellman, T (corresponding author), Med Sans Frontieres, London WC1R 5DJ, England.	tom.ellman@msf.org						CHAIX ML, 2004, ANTIVIR THER, V9, pS176; Hankins CA, 2002, AIDS, V16, P2245, DOI 10.1097/00002030-200211220-00003; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Hehenkamp A, 2003, LANCET, V362, pS30, DOI 10.1016/S0140-6736(03)15066-0; *HUM RIGHTS WATCH, 1995, RAP WEAP WAR TOL P; *INT CRIS GROUP, 2004, HIV AIDS SEC ISS AFR; *INT CRIS GROUP, 2004, ICG CRIS WATCH; International Crisis Group, 2001, HIV AIDS SEC ISS; Tangermann RH, 2000, B WORLD HEALTH ORGAN, V78, P330; *UNAIDS, 1998, AIDS MIL; 2004, INT AIDS C BANGK THA	11	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 22	2005	365	9456					278	280						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664207				2022-12-01	WOS:000226449600008
J	Edwards, AO; Ritter, R; Abel, KJ; Manning, A; Panhuysen, C; Farrer, LA				Edwards, AO; Ritter, R; Abel, KJ; Manning, A; Panhuysen, C; Farrer, LA			Complement factor H polymorphism and age-related macular degeneration	SCIENCE			English	Article							C-REACTIVE PROTEIN; GENOMEWIDE-SCAN; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; ASSOCIATION; MACULOPATHY; ACTIVATION; DISEASE; LINKAGE; GLOMERULONEPHRITIS	Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association (P = 4.95 x 10(-10)) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 --> histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.	Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA; Sequenom Inc, San Diego, CA 92121 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Genet Program, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Sequenom; Boston University; Boston University; Boston University; Boston University; Boston University	Edwards, AO (corresponding author), Inst Retina Res, 3215 Princess Lane, Dallas, TX 75229 USA.	albert-edwards@swbell.net	Mohammed, Imran/J-8271-2012; Farrer, Lindsay/AAS-1035-2020; Manning, Alisa Knodle/ABC-7711-2021	Mohammed, Imran/0000-0002-8412-0768; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Acosta J, 2004, CURR PHARM DESIGN, V10, P203, DOI 10.2174/1381612043453441; Backes JM, 2004, ANN PHARMACOTHER, V38, P110, DOI 10.1345/aph.1D203; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dragon-Durey MA, 2004, J AM SOC NEPHROL, V15, P787, DOI 10.1097/01.ASN.0000115702.28859.A7; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wener MH, 2000, J RHEUMATOL, V27, P2351; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636	28	1887	2040	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					421	424		10.1126/science.1110189	http://dx.doi.org/10.1126/science.1110189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761121				2022-12-01	WOS:000228492000056
J	Pluta, RM; Dejam, A; Grimes, G; Gladwin, MT; Oldfield, EH				Pluta, RM; Dejam, A; Grimes, G; Gladwin, MT; Oldfield, EH			Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRAVENTRICULAR SODIUM-NITROPRUSSIDE; OXIDE SYNTHASE ACTIVITY; CEREBROSPINAL-FLUID; BLOOD-FLOW; INTRAVENOUS NITROGLYCERIN; ENDOTHELIAL DYSFUNCTION; S-NITROSOHEMOGLOBIN; HYPOXIC CONDITIONS; GUANYLATE-CYCLASE; ANEURYSM-SURGERY	Context Delayed cerebral vasospasm causes permanent neurological deficits or death in at least 15% of patients following otherwise successful treatment for ruptured intracranial aneurysm. Decreased bioavailability of nitric oxide has been associated with the development of cerebral vasospasm. Objective To determine whether infusions of nitrite will prevent delayed cerebral vasospasm. Design, Setting, and Subjects A total of 14 anesthetized cynomolgus monkeys had an autologous blood clot placed around the right middle cerebral artery. Cerebral arteriography was performed before clot placement and on days 7 and 14 to assess vasospasm. The study was conducted from August 2003 to February 2004. Interventions A 90-mg sodium nitrite intravenous solution infused over 24 hours plus a 45-mg sodium nitrite bolus daily (n=31); a 180-mg sodium nitrite intravenous solution infused over 24 hours (n=3); or a control saline solution infusion (n=8). Each was infused continuously for 14 days. Main Outcome Measures Nitrite, S-nitrosothiol, and methemoglobin levels in blood and cerebrospinal fluid and degree of arteriographic vasospasm. Results In control monkeys, mean (SD) cerebrospinal fluid nitrite levels decreased from 3.1 (1.5) mu mol/L to 0.4 (0.1) mu mol/L at day 7 and to 0.4 (0.4) mu mol/L at day 14 (P=.03). All 8 control monkeys developed significant vasospasm of the right middle cerebral artery which was complicated by stroke and death in I animal. Sodium nitrite infusions increased the nitrite and methemoglobin levels (<2.1% of total hemoglobin) in the blood and cerebrospinal fluid without evoking systemic hypotension. Nitrite infusion prevented development of vasospasm (no animals developed significant vasospasm; mean [SD] reduction in right middle cerebral artery area on day 7 after subarachnoid hemorrhage of 8% [9%] in nitrite-treated monkeys vs 47% [5%] in saline-treated controls; P<.001). There was a negative correlation between the concentration of nitrite in cerebrospinal fluid and the degree of cerebral vasospasm (P<.001). Pharmacological effects of nitrite infusion were also associated with the formation of S-nitrosothiol in cerebrospinal fluid. There was no clinical or pathological evidence of nitrite toxicity. Conclusion Subacute sodium nitrite infusions prevented delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage.	NINDS, Surg Neurol Branch, Bethesda, MD 20892 USA; NIDDKD, Biol Chem Lab, Bethesda, MD 20892 USA; NHLBI, Dept Pharm, Ctr Clin, Vasc Therapeut Sect,Cardiovasc Branch, Bethesda, MD 20892 USA; NIH, Dept Crit Care Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA	Pluta, RM (corresponding author), NINDS, Surg Neurol Branch, 10 Ctr Dr,Room 5D37, Bethesda, MD 20892 USA.	rysiek@ninds.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002854] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AFSHAR JKB, 1995, J NEUROSURG, V83, P118, DOI 10.3171/jns.1995.83.1.0118; Asano T, 1999, CRIT REV NEUROSURG, V9, P303, DOI 10.1007/s003290050147; BAETMANN A, 1985, CEREBRAL VASCULAR SP, P209; BARKOVICH AJ, 1988, RADIOL CLIN N AM, V26, P801; BROWN FD, 1977, SURG NEUROL, V7, P67; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; BURNETT M, 2004, MANAGEMENT CEREBRAL, P127; Clark JF, 2002, J CEREBR BLOOD F MET, V22, P472, DOI 10.1097/00004647-200204000-00011; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dejam A, 2004, BLOOD CELL MOL DIS, V32, P423, DOI 10.1016/j.bcmd.2004.02.002; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; EGEMEN N, 1993, NEUROL RES, V15, P310; ESPINOSA F, 1984, J NEUROSURG, V60, P1167, DOI 10.3171/jns.1984.60.6.1167; FRAZEE JG, 1981, J NEUROSURG, V55, P865, DOI 10.3171/jns.1981.55.6.0865; Gabikian P, 2002, STROKE, V33, P2681, DOI 10.1161/01.STR.0000033931.62992.B1; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gladwin MT, 2002, J BIOL CHEM, V277, P27818, DOI 10.1074/jbc.M203236200; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; HASHI K, 1972, J NEUROL SCI, V17, P1, DOI 10.1016/0022-510X(72)90016-0; Heros R C, 1976, Surg Neurol, V6, P227; HEROS RC, 1983, ANN NEUROL, V14, P599, DOI 10.1002/ana.410140602; Hino A, 1996, NEUROSURGERY, V39, P562, DOI 10.1097/00006123-199609000-00026; Hunter CJ, 2004, NAT MED, V10, P1122, DOI 10.1038/nm1109; IGNARRO LJ, 1980, BIOCHIM BIOPHYS ACTA, V631, P221, DOI 10.1016/0304-4165(80)90297-4; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; Ito Y, 2000, J CARDIOVASC PHARM, V35, P45, DOI 10.1097/00005344-200001000-00006; Iuliano BA, 2004, J NEUROSURG, V100, P287, DOI 10.3171/jns.2004.100.2.0287; Jung CS, 2004, J NEUROSURG, V101, P836, DOI 10.3171/jns.2004.101.5.0836; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KASSELL NF, 1984, STROKE, V15, P566, DOI 10.1161/01.STR.15.3.566; KASUYA H, 1995, J NEUROSURG, V82, P250, DOI 10.3171/jns.1995.82.2.0250; Khaldi A, 2001, NEUROSURGERY, V49, P33; KIM P, 1990, CEREBRAL VASOSPASM, P83; KISTLER JP, 1979, STROKE, V10, P26, DOI 10.1161/01.STR.10.1.26; Kranc KR, 2000, EUR J BIOCHEM, V267, P7094, DOI 10.1046/j.1432-1327.2000.01812.x; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; Macdonald RL, 2001, CEREBRAL VASOSPASM; Meyer F B, 1990, Neurosurg Clin N Am, V1, P367; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nakao K, 1996, STROKE, V27, P1882, DOI 10.1161/01.STR.27.10.1882; Ng WH, 2001, NEUROSURGERY, V49, P622, DOI 10.1097/00006123-200109000-00016; NISHIZAWA S, 1995, STROKE, V26, P1916, DOI 10.1161/01.STR.26.10.1916; PAKARINEN S, 1967, ACTA NEUROL SCAND  S, V29, P1; Park KW, 2001, ANESTH ANALG, V92, P990; PAULSON OB, 1970, NEUROLOGY, V20, P63, DOI 10.1212/WNL.20.1.63; PLUTA R, 2004, VAS P 8 INT C NEW YO, P71; Pluta RM, 1998, J NEUROSURG, V88, P557, DOI 10.3171/jns.1998.88.3.0557; PLUTA RM, 1992, J NEUROSURG, V77, P740, DOI 10.3171/jns.1992.77.5.0740; Pluta RM, 1996, J NEUROSURG, V84, P648, DOI 10.3171/jns.1996.84.4.0648; Pluta RM, 2001, ACT NEUR S, V77, P67; Pluta RM, 1997, J NEUROSURG, V87, P746, DOI 10.3171/jns.1997.87.5.0746; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Polin RS, 1998, NEUROSURGERY, V42, P1256, DOI 10.1097/00006123-199806000-00031; Raabe A, 2002, NEUROSURGERY, V50, P1006, DOI 10.1097/00006123-200205000-00013; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sadamitsu D, 2001, CRIT CARE MED, V29, P77, DOI 10.1097/00003246-200101000-00018; Sakowitz OW, 2001, J CEREBR BLOOD F MET, V21, P1067, DOI 10.1097/00004647-200109000-00004; SAMBROOK MA, 1973, BRAIN, V96, P171, DOI 10.1093/brain/96.1.171; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; SHIMODA M, 1993, J NEUROSURG, V78, P423, DOI 10.3171/jns.1993.78.3.0423; Suzuki M, 1999, NEUROSURG REV, V22, P96, DOI 10.1007/s101430050038; Thomas JE, 1999, NEUROSURGERY, V44, P48, DOI 10.1097/00006123-199901000-00026; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TODA N, 1993, CIRC RES, V72, P206, DOI 10.1161/01.RES.72.1.206; Treggiari-Venzi MM, 2001, NEUROSURGERY, V48, P249, DOI 10.1097/00006123-200102000-00001; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; Weyerbrock A, 2003, J NEUROSURG, V99, P728, DOI 10.3171/jns.2003.99.4.0728; Woszczyk A, 2003, ACTA NEUROCHIR, V145, P257, DOI 10.1007/s00701-003-0004-7; Yamamoto S, 1997, BRAIN RES, V757, P1, DOI 10.1016/S0006-8993(96)01433-3; Yang BK, 2003, FREE RADICAL RES, V37, P1, DOI 10.1080/1071576021000033112; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	79	211	218	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1477	1484		10.1001/jama.293.12.1477	http://dx.doi.org/10.1001/jama.293.12.1477			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784871	Bronze			2022-12-01	WOS:000227784700027
J	Head, JW; Neukum, G; Jaumann, R; Hiesinger, H; Hauber, E; Carr, M; Masson, P; Foing, B; Hoffmann, H; Kreslavsky, M; Werner, S; Milkovich, S; van Gasselt, S				Head, JW; Neukum, G; Jaumann, R; Hiesinger, H; Hauber, E; Carr, M; Masson, P; Foing, B; Hoffmann, H; Kreslavsky, M; Werner, S; Milkovich, S; van Gasselt, S		HRSC Co-Investigator Team	Tropical to mid-latitude snow and ice accumulation, flow and glaciation on Mars	NATURE			English	Article							ROCK GLACIERS; EVOLUTION; FEATURES; DEBRIS	Images from the Mars Express HRSC (High-Resolution Stereo Camera) of debris aprons at the base of massifs in eastern Hellas reveal numerous concentrically ridged lobate and pitted features and related evidence of extremely ice-rich glacier-like viscous flow and sublimation. Together with new evidence for recent ice-rich rock glaciers at the base of the Olympus Mons scarp superposed on larger Late Amazonian debris-covered piedmont glaciers, we interpret these deposits as evidence for geologically recent and recurring glacial activity in tropical and mid-latitude regions of Mars during periods of increased spin-axis obliquity when polar ice was mobilized and redeposited in microenvironments at lower latitudes. The data indicate that abundant residual ice probably remains in these deposits and that these records of geologically recent climate changes are accessible to future automated and human surface exploration.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; DLR, Inst Planetenforsch, D-12489 Berlin, Germany; US Geol Survey, Menlo Pk, CA 94025 USA; Orsay Terre, F-91405 Orsay, France; ESTEC, SCISR, NL-2200 AG Noordwijk, Netherlands	Brown University; Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); United States Department of the Interior; United States Geological Survey; European Space Agency	Head, JW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	james_head@brown.edu	van Gasselt, Stephan/L-9762-2013; Hauber, Ernst/U-2521-2018; Werner, Stephanie C/A-6438-2012; Jaumann, Ralf/N-1001-2018; Kreslavsky, Mikhail/J-3425-2013	van Gasselt, Stephan/0000-0003-2130-6343; Hauber, Ernst/0000-0002-1375-304X; Werner, Stephanie C/0000-0001-5704-0909; Jaumann, Ralf/0000-0002-9759-6597; Kreslavsky, Mikhail/0000-0002-1900-826X				BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Baratoux D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013779; BENN DI, 1998, GLACIERS GLACIATION, P237; Boulton GS, 1971, TILL S, P41; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; Eyles N., 1978, J GLACIOL, V20, P99, DOI [10.3189/S0022143000021249, DOI 10.1017/S0022143000021249]; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Grove JM, 1988, LITTLE ICE AGE; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; HARTSHORN JH, 1952, GEOL SOC AM BULL, V63, P1259; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Head JW, 2003, GEOLOGY, V31, P641, DOI 10.1130/0091-7613(2003)031<0641:CMGOMW>2.0.CO;2; HEAD JW, 2003, 3 MARS POL C; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; JOHNSON PG, 1980, ARCTIC ALPINE RES, V12, P195, DOI 10.2307/1550516; KARGEL JS, 1992, GEOLOGY, V20, P3, DOI 10.1130/0091-7613(1992)020<0003:AGOM>2.3.CO;2; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; Mangold N, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001885; Mangold N, 2002, PLANET SPACE SCI, V50, P385, DOI 10.1016/S0032-0633(02)00005-3; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MARTIN HE, 1987, PROG PHYS GEOG, V11, P260; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; MILKOVICH SM, 2003, 6 INT MARS C; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; MORRIS EC, 1994, MISC INV SER US GEOL; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Neukum G., 2004, MARS EXPRESS SCI PAY, V1240, P17; Pierce TL, 2003, ICARUS, V163, P46, DOI 10.1016/S0019-1035(03)00046-0; POTTER N, 1984, J GEOL EDUC, V32, P226, DOI 10.5408/0022-1368-32.4.226; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001536; SHEAN DE, 2004, LUNAR PLANET SCI, V35; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; SQUYRES SW, 1978, ICARUS, V34, P600, DOI 10.1016/0019-1035(78)90048-9; WARREN CR, 1995, GEOGR REV, V8, P2	38	253	256	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					346	351		10.1038/nature03359	http://dx.doi.org/10.1038/nature03359			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772652				2022-12-01	WOS:000227715100042
J	Kraemer, DJM; Macrae, CN; Green, AE; Kelley, WM				Kraemer, DJM; Macrae, CN; Green, AE; Kelley, WM			Musical imagery - Sound of silence activates auditory cortex	NATURE			English	Editorial Material							VISUAL-CORTEX; EVENT		Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland	Dartmouth College; University of Aberdeen	Kraemer, DJM (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	william.kelley@dartmouth.edu	Macrae, Neil/C-4761-2008					FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hughes HC, 2001, NEUROIMAGE, V13, P1073, DOI 10.1006/nimg.2001.0766; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013	9	179	182	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					158	158		10.1038/434158a	http://dx.doi.org/10.1038/434158a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758989	Bronze			2022-12-01	WOS:000227494500033
J	Brown, JW; Braver, TS				Brown, JW; Braver, TS			Learned predictions of error likelihood in the anterior cingulate cortex	SCIENCE			English	Article							FRONTAL-CORTEX; COGNITIVE CONTROL; DOPAMINE NEURONS; REWARD; PERFORMANCE; BRAIN; GO	The anterior cingulate cortex (ACC) and the related medial wall play a critical role in recruiting cognitive control. Although ACC exhibits selective error and conflict responses, it has been unclear how these develop and become context-specific. With use of a modified stop-signal task, we show from integrated computational neural modeling and neuroimaging studies that ACC learns to predict error likelihood in a given context, even for trials in which there is no error or response conflict. These results support a more general error-likelihood theory of ACC function based on reinforcement learning, of which conflict and error detection are special cases.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL)	Brown, JW (corresponding author), Washington Univ, Dept Psychol, CB 1125, St Louis, MO 63130 USA.	jwbrown@artsci.wustl.edu	Brown, Joshua/G-2867-2011	Braver, Todd/0000-0002-2631-3393				Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BERNSTEIN PS, 1995, J EXP PSYCHOL HUMAN, V21, P1312, DOI 10.1037/0096-1523.21.6.1312; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P28; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GEHRING WJ, 1990, PSYCHOPHYSIOLOGY, V27, P34; HERMSTEIN RJ, 1961, J EXPT ANAL BEHAV, V4, P267; Hohnsbein J., 1989, J PSYCHOPHYSIOL, V3, P32; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765	26	648	656	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2005	307	5712					1118	1121		10.1126/science.1105783	http://dx.doi.org/10.1126/science.1105783			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718473				2022-12-01	WOS:000227197300051
J	Kragelund, C; Gronning, B; Kober, L; Hildebrandt, P; Steffensen, R				Kragelund, C; Gronning, B; Kober, L; Hildebrandt, P; Steffensen, R			N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR SYSTOLIC FUNCTION; ARTERY-DISEASE; CARDIOVASCULAR EVENTS; RISK STRATIFICATION; EXPRESSION; PROGNOSIS; ISCHEMIA; ANGINA; ATRIAL	BACKGROUND: The level of the inactive N-terminal fragment of pro-brain (B-type) natriuretic peptide (BNP) is a strong predictor of mortality among patients with acute coronary syndromes and may be a strong prognostic marker in patients with chronic coronary heart disease as well. We assessed the relationship between N-terminal pro-BNP (NT-pro-BNP) levels and long-term mortality from all causes in a large cohort of patients with stable coronary heart disease. METHODS: NT-pro-BNP was measured in baseline serum samples from 1034 patients referred for angiography because of symptoms or signs of coronary heart disease. The rate of death from all causes was determined after a median follow-up of nine years. RESULTS: At follow-up, 288 patients had died. The median NT-pro-BNP level was significantly lower among patients who survived than among those who died (120 pg per milliliter [interquartile range, 50 to 318] vs. 386 pg per milliliter [interquartile range, 146 to 897], P<0.001). Patients with NT-pro-BNP levels in the highest quartile were older, had a lower left ventricular ejection fraction (LVEF) and a lower creatinine clearance rate, and were more likely to have a history of myocardial infarction, clinically significant coronary artery disease, and diabetes than patients with NT-pro-BNP levels in the lowest quartile. In a multivariable Cox regression model, the hazard ratio for death from any cause for the patients with NT-pro-BNP levels in the fourth quartile as compared with those in the first quartile was 2.4 (95 percent confidence interval, 1.5 to 4.0; P<0.001); the NT-pro-BNP level added prognostic information beyond that provided by conventional risk factors, including the patient's age; sex; family history with respect to ischemic heart disease; the presence or absence of a history of myocardial infarction, angina, hypertension, diabetes, or chronic heart failure; creatinine clearance rate; body-mass index; smoking status; plasma lipid levels; LVEF; and the presence or absence of clinically significant coronary artery disease on angiography. CONCLUSIONS: NT-pro-BNP is a marker of long-term mortality in patients with stable coronary disease and provides prognostic information above and beyond that provided by conventional cardiovascular risk factors and the degree of left ventricular systolic dysfunction.	Univ Copenhagen, Frederiksberg Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark; Hillerod Univ Hosp, Dept Cardiol, Copenhagen, Denmark; Rigshosp, Dept Cardiol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kragelund, C (corresponding author), Univ Copenhagen, Frederiksberg Hosp, Dept Cardiol & Endocrinol, Nordre Fasanvej 57, DK-2000 Copenhagen, Denmark.	kragelund@dadlnet.dk		Kober, Lars/0000-0002-6635-1466				Bibbins-Domingo K, 2003, CIRCULATION, V108, P2987, DOI 10.1161/01.CIR.0000103681.04726.9C; Cole JH, 2003, J AM COLL CARDIOL, V41, P521, DOI 10.1016/S0735-1097(02)02862-0; D'Souza SP, 2004, PHARMACOL THERAPEUT, V101, P113, DOI 10.1016/j.pharmthera.2003.11.001; D'Souza SP, 2003, HEART, V89, P707, DOI 10.1136/heart.89.7.707; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; DODGE HT, 1983, J AM COLL CARDIOL, V1, P73, DOI 10.1016/S0735-1097(83)80012-6; Fox KM, 2003, LANCET, V362, P782; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Gill D, 2004, CLIN SCI, V106, P135, DOI 10.1042/CS20030131; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Jernberg T, 2002, J AM COLL CARDIOL, V40, P437, DOI 10.1016/S0735-1097(02)01986-1; Levin ER, 1998, NEW ENGL J MED, V339, P321; MARUMOTO K, 1995, CLIN SCI, V88, P551, DOI 10.1042/cs0880551; McGowan JH, 2003, AM HEART J, V146, P388, DOI 10.1016/S0002-8703(03)00248-5; MORITA E, 1993, CIRCULATION, V88, P82, DOI 10.1161/01.CIR.88.1.82; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1264, DOI 10.1016/S0735-1097(03)00168-2; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1853, DOI 10.1016/S0735-1097(03)00571-0; Nilsson JC, 2002, AM HEART J, V143, P696, DOI 10.1067/mhj.2002.120293; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Sabatine MS, 2002, CIRCULATION, V105, P1760, DOI 10.1161/01.CIR.0000015464.18023.0A; Talwar S, 2000, HEART, V84, P421, DOI 10.1136/heart.84.4.421; Talwar S, 2000, EUR HEART J, V21, P1514, DOI 10.1053/euhj.1999.2045; Tateishi J, 2000, CLIN CARDIOL, V23, P776, DOI 10.1002/clc.4960231016; Tsutamoto T, 1997, CIRCULATION, V96, P509; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wiviott SD, 2004, CIRCULATION, V109, P580, DOI 10.1161/01.CIR.0000109491.66226.26	30	509	540	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2005	352	7					666	675		10.1056/NEJMoa042330	http://dx.doi.org/10.1056/NEJMoa042330			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897UO	15716560				2022-12-01	WOS:000227031100005
J	Nieschlag, E; Henke, A				Nieschlag, E; Henke, A			Hopes for male contraception	LANCET			English	Editorial Material							HORMONAL MALE CONTRACEPTION; MONKEYS; IMPACT; EPPIN		Univ Munster, Inst Reprod Med, D-48129 Munster, Germany	University of Munster	Nieschlag, E (corresponding author), Univ Munster, Inst Reprod Med, Steinfurter Str 107, D-48129 Munster, Germany.	eberhard.nieschlag@ukmuenster.de						[Anonymous], 1990, Lancet, V336, P955; DARCANGUES C, 2000, DEP REPROD HLTH RES, P109; Diczfalusy E, 2004, MOL CELL ENDOCRINOL, V216, P1, DOI 10.1016/j.mce.2003.10.067; Kamischke A, 2004, TRENDS PHARMACOL SCI, V25, P49, DOI 10.1016/j.tips.2003.11.009; Martin CW, 2000, HUM REPROD, V15, P637, DOI 10.1093/humrep/15.3.637; Moudgal NR, 1997, HUM REPROD UPDATE, V3, P335, DOI 10.1093/humupd/3.4.335; Nieschlag E, 2001, ANDROLOGY, 2ND EDITION, P399; Nieschlag E, 2004, TESTOSTERONE ACTION, P685; Nieschlag E, 1986, MALE CONTRACEPTION A, p[1986, 395]; O'Rand MG, 2004, SCIENCE, V306, P1189, DOI 10.1126/science.1099743; Richardson RT, 2001, GENE, V270, P93, DOI 10.1016/S0378-1119(01)00462-0; THAU RB, 1987, AM J REPROD IMMUNOL, V15, P92; Waites GMH, 2003, FERTIL STERIL, V80, P1, DOI 10.1016/S0015-0282(03)00577-6; 2002, INT J ANDROL, V25, P375	14	28	29	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					554	556						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708085				2022-12-01	WOS:000226984300008
J	Briggman, KL; Abarbanel, HDI; Kristan, WB				Briggman, KL; Abarbanel, HDI; Kristan, WB			Optical imaging of neuronal populations during decision-making	SCIENCE			English	Article							BEHAVIORAL CHOICE; MEDICINAL LEECH; PERCEPTUAL DECISION; PARIETAL CORTEX; NEURAL BASIS; SWIM; PLEUROBRANCHAEA; MECHANISMS; INITIATION; TARGETS	We investigated decision-making in the leech nervous system by stimulating identical sensory inputs that sometimes elicit crawling and other times swimming. Neuronal populations were monitored with voltage-sensitive dyes after each stimulus. By quantifying the discrimination time of each neuron, we found single neurons that discriminate before the two behaviors are evident. We used principal component analysis and linear discriminant analysis to find populations of neurons that discriminated earlier than any single neuron. The analysis highlighted the neuron cell 208. Hyperpolarizing cell 208 during a stimulus biases the leech to swim; depolarizing it biases the leech to crawl or to delay swimming.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Kristan, WB (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wkristan@ucsd.edu	Abarbanel, Henry Don Isaac/AAX-3192-2021		NIMH NIH HHS [MH43396] Funding Source: Medline; NINDS NIH HHS [NS40110] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040110] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abarbanel H., 1996, ANAL OBSERVED CHAOTI; BRODFUEHRER PD, 1995, NEUROBIOL LEARN MEM, V63, P192, DOI 10.1006/nlme.1995.1020; Broomhead D S., 1987, J PHYS A, V20, P563; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Cacciatore TW, 2000, J NEUROSCI, V20, P1643; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; Duda R.O., 2000, PATTERN CLASSIFICATI; Eisenhart FJ, 2000, J COMP PHYSIOL A, V186, P631, DOI 10.1007/s003590000117; Esch T, 2002, INTEGR COMP BIOL, V42, P716, DOI 10.1093/icb/42.4.716; Esch T, 2002, J NEUROSCI, V22, P11045; Glimcher PW, 2001, TRENDS NEUROSCI, V24, P654, DOI 10.1016/S0166-2236(00)01932-9; Glimcher PW, 2003, BRADFORD BOOKS, P1; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gonzalez JE, 1999, DRUG DISCOV TODAY, V4, P431, DOI 10.1016/S1359-6446(99)01383-5; KAPLAN D, 1995, UNDERSTANDING NONLIN; KOVAC MP, 1980, J NEUROPHYSIOL, V43, P469, DOI 10.1152/jn.1980.43.2.469; KOVAC MP, 1977, SCIENCE, V198, P632, DOI 10.1126/science.918659; KRISTAN WB, 1982, J EXP BIOL, V96, P143; Kristan WB, 1997, CURR OPIN NEUROBIOL, V7, P826, DOI 10.1016/S0959-4388(97)80142-0; KRISTAN WB, 1976, J EXP BIOL, V65, P643; KRISTAN WB, 1982, J EXP BIOL, V96, P161; Mardia K.V, 1980, MULTIVARIATE ANAL; MULLER KJ, 1981, NEUROBIOLOGY LEECH; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Schall JD, 2000, CURR BIOL, V10, pR404, DOI 10.1016/S0960-9822(00)00504-2; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shaw BK, 1997, J NEUROSCI, V17, P786; Taylor AL, 2003, J NEUROSCI, V23, P11402; WEEKS JC, 1978, J EXP BIOL, V77, P71; WEEKS JC, 1982, J COMP PHYSIOL, V148, P265, DOI 10.1007/BF00619133; Zochowski M, 2000, J NEUROSCI, V20, P8485, DOI 10.1523/JNEUROSCI.20-22-08485.2000	35	229	232	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					896	901		10.1126/science.1103736	http://dx.doi.org/10.1126/science.1103736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705844				2022-12-01	WOS:000226985100045
J	Hetz, SK; Bradley, TJ				Hetz, SK; Bradley, TJ			Insects breathe discontinuously to avoid oxygen toxicity	NATURE			English	Article							GAS-EXCHANGE CYCLES; SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; LIFE-SPAN; RESPIRATION; OVEREXPRESSION; HYPOTHESES; SCARABAEIDAE; VENTILATION; DIFFUSION	The respiratory organs of terrestrial insects consist of tracheal tubes with external spiracular valves that control gas exchange. Despite their relatively high metabolic rate, many insects have highly discontinuous patterns of gas exchange, including long periods when the spiracles are fully closed. Two explanations have previously been put forward to explain this behaviour: first, that this pattern serves to reduce respiratory water loss(1), and second, that the pattern may have initially evolved in underground insects as a way of dealing with hypoxic or hypercapnic conditions(2). Here we propose a third possible explanation based on the idea that oxygen is necessary for oxidative metabolism but also acts as a toxic chemical that can cause oxidative damage of tissues even at relatively low concentrations. At physiologically normal partial pressures of CO2, the rate of CO2 diffusion out of the insect respiratory system is slower than the rate of O-2 entry; this leads to a build-up of intratracheal CO2. The spiracles must therefore be opened at intervals to rid the insect of accumulated CO2, a process that exposes the tissues to dangerously high levels of O-2. We suggest that the cyclical pattern of open and closed spiracles observed in resting insects is a necessary consequence of the need to rid the respiratory system of accumulated CO2, followed by the need to reduce oxygen toxicity.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Humboldt Univ, Dept Anim Physiol, D-10115 Berlin, Germany	University of California System; University of California Irvine; Humboldt University of Berlin	Bradley, TJ (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	tbradley@uci.edu	Hetz, Stefan/E-9094-2010	Hetz, Stefan/0000-0002-4928-8506				Bradley TJ, 2003, PHYSIOL BIOCHEM ZOOL, V76, P302, DOI 10.1086/367953; Chown SL, 2000, J EXP BIOL, V203, P397; Davis ALV, 1999, PHYSIOL BIOCHEM ZOOL, V72, P555, DOI 10.1086/316698; Fielden LJ, 1996, PHYSIOL ZOOL, V69, P599, DOI 10.1086/physzool.69.3.30164218; FRIDOVICH I, 1977, BIOSCIENCE, V27, P462, DOI 10.2307/1297527; HADLEY NF, 1994, PHYSIOL ZOOL, V67, P175, DOI 10.1086/physzool.67.1.30163841; HETZ SK, 1994, BIOELECTROCH BIOENER, V33, P165, DOI 10.1016/0302-4598(94)85008-9; JAMIESON D, 1989, FREE RADICAL BIO MED, V7, P87, DOI 10.1016/0891-5849(89)90103-2; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P95, DOI 10.1007/BF01722125; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P113, DOI 10.1007/BF01722126; LEVY RI, 1966, J INSECT PHYSIOL, V12, P83, DOI 10.1016/0022-1910(66)90068-0; LIGHTON JRB, 1988, J EXP BIOL, V134, P363; LIGHTON JRB, 1995, J EXP BIOL, V198, P1613; Lighton JRB, 1998, AM ZOOL, V38, P483; Lighton JRB, 1996, ANNU REV ENTOMOL, V41, P309, DOI 10.1146/annurev.en.41.010196.001521; Lighton JRB, 1996, J INSECT PHYSIOL, V42, P347, DOI 10.1016/0022-1910(95)00112-3; Lighton JRB, 2002, PHYSIOL BIOCHEM ZOOL, V75, P345, DOI 10.1086/342252; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1; Slama K, 1999, ANN ENTOMOL SOC AM, V92, P916, DOI 10.1093/aesa/92.6.916; SLAMA K, 1988, BIOL BULL-US, V175, P289, DOI 10.2307/1541570; SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671; Sun JT, 2002, GENETICS, V161, P661; Weibel ER, 1996, J EXP BIOL, V199, P1699; WEIBEL ER, 1998, PRINCIPLES ANIMAL DE; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; WIGGLESWORTH VB, 1970, PRINCIPLES INSECT PH; Williams AE, 1998, J EXP BIOL, V201, P2953; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	30	231	245	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					516	519		10.1038/nature03106	http://dx.doi.org/10.1038/nature03106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690040				2022-12-01	WOS:000226727200047
J	Martel, MJ; Rey, E; Beauchesne, MF; Perreault, S; Lefebvre, G; Forget, A; Blais, L				Martel, MJ; Rey, E; Beauchesne, MF; Perreault, S; Lefebvre, G; Forget, A; Blais, L			Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASTHMATIC WOMEN; PERINATAL OUTCOMES; DRUG-USE; INFORMATION; RECALL; MEDICATIONS; POPULATION; SELECTION; ACCURACY; DATABASE	Objective To determine whether the use of inhaled corticosteroids during pregnancy increases the risk of pregnancy induced hypertension and pre-eclampsia among asthmatic women. Design Nested case-control study. Setting Three administrative health databases from Quebec: RAMQ MED-ECHO, and Fichier des evenements demographiques. Participants 3505 women with asthma, totalling 4593 pregnancies, between 1990 and 2000. Main outcome measures Pregnancy induced hypertension and pre-eclampsia. Results 302 cases of pregnancy induced hypertension and 165 cases of pre-eclampsia were identified. Use of inhaled corticosteroids from conception until date of outcome was not associated with an increased risk of pregnancy induced hypertension (adjusted odds ratio 1.02, 95% confidence interval 0.77 to 1.34) or pre-eclampsia (1.06,0.74 to 1.53). No significant dose-response relation was observed between inhaled corticosteroids and pregnancy induced hypertension or pre-eclampsia. Oral corticosteroids were significantly associated with the risk of pregnancy induced hypertension (adjusted odds ratio 1.57, 1.02 to 2.41), and a trend was seen for pre-eclampsia (1.72, 0.98 to 3.02). Conclusion No significant increase of the risk of pregnancy induced hypertension or pre-eclampsia was detected among users of inhaled corticosteroids during pregnancy, while markers of uncontrolled and severe asthma were found to significantly increase the risks of pregnancy induced hypertension and pre-eclampsia.	Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Fac Med, Dept Obstet & Gynecol, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Math & Stat, Montreal, PQ H3C 3J7, Canada; Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Blais, L (corresponding author), Univ Montreal, Fac Pharm, CP 6128,Succursale Centreville, Montreal, PQ H3C 3J7, Canada.	lucie.blais@umontreal.ca	Perreault, Sylvie/AAM-8009-2020	Perreault, Sylvie/0000-0002-0066-0127				Alexander S, 1998, OBSTET GYNECOL, V92, P435, DOI 10.1016/S0029-7844(98)00191-4; AVRON J, 1998, JAMA-J AM MED ASSOC, V279, P1458; BAHNA SL, 1972, ACTA ALLERGOL, V27, P397, DOI 10.1111/j.1398-9995.1972.tb01439.x; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Boulet LP, 1999, CAN MED ASSOC J, V161, pS1; Demissie K, 1998, AM J RESP CRIT CARE, V158, P1091, DOI 10.1164/ajrccm.158.4.9802053; Dombrowski MP, 2004, AM J OBSTET GYNECOL, V190, P737, DOI 10.1016/j.ajog.2003.09.071; Duley L, 2003, BRIT MED BULL, V67, P161, DOI 10.1093/bmb/ldg005; Garbe E, 1997, LANCET, V350, P979, DOI 10.1016/S0140-6736(97)03392-8; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; LEHRER S, 1993, AM J OBSTET GYNECOL, V168, P1463, DOI 10.1016/S0002-9378(11)90782-0; LEVY AR, 1995, AM J EPIDEMIOL, V142, P428, DOI 10.1093/oxfordjournals.aje.a117651; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; *NAT ASTHM ED PREV, 2 NIH NAT ASTHM ED P; Olesen C, 1999, EUR J CLIN PHARMACOL, V55, P139, DOI 10.1007/s002280050608; PAGANINIHILL A, 1982, AM J EPIDEMIOL, V116, P114; PERLOW JH, 1992, AM J OBSTET GYNECOL, V167, P963, DOI 10.1016/S0002-9378(12)80020-2; *QUEB GOV, 1997, REG ASS MAL QUEB STA; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P115; SCHATZ M, 1995, AM J RESP CRIT CARE, V151, P1170; Schatz M, 1997, J ALLERGY CLIN IMMUN, V100, P301, DOI 10.1016/S0091-6749(97)70241-0; STENIUSAARNIALA B, 1988, THORAX, V43, P12, DOI 10.1136/thx.43.1.12; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; TILLEY BC, 1985, AM J EPIDEMIOL, V121, P269, DOI 10.1093/oxfordjournals.aje.a113997; Van den Berg LTWDJ, 1999, TERATOLOGY, V60, P33; VANDENBRANDT PA, 1991, PHARM WEEKBLAD, V13, P91, DOI 10.1007/BF01974987; Wen SW, 2001, ANN EPIDEMIOL, V11, P7, DOI 10.1016/S1047-2797(00)00077-6; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563	29	96	101	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2005	330	7485					230	233		10.1136/bmj.38313.624352.8F	http://dx.doi.org/10.1136/bmj.38313.624352.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894GR	15659480	Bronze, Green Published			2022-12-01	WOS:000226779400021
J	Bar-Nahum, G; Epshtein, V; Ruckenstein, AE; Rafikov, R; Mustaev, A; Nudler, E				Bar-Nahum, G; Epshtein, V; Ruckenstein, AE; Rafikov, R; Mustaev, A; Nudler, E			A ratchet mechanism of transcription elongation and its control	CELL			English	Article							RNA-POLYMERASE-II; 3.3 ANGSTROM RESOLUTION; ESCHERICHIA-COLI; STRUCTURAL BASIS; ACTIVE-CENTER; NUCLEOSIDE TRIPHOSPHATES; CATALYTIC RESIDUES; ALLOSTERIC BINDING; CRYSTAL-STRUCTURE; BASIC MECHANISMS	RNA chain elongation is a highly processive and accurate process that is finely regulated by numerous intrinsic and extrinsic signals. Here we describe a general mechanism that governs RNA polymerase (RNAP) movement and response to regulatory inputs such as pauses, terminators, and elongation factors. We show that E.coli RNAP moves by a complex Brownian ratchet mechanism, which acts prior to phosphodiester bond formation. The incoming substrate and the flexible F bridge domain of the catalytic center serve as two separate ratchet devices that function in concert to drive forward translocation. The adjacent G loop domain controls F bridge motion, thus keeping the proper balance between productive and inactive states of the elongation complex. This balance is critical for cell viability since it determines the rate, processivity, and fidelity of transcription.	NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA; Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; Publ Hlth Res Inst, Newark, NJ 07103 USA	New York University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Nudler, E (corresponding author), NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@med.nyu.edu	Rafikov, Ruslan/AAG-9352-2019	Rafikov, Ruslan/0000-0001-5950-4076; Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750, P20GM064375] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM58750, P20 GM64375] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; BUROVA E, 1995, J BACTERIOL, V177, P1388, DOI 10.1128/jb.177.5.1388-1392.1995; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Landick R, 1996, ESCHERICHIA COLI SAL, P1263; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Mustaev A, 2003, METHOD ENZYMOL, V371, P191; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 2003, METHOD ENZYMOL, V371, P369; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; SCHMIDT MC, 1984, BIOCHEMISTRY-US, V23, P197, DOI 10.1021/bi00297a004; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Sousa R, 2001, TRENDS BIOCHEM SCI, V26, P695, DOI 10.1016/S0968-0004(01)02000-X; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; VOGEL U, 1994, J BIOL CHEM, V269, P16236; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zakharova N, 1998, J BIOL CHEM, V273, P24912, DOI 10.1074/jbc.273.38.24912; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	46	260	268	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					183	193		10.1016/j.cell.2004.11.045	http://dx.doi.org/10.1016/j.cell.2004.11.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680325	Bronze			2022-12-01	WOS:000226740000008
J	Casalino, LP				Casalino, LP			Disease management and the organization of physician practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPROVING PRIMARY-CARE; CHRONIC ILLNESS; QUALITY; PROGRAMS; MODEL		Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago	Casalino, LP (corresponding author), Univ Chicago, Dept Hlth Studies, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	lcasalin@uchicago.edu	Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859				Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Congressional Budget Office, 2004, AN LIT DIS MAN PROGR; DeBusk RF, 1999, ARCH INTERN MED, V159, P2739, DOI 10.1001/archinte.159.22.2739; ENTHOVEN A, 2004, 21 CENTURY HLTH SYST; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Fernandez A, 2001, J GEN INTERN MED, V16, P163, DOI 10.1046/j.1525-1497.2001.91226.x; Fonarow GC, 2004, CIRCULATION, V110, P3506, DOI 10.1161/01.CIR.0000151101.17629.20; FOOTE SM, 2003, HLTH AFF MILLWOOD; Grumbach K, 2004, JAMA-J AM MED ASSOC, V291, P1246, DOI 10.1001/jama.291.10.1246; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Neil Nancy, 2003, Jt Comm J Qual Saf, V29, P610; Nobel Jeremy J, 2003, Dis Manag, V6, P219, DOI 10.1089/109350703322682531; ROBINSON JC, 2004, HLTH AFF MILLWOOD; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; Scott JC, 2004, J AM GERIATR SOC, V52, P1463, DOI 10.1111/j.1532-5415.2004.52408.x; SUPER N, MEDICARES CHRONIC CA; Villagra V, 2004, MED CARE, V42, P24, DOI 10.1097/01.mlr.0000119395.13327.e9; VILLAGRA V, 2004, HLTH AFF MILLWOOD; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 2004, ANN INTERN MED, V141, P644, DOI 10.7326/0003-4819-141-8-200410190-00015; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Welch WP, 2002, AM J MANAG CARE, V8, P353; Wilson Thomas W, 2004, Jt Comm J Qual Saf, V30, P614	25	91	91	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2005	293	4					485	488		10.1001/jama.293.4.485	http://dx.doi.org/10.1001/jama.293.4.485			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890DW	15671434				2022-12-01	WOS:000226492900028
J	Ponsonby, AL; van der Mei, I; Dwyer, T; Blizzard, L; Taylor, B; Kemp, A; Simmons, R; Kilpatrick, T				Ponsonby, AL; van der Mei, I; Dwyer, T; Blizzard, L; Taylor, B; Kemp, A; Simmons, R; Kilpatrick, T			Exposure to infant siblings during early life and risk of multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPSTEIN-BARR-VIRUS; BIRTH-ORDER; CELL RESPONSE; T-CELLS; INFECTIONS; ACTIVATION; ANTIBODIES; VARICELLA; CHILDREN; ANTIGEN	Context The "hygiene hypothesis" has implicated sibship as a marker of infection load during early life and suggests that exposure or reexposure to infections can influence the developing immune system. Viral infection has also been implicated in the pathogenesis of multiple sclerosis (MS). Objectives To evaluate whether exposure to infant siblings in early life is associated with the risk of MS, and to explore the possible mechanism for any apparent protective effect, including altered Epstein-Barr virus (EBV) infection patterns. Design, Setting, and Patients Population-based case-control study in Tasmania, Australia, from 1999 to 2001 based on 136 cases of magnetic resonance imaging confirmed MS and 272 community controls, matched on sex and year of birth. Main Outcome Measure Risk of MS by duration of contact with younger siblings aged less than 2 years in the first 6 years of life. Results Increasing duration of contact with a younger sibling aged less than 2 years in the first 6 years of life was associated with reduced MS risk (adjusted odds ratios [AORs]: <1 infant-year, 1.00 [reference); 1 to <3 infant-years, 0.57 (95% confidence interval (0), 0.33-0.98]; 3 to <5 infant-years, 0.40 (95% Cl. 0.19-0.92); >= 5 infant-years, 0.12 [95% Cl, 0.02-0.88); test for trend, P=.002). A history of exposure to infant siblings was associated with a reduced IgG response to EBV among controls. Controls with at least 1 infant-year contact had a reduced risk of infectious mononucleosis and a reduced risk of very high composite EBV IgG titers (AOR, 0.33; 95% Cl, 0.11-0.98) compared with other controls. The inverse association between higher infant contact and MS was independent of EBV IgG titer. Conclusion Higher infant sibling exposure in the first 6 years of life was associated with a reduced risk of MS, possibly by altering childhood infection patterns and related immune responses.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; Royal Hobart Hosp, Hobart, Tas, Australia; Univ Sydney, Discipline Paediat & Child Hlth, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; Canberra Hosp, Canberra, ACT, Australia; Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Melbourne, Vic, Australia	Australian National University; University of Tasmania; Menzies Institute for Medical Research; Royal Hobart Hospital; University of Sydney; Australian National University; Canberra Hospital; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Ponsonby, AL (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	anne-louise.ponsonby@anu.edu.au	van der Mei, Ingrid/J-7457-2014; van der Mei, Ingrid/AAI-2566-2020; Ponsonby, Anne-Louise/AAE-4351-2019	van der Mei, Ingrid/0000-0001-9009-7472; van der Mei, Ingrid/0000-0001-9009-7472; Kilpatrick, Trevor/0000-0003-3999-085X; Ponsonby, Anne-Louise/0000-0002-6581-3657				Aalto SM, 1998, J MED VIROL, V56, P186, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;186::AID-JMV2&gt;3.0.CO;2-3; Adams CL, 2003, IMMUNOLOGY, V108, P274, DOI 10.1046/j.1365-2567.2003.01583.x; Alotaibi S, 2004, JAMA-J AM MED ASSOC, V291, P1875, DOI 10.1001/jama.291.15.1875; Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; ARVIN AM, 1983, J INFECT DIS, V148, P200, DOI 10.1093/infdis/148.2.200; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; CUOMO L, 1995, AIDS RES HUM RETROV, V11, P1241, DOI 10.1089/aid.1995.11.1241; DAGAN R, 1994, EUR J CLIN MICROBIOL, V13, P1029, DOI 10.1007/BF02111822; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; FARR TJ, 1990, EPIDEMIOL INFECT, V105, P603, DOI 10.1017/S095026880004824X; Gartner BC, 2003, CLIN DIAGN LAB IMMUN, V10, P78, DOI 10.1128/CDLI.10.1.78-82.2003; Haahr S, 1995, Mult Scler, V1, P73; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; Hollsberg P, 2003, CLIN EXP IMMUNOL, V132, P137, DOI 10.1046/j.1365-2249.2003.02114.x; HOLT PG, 1994, LANCET, V344, P456, DOI 10.1016/S0140-6736(94)91776-0; Hosmer D.W., 2000, WILEY PS TX, DOI 10.1002/0471722146; HUANG LM, 1993, ARCH DIS CHILD, V68, P408, DOI 10.1136/adc.68.3.408; ISAGER H, 1980, ACTA NEUROL SCAND, V61, P393; Kim BS, 2001, IMMUNOL RES, V24, P121, DOI 10.1385/IR:24:2:121; Knipe D, 2001, FIELDS VIROLOGY, V2; KOCHHENRIKSEN N, 1989, ACTA NEUROL SCAND, V124, pS1; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; MATIASGUIU J, 1994, NEUROEPIDEMIOLOGY, V13, P129, DOI 10.1159/000110371; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Olson JK, 2002, J IMMUNOL, V169, P2719, DOI 10.4049/jimmunol.169.5.2719; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P150; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Savoldo B, 2002, J IMMUNOL, V168, P909, DOI 10.4049/jimmunol.168.2.909; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Ullrich SE, 2002, FRONT BIOSCI-LANDMRK, V7, pD684, DOI 10.2741/ullrich; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; Villoslada P, 2003, NEUROLOGY, V60, P1944, DOI 10.1212/01.WNL.0000069461.53733.F7; VISSCHER BR, 1982, ACTA NEUROL SCAND, V66, P209, DOI 10.1111/j.1600-0404.1982.tb04518.x; Wedderburn LR, 2001, IMMUNOLOGY, V102, P301, DOI 10.1046/j.1365-2567.2001.01194.x; Wing K, 2003, EUR J IMMUNOL, V33, P579, DOI 10.1002/eji.200323701; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZILBER N, 1988, ACTA NEUROL SCAND, V78, P313, DOI 10.1111/j.1600-0404.1988.tb03662.x	42	117	120	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2005	293	4					463	469		10.1001/jama.293.4.463	http://dx.doi.org/10.1001/jama.293.4.463			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890DW	15671431	Bronze			2022-12-01	WOS:000226492900025
J	Nadelman, RB; Wormser, GP				Nadelman, RB; Wormser, GP			Poly-ticks: Blue State versus Red State for Lyme disease	LANCET			English	Editorial Material							AMBLYOMMA-AMERICANUM		New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA	New York Medical College	Nadelman, RB (corresponding author), New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA.	robert_nadelman@nymc.edu						Masters E, 1998, ARCH DERMATOL, V134, P955, DOI 10.1001/archderm.134.8.955; PIESMAN J, 1988, J MED ENTOMOL, V25, P336, DOI 10.1093/jmedent/25.5.336; SCHULZE TL, 1984, SCIENCE, V224, P601, DOI 10.1126/science.6710158; WORMSER GP, IN PRESS CLIN INFECT; [No title captured]	5	3	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 22	2005	365	9456					280	280						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664208				2022-12-01	WOS:000226449600009
J	Sanchez, PA; Swaminathan, MS				Sanchez, PA; Swaminathan, MS			Cutting world hunger in half	SCIENCE			English	Editorial Material									Columbia Univ, Earth Inst, Palisades, NY 10964 USA; MS Swaminathan Res Fdn, Madras 600113, Tamil Nadu, India	Columbia University	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, Palisades, NY 10964 USA.	sanchez@iri.columbia.edu; msswami@mssrf.res.in						Food and Agriculture Organization of the United Nations, 2004, STAT FOOD INS WORLD; KADIYALA S, 2003, 159 INT FOOD POL RES; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; *UN MILL PROJ, 2005, TASK FORC HUNG HALV; UN Millennium Project, 2005, INV DEV PRACT PLAN A	6	123	133	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					357	359		10.1126/science.1109057	http://dx.doi.org/10.1126/science.1109057			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15661994				2022-12-01	WOS:000226492300023
J	Lieberman, E; Hauert, C; Nowak, MA				Lieberman, E; Hauert, C; Nowak, MA			Evolutionary dynamics on graphs	NATURE			English	Article							SUBDIVIDED POPULATION; NETWORK FORMATION; FIXATION; PROBABILITY; COOPERATION; MODEL	Evolutionary dynamics have been traditionally studied in the context of homogeneous or spatially extended populations(1-4). Here we generalize population structure by arranging individuals on a graph. Each vertex represents an individual. The weighted edges denote reproductive rates which govern how often individuals place offspring into adjacent vertices. The homogeneous population, described by the Moran process(3), is the special case of a fully connected graph with evenly weighted edges. Spatial structures are described by graphs where vertices are connected with their nearest neighbours. We also explore evolution on random and scale-free networks(5-7). We determine the fixation probability of mutants, and characterize those graphs for which fixation behaviour is identical to that of a homogeneous population(7). Furthermore, some graphs act as suppressors and others as amplifiers of selection. It is even possible to find graphs that guarantee the fixation of any advantageous mutant. We also study frequency-dependent selection and show that the outcome of evolutionary games can depend entirely on the structure of the underlying graph. Evolutionary graph theory has many fascinating applications ranging from ecology to multi-cellular organization and economics.	Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Harvard Univ, Dept Math, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Harvard Univ, Dept Appl Math, Program Evolutionary Dynam, Cambridge, MA 02138 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); University of British Columbia	Lieberman, E (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	erez@erez.com	Nowak, Martin A/A-6977-2008; Aiden, Erez Lieberman/A-2908-2010; Hauert, Christoph/E-5369-2011	Hauert, Christoph/0000-0002-1239-281X				Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; [Anonymous], 1988, LECT NOTES PARTICLE; Asavathiratham C, 2001, IEEE CONTR SYST MAG, V21, P52, DOI 10.1109/37.969135; Bala V, 2000, ECONOMETRICA, V68, P1181, DOI 10.1111/1468-0262.00155; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARTON NH, 1993, GENET RES, V62, P149, DOI 10.1017/S0016672300031748; Boyd S, 2004, SIAM REV, V46, P667, DOI 10.1137/s0036144503423264; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; ERDOS P, 1960, B INT STATIST INST, V38, P343; FISHER RA, 1950, HEREDITY, V4, P117, DOI 10.1038/hdy.1950.8; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J., 1998, EVOLUTIONARY GAMES P, DOI 10.1017/CBO9781139173179; Jackson MO, 2002, GAME ECON BEHAV, V41, P265, DOI 10.1016/S0899-8256(02)00504-3; Liggett T. M., 1999, STOCHASTIC INTERACTI, V]; MARUYAMA T, 1970, Theoretical Population Biology, V1, P273, DOI 10.1016/0040-5809(70)90047-X; Moran P. A. P., 1958, P CAMB PHILOS SOC, V54, P60, DOI DOI 10.1017/S0305004100033193); NAGYLAKI T, 1980, GENETICS, V94, P497; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Neuhauser C, 2001, NOTICES AM MATH SOC, V48, P1304; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; SLATKIN M, 1981, EVOLUTION, V35, P477, DOI [10.2307/2408196, 10.1111/j.1558-5646.1981.tb04911.x]; Tilman D., 1997, SPATIAL ECOLOGY ROLE; Whitlock MC, 2003, GENETICS, V164, P767; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1932, P INT C GENET, V6, P356	31	800	822	12	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					312	316		10.1038/nature03204	http://dx.doi.org/10.1038/nature03204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662424				2022-12-01	WOS:000226381300055
J	Kinoshita, T; Cano-Delgado, AC; Seto, H; Hiranuma, S; Fujioka, S; Yoshida, S; Chory, J				Kinoshita, T; Cano-Delgado, AC; Seto, H; Hiranuma, S; Fujioka, S; Yoshida, S; Chory, J			Binding of brassinosteroids to the extracellular domain of plant receptor kinase BRI1	NATURE			English	Article							SIGNAL-TRANSDUCTION; GENE-EXPRESSION; CRYSTAL-STRUCTURE; ARABIDOPSIS; PROTEIN; PERCEPTION; MUTANTS; PATHWAY	Both animals and plants use steroids as signalling molecules during growth and development. Animal steroids are principally recognized by members of the nuclear receptor superfamily of transcription factors(1). In plants, BRI1, a leucine-rich repeat (LRR) receptor kinase localized to the plasma membrane, is a critical component of a receptor complex for brassinosteroids(2,3). Here, we present the first evidence for direct binding of active brassinosteroids to BRI1 using a biotin-tagged photoaffinity castasterone (BPCS), a biosynthetic precursor of brassinolide (the most active of the brassinosteroids). Binding studies using BPCS, H-3-labelled brassinolide and recombinant BRI1 fragments show that the minimal binding domain for brassinosteroids consists of a 70-amino acid island domain (ID) located between LRR21 and LRR22 in the extracellular domain of BRI1, together with the carboxy-terminal flanking LRR (ID-LRR22). Our results demonstrate that brassinosteroids bind directly to the 94 amino acids comprising ID-LRR22 in the extracellular domain of BRI1, and define a new binding domain for steroid hormones.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; RIKEN, Plant Funct Lab, Wako, Saitama 3510198, Japan; RIKEN, Plant Sci Ctr, Kanagawa 2300045, Japan	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Kyushu University; RIKEN; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Kinoshita, Toshinori/C-2891-2012	Kinoshita, Toshinori/0000-0001-7621-1259				Altmann T, 1999, PLANTA, V208, P1, DOI 10.1007/s004250050528; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Clouse SD, 2002, MOL CELL, V10, P973, DOI 10.1016/S1097-2765(02)00744-X; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1999, BRASSINOSTEROIDS, P163; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GALLAGHER S, 1992, CURRENT PROTOCOLS MO; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Konoki K, 2000, TETRAHEDRON, V56, P9003, DOI 10.1016/S0040-4020(00)00752-3; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Seto H, 2002, TETRAHEDRON, V58, P9741, DOI 10.1016/S0040-4020(02)01247-4; Seto H, 1998, TETRAHEDRON LETT, V39, P7525, DOI 10.1016/S0040-4039(98)01636-0; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Ward CW, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-4; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yin YH, 2002, P NATL ACAD SCI USA, V99, P9090, DOI 10.1073/pnas.152330799; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	27	454	481	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					167	171		10.1038/nature03227	http://dx.doi.org/10.1038/nature03227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650741				2022-12-01	WOS:000226252200040
J	Danesh, J				Danesh, J			Antibiotics in the prevention of heart attacks	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ACUTE MYOCARDIAL-INFARCTION; WAVE CORONARY SYNDROMES; CHLAMYDIA-PNEUMONIAE; SECONDARY PREVENTION; DISEASE; AZITHROMYCIN; EVENTS; TWAR; ROXITHROMYCIN		Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England	University of Cambridge	Danesh, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	john.danesh@phpc.cam.ac.uk						CANNON CP, 2004, EUR SOC CARD C AUG 2; Cercek B, 2003, LANCET, V361, P809, DOI 10.1016/S0140-6736(03)12706-7; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 1998, Expert Opin Investig Drugs, V7, P691, DOI 10.1517/13543784.7.5.691; Danesh J, 2000, BRIT MED J, V321, P208, DOI 10.1136/bmj.321.7255.208; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757, DOI 10.1093/clind/15.5.757; GRAYSTON JT, 2004, EUR SOC CARD C AUG 2; Gupta S, 1997, CIRCULATION, V96, P404; Gurfinkel E, 1999, EUR HEART J, V20, P121, DOI 10.1053/euhj.1998.1283; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Hu H, 1999, J CLIN INVEST, V103, P747, DOI 10.1172/JCI4582; KUO CC, 1995, P NATL ACAD SCI USA, V92, P6911, DOI 10.1073/pnas.92.15.6911; Leowattana Wattana, 2001, Journal of the Medical Association of Thailand, V84, pS669; Muhlestein JB, 2000, CIRCULATION, V102, P1755; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Sinisalo J, 2002, CIRCULATION, V105, P1555, DOI 10.1161/01.CIR.0000012544.07696.1F; Stone AFM, 2002, CIRCULATION, V106, P1219, DOI 10.1161/01.CIR.0000027820.66786.CF; Zahn R, 2003, CIRCULATION, V107, P1253, DOI 10.1161/01.CIR.0000054613.57105.06	19	28	28	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					365	367						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680439				2022-12-01	WOS:000226610900006
J	Roberts, RJ; Burgess, IF				Roberts, RJ; Burgess, IF			New head-lice treatments: hope or hype?	LANCET			English	Editorial Material							SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; PERMETHRIN; KDR; MALATHION		Natl Publ Hlth Serv Wales, Mold, Flintshire, Wales; Insect Res & Dev Ltd, Royston, Herts, England		Roberts, RJ (corresponding author), Natl Publ Hlth Serv Wales, Mold, Flintshire, Wales.	roberts@doctors.org.uk	Burgess, Ian/N-2977-2013	Burgess, Ian/0000-0003-0747-3938				DODD CS, 2001, COCHRANE LIB; Downs AMR, 1999, BRIT J DERMATOL, V141, P508, DOI 10.1046/j.1365-2133.1999.03046.x; Gao JR, 2003, PESTIC BIOCHEM PHYS, V77, P115, DOI 10.1016/j.pestbp.2003.08.003; Lee SH, 2000, PESTIC BIOCHEM PHYS, V66, P130, DOI 10.1006/pest.1999.2460; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205; Park Y, 1997, INSECT BIOCHEM MOLEC, V27, P9, DOI 10.1016/S0965-1748(96)00077-X; Pearlman DL, 2004, PEDIATRICS, V114, pE275, DOI 10.1542/peds.2003-0666-F; Roberts RJ, 2002, NEW ENGL J MED, V346, P1645, DOI 10.1056/NEJMcp012640; Roberts RJ, 2000, LANCET, V356, P540, DOI 10.1016/S0140-6736(00)02578-2; *UPD SOFTW LTD, 2004, NAT RES REG 2004	11	15	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					8	10		10.1016/S0140-6736(04)17677-0	http://dx.doi.org/10.1016/S0140-6736(04)17677-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639662				2022-12-01	WOS:000226213100006
J	Dougan, S; Gilbart, VL; Sinka, K; Evans, BG				Dougan, S; Gilbart, VL; Sinka, K; Evans, BG			HIV infections acquired through heterosexual intercourse in the United Kingdom: findings from national surveillance	BRITISH MEDICAL JOURNAL			English	Article									Hlth Protect Agcy Ctr Infect, London NW9 5EQ, England	Health Protection Agency	Dougan, S (corresponding author), Hlth Protect Agcy Ctr Infect, London NW9 5EQ, England.	sarah.dougan@hpa.org.uk						Health Protection Agency Scottish Centre for Infection and Environmental Health National Public Health Service for Wales Communicable Disease Surveillance Centre Northern Ireland Unlinked Anonymous Surveys Steering Group, 2003, REN FOC HIV OTH SEX; *PUBL HLTH LAB SER, 2001, HIV AIDS UK EP REV 2; *UK COLL GROUP HIV, 2004, FOC PREV HIV OTH SEX	3	15	15	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 4	2005	330	7503					1303	1304		10.1136/bmj.38393.572188.EB	http://dx.doi.org/10.1136/bmj.38393.572188.EB			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	933TL	15764624	Green Published, Bronze			2022-12-01	WOS:000229655700022
J	Pandolfi, JM; Jackson, JBC; Baron, N; Bradbury, RH; Guzman, HM; Hughes, TP; Kappel, CV; Micheli, F; Ogden, JC; Possingham, HP; Sala, E				Pandolfi, JM; Jackson, JBC; Baron, N; Bradbury, RH; Guzman, HM; Hughes, TP; Kappel, CV; Micheli, F; Ogden, JC; Possingham, HP; Sala, E			Ecology - Are US coral reefs on the slippery slope to slime?	SCIENCE			English	Article							RESILIENCE; ECOSYSTEMS		Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia; Univ Queensland, Dept Earth Sci, St Lucia, Qld 4072, Australia; Univ Queensland, Dept Math, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Life Sci, St Lucia, Qld 4072, Australia; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; Smithsonian Trop Res Inst, Balboa, Panama; Natl ctr Ecol Anal & Synth, Santa Barbara, CA USA; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; James Cook Univ N Queensland, Sch Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Florida Inst Oceanog, St Petersburg, FL 33701 USA	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute; National Center for Ecological Analysis & Synthesis; Australian National University; James Cook University; Stanford University	Pandolfi, JM (corresponding author), Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia.	j.pandolfi@uq.edu.au	Hughes, Terry P/L-4721-2013; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Pandolfi, John M/A-3121-2009; Kappel, Carrie Vanessa/B-9534-2009	Hughes, Terry P/0000-0002-5257-5063; Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Pandolfi, John M/0000-0003-3047-6694; Kappel, Carrie Vanessa/0000-0003-2507-8042; Bradbury, Roger/0000-0002-0940-3493; Micheli, Fiorenza/0000-0002-6865-1438; Guzman, Hector M./0000-0001-9928-8523				Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bohnsack James A., 2003, Gulf and Caribbean Research, V14, P1; BRUMBAUGH DR, 2003, P FOR 2003 C NASS BA; Bryant D., 1998, REEFS RISK MAP BASED; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; ESTRADA R, 2003, SISTEMA NACL AREAS M; *FL KEYS NATL MAR, 1995, DRAFT MAN PLAN ENV I, V1, P1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; *INT UN CONS NAT N, RED LIST THREAT SPEC; JAAP WC, 2003, ENV PROTECTION AGENC; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JARAGOS J, 2002, CORAL REEF ECOSYSTEM; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Porter James W., 2002, P749; SAFINA C, 2003, EYE ALBATROSS; WILKINSON CR, IN PRESS STATUS CORA, V1; [No title captured]	22	345	364	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1725	1726		10.1126/science.1104258	http://dx.doi.org/10.1126/science.1104258			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774744				2022-12-01	WOS:000227883900028
J	Birkhead, TR; Pellatt, EJ; Brekke, P; Yeates, R; Castillo-Juarez, H				Birkhead, TR; Pellatt, EJ; Brekke, P; Yeates, R; Castillo-Juarez, H			Genetic effects on sperm design in the zebra finch	NATURE			English	Article							EJACULATE QUALITY; COMPETITION; SELECTION; EVOLUTION; POPULATION; DETERMINES; MOBILITY; LENGTH	Sperm design and function are important determinants of male reproductive success and are expected to be under strong selection(1,2). The way that spermatozoa phenotypes evolve is poorly understood, because there have been few studies of the quantitative genetics of sperm(3-5). Here we show, in the zebra finch Taeniopygia guttata, an extraordinary degree of inter-male variation in sperm design that is independent of sperm swimming velocity. A quantitative genetics study using data from over 900 zebra finches in a complex breeding experiment showed that sperm head, mid-piece and flagellum length are heritable, that negative genetic correlations exist between sperm traits, and that significant indirect ( maternal) genetic effects exist. Selection on the zebra finch sperm phenotype may be low because sperm competition is infrequent in this species(6), and this, in combination with negative genetic correlations and maternal genetic effects, may account for the variation in sperm phenotype between males. These results have important implications for the evolution of sperm in other taxa.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Autonoma Metropolitana Xochimilco, Mexico City 04960, DF, Mexico	University of Sheffield; Universidad Autonoma Metropolitana - Mexico	Birkhead, TR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	T.R.Birkhead@sheffield.ac.uk		Castillo-Juarez, Hector/0000-0002-5550-4180				Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; BEATTY RA, 1970, BIOL REV, V45, P73, DOI 10.1111/j.1469-185X.1970.tb01076.x; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1995, NATURE, V377, P422, DOI 10.1038/377422a0; Birkhead TR, 1995, P ROY SOC B-BIOL SCI, V262, P329, DOI 10.1098/rspb.1995.0213; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Boldman K.G., 1995, MANUAL USE MTDFREML; CARDULLO RA, 1991, CELL MOTIL CYTOSKEL, V19, P180, DOI 10.1002/cm.970190306; CHEVERUD JM, 1983, GENET RES, V42, P65, DOI 10.1017/S0016672300021492; COHEN J, 1974, J REPROD FERTIL, V39, P297, DOI 10.1530/jrf.0.0390297; Cohen J., 1977, REPRODUCTION; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Froman DP, 1998, BIOL REPROD, V58, P379, DOI 10.1095/biolreprod58.2.379; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Jamieson BGM, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P303; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Lynch M., 1998, AM J HUM GENET; MCFARLANE RW, 1963, P 13 INT ORN C ITH N, P91; Morrow EH, 2001, HEREDITY, V87, P356, DOI 10.1046/j.1365-2540.2001.00921.x; Morrow EH, 2001, J ZOOL, V254, P147, DOI 10.1017/S0952836901000656; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Roff D, 2000, HEREDITY, V84, P135, DOI 10.1046/j.1365-2540.2000.00695.x; Royle NJ, 2003, FUNCT ECOL, V17, P472, DOI 10.1046/j.1365-2435.2003.00752.x; SEH J, 2004, P R SOC LOND B S, V271, pS306; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Zann R.A., 1996, ZEBRA FINCH SYNTHESI	30	156	158	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					383	387		10.1038/nature03374	http://dx.doi.org/10.1038/nature03374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772662				2022-12-01	WOS:000227715100052
J	Plusa, B; Hadjantonakis, AK; Gray, D; Piotrowska-Nitsche, K; Jedrusik, A; Papaioannou, VE; Glover, DM; Zernicka-Goetz, M				Plusa, B; Hadjantonakis, AK; Gray, D; Piotrowska-Nitsche, K; Jedrusik, A; Papaioannou, VE; Glover, DM; Zernicka-Goetz, M			The first cleavage of the mouse zygote predicts the blastocyst axis	NATURE			English	Article							1ST CLEAVAGE; BLASTOMERES; DIVISION; EGG	One of the unanswered questions in mammalian development is how the embryonic - abembryonic axis of the blastocyst is first established. It is possible that the first cleavage division contributes to this process, because in most mouse embryos the progeny of one two-cell blastomere primarily populate the embryonic part of the blastocyst and the progeny of its sister populate the abembryonic part(1-4). However, it is not known whether the embryonic - abembryonic axis is set up by the first cleavage itself, by polarity in the oocyte that then sets the first cleavage plane with respect to the animal pole, or indeed whether it can be divorced entirely from the first cleavage and established in relation to the animal pole. Here we test the importance of the orientation of the first cleavage by imposing an elongated shape on the zygote so that the division no longer passes close to the animal pole, marked by the second polar body. Non-invasive lineage tracing shows that even when the first cleavage occurs along the short axis imposed by this experimental treatment, the progeny of the resulting two-cell blastomeres tend to populate the respective embryonic and abembryonic parts of the blastocyst. Thus, the first cleavage contributes to breaking the symmetry of the embryo, generating blastomeres with different developmental characteristics.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	University of Cambridge; University of Cambridge; Columbia University	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	mzg@mole.bio.cam.ac.uk		Plusa, Berenika/0000-0003-2214-5940; Papaioannou, Virginia/0000-0001-7558-8601; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Glover, David/0000-0003-0956-0103; Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Wellcome Trust [064421] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DONAHUE RP, 1972, J EXP ZOOL, V180, P305, DOI 10.1002/jez.1401800303; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2001, DEVELOPMENT, V128, P839; GARNER W, 1974, J EMBRYOL EXP MORPH, V32, P495; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Mayer W, 2000, J CELL BIOL, V148, P629, DOI 10.1083/jcb.148.4.629; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; Plusa B, 2002, NAT CELL BIOL, V4, P811, DOI 10.1038/ncb860	14	107	119	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					391	395		10.1038/nature03388	http://dx.doi.org/10.1038/nature03388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772664				2022-12-01	WOS:000227715100054
J	Vasan, RS; Sullivan, LM; Wilson, PWF; Sempos, CT; Sundstrom, J; Kannel, WB; Levy, D; D'Agostino, RB				Vasan, RS; Sullivan, LM; Wilson, PWF; Sempos, CT; Sundstrom, J; Kannel, WB; Levy, D; D'Agostino, RB			Relative importance of borderline and elevated levels of coronary heart disease risk factors	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SERUM-CHOLESTEROL; TASK-FORCE; PREVENTION; POPULATION; PREDICTION; MORTALITY; SMOKING	Background: Clinical trials indicate that a sizable proportion of adults have multiple borderline coronary risk factors and may benefit from treatment. Objective: To estimate the relative and absolute contributions of borderline and elevated risk factors to the population burden of coronary heart disease (CHD) events. Design: A prospective cohort study and a national crosssectional survey. Setting: The Framingham Study and the Third National Health and Nutrition Examination Survey (NHANES III). Participants: White non-Hispanic persons in the Framingham Study and in NHANES III who were between 35 to 74 years of age and had no CHD. Measurements: Occurrence of first CHD events according to 5 major CHD risk factors: blood pressure, low-density lipoprotein and high-density lipoprotein cholesterol levels, glucose intolerance, and smoking. Three categories - optimal, borderline, and elevated-were defined for each risk factor per national guide-lines. Sex-specific 10-year CHD event rates from the Framingham Study were applied to numbers of at-risk individuals estimated from NHANES III and the 2000 U.S. Census. Results: Twenty-six percent of men and 41% of women had at least 1 borderline risk factor in NHANES III. According to estimates, more than 90% of CHD events will occur in individuals with at least 1 elevated risk factor, and approximately 8% will occur in people with only borderline levels of multiple risk factors. Absolute 10-year CHD risk exceeded 10% in men older than age 45 years who had 1 elevated risk factor and 4 or more borderline risk factors and in those who had at least 2 elevated risk factors. In women, absolute CHD risk exceeded 10% only in those older than age 55 years who had at least 3 elevated risk factors. Limitations: The generalizability of the findings to persons of other ethnic backgrounds is unknown. Conclusions: Borderline CHD risk factors alone account for a small proportion of CHD events.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Med Univ S Carolina, Charleston, SC 29425 USA; SUNY Buffalo, Buffalo, NY 14260 USA; NHLBI, Bethesda, MD 20892 USA; Boston Univ, Boston, MA 02215 USA	Framingham Heart Study; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayne Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	Wilson, Peter W.F./J-2455-2016; Sundstrom, Johan/R-2139-2019; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Levy, Daniel/0000-0003-1843-8724; Sundström, Johan/0000-0003-2247-8454; Sullivan, Lisa/0000-0003-0726-7149; Ramachandran, Vasan/0000-0001-7357-5970				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1994, VITAL HLTH STAT, V1, P1; Benjamin EJ, 2002, J AM COLL CARDIOL, V40, P588, DOI 10.1016/S0735-1097(02)02082-X; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; *CDCP, 1996, NHANES 3 1988 94 REF; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P4; Chobanian AV, 2000, HYPERTENSION, V35, P858, DOI 10.1161/01.HYP.35.4.858; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Eide GE, 2001, STAT METHODS MED RES, V10, P159, DOI 10.1191/096228001680195148; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 1999, CIRCULATION, V100, P988, DOI 10.1161/01.CIR.100.9.988; Jousilahti P, 1998, CIRCULATION, V97, P1087, DOI 10.1161/01.CIR.97.11.1087; KANNEL WB, 1995, CIRCULATION, V92, P3350, DOI 10.1161/01.CIR.92.11.3350; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannel WB., 1987, SECTION 34 SOME RISK; Keil U, 1998, EUR HEART J, V19, P1197, DOI 10.1053/euhj.1998.1089; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; *NAT CTR HLTH STAT, 2003, HLTH US 2003 CHARTB, P95; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Pasternak Richard C., 2003, Journal of the American College of Cardiology, V41, P1863, DOI 10.1016/S0735-1097(03)00358-9; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	36	142	151	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					393	402		10.7326/0003-4819-142-6-200503150-00005	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767617				2022-12-01	WOS:000227621100001
J	Barrios-Rodiles, M; Brown, KR; Ozdamar, B; Bose, R; Liu, Z; Donovan, RS; Shinjo, F; Liu, YM; Dembowy, J; Taylor, IW; Luga, V; Przulj, N; Robinson, M; Suzuki, H; Hayashizaki, Y; Jurisica, I; Wrana, JL				Barrios-Rodiles, M; Brown, KR; Ozdamar, B; Bose, R; Liu, Z; Donovan, RS; Shinjo, F; Liu, YM; Dembowy, J; Taylor, IW; Luga, V; Przulj, N; Robinson, M; Suzuki, H; Hayashizaki, Y; Jurisica, I; Wrana, JL			High-throughput mapping of a dynamic signaling network in mammalian cells	SCIENCE			English	Article							GROWTH-FACTOR-BETA; PROTEIN INTERACTIONS; TRANSDUCTION; MAP	Signaling pathways transmit information through protein interaction networks that are dynamically regulated by complex extracellular cues. We developed LUMIER (for luminescence-based mammalian interactome mapping), an automated high-throughput technology, to map protein-protein interaction networks systematically in mammalian cells and applied it to the transforming growth factor-beta (TGFbeta) pathway. Analysis using self-organizing maps and k-means clustering identified links of the TGFbeta pathway to the p21 activated kinase (PAK) network, to the polarity complex, and to Occludin, a structural component of tight junctions. We show that Occludin regulates TGFbeta type I receptor localization for efficient TGFbeta-dependent dissolution of tight junctions during epithelial-to-mesenchymal transitions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 2M9, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3H5, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; RIKEN Genom Sci Ctr, Yokohama Inst, Lab Genome Explorat Res Grp, Yokohama, Kanagawa 2300045, Japan; Princess Margaret Hosp, Ontario Canc Inst, Div Canc Informat, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; RIKEN; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@mshri.on.ca	Wrana, Jeffrey/F-8857-2013; Robinson, Mark D./O-2254-2019; Suzuki, Harukazu/N-9553-2015; Przulj, Natasa/AAO-2850-2020; Bose, Rohit/O-9825-2018; Robinson, Mark D/A-6432-2015	Robinson, Mark D./0000-0002-3048-5518; Suzuki, Harukazu/0000-0002-8087-0836; Bose, Rohit/0000-0002-6785-0697; Robinson, Mark D/0000-0002-3048-5518; Przulj, Natasa/0000-0002-1290-853X; Brown, Kevin/0000-0002-5514-2538	NIGMS NIH HHS [P50 GM-62413] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062413] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BARRIOSRODILES M, UNPUB; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; OZDAMAR B, IN PRESS; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Sultan M, 2002, Bioinformatics, V18 Suppl 1, pS111; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	23	539	566	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1621	1625		10.1126/science.1105776	http://dx.doi.org/10.1126/science.1105776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761153				2022-12-01	WOS:000227622400047
J	He, JX; Gendron, JM; Sun, Y; Gampala, SSL; Gendron, N; Sun, CQ; Wang, ZY				He, JX; Gendron, JM; Sun, Y; Gampala, SSL; Gendron, N; Sun, CQ; Wang, ZY			BZR1 is a transcriptional repressor with dual roles in brassinosteroid homeostasis and growth responses	SCIENCE			English	Article							REGULATED GENES; ARABIDOPSIS; CYTOCHROME-P450; RECEPTOR; KINASE; BIOSYNTHESIS; ELONGATION; EXPRESSION; STEROIDS; RESCUE	Brassinosteroid (BR) homeostasis and signaling are crucial for normal growth and development of plants. BR signaling through cell-surface receptor kinases and intracellular components leads to dephosphorylation and accumulation of the nuclear protein BZR1. How BR signaling regulates gene expression, however, remains unknown. Here we show that BZR1 is a transcriptional repressor that has a previously unknown DNA binding domain and binds directly to the promoters of feed back-regulated BR biosynthetic genes. Microarray analyses identified additional potential targets of BZR1 and illustrated, together with physiological studies, that BZR1 coordinates BR homeostasis and signaling by playing dual roles in regulating BR biosynthesis and downstream growth responses.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Wang, ZY (corresponding author), Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM066258] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007276, R01 GM066258-04, R01 GM66258-01, R01 GM066258, 5T32GM007276] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann T, 1998, TRENDS GENET, V14, P490, DOI 10.1016/S0168-9525(98)01598-4; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Bishop GJ, 1996, PLANT CELL, V8, P959, DOI 10.1105/tpc.8.6.959; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Dharmasiri N, 2004, TRENDS PLANT SCI, V9, P302, DOI 10.1016/j.tplants.2004.04.003; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; GODA H, ARABIDOPSIS INFORMAT; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 2003, CURR OPIN PLANT BIOL, V6, P494, DOI 10.1016/S1369-5266(03)00088-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Shimada Y, 2003, PLANT PHYSIOL, V131, P287, DOI 10.1104/pp.013029; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Wang ZY, 2004, TRENDS PLANT SCI, V9, P91, DOI 10.1016/j.tplants.2003.12.009; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	25	540	602	5	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1634	1638		10.1126/science.1107580	http://dx.doi.org/10.1126/science.1107580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15681342	Green Accepted			2022-12-01	WOS:000227622400050
J	Chih, B; Engelman, H; Scheiffele, P				Chih, B; Engelman, H; Scheiffele, P			Control of excitatory and inhibitory synapse formation by neuroligins	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; MENTAL-RETARDATION; ADHESION MOLECULE; AUTISM; CELLS; DISORDERS; MUTATIONS; RECEPTORS; BALANCE; PSD-95	The normal function of neural networks depends on a delicate balance between excitatory and inhibitory synaptic inputs. Synapse formation is thought to be regulated by bidirectional signaling between pre- and postsynaptic cells. We demonstrate that members of the Neuroligin family promote postsynaptic differentiation in cultured rat hippocampal neurons. Down-regulation of neuroligin isoform expression by RNA interference results in a loss of excitatory and inhibitory synapses. Etectrophysiological analysis revealed a predominant reduction of inhibitory synaptic function. Thus, neuroligins control the formation and functional balance of excitatory and inhibitory synapses in hippocampal neurons.	Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Scheiffele, P (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	ps20l8@columbia.edu						Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; CHIH B, UNPUB; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Nusser Z, 1998, J NEUROSCI, V18, P1693; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	27	528	544	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1324	1328		10.1126/science.1107470	http://dx.doi.org/10.1126/science.1107470			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15681343				2022-12-01	WOS:000227313200063
J	Lang, D; Lu, MM; Huang, L; Engleka, KA; Zhang, MZ; Chu, EY; Lipner, S; Skoultchi, A; Millar, SE; Epstein, JA				Lang, D; Lu, MM; Huang, L; Engleka, KA; Zhang, MZ; Chu, EY; Lipner, S; Skoultchi, A; Millar, SE; Epstein, JA			Pax3 functions at a nodal point in melanocyte stem cell differentiation	NATURE			English	Article							HAIR FOLLICLE DEVELOPMENT; TRANSCRIPTION FACTOR; NEURAL CREST; BETA-CATENIN; WAARDENBURG-SYNDROME; SOX10; MITF; MORPHOGENESIS; INITIATION; INTERACTS	Most stem cells are not totipotent. Instead, they are partially committed but remain undifferentiated. Upon appropriate stimulation they are capable of regenerating mature cell types(1). Little is known about the genetic programmes that maintain the undifferentiated phenotype of lineage-restricted stem cells. Here we describe the molecular details of a nodal point in adult melanocyte stem cell differentiation in which Pax3 simultaneously functions to initiate a melanogenic cascade while acting downstream to prevent terminal differentiation. Pax3 activates expression of Mitf, a transcription factor critical for melanogenesis(2,3), while at the same time it competes with Mitf for occupancy of an enhancer required for expression of dopachrome tautomerase, an enzyme that functions in melanin synthesis(4). Pax3-expressing melanoblasts are thus committed but undifferentiated until Pax3-mediated repression is relieved by activated beta-catenin. Thus, a stem cell transcription factor can both determine cell fate and simultaneously maintain an undifferentiated state, leaving a cell poised to differentiate in response to external stimuli.	Univ Penn, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA; Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	University of Pennsylvania; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine	Epstein, JA (corresponding author), Univ Penn, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA.	epsteinj@mail.med.upenn.edu		Epstein, Jonathan/0000-0001-8637-4465; Millar, Sarah/0000-0001-8792-6890; Lang, Deborah/0000-0003-1057-0923				Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Brault V, 2001, DEVELOPMENT, V128, P1253; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; STEEL KP, 1992, DEVELOPMENT, V115, P1111; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703	30	282	299	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					884	887		10.1038/nature03292	http://dx.doi.org/10.1038/nature03292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729346				2022-12-01	WOS:000227174600047
J	Tomoyasu, Y; Wheeler, SR; Denell, RE				Tomoyasu, Y; Wheeler, SR; Denell, RE			Ultrabithorax is required for membranous wing identity in the beetle Tribolium castaneum	NATURE			English	Article							GENE-COMPLEX; DROSOPHILA-MELANOGASTER; HOMEOTIC COMPLEX; EVOLUTION; EXPRESSION; SPECIFICATION; MORPHOGENESIS; ORTHOLOG; SEQUENCE; DPP	The two pairs of wings that are characteristic of ancestral pterygotes ( winged insects) have often undergone evolutionary modification. In the fruitfly, Drosophila melanogaster, differences between the membranous forewings and the modified hindwings ( halteres) depend on the Hox gene Ultrabithorax ( Ubx). The Drosophila forewings develop without Hox input, while Ubx represses genes that are important for wing development, promoting haltere identity(1,2). However, the idea that Hox input is important to the morphologically specialized wing derivatives such as halteres, and not the more ancestral wings, requires examination in other insect orders. In beetles, such as Tribolium castaneum, it is the forewings that are modified ( to form elytra), while the hindwings retain a morphologically more ancestral identity. Here we show that in this beetle Ubx ' despecializes' the hindwings, which are transformed to elytra when the gene is knocked down. We also show evidence that elytra result from a Hox- free state, despite their diverged morphology. Ubx function in the hindwing seems necessary for a change in the expression of spalt, iroquois and achaete- scute homologues from elytron- like to more typical wing- like patterns. This counteracting effect of Ubx in beetle hindwings represents a previously unknown mode of wing diversification in insects.	Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Kansas State University; Washington University (WUSTL)	Tomoyasu, Y (corresponding author), Kansas State Univ, Div Biol, Chalmers Hall, Manhattan, KS 66506 USA.	tomoyasu@ksu.edu	Tomoyasu, Yoshinori/D-3061-2017	Tomoyasu, Yoshinori/0000-0001-9824-3454				Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Beeman R.W., 1990, P21; BEEMAN RW, 1987, NATURE, V327, P247, DOI 10.1038/327247a0; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Beeman RW, 1997, INSECT MOL BIOL, V6, P83, DOI 10.1046/j.1365-2583.1997.00159.x; Bennett RL, 1999, DEV GENES EVOL, V209, P608, DOI 10.1007/s004270050295; Brown SJ, 2002, GENETICS, V160, P1067; CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Curtis CD, 2001, GENESIS, V30, P12, DOI 10.1002/gene.1027; de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; El-Kifl A. H., 1953, Bulletin de la Societe Fouad ler d'Entomologie, V37, P173; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; QUENNEDEY A, 1990, TISSUE CELL, V22, P721, DOI 10.1016/0040-8166(90)90067-J; SanchezSalazar J, 1996, DEV GENES EVOL, V206, P237, DOI 10.1007/s004270050049; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STUART JJ, 1991, NATURE, V350, P72, DOI 10.1038/350072a0; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Wheeler SR, 2003, DEVELOPMENT, V130, P4373, DOI 10.1242/dev.00646	28	144	148	5	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2005	433	7026					643	647		10.1038/nature03272	http://dx.doi.org/10.1038/nature03272			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703749				2022-12-01	WOS:000226862000047
J	Elion, EA; Qi, MS; Chen, WD				Elion, EA; Qi, MS; Chen, WD			Signaling specificity in yeast	SCIENCE			English	Editorial Material							TRANSCRIPTION FACTOR; INVASIVE GROWTH; TEC1; DIFFERENTIATION		Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Elion, EA (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	elaine_elion@hms.harvard.edu						Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bruckner S, 2004, CURR GENET, V46, P331, DOI 10.1007/s00294-004-0545-1; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Palecek SP, 2000, GENETICS, V156, P1005; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	12	44	44	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2005	307	5710					687	688		10.1126/science.1109500	http://dx.doi.org/10.1126/science.1109500			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692041				2022-12-01	WOS:000226814900031
J	Storch, D; Marquet, PA; Gaston, KJ				Storch, D; Marquet, PA; Gaston, KJ			Untangling an entangled bank	SCIENCE			English	Editorial Material							BIODIVERSITY; PATTERNS		Charles Univ Prague, Ctr Theoret Study, CZ-11000 Prague 1, Czech Republic; Pontificia Univ Catolica Chile, Dept Ecol, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	Charles University Prague; Pontificia Universidad Catolica de Chile; University of Sheffield	Storch, D (corresponding author), Charles Univ Prague, Ctr Theoret Study, CZ-11000 Prague 1, Czech Republic.		Marquet, Pablo A/B-7732-2009; Storch, David/C-3339-2017	Marquet, Pablo A/0000-0001-6369-9339; Storch, David/0000-0001-5967-1544				Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; *CZECH REP, 2004, SCAL BIOD; Darwin Ch., 1959, ORIGIN SPECIES MEANS; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; Hubbell Stephen P., 2001, V32, pi; Sizling AL, 2004, ECOL LETT, V7, P60, DOI 10.1046/j.1461-0248.2003.00549.x; Storch D, 2003, SCIENCE, V299	10	11	11	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					684	686		10.1126/science.1106935	http://dx.doi.org/10.1126/science.1106935			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692039				2022-12-01	WOS:000226814900029
J	Thomas, WG				Thomas, WG			Double trouble for type 1 angiotensin receptors in atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Baker Heart Res Inst, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute	Thomas, WG (corresponding author), Baker Heart Res Inst, Melbourne, Vic, Australia.		Thomas, Walter/I-2208-2015	Thomas, Walter/0000-0003-0685-2952				AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.	5	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2005	352	5					506	508		10.1056/NEJMcibr043928	http://dx.doi.org/10.1056/NEJMcibr043928			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893NE	15689592				2022-12-01	WOS:000226725400015
J	Semmo, N; Barnes, E; Taylor, C; Kurtz, J; Harcourt, G; Smith, N; Klenerman, P				Semmo, N; Barnes, E; Taylor, C; Kurtz, J; Harcourt, G; Smith, N; Klenerman, P			T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors	LANCET			English	Article							INFECTION	Blood donors are routinely screened for hepatitis C virus infection. Some individuals have weak or restricted virus-specific antibody responses, and are classed as indeterminate. Such donors are almost always negative for viral RNA in blood. We postulated that previous transient virus exposure might account for some of these cases. With sensitive ex-vivo analyses of T-cell responses, we identified virus-specific responses in 15 of 30 indeterminate blood donors tested, compared with none in controls (p=0.0013). Additionally, these responses were typically focused on core. derived peptides. These findings suggest previous exposure to the virus in many indeterminate blood donors.	Univ Oxford, Oxford OX1 3SY, England; Natl Brood Serv, Birmingham, W Midlands, England	University of Oxford	Klenerman, P (corresponding author), Univ Oxford, Peter Medawar Bldg Pathogen Res,S Parks Rd, Oxford OX1 3SY, England.	paul.klenerman@medawar.ox.ac.uk		klenerman, paul/0000-0003-4307-9161; Barnes, Eleanor/0000-0002-0860-0831				Barnes E, 2002, HEPATOLOGY, V36, P743, DOI 10.1053/jhep.2002.35344; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; Dufour DR, 2003, CLIN CHEM, V49, P479, DOI 10.1373/49.3.479; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; *NAT BLOOD SERV IN, 2003, MONTHL DON TEST REP; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001	7	44	48	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2005	365	9456					327	329						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664228				2022-12-01	WOS:000226449600036
J	Maeda, T; Hobbs, RM; Merghoub, T; Guernah, I; Zelent, A; Cordon-Cardo, C; Teruya-Feldstein, J; Pandolfi, PP				Maeda, T; Hobbs, RM; Merghoub, T; Guernah, I; Zelent, A; Cordon-Cardo, C; Teruya-Feldstein, J; Pandolfi, PP			Role of the proto-oncogene Pokemon in cellular transformation and ARF repression	NATURE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL REPRESSOR; TISSUE MICROARRAY; BMI-1 ONCOPROTEIN; GENE-EXPRESSION; CYCLE ARREST; C-MYC; LYMPHOMA; SENESCENCE	Aberrant transcriptional repression through chromatin remodelling and histone deacetylation has been postulated to represent a driving force underlying tumorigenesis because histone deacetylase inhibitors have been found to be effective in cancer treatment. However, the molecular mechanisms by which transcriptional derepression would be linked to tumour suppression are poorly understood. Here we identify the transcriptional repressor Pokemon (encoded by the Zbtb7 gene) as a critical factor in oncogenesis. Mouse embryonic fibroblasts lacking Zbtb7 are completely refractory to oncogene-mediated cellular transformation. Conversely, Pokemon overexpression leads to overt oncogenic transformation both in vitro and in vivo in transgenic mice. Pokemon can specifically repress the transcription of the tumour suppressor gene ARF through direct binding. We find that Pokemon is aberrantly overexpressed in human cancers and that its expression levels predict biological behaviour and clinical outcome. Pokemon's critical role in cellular transformation makes it an attractive target for therapeutic intervention.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Inst Canc Res, Chester Beatty Labs, Leukaemia Res Fund Ctr, London SW3 6JB, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Maeda, Takahiro/AAC-4563-2019; Zelent, Arthur/B-3532-2009; Hobbs, Robin/I-2577-2014	Maeda, Takahiro/0000-0003-4530-6460; Zelent, Arthur/0000-0002-7968-9888; Hobbs, Robin/0000-0002-3853-2614	NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102142] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONLON JA, 1977, NEW ENGL J MED, V297, P461, DOI 10.1056/NEJM197709012970901; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jaffe E. S., 2001, PATHOLOGY GENETICS T; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; QUELLE DE, 1995, CELL, V83, P993; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Sanchez-Beato M, 2003, BLOOD, V101, P1220, DOI 10.1182/blood-2002-07-2009; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Weinberg RA, 1997, CELL, V88, P573, DOI 10.1016/S0092-8674(00)81897-8; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	49	272	325	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					278	285		10.1038/nature03203	http://dx.doi.org/10.1038/nature03203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662416				2022-12-01	WOS:000226381300046
J	Bertone-Johnson, ER				Bertone-Johnson, ER			Epidemiology of ovarian cancer: a status report	LANCET			English	Editorial Material							FOLLOW-UP; RISK; WOMEN		Univ Massachusetts, Dept Publ Hlth, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Bertone-Johnson, ER (corresponding author), Univ Massachusetts, Dept Publ Hlth, Amherst, MA 01003 USA.	ebertone@schoolph.umass.edu						Anderson JP, 2004, CANCER-AM CANCER SOC, V100, P1515, DOI 10.1002/cncr.20146; Barnett GL, 2004, CURR OPIN OBSTET GYN, V16, P79, DOI 10.1097/00001703-200402000-00014; Bray F, 2005, INT J CANCER, V113, P977, DOI 10.1002/ijc.20649; Engeland A, 2003, JNCI-J NATL CANCER I, V95, P1244, DOI 10.1093/jnci/djg010; Kashyap S, 2004, OBSTET GYNECOL, V103, P785, DOI 10.1097/01.AOG.0000119226.39514.1d; Kjaer SK, 2004, INT J EPIDEMIOL, V33, P596, DOI 10.1093/ije/dyh046; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; Larsson SC, 2004, AM J CLIN NUTR, V80, P1353, DOI 10.1093/ajcn/80.5.1353; Purdie DM, 2003, GYNECOL ONCOL, V88, pS145, DOI 10.1006/gyno.2002.6706; Riman T, 2004, ACTA OBSTET GYN SCAN, V83, P783, DOI 10.1111/j.0001-6349.2004.00550.x	10	35	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					101	102		10.1016/S0140-6736(05)17716-2	http://dx.doi.org/10.1016/S0140-6736(05)17716-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639276				2022-12-01	WOS:000226170700005
J	Croxall, JP; Silk, JRD; Phillips, RA; Afanasyev, V; Briggs, DR				Croxall, JP; Silk, JRD; Phillips, RA; Afanasyev, V; Briggs, DR			Global circumnavigations: Tracking year-round ranges of nonbreeding albatrosses	SCIENCE			English	Article							AUSTRALIA; OCEAN	Although albatrosses are paradigms of oceanic specialization, their foraging areas and migration routes when not breeding remain essentially unknown. Our continuous remote tracking of 22 adult gray-headed albatrosses for over 30 bird-years reveals three distinct strategies: (i) Stay in breeding home range; (ii) make return migrations to a specific area of the southwest Indian Ocean; and (iii) make one or more global circumnavigations (the fastest in just 46 days). The consistencies in patterns, routes, and timings offer the first hope of identifying areas of critical habitat for nonbreeding albatrosses, wherein appropriate management of longline fisheries might alleviate the plight of the world's most threatened family of birds.	British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Croxall, JP (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.							Brothers N, 1998, IBIS, V140, P446, DOI 10.1111/j.1474-919X.1998.tb04606.x; Croxall JP, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P69; Huin N, 2002, AQUAT CONSERV, V12, P89, DOI 10.1002/aqc.479; NICHOLLS D, 1995, EMU, V95, P223, DOI 10.1071/MU9950223; Nicholls DG, 2002, MAR ECOL PROG SER, V231, P269, DOI 10.3354/meps231269; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Prince PA, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P137; Tickell W. L. N., 1968, Antarctic Research Series Washington, V12, P1; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Weimerskirch H, 2000, NATURE, V406, P955, DOI 10.1038/35023068	11	227	240	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2005	307	5707					249	250		10.1126/science.1106042	http://dx.doi.org/10.1126/science.1106042			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653503				2022-12-01	WOS:000226361900041
J	Vanhorebeek, I; De Vos, R; Mesotten, D; Wouters, PJ; De Wolf-Peeters, C; Van den Berghe, G				Vanhorebeek, I; De Vos, R; Mesotten, D; Wouters, PJ; De Wolf-Peeters, C; Van den Berghe, G			Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients	LANCET			English	Article							OXIDATIVE STRESS; CRITICAL ILLNESS; ORGAN DYSFUNCTION; MODEL; THERAPY; PHOSPHORYLATION; SEVERITY; MUSCLE; LIPIDS; DAMAGE	Background Maintenance of normoglycaemia by use of insulin reduces morbidity and mortality of patients in surgical intensive care. Studies on mitochondrial function in critical illness or diabetes suggest that effects of intensive insulin therapy on mitochondrial integrity contribute to the clinical benefits. Methods Enzyme activities of the respiratory-chain complexes and oxidative-stress-sensitive glyceraldehyde-3. phosphate dehydrogenase (GAPDH) were measured by spectrophotometry in 36 snap-frozen samples of liver and skeletal muscle obtained after death from patients who had been randomly assigned intensive (normoglycaemia) or conventional (hyperglycaemia) insulin therapy and who were similar in terms of admission diagnoses and causes of death. Mitochondrial ultrastructure was examined by electron microscopy in a random subgroup (n=20). Findings In the liver, hypertrophic mitochondria with an increased number of abnormal and irregular cristae and reduced matrix electron density were observed in seven of nine conventionally treated patients. Only one of 11 patients given intensive insulin treatment had these morphological abnormalities (p=0.005). The effect on ultrastructure was associated with higher activities of respiratory-chain complex I (median 1.53 [IQR 1.14-3.01] vs 0.81 [0.54-1.43] U/g liver; p=0.008) and complex IV (1.69 [1.40-1.97] vs 1.16 [0.97-1.40] U/g; p=0.008) in the intensive group than in the conventional group. There was no detectable difference in GAPDH activity. In skeletal muscle, mitochondrial ultrastructure and function were not affected by intensive insulin therapy. Interpretation Strict glycaemic control with intensive insulin therapy prevented or reversed ultrastructural and functional abnormalities of hepatocyte mitochondria. The lack of effect on skeletal-muscle mitochondria suggests a direct effect of glucose toxicity and glucose control, rather than of insulin, as the likely explanation. Relevance to practice Maintenance or restoration of mitochondrial function and cellular energetics is another therapeutic target, in addition to optimisation of cardiac output, systemic oxygen delivery, and regional blood flow, that might improve outcome for critically ill patients. Our findings could help to explain the mechanism underlying the reduction in mortality found when normoglycaemia was maintained with insulin, and further support use of intensive insulin therapy in this setting.	Catholic Univ Louvain, Dept Intens Care Med, B-3000 Louvain, Belgium; Catholic Univ Louvain, Dept Morphol & Mol Pathol, B-3000 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Van den Berghe, G (corresponding author), Catholic Univ Louvain, Dept Intens Care Med, B-3000 Louvain, Belgium.	greta.vandenberghe@med.kuleuven.ac.be	Van den Berghe, Greet/J-6788-2018; Mesotten, Dieter/ABE-4176-2020	Van den Berghe, Greet/0000-0002-5320-1362; Mesotten, Dieter/0000-0002-3258-4720; Vanhorebeek, Ilse/0000-0002-5261-5192				Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; BERGMEYER HU, 1985, METHOD ENZYMAT AN, P211; Bissler JJ, 2002, LAB INVEST, V82, P335, DOI 10.1038/labinvest.3780427; Bonnefont-Rousselot D, 2002, CURR OPIN CLIN NUTR, V5, P561, DOI 10.1097/00075197-200209000-00016; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BREALEY DA, 2003, 16 ANN C AMST NETH O, pS134; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bulger EM, 2001, ARCH SURG-CHICAGO, V136, P1201, DOI 10.1001/archsurg.136.10.1201; Crouser ED, 2002, CRIT CARE MED, V30, P2722, DOI 10.1097/00003246-200212000-00017; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Fink MP, 2002, INTENS CARE MED, V28, P369, DOI 10.1007/s00134-001-1205-2; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; HALL JC, 1960, J BIOL CHEM, V235, P1536; HALL JC, 1960, J BIOL CHEM, V235, P6; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P1082, DOI 10.1210/jc.2002-021478; HUNT JV, 1988, BIOCHEM J, V256, P205, DOI 10.1042/bj2560205; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Mesotten D, 2004, J CLIN ENDOCR METAB, V89, P219, DOI 10.1210/jc.2003-030760; Miranda DR, 1996, CRIT CARE MED, V24, P64, DOI 10.1097/00003246-199601000-00012; Munnich A., 2001, METABOLIC MOL BASES, P2261; Oldham KM, 1998, J AM DIET ASSOC, V98, P1001, DOI 10.1016/S0002-8223(98)00230-2; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; RINEHART RW, 1982, ARCH BIOCHEM BIOPHYS, V213, P341, DOI 10.1016/0003-9861(82)90559-8; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338; Tomita M, 1996, JPN CIRC J, V60, P673, DOI 10.1253/jcj.60.673; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VESTER JW, 1957, J BIOL CHEM, V227, P669; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Weekers F, 2002, ENDOCRINOLOGY, V143, P764, DOI 10.1210/en.143.3.764; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x; Wolfe RR, 2000, WORLD J SURG, V24, P639, DOI 10.1007/s002689910105	35	311	335	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					53	59		10.1016/S0140-6736(04)17665-4	http://dx.doi.org/10.1016/S0140-6736(04)17665-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639679				2022-12-01	WOS:000226213100028
J	Pizarro, JC; Vulliez-Le Normand, B; Chesne-Seck, ML; Coilins, CR; Withers-Martinez, C; Hackett, F; Blackman, MJ; Faber, BW; Remarque, EJ; Kocken, CHM; Thomas, AW; Bentley, GA				Pizarro, JC; Vulliez-Le Normand, B; Chesne-Seck, ML; Coilins, CR; Withers-Martinez, C; Hackett, F; Blackman, MJ; Faber, BW; Remarque, EJ; Kocken, CHM; Thomas, AW; Bentley, GA			Crystal structure of the malaria vaccine candidate apical membrane antigen 1	SCIENCE			English	Article							PLASMODIUM-KNOWLESI; ERYTHROCYTE INVASION; APPLE DOMAINS; PAN MODULE; PROTEIN; IMMUNIZATION; MEROZOITES; EXPRESSION; HOMOLOG; PROGRAM	Apical membrane antigen 1 from Plasmodium is a leading malaria vaccine candidate. The protein is essential for host-cell invasion, but its molecular function is unknown. The crystal structure of the three domains comprising the ectoplasmic region of the antigen from P. vivax, solved at 1.8 angstrom resolution, shows that domains I and II belong to the PAN motif, which defines a superfamily of protein folds implicated in receptor binding. We also mapped the epitope of an invasion-inhibitory monoclonal antibody specific for the P. falciparum ortholog and modeled this to the structure. The location of the epitope and current knowledge on structure-function correlations for PAN domains together suggest a receptor-binding role during invasion in which domain II plays a critical part. These results are likely to aid vaccine and drug design.	Inst Pasteur, CNRS, URA 2185, Unite Immunol Struct, F-75724 Paris, France; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; MRC National Institute for Medical Research	Bentley, GA (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite Immunol Struct, 25 Rue Docteur Roux, F-75724 Paris, France.	bentley@pasteur.fr	Bentley, Graham/B-3623-2011; Remarque, Ed/AAE-8643-2020; Remarque, Edmond J/B-2217-2010	Faber, Bart/0000-0001-6808-1204; Marie-Laure, Chesne-Seck/0000-0002-0963-2181; Kocken, Clemens/0000-0002-4784-1734	Medical Research Council [MC_U117532063] Funding Source: Medline; MRC [MC_U117532063] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Brown PJ, 2001, FEBS LETT, V497, P31, DOI 10.1016/S0014-5793(01)02424-3; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huizinga EG, 2001, ACTA CRYSTALLOGR D, V57, P1071, DOI 10.1107/S0907444901007405; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; Tomley FM, 2001, TRENDS PARASITOL, V17, P81, DOI 10.1016/S1471-4922(00)01761-X; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Vulliez-Le Normand B, 2004, ACTA CRYSTALLOGR D, V60, P2040, DOI 10.1107/S090744490402116X; WATERS AP, 1990, J BIOL CHEM, V265, P17974	27	157	166	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					408	411		10.1126/science.1107449	http://dx.doi.org/10.1126/science.1107449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15731407				2022-12-01	WOS:000228492000051
J	Ho, LP; Urban, BC; Thickett, DR; Davies, RJO; McMichael, AJ				Ho, LP; Urban, BC; Thickett, DR; Davies, RJO; McMichael, AJ			Deficiency of a subset of T cells with immunoregulatory properties in sarcoidosis	LANCET			English	Article							NKT CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T(H)2 BIAS; EXPRESSION; ACTIVATION; PREVENTS; IL-12; LYMPHOCYTES	Background Sarcoidosis is a multisystem disorder that predominantly involves the lungs, characterised by a T-helper-1 (Th1) biased CD4-positive T-cell response and granuloma formation, for which the explanation is unknown. A newly identified subset of T cells with immunoregulatory functions, CD1d-restricted natural-killer T (NKT) cells, has been shown to protect against disorders with increased CD4-positive Th1 responses in animals. We explored whether abnormalities in these cells are implicated in the pathogenesis of sarcoidosis. Methods We generated fluorescence-labelled CD1d-tetrameric complexes and used them, with monoclonal antibodies to V alpha 24 and V beta 11 T-cell receptor, to assess the frequency of CD1d-restricted NKT cells in the peripheral blood of 60 patients with histologically proven sarcoidosis (16 with Lofgren's syndrome) and 60 healthy controls. Lung lymphocytes were also analysed in 16 of the patients with sarcoidosis. Findings CD1d-restricted NKT cells were absent or greatly reduced in peripheral blood from all patients with sarcoidosis, except those with Lofgren's syndrome (median proportion of lymphocytes 0.01% [IQR 0-0.03] vs 0.06% [0.03-0.12] in controls; p=0.0004). The deficiency was found in both acute and resolved disease and was unrelated to systemic corticosteroid therapy. There was no difference in the proportion of CD1d-restricted NKT cells between peripheral blood and lungs in patients, suggesting that the peripheral-blood deficiency is not due to sequestration of these cells in the lungs. The NKT cells were not observed in mediastinal lymph nodes or granulomatous lesions. CD1d expression on antigen-presenting cells of patients was normal, thus the deficiency of CD1d-restricted NKT cells is not explained by abnormal CD1d expression. Interpretation Loss of immunoregulation by CD1d-restricted NKT cells could explain the amplified and persistent T-cell activity that characterises sarcoidosis. Relevance to practice Our findings give new insight into the pathogenesis of sarcoidosis and draw attention to a potential target for therapeutic modulation in sarcoidosis.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 7DS, England; Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England; Univ Birmingham, Dept Med Sci, Lung Injury & Fibrosis Treatment Programme, Birmingham, W Midlands, England	University of Oxford; University of Oxford; University of Birmingham	Ho, LP (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 7DS, England.		Urban, Britta/W-6087-2018; thickett, david/I-4770-2012; Ho, Ling-Pei/AAL-4776-2021	Urban, Britta/0000-0002-4197-8393; thickett, david/0000-0002-5456-6080; Ho, Ling Pei/0000-0001-8319-301X				Agostini C, 2002, CURR OPIN PULM MED, V8, P435, DOI 10.1097/00063198-200209000-00016; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Araki M, 2003, INT IMMUNOL, V15, P279, DOI 10.1093/intimm/dxg029; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Carnaud C, 1999, J IMMUNOL, V163, P4647; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Gansert JL, 2003, J IMMUNOL, V170, P3154, DOI 10.4049/jimmunol.170.6.3154; Gillessen S, 2003, P NATL ACAD SCI USA, V100, P8874, DOI 10.1073/pnas.1033098100; Ho LP, 2004, J IMMUNOL, V172, P7350, DOI 10.4049/jimmunol.172.12.7350; Ho LP, 2002, CHEST, V121, P1421, DOI 10.1378/chest.121.5.1421; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hosoda Y, 1997, CLIN CHEST MED, V18, P681, DOI 10.1016/S0272-5231(05)70412-3; Illes Z, 2000, J IMMUNOL, V164, P4375, DOI 10.4049/jimmunol.164.8.4375; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KONISHI K, 1988, J CLIN INVEST, V82, P775, DOI 10.1172/JCI113678; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moller DR, 1996, J IMMUNOL, V156, P4952; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shigehara K, 2001, J IMMUNOL, V166, P642, DOI 10.4049/jimmunol.166.1.642; SILTZBACH LE, 1967, MED CLIN N AM, V51, P483, DOI 10.1016/S0025-7125(16)33069-3; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Spagnolo P, 2003, AM J RESP CRIT CARE, V168, P1162, DOI 10.1164/rccm.200303-456OC; Taha RA, 1999, AM J RESP CRIT CARE, V160, P1119, DOI 10.1164/ajrccm.160.4.9807120; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Yang OO, 2000, J IMMUNOL, V165, P3756, DOI 10.4049/jimmunol.165.7.3756	34	67	69	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1062	1072		10.1016/S0140-6736(05)71143-0	http://dx.doi.org/10.1016/S0140-6736(05)71143-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781102				2022-12-01	WOS:000227731800031
J	Veneti, Z; Bentley, JK; Koana, T; Braig, HR; Hurst, GDD				Veneti, Z; Bentley, JK; Koana, T; Braig, HR; Hurst, GDD			A functional dosage compensation complex required for male killing in Drosophila	SCIENCE			English	Article							SEX; MELANOGASTER; GENE; WILLISTONI	Bacteria that selectively kilt males ("male-killers") were first characterized more than 50 years ago in Drosophila and have proved to be common in insects. However, the mechanism by which sex specificity of virulence is achieved has remained unknown. We tested the ability of Spiroplasma poulsonii to kill Drosophila melanogaster mates carrying mutations in genes that encode the dosage compensation complex. The bacterium failed to kill mates lacking any of the five protein components of the complex.	UCL, Dept Biol, London NW1 2HE, England; Cent Res Inst Elect Power Ind, Low Dose Radiat Res Ctr, Tokyo 2018511, Japan; Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales	University of London; University College London; Central Research Institute of Electric Power Industry - Japan; Bangor University	Hurst, GDD (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	g.hurst@ucl.ac.uk	Hurst, Gregory D D/C-2723-2008; Braig, Henk/I-5477-2013	Hurst, Gregory D D/0000-0002-7163-7784; Braig, Henk/0000-0001-9592-1141				CLINE TW, 1984, GENETICS, V107, P231; COUNCE SJ, 1962, J EXP ZOOL, V151, P17, DOI 10.1002/jez.1401510103; Dyson EA, 2004, P NATL ACAD SCI USA, V101, P6520, DOI 10.1073/pnas.0304068101; Franke A, 1996, DEVELOPMENT, V122, P2751; Gilfillan GD, 2004, FEBS LETT, V567, P8, DOI 10.1016/j.febslet.2004.03.110; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2003, CONT T ENT, P177; Jiggins FM, 2000, P ROY SOC B-BIOL SCI, V267, P69, DOI 10.1098/rspb.2000.0968; MAGNI GE, 1953, NATURE, V172, P81, DOI 10.1038/172081a0; SAKAGUCHI B, 1963, GENETICS, V48, P841; SANCHEZ L, 1983, EMBO J, V2, P485, DOI 10.1002/j.1460-2075.1983.tb01451.x; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	13	73	74	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1461	1463		10.1126/science.1107182	http://dx.doi.org/10.1126/science.1107182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746426				2022-12-01	WOS:000227503100045
J	Horstmann, E; McCabe, MS; Grochow, L; Yamamoto, S; Rubinstein, L; Budd, T; Shoemaker, D; Emanuel, EJ; Grady, C				Horstmann, E; McCabe, MS; Grochow, L; Yamamoto, S; Rubinstein, L; Budd, T; Shoemaker, D; Emanuel, EJ; Grady, C			Risks and benefits of phase 1 oncology trials, 1991 through 2002	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL-CANCER-INSTITUTE; CLINICAL-TRIALS; I TRIALS; THERAPEUTIC RESPONSE; PROGNOSTIC-FACTORS; ANTICANCER AGENTS; ETHICS; DESIGN; SURVIVAL; RATES	BACKGROUND Previous reviews of phase 1 oncology trials reported a rate of response to treatment of 4 to 6 percent and a toxicity-related death rate of 0.5 percent. These results may not reflect the rates in current phase 1 oncology trials. METHODS We reviewed all nonpediatric phase 1 oncology trials sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute between 1991 and 2002. We report the rates of response to treatment, of stable disease, of grade 4 toxic events, and of treatment-related deaths. RESULTS We analyzed 460 trials involving 11,935 participants, all of whom were assessed for toxicity and 10,402 of whom were assessed for a response to therapy. The overall response rate (i.e., for both complete and partial responses) was 10.6 percent, with considerable variation among trials. ``Classic'' phase 1 trials of single investigational chemotherapeutic agents represented only 20 percent of the trials and had a response rate of 4.4 percent. Studies that included at least one anticancer agent approved by the Food and Drug Administration constituted 46.3 percent of the trials and had a response rate of 17.8. An additional 34.1 percent of participants had stable disease or a less-than-partial response. The overall rate of death due to toxic events was 0.49 percent. Of 3465 participants for whom data on patient-specific grade 4 toxic events were available, 14.3 percent had had at least one episode of grade 4 toxic events. CONCLUSIONS Overall response rates among phase 1 oncology trials are higher than previously reported, although they have not changed for classic phase 1 trials, and toxicity-related death rates have remained stable. Rates of response and toxicity vary, however, among the various types of phase 1 oncology trials.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, Canc Therapy Evaluat Program, NIH, Rockville, MD USA; Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan	National Institutes of Health (NIH) - USA; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Cancer Center - Japan	Grady, C (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Rm 1C118, Bethesda, MD 20892 USA.	cgrady@nih.gov		Rubinstein, Lawrence/0000-0002-9720-9737	CLINICAL CENTER [Z01CL010522] Funding Source: NIH RePORTER	CLINICAL CENTER		Agrawal M, 2003, JAMA-J AM MED ASSOC, V290, P1075, DOI 10.1001/jama.290.8.1075; Annas G J, 1992, Health Matrix Clevel, V2, P119; Ansher SS, 2001, ANN NY ACAD SCI, V949, P333; Bachelot T, 2000, ANN ONCOL, V11, P151, DOI 10.1023/A:1008368319526; *CANC THER EV PROG, 1999, COMM TOX CRIT CTC VE; Chen EX, 2004, JAMA-J AM MED ASSOC, V292, P2150, DOI 10.1001/jama.292.17.2150; Daugherty CK, 1997, ANN INTERN MED, V126, P892, DOI 10.7326/0003-4819-126-11-199706010-00008; DECOSTER G, 1990, ANN ONCOL, V1, P175, DOI 10.1093/oxfordjournals.annonc.a057716; Dent SF, 1996, ANN ONCOL, V7, P561; Eisenhauer EA, 2000, J CLIN ONCOL, V18, P684, DOI 10.1200/JCO.2000.18.3.684; EMANUEL EJ, 1995, J CLIN ONCOL, V13, P1049, DOI 10.1200/JCO.1995.13.5.1049; ESTEY E, 1986, CANCER TREAT REP, V70, P1105; Goldman DP, 2003, JAMA-J AM MED ASSOC, V289, P2970, DOI 10.1001/jama.289.22.2970; Han C, 2003, BRIT J CANCER, V89, P1166, DOI 10.1038/sj.bjc.6601218; ITOH K, 1994, CANCER CHEMOTH PHARM, V34, P451, DOI 10.1007/BF00685653; KODISH E, 1992, J CLIN ONCOL, V10, P1810, DOI 10.1200/JCO.1992.10.11.1810; LIPSETT MB, 1982, JAMA-J AM MED ASSOC, V248, P941, DOI 10.1001/jama.248.8.941; MARKMAN M, 1992, J CANCER RES CLIN, V119, P5, DOI 10.1007/BF01209482; Markman M, 2003, CLEV CLIN J MED, V70, P1008, DOI 10.3949/ccjm.70.12.1008; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Miller M, 2000, HASTINGS CENT REP, V30, P34, DOI 10.2307/3527646; Miller M, 2001, Int Anesthesiol Clin, V39, P13; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Sekine I, 2002, ANN ONCOL, V13, P1300, DOI 10.1093/annonc/mdf202; Shanafelt TD, 2004, J CLIN ONCOL, V22, P1966, DOI 10.1200/JCO.2004.08.176; Smith TL, 1996, J CLIN ONCOL, V14, P287, DOI 10.1200/JCO.1996.14.1.287; Takimoto CH, 2003, CANCER CHEMOTH PHARM, V52, pS29, DOI 10.1007/s00280-003-0623-y; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; VONHOFF DD, 1991, INVEST NEW DRUG, V9, P115, DOI 10.1007/BF00194562	29	332	340	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					895	904		10.1056/NEJMsa042220	http://dx.doi.org/10.1056/NEJMsa042220			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745980				2022-12-01	WOS:000227310700008
J	Cattadori, IM; Haydon, DT; Hudson, PJ				Cattadori, IM; Haydon, DT; Hudson, PJ			Parasites and climate synchronize red grouse populations	NATURE			English	Article							TRICHOSTRONGYLUS-TENUIS; DYNAMICS; STABILITY; BEHAVIOR; SYSTEM	There is circumstantial evidence that correlated climatic conditions can drive animal populations into synchronous fluctuations in abundance(1-5). However, it is unclear whether climate directly affects the survival and fecundity of individuals, or indirectly, by influencing food and natural enemies. Here we propose that climate affects trophic interactions and could be an important mechanism for synchronizing spatially distributed populations. We show that in specific years the size of red grouse populations in northern England either increases or decreases in synchrony. In these years, widespread and correlated climatic conditions during May and July affect populations regionally and influence the density-dependent transmission of the gastrointestinal nematode Trichostrongylus tenuis, a parasite that reduces grouse fecundity(6). This in turn forces grouse populations into synchrony. We conclude that specific climatic events may lead to outbreaks of infectious diseases or pests that may cause dramatic, synchronized changes in the abundance of their hosts.	Penn State Univ, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Glasgow	Cattadori, IM (corresponding author), Penn State Univ, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	imc3@psu.edu	Hudson, Peter/AAB-8080-2020	Hudson, Peter/0000-0003-0468-3403; Cattadori, Isabella/0000-0001-6618-316X; Haydon, Daniel/0000-0002-1240-1886				Anderson R.C., 2000, NEMATODE PARASITES V; Bjornstad ON, 2002, SCIENCE, V298, P1020, DOI 10.1126/science.1075182; Buonaccorsi JP, 2001, ECOLOGY, V82, P1668, DOI 10.2307/2679809; Cattadori IM, 2000, J ANIM ECOL, V69, P620, DOI 10.1046/j.1365-2656.2000.00421.x; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; Greenman JV, 2001, OIKOS, V93, P343, DOI 10.1034/j.1600-0706.2001.930217.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P435, DOI 10.1098/rspb.2002.2230; Haydon DT, 2002, P ROY SOC B-BIOL SCI, V269, P1609, DOI 10.1098/rspb.2002.2053; Hudson P.J., 1992, GROUSE SPACE TIME; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; HUDSON PJ, 1986, J ANIM ECOL, V55, P85, DOI 10.2307/4694; Hudson PJ, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P109; Hudson PJ, 2002, PHILOS T R SOC B, V357, P1259, DOI 10.1098/rstb.2002.1126; HUDSON PJ, 1995, INFECT DIS NATURAL P, P144; HUDSON PJ, 1999, SCIENCE, V286, P2425; Lee D.L., 2002, BIOL NEMATODES, DOI 10.1201/b12614; Marquardt W.C., 2000, PARASITOLOGY VECTOR; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mougeot F, 2003, NATURE, V421, P737, DOI 10.1038/nature01395; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Pugesek BH, 2003, STRUCTURAL EQUATION; RANTA E, 1995, P ROY SOC B-BIOL SCI, V262, P113, DOI 10.1098/rspb.1995.0184; Ranta E, 1997, OIKOS, V78, P136, DOI 10.2307/3545809; Shipley B., 2000, CAUSE CORRELATION BI; SLAGSVOLD T, 1975, Norwegian Journal of Zoology, V23, P269; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; WATSON A, 1984, J ANIM ECOL, V53, P663, DOI 10.2307/4542	29	128	133	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					737	741		10.1038/nature03276	http://dx.doi.org/10.1038/nature03276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716952				2022-12-01	WOS:000227039200038
J	Derry, LA; Kurtz, AC; Ziegler, K; Chadwick, OA				Derry, LA; Kurtz, AC; Ziegler, K; Chadwick, OA			Biological control of terrestrial silica cycling and export fluxes to watersheds	NATURE			English	Article							GERMANIUM; FRACTIONATION; GEOCHEMISTRY; ALUMINUM; FOREST; RIVERS; GE/SI	Silicon has a crucial role in many biogeochemical processes - for example, as a nutrient for marine and terrestrial biota, in buffering soil acidification and in the regulation of atmospheric carbon dioxide. Traditionally, silica fluxes to soil solutions and stream waters are thought to be controlled by the weathering and subsequent dissolution of silicate minerals(1,2). Rates of mineral dissolution can be enhanced by biological processes(3). But plants also take up considerable quantities of silica from soil solution, which is recycled into the soil from falling litter in a separate soil - plant silica cycle that can be significant in comparison with weathering input and hydrologic output(4-8). Here we analyse soil water in basaltic soils across the Hawaiian islands to assess the relative contributions of weathering and biogenic silica cycling by using the distinct signatures of the two processes in germanium/silicon ratios. Our data imply that most of the silica released to Hawaiian stream water has passed through the biogenic silica pool, whereas direct mineral - water reactions account for a smaller fraction of the stream silica flux. We expect that other systems exhibiting strong Si depletion of the mineral soils and/or high Si uptake rates by biomass will also have strong biological control on silica cycling and export.	Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA; Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	Cornell University; Boston University; University of California System; University of California Santa Barbara	Derry, LA (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA.	lad9@cornell.edu	Derry, Louis A/H-5637-2016	Derry, Louis A/0000-0001-7062-7333				Alexandre A, 1997, GEOCHIM COSMOCHIM AC, V61, P677, DOI 10.1016/S0016-7037(97)00001-X; BARTOLI F, 1980, SOIL SCI SOC AM J, V44, P873, DOI 10.2136/sssaj1980.03615995004400040043x; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; DEARGOLLO R, 1978, GEOCHIM COSMOCHIM AC, V42, P623, DOI 10.1016/0016-7037(78)90007-8; Dove P.M., 1995, CHEM WEATHERING RATE, P235; Drees L.R., 1989, MINERALS SOIL ENV, P914; Drever J.I., 1988, GEOCHEMISTRY NATURAL; Exley C, 2002, COORDIN CHEM REV, V228, P127, DOI 10.1016/S0010-8545(02)00077-2; Fraysse F, 2004, GEOCHIM COSMOCHIM AC, V68, pA216; Froelich PN, 1992, PALEOCEANOGRAPHY, V7, P739, DOI 10.1029/92PA02090; FROELICH PN, 1981, SCIENCE, V213, P205, DOI 10.1126/science.213.4504.205; FROELICH PN, 1985, J GEOPHYS RES-OCEANS, V90, P1133, DOI 10.1029/JC090iC01p01133; Garrels R.M., 1967, RES GEOCHEMISTRY, P405; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Kelly EF, 1998, BIOGEOCHEMISTRY, V42, P21, DOI 10.1023/A:1005919306687; Kurtz A., 2004, P 11 INT S WAT ROCK, P833; Kurtz AC, 2001, GEOCHIM COSMOCHIM AC, V65, P1971, DOI 10.1016/S0016-7037(01)00575-0; Kurtz AC, 2002, GEOCHIM COSMOCHIM AC, V66, P1525, DOI 10.1016/S0016-7037(01)00869-9; Lajtha K, 1999, LT EC RES NETWK SER, V2, P166; LUCAS Y, 1993, SCIENCE, V260, P521, DOI 10.1126/science.260.5107.521; Markewitz D, 1998, BIOGEOCHEMISTRY, V42, P235, DOI 10.1023/A:1005901417165; Meunier JD, 2004, GEOCHIM COSMOCHIM AC, V68, pA411; Meunier JD, 1999, GEOLOGY, V27, P835; MORTLOCK RA, 1987, GEOCHIM COSMOCHIM AC, V51, P2075, DOI 10.1016/0016-7037(87)90257-2; Mortlock RA, 1996, ANAL CHIM ACTA, V332, P277, DOI 10.1016/0003-2670(96)00230-9; Moulton KL, 2000, AM J SCI, V300, P539, DOI 10.2475/ajs.300.7.539; MURNANE RJ, 1990, NATURE, V344, P749, DOI 10.1038/344749a0; VITOUSEK PM, 1995, J TROP ECOL, V11, P189, DOI 10.1017/S0266467400008634; VITOUSEK PM, 1997, GSA TODAY, V7, P1	30	343	366	6	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					728	731		10.1038/nature03299	http://dx.doi.org/10.1038/nature03299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716949				2022-12-01	WOS:000227039200035
J	Ojikutu, BO; Stone, VE				Ojikutu, BO; Stone, VE			Women, inequality, and the burden of HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ojikutu, BO (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.			Ojikutu, Bisola/0000-0001-7957-8881				*CDCP, 2004, HIV AIDS SURV REP, V15, P18; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; *UNAIDS, 2004, 2004 REP GLOB AIDS E, P22	4	31	32	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2005	352	7					649	652		10.1056/NEJMp048318	http://dx.doi.org/10.1056/NEJMp048318			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897UO	15716557				2022-12-01	WOS:000227031100002
J	Larrabee, PB; Johnson, KL; Lai, CQ; Ordovas, J; Cowan, JM; Tantravahi, U; Bianchi, DW				Larrabee, PB; Johnson, KL; Lai, CQ; Ordovas, J; Cowan, JM; Tantravahi, U; Bianchi, DW			Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MATERNAL PLASMA; CANCER-PATIENTS; MICROSATELLITE ALTERATIONS; FETAL DNA; SERUM; ARRAYS; OLIGONUCLEOTIDE; AQUAPORIN-1	Context No molecular biological tests are available to monitor the ongoing development of human fetuses in vivo. Objective To determine whether cell-free fetal messenger RNA (mRNA) in amniotic fluid can be detected using oligonucleotide microarrays to study large-scale gene expression in living human fetuses, with analysis of sex, gestational age, and fetal pathology as variables. Design, Setting, and Patients Four samples of cell-free amniotic fluid were analyzed from pregnant women between 20 and 32 weeks' gestation and undergoing amnioreduction for polyhydramnios associated with twin-twin transfusion syndrome or hydrops fetalis (cases). The control consisted of 6 pooled amniotic fluid samples from women at 17 weeks' gestation and undergoing genetic amniocentesis. After extraction from the normally discarded fraction of amniotic fluid, RNA was amplified twice, labeled, and analyzed using gene expression microarrays. Main Outcome Measure Relative mRNA expression in cell-free samples of amniotic fluid from fetuses with polyhydramnios at different gestational ages vs cell-free amniotic fluid from a pooled control. Results Thirty-six percent of 22 283 probe sets represented on the arrays were present in the cell-free amniotic fluid, and a median of 20% of all probe sets differed between cases and the pooled control. Only male samples expressed 1 Y chromosome transcript. The expression of some developmental transcripts, such as surfactant proteins, mucins, and keratins, changed with gestational age by up to 64-fold. A water transporter gene transcript was increased up to 18-fold in both twin-twin transfusion samples. Placental gene transcripts were not present in any samples., Conclusions This pilot study demonstrates that cell-free fetal mRNA can be extracted from amniotic fluid and successfully hybridized to gene expression microarrays. Preliminary analysis suggests that gene expression changes can be detected in fetuses of different sexes, gestational age, and disease status. Cell-free mRNA in amniotic fluid appears to originate from the fetus and not the placenta.	Tufts Univ, New England Med Ctr, Div Genet, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr, Dept Pediat, Div Newborn Med, Boston, MA 02111 USA; Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA; Brown Univ, Women & Infants Hosp, Dept Pathol & Lab Med, Providence, RI USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Tufts University; Brown University; Women & Infants Hospital Rhode Island	Bianchi, DW (corresponding author), Tufts Univ, New England Med Ctr, Div Genet, 750 Washington St,NEMC 394, Boston, MA 02111 USA.	dbianchi@tufts-nemc.org	Ordovas, Jose/B-8727-2013	Ordovas, Jose/0000-0002-7581-5680; Lai, Chao-Qiang/0000-0003-1107-8375	NICHD NIH HHS [HD42053] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042053] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bianchi DW, 2001, CLIN CHEM, V47, P1867; Botezatu I, 2000, CLIN CHEM, V46, P1078; Chen XQ, 1996, NAT MED, V2, P1033; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Jonker SS, 2003, EXP PHYSIOL, V88, P691, DOI 10.1113/eph8802626; LARSEN WJ, 1993, HUMAN EMBRYOLOGY, P421; LEON SA, 1977, CANCER RES, V37, P646; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mann SE, 2002, AM J OBSTET GYNECOL, V187, P902, DOI 10.1067/mob.2002.127168; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Ng EKO, 2002, CLIN CHEM, V48, P1212; Poon LLM, 2000, CLIN CHEM, V46, P1832; Sekizawa A, 2003, HUM GENET, V113, P307, DOI 10.1007/s00439-003-0987-4; Tsui NBY, 2002, CLIN CHEM, V48, P1647	21	51	53	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2005	293	7					836	842		10.1001/jama.293.7.836	http://dx.doi.org/10.1001/jama.293.7.836			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DQ	15713773	Bronze			2022-12-01	WOS:000226984600025
J	Nettles, RE; Kieffer, TL; Kwon, P; Monie, D; Han, YF; Parsons, T; Cofrancesco, J; Gallant, JE; Quinn, TC; Jackson, B; Flexner, C; Carson, K; Ray, S; Persaud, D; Siliciano, RF				Nettles, RE; Kieffer, TL; Kwon, P; Monie, D; Han, YF; Parsons, T; Cofrancesco, J; Gallant, JE; Quinn, TC; Jackson, B; Flexner, C; Carson, K; Ray, S; Persaud, D; Siliciano, RF			Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD; RNA LEVELS; HIV-1-INFECTED PATIENTS; INFLUENZA VACCINATION; VIROLOGICAL FAILURE; GENOTYPIC ANALYSIS; LATENT RESERVOIR; STEADY-STATE	Context Many patients infected with human immunodeficiency virus type 1 (HIV-1) and receiving highly active antiretroviral therapy experience intermittent episodes of detectable viremia ("blips"), which may raise concerns about drug resistance, lead to costly repeat measurements of viral RNA, and sometimes trigger alterations in therapy. Objective To test the hypothesis that blips represent random biological and statistical variation around mean steady-state HIV-1 RNA levels slightly below 50 copies/mL rather than biologically significant elevations in viremia. Design, Setting, and Patients Between June 19, 2003, and February 9, 2004, patients receiving therapy underwent intensive sampling (every 2-3 days) over 3 to 4 months to define the frequency, magnitude, and duration of blips and their association with drug levels and other clinical variables. Blips were defined as HIV-1 RNA measurements greater than or equal to 50 copies/mL preceded and followed by measurements less than 50 copies/mL without a change in treatment. To-determine whether blips result from or lead to drug resistance, an ultrasensitive genotyping assay was used to detect drug resistance mutations before, during, and after blips. Patients were 10 HIV-1-infected asymptomatic adults recruited by clinicians and followed up in the Moore Clinic at the Johns Hopkins Hospital. Patients had suppression of viremia to below 50 copies/mL while receiving a stable antiretroviral regimen for 6 months or longer. Main Outcome Measures At each time point, plasma HIV-1 RNA levels were measured in 2 independent laboratories and drug resistance mutations were analyzed by clonal sequencing. Results With the intensive sampling, blips were detected in 9 of 10 patients. Statistical analysis was consistent with random assay variation around a mean viral load below 50 copies/mL. Blips were not concordant on independent testing and had a short duration (median, <3 days) and low magnitude (median, 79 copies/mL). Blip frequency was not associated with demographic, clinical, or treatment variables. Blips did not occur in relation to illness, vaccination, or directly measured antiretroviral drug concentrations. Blips were marginally associated (P=.08) with reported episodes of nonadherence. Most importantly, in approximately 1000 independent clones sequenced for both protease and reverse transcriptase, no new resistance mutations were seen before, during, or shortly after blips. Conclusion Most blips in this population appear to represent random biological and statistical variation around mean HIV-1 levels below 50 copies/mL rather than clinically significant elevations in viremia.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; NIAID, NIH, Bethesda, MD 20892 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 879 Broadway Res Bldg,733 N Broadway, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu	Ray, Stuart C./B-7527-2008; Quinn, Thomas/A-2494-2010	Ray, Stuart C./0000-0002-1051-7260; jackson, brooks/0000-0001-9458-135X	NCRR NIH HHS [M01-RR00052] Funding Source: Medline; NIAID NIH HHS [F32 AI056696, AI51178, AI43222, K08 AI060367] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222, R37AI051178, Z01AI000361, K08AI060367, F32AI056696, R01AI051178] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aleman S, 2002, AIDS, V16, P1039, DOI 10.1097/00002030-200205030-00010; Armitage P., 1987, STAT METHODS MED RES; BARTLETT JG, 2004, GUIDELINES USE ANTIR; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Crommentuyn KML, 2004, ANTIVIR THER, V9, P779; Deeks SG, 1997, J INFECT DIS, V176, P514, DOI 10.1086/517278; Di Mascio M, 2004, MATH BIOSCI, V188, P47, DOI 10.1016/j.mbs.2003.08.003; Di Mascio M, 2004, J VIROL, V78, P10566, DOI 10.1128/JVI.78.19.10566-10573.2004; Di Mascio M, 2003, J VIROL, V77, P12165, DOI 10.1128/JVI.77.22.12165-12172.2003; DOMADULA G, 1999, JAMA-J AM MED ASSOC, V282, P1627; Easterbrook PJ, 2002, AIDS, V16, P1521, DOI 10.1097/00002030-200207260-00009; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 2000, J INFECT DIS, V181, P522, DOI 10.1086/315260; Gunthard HF, 1999, J VIROL, V73, P9404; Gunthard HF, 1998, J VIROL, V72, P2422; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HAMMOND J, 2004, LOS ALAMOS HIV SEQUE; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; HOLODNIY M, 1994, J ACQ IMMUN DEF SYND, V7, P363; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jackson JB, 2004, J CLIN MICROBIOL, V42, P2774, DOI 10.1128/JCM.42.6.2774-2776.2004; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kolber MA, 2002, AIDS, V16, P537, DOI 10.1097/00002030-200203080-00004; Lamotte C, 1999, J CHROMATOGR B, V735, P159, DOI 10.1016/S0378-4347(99)00419-3; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Miller LG, 2004, J INFECT DIS, V189, P1487, DOI 10.1086/382895; Mira JA, 2002, ANTIVIR THER, V7, P251; Moore AL, 2002, AIDS, V16, P615, DOI 10.1097/00002030-200203080-00013; Parkin NT, 2000, AIDS, V14, P2877, DOI 10.1097/00002030-200012220-00009; Pav JW, 1999, J PHARMACEUT BIOMED, V20, P91, DOI 10.1016/S0731-7085(98)00312-4; Percus JK, 2003, B MATH BIOL, V65, P263, DOI 10.1016/S0092-8240(02)00095-2; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 2002, AIDS, V16, P1627, DOI 10.1097/00002030-200208160-00008; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; *ROCH DIAGN CORP, 2002, ROCH AMPL HIV 1 MON; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHAFER RW, 2004, GM STANFORD HIV RT P; Sklar PA, 2002, AIDS, V16, P2035, DOI 10.1097/00002030-200210180-00008; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Stuart JWTC, 2001, J ACQ IMMUN DEF SYND, V28, P105, DOI 10.1097/00042560-200110010-00001; Swofford D, 2000, PAUP PHYLOGENETIC AN; Wain-Hobson S, 2003, J GEN VIROL, V84, P885, DOI 10.1099/vir.0.18894-0; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	59	296	300	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2005	293	7					817	829		10.1001/jama.293.7.817	http://dx.doi.org/10.1001/jama.293.7.817			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DQ	15713771	Bronze			2022-12-01	WOS:000226984600023
J	Boire, A; Covic, L; Agarwal, A; Jacques, S; Sherifl, S; Kuliopulos, A				Boire, A; Covic, L; Agarwal, A; Jacques, S; Sherifl, S; Kuliopulos, A			PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells	CELL			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; THROMBIN-RECEPTOR; ENDOTHELIAL-CELLS; TISSUE FACTOR; EXPRESSION; INHIBITION; TRANSFORMATION; ANGIOGENESIS; METASTASIS; ANTAGONIST	Protease-activated receptors (PARs) are a unique class of G protein-coupled receptors that play critical roles in thrombosis, inflammation, and vascular biology. PAR1 is proposed to be involved in the invasive and metastatic processes of various cancers. However, the protease responsible for activating the pro-invasive functions of PAR1 remains to be identified. Here, we show that expression of PAR1 is both required and sufficient to promote growth and invasion of breast carcinoma cells in a xenograft model. Further, we show that the matrix metalloprotease, MMP-1, functions as a protease agonist of PAR1 cleaving the receptor at the proper site to generate PAR1-dependent Ca2+ signals and migration. MMP-1 activity is derived from fibroblasts and is absent from the breast cancer cells. These results demonstrate that MMP-1 in the stromal-tumor microenvironment can alter the behavior of cancer cells through PAR1 to promote cell migration and invasion.	Tufts Univ, Sch Med, Mol Oncol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Div Hematol Oncol, Tufts New England Med Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Mt Auburn Hosp, Dept Pathol, Cambridge, MA 02138 USA	Tufts University; Tufts Medical Center; Tufts University; Tufts University; Harvard University; Mount Auburn Hospital	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Mol Oncol Res Inst, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu	Boire, Adrienne/AAJ-9352-2021; Boire, Adrienne/AAA-3578-2022	Boire, Adrienne/0000-0002-9029-1248	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064701] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64701] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Bernatowicz MS, 1996, J MED CHEM, V39, P4879, DOI 10.1021/jm960455s; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Caunt M, 2003, J THROMB HAEMOST, V1, P2097, DOI 10.1046/j.1538-7836.2003.00426.x; CHEN J, 1994, J BIOL CHEM, V269, P16041; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2003, J PATHOL, V200, P47, DOI 10.1002/path.1338; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; FISCHER EG, 1995, CANCER RES, V55, P1629; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Heppner KJ, 1996, AM J PATHOL, V149, P273; Jacques SL, 2003, BIOCHEM J, V376, P733, DOI 10.1042/BJ20030954; Kamath L, 2001, CANCER RES, V61, P5933; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Ku DD, 1997, J CARDIOVASC PHARM, V30, P649, DOI 10.1097/00005344-199711000-00016; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murray GI, 1998, J PATHOL, V185, P256; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Nierodzik ML, 1998, BLOOD, V92, P3694, DOI 10.1182/blood.V92.10.3694.422k40_3694_3700; NIERODZIK MLR, 1992, CANCER RES, V52, P3267; ODAKE S, 1994, BIOCHEM BIOPH RES CO, V199, P1442, DOI 10.1006/bbrc.1994.1392; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Yamamoto A, 2003, INT J CANCER, V103, P822, DOI 10.1002/ijc.10875; Yin YJ, 2003, FASEB J, V17, P163, DOI 10.1096/fj.02-0316com; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Zain J, 2000, BLOOD, V95, P3133; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.0.CO;2-A	43	648	685	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					303	313		10.1016/j.cell.2004.12.018	http://dx.doi.org/10.1016/j.cell.2004.12.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707890	Bronze			2022-12-01	WOS:000227028900007
J	Sanders, GD; Bayoumi, AM; Sundaram, V; Bilir, SP; Neukermans, CP; Rydzak, CE; Douglass, LR; Lazzeroni, LC; Holodniy, M; Owens, DK				Sanders, GD; Bayoumi, AM; Sundaram, V; Bilir, SP; Neukermans, CP; Rydzak, CE; Douglass, LR; Lazzeroni, LC; Holodniy, M; Owens, DK			Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITOR THERAPY; CD4 CELL COUNT; VIROLOGICAL TREATMENT FAILURE; PLASMA VIRAL LOAD; SEXUALLY-TRANSMITTED-DISEASES; SAQUINAVIR SOFT GELATIN; RNA LEVELS; HETEROSEXUAL TRANSMISSION; COMBINATION THERAPY	BACKGROUND: The costs, benefits, and cost-effectiveness of screening for human immunodeficiency virus (HIV) in health care settings during the era of highly active antiretroviral therapy (HAART) have not been determined. METHODS: We developed a Markov model of costs, quality of life, and survival associated with an HIV-screening program as compared with current practice. In both strategies, symptomatic patients were identified through symptom-based case finding. Identified patients started treatment when their CD4 count dropped to 350 cells per cubic millimeter. Disease progression was defined on the basis of CD4 levels and viral load. The likelihood of sexual transmission was based on viral load, knowledge of HIV status, and efficacy of counseling. RESULTS: Given a 1 percent prevalence of unidentified HIV infection, screening increased life expectancy by 5.48 days, or 4.70 quality-adjusted days, at an estimated cost of $194 per screened patient, for a cost-effectiveness ratio of $15,078 per quality-adjusted life-year. Screening cost less than $50,000 per quality-adjusted life-year if the prevalence of unidentified HIV infection exceeded 0.05 percent. Excluding HIV transmission, the cost-effectiveness of screening was $41,736 per quality-adjusted life-year. Screening every five years, as compared with a one-time screening program, cost $57,138 per quality-adjusted life-year, but was more attractive in settings with a high incidence of infection. Our results were sensitive to the efficacy of behavior modification, the benefit of early identification and therapy, and the prevalence and incidence of HIV infection. CONCLUSIONS: The cost-effectiveness of routine HIV screening in health care settings, even in relatively low-prevalence populations, is similar to that of commonly accepted interventions, and such programs should be expanded.	Duke Univ, Duke Clin Res Inst, Durham, NC 27715 USA; Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Div Gen Med, Toronto, ON M5B 1W8, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Palo Alto Vet Affairs Hlth Care Syst, Palo Alto, CA USA	Duke University; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Sanders, GD (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	gillian.sanders@duke.edu	Abrams, William R/A-5782-2008; Lazzeroni, Laura/F-2903-2010	Lazzeroni, Laura/0000-0002-1846-6920; Holodniy, Mark/0000-0002-6655-7982	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA15612-01] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ahdieh-Grant L, 2003, AM J EPIDEMIOL, V157, P738, DOI 10.1093/aje/kwg036; Anastos K, 2002, ARCH INTERN MED, V162, P1973, DOI 10.1001/archinte.162.17.1973; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bayoumi AM, 1998, AIDS, V12, P1503, DOI 10.1097/00002030-199812000-00013; Bellman PC, 1998, AIDS, V12, P1333, DOI 10.1097/00002030-199811000-00015; Bernasconi E, 2000, AIDS, V14, P95, DOI 10.1097/00002030-200001070-00015; Bindman AB, 1998, JAMA-J AM MED ASSOC, V280, P1416, DOI 10.1001/jama.280.16.1416; Bonfanti P, 2000, J ACQ IMMUN DEF SYND, V23, P236; Bonfanti P, 1998, AIDS, V12, P1111; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; BrunVezinet F, 1997, LANCET, V350, P983, DOI 10.1016/S0140-6736(97)03380-1; Buchbinder SP, 1996, J INFECT DIS, V174, P954, DOI 10.1093/infdis/174.5.954; Butcher D, 2000, ARCH INTERN MED, V160, P394, DOI 10.1001/archinte.160.3.394-a; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Cameron DW, 1999, AIDS, V13, P213, DOI 10.1097/00002030-199902040-00009; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Casado JL, 1998, AIDS, V12, pF131, DOI 10.1097/00002030-199811000-00005; *CDCP, 2001, HIV COUNS TEST PUBL; *CDCP, 2002, HIV AIDS SURV REP, V14; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329; Chene G, 1998, AIDS, V12, P2313, DOI 10.1097/00002030-199817000-00013; Clough LA, 1999, CLIN INFECT DIS, V29, P75, DOI 10.1086/520185; COHEN C, 2000, P 7 C RETR OPP INF S; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; Coombs RW, 1996, J INFECT DIS, V174, P704, DOI 10.1093/infdis/174.4.704; Cooper D, 1999, LANCET, V353, P2061, DOI 10.1016/S0140-6736(98)10391-4; D'Amato RM, 1998, ANTIVIR THER, V3, P147; De Wit S, 1999, AIDS, V13, P864, DOI 10.1097/00002030-199905070-00020; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Deschamps MM, 1996, ANN INTERN MED, V125, P324, DOI 10.7326/0003-4819-125-4-199608150-00011; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; DICLEMENTE RJ, 1995, JAMA-J AM MED ASSOC, V274, P1271, DOI 10.1001/jama.274.16.1271; Drusano GL, 1998, ANTIMICROB AGENTS CH, V42, P358; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; DURANT J, 1999, LANCET, V354, P118; Erb P, 2000, ARCH INTERN MED, V160, P1134, DOI 10.1001/archinte.160.8.1134; ERICKSON B, 1990, SEX TRANSM DIS, V17, P194, DOI 10.1097/00007435-199010000-00009; Fatkenheuer G, 1997, AIDS, V11, pF113, DOI 10.1097/00002030-199714000-00001; FERRER E, 2003, P 10 C RETR OPP INF, P910; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gable CB, 1996, J ACQ IMMUN DEF SYND, V12, P413, DOI 10.1097/00042560-199608010-00013; GalettoLacour A, 1996, J INFECT DIS, V173, P1388, DOI 10.1093/infdis/173.6.1388; *GEN ACC OFF, 1998, GAOHEHS992; Guardiola JM, 1999, ARCH INTERN MED, V159, P194, DOI 10.1001/archinte.159.2.194; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hall CS, 1999, AIDS, V13, P1207, DOI 10.1097/00002030-199907090-00009; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HARRIS RL, 1990, INFECT CONT HOSP EP, V11, P628; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Hightow LB, 2003, AIDS EDUC PREV, V15, P282, DOI 10.1521/aeap.15.4.282.23826; Hogg RS, 1998, AIDS, V12, P279, DOI 10.1097/00002030-199803000-00005; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; HOLMAN S, 1994, PUBLIC HEALTH REP, V109, P521; HONIDEN S, 2002, MED DECIS MAKING, V22, P560; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; Ioannidis JPA, 1996, AIDS, V10, P255, DOI 10.1097/00002030-199603000-00003; Irwin K, 1996, ANN INTERN MED, V125, P471, DOI 10.7326/0003-4819-125-6-199609150-00007; JANSSEN RS, 1992, NEW ENGL J MED, V327, P445, DOI 10.1056/NEJM199208133270701; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Kassler WJ, 1997, AIDS, V11, P1045, DOI 10.1097/00002030-199708000-00014; Katzenstein DA, 1997, NEW ENGL J MED, V337, P1097; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4; Kaufmann GR, 1998, AIDS, V12, P1625, DOI 10.1097/00002030-199813000-00009; KEET IPM, 1992, AIDS, V6, P223, DOI 10.1097/00002030-199202000-00014; Keet IPM, 1997, J INFECT DIS, V176, P665, DOI 10.1086/514088; Keiser P, 1999, J ACQ IMMUN DEF SYND, V20, P28, DOI 10.1097/00042560-199901010-00004; Keita-Perse O, 1998, AIDS, V12, pF175, DOI 10.1097/00002030-199815000-00002; Kelen GD, 1999, ANN EMERG MED, V33, P147, DOI 10.1016/S0196-0644(99)70387-2; Kelen GD, 1996, ANN EMERG MED, V27, P687, DOI 10.1016/S0196-0644(96)70184-1; Kempf DJ, 1998, AIDS, V12, pF9, DOI 10.1097/00002030-199805000-00001; Kirk O, 1999, AIDS, V13, pF9, DOI 10.1097/00002030-199901140-00002; KOZAK LJ, 2004, VITAL HLTH STAT, V156, P1; Laumann E.O., 2000, SOCIAL ORG SEXUALITY; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; LEMP GF, 1994, JAMA-J AM MED ASSOC, V272, P449, DOI 10.1001/jama.272.6.449; Lepri AC, 2001, AIDS, V15, P983, DOI 10.1097/00002030-200105250-00006; LOVEDAY C, 1995, LANCET, V345, P790, DOI 10.1016/S0140-6736(95)90668-1; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; LURIE P, 1994, JAMA-J AM MED ASSOC, V272, P1832, DOI 10.1001/jama.272.23.1832; LURIE P, 1995, JAMA-J AM MED ASSOC, V273, P1000; MACDONALD KL, 1989, ANN INTERN MED, V110, P617, DOI 10.7326/0003-4819-110-8-617; Maher K, 1999, J ACQ IMMUN DEF SYND, V22, P358; Mankiw N.G., 2001, PRINCIPLES EC; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; MCCARTHY BD, 1993, ARCH INTERN MED, V153, P1107, DOI 10.1001/archinte.153.9.1107; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, SCIENCE, V275, P14; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Michael RT, 1998, AM J PUBLIC HEALTH, V88, P749, DOI 10.2105/AJPH.88.5.749; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Mole L, 1999, PHARMACOECONOMICS, V16, P307, DOI 10.2165/00019053-199916030-00007; Monforte AD, 1998, AIDS, V12, P1631, DOI 10.1097/00002030-199813000-00010; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Montaner JSG, 1998, AIDS, V12, pF23, DOI 10.1097/00002030-199805000-00003; Moyle G, 2000, J ACQ IMMUN DEF SYND, V23, P128; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; NEAL JJ, 2002, P 9 C RETR OPP INF S; *NIH, 1998, MMWR-MORBID MORTAL W, V47, P1; Notermans DW, 1998, AIDS, V12, P167, DOI 10.1097/00002030-199802000-00006; O'Brien TR, 1998, J ACQ IMMUN DEF SYND, V18, P155, DOI 10.1097/00042560-199806010-00007; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Operskalski EA, 1997, AM J EPIDEMIOL, V146, P655, DOI 10.1093/oxfordjournals.aje.a009331; Opravil M, 2002, AIDS, V16, P1371, DOI 10.1097/00002030-200207050-00009; Owens DK, 1996, ARCH INTERN MED, V156, P394, DOI 10.1001/archinte.156.4.394; OWENS DK, 2003, MED DECIS MAKING, V23, P569; OWENS DK, 2002, MED DECIS MAKING, V22, P534; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; *PAN CLIN PRACT TR, 2004, GUID US ANT AG HIV I; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Paredes R, 1999, J ACQ IMMUN DEF SYND, V22, P132; Paris D, 1999, AIDS RES HUM RETROV, V15, P1631, DOI 10.1089/088922299309676; Pedersen C, 1997, J ACQ IMMUN DEF SYND, V16, P93, DOI 10.1097/00042560-199710010-00004; Phillips AN, 1996, AIDS, V10, P859, DOI 10.1097/00002030-199607000-00009; Phillips AN, 2003, AIDS, V17, P1863, DOI 10.1097/00002030-200309050-00004; Phillips AN, 1997, AIDS, V11, P169, DOI 10.1097/00002030-199702000-00006; Phillips KA, 2000, AIDS, V14, P2159, DOI 10.1097/00002030-200009290-00013; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 1999, J ACQ IMMUN DEF SYND, V22, P260; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Reijers MHE, 2000, AIDS, V14, P59, DOI 10.1097/00002030-200001070-00007; REVICKI DA, 1995, MED CARE, V33, pAS173; Rhone SA, 1998, AIDS, V12, P619, DOI 10.1097/00002030-199806000-00011; Roca B, 1999, J INFECTION, V39, P141, DOI 10.1016/S0163-4453(99)90006-3; Roca B, 2000, AIDS, V14, P157, DOI 10.1097/00002030-200001280-00011; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; Sabin CA, 2000, J ACQ IMMUN DEF SYND, V23, P172; Sabin CA, 1998, AIDS, V12, P1347, DOI 10.1097/00002030-199811000-00017; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Salzberger B, 1999, Eur J Med Res, V4, P449; SAMUEL MC, 1993, J ACQ IMMUN DEF SYND, V6, P303; SCHWARTZ JS, 1990, JAMA-J AM MED ASSOC, V264, P1704, DOI 10.1001/jama.264.13.1704; Shulman NS, 2000, J ACQ IMMUN DEF SYND, V23, P221; Sinclair M, 2004, INT J STD AIDS, V15, P33, DOI 10.1258/095646204322637236; Spijkerman IJB, 1997, AIDS, V11, P1383, DOI 10.1097/00002030-199711000-00013; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Staszewski S, 1998, AIDS, V12, P2360; Stone PW, 2000, AM J PREV MED, V19, P15, DOI 10.1016/S0749-3797(00)00151-3; Stuart JWTC, 1999, AIDS, V13, pF53, DOI 10.1097/00002030-199905070-00001; Sullivan AK, 1998, INT J STD AIDS, V9, P711, DOI 10.1258/0956462981921251; Sullivan PS, 2004, JAIDS-J ACQ IMM DEF, V35, P511, DOI 10.1097/00126334-200404150-00009; Tebas P, 1999, AIDS, V13, pF23, DOI 10.1097/00002030-199902040-00002; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Tsevat J, 1996, MED CARE, V34, P44, DOI 10.1097/00005650-199601000-00004; Tsevat J, 1999, ANN INTERN MED, V131, P194, DOI 10.7326/0003-4819-131-3-199908030-00006; TURNER BJ, 1994, ARCH INTERN MED, V154, P1561, DOI 10.1001/archinte.154.14.1561; *US GOV, 2004, BUDG US GOV; Valdez H, 1999, ARCH INTERN MED, V159, P1771, DOI 10.1001/archinte.159.15.1771; van Roon EN, 1999, J ACQ IMMUN DEF SYND, V20, P290, DOI 10.1097/00042560-199903010-00012; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Welch K, 2000, CLIN INFECT DIS, V30, P407, DOI 10.1086/313670; Welles SL, 1996, J INFECT DIS, V174, P696, DOI 10.1093/infdis/174.4.696; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251; Yerly S, 1998, ARCH INTERN MED, V158, P247, DOI 10.1001/archinte.158.3.247; Zingmond DS, 2001, AM J PUBLIC HEALTH, V91, P1117, DOI 10.2105/AJPH.91.7.1117; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003; 2001, MMWR MORB MORTAL WKL, V50, P538; 1988, MMWR MORB MORTAL WKL, V36, P833; 2004, MMWR MORB MORTAL WKL, V53, P523; 2004, COMP 2 WAYS MANAGE A; 1998, MMWR MORB MORTAL WKL, V47, P309; 2000, MED LETT DRUGS THER, V42, P1; 2004, ADV HIV PREVENTION N	182	455	464	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2005	352	6					570	585		10.1056/NEJMsa042657	http://dx.doi.org/10.1056/NEJMsa042657			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	895KY	15703422				2022-12-01	WOS:000226862100007
J	Bartlett, S				Bartlett, S			A hitch-hiker's guide to Titan	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Bartlett, S (corresponding author), The Lancet, London NW1 7BY, England.							*MUSIC2TITAN, 2005, SIL MUS	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2005	365	9458					460	460						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894SS	15705445				2022-12-01	WOS:000226812500009
J	Hessa, T; Kim, H; Bihlmaier, K; Lundin, C; Boekel, J; Andersson, H; Nilsson, I; White, SH; von Heijne, G				Hessa, T; Kim, H; Bihlmaier, K; Lundin, C; Boekel, J; Andersson, H; Nilsson, I; White, SH; von Heijne, G			Recognition of transmembrane helices by the endoplasmic reticulum translocon	NATURE			English	Article							SEMLIKI-FOREST-VIRUS; MEMBRANE-PROTEIN; PEPTIDES; INTEGRATION; PREDICTION; INTERFACES; STABILITY; SEQUENCE; CHANNEL; DOMAIN	Membrane proteins depend on complex translocation machineries for insertion into target membranes. Although it has long been known that an abundance of nonpolar residues in transmembrane helices is the principal criterion for membrane insertion, the specific sequence-coding for transmembrane helices has not been identified. By challenging the endoplasmic reticulum Sec61 translocon with an extensive set of designed polypeptide segments, we have determined the basic features of this code, including a 'biological' hydrophobicity scale. We find that membrane insertion depends strongly on the position of polar residues within transmembrane segments, adding a new dimension to the problem of predicting transmembrane helices from amino acid sequences. Our results indicate that direct protein - lipid interactions are critical during translocon-mediated membrane insertion.	Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Program Macromol Struct, Irvine, CA 92697 USA; Karolinska Inst, NOVUM, Dept Biosci, SE-14157 Huddinge, Sweden	Stockholm University; University of California System; University of California Irvine; University of California System; University of California Irvine; Karolinska Institutet	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	Nilsson, IngMarie/H-2887-2012; White, Stephen H/B-1053-2009; White, Stephen/N-1507-2019; von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	White, Stephen H/0000-0001-8540-7907; von Heijne, Gunnar/0000-0002-4490-8569; Boekel, Carolina/0000-0003-2862-6526; Kallgren, Carolina/0000-0002-2372-9721				Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Bechinger B, 2001, BIOPHYS J, V81, P2251, DOI 10.1016/S0006-3495(01)75872-9; Beuming T, 2004, BIOINFORMATICS, V20, P1822, DOI 10.1093/bioinformatics/bth143; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; DEGLIESPOSTI M, 1990, EUR J BIOCHEM, V190, P207, DOI 10.1111/j.1432-1033.1990.tb15566.x; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Jayasinghe S, 2001, J MOL BIOL, V312, P927, DOI 10.1006/jmbi.2001.5008; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUROIWA T, 1991, J BIOL CHEM, V266, P9251; Lewis RNAH, 2001, BIOCHEMISTRY-US, V40, P12103, DOI 10.1021/bi010555m; LILJESTROM P, 1991, J VIROL, V65, P4107; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Saaf A, 1998, EUR J BIOCHEM, V251, P821, DOI 10.1046/j.1432-1327.1998.2510821.x; Snapp EL, 2004, J CELL BIOL, V164, P997, DOI 10.1083/jcb.200312079; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Von Heijne G, 2003, ADV PROTEIN CHEM, V63, P1; von Heijne G, 1999, Q REV BIOPHYS, V32, P285, DOI 10.1017/S0033583500003541; Wallin E, 1997, PROTEIN SCI, V6, P808; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yohannan S, 2004, J MOL BIOL, V341, P1, DOI 10.1016/j.jmb.2004.06.025	36	777	797	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					377	381		10.1038/nature03216	http://dx.doi.org/10.1038/nature03216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674282				2022-12-01	WOS:000226546200033
J	Quinlan, ME; Heuser, JE; Kerkhoff, E; Mullins, RD				Quinlan, ME; Heuser, JE; Kerkhoff, E; Mullins, RD			Drosophila Spire is an actin nucleation factor	NATURE			English	Article							MESSENGER-RNA LOCALIZATION; WISKOTT-ALDRICH-SYNDROME; ARP2/3 COMPLEX; FILAMENT NUCLEATION; WASP/SCAR PROTEINS; STRUCTURAL BASIS; FISSION YEAST; FORMINS; OOCYTE; RAB11	The actin cytoskeleton is essential for many cellular functions including shape determination, intracellular transport and locomotion. Previous work has identified two factors - the Arp2/3 complex and the formin family of proteins - that nucleate new actin filaments via different mechanisms. Here we show that the Drosophila protein Spire represents a third class of actin nucleation factor. In vitro, Spire nucleates new filaments at a rate that is similar to that of the formin family of proteins but slower than in the activated Arp2/3 complex, and it remains associated with the slow-growing pointed end of the new filament. Spire contains a cluster of four WASP homology 2 (WH2) domains, each of which binds an actin monomer. Maximal nucleation activity requires all four WH2 domains along with an additional actin-binding motif, conserved among Spire proteins. Spire itself is conserved among metazoans and, together with the formin Cappuccino, is required for axis specification in oocytes and embryos, suggesting that multiple actin nucleation factors collaborate to construct essential cytoskeletal structures.	Univ Calif San Francisco, Sch Med, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA; Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany	University of California System; University of California San Francisco; Washington University (WUSTL); University of Wurzburg	Mullins, RD (corresponding author), Univ Calif San Francisco, Sch Med, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA.	dyche@mullinslab.ucsf.edu	Heuser, John/H-5940-2012					Abo A, 1998, CELL MOL LIFE SCI, V54, P1145, DOI 10.1007/s000180050242; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; Dollar G, 2002, DEVELOPMENT, V129, P517; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Fehrenbacher K, 2003, J EXP BIOL, V206, P1977, DOI 10.1242/jeb.00240; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hertzog M, 2002, J BIOL CHEM, V277, P14786, DOI 10.1074/jbc.M112064200; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Jankovics F, 2001, GENETICS, V158, P1177; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Manseau L, 1996, DEVELOPMENT, V122, P2109; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; O'Rourke DA, 2000, J AM SOC NEPHROL, V11, P2212, DOI 10.1681/ASN.V11122212; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schumacher N, 2004, GENE EXPR PATTERNS, V4, P249, DOI 10.1016/j.modgep.2003.11.006; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Wellington A, 1999, DEVELOPMENT, V126, P5267; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	34	252	258	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					382	388		10.1038/nature03241	http://dx.doi.org/10.1038/nature03241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674283				2022-12-01	WOS:000226546200034
J	Kurner, J; Frangakis, AS; Baumeister, W				Kurner, J; Frangakis, AS; Baumeister, W			Cryo-electron tomography reveals the cytoskeletal structure of Spiroplasma melliferum	SCIENCE			English	Article							ELECTRON TOMOGRAPHY; ESCHERICHIA-COLI; CELL-SHAPE; PROTEIN; ORGANIZATION; MOLLICUTES; BACTERIA; SEQUENCE; FIBRILS; MOTOR	Evidence has accumulated recently that not only eukaryotes but also bacteria can have a cytoskeleton. We used cryo-electron tomography to study the three-dimensional structure of Spiroplasma melliferum cells in a close-to-native state at similar to4-nanometer resolution. We showed that these cells possess two types of filaments arranged in three parallel ribbons underneath the cell membrane. These two filamentous structures are built of the fibril protein and possibly the actin-like protein MreB. On the basis of our structural data, we could model the motility modes of these cells and explain how helical Mollicutes can propel themselves by means of coordinated length changes of their cytoskeletal ribbons.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Frangakis, AS (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	frangak@embl.de; baumeist@biochem.mpg.de		Frangakis, Achilleas/0000-0002-8067-6611				Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kimmel R, 1998, P NATL ACAD SCI USA, V95, P8431, DOI 10.1073/pnas.95.15.8431; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; KURNER J, UNPUB; NEIMARK H, 1983, YALE J BIOL MED, V56, P419; RUSS JC, 2002, IMAGE PROCESSING HDB, P496; TOWNSEND R, 1985, J GEN MICROBIOL, V131, P983; TOWNSEND R, 1983, J GEN MICROBIOL, V129, P199; TOWNSEND R, 1980, J BACTERIOL, V142, P694, DOI 10.1128/JB.142.2.694-700.1980; Trachtenberg S, 2003, J BACTERIOL, V185, P1987, DOI 10.1128/JB.185.6.1987-1994.2003; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; Trachtenberg S, 1998, J STRUCT BIOL, V124, P244, DOI 10.1006/jsbi.1998.4063; Tully JG, 1992, ENCY MICROBIOLOGY, P181; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WILLIAMSON DL, 1991, J BACTERIOL, V173, P4353, DOI 10.1128/JB.173.14.4353-4362.1991; WILLIAMSON DL, 1974, J BACTERIOL, V117, P904, DOI 10.1128/JB.117.2.904-906.1974; Wolgemuth CW, 2003, BIOPHYS J, V85, P828, DOI 10.1016/S0006-3495(03)74523-8	20	161	165	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					436	438		10.1126/science.1104031	http://dx.doi.org/10.1126/science.1104031			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662018				2022-12-01	WOS:000226492300051
J	Chen, LY; Widom, J				Chen, LY; Widom, J			Mechanism of transcriptional silencing in yeast	CELL			English	Article							RNA-POLYMERASE-II; MATING-TYPE LOCUS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; REGULATORY PROTEIN; DNA-BINDING; CHROMATIN; GENE; ACCESSIBILITY; REPRESSION	Transcriptional silencing is a phenomenon in which the transcription of a gene by RNA polymerase 11 or III is repressed or not, dependent only on the gene's chromosomal location. Two prevailing models exist for silencing: (1) steric hindrance in silenced chromatin inhibits the binding of upstream activator proteins or polymerase or (2) silencing primarily blocks steps downstream of transcription preinitiation complex formation. Here, we test these models quantitatively for the case of SIR2-dependent silencing in budding yeast, using foreign and endogenous reporter proteins, at transgenic and endogenous loci. Our results contradict both models and show instead that transcriptional silencing at several URA3 transgenes, and at the naturally silenced endogenous HMRa and HMLalpha mating type genes, acts downstream of gene activator protein binding to strongly reduce the occupancy of TFIIB, RNA polymerase II, and TFIIE at the silenced promoters.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Widom, J (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-widom@northwestem.edu	Chen, Lingyi/G-6309-2013		NIGMS NIH HHS [GM54692, GM58617] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054692, R01GM058617] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chen LY, 2004, BIOCHEM CELL BIOL, V82, P413, DOI 10.1139/O04-035; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Fitzgerald DP, 2001, MOL CELL BIOL, V21, P6585, DOI 10.1128/MCB.21.19.6585-6597.2001; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LLOUBES R, 1991, J BIOL CHEM, V266, P2303; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; LOSSON R, 1985, J MOL BIOL, V185, P65, DOI 10.1016/0022-2836(85)90183-4; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; NASMYTH KA, 1981, NATURE, V289, P244, DOI 10.1038/289244a0; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Ptashne M., 2004, GENETIC SWITCH PHAGE; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; SCHLOSSHERR J, 1994, MOL GEN GENET, V243, P453; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; SILICIANO PG, 1984, CELL, V37, P969, DOI 10.1016/0092-8674(84)90431-8; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Tanaka M, 1996, P NATL ACAD SCI USA, V93, P4311, DOI 10.1073/pnas.93.9.4311; TERLETH C, 1989, NUCLEIC ACIDS RES, V17, P4433, DOI 10.1093/nar/17.12.4433; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3	29	68	71	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					37	48		10.1016/j.cell.2004.11.030	http://dx.doi.org/10.1016/j.cell.2004.11.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652480	Bronze			2022-12-01	WOS:000226365400009
J	Vargas, D; Garcia, L; Gilman, RH; Evans, C; Ticona, E; Navincopa, M; Luo, RF; Caviedes, L; Hong, C; Escombe, R; Moore, DAJ				Vargas, D; Garcia, L; Gilman, RH; Evans, C; Ticona, E; Navincopa, M; Luo, RF; Caviedes, L; Hong, C; Escombe, R; Moore, DAJ			Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru	LANCET			English	Article								Sputum induction, bronchoalveolar lavage, or gastric aspiration are often needed to produce adequate diagnostic respiratory samples from people with HIV in whom tuberculosis is suspected. Since these procedures are rarely appropriate in less-developed countries, we compared the performances of a simple string test and the gold-standard sputum induction. 160 HIV-positive adults under investigation for tuberculosis, and 52 asymptomatic HIV-positive control patients underwent the string test followed by sputum induction. The string test detected tuberculosis in 14 patients in whom this disease was suspected; sputum induction detected only eight of them (McNemar's test, p=0.03). These preliminary data suggest that the string test is safe and effective for retrieval of useful clinical specimens for diagnosis of pulmonary tuberculosis, and is at least as sensitive as sputum induction.	Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Clin Trop Med, London W12 0NN, England; Asociac Benefica Proyectos Informat Salud Med & A, Lima, Peru; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Hosp Nacl Mayo, Lima, Peru; Univ Peruana Cayetano Heredia, Lima, Peru	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia	Moore, DAJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Clin Trop Med, Hammersmith Campus,DuCane Rd, London W12 0NN, England.	daj.moore@imperial.ac.uk	Evans, Carlton/AAI-1653-2020; Vargas-Pacherrez, Daniel/N-9349-2016	Evans, Carlton/0000-0002-6873-5447; Vargas-Pacherrez, Daniel/0000-0003-0989-1199; Ticona, Eduardo/0000-0002-6556-1082; Navincopa, Marcos/0000-0002-9951-8234; Moore, David/0000-0002-3748-0154	PHS HHS [T35A107646] Funding Source: Medline; Wellcome Trust [057434, 064672] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		BEAL CB, 1970, AM J TROP MED HYG, V19, P349, DOI 10.4269/ajtmh.1970.19.349; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Conde MB, 2000, AM J RESP CRIT CARE, V162, P2238, DOI 10.1164/ajrccm.162.6.2003125; GILMAN RH, 1979, LANCET, V1, P795	4	47	48	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					150	152		10.1016/S0140-6736(05)17705-8	http://dx.doi.org/10.1016/S0140-6736(05)17705-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639297	Green Accepted			2022-12-01	WOS:000226170700030
J	Carpenter, RG; Waite, A; Coombs, RC; Daman-Willems, C; McKenzie, A; Huber, J; Emery, JL				Carpenter, RG; Waite, A; Coombs, RC; Daman-Willems, C; McKenzie, A; Huber, J; Emery, JL			Repeat sudden unexpected and unexplained infant deaths: natural or unnatural?	LANCET			English	Article							INTRAALVEOLAR HEMORRHAGE; RECURRENCE; RISK	Background There have been suggestions that when two or three unexpected unexplained infant deaths occur within a family they are more likely to be unnatural than natural. We aimed to estimate the probability that a second infant death is natural versus unnatural. Methods The Care of Next Infant programme (CONI) supports parents who have previously had an unexpected and apparently unexplained infant death and is currently available in over 90% of health districts in England, Wales, and Northern Ireland. We studied all deaths in 6373 infants who had completed the CONI programme by December, 1999. After a CONI death, we made detailed enquiries into the previous death and the CONI death, including a family interview, a review of autopsies, and case discussion. Findings 57 (8.9 per 1000) CONI infants died. Nine deaths were inevitable, and 48 were unexpected. 44 families lost one child, and two families lost two children. Of the 46 first CONI deaths, 40 were natural; the other six were probable homicides, five committed by one or both parents (two criminally convicted). The ratio of 40 natural to six unnatural deaths is 6.7 (95% CI 2.8-19.4). Enquiries identified 18 families with two SIDS (sudden infant death syndrome) deaths and two families with probable covert double homicides (ratio 9.0 [2.2 to 80.0]). There were no convictions in 13 incomplete cases. Families with three deaths are reported.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, London WC1E 7HT, England; Univ Sheffield, Sheffield Childrens Hosp, Acad Unit Child Hlth, Care Next Infant CONI Programme, Sheffield, S Yorkshire, England; Royal Hallamshire Hosp, Neonatal Intens Care Unit, Sheffield S10 2JF, S Yorkshire, England; Univ Hosp, London, England; Univ Hosp Children & Youth, Utrecht, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield; University of Sheffield; Wilhelmina Kinderziekenhuis	Carpenter, RG (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, Keppel St, London WC1E 7HT, England.	bob.carpenter@lshtm.ac.uk						BARRETT AM, 1954, RECENT ADV PAEDIATRI, P301; BEAL SM, 1988, ARCH DIS CHILD, V63, P924, DOI 10.1136/adc.63.8.924; Berry PJ, 1999, J CLIN PATHOL, V52, P553, DOI 10.1136/jcp.52.8.553; CARPENTER RG, 1977, ARCH DIS CHILD, V52, P606, DOI 10.1136/adc.52.8.606; DiMaio V J M, 1989, FORENSIC PATHOLOGY; EMERY JL, 1985, ARCH DIS CHILD, V60, P505, DOI 10.1136/adc.60.6.505; EMERY JL, 1986, LANCET, V1, P313; EMERY JL, 1993, AM J DIS CHILD, V147, P1097, DOI 10.1001/archpedi.1993.02160340083019; Firstman R, 2001, SUDDEN INFANT DEATH, P291; Fleming P., 2000, SUDDEN UNEXPECTED DE; GUNTHEROTH WG, 1990, J PEDIATR-US, V116, P520, DOI 10.1016/S0022-3476(05)81596-3; GUNTHEROTH WG, 1995, CRIB DEATH SUDDEN IN; KUKULL WA, 1977, AM J EPIDEMIOL, V106, P485, DOI 10.1093/oxfordjournals.aje.a112495; Levene S, 2004, ARCH DIS CHILD, V89, P443, DOI 10.1136/adc.2003.036202; LEVINE M, 1999, LEVINE CORONERS COUR; MCKENZIE A, 1995, HLTH VISITOR, V68, P239; Meadow R, 1999, ARCH DIS CHILD, V80, P7, DOI 10.1136/adc.80.1.7; MEADOW R, 1997, ABC CHILD ABUSE, P27; Oyen N, 1996, AM J EPIDEMIOL, V144, P300, DOI 10.1093/oxfordjournals.aje.a008925; PETERSON DR, 1980, J PEDIATR-US, V97, P265, DOI 10.1016/S0022-3476(80)80491-4; *PRES ROYAL STAT S, 2001, RSS NEWS         DEC; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Stanton AN, 2003, ARCH DIS CHILD, V88, P699, DOI 10.1136/adc.88.8.699; TAYLOR EM, 1983, BRIT MED J, V287, P871, DOI 10.1136/bmj.287.6396.871; TAYLOR EM, 1982, ARCH DIS CHILD, V57, P668, DOI 10.1136/adc.57.9.668; VALDESDAPENA MA, 1967, PEDIATRICS, V39, P123; Vege A., 1995, P67; WAITE A, 1998, REPORT 5000 BABIES U; WOLKIND S, 1993, ACTA PAEDIATR, V82, P873, DOI 10.1111/j.1651-2227.1993.tb12583.x; Yukawa N, 1999, J CLIN PATHOL, V52, P581, DOI 10.1136/jcp.52.8.581; [No title captured]	31	42	43	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					29	35		10.1016/S0140-6736(04)17662-9	http://dx.doi.org/10.1016/S0140-6736(04)17662-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639677				2022-12-01	WOS:000226213100025
J	Domino, KB; Hornbein, TF; Polissar, NL; Renner, G; Johnson, J; Alberti, S; Hankes, L				Domino, KB; Hornbein, TF; Polissar, NL; Renner, G; Johnson, J; Alberti, S; Hankes, L			Risk factors for relapse in health care professionals with substance use disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED PHYSICIANS; ABUSE; ANESTHESIOLOGISTS; PROGRAMS; PREVALENCE; EXPERIENCE; ADDICTION; MODEL	Context Substance use disorders among physicians are important and persistent problems. Considerable debate exists over whether,use of major opioids, especially among anesthesiologists, is associated with a higher relapse rate compared with alcohol and nonopioids. Moreover, the risk factors for relapse with current treatment and monitoring strategies are unknown. Objective To test the hypothesis that chemically dependent healthcare professionals using a major opioid (eg, fentanyl, sufentanil, morphine, meperidine) as drug of choice are at higher risk of relapse. Design, Setting, and Participants Retrospective cohort study of 292 health care professionals enrolled in the Washington Physicians Health Program, an independent posttreatment monitoring program, followed up between January 1, 1991, and December 31, 2001. Main Outcome Measure Factors associated with relapse, defined as the resumption of substance use after initial diagnosis and completion of primary treatment for chemical dependency. Results Twenty-five percent (74 of 292 individuals) had at least 1 relapse. A family history of a substance use disorder increased the risk of relapse (hazard ratio [HR], 2.29; 95% confidence interval [CI], 1.44-3.64). The use of a major opioid increased the risk of relapse significantly in the presence of a coexisting psychiatric disorder (HR, 5.79; 95% Cl, 2.89-11.42) but not in the absence of a coexisting psychiatric disorder (HR, 0.85; 95% Cl, 0.33-2.17). The presence of all 3 factors major opioid use, dual diagnosis, and family history-markedly increased the risk of relapse (HR, 13.25; 95% Cl, 5.22-33.59). The risk of subsequent relapses increased after the first relapse (HR, 1.69; 95% Cl, 1.13-2.53). Conclusions The risk of relapse with substance use was increased in health care professionals who used a major opioid or had a coexisting psychiatric illness or a family history of a substance use disorder. The presence of more than 1 of these risk factors and previous relapse further increased the likelihood of relapse. These observations should be considered in monitoring the recovery of health care professionals.	Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; Whisper Light Stat Consulting, Seattle, WA USA; Washington Phys Hlth Program, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Domino, KB (corresponding author), Univ Washington, Dept Anesthesiol, Box 356540, Seattle, WA 98195 USA.	kdomino@u.washington.edu						Alexander BH, 2000, ANESTHESIOLOGY, V93, P922, DOI 10.1097/00000542-200010000-00008; Angres D. H., 1998, HEALING HEALER ADDIC, P34; Bohigian G M, 1994, Mo Med, V91, P275; Booth JV, 2002, ANESTH ANALG, V95, P1024, DOI 10.1213/01.ANE.0000026379.66419.DB; GALANTER M, 1990, AM J PSYCHIAT, V147, P64; Gallegos K V, 1988, QRB Qual Rev Bull, V14, P116; Gallegos K V, 1992, Md Med J, V41, P315; HANKES L, 1992, SUBSTANCE ABUSE COMP, P897; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; Leshner AI, 1999, JAMA-J AM MED ASSOC, V282, P1314, DOI 10.1001/jama.282.14.1314; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; LINK CL, 1984, BIOMETRICS, V40, P601, DOI 10.2307/2530904; MENK EJ, 1990, JAMA-J AM MED ASSOC, V263, P3060, DOI 10.1001/jama.263.22.3060; MORSE RM, 1984, JAMA-J AM MED ASSOC, V251, P743, DOI 10.1001/jama.251.6.743; Paris RT, 1999, J ADDICT DIS, V18, P1, DOI 10.1300/J069v18n01_01; PELTON C, 1991, J PSYCHOACTIVE DRUGS, V23, P427, DOI 10.1080/02791072.1991.10471613; Reading E G, 1992, Md Med J, V41, P325; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; SHORE JH, 1987, JAMA-J AM MED ASSOC, V257, P2931; SPIEGELMAN WG, 1984, ANESTHESIOLOGY, V60, P335, DOI 10.1097/00000542-198404000-00009; TALBOTT GD, 1987, JAMA-J AM MED ASSOC, V257, P2927, DOI 10.1001/jama.257.21.2927; TALBOTT GD, 2003, PRINCIPLES ADDICTION, P1009; Zacny JP, 1999, ANESTHESIOLOGY, V90, P269, DOI 10.1097/00000542-199901000-00033	23	132	139	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1453	1460		10.1001/jama.293.12.1453	http://dx.doi.org/10.1001/jama.293.12.1453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784868				2022-12-01	WOS:000227784700024
J	De Serres, G; Duval, B				De Serres, G; Duval, B			Pertussis vaccination beyond childhood	LANCET			English	Editorial Material							COMPUTER-SIMULATIONS; STRATEGIES; INFANCY		Quebec Natl Inst Publ Hlth, Quebec City, PQ G1E 7G9, Canada; Univ Laval, Quebec City, PQ, Canada	Laval University	De Serres, G (corresponding author), Quebec Natl Inst Publ Hlth, Quebec City, PQ G1E 7G9, Canada.	gaston.deserres@ssss.gouv.qc.ca						*CDC, 1999, PERC PERS AG 18 YEAR; Edmunds WJ, 2002, VACCINE, V20, P1316, DOI 10.1016/S0264-410X(01)00473-X; Forsyth KD, 2004, CLIN INFECT DIS, V39, P1802, DOI 10.1086/426020; Hethcote HW, 2004, VACCINE, V22, P2181, DOI 10.1016/j.vaccine.2003.11.053; Lugauer S, 2002, EUR J PEDIATR, V161, P142, DOI 10.1007/s00431-001-0893-5; Olin P, 2003, VACCINE, V21, P2015, DOI 10.1016/S0264-410X(02)00777-6; SALISBURY D M, 2004, VACCINES, P1387; Salmaso S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e81; Skowronski DM, 2004, VACCINE, V23, P353, DOI 10.1016/j.vaccine.2004.05.033; Van Rie A, 2004, VACCINE, V22, P3154, DOI 10.1016/j.vaccine.2004.01.067; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012	11	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1015	1016						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781085				2022-12-01	WOS:000227731800010
J	Ortiz-Urda, S; Garcia, J; Green, CL; Chen, L; Lin, Q; Veitch, DP; Sakai, LY; Lee, H; Marinkovich, MP; Khavari, PA				Ortiz-Urda, S; Garcia, J; Green, CL; Chen, L; Lin, Q; Veitch, DP; Sakai, LY; Lee, H; Marinkovich, MP; Khavari, PA			Type VII collagen is required for Ras-driven human epidermal tumorigenesis	SCIENCE			English	Article							SQUAMOUS-CELL CARCINOMAS; EPIDERMOLYSIS-BULLOSA; ANCHORING FIBRILS; NC1 DOMAIN; LAMININ-5; BINDS; SKIN	Type VII collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a blistering skin disorder often accompanied by epidermal cancers. To study the role of collagen VII in these cancers, we examined Ras-driven tumorigenesis in RDEB keratinocytes. Cells devoid of collagen VII did not form tumors in mice, whereas those retaining a specific collagen VII fragment (the amino-terminal noncollagenous domain NC1) were tumorigenic. Forced NC1 expression restored tumorigenicity to collagen VII-null epidermis in a non-cell-autonomous fashion. Fibronectin-like sequences within NC1 (FNC1) promoted tumor cell invasion in a laminin 5-dependent manner and were required for tumorigenesis. Tumor-stroma interactions mediated by collagen VII thus promote neoplasia, and retention of NC1 sequences in a subset of RDEB patients may contribute to their increased susceptibility to squamous cell carcinoma.	VA Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Oregon Health & Science University	Khavari, PA (corresponding author), VA Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.	khavari@cmgm.stanford.edu			NIAMS NIH HHS [AR43799, AR44012] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043799, P01AR044012, R29AR043799] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Bruckner-Tuderman L, 1999, MATRIX BIOL, V18, P43, DOI 10.1016/S0945-053X(98)00007-9; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; Chen M, 1999, J INVEST DERMATOL, V112, P177, DOI 10.1046/j.1523-1747.1999.00491.x; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; HESSLE H, 1984, DIFFERENTIATION, V26, P49, DOI 10.1111/j.1432-0436.1984.tb01372.x; Kainulainen T, 1997, BRIT J DERMATOL, V136, P331, DOI 10.1046/j.1365-2133.1997.5581514.x; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Li J, 2003, EMBO J, V22, P2400, DOI 10.1093/emboj/cdg239; LUNSTRUM GP, 1986, J BIOL CHEM, V261, P9042; Mallipeddi R, 2002, CLIN EXP DERMATOL, V27, P616, DOI 10.1046/j.1365-2230.2002.01130.x; MARINKOVICH MP, 2003, DERMATOLOGY GEN MED, V1, P596; Ortiz-Urda S, 2003, J CLIN INVEST, V111, P251, DOI 10.1172/JCI200317193; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; SAVOIA P, 1993, J INVEST DERMATOL, V101, P352, DOI 10.1111/1523-1747.ep12365531; WETZELS RHW, 1991, AM J PATHOL, V139, P451	18	100	103	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1773	1776		10.1126/science.1106209	http://dx.doi.org/10.1126/science.1106209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774758				2022-12-01	WOS:000227883900044
J	Switzer, WM; Salemi, M; Shanmugam, V; Gao, F; Cong, ME; Kuiken, C; Bhullar, V; Beer, BE; Vallet, D; Gautier-Hion, A; Tooze, Z; Villinger, F; Holmes, EC; Heneine, W				Switzer, WM; Salemi, M; Shanmugam, V; Gao, F; Cong, ME; Kuiken, C; Bhullar, V; Beer, BE; Vallet, D; Gautier-Hion, A; Tooze, Z; Villinger, F; Holmes, EC; Heneine, W			Ancient co-speciation of simian foamy viruses and primates	NATURE			English	Article							MOLECULAR EVOLUTION; DIVERGENCE TIMES; ABSOLUTE RATES; DNA EVIDENCE; PHYLOGENY; SEQUENCES; GENE; HOSTS; COSPECIATION; COEVOLUTION	Although parasite - host co-speciation is a long-held hypothesis, convincing evidence for long-term co-speciation remains elusive, largely because of small numbers of hosts and parasites studied and uncertainty over rates of evolutionary change(1-5). Cospeciation is especially rare in RNA viruses, in which cross-species transfer is the dominant mode of evolution(6-9). Simian foamy viruses (SFVs) are ubiquitous, non-pathogenic retroviruses that infect all primates(10,11). Here we test the co-speciation hypothesis in SFVs and their primate hosts by comparing the phylogenies of SFV polymerase and mitochondrial cytochrome oxidase subunit II from African and Asian monkeys and apes. The phylogenetic trees were remarkably congruent in both branching order and divergence times, strongly supporting cospeciation. Molecular clock calibrations revealed an extremely low rate of SFV evolution, 1.7 x 10(-8) substitutions per site per year, making it the slowest-evolving RNA virus documented so far. These results indicate that SFVs might have co-speciated with Old World primates for at least 30 million years, making them the oldest known vertebrate RNA viruses.	Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; Duke Univ, Human Vaccine Inst, Durham, NC 27710 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; So Res Inst, Frederick, MD 21701 USA; Univ Rennes 1, CNRS, Biol Stn, F-35380 Paimpont, France; Cercopan, Calabar, Cross River Sta, Nigeria; Emory Univ, Winship Canc Ctr, Dept Pathol, Atlanta, GA 30322 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Duke University; United States Department of Energy (DOE); Los Alamos National Laboratory; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes 1; Emory University; University of Oxford	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd,MS G-19, Atlanta, GA 30333 USA.	bis3@cdc.gov	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; VALLET, Dominique/L-2309-2018	Holmes, Edward/0000-0001-9596-3552; VALLET, Dominique/0000-0002-8551-6019				ADKINS RM, 1994, J MOL EVOL, V38, P215; BROOKS DR, 1987, INT J PARASITOL, V17, P291, DOI 10.1016/0020-7519(87)90052-X; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Charrel RN, 1999, J GEN VIROL, V80, P2329, DOI 10.1099/0022-1317-80-9-2329; DISOTELL TR, 1992, MOL BIOL EVOL, V9, P1; Gojobori T, 2000, AIDS REV, V2, P39; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Groves CP., 2001, PRIMATE TAXONOMY; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Harris EE, 1998, MOL BIOL EVOL, V15, P892, DOI 10.1093/oxfordjournals.molbev.a025993; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Lochelt M, 2003, CURR TOP MICROBIOL, V277, P27; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; PAGE RDM, 1990, SYST ZOOL, V39, P205, DOI 10.2307/2992182; Page SL, 2001, MOL PHYLOGENET EVOL, V18, P14, DOI 10.1006/mpev.2000.0895; Page SL, 1999, MOL PHYLOGENET EVOL, V13, P348, DOI 10.1006/mpev.1999.0653; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; RUVOLO M, 1991, P NATL ACAD SCI USA, V88, P1570, DOI 10.1073/pnas.88.4.1570; Salemi M, 2003, J VIROL, V77, P7202, DOI 10.1128/JVI.77.13.7202-7213.2003; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SHADAN FF, 1993, P NATL ACAD SCI USA, V90, P4117, DOI 10.1073/pnas.90.9.4117; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059	30	211	226	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					376	380		10.1038/nature03341	http://dx.doi.org/10.1038/nature03341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772660	Green Published			2022-12-01	WOS:000227715100050
J	Kiessling, AA				Kiessling, AA			Eggs alone - Human parthenotes: an ethical source of stem cells for therapies?	NATURE			English	Editorial Material									Harvard Inst Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kiessling, AA (corresponding author), Harvard Inst Med, 4 Blackfan Circle, Boston, MA 02115 USA.							Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; KIESSLING AA, 2003, HUMAN EMBRYONIC STEM; Kiessling Ann A, 2004, Conn Law Rev, V36, P1051; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402	4	18	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2005	434	7030					145	145		10.1038/434145a	http://dx.doi.org/10.1038/434145a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758976	Bronze			2022-12-01	WOS:000227494500022
J	de la Chica, RA; Ribas, I; Giraldo, J; Egozcue, J; Fuster, C				de la Chica, RA; Ribas, I; Giraldo, J; Egozcue, J; Fuster, C			Chromosomal instability in amniocytes from fetuses of mothers who smoke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOBACCO-SPECIFIC CARCINOGEN; SISTER-CHROMATID EXCHANGE; FRAGILE SITES; CIGARETTE-SMOKING; CHILDHOOD-CANCER; MATERNAL SMOKING; IN-UTERO; ABERRATION; WOMEN; REARRANGEMENTS	Context Tobacco increases the risk of systemic diseases, and it has adverse effects on pregnancy. However, only indirect data have been published on a possible genotoxic effect on pregnancy in humans. Objectives To determine whether maternal smoking has a genotoxic effect on amniotic cells, expressed as an increased chromosomal instability, and to analyze whether any chromosomal regions are especially affected by exposure to tobacco. Design, Setting, and Patients In this prospective study, amniocytes were obtained by routine amniocentesis for prenatal diagnosis from 25 controls and 25 women who smoke (greater than or equal to10 cigarettes/d for greater than or equal to10 years), who were asked to fill out a smoking questionnaire concerning their smoking habits. Chromosomal instability was analyzed in blinded fashion by 2 independent observers in routine chromosome spreads. Breakpoints implicated in chromosomal abnormalities were identified by G-banding. Main Outcome Measures Association between maternal smoking and increased chromosomal instability in amniotic fluid cells, expressed as chromosomal lesions (gaps and breaks) and structural chromosomal abnormalities. Results Comparison of cytogenetic data between smokers and nonsmokers (controls) showed important differences for the proportion of structural chromosomal abnormalities (smokers: 12.1 % [96/793]; controls: 3.5% [26/752]; P=.002) and to a lesser degree for the proportion of metaphases with chromosomal instability (smokers: 10.5% [262/2492]; controls: 8.0% [210/2637]; P=.04), and for the proportion of chromosomal lesions (smokers: 15.7% [391/2492]; controls: 10.1 % [267/2637]; P=.045). Statistical analysis of the 689 breakpoints detected showed that band 11q23, which is a band commonly implicated in hematopoietic malignancies, was the chromosomal region most affected by tobacco. Conclusions Our findings show that smoking 10 or more cigarettes per day for at least 10 years and during pregnancy is associated with increased chromosomal instability in amniocytes. Band 11q23, known to be involved in leukemogenesis, seems especially sensitive to genotoxic compounds contained in tobacco.	Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Fac Med, E-08193 Barcelona, Spain; Ctr Patol Celular, Barcelona, Spain; Univ Autonoma Barcelona, Unitat Bioestadist, Bellaterra, Spain	Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona	Egozcue, J (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Fac Med, E-08193 Barcelona, Spain.	joselp.egozcue@uab.es	Giraldo, Jesus/F-9881-2011	Giraldo, Jesus/0000-0001-7082-4695				Anderson D, 1997, ENVIRON MOL MUTAGEN, V30, P95, DOI 10.1002/(SICI)1098-2280(1997)30:2<95::AID-EM1>3.0.CO;2-B; BAN S, 1995, MUTAT RES-ENVIR MUTA, V334, P197, DOI 10.1016/0165-1161(95)90011-X; BOHM U, 1995, HUM GENET, V95, P249, DOI 10.1007/BF00225189; CAPOROSSI D, 1995, HUM GENET, V96, P269; CHEN CS, 1993, BLOOD, V81, P2386; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Glover TW, 1998, RECENT RES CANCER, V154, P185; Greenbaum IF, 1997, HUM GENET, V101, P109, DOI 10.1007/s004390050596; Hall GW, 2001, BEST PRACT RES CL HA, V14, P573, DOI 10.1053/beha.2001.0155; JAFFE ES, 2001, WHO CLASSIFICATION T, P86; Jalili T, 1998, CANCER RES, V58, P2633; Jauniaux E, 1999, OBSTET GYNECOL, V93, P25, DOI 10.1016/S0029-7844(98)00318-4; KERBER S, 1993, PRENATAL DIAG, V13, P21, DOI 10.1002/pd.1970130105; Kolialexi A, 1998, ANTICANCER RES, V18, P2359; Lackmann GM, 1999, J NATL CANCER I, V91, P459, DOI 10.1093/jnci/91.5.459; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LITTLEFIELD LG, 1986, MUTAT RES, V170, P145, DOI 10.1016/0165-1218(86)90028-5; MIGUEZ L, 1991, EARLY HUM DEV, V26, P93, DOI 10.1016/0378-3782(91)90013-S; Milunsky A, 2000, PRENATAL DIAG, V20, P307, DOI 10.1002/(SICI)1097-0223(200004)20:4<307::AID-PD797>3.0.CO;2-M; Musthapa MS, 2004, ENVIRON MOL MUTAGEN, V43, P243, DOI 10.1002/em.20018; Norppa Hannu, 2004, IARC Sci Publ, P179; Pluth JM, 2000, MUTAT RES-GEN TOX EN, V465, P101, DOI 10.1016/S1383-5718(99)00217-X; PRICE PJ, 1988, KARYOGRAM, V14, P10; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Rowland RE, 1999, HEREDITAS, V131, P143, DOI 10.1111/j.1601-5223.1999.00143.x; SALONEN K, 1993, MUTAT RES, V298, P285, DOI 10.1016/0165-1218(93)90008-2; Sasco AJ, 1999, HUM EXP TOXICOL, V18, P192, DOI 10.1191/096032799678839905; SHULMAN LP, 1991, AM J OBSTET GYNECOL, V165, P1877, DOI 10.1016/0002-9378(91)90049-W; SOLOMON E, 1991, CYTOGENET CELL GENET, V58, P1, DOI 10.1159/000133157; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; Stein CK, 2002, GENE CHROMOSOME CANC, V34, P333, DOI 10.1002/gcc.10061; Stokes ME, 2000, CATEGORICAL DATA ANA; Vogler GP, 2002, JAMA-J AM MED ASSOC, V287, P241, DOI 10.1001/jama.287.2.241	35	55	58	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1212	1222		10.1001/jama.293.10.1212	http://dx.doi.org/10.1001/jama.293.10.1212			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904LB	15755944	Bronze			2022-12-01	WOS:000227498400022
J	Stephens, DS; Zughaier, SM; Whitney, CG; Baughman, WS; Barker, L; Gay, K; Jackson, D; Orenstein, WA; Arnold, K; Schuchat, A; Farley, MM				Stephens, DS; Zughaier, SM; Whitney, CG; Baughman, WS; Barker, L; Gay, K; Jackson, D; Orenstein, WA; Arnold, K; Schuchat, A; Farley, MM		Georgia Emerging Infections Progra	Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment	LANCET			English	Article							EFFLUX; PREVALENCE; MEF(A); GENES; MEFE	Background The prevalence of macrolide resistance in Streptococcus pneumoniae has risen in recent years after the introduction of new macrolides and their increased use. We assessed emergence of macrolide-resistant invasive S pneumoniae disease in Atlanta, CA, USA, before and after the licensing, in February 2000, of the heptavalent pneumococcal conjugate vaccine for young children. Methods Prospective population-based surveillance was used to obtain pneumococcal isolates and demographic data from patients with invasive pneumococcal disease. We calculated cumulative incidence rates for invasive pneumococcal disease for 1994-2002 using population estimates and census data from the US Census Bureau. Findings The incidence of invasive pneumococcal disease in Atlanta fell from 30.2 per 100 000 population (mean annual incidence 1994-99) to 13.1 per 100 000 in 2002 (p < 0.0001). Striking reductions were seen in children younger than 2 years (82% decrease) and in those 2-4 years (71% decrease), age-groups targeted to receive pneumococcal conjugate vaccine. Significant declines were also noted in adults aged 20-39 (54%), 40-64 (25%), and 65 years and older (39%). Macrolide resistance in invasive S pneumoniae disease in Atlanta, after increasing steadily from 4.5 per 100 000 in 1994 to 9.3 per 100 000 in 1999, fell to 2.9 per 100 000 by 2002. Reductions in disease caused by mefE-mediated and erm-mediated macrolide-resistant isolates of conjugate-vaccine serotypes 6B, 9V, 19F, and 23F, and the vaccine-associated serotype 6A were also recorded. Interpretation Vaccines can be a powerful strategy for reducing antibiotic resistance in a community.	Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; VA Med Ctr, Res Serv, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA; Georgia Dept Human Resources, Div Publ Hlth, Atlanta, GA USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Stephens, DS (corresponding author), Emory Univ Hosp, Dept Med, 1364 Clifton Rd NE, Atlanta, GA 30322 USA.	dstep01@emory.edu	Zughaier, Susu/N-3185-2019; Zughaier, Susu/GLQ-9288-2022; Stephens, David S/A-8788-2012	Zughaier, Susu/0000-0001-7487-8770; 				Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1; Angot P, 2000, EUR J CLIN MICROBIOL, V19, P755, DOI 10.1007/PL00011229; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arpin C, 1999, ANTIMICROB AGENTS CH, V43, P944, DOI 10.1128/AAC.43.4.944; *CDC, 2004, MMWR-MORBID MORTAL W, V53, P658; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P1140; Centers for Disease Control and Prevention (CDC), 2003, MMWR MORB MORTAL WKL, V52, P987; Clancy J, 1996, MOL MICROBIOL, V22, P867, DOI 10.1046/j.1365-2958.1996.01521.x; Del Grosso M, 2002, J CLIN MICROBIOL, V40, P774, DOI 10.1128/JCM.40.3.774-778.2002; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Gay K, 2001, J INFECT DIS, V184, P56, DOI 10.1086/321001; Gay K, 2000, J INFECT DIS, V182, P1417, DOI 10.1086/315853; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Huebner RE, 2000, Int J Infect Dis, V4, P214, DOI 10.1016/S1201-9712(00)90112-7; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Johnston NJ, 1998, ANTIMICROB AGENTS CH, V42, P2425, DOI 10.1128/AAC.42.9.2425; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; KLUGMAN KP, 2002, EUR RESPIR J, V36, P3; Lonks JR, 2002, CLIN INFECT DIS, V35, P556, DOI 10.1086/341978; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; *NAT COMM CLIN LAB, 1998, M100SB NCCLS; Nuermberger E, 2004, CLIN INFECT DIS, V38, P99, DOI 10.1086/380126; Okamoto Hiroki, 2002, Journal of Infection and Chemotherapy, V8, P28; Santagati M, 2000, ANTIMICROB AGENTS CH, V44, P2585, DOI 10.1128/AAC.44.9.2585-2587.2000; Smith PJ, 2001, AM J PREV MED, V20, P17, DOI 10.1016/S0749-3797(01)00285-9; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Tait-Kamradt A, 2000, ANTIMICROB AGENTS CH, V44, P2118, DOI 10.1128/AAC.44.8.2118-2125.2000; TaitKamradt A, 1997, ANTIMICROB AGENTS CH, V41, P2251, DOI 10.1128/AAC.41.10.2251; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	30	127	134	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					855	863		10.1016/S0140-6736(05)71043-6	http://dx.doi.org/10.1016/S0140-6736(05)71043-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752529				2022-12-01	WOS:000227444600027
J	Dommett, E; Coizet, W; Blaha, CD; Martindale, J; Lefebvre, W; Walton, N; Mayhew, JEW; Overton, PG; Redgrave, P				Dommett, E; Coizet, W; Blaha, CD; Martindale, J; Lefebvre, W; Walton, N; Mayhew, JEW; Overton, PG; Redgrave, P			How visual stimuli activate dopaminergic neurons at short latency	SCIENCE			English	Article							PRIMATE SUPERIOR COLLICULUS; MIDBRAIN DOPAMINE; SUBSTANTIA-NIGRA; RATS; INHIBITION; RECEPTORS; RESPONSES; RELEASE; EVENTS; SIGNAL	Unexpected, biologically salient stimuli elicit a short-latency, phasic response in midbrain dopaminergic (DA) neurons. Although this signal is, important for reinforcement learning the information it conveys to forebrain target structures remains uncertain. One way to decode the phasic DA signal would be to determine the perceptual properties of sensory inputs to DA neurons. After local disinhibition of the superior colliculus in anesthetized rats, DA neurons became visually responsive, whereas disinhibition of the visual cortex was ineffective. As the primary source of visual afferents, the limited processing capacities of the colliculus may constrain the visual information content of phasic DA responses.	Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	University of Sheffield; Macquarie University	Redgrave, P (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.	P.Redgrave@sheffield.ac.uk	Coizet, Véronique/T-1601-2019	Coizet, Véronique/0000-0001-5192-6610; Overton, Paul/0000-0003-4334-261X; Blaha, Charles/0000-0001-5155-1505; Dommett, Eleanor/0000-0002-6973-8762				BINNS KE, 1995, VISUAL NEUROSCI, V12, P563, DOI 10.1017/S0952523800008452; Comoli E, 2003, NAT NEUROSCI, V6, P974, DOI 10.1038/nn1113; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Forster GL, 2003, EUR J NEUROSCI, V17, P751, DOI 10.1046/j.1460-9568.2003.02511.x; FREEMAN AS, 1985, LIFE SCI, V36, P1983, DOI 10.1016/0024-3205(85)90448-5; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Katsuta H, 2003, NEUROSCI RES, V46, P73, DOI 10.1016/S0168-0102(03)00029-4; Michael DJ, 1999, J PHARMACEUT BIOMED, V19, P33, DOI 10.1016/S0731-7085(98)00145-9; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; REDGRAVE P, 1981, PSYCHOPHARMACOLOGY, V75, P198, DOI 10.1007/BF00432187; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sefton Ann Jervie, 1995, P833; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; STEIN BE, 1991, ELECTROPHYSIOLOGY VI, P85; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	26	214	224	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1476	1479		10.1126/science.1107026	http://dx.doi.org/10.1126/science.1107026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746431				2022-12-01	WOS:000227503100050
J	Loog, M; Morgan, DO				Loog, M; Morgan, DO			Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates	NATURE			English	Article							B-TYPE CYCLINS; S-PHASE; SACCHAROMYCES-CEREVISIAE; RECOGNITION MOTIF; FISSION YEAST; BUDDING YEAST; CELL CYCLE; MITOSIS; REPLICATION; EXIT	Cell-cycle events are controlled by cyclin-dependent kinases (CDKs), whose periodic activation is driven by cyclins. Different cyclins promote distinct cell-cycle events, but the molecular basis for these differences remains unclear(1,2). Here we compare the specificity of two budding yeast cyclins, the S-phase cyclin Clb5 and the M-phase cyclin Clb2, in the phosphorylation of 150 Cdk1 (Cdc28) substrates. About 24% of these proteins were phosphorylated more efficiently by Clb5 - Cdk1 than Clb2 - Cdk1. The Clb5-specific targets include several proteins (Sld2, Cdc6, Orc6, Mcm3 and Cdh1) involved in early S-phase events. Clb5 specificity depended on an interaction between a hydrophobic patch in Clb5 and a short sequence in the substrate ( the RXL or Cy motif). Phosphorylation of Clb5-specific targets during S phase was reduced by replacing Clb5 with Clb2 or by mutating the substrate RXL motif, confirming the importance of Clb5 specificity in vivo. Although we did not identify any highly Clb2-specific substrates, we found that Clb2 - Cdk1 possessed higher intrinsic kinase activity than Clb5 - Cdk1, enabling efficient phosphorylation of a broad range of mitotic Cdk1 targets. Thus, Clb5 and Clb2 use distinct mechanisms to enhance the phosphorylation of S-phase and M-phase substrates.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	dmorgan@cgl.ucsf.edu		Morgan, David/0000-0001-8753-4416	NIGMS NIH HHS [R01 GM069901] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1996, MOL CELL BIOL, V16, P6623; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cross FR, 2000, MOL CELL BIOL, V20, P4782, DOI 10.1128/MCB.20.13.4782-4790.2000; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Donaldson AD, 2000, EMBO REP, V1, P507; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Miller ME, 2001, J CELL SCI, V114, P1811; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roberts JM, 1999, CELL, V98, P129, DOI 10.1016/S0092-8674(00)81007-7; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Stern B, 1996, TRENDS GENET, V12, P345; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X	29	286	288	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					104	108		10.1038/nature03329	http://dx.doi.org/10.1038/nature03329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744308				2022-12-01	WOS:000227334600052
J	Poulsen, M; Boomsma, JJ				Poulsen, M; Boomsma, JJ			Mutualistic fungi control crop diversity in fungus-growing ants	SCIENCE			English	Article							LEAF-CUTTING ANTS; SYMBIOTIC FUNGI; SOMATIC INCOMPATIBILITY; EVOLUTION; SPECIALIZATION; AGRICULTURE; HYMENOPTERA; CONFLICT	Leaf-cutting ants rear clonal fungi for food and transmit the fungi from mother to daughter colonies so that symbiont mixing and conflict, which result from competition between genetically different clones, are avoided. Here we show that despite millions of years of predominantly vertical transmission, the domesticated fungi actively reject mycelial fragments from neighboring colonies, and that the strength of these reactions are in proportion to the overall genetic difference between these symbionts. Fungal incompatibility compounds remain intact during ant digestion, so that fecal droplets, which are used for manuring newly grown fungus, elicit similar hostile reactions when applied to symbionts from other colonies. Symbiont control over new mycelial growth by manurial imprinting prevents the rearing of multiple crops in fungus gardens belonging to the same colony.	Univ Copenhagen, Dept Populat Biol, Inst Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen	Poulsen, M (corresponding author), Univ Copenhagen, Dept Populat Biol, Inst Biol, Univ Pk 15, DK-2100 Copenhagen, Denmark.	Mpoulsen@bi.ku.dk	Poulsen, Michael/C-6276-2012; Boomsma, Jacobus J/M-2785-2014	Poulsen, Michael/0000-0002-2839-1715; Boomsma, Jacobus J/0000-0002-3598-1609				Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Adams RMM, 2000, NATURWISSENSCHAFTEN, V87, P491, DOI 10.1007/s001140050765; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Bekkevold D, 1999, BEHAV ECOL SOCIOBIOL, V46, P103, DOI 10.1007/s002650050598; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; CURRIE C, COMMUNICATION; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Diamond J, 1998, SCIENCE, V281, P1974, DOI 10.1126/science.281.5385.1974; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Frank SA, 2003, EVOLUTION, V57, P693; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; HANSEN EM, 1993, MYCOL RES, V97, P1229, DOI 10.1016/S0953-7562(09)81290-2; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Holldobler B., 1990, pi; Katoh H, 2002, MOL ECOL, V11, P1565, DOI 10.1046/j.1365-294X.2002.01535.x; MARTIN MM, 1970, SCIENCE, V169, P16, DOI 10.1126/science.169.3940.16; Mueller UG, 1996, MOL ECOL, V5, P119, DOI 10.1111/j.1365-294X.1996.tb00297.x; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Murata M., 1997, Recent Research Developments in Agricultural & Biological Chemistry, V1, P15; North RD, 1997, TRENDS ECOL EVOL, V12, P386, DOI 10.1016/S0169-5347(97)87381-8; Ridley P, 1996, EXPERIENTIA, V52, P631, DOI 10.1007/BF01969745; RISSING SW, 1989, NATURE, V338, P420, DOI 10.1038/338420a0; Ronhede S, 2004, MYCOL RES, V108, P101, DOI 10.1017/S0953756203008931; Schultz TR, 1998, INSECT SOC, V45, P457, DOI 10.1007/s000400050101; SCHULTZ TR, 2004, ECOLOGICAL EVOLUTION, P149; Viana AMM, 2001, CHEMOECOLOGY, V11, P29, DOI 10.1007/PL00001829; Villesen P, 2004, EVOLUTION, V58, P2252; Weber N. A., 1972, GARDENING ANTS ATTIN; Worrall JJ, 1997, MYCOLOGIA, V89, P24, DOI 10.2307/3761169; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	33	127	130	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					741	744		10.1126/science.1106688	http://dx.doi.org/10.1126/science.1106688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692054				2022-12-01	WOS:000226814900048
J	Irwin, DE; Bensch, S; Irwin, JH; Price, TD				Irwin, DE; Bensch, S; Irwin, JH; Price, TD			Speciation by distance in a ring species	SCIENCE			English	Article							WORLD LEAF WARBLERS; PHYLLOSCOPUS; GRADIENTS	Ring species, which consist of two reproductively isolated forms connected by a chain of intergrading populations, have often been described as examples of speciation despite gene flow between populations, but this has never been demonstrated. We used amplified fragment length polymorphism (AFLP) markers to study gene flow in greenish warblers (Phylloscopus trochiloides). These genetic markers show distinct differences between two reproductively isolated forms but gradual change through the ring connecting these forms. These findings provide the strongest evidence yet for "speciation by force of distance" in the face of ongoing gene flow.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of British Columbia; Lund University; University of Chicago	Irwin, DE (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	irwin@zoology.ubc.ca	Irwin, Darren E./G-6183-2012	Irwin, Darren E./0000-0002-1050-5841				Badyaev AV, 1997, AUK, V114, P40, DOI 10.2307/4089063; Coyne J.A., 2004, SPECIATION; Dobzhansky T., 1958, CENTURY DARWIN, P19; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Gavrilets S, 1998, P ROY SOC B-BIOL SCI, V265, P1483, DOI 10.1098/rspb.1998.0461; Irwin DE, 2000, EVOLUTION, V54, P998; Irwin DE, 2001, GENETICA, V112, P223, DOI 10.1023/A:1013319217703; Irwin DE, 2002, EVOLUTION, V56, P2383; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; MARCHETTI K, 1993, NATURE, V362, P149, DOI 10.1038/362149a0; Marchetti K, 1997, OIKOS, V79, P410, DOI 10.2307/3546026; Mayr E., 1942, SYSTEMATICS ORIGIN S, DOI 10.2307/1790142; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Noest AJ, 1997, P ROY SOC B-BIOL SCI, V264, P1389, DOI 10.1098/rspb.1997.0193; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; Schneider CJ, 1999, P NATL ACAD SCI USA, V96, P13869, DOI 10.1073/pnas.96.24.13869; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Ticehurst CB., 1938, SYSTEMATIC REV GENUS	20	146	169	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					414	416		10.1126/science.1105201	http://dx.doi.org/10.1126/science.1105201			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662011				2022-12-01	WOS:000226492300043
J	Falini, B; Mecucci, C; Tiacci, E; Alcalay, M; Rosati, R; Pasqualucci, L; La Starza, R; Diverio, D; Colombo, E; Santucci, A; Bigerna, B; Pacini, R; Pucciarini, A; Liso, A; Vignetti, M; Fazi, P; Meani, N; Pettirossi, V; Saglio, G; Mandelli, F; Lo-Coco, F; Pelicci, P; Martelli, MF				Falini, B; Mecucci, C; Tiacci, E; Alcalay, M; Rosati, R; Pasqualucci, L; La Starza, R; Diverio, D; Colombo, E; Santucci, A; Bigerna, B; Pacini, R; Pucciarini, A; Liso, A; Vignetti, M; Fazi, P; Meani, N; Pettirossi, V; Saglio, G; Mandelli, F; Lo-Coco, F; Pelicci, P; Martelli, MF		GIMEMA Acute Leukemia Working	Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; TUMOR-SUPPRESSOR PROTEIN; MINIMAL-RESIDUAL-DISEASE; NON-HODGKINS-LYMPHOMA; FLT3 MUTATIONS; ADULT PATIENTS; FUSION GENE; RT-PCR; NPM	BACKGROUND: Nucleophosmin (NPM), a nucleocytoplasmic shuttling protein with prominent nucleolar localization, regulates the ARF-p53 tumor-suppressor pathway. Translocations involving the NPM gene cause cytoplasmic dislocation of the NPM protein. METHODS: We used immunohistochemical methods to study the subcellular localization of NPM in bone marrow-biopsy specimens from 591 patients with primary acute myelogenous leukemia (AML). We then correlated the presence of cytoplasmic NPM with clinical and biologic features of the disease. RESULTS: Cytoplasmic NPM was detected in 208 (35.2 percent) of the 591 specimens from patients with primary AML but not in 135 secondary AML specimens or in 980 hematopoietic or extrahematopoietic neoplasms other than AML. It was associated with a wide spectrum of morphologic subtypes of the disease, a normal karyotype, and responsiveness to induction chemotherapy, but not with recurrent genetic abnormalities. There was a high frequency of FLT3 internal tandem duplications and absence of CD34 and CD133 in AML specimens with a normal karyotype and cytoplasmic dislocation of NPM, but not in those in which the protein was restricted to the nucleus. AML specimens with cytoplasmic NPM carried mutations of the NPM gene that were predicted to alter the protein at its C-terminal; this mutant gene caused cytoplasmic localization of NPM in transfected cells. CONCLUSIONS: Cytoplasmic NPM is a characteristic feature of a large subgroup of patients with AML who have a normal karyotype, NPM gene mutations, and responsiveness to induction chemotherapy.	Univ Perugia, Monteluce Policlin, Inst Hematol, I-06122 Perugia, Italy; Univ Perugia, Dept Biochem & Mol Biotechnol, I-06122 Perugia, Italy; European Inst Oncol, Milan, Italy; Columbia Univ, Inst Canc Genet, New York, NY USA; Univ Roma La Sapienza, Inst Hematol, Rome, Italy; Univ Foggia, Inst Hematol, Foggia, Italy; Grp Italiano Malattie Ematol Adulto Data Ctr, Rome, Italy; Osped S Luigi, Div Internal Med & Hematol, Orbassano, Italy; Univ Roma Tor Vergata, Dept Biopathol, Rome, Italy	University of Perugia; University of Perugia; IRCCS European Institute of Oncology (IEO); Columbia University; Sapienza University Rome; University of Foggia; University of Rome Tor Vergata	Falini, B (corresponding author), Univ Perugia, Monteluce Policlin, Inst Hematol, I-06122 Perugia, Italy.	faliniem@unipg.it	Rosati, Roberto/AAF-3708-2020; Alcalay, Myriam/B-3182-2016; Alcalay, Myriam/AAB-4300-2019; Liso, Arcangelo/AAL-2183-2020; Pelicci, Pier Giuseppe/AAL-6572-2020; La Starza, Roberta/ABD-0836-2022; Colombo, Emanuela/AAO-8113-2020	Rosati, Roberto/0000-0002-0475-3654; Alcalay, Myriam/0000-0002-5558-4272; Alcalay, Myriam/0000-0002-5558-4272; Liso, Arcangelo/0000-0001-5638-227X; Colombo, Emanuela/0000-0003-2079-7398; Vignetti, Marco/0000-0003-1278-604X; Saglio, Giuseppe/0000-0002-1046-3514; FALINI, Brunangelo/0000-0002-7198-5965				Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Carnicer MJ, 2004, LEUKEMIA RES, V28, P19, DOI 10.1016/S0145-2126(03)00125-5; Chang JH, 1998, BIOCHEM J, V329, P539; Christiansen DH, 2001, LEUKEMIA, V15, P1848, DOI 10.1038/sj.leu.2402246; CIMINO G, 1995, CANCER RES, V55, P1625; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Cordell JL, 1999, BLOOD, V93, P632, DOI 10.1182/blood.V93.2.632; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; Crescenzi B, 2000, CANCER GENET CYTOGEN, V120, P25, DOI 10.1016/S0165-4608(99)00245-9; DUMBAR TS, 1989, BIOCHEMISTRY-US, V28, P9495, DOI 10.1021/bi00450a037; Falini B, 1999, BLOOD, V93, P2697; Falini B, 2002, BLOOD, V99, P409, DOI 10.1182/blood.V99.2.409; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Jaffe E. S., 2001, PATHOLOGY GENETICS T; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Mitelman F, 1995, ISCN INT SYSTEM HUMA; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; MORRIS SW, 1995, SCIENCE, V267, P316, DOI 10.1126/science.267.5196.316-b; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; Noguera N, 2002, LEUKEMIA, V16, P2185, DOI 10.1038/sj.leu.2402723; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Redner RL, 1996, BLOOD, V87, P882, DOI 10.1182/blood.V87.3.882.bloodjournal873882; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; SOEKARMAN D, 1992, BLOOD, V79, P2990; Steudel C, 2003, GENE CHROMOSOME CANC, V37, P237, DOI 10.1002/gcc.10219; Umekawa H, 2001, J BIOCHEM-TOKYO, V130, P199, DOI 10.1093/oxfordjournals.jbchem.a002973; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; YonedaKato N, 1996, ONCOGENE, V12, P265	41	1310	1388	3	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2005	352	3					254	266		10.1056/NEJMoa041974	http://dx.doi.org/10.1056/NEJMoa041974			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888JP	15659725	Bronze			2022-12-01	WOS:000226370500006
J	Higo, T; Hattori, M; Nakamura, T; Natsume, T; Michikawa, T; Mikoshiba, K				Higo, T; Hattori, M; Nakamura, T; Natsume, T; Michikawa, T; Mikoshiba, K			Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44	CELL			English	Article							ENDOPLASMIC-RETICULUM; CELL-DEATH; CALCIUM; CA2+; TYPE-1; PH; CALRETICULIN; CHROMOGRANIN; RELEASE; ROLES	Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) are intracellular channel proteins that mediate Ca2+ release from the endoplasmic reticulum (ER) and are involved in many biological processes and diseases. IP(3)Rs are differentially regulated by a variety of cytosolic proteins, but their regulation by ER lumenal protein(s) remains largely unexplored. In this study, we found that ERp44, an ER lumenal protein of the thioredoxin family, directly interacts with the third lumenal loop of IP3R type 1 (IP(3)R1) and that the interaction is dependent on pH, Call concentration, and redox state: the presence of free cysteine residues in the loop is required. Ca2+-imaging experiments and single-channel recording Of IP3R1 activity with a planar lipid bilayer system demonstrated that IP3R1 is directly inhibited by ERp44. Thus, ERp44 senses the environment in the ER lumen and modulates IP3R1 activity accordingly, which should in turn contribute to regulating both intralumenal conditions and the complex patterns of cytosolic Ca2+ concentrations.	Univ Tokyo, Dept Mol Neurobiol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; RIKEN, Dev Neurobiol Lab, Brain Sci Inst, Wako, Saitama 3510198, Japan; JST, ICORP, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan; Japan Biol Informat Res Ctr, Prot Network Team, Funct Genome Grp, Koto Ku, Tokyo 1358073, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), Univ Tokyo, Dept Mol Neurobiol, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	mikosiba@ims.u-tokyo.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Hattori, Mitsuharu/F-3859-2010	Hattori, Mitsuharu/0000-0002-0503-4969				Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; Caroppo R, 2003, J BIOL CHEM, V278, P39503, DOI 10.1074/jbc.M305823200; Choe CU, 2004, J BIOL CHEM, V279, P35551, DOI 10.1074/jbc.M311261200; FOYOUZIYOUSSEFI R, 2000, PO NATL ACAD SCI, V97, P5273; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Kamp F, 1998, BIOPHYS J, V74, P290, DOI 10.1016/S0006-3495(98)77786-0; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paschen W, 2003, CELL CALCIUM, V34, P305, DOI 10.1016/S0143-4160(03)00138-6; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; Roderick HL, 1998, CELL CALCIUM, V24, P253, DOI 10.1016/S0143-4160(98)90049-5; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899	35	288	295	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					85	98		10.1016/j.cell.2004.11.048	http://dx.doi.org/10.1016/j.cell.2004.11.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652484	Bronze			2022-12-01	WOS:000226365400013
J	Richly, H; Rape, M; Braun, S; Rumpf, S; Hoege, C; Jentsch, S				Richly, H; Rape, M; Braun, S; Rumpf, S; Hoege, C; Jentsch, S			A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting	CELL			English	Article							AAA-ATPASE CDC48/P97; TRANSCRIPTION FACTOR; DNA-REPAIR; CELL-CYCLE; PROTEIN; ER; RAD23; CHAIN; COMPLEX; DOMAIN	Protein degradation in eukaryotes usually requires multi-ubiquitylation and subsequent delivery of the tagged substrates to the proteasome. Recent studies suggest the involvement of the AAA ATPase CDC48, its cofactors, and other ubiquitin binding factors in protein degradation, but how these proteins work together is unclear. Here we show that these factors cooperate sequentially through protein-protein interactions and thereby escort ubiquitin-protein conjugates to the proteasome. Central to this pathway is the chaperone CDC48/p97, which coordinates substrate recruitment, E4-catalyzed multiubiquitin chain assembly, and proteasomal targeting. Concomitantly, CDC48 prevents the formation of excessive multiubiquitin chain sizes that are surplus to requirements for degradation. In yeast, this escort pathway guides a transcription factor from its activation in the cytosol to its final degradation and also mediates proteolysis at the endoplasmic reticulum by the ERAD pathway.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Rumpf, Sebastian/AHC-9393-2022	Braun, Sigurd/0000-0001-6399-8574; Rape, Michael/0000-0003-4849-6343				Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fu HY, 1999, MOL BIOL REP, V26, P137, DOI 10.1023/A:1006926322501; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; HUYTON T, 2003, J STRUCT BIOL, V102, P577; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Lambertson D, 1999, GENETICS, V153, P69; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Saeki Y, 2004, BIOCHEM BIOPH RES CO, V320, P840, DOI 10.1016/j.bbrc.2004.05.216; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang SR, 1999, GENETICS, V151, P473	48	401	418	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					73	84		10.1016/j.cell.2004.11.013	http://dx.doi.org/10.1016/j.cell.2004.11.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652483	Bronze			2022-12-01	WOS:000226365400012
J	Fletcher, SW; Elmore, JG				Fletcher, SW; Elmore, JG			False-positive mammograms - can the USA learn from Europe?	LANCET			English	Editorial Material							SCREENING MAMMOGRAPHY		Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Boston, MA 02115 USA; Univ Washington, Dept Med, Seattle, WA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Washington; University of Washington Seattle	Fletcher, SW (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA.	suzanne_fletcher@hms.harvard.edu						Barton MB, 2001, J GEN INTERN MED, V16, P150, DOI 10.1046/j.1525-1497.2001.00329.x; BASSETT LW, 1994, AGENCY HLTH CARE POL; BROWN ML, 1995, AM J ROENTGENOL, V165, P1373, DOI 10.2214/ajr.165.6.7484568; de Wolf CJ, 1996, EUROPEAN GUIDELINES; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P1384, DOI 10.1093/jnci/djg048; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; JOY JE, 2004, SAVING WOMENS LIVES; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Vainio H, 2002, IARC HDB CANC PREVEN, V7	12	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2005	365	9453					7	8		10.1016/S0140-6736(04)17676-9	http://dx.doi.org/10.1016/S0140-6736(04)17676-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886FU	15639661				2022-12-01	WOS:000226213100005
J	Falk, D; Hildebolt, C; Smith, K; Morwood, MJ; Sutikna, T; Brown, P; Jatmiko; Saptomo, EW; Brunsden, B; Prior, F				Falk, D; Hildebolt, C; Smith, K; Morwood, MJ; Sutikna, T; Brown, P; Jatmiko; Saptomo, EW; Brunsden, B; Prior, F			The brain of LB1, Homo floresiensis	SCIENCE			English	Article							INDONESIA; EVOLUTION; HOMININ; APES	The brain of Homo floresiensis was assessed by comparing a virtual endocast from the type specimen (LB1) with endocasts from great apes, Homo erectus, Homo sapiens, a human pygmy, a human microcephalic, specimen number Sts 5 (Australopithecus africanus), and specimen number WT 17000 (Paranthropus aethiopicus). Morphometric, allometric, and shape data indicate that LB1 is not a microcephalic or pygmy. LB1's brain/body size ratio scales like that of an australopithecine, but its endocast shape resembles that of Homo erectus. LB1 has derived frontal and temporal lobes and a lunate sulcus in a derived position, which are consistent with capabilities for higher cognitive processing.	Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; Univ New England, Armidale, NSW 2351, Australia; Indonesian Ctr Archaeol, Jakarta 12001, Indonesia	State University System of Florida; Florida State University; Washington University (WUSTL); University of New England	Falk, D (corresponding author), Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA.	dfalk@fsu.edu	Brown, Peter/C-8763-2018; Falk, Dean/C-6400-2019; Sutikna, Thomas/C-4709-2018	Falk, Dean/0000-0003-1654-0469; Sutikna, Thomas/0000-0002-9742-4226				Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; CAVALLISFORZA LL, 1986, AFRICAN PYGMIES, P81; Connolly CJ, 1950, EXTERNAL MORPHOLOGY; Conroy G.C., 1985, P419; CONROY GC, 1990, SCIENCE, V247, P838, DOI 10.1126/science.2305255; Conroy GC, 1998, SCIENCE, V280, P1730, DOI 10.1126/science.280.5370.1730; Diamond J, 2004, SCIENCE, V306, P2047, DOI 10.1126/science.1107565; FALK D, 1983, SCIENCE, V221, P1072, DOI 10.1126/science.221.4615.1072; Falk D, 2000, J HUM EVOL, V38, P695, DOI 10.1006/jhev.1999.0378; FALK D, 1993, AM J PHYS ANTHROPOL, V92, P81, DOI 10.1002/ajpa.1330920107; FLOWER WH, 1889, J ANTHR I, V18, P3; GROVES C, 2004, BEFORE FARMING, V4; HENNEBERG M, 2004, BEFORE FARMING, V4; Holloway RL, 2004, HUMAN FOSSIL RECORD, V3; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; Kumar A, 2002, J BIOSCIENCES, V27, P629, DOI 10.1007/BF02708369; LEMAY M, 1992, AM J NEURORADIOL, V13, P493; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; PASSINGHAM R, 1975, NEW SCI, V27, P510; Rilling JK, 2002, J HUM EVOL, V42, P505, DOI 10.1006/jhev.2001.0537; Schultz A, 1956, PRIMATOLOGIA, P887; Semendeferi K, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P257; Semendeferi K, 2000, J HUM EVOL, V38, P317, DOI 10.1006/jhev.1999.0381; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Shea BT, 1996, AM J PHYS ANTHROPOL, V100, P311; Spoor F, 2000, J ANAT, V197, P61, DOI 10.1046/j.1469-7580.2000.19710061.x; VERLOES A, 2004, ORPHANET ENCY; WEIDENREICH FRANZ, 1938, PALEONTOL SINICA SER D, V3, P1	28	172	182	5	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					242	245		10.1126/science.1109727	http://dx.doi.org/10.1126/science.1109727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15749690	Green Submitted			2022-12-01	WOS:000228273700050
J	Burgess, C; Cornelius, V; Love, S; Graham, J; Richards, M; Ramirez, A				Burgess, C; Cornelius, V; Love, S; Graham, J; Richards, M; Ramirez, A			Depression and anxiety in women with early breast cancer: five year observational cohort study	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; PSYCHIATRIC MORBIDITY; PSYCHOLOGICAL MORBIDITY; MASTECTOMY; CONSERVATION; PREVALENCE; PREDICTORS; DISEASE; IMPACT; TRIAL	Objective To examine the prevalence of, and risk factors for, depression and anxiety in women with early breast cancer in the five years after diagnosis. Design Observational cohort study. Setting NHS breast clinic, London. Participants 222 women with early breast cancer: 170 (77%) provided complete interview data up to either five years after diagnosis or recurrence. Main outcome measures Prevalence of clinically important depression and anxiety (structured psychiatric interview with standardised diagnostic criteria) and clinical and patient risk factors, including stressful life experiences (Bedford College life events and difficulties schedule). Results Nearly 50% of the women with early breast cancer had depression, anxiety, or both in the year after diagnosis, 25% in the second, third, and fourth years, and 15% in the fifth year. Point prevalence was 33% at diagnosis, falling to 15% after one year. 45% of those with recurrence experienced depression, anxiety, or both within three months of the diagnosis. Previous psychological treatment predicted depression, anxiety, or both in the period around diagnosis (one month before diagnosis to four months after diagnosis). Longer term depression and anxiety were associated with previous psychological treatment, lack of an intimate confiding relationship, younger age, and severely stressful non-cancer life experiences. Clinical factors were not associated with depression and anxiety at any time. Lack of intimate confiding support also predicted more protracted episodes of depression and anxiety. Conclusion Increased levels of depression and anxiety in the first year after a diagnosis of early breast cancer highlight the need for dedicated service provision during this time. Psychological interventions for women with breast cancer who remain disease free should take account of the broader social context in which the cancer occurs, with a focus on improving social support.	Kings Coll London, St Thomas Hosp, Inst Psychiat, Canc Res UL London Psychosocial Grp, London SE1 7EH, England; Inst Hlth Sci, Canc Res UK Med Stat Grp, Ctr Stat Med, Oxford OX3 7LF, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK; University of Oxford	Burgess, C (corresponding author), Kings Coll London, St Thomas Hosp, Inst Psychiat, Canc Res UL London Psychosocial Grp, London SE1 7EH, England.	caroline.burgess@kcl.ac.uk		Cornelius, Victoria/0000-0002-0080-1065; Love, Sharon/0000-0002-6695-5390				*AM PSYCH ASS COMM, 1987, DIAGN STAT MAN MENT; [Anonymous], [No title captured]; Brown G., 1978, SOCIAL ORIGINS DEPRE; Burgess CC, 2002, EUR J CANCER, V38, P1622, DOI 10.1016/S0959-8049(02)00132-6; CHIA SKL, 2003, P AN M AM SOC CLIN, V22, P6; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; DEAN C, 1987, J PSYCHOSOM RES, V31, P385, DOI 10.1016/0022-3999(87)90059-6; FALLOWFIELD LJ, 1994, BRIT MED J, V309, P448, DOI 10.1136/bmj.309.6952.448; FALLOWFIELD LJ, 1986, BMJ-BRIT MED J, V293, P1331, DOI 10.1136/bmj.293.6558.1331; FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575, DOI 10.1136/bmj.301.6752.575; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; Haddad P, 1994, BREAST, V3, P218, DOI DOI 10.1016/0960-9776(94)90049-3; Hall A., 1996, BREAST J, V2, P197; HARRISON J, 1994, BRIT J PSYCHIAT, V165, P593, DOI 10.1192/bjp.165.5.593; HUGHSON AVM, 1986, BMJ-BRIT MED J, V293, P1268, DOI 10.1136/bmj.293.6557.1268; KIEBERT GM, 1991, J CLIN ONCOL, V9, P1059, DOI 10.1200/JCO.1991.9.6.1059; LEE MS, 1992, EUR J CANCER, V28A, P1340, DOI 10.1016/0959-8049(92)90514-3; *NAT I CLIN EXC, 2004, SUPP PALL CAR PEOPL; O'Shaughnessy J, 2002, J CLIN ONCOL, V20, P2812, DOI 10.1200/JCO.2002.09.002; Okamura H, 2000, BREAST CANCER RES TR, V61, P131, DOI 10.1023/A:1006491417791; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; PINDER KL, 1994, PSYCHO-ONCOLOGY, V3, P129; RAMIREZ AJ, 1995, BRIT J CANCER, V72, P1509, DOI 10.1038/bjc.1995.538; Spitzer R.L., 1990, STRUCTURED CLIN INTE	24	813	840	4	84	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 26	2005	330	7493					702	705		10.1136/bmj.38343.670868.D3	http://dx.doi.org/10.1136/bmj.38343.670868.D3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	912IT	15695497	Bronze, Green Published			2022-12-01	WOS:000228071900016
J	Harris, TG; Burk, RD; Palefsky, JM; Massad, LS; Bang, JY; Anastos, K; Minkoff, H; Hall, CB; Bacon, MC; Levine, AM; Watts, DH; Silverberg, MJ; Xue, XN; Melnick, SL; Strickler, HD				Harris, TG; Burk, RD; Palefsky, JM; Massad, LS; Bang, JY; Anastos, K; Minkoff, H; Hall, CB; Bacon, MC; Levine, AM; Watts, DH; Silverberg, MJ; Xue, XN; Melnick, SL; Strickler, HD			Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	8th International Conference on Malignancies in AIDS and Other Immunodeficiencies	APR 29-30, 2004	Bethesda, MD				HIGH-RISK HPV; CYTOLOGY; WOMEN; NEOPLASIA; CANCER; ABNORMALITIES; SMEARS	Context Recent cervical cancer screening guidelines state that the interval between screenings can be safely extended to 3 years in healthy women 30 years or older who have normal cytology results and have negative test results for oncogenic human papillomavirus (HPV) DNA. Objective To determine the incidence of squamous intraepithelial lesions (SILs) in HIV-seropositive women with normal cytology results, by baseline HPV DNA results. Design, Setting, and Patients Participants were HIV-seropositive (n=855; mean age, 36 years) and HIV-seronegative (n=343; mean age, 34 years) US women with normal baseline cervical cytology who were enrolled in the Women's Interagency HIV Study (WIHS), a large, multi-institutional prospective cohort study. Since their recruitment during 1994-1995, WIHS participants have been followed up semi-annually with repeated Pap smears for a median of 7 years. Main Outcome Measure The cumulative incidence of any SIL and high-grade SIL or cancer (HSIL+) was estimated according to baseline HPV DNA results, stratified by HIV serostatus and CD4 T-cell count. Results Development of any SIL in women with negative HPV results (both oncogenic and nononcogenic) at 2 years was as follows: in HIV-seropositive women with CD4 counts less than 200/mu L, 9% (95% Cl, 1%-18%); with CD4 counts between 200/mu L and 500/mu L, 9% (95% Cl, 4%-13%); and with CD4 counts greater than 500/ mu L, 4% (95% Cl, 1%-7%). The Cis for these estimates overlapped with those for HIV-seronegative women with normal baseline cytology who were HPV-negative (3%; 95% Cl, 1%-5%), indicating that at 2 years, there were no large absolute differences in the cumulative incidence of any SIL between groups. Furthermore, no HPV-negative participants in any group developed HSIL+ lesions within 3 years. Multivariate Cox models showed that on a relative scale, the incidence of any SIL among HIV-seropositive women with CD4 counts greater than 500/mu L (hazard ratio [HR], 1.2; 95% Cl, 0.5-3.0), but not those with CD4 counts less than or equal to 500/mu L (HR, 2.9; 95% C1, 1.2-7.1), was similar to that in HIV-seronegative women. Conclusion The similar low cumulative incidence of any SIL among HIV-seronegative and HIV-seropositive women with CD4 counts greater than 500/mu L and who had normal cervical cytology and HPV-negative test results suggests that similar cervical cancer screening practices may be applicable to both groups, although this strategy warrants evaluation in an appropriate clinical trial.	Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; So Illinois Univ, Sch Med, Springfield, IL USA; Maimonides Hosp, Brooklyn, NY 11219 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; Univ So Calif, Los Angeles, CA USA; NICHHD, Bethesda, MD 20892 USA; Johns Hopkins Univ, Baltimore, MD USA; NCI, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; Southern Illinois University System; Southern Illinois University; Maimonides Medical Center; Georgetown University; University of Southern California; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harris, TG (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave,Belfer 1308A, Bronx, NY 10461 USA.	tharris@aecom.yu.edu	Hall, Charles B./AAX-8216-2020	Harris, Tiffany/0000-0003-2212-0874; Hall, Charles/0000-0001-9982-8120	NATIONAL CANCER INSTITUTE [R01CA085178] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, M01RR000083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, U01AI034994, U01AI031834, U01AI035004, U01AI042590, U01AI034993] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA-085178] Funding Source: Medline; NCRR NIH HHS [M01-RR-00083, M01-RR-0007, M01-RR-00079] Funding Source: Medline; NIAID NIH HHS [U01-AI-34989, U01-AI-31834, U01-AI-34993, U01-AI-34994, U01-AI-35004, U01-AI-42590] Funding Source: Medline; OID CDC HHS [U01-CH-32632] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OID CDC HHS		*2 NAT CANC I WORK, 1993, ACTA CYTOL, V37, P115; ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415; [Anonymous], 1995, Clin Infect Dis, V21 Suppl 1, pS32; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Clavel C, 2004, BRIT J CANCER, V90, P1803, DOI 10.1038/sj.bjc.6601726; COX DR, 1972, J R STAT SOC B, V34, P187; Delmas MC, 2000, AIDS, V14, P1775, DOI 10.1097/00002030-200008180-00013; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Goldie SJ, 2001, AM J MED, V111, P140, DOI 10.1016/S0002-9343(01)00780-X; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Lawless, 2011, STAT MODELS METHODS; LONKY NM, 1995, OBSTET GYNECOL, V85, P716, DOI 10.1016/0029-7844(95)00041-O; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Rozendaal L, 2000, J CLIN PATHOL, V53, P606, DOI 10.1136/jcp.53.8.606; Schneider A, 2000, INT J CANCER, V89, P529, DOI 10.1002/1097-0215(20001120)89:6&lt;529::AID-IJC11&gt;3.0.CO;2-G; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; WRIGHT TC, 1995, OBSTET GYNECOL, V85, P202, DOI 10.1016/0029-7844(94)00373-L	24	134	135	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1471	1476		10.1001/jama.293.12.1471	http://dx.doi.org/10.1001/jama.293.12.1471			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	908KA	15784870	Bronze			2022-12-01	WOS:000227784700026
J	Gibson, MC; Perrimon, N				Gibson, MC; Perrimon, N			Extrusion and death of DPP/BMP-compromised epithelial cells in the developing Drosophila wing	SCIENCE			English	Article							DPP MORPHOGEN GRADIENT; JUVENILE POLYPOSIS; THICK VEINS; I RECEPTORS; APOPTOSIS; MUTATIONS; JNK; MECHANISMS; SURVIVAL; KINASE	During animal development, epithelial cell fates are specified according to spatial position by extracellular signaling pathways. Among these, the transforming growth factor beta/bone morphogenetic protein (TGF-beta/BMP) pathways are evolutionarily conserved and play crucial roles in the development and homeostasis of a wide range of multicellular tissues. Here we show that in the developing Drosophila wing imaginal epithelium, cell clones deprived of the BMP-like ligand Decapentaplegic (DPP) do not die as previously thought but rather extrude from the cell layer as viable cysts exhibiting marked abnormalities in cell shape and cytoskeletal organization. We propose that in addition to assigning cell fates, a crucial developmental function of DPP/BMP signaling is the position-specific control of epithelial. architecture.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	perrimon@receptor.med.harvard.edu		Gibson, Matthew/0000-0001-5588-8842; Perrimon, Norbert/0000-0001-7542-472X				Adachi-Yamada T, 2004, J BIOCHEM, V136, P13, DOI 10.1093/jb/mvh099; Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Auerbach C., 1936, Transactions of the Royal Society of Edinburgh, V58, P787; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Burke R, 1996, DEVELOPMENT, V122, P2261; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; COHEN SM, 1993, DEV DROSOPHILA MELAN, V2, P74; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Ingram AJ, 2000, KIDNEY INT, V58, P1431, DOI 10.1046/j.1523-1755.2000.00305.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ricos MG, 1999, J CELL SCI, V112, P1225; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Sayed MG, 2002, ANN SURG ONCOL, V9, P901, DOI 10.1007/BF02557528; Singer MA, 1997, DEVELOPMENT, V124, P79	29	148	150	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1785	1789		10.1126/science.1104751	http://dx.doi.org/10.1126/science.1104751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774762				2022-12-01	WOS:000227883900048
J	Rocks, O; Peyker, A; Kahms, M; Verveer, PJ; Koerner, C; Lumbierres, M; Kuhlmann, J; Waldmann, H; Wittinghofer, A; Bastiaens, PIH				Rocks, O; Peyker, A; Kahms, M; Verveer, PJ; Koerner, C; Lumbierres, M; Kuhlmann, J; Waldmann, H; Wittinghofer, A; Bastiaens, PIH			An acylation cycle regulates localization and activity of palmitoylated Ras isoforms	SCIENCE			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; PROTEIN PALMITOYLATION; CAAX MOTIF; STRUCTURAL DETERMINANTS; GOLGI-APPARATUS; H-RAS; N-RAS; CELLS; TRAFFICKING	We show that the specific subcellular distribution of H- and Nras guanosine triphosphate-binding proteins is generated by a constitutive de/reacylation cycle that operates on palmitoylated proteins, driving their rapid exchange between the plasma membrane (PM) and the Golgi apparatus. Depalmitoylation redistributes farnesylated Ras in all membranes, followed by repalmitoylation and trapping of Ras at the Golgi, from where it is redirected to the PM via the secretory pathway. This continuous cycle prevents Ras from nonspecific residence on endomembranes, thereby maintaining the specific intracellular compartmentalization. The de/reacylation cycle also initiates Ras activation at the Golgi by transport of PM-localized Ras guanosine triphosphate. Different de/repalmitoylation kinetics account for isoform-specific activation responses to growth factors.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany; Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society; Max Planck Society	Wittinghofer, A (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de; bastiaen@embl.de	Rocks, Oliver/AFI-7418-2022; Waldmann, Herbert/B-7406-2017; Rocks, Oliver/ABG-3341-2020	Waldmann, Herbert/0000-0002-9606-7247; Rocks, Oliver/0000-0001-6349-9193; Lorentzen, Anna/0000-0002-4405-935X				Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bader B, 2000, NATURE, V403, P223, DOI 10.1038/35003249; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bizzozero OA, 2001, BBA-PROTEIN STRUCT M, V1545, P278, DOI 10.1016/S0167-4838(00)00291-0; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; LOWY DR, 1989, NATURE, V341, P384, DOI 10.1038/341384a0; LU JY, 1995, J BIOL CHEM, V270, P7251, DOI 10.1074/jbc.270.13.7251; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Navarro-Lerida I, 2002, J CELL SCI, V115, P3119; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; ROCKS O, UNPUB; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Schroeder H, 1997, BIOCHEMISTRY-US, V36, P13102, DOI 10.1021/bi9709497; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Ten Brinke A, 2002, BIOCHEM J, V361, P663, DOI 10.1042/0264-6021:3610663; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	40	602	620	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1746	1752		10.1126/science.1105654	http://dx.doi.org/10.1126/science.1105654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15705808				2022-12-01	WOS:000227883900037
J	Najemnik, J; Geisler, WS				Najemnik, J; Geisler, WS			Optimal eye movement strategies in visual search	NATURE			English	Article							SIGNAL-DETECTION; MODEL	To performvisual search, humans, like many mammals, encode a large field of view with retinas having variable spatial resolution, and then use high-speed eye movements to direct the highest-resolution region, the fovea, towards potential target locations(1,2). Good search performance is essential for survival, and hence mammals may have evolved efficient strategies for selecting fixation locations. Here we address two questions: what are the optimal eye movement strategies for a foveated visual system faced with the problem of finding a target in a cluttered environment, and do humans employ optimal eye movement strategies during a search? We derive the ideal bayesian observer(3-6) for search tasks in which a target is embedded at an unknown location within a random background that has the spectral characteristics of natural scenes(7). Our ideal searcher uses precise knowledge about the statistics of the scenes in which the target is embedded, and about its own visual system, to make eye movements that gain the most information about target location. We find that humans achieve nearly optimal search performance, even though humans integrate information poorly across fixations(8-10). Analysis of the ideal searcher reveals that there is little benefit from perfect integration across fixations - much more important is efficient processing of information on each fixation. Apparently, evolution has exploited this fact to achieve efficient eye movement strategies with minimal neural resources devoted to memory.	Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Geisler, WS (corresponding author), Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA.	geisler@psy.utexas.edu		Geisler, Wilson/0000-0003-4630-6614				Blake A., 1992, ACTIVE VISION; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; BURGESS AE, 1984, J OPT SOC AM A, V1, P906, DOI 10.1364/JOSAA.1.000906; Carpenter RHS, 1991, EYE MOVEMENTS; Eckstein MP, 2001, PERCEPTION, V30, P1389, DOI 10.1068/p3128; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Geisler WS, 2003, COGNITIVE SCI, V27, P379, DOI 10.1016/S0364-0213(03)00009-0; Geman D, 1996, IEEE T PATTERN ANAL, V18, P1, DOI 10.1109/34.476006; Green DG., 1966, SIGNAL DETECTION THE, DOI 10.1901/jeab.1969.12-475; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Legge GE, 2002, VISION RES, V42, P2219, DOI 10.1016/S0042-6989(02)00131-1; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; Rajashekar U., 2002, Proceedings ETRA 2002. Eye Tracking Research and Applications Symposium, P119, DOI 10.1145/507072.507096; Rao RPN, 2002, VISION RES, V42, P1447, DOI 10.1016/S0042-6989(02)00040-8; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Schall J. D., 2004, VISUAL NEUROSCIENCES, P1369; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Zelinsky GJ, 1997, PSYCHOL SCI, V8, P448, DOI 10.1111/j.1467-9280.1997.tb00459.x	26	545	563	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					387	391		10.1038/nature03390	http://dx.doi.org/10.1038/nature03390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772663				2022-12-01	WOS:000227715100053
J	Peiter, E; Maathuis, FJM; Mills, LN; Knight, H; Pelloux, J; Hetherington, AM; Sanders, D				Peiter, E; Maathuis, FJM; Mills, LN; Knight, H; Pelloux, J; Hetherington, AM; Sanders, D			The vacuolar Ca2+-activated channel TPC1 regulates germination and stomatal movement	NATURE			English	Article							INDUCED CALCIUM-RELEASE; GUARD-CELL VACUOLES; ION CHANNELS; ARABIDOPSIS; PROTEIN; IDENTIFICATION; TRANSFORMATION; OSCILLATIONS; SODIUM; SYSTEM	Cytosolic free calcium ([Ca2+](cyt)) is a ubiquitous signalling component in plant cells(1). Numerous stimuli trigger sustained or transient elevations of [Ca2+](cyt) that evoke downstream stimulus-specific responses. Generation of [Ca2+](cyt) signals is effected through stimulus-induced opening of Ca2+-permeable ion channels that catalyse a flux of Ca2+ into the cytosol from extracellular or intracellular stores. Many classes of Ca2+ current have been characterized electrophysiologically in plant membranes(2). However, the identity of the ion channels that underlie these currents has until now remained obscure. Here we show that the TPC1 ('two-pore channel 1') gene of Arabidopsis thaliana encodes a class of Ca2+-dependent Ca2+-release channel that is known from numerous electrophysiological studies as the slow vacuolar channel(3-5). Slow vacuolar channels are ubiquitous in plant vacuoles, where they form the dominant conductance at micromolar [Ca2+](cyt). We show that a tpc1 knockout mutant lacks functional slow vacuolar channel activity and is defective in both abscisic acid-induced repression of germination and in the response of stomata to extracellular calcium. These studies unequivocally demonstrate a critical role of intracellular Ca2+-release channels in the physiological processes of plants.	Univ York, Dept Biol, Area 9, York YO10 5YW, N Yorkshire, England; Univ Lancaster, Dept Biol, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of York - UK; Lancaster University; University of Oxford	Sanders, D (corresponding author), Univ York, Dept Biol, Area 9, POB 373, York YO10 5YW, N Yorkshire, England.	ds10@york.ac.uk	Peiter, Edgar/C-2577-2013	Peiter, Edgar/0000-0002-9104-3238; Hetherington, Alistair/0000-0001-6060-9203; Knight, Heather/0000-0003-2047-6084; Pelloux, Jerome/0000-0002-9371-1711	Biotechnology and Biological Sciences Research Council [P18580] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Allen GJ, 1997, ADV BOT RES, V25, P217, DOI 10.1016/S0065-2296(08)60154-8; Allen GJ, 1996, PLANT J, V10, P1055, DOI 10.1046/j.1365-313X.1996.10061055.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bewell MA, 1999, FEBS LETT, V458, P41, DOI 10.1016/S0014-5793(99)01109-6; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hashimoto K, 2004, PLANT CELL PHYSIOL, V45, P496, DOI 10.1093/pcp/pch053; HEDRICH R, 1987, NATURE, V329, P833, DOI 10.1038/329833a0; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; HOFTE H, 1991, PLANTA, V184, P431, DOI 10.1007/BF00197889; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kadota Y, 2004, BIOCHEM BIOPH RES CO, V317, P823, DOI 10.1016/j.bbrc.2004.03.114; Kurusu T, 2004, PLANT CELL PHYSIOL, V45, P693, DOI 10.1093/pcp/pch082; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Maathuis FJM, 1995, METHOD CELL BIOL, V49, P293, DOI 10.1016/S0091-679X(08)61461-2; Maathuis FJM, 2001, PLANT PHYSIOL, V127, P1617, DOI 10.1104/pp.010502; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; Muir SR, 1997, PLANT PHYSIOL, V114, P1511, DOI 10.1104/pp.114.4.1511; Pottosin II, 2001, J MEMBRANE BIOL, V181, P55, DOI 10.1007/s0023200100073; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schonknecht G, 2002, FEBS LETT, V511, P28, DOI 10.1016/S0014-5793(01)03273-2; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Szponarski W, 2004, PROTEOMICS, V4, P397, DOI 10.1002/pmic.200300607; WARD JM, 1994, PLANT CELL, V6, P669; White PJ, 2000, BBA-BIOMEMBRANES, V1465, P171, DOI 10.1016/S0005-2736(00)00137-1	30	376	399	2	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					404	408		10.1038/nature03381	http://dx.doi.org/10.1038/nature03381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772667				2022-12-01	WOS:000227715100057
J	Beman, JM; Arrigo, KR; Matson, PA				Beman, JM; Arrigo, KR; Matson, PA			Agricultural runoff fuels large phytoplankton blooms in vulnerable areas of the ocean	NATURE			English	Article							GULF-OF-CALIFORNIA; NITROGEN-FIXATION; DENITRIFICATION; VARIABILITY; PHOSPHORUS; PATTERNS; NITRATE; WATERS; SEA; BAY	Biological productivity in most of the world's oceans is controlled by the supply of nutrients to surface waters. The relative balance between supply and removal of nutrients - including nitrogen, iron and phosphorus - determines which nutrient limits phytoplankton growth. Although nitrogen limits productivity in much of the ocean(1,2), large portions of the tropics and subtropics are defined by extreme nitrogen depletion. In these regions, microbial denitrification removes biologically available forms of nitrogen from the water column, producing substantial deficits relative to other nutrients(3-5). Here we demonstrate that nitrogen-deficient areas of the tropical and subtropical oceans are acutely vulnerable to nitrogen pollution. Despite naturally high nutrient concentrations and productivity(6-8), nitrogen-rich agricultural runoff fuels large (54 - 577 km(2)) phytoplankton blooms in the Gulf of California. Runoff exerts a strong and consistent influence on biological processes, in 80% of cases stimulating blooms within days of fertilization and irrigation of agricultural fields. We project that by the year 2050, 27 - 59% of all nitrogen fertilizer will be applied in developing regions located upstream of nitrogen-deficient marine ecosystems. Our findings highlight the present and future vulnerability of these ecosystems to agricultural runoff.	Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; Stanford Univ, Sch Earth Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Beman, JM (corresponding author), Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA.	beman@stanford.edu		Arrigo, Kevin/0000-0002-7364-876X				Alvarez-Borrego S., 1978, CIENC MAR, V5, P53, DOI [10.7773/cm.v5i2.322, DOI 10.7773/CM.V5I2.322]; Alvarez-Borrego Saul, 2002, P41; Beron-Vera FJ, 2000, J GEOPHYS RES-OCEANS, V105, P11441, DOI 10.1029/2000JC900038; Chen YLL, 2004, CONT SHELF RES, V24, P527, DOI 10.1016/j.csr.2003.12.006; Corredor JE, 1999, BIOGEOCHEMISTRY, V46, P163; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gaxiola-Castro G, 1999, J PLANKTON RES, V21, P231, DOI 10.1093/plankt/21.2.231; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Harrison J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001991; Harrison J.A., 2003, THESIS STANFORD U; Howell EA, 1997, GEOPHYS RES LETT, V24, P2549, DOI 10.1029/97GL01538; Kahru M, 2004, DEEP-SEA RES PT II, V51, P139, DOI 10.1016/j.dsr2.2003.04.001; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; McCullagh P, 2019, GEN LINEAR MODELS; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; NAYLOR RL, 2001, 0101 CIMMYT; Pegau WS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014076; Riley WJ, 2001, NUTR CYCL AGROECOSYS, V61, P223, DOI 10.1023/A:1013758116346; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; Switzer AC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000444; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Tyrrell T, 1998, NATURE, V393, P318, DOI 10.1038/30632; Tyrrell T, 2002, CONT SHELF RES, V22, P2497, DOI 10.1016/S0278-4343(02)00077-8; VALSARAJ CP, 1994, HYDROBIOLOGIA, V286, P139, DOI 10.1007/BF00006245; ZEITZSCHEL B, 1969, MAR BIOL, V3, P201, DOI 10.1007/BF00360952	28	363	387	13	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					211	214		10.1038/nature03370	http://dx.doi.org/10.1038/nature03370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758999				2022-12-01	WOS:000227494500044
J	Kelley, DS; Karson, JA; Fruh-Green, GL; Yoerger, DR; Shank, TM; Butterfield, DA; Hayes, JM; Schrenk, MO; Olson, EJ; Proskurowski, G; Jakuba, M; Bradley, A; Larson, B; Ludwig, K; Glickson, D; Buckman, K; Bradley, AS; Brazelton, WJ; Roe, K; Elend, MJ; Delacour, A; Bernasconi, SM; Lilley, MD; Baross, JA; Summons, RT; Sylva, SP				Kelley, DS; Karson, JA; Fruh-Green, GL; Yoerger, DR; Shank, TM; Butterfield, DA; Hayes, JM; Schrenk, MO; Olson, EJ; Proskurowski, G; Jakuba, M; Bradley, A; Larson, B; Ludwig, K; Glickson, D; Buckman, K; Bradley, AS; Brazelton, WJ; Roe, K; Elend, MJ; Delacour, A; Bernasconi, SM; Lilley, MD; Baross, JA; Summons, RT; Sylva, SP			A serpentinite-hosted ecosystem: The lost city hydrothermal field	SCIENCE			English	Article							MID-ATLANTIC RIDGE; PERIDOTITE; REDUCTION; FLUIDS; ROCKS; EARTH; CH4; CO2	The serpentinite-hosted Lost City hydrothermal field is a remarkable submarine ecosystem in which geological, chemical, and biological processes are intimately interlinked. Reactions between seawater and upper mantle peridotite produce methane- and hydrogen-rich fluids, with temperatures ranging from <40 degrees to 90 degrees C at pH 9 to 11, and carbonate chimneys 30 to 60 meters tall. A low diversity of microorganisms related to methane-cycling Archaea thrive in the warm porous interiors of the edifices. Macrofaunal communities show a degree of species diversity at least as high as that of black smoker vent sites along the Mid-Atlantic Ridge, but they lack the high biomasses of chemosynthetic organisms that are typical of volcanically driven systems.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; ETH Zentrum, Dept Earth Sci, Zurich, Switzerland; Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98115 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Woods Hole Oceanog Inst, MIT WHOI Joint Program, Woods Hole, MA 02543 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Kelley, DS (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	kelley@ocean.washington.edu	Sylva, Sean/D-4400-2014; Summons, Roger Everett/AAL-3789-2020; Butterfield, David/H-3815-2016; Bernasconi, Stefano M/E-5394-2010; Delacour, Adélie/B-8639-2012; Larson, Benjamin/K-4859-2016; Proskurowski, Giora/B-3862-2013; Matthew, Schrenk/AAH-5682-2020; Bradley, Alexander/A-9391-2009	Sylva, Sean/0000-0002-4727-440X; Butterfield, David/0000-0002-1595-9279; Bernasconi, Stefano M/0000-0001-7672-8856; Larson, Benjamin/0000-0002-1007-1684; Bradley, Alexander/0000-0002-4044-2802; Ludwig, Kristin/0000-0002-0935-9410; Schrenk, Matthew/0000-0002-5623-8558				ABRAJANO TA, 1988, CHEM GEOL, V71, P211, DOI 10.1016/0009-2541(88)90116-7; Bach W, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000279; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; Blackman DK, 2002, MAR GEOPHYS RES, V23, P443, DOI 10.1023/B:MARI.0000018232.14085.75; BONATTI E, 1989, EARTH PLANET SC LETT, V91, P297, DOI 10.1016/0012-821X(89)90005-8; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Edmonds HN, 2003, NATURE, V421, P252, DOI 10.1038/nature01351; Fritz P., 1992, P 7 INT S WAT ROCK I, V7, P793; Fruh-Green GL, 2003, SCIENCE, V301, P495, DOI 10.1126/science.1085582; Fryer P, 1999, GEOLOGY, V27, P103, DOI 10.1130/0091-7613(1999)027<0103:MBMVIF>2.3.CO;2; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Gracia E, 2000, EARTH PLANET SC LETT, V177, P89, DOI 10.1016/S0012-821X(00)00034-0; Grove TL, 2004, EARTH PLANET SC LETT, V219, P173, DOI 10.1016/S0012-821X(04)00002-0; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; JANECKY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P1357, DOI 10.1016/0016-7037(86)90311-X; Karson JA, 1998, GEOPH MONOG SERIES, V106, P177; Kelley DS, 2004, GEOPHYS MONOGR SER, V144, P167, DOI 10.1029/144GM11; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Lagabrielle Y, 1998, GEOPH MONOG SERIES, V106, P153; LILLEY MD, 1993, NATURE, V364, P45, DOI 10.1038/364045a0; Lilley MD, 2003, NATURE, V422, P878, DOI 10.1038/nature01569; LOWELL RP, 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1029/2001GL01411; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; Michael P, 2002, NATURE, V419, P445, DOI 10.1038/419445a; Mottl MJ, 2003, GEOCHEM GEOPHY GEOSY, V4, P11; NEAL C, 1983, EARTH PLANET SC LETT, V66, P315, DOI 10.1016/0012-821X(83)90144-9; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Reston TJ, 2001, GEOLOGY, V29, P587, DOI 10.1130/0091-7613(2001)029<0587:DFMSAS>2.0.CO;2; Reysenbach A.-L., 2002, BIODIVERSITY MICROBI, P345; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schrenk MO, 2004, ENVIRON MICROBIOL, V6, P1086, DOI 10.1111/j.1462-2920.2004.00650.x; Schroeder T, 2002, GEOLOGY, V30, P367, DOI 10.1130/0091-7613(2002)030<0367:GIOSCT>2.0.CO;2; Shock EL, 1998, J GEOPHYS RES-PLANET, V103, P28513, DOI 10.1029/98JE02142; SPIESS FN, 1980, SCIENCE, V207, P1421, DOI 10.1126/science.207.4438.1421; Surour AA, 1997, J AFR EARTH SCI, V24, P315, DOI 10.1016/S0899-5362(97)00046-8; Treves B, 1994, OFIOLITI, V19, P435; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; WELHAN J, 1979, EOS, V60, P863; Welhan J.A., 1983, HYDROTHERMAL PROCESS, P391, DOI [10.1007/978-1-4899-0402-7_17, DOI 10.1007/978-1-4899-0402-7_17]; Wetzel LR, 2000, J GEOPHYS RES-SOL EA, V105, P8319, DOI 10.1029/1999JB900382; WILCOCK WW, 2004, GEOPHYSICAL MONOGRAP, V144	44	798	836	8	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1428	1434		10.1126/science.1102556	http://dx.doi.org/10.1126/science.1102556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746419				2022-12-01	WOS:000227503100036
J	Alverson, K				Alverson, K			Watching over the world's oceans	NATURE			English	Editorial Material									UNESCO, Global Ocean Observing Syst Intergovt Oceanog Com, F-75732 Paris 15, France		Alverson, K (corresponding author), UNESCO, Global Ocean Observing Syst Intergovt Oceanog Com, 1 Rue Miollis, F-75732 Paris 15, France.								0	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					19	20		10.1038/434019a	http://dx.doi.org/10.1038/434019a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744274				2022-12-01	WOS:000227334600021
J	Rodgers, JT; Lerin, C; Haas, W; Gygi, SP; Spiegelman, BM; Puigserver, P				Rodgers, JT; Lerin, C; Haas, W; Gygi, SP; Spiegelman, BM; Puigserver, P			Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1	NATURE			English	Article							HEPATIC GLUCONEOGENESIS; LIFE-SPAN; METABOLISM; P53	Homeostatic mechanisms in mammals respond to hormones and nutrients to maintain blood glucose levels within a narrow range. Caloric restriction causes many changes in glucose metabolism and extends lifespan; however, how this metabolism is connected to the ageing process is largely unknown. We show here that the Sir2 homologue, SIRT1 - which modulates ageing in several species(1-3) - controls the gluconeogenic/glycolytic pathways in liver in response to fasting signals through the transcriptional coactivator PGC-1alpha. A nutrient signalling response that is mediated by pyruvate induces SIRT1 protein in liver during fasting. We find that once SIRT1 is induced, it interacts with and deacetylates PGC-1alpha at specific lysine residues in an NAD(+)-dependent manner. SIRT1 induces gluconeogenic genes and hepatic glucose output through PGC-1alpha, but does not regulate the effects of PGC-1alpha on mitochondrial genes. In addition, SIRT1 modulates the effects of PGC-1alpha repression of glycolytic genes in response to fasting and pyruvate. Thus, we have identified a molecular mechanism whereby SIRT1 functions in glucose homeostasis as a modulator of PGC-1alpha. These findings have strong implications for the basic pathways of energy homeostasis, diabetes and lifespan.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Puigserver, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	ppuigse1@bs.jhmi.edu	Lerin, Carles/AAP-9916-2020	Lerin, Carles/0000-0003-0950-4363; Rodgers, Joseph/0000-0002-6598-5520				Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MACDONALD M, 1976, AM J PHYSIOL, V231, P619, DOI 10.1152/ajplegacy.1976.231.2.619; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598	22	2417	2525	4	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					113	118		10.1038/nature03354	http://dx.doi.org/10.1038/nature03354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744310				2022-12-01	WOS:000227334600054
J	Rubin, EJ				Rubin, EJ			Clinical implications of basic research: Toward a new therapy for tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Rubin, Eric/0000-0001-5120-962X				Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753	1	11	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					933	934		10.1056/NEJMcibr044438	http://dx.doi.org/10.1056/NEJMcibr044438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745987				2022-12-01	WOS:000227310700016
J	Jagasia, R; Grote, P; Westermann, B; Conradt, B				Jagasia, R; Grote, P; Westermann, B; Conradt, B			DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C-elegans	NATURE			English	Article							PROTEIN; APOPTOSIS; FISSION; CED-9; DYNAMICS; NEMATODE; EGL-1	Genetic analyses in Caenorhabditis elegans have been instrumental in the elucidation of the central cell-death machinery, which is conserved from C. elegans to mammals(1,2). One possible difference that has emerged is the role of mitochondria. By releasing cytochrome c, mitochondria are involved in the activation of caspases in mammals(3,4). However, there has previously been no evidence that mitochondria are involved in caspase activation in C. elegans. Here we show that mitochondria fragment in cells that normally undergo programmed cell death during C. elegans development. Mitochondrial fragmentation is induced by the BH3-only protein EGL-1 and can be blocked by mutations in the bcl-2-like gene ced-9, indicating that members of the Bcl-2 family might function in the regulation of mitochondrial fragmentation in apoptotic cells. Mitochondrial fragmentation is independent of CED-4/Apaf-1 and CED-3/caspase, indicating that it occurs before or simultaneously with their activation. Furthermore, DRP-1/dynamin-related protein, a key component of the mitochondrial fission machinery, is required and sufficient to induce mitochondrial fragmentation and programmed cell death during C. elegans development. These results assign an important role to mitochondria in the cell-death pathway in C. elegans.	Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA; Univ Bayreuth, D-95440 Bayreuth, Germany; Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany; Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Dartmouth College; University of Bayreuth; University of Munich; Max Planck Society	Conradt, B (corresponding author), Dartmouth Coll, Sch Med, Dept Genet, 7400 Remsen, Hanover, NH 03755 USA.	barbara.conradt@dartmouth.edu	Westermann, Benedikt/H-7766-2013; Conradt, Barbara/K-2665-2014; Grote, Phillip/AAG-9188-2020	Westermann, Benedikt/0000-0002-2991-1604; Grote, Phillip/0000-0002-9254-1458; Conradt, Barbara/0000-0002-3731-4308				Aspock G, 2003, DEVELOPMENT, V130, P3369, DOI 10.1242/dev.00551; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; FRANCIS B, 2001, SEX ED, V1, P1; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Mello C, 1995, METHOD CELL BIOL, V48, P451; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Parrish J, 2000, P NATL ACAD SCI USA, V97, P11916, DOI 10.1073/pnas.210391597; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Riddle DL, 1997, C ELEGANS, P739; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194	30	264	276	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					754	760		10.1038/nature03316	http://dx.doi.org/10.1038/nature03316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716954				2022-12-01	WOS:000227039200042
J	Schleinitz, MD; Heidenreich, PA				Schleinitz, MD; Heidenreich, PA			A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: Clopidogrel plus aspirin versus aspirin alone	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSIENT ISCHEMIC ATTACK; ACUTE STROKE CARE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; ARTERY-DISEASE; RESOURCE USE; BYPASS SURGERY; MEDICAL-CARE	Background: Although clopidogrel plus aspirin is more effective than aspirin alone in preventing subsequent vascular events in patients with unstable angina, the cost-effectiveness of this combination has yet to be examined in this high-risk population. Objective: To determine the cost-effectiveness of clopidogrel plus aspirin compared with aspirin alone. Design: Cost-utility analysis. Data Sources: Published literature. Target Population: Patients with unstable angina and electrocardiographic changes or non-Q-wave myocardial infarction. T ime Horizon: Lifetime. Perspective: Societal. Interventions: Combination therapy with clopidogrel, 75 mg/d, plus aspirin, 325 mg/d, for 1 year, followed by aspirin monotherapy, was compared with lifelong aspirin therapy, 325 mg/d. Outcome Measures: Lifetime costs, life expectancy in quality-adjusted life-years (QALYs), and the incremental cost-effectiveness ratio. Results of Base-Case Analysis: Patients treated with aspirin alone lived 9.51 QALYs after their initial event and incurred expenses of $127 700; the addition of clopidogrel increased life expectancy to 9.61 QALYs and costs to $129 300. The incremental cost-effectiveness ratio for clopidogrel plus aspirin compared with aspirin alone was $15400 per QALY. Results of Sensitivity Analyses: The analysis of 1 year of therapy was robust to all sensitivity analyses. In the probabilistic sensitivity analysis, fewer than 3% of simulations resulted in cost-effectiveness ratios over $50000 per QALY. The cost-effectiveness of longer combination therapy depends critically on the balance of thrombotic event rates, durable efficacy, and the increased bleeding rate in patients taking clopidogrel. Limitations: This analysis may not apply to patients with severe heart failure, those undergoing long-term anticoagulant therapy, those recently managed with revascularization, or those undergoing short-term treatment with glycoprotein IIb/IIIa inhibitors. Conclusions: in patients with high-risk acute coronary syndromes, I year of therapy with clopidogrel plus aspirin results in greater life expectancy than aspirin alone, at a cost within the traditional limits of cost-effectiveness. The durable efficacy of clopidogrel relative to the risk for hemorrhage should be further explored before more protracted therapy can be recommended.	Brown Univ, Div Gen Internal Med, Providence, RI 02903 USA; Rhode Isl Hosp, Providence, RI 02903 USA; Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA; VA Palo Alto Healthcare Syst, Palo Alto, CA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Schleinitz, MD (corresponding author), Brown Univ, Div Gen Internal Med, 593 Eddy St,MPB-1, Providence, RI 02903 USA.	Mark-Schleinitz@Brown.edu	Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043447] Funding Source: NIH RePORTER; NICHD NIH HHS [HD43447] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alberts MJ, 1996, STROKE, V27, P1825, DOI 10.1161/01.STR.27.10.1825; Ashraf T, 1996, AM J CARDIOL, V78, P409, DOI 10.1016/S0002-9149(96)00328-1; Bennett CL, 2000, NEW ENGL J MED, V343, P1193; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; BERGER CJ, 1992, JAMA-J AM MED ASSOC, V268, P1545, DOI 10.1001/jama.268.12.1545; BERGMAN L, 1995, STROKE, V26, P1830, DOI 10.1161/01.STR.26.10.1830; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Diener HC, 2004, CEREBROVASC DIS, V17, P253, DOI 10.1159/000076962; Diringer MN, 1999, STROKE, V30, P724, DOI 10.1161/01.STR.30.4.724; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Duncan PW, 1997, STROKE, V28, P740, DOI 10.1161/01.STR.28.4.740; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hallan S, 1999, J INTERN MED, V246, P309, DOI 10.1046/j.1365-2796.1999.00531.x; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; HLATKY MA, 1990, CIRCULATION, V82, P208; *HLTH CAR INV AN I, 1999, DRG HDB; Holloway RG, 1996, NEUROLOGY, V46, P854; Jiranek GC, 1996, SURG CLIN N AM, V76, P83, DOI 10.1016/S0039-6109(05)70424-2; Jorgensen HS, 1997, STROKE, V28, P1138, DOI 10.1161/01.STR.28.6.1138; Kozak LJ, 2002, VITAL HLTH STAT, V13, P1; Leibson CL, 1996, NEUROLOGY, V46, P861; Lipscomb J, 1996, COST EFFECTIVENESS H, P216; Mark DB, 2000, CIRCULATION, V101, P366, DOI 10.1161/01.CIR.101.4.366; Mitchell JB, 1996, STROKE, V27, P1937, DOI 10.1161/01.STR.27.11.1937; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; MURRAY L, 2002, DRUG TOPICS RED BOOK; Naglie G, 1997, MED DECIS MAKING, V17, P136, DOI 10.1177/0272989X9701700203; *NASA, GROSS DOM PROD DEFL; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; Porsdal V, 1998, STROKE, V29, P2321, DOI 10.1161/01.STR.29.11.2321; Roberts JA, 2000, J PUBLIC HEALTH MED, V22, P99, DOI 10.1093/pubmed/22.1.99; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Samsa GP, 1998, AM HEART J, V136, P703, DOI 10.1016/S0002-8703(98)70019-5; Sanders GD, 2001, ANN INTERN MED, V135, P870, DOI 10.7326/0003-4819-135-10-200111200-00007; Sarasin FP, 2000, ARCH INTERN MED, V160, P2773, DOI 10.1001/archinte.160.18.2773; Schleinitz MD, 2004, AM J MED, V116, P797, DOI 10.1016/j.amjmed.2004.01.014; Shin AY, 1997, STROKE, V28, P2395, DOI 10.1161/01.STR.28.12.2395; SMURAWSKA LT, 1994, STROKE, V25, P1628, DOI 10.1161/01.STR.25.8.1628; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Torrance GW., 1996, COST EFFECTIVENESS H, P54; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Tung CY, 1999, CIRCULATION, V99, P370, DOI 10.1161/01.CIR.99.3.370; *US DEP LAB BUR LA, 2003, 966 US DEP LAB BUR L; WEINTRAUB WS, 1995, CIRCULATION, V92, P2831, DOI 10.1161/01.CIR.92.10.2831; Weintraub WS, 1998, CIRCULATION, V98, pII23; Yusuf S, 2001, NEW ENGL J MED, V345, P494	53	68	69	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2005	142	4					251	259		10.7326/0003-4819-142-4-200502150-00007	http://dx.doi.org/10.7326/0003-4819-142-4-200502150-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900UJ	15710958				2022-12-01	WOS:000227239500003
J	McGraw, JB; Furedi, MA				McGraw, JB; Furedi, MA			Deer browsing and population viability of a forest understory plant	SCIENCE			English	Article							WHITE-TAILED DEER; AMERICAN GINSENG; PANAX-QUINQUEFOLIUS; ARALIACEAE; ECOSYSTEMS; IMPACTS; GROWTH	American ginseng is the premier medicinal plant harvested from the wild in the United States. In this study, seven populations of ginseng plants were censused every 3 weeks during-the growing season over 5 years to monitor deer browse and harvest and to project population growth and viability. The minimum viable population size was similar to800 plants, a value greater than that of all populations currently being monitored. When simulated deer browsing rates were reduced 50% or more, population viability rose sharply. Without more effective deer population control, ginseng and many other valuable understory herbs are Likely to become extinct, in the coming century.	W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	McGraw, JB (corresponding author), W Virginia Univ, Dept Biol, POB 6057, Morgantown, WV 26506 USA.	jmcgraw@wvu.edu	Liu, Yi-Chun/H-5463-2012					ANDERSON RC, 1993, AM MIDL NAT, V129, P357, DOI 10.2307/2426517; Augustine DJ, 1998, CONSERV BIOL, V12, P995, DOI 10.1046/j.1523-1739.1998.97248.x; CARLSON AW, 1986, ECON BOT, V40, P233, DOI 10.1007/BF02859148; CARPENTER SG, 1982, CAN J BOT, V60, P2692, DOI 10.1139/b82-328; Caswell H., 2001, MATRIX POPULATION MO, V2nd; CHARRON D, 1991, J ECOL, V79, P431, DOI 10.2307/2260724; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Knight TM, 2004, ECOL APPL, V14, P915, DOI 10.1890/03-5048; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; McGraw JB, 2003, J TORREY BOT SOC, V130, P62, DOI 10.2307/3557530; McGraw JB, 2001, BIOL CONSERV, V98, P25, DOI 10.1016/S0006-3207(00)00138-5; Morris W.F., 2002, QUANTITATIVE CONSERV; Nantel P, 1996, CONSERV BIOL, V10, P608, DOI 10.1046/j.1523-1739.1996.10020608.x; Robbins CS, 2000, CONSERV BIOL, V14, P1422, DOI 10.1046/j.1523-1739.2000.99100.x; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718	18	124	127	4	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					920	922		10.1126/science.1107036	http://dx.doi.org/10.1126/science.1107036			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705851				2022-12-01	WOS:000226985100052
J	Kao, MH; Doupe, AJ; Brainard, MS				Kao, MH; Doupe, AJ; Brainard, MS			Contributions of an avian basal ganglia-forebrain circuit to real-time modulation of song	NATURE			English	Article							PURSUIT EYE-MOVEMENTS; ZEBRA FINCH; NEURAL ACTIVITY; NUCLEUS; MECHANISMS; LESIONS; STIMULATION; BIRDSONG; NEURONS; PATHWAY	Cortical - basal ganglia circuits have a critical role in motor control and motor learning(1). In songbirds, the anterior forebrain pathway ( AFP) is a basal ganglia - forebrain circuit required for song learning and adult vocal plasticity but not for production of learned song(2 - 5). Here, we investigate functional contributions of this circuit to the control of song, a complex, learned motor skill. We test the hypothesis that neural activity in the AFP of adult birds can direct moment- by- moment changes in the primary motor areas responsible for generating song. We show that song- triggered microstimulation in the output nucleus of the AFP induces acute and specific changes in learned parameters of song(6,7). Moreover, under both natural and experimental conditions, variability in the pattern of AFP activity is associated with variability in song structure. Finally, lesions of the output nucleus of the AFP prevent naturally occurring modulation of song variability. These findings demonstrate a previously unappreciated capacity of the AFP to direct real- time changes in song. More generally, they suggest that frontal cortical and basal ganglia areas may contribute to motor learning by biasing motor output towards desired targets or by introducing stochastic variability required for reinforcement learning.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kao, MH (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.	mimi@phy.ucsf.edu		Kao, Mimi/0000-0001-8884-9022; Brainard, Michael/0000-0002-9425-9907	NIDCD NIH HHS [R01 DC006636] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006636] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Brumm H, 2004, ANIM BEHAV, V67, P281, DOI 10.1016/j.anbehav.2003.06.006; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Doya Kenji, 2000, P469; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Kittelberger JM, 1999, J NEUROSCI, V19, P9385; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MOONEY R, 1991, P NATL ACAD SCI USA, V88, P4075, DOI 10.1073/pnas.88.10.4075; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Perkel DJ, 2004, ANN NY ACAD SCI, V1016, P736, DOI 10.1196/annals.1298.039; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Stark LL, 1999, J NEUROSCI, V19, P9107, DOI 10.1523/JNEUROSCI.19-20-09107.1999; Tanaka M, 2001, NATURE, V409, P191, DOI 10.1038/35051582; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Troyer TW, 2001, CURR OPIN NEUROBIOL, V11, P721, DOI 10.1016/S0959-4388(01)00275-6; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1224, DOI 10.1152/jn.2000.84.3.1224; VICARIO DS, 1995, J NEUROPHYSIOL, V73, P2602, DOI 10.1152/jn.1995.73.6.2602; VU ET, 1994, J NEUROSCI, V14, P6924; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X; WILLIAMS H, 1989, J COMP PSYCHOL, V103, P366, DOI 10.1037/0735-7036.103.4.366; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	30	365	370	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					638	643		10.1038/nature03127	http://dx.doi.org/10.1038/nature03127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703748				2022-12-01	WOS:000226862000046
J	Chen, XJ; Wang, XW; Kaufman, BA; Butow, RA				Chen, XJ; Wang, XW; Kaufman, BA; Butow, RA			Aconitase couples metabolic regulation to mitochondrial DNA maintenance	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; CYTOSOLIC ACONITASE; PROTEIN-COMPONENTS; OXIDATIVE DAMAGE; BINDING-PROTEIN; YEAST; NUCLEOIDS; IDENTIFICATION	Mitochondrial DNA (mtDNA) is essential for cells to maintain respiratory competency and is inherited as a protein-DNA complex called the nucleoid. We have identified 22 mtDNA-associated proteins in yeast, among which is mitochondrial aconitase (Aco1p). We show that this Krebs-cycle enzyme is essential for mtDNA maintenance independent of its catalytic activity. Regulation of ACO1 expression by the HAP and retrograde metabolic signaling pathways directly affects mtDNA maintenance. When constitutively expressed, Aco1p can replace the mtDNA packaging function of the high-mobility-group protein Abf2p. Thus, Aco1p may integrate metabolic signals and mtDNA maintenance.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Butow, RA (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	ronald.butow@utsouthwestern.edu			NIA NIH HHS [R01 AG023731] Funding Source: Medline; NIGMS NIH HHS [GM33510, GM22525] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022525, R37GM022525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023731] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DIFFLEY JFX, 1991, P NATL ACAD SCI USA, V88, P7864, DOI 10.1073/pnas.88.17.7864; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Jia YK, 1997, MOL MICROBIOL, V24, P53, DOI 10.1046/j.1365-2958.1997.3011669.x; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kaufman BA, 2003, J CELL BIOL, V163, P457, DOI 10.1083/jcb.200306132; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KLAUSNER RD, 1993, MOL BIOL CELL, V4, P1; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LAUBLE H, 1994, J MOL BIOL, V237, P437, DOI 10.1006/jmbi.1994.1246; LAWRENCE JJ, 1976, BIOCHEMISTRY-US, V15, P3301, DOI 10.1021/bi00660a021; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; McCammon MT, 2003, MOL BIOL CELL, V14, P958, DOI 10.1091/mbc.E02-07-0422; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; MEGRAW TL, 1993, J BIOL CHEM, V268, P12758; MIYAKAWA I, 1987, J CELL SCI, V88, P431; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; Sato H, 2002, PROTOPLASMA, V219, P51, DOI 10.1007/s007090200005; Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	29	248	260	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					714	717		10.1126/science.1106391	http://dx.doi.org/10.1126/science.1106391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692048				2022-12-01	WOS:000226814900040
J	Kobayashi, KS; Chamaillard, M; Ogura, Y; Henegariu, O; Inohara, N; Nunez, G; Flavell, RA				Kobayashi, KS; Chamaillard, M; Ogura, Y; Henegariu, O; Inohara, N; Nunez, G; Flavell, RA			Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; AVIUM SUBSPECIES PARATUBERCULOSIS; NF-KAPPA-B; CROHNS-DISEASE; ALPHA-DEFENSIN; PANETH CELLS; NOD2 GENE; ACTIVATION; MUTATIONS; MICE	The gene encoding the Nod2 protein is frequently mutated in Crohn's disease (CD) patients, although the physiological function of Nod2 in the intestine remains elusive. Here we show that protective immunity mediated by Nod2 recognition of bacterial muramyl dipeptide is abolished in Nod2-deficient mice. These animals are susceptible to bacterial infection via the oral route but not through intravenous or peritoneal delivery. Nod2 is required for the expression of a subgroup of intestinal anti-microbial peptides, known as cryptdins. The Nod2 protein is thus a critical regulator of bacterial immunity within the intestine, providing a possible mechanism for Nod2 mutations in CD.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	Yale University; Howard Hughes Medical Institute; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA.	richard.flavell@yale.edu	Chamaillard, Mathias/L-6542-2013; Nuñez, Gabriel/A-7160-2014	Chamaillard, Mathias/0000-0002-0243-9717; Kobayashi, Koichi/0000-0003-2930-0114				Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Darmoul D, 1996, AM J PHYSIOL-GASTR L, V271, pG68, DOI 10.1152/ajpgi.1996.271.1.G68; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ouellette AJ, 1999, INFECT IMMUN, V67, P6643; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Schmid M, 2004, Z GASTROENTEROL, V42, P333, DOI 10.1055/s-2004-813072; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Selby WS, 2004, LANCET, V364, P1013, DOI 10.1016/S0140-6736(04)17071-2; Takada H, 2002, J ENDOTOXIN RES, V8, P337, DOI 10.1179/096805102125000669; Tani K, 2000, INT IMMUNOL, V12, P691, DOI 10.1093/intimm/12.5.691; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9	35	1369	1435	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					731	734		10.1126/science.1104911	http://dx.doi.org/10.1126/science.1104911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692051				2022-12-01	WOS:000226814900045
J	Nguyen, HQ; Jumaan, AO; Seward, JF				Nguyen, HQ; Jumaan, AO; Seward, JF			Decline in mortality due to varicella after implementation of varicella vaccination in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEATHS	BACKGROUND: Varicella disease has been preventable in the United States since 1995. Starting in 1999, active and passive surveillance data showed sharp decreases in varicella disease. We reviewed national death records to assess the effect of the vaccination program on mortality associated with varicella. METHODS: Data on deaths for which varicella was listed as an underlying or contributing cause were obtained from National Center for Health Statistics Multiple Cause-of-Death Mortality Data for 1990 through 2001. We calculated the numbers and rates of death due to varicella according to age, sex, race, ethnic background, and birthplace. RESULTS: The rate of death due to varicella fluctuated from 1990 through 1998 and then declined sharply. For the interval from 1990 through 1994, the average number of varicella-related deaths was 145 per year (varicella was listed as the underlying cause in 105 deaths and as a contributing cause in 40); it then declined to 66 per year during 1999 through 2001. For deaths for which varicella was listed as the underlying cause, age-adjusted mortality rates dropped by 66 percent, from an average of 0.41 death per 1 million population during 1990 through 1994 to 0.14 during 1999 through 2001 (P<0.001). This decline was observed in all age groups under 50 years, with the greatest reduction (92 percent) among children 1 to 4 years of age. In addition, by the period from 1999 through 2001, the average rates of mortality due to varicella among all racial and ethnic groups were below 0.15 per 1 million population, as compared with rates ranging from 0.37 per 1 million for whites to 0.66 per 1 million for other races in the period from 1990 through 1994. CONCLUSIONS: The program of universal childhood vaccination against varicella in the United States has resulted in a sharp decline in the rate of death due to varicella.	CDCP, Viral Vaccine Preventable Dis Branch, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Seward, JF (corresponding author), CDCP, Viral Vaccine Preventable Dis Branch, Natl Immunizat Program, 1600 Clifton Rd,Mailstop E-61, Atlanta, GA 30333 USA.	jseward@cdc.gov						[Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Boelle PY, 2002, EPIDEMIOL INFECT, V129, P599, DOI 10.1017/S0950268802007720; Bramley J C, 2000, Commun Dis Public Health, V3, P282; Centers for Disease Control and Prevention, NAT IMM SURV NIS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P884; Chant KG, 1998, AUST NZ J PUBL HEAL, V22, P413, DOI 10.1111/j.1467-842X.1998.tb01405.x; Chant KG, 1998, AUST NZ J PUBL HEAL, V22, P630; Davis MM, 2004, PEDIATRICS, V114, P786, DOI 10.1542/peds.2004-0012; Fairley CK, 1996, J INFECT DIS, V174, pS314, DOI 10.1093/infdis/174.Supplement_3.S314; Galil K, 2002, AM J PUBLIC HEALTH, V92, P1248, DOI 10.2105/AJPH.92.8.1248; KILGORE PE, 2003, J MED VIROL S1, V10, pS111; Lam M. S., 1993, Singapore Medical Journal, V34, P213; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; *NAT CTR HLTH STAT, 2004, ICD 0 ACME DEC TA 2C; *NAT CTR HLTH STAT, 2002, BRIDG RAC VINT 2002; *NAT CTR HLTH STAT, 1999, BRIDG RAC INT POP ES; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; Rawson H, 2001, BRIT MED J, V323, P1091, DOI 10.1136/bmj.323.7321.1091; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; *US BUR CENS, ANN TIM SER STAT POP; *WHO, 1977, MAN INT STAT CLASS D; 2002, MMWR MORB MORTAL WKL, V51, P664	23	271	301	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2005	352	5					450	458		10.1056/NEJMoa042271	http://dx.doi.org/10.1056/NEJMoa042271			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893NE	15689583				2022-12-01	WOS:000226725400005
J	Marton, ML; Cordts, S; Broadhvest, J; Dresselhaus, T				Marton, ML; Cordts, S; Broadhvest, J; Dresselhaus, T			Micropylar pollen tube guidance by egg apparatus 1 of maize	SCIENCE			English	Article							FERTILIZATION; POLLINATION; PROTEIN; GROWTH; FEMALE; CELL	Pollen tube guidance precedes the double fertilization of flowering plants. Here, we report the identification of a small maize protein of 94 amino acids involved in short-range signaling required for pollen tube attraction by the female gametophyte. ZmEA1 is exclusively expressed in the egg apparatus, consisting of the egg cell and two synergids. Chimeric ZmEA1 fused to green fluorescent protein (ZmEA1:GFP) was first visible within the filiform apparatus and later was localized to nucellar cell watts below the micropylar opening of the ovule. Transgenic down-regulation of the ZmEA1 gene led to ovule sterility caused by loss of close-range pollen tube guidance to the micropyle.	Univ Hamburg, Bioctr Klein Flottbek, D-22609 Hamburg, Germany; Bayer Biosci NV, B-9052 Ghent, Belgium	University of Hamburg; Bayer AG	Dresselhaus, T (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Ohnhorststr 18, D-22609 Hamburg, Germany.	dresselh@botanik.uni-hamburg.de						Brettschneider R, 1997, THEOR APPL GENET, V94, P737, DOI 10.1007/s001220050473; DIBOLL ALFRED G., 1968, AMER J BOT, V55, P797, DOI 10.2307/2440968; DRESSELHAUS T, 1994, PLANT J, V5, P605, DOI 10.1046/j.1365-313X.1994.5040605.x; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 2003, CURR OPIN PLANT BIOL, V6, P36, DOI 10.1016/S1369-5266(02)00010-9; Ishikawa M, 1918, ANN BOT-LONDON, V32, P279; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Marton M., UNPUB; Mol R, 2000, PLANTA, V210, P749, DOI 10.1007/s004250050676; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Sanchez AM, 2004, PLANT CELL, V16, pS98, DOI 10.1105/tpc.017806; SHARMA HC, 1995, EUPHYTICA, V82, P43, DOI 10.1007/BF00028709; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Van der Pluijm JE, 1964, POLLEN PHYSL FERTILI, P8; Weterings K, 2004, PLANT CELL, V16, pS107, DOI 10.1105/tpc.016873; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x	16	233	258	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					573	576		10.1126/science.1104954	http://dx.doi.org/10.1126/science.1104954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681383				2022-12-01	WOS:000226694000045
J	Yin, YH; Vafeados, D; Tao, Y; Yoshida, S; Asami, T; Chory, J				Yin, YH; Vafeados, D; Tao, Y; Yoshida, S; Asami, T; Chory, J			A new class of transcription factors mediates brassinosteroid-regulated gene expression in Arabidopsis	CELL			English	Article							PLANT-GROWTH; SIGNAL-TRANSDUCTION; KINASE; RECEPTOR; BRI1; DNA; BIOSYNTHESIS; PERCEPTION; MEMBRANE; THALIANA	Brassinosteroids (BRs) signal through a plasma membrane-localized receptor kinase to regulate plant growth and development. We showed previously that a novel protein, BES1, accumulates in the nucleus in response to BRs, where it plays a role in BR-regulated gene expression; however, the mechanism by which BES1 regulates gene expression is unknown. In this study, we dissect BES1 subdomains and establish that BES1 is a transcription factor that binds to and activates BR target gene promoters both in vitro and in vivo. BES1 interacts with a basic helix-loop-helix protein, BIM1, to synergistically bind to E box (CANNTG) sequences present in many BR-induced promoters. Loss-of-function and gain-of-function mutants of BIM1 and its close family members display BR response phenotypes. Thus, BES1 defines a new class of plant-specific transcription factors that cooperate with transcription factors such as BIM1 to regulate BR-induced genes.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; RIKEN, Plant Funct Lab, Inst Phys & Chem Res, Wako, Saitama 351098, Japan	Howard Hughes Medical Institute; Salk Institute; Salk Institute; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Tao, Yi/B-7718-2012	Tao, Yi/0000-0002-7460-7927	NIGMS NIH HHS [R01 GM060519, F32 GM020558] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 2002, MOL CELL, V10, P973, DOI 10.1016/S1097-2765(02)00744-X; Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Coll-Garcia D, 2004, FEBS LETT, V563, P82, DOI 10.1016/S0014-5793(04)00255-8; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Friedrichsen DM, 2002, GENETICS, V162, P1445; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Iliev EA, 2002, PLANT PHYSIOL, V130, P770, DOI 10.1104/pp.008680; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; LI J, 1999, J EXP BOT, V50, P332; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.pp.39.060188.000323; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Mussig C, 2002, PLANT PHYSIOL, V129, P1241, DOI 10.1104/pp.011003; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spinner DS, 2002, J MOL BIOL, V317, P431, DOI 10.1006/jmbi.2002.5440; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; YIN YH, 1995, PLANT J, V7, P969, DOI 10.1046/j.1365-313X.1995.07060969.x; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	48	512	592	14	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					249	259		10.1016/j.cell.2004.11.044	http://dx.doi.org/10.1016/j.cell.2004.11.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680330	Bronze			2022-12-01	WOS:000226740000013
J	Olson, TM; Michels, VV; Ballew, JD; Reyna, SP; Karst, ML; Herron, KJ; Horton, SC; Rodeheffer, RJ; Anderson, JL				Olson, TM; Michels, VV; Ballew, JD; Reyna, SP; Karst, ML; Herron, KJ; Horton, SC; Rodeheffer, RJ; Anderson, JL			Sodium channel mutations and susceptibility to heart failure and atrial fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; LONG-QT SYNDROME; CONDUCTION-SYSTEM DISEASE; LAMIN A/C GENE; VENTRICULAR-FIBRILLATION; CARDIAC-ARRHYTHMIAS; BRUGADA-SYNDROME; SCN5A; FREQUENCY; RELATIVES	Context Dilated cardiomyopathy (DCM), a genetically heterogeneous disorder, causes heart failure and rhythm disturbances. The majority of identified DCM genes encode structural proteins of the contractile apparatus and cytoskeleton. Recently, genetic defects in,calcium and potassium regulation have been discovered in patients with DCM, implicating an alternative disease mechanism. The full spectrum of genetic defects in DCM, however, has not been established. Objectives To identify a novel gene for DCM at a previously mapped locus, define the spectrum of mutations in this gene within a DCM cohort and determine the frequency of DCM among relatives inheriting a mutation in this gene. Design, Setting, and Participants Refined mapping of a DCM locus on chromosome 3p,in a multigenerational family and mutation scanning in 156 unrelated probands with DCM, prospectively identified at the Mayo Clinic between 1987 and 2004. Relatives underwent screening echocardiography and electrocardiography and DNA sample procurement. Main Outcome Measure Correlation of identified mutations with cardiac phenotype. Results Refined locus mapping revealed SCN5A, encoding the cardiac sodium channel, as a candidate gene. Mutation scans identified a missense mutation (D1275N) that cosegregated with an age-dependent, variably expressed phenotype of DCM, atrial fibrillation, impaired automaticity, and conduction delay. In the DCM, cohort, additional missense (T2201, R814W, D1595H) and truncation (2550-2551insTG) SCN5A mutations, segregating with cardiac disease or arising de novo, were discovered in unrelated probands. Among individuals with an SCN5A mutation 27% had early features of DCM (mean age at diagnosis, 20.3 years), 38% had DCM (mean age at diagnosis, 47.9 years), and 43% had atrial fibrillation (mean age at diagnosis, 27.8 years). Conclusions Heritable SCN5A defects are associated with susceptibility to early-onset DCM and atrial fibrillation. Similar or even identical mutations may lead to heart failure, arrhythmia, or both.	Mayo Clin & Mayo Fdn, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, Div Pediat Cardiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Med Genet, Rochester, MN 55905 USA; Univ Utah, Latter Day St Hosp, Cardiovasc Dept, Salt Lake City, UT 84143 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Utah System of Higher Education; University of Utah	Olson, TM (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Internal Med, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	olson.timothy@mayo.edu		Olson, Timothy/0000-0003-2716-9423	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071225] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071225, R01 HL071225-03, R01 HL71225] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akai J, 2000, FEBS LETT, V479, P29, DOI 10.1016/S0014-5793(00)01875-5; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chen S, 2002, J MED GENET, V39, P913, DOI 10.1136/jmg.39.12.913; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Flesch M, 2001, CARDIOVASC DRUG THER, V15, P379, DOI 10.1023/A:1013329203750; Grant AO, 2002, J CLIN INVEST, V110, P1201, DOI 10.1172/JCI200215570; GREENLEE PR, 1986, WESTERN J MED, V144, P33; Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; Michels VV, 2003, AM J CARDIOL, V91, P1389, DOI 10.1016/S0002-9149(03)00341-2; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Pieske B, 2003, CARDIOVASC RES, V57, P871, DOI 10.1016/S0008-6363(02)00849-0; Plassart Emmanuelle, 1994, European Journal of Human Genetics, V2, P110; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schonberger J, 2001, AM J HUM GENET, V69, P249, DOI 10.1086/321978; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Tan HL, 2003, CARDIOVASC RES, V57, P961, DOI 10.1016/S0008-6363(02)00714-9; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Viswanathan PC, 2004, TRENDS CARDIOVAS MED, V14, P28, DOI 10.1016/j.tcm.2003.10.001; Wang DW, 2002, CIRCULATION, V105, P341, DOI 10.1161/hc0302.102592; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; ZIPES DP, 1997, HEART DIS TXB CARDIO, P597	38	390	411	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2005	293	4					447	454		10.1001/jama.293.4.447	http://dx.doi.org/10.1001/jama.293.4.447			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890DW	15671429	Green Accepted, Bronze			2022-12-01	WOS:000226492900023
J	Wisloff, U; Najjar, SM; Ellingsen, O; Haram, PM; Swoap, S; Al-Share, Q; Fernstrom, M; Rezaei, K; Lee, SJ; Koch, LG; Britton, SL				Wisloff, U; Najjar, SM; Ellingsen, O; Haram, PM; Swoap, S; Al-Share, Q; Fernstrom, M; Rezaei, K; Lee, SJ; Koch, LG; Britton, SL			Cardiovascular risk factors emerge after artificial selection for low aerobic capacity	SCIENCE			English	Article							INSULIN-RESISTANCE; CARDIAC REHABILITATION; YOUNG ADULTHOOD; HEART-FAILURE; MORTALITY; DYSFUNCTION; CHILDHOOD; PARENTS; DISEASE	In humans, the strong statistical association between fitness and survival suggests a link between impaired oxygen metabolism and disease. We hypothesized that artificial selection of rats based on low and high intrinsic exercise capacity would yield models that also contrast for disease risk. After 11 generations, rats with low aerobic capacity scored high on cardiovascular risk factors that constitute the metabolic syndrome. The decrease in aerobic capacity was associated with decreases in the amounts of transcription factors required for mitochondrial biogenesis and in the amounts of oxidative enzymes in skeletal muscle. Impairment of mitochondrial function may link reduced fitness to cardiovascular and metabolic disease.	Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7489 Trondheim, Norway; St Olavs Hosp, Dept Cardiol, N-7006 Trondheim, Norway; Med Coll Ohio, Dept Pharmacol Cardiovasc Biol & Metab Dis, Toledo, OH USA; Williams Coll, Dept Biol, Williamstown, MA 01267 USA; Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Williams College; University of Michigan System; University of Michigan	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Olav Kyrres Gt 3, N-7489 Trondheim, Norway.	ulrik.wisloff@medisin.ntnu.no	Koch, Lauren/D-1258-2010; Najjar, Sonia M/GXW-2217-2022; Wisloff, Ulrik/K-2899-2012	Al-Share, Qusai/0000-0002-2306-6198; Wisloff, Ulrik/0000-0002-7211-3587	NCRR NIH HHS [RR 17718] Funding Source: Medline; NHLBI NIH HHS [HL 64270] Funding Source: Medline; NIDDK NIH HHS [DK 54254, DK 57497] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054254, R21DK057497] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Hambrecht R, 2000, JAMA-J AM MED ASSOC, V283, P3095, DOI 10.1001/jama.283.23.3095; Kavanagh T, 2003, J AM COLL CARDIOL, V42, P2139, DOI 10.1016/j.jacc.2003.07.028; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Srinivasan SR, 2003, METABOLISM, V52, P443, DOI 10.1053/meta.2003.50065; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; WISLOFF U, 2001, AM J PHYSIOL, V280, pH1302; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Youssef AA, 2002, ANN EPIDEMIOL, V12, P553, DOI 10.1016/S1047-2797(01)00286-1; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	18	481	491	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					418	420		10.1126/science.1108177	http://dx.doi.org/10.1126/science.1108177			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662013				2022-12-01	WOS:000226492300045
J	Wik, L; Kramer-Johansen, J; Myklebust, H; Sorebo, H; Svensson, L; Fellows, B; Steen, PA				Wik, L; Kramer-Johansen, J; Myklebust, H; Sorebo, H; Svensson, L; Fellows, B; Steen, PA			Quality of cardiopulmonary resuscitation during out-of-hospital cardiac arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUTOMATED EXTERNAL DEFIBRILLATOR; CORONARY BLOOD-FLOW; BASIC LIFE-SUPPORT; VENTRICULAR-FIBRILLATION; CPR PERFORMANCE; COMPRESSION; RETENTION; SKILLS; GUIDELINES; SURVIVAL	Context Cardiopulmonary resuscitation (CPR) guidelines recommend target values for compressions, ventilations, and CPR-free intervals allowed for rhythm analysis and defibrillation. There is little information on adherence to these guidelines during advanced cardiac life support in the field. Objective To measure the quality of out-of-hospital CPR performed by ambulance personnel, as measured by adherence to CPR guidelines. Design and Setting Case series of 176 adult patients with out-of-hospital cardiac arrest treated by paramedics and nurse anesthetists in Stockholm Sweden, London, England, and Akershus, Norway, between March 2002 and October 2003. The defibrillators recorded chest compressions via a sternal pad fitted with an accelerometer and ventilations by changes in thoracic impedance between the defibrillator pads, in addition to standard event and electrocardiographic recordings. Main Outcome Measure Adherence to international guidelines for CPR. Results Chest compressions were not given 48% (95% CI, 45%-51%) of the time without spontaneous circulation; this percentage was 38% (95% CI, 36%-41%) when subtracting the time necessary for electrocardiographic analysis and defibrillation. Combining these data with a mean compression rate of 121/min (95% CI, 118-124/min) when compressions were given resulted in a mean compression rate of 64/min (95% CI, 61-67/min). Mean compression depth was 34 mm (95% CI, 33-35 mm), 28% (95% CI, 24%-32%) of the compressions had a depth of 38 mm to 51 mm (guidelines recommendation), and the compression part of the duty cycle was 42% (95% CI, 41%-42%). A mean of 11 (95% Cl, 11-12) ventilations were given per minute. Sixty-one patients (35%) had return of spontaneous circulation, and 5 of 6 patients discharged alive from the hospital had normal neurological outcomes. Conclusions In this study of CPR during out-of-hospital cardiac arrest, chest compressions were not delivered half of the time, and most compressions were too shallow. Electrocardiographic analysis and defibrillation accounted for only small parts of intervals without chest compressions.	Ullevaal Univ Hosp, Expt Med Res Inst, N-0407 Oslo, Norway; Ullevaal Univ Hosp, Natl Competence Ctr Emergency Med, N-0407 Oslo, Norway; Ullevaal Univ Hosp, Div Prehosp Emergency Med, N-0407 Oslo, Norway; Ullevaal Univ Hosp, Div Surg, N-0407 Oslo, Norway; Norwegian Air Ambulance, Dept Res & Educ Acute Med, Drobak, Norway; Laerdal Med Corp, Stavanger, Norway; Soder Sjukhuset, S-10064 Stockholm, Sweden; London Ambulance Serv NHS Trust, London, England	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Sodersjukhuset Hospital	Wik, L (corresponding author), Ullevaal Univ Hosp, Expt Med Res Inst, N-0407 Oslo, Norway.		Kramer-Johansen, Jo/P-5132-2018	Kramer-Johansen, Jo/0000-0002-7881-1757				Aase SO, 2002, IEEE T BIO-MED ENG, V49, P263, DOI 10.1109/10.983461; ANDERSEN HS, 2003, THESIS STAVANGER U S; [Anonymous], 2000, GUID 2000 CARD RES E; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; BELLAMY RF, 1984, CIRCULATION, V69, P174, DOI 10.1161/01.CIR.69.1.174; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Broomfield R, 1996, J ADV NURS, V23, P1016; Chamberlain DA, 2003, RESUSCITATION, V59, P11, DOI 10.1016/j.resuscitation.2003.08.011; *CPR, 1974, JAMA-J AM MED ASSOC, V227, P864; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Donnelly P, 2000, RESUSCITATION, V45, P195, DOI 10.1016/S0300-9572(00)00186-6; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; GEDDES LA, 1989, PRINCIPLES APPL BIO; Handley AJ, 2003, RESUSCITATION, V57, P57, DOI 10.1016/S0300-9572(02)00400-8; KAYE W, 1986, CRIT CARE MED, V14, P620, DOI 10.1097/00003246-198607000-00007; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Liberman M, 1999, RESUSCITATION, V42, P47, DOI 10.1016/S0300-9572(99)00082-9; MAIER GW, 1986, CIRCULATION, V74, P51; Marn-Pernat A, 2001, CRIT CARE MED, V29, P2360, DOI 10.1097/00003246-200112000-00019; MOSER DK, 1992, HEART LUNG, V21, P372; ORNATO JP, 1989, ANN EMERG MED, V18, P732, DOI 10.1016/S0196-0644(89)80005-8; Pellis T, 2002, CRIT CARE MED, V30, pS176, DOI 10.1097/00003246-200204001-00012; Sunde K, 1998, RESUSCITATION, V39, P197, DOI 10.1016/S0300-9572(98)00139-7; Sunde K, 1997, RESUSCITATION, V34, P235, DOI 10.1016/S0300-9572(96)01087-8; van Alem AP, 2003, ANN EMERG MED, V42, P449, DOI 10.1067/S0196-0644(03)00383-4; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; WIK L, 1994, RESUSCITATION, V28, P195, DOI 10.1016/0300-9572(94)90064-7; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Wik L, 2001, RESUSCITATION, V50, P167, DOI 10.1016/S0300-9572(01)00331-8; WOLFE JA, 1988, J THORAC CARDIOV SUR, V95, P523; World Medical Association, 1964, DECL HELS; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E; 2000, RESUSCITATION, V46, P1	33	956	1019	1	41	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2005	293	3					299	304		10.1001/jama.293.3.299	http://dx.doi.org/10.1001/jama.293.3.299			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888FA	15657322	Bronze, Green Published			2022-12-01	WOS:000226358400023
J	Takyar, S; Hickerson, RP; Noller, HF				Takyar, S; Hickerson, RP; Noller, HF			MRNA helicase activity of the ribosome	CELL			English	Article							ELONGATION-FACTOR TU; SECONDARY STRUCTURE; COLI RIBOSOME; TRANSLOCATION; COMPLEXES; SUBUNIT; SITE; MECHANISM; PROTEIN; MODEL	Most mRNAs contain secondary structure, yet their codons must be in single-stranded form to be translated. Until now, no helicase activity has been identified which could account for the ability of ribosomes to translate through downstream mRNA secondary structure. Using an oligonucleotide displacement assay, together with a stepwise in vitro translation system made up of purified components, we show that ribosomes are able to disrupt downstream helices, including a perfect 27 base pair helix of predicted T-m = 70degrees. Using helices of different lengths and registers, the helicase active site can be localized to the middle of the downstream tunnel, between the head and shoulder of the 30S subunit. Mutation of residues in proteins S3 and S4 that line the entry to the tunnel impairs helicase activity. We conclude that the ribosome itself is an mRNA helicase and that proteins S3 and S4 may play a role in its processivity.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Mol Biol, RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu			NIGMS NIH HHS [GM-17129] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017129, R01GM017129] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; BIRERLEY L, 2001, COLD SPRING HARB SYM, P233; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; DOTY P., 1959, PROC NATL ACAD SCI, V45, P482, DOI 10.1073/pnas.45.4.482; FAVRE A, 1975, EUR J BIOCHEM, V57, P147, DOI 10.1111/j.1432-1033.1975.tb02285.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HOLDER JW, 1975, BIOCHEMISTRY-US, V14, P4209, DOI 10.1021/bi00690a009; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; LINGELBACH K, 1988, NUCLEIC ACIDS RES, V16, P3405, DOI 10.1093/nar/16.8.3405; Min Jou W, 1972, Nature, V237, P82; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Nakano S, 1999, NUCLEIC ACIDS RES, V27, P2957, DOI 10.1093/nar/27.14.2957; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; PESTKA S, 1969, J BIOL CHEM, V244, P1533; SHATSKY IN, 1991, BIOCHIMIE, V73, P937, DOI 10.1016/0300-9084(91)90135-N; Southworth DR, 2002, J MOL BIOL, V324, P611, DOI 10.1016/S0022-2836(02)01196-8; VANHIMBERGEN J, 1993, NUCLEIC ACIDS RES, V21, P1713, DOI 10.1093/nar/21.8.1713; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	34	363	369	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					49	58		10.1016/j.cell.2004.11.042	http://dx.doi.org/10.1016/j.cell.2004.11.042			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652481	Bronze			2022-12-01	WOS:000226365400010
J	Kenward, B; Weir, AAS; Rutz, C; Kacelnik, A				Kenward, B; Weir, AAS; Rutz, C; Kacelnik, A			Tool manufacture by naive juvenile crows	NATURE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Kenward, B (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	alex.kacelnik@zoology.ox.ac.uk	Kenward, Ben/A-5558-2009; Weir, Alex/B-4664-2008	Rutz, Christian/0000-0001-5187-7417	Biotechnology and Biological Sciences Research Council [BB/C517392/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Celli ML, 2004, INT J PRIMATOL, V25, P1267, DOI 10.1023/B:IJOP.0000043962.60837.16; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; SPAULDING B, IN PRESS ANIM BEHAV; Tebbich S, 2001, P ROY SOC B-BIOL SCI, V268, P2189, DOI 10.1098/rspb.2001.1738; Tomasello M, 1999, ANNU REV ANTHROPOL, V28, P509, DOI 10.1146/annurev.anthro.28.1.509; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; WESTERGAARD GC, 1987, J COMP PSYCHOL, V101, P159, DOI 10.1037/0735-7036.101.2.159; WESTERGAARD GC, 1989, PERCEPT MOTOR SKILL, V68, P558, DOI 10.2466/pms.1989.68.2.558	11	154	161	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					121	121		10.1038/433121a	http://dx.doi.org/10.1038/433121a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650729	Bronze			2022-12-01	WOS:000226252200025
J	Patel, RR; Murphy, DJ; Peters, TJ				Patel, RR; Murphy, DJ; Peters, TJ		ALSPAC	Operative delivery and postnatal depression: a cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; CHILDREN; IMPACT	Objectives To assess the association between elective caesarean section and postnatal depression compared with planned vaginal delivery and whether emergency caesarean section or assisted vaginal delivery is associated with postnatal depression compared with spontaneous vaginal delivery. Design Prospective population based cohort study. Setting ALSPAC (the Avon longitudinal study of parents and children). Participants 14 663 women recruited antenatally with a due date between I April 1991 and 31 December 1992. Main outcome measure Edinburgh postnatal depression scale score >= 13 at eight weeks postnatal on self completed questionnaire. Results Albeit with wide confidence intervals, there was no evidence that elective caesarean section altered the odds of postnatal depression compared with planned vaginal delivery (adjusted odds ratio 1.06, 95% confidence interval 0.66 to 1.70, P = 0.80). Among planned vaginal deliveries there was similarly little evidence of a difference between women who have emergency caesarean section or assisted vaginal delivery and those who have spontaneous vaginal delivery (1.17, 0.77 to 1.79, P = 0.46, and 0.89, 0.68 to 1.18, P = 0.42, respectively). Conclusions There is no reason for women at risk of postnatal depression to be managed differently with regard to mode of delivery. Elective caesarean section does not protect against postnatal depression. Women who plan vaginal delivery and require emergency caesarean section or assisted vaginal delivery can be reassured that there is no reason to believe that they are at increased risk of postnatal depression.	Univ Bristol, St Michaels Hosp, Div Obstet & Gynaecol, Bristol BS2 8EG, Avon, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Maternal & Child Hlth Sci, Dundee DD1 9SY, Scotland; Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 1AU, Avon, England	University of Bristol; University of Dundee; University of Bristol	Patel, RR (corresponding author), Univ Bristol, St Michaels Hosp, Div Obstet & Gynaecol, Level D, Bristol BS2 8EG, Avon, England.	roshni.patel@bristol.ac.uk		Murphy, Deirdre/0000-0001-6074-6718; Peters, Tim/0000-0003-2881-4180; Patel, Roshni/0000-0002-1399-3131				BOYCE PM, 1992, MED J AUSTRALIA, V157, P172, DOI 10.5694/j.1326-5377.1992.tb137080.x; COGILL SR, 1986, BMJ-BRIT MED J, V292, P1165, DOI 10.1136/bmj.292.6529.1165; Cooper PJ, 1998, BMJ-BRIT MED J, V316, P1884; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Forman DN, 2000, BRIT J OBSTET GYNAEC, V107, P1210; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hay DF, 2001, J CHILD PSYCHOL PSYC, V42, P871, DOI 10.1111/1469-7610.00784; Johnstone SJ, 2001, AUST NZ J PSYCHIAT, V35, P69, DOI 10.1046/j.1440-1614.2001.00862.x; Koo V, 2003, J OBSTET GYNAECOL RE, V29, P246, DOI 10.1046/j.1341-8076.2003.00104.x; Lydon-Rochelle MT, 2001, PAEDIATR PERINAT EP, V15, P232, DOI 10.1046/j.1365-3016.2001.00345.x; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; *NAT COLL CTR WOM, 2004, CAESAREAN SECTION CL; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; ONEILL T, 1990, IRISH MED J, V83, P17; PATEL RR, 2004, IN PRESS INT J EPIDE; Saisto T, 2001, ACTA OBSTET GYN SCAN, V80, P39, DOI 10.1034/j.1600-0412.2001.800108.x; Sharp D, 1995, J CHILD PSYCHOL PSYC, V36, P1315, DOI 10.1111/j.1469-7610.1995.tb01666.x; Singleton N., 2001, PSYCHIAT MORBIDITY A; Thompson JF, 2002, BIRTH-ISS PERINAT C, V29, P83, DOI 10.1046/j.1523-536X.2002.00167.x; Verdoux H, 2002, ACTA PSYCHIAT SCAND, V106, P212, DOI 10.1034/j.1600-0447.2002.02398.x; WRATE RM, 1985, BRIT J PSYCHIAT, V146, P622, DOI 10.1192/bjp.146.6.622; 2003, AVON LONGITUDINAL ST	24	52	55	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2005	330	7496					879	881		10.1136/bmj.38376.603426.D3	http://dx.doi.org/10.1136/bmj.38376.603426.D3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	917UA	15734748	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000228493500018
J	Falck, J; Coates, J; Jackson, SP				Falck, J; Coates, J; Jackson, SP			Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; CATALYTIC SUBUNIT; S-PHASE; IONIZING-RADIATION; MRE11 COMPLEX; IN-VITRO; CHECKPOINT; ACTIVATION; REPAIR	Ataxia-telangiectasia mutated (ATM), ataxia-telangiectasia and Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) are members of the phosphoinositide-3-kinase-related protein kinase (PIKK) family, and are rapidly activated in response to DNA damage. ATM and DNA-PKcs respond mainly to DNA double-strand breaks, whereas ATR is activated by single-stranded DNA and stalled DNA replication forks. In all cases, activation involves their recruitment to the sites of damage. Here we identify related, conserved carboxy-terminal motifs in human Nbs1, ATRIP and Ku80 proteins that are required for their interaction with ATM, ATR and DNA-PKcs, respectively. These motifs are essential not only for efficient recruitment of ATM, ATR and DNA-PKcs to sites of damage, but are also critical for ATM-, ATR- and DNA-PKcs-mediated signalling events that trigger cell cycle checkpoints and DNA repair. Our findings reveal that recruitment of these PIKKs to DNA lesions occurs by common mechanisms through an evolutionarily conserved motif, and provide direct evidence that PIKK recruitment is required for PIKK-dependent DNA-damage signalling.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937				Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brewerton SC, 2004, J STRUCT BIOL, V145, P295, DOI 10.1016/j.jsb.2003.11.024; Brodsky MH, 2000, GENE DEV, V14, P666; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wolkow TD, 2002, MOL BIOL CELL, V13, P480, DOI 10.1091/mbc.01-03-0104; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	42	947	1003	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					605	611		10.1038/nature03442	http://dx.doi.org/10.1038/nature03442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15758953				2022-12-01	WOS:000228011000036
J	Lazarov, O; Robinson, J; Tang, YP; Hairston, IS; Korade-Mirnics, Z; Lee, VMY; Hersh, LB; Sapolsky, RM; Mirnics, K; Sisodia, SS				Lazarov, O; Robinson, J; Tang, YP; Hairston, IS; Korade-Mirnics, Z; Lee, VMY; Hersh, LB; Sapolsky, RM; Mirnics, K; Sisodia, SS			Environmental enrichment reduces A beta levels and amyloid deposition in transgenic mice	CELL			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; MOUSE MODEL; DENTATE GYRUS; IN-VIVO; MEMORY CONSOLIDATION; SYNAPTIC PLASTICITY; PHYSICAL-ACTIVITY; GENE-EXPRESSION; AGING BRAIN	Cerebral deposition of beta-amyloid (A beta) peptides is an invariant pathological hallmark in brains of patients with Alzheimer's disease (AD) and transgenic mice coexpressing familial AD-linked APP and PS1 variants. We now report that exposure of transgenic mice to an "enriched environment" results in pronounced reductions in cerebral A beta levels and amyloid deposits, compared to animals raised under "standard housing" conditions. The enzymatic activity of an A beta-degrading endopeptidase, neprilysin, is elevated in the brains of "enriched" mice and inversely correlated with amyloid burden. Moreover, DNA microarray analysis revealed selective upregulation in levels of transcripts encoded by genes associated with learning and memory, vasculogenesis, neurogenesis, cell survival pathways, A beta sequestration, and prostaglandin synthesis. These studies provide evidence that environmental enrichment leads to reductions in steady-state levels of cerebral A beta peptides and amyloid deposition and selective upregulation in levels of specific transcripts in brains of transgenic mice.	Univ Pittsburgh, Dept Psychiat, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; University of Chicago; Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; University of Kentucky	Mirnics, K (corresponding author), Univ Pittsburgh, Dept Psychiat, Dept Neurobiol, Pittsburgh, PA 15261 USA.	karoly+@pitt.edu; ssisodia@drugs.bsd.uchicago.edu	Lazarov, Orly/F-9406-2015; Mirnics, Karoly/E-6730-2010; Tang, Ya-Ping/A-1035-2011; Hairston, Ilana/AAT-7442-2021	Mirnics, Karoly/0000-0002-5521-0254; Lazarov, Orly/0000-0002-5887-948X; Korade, Zeljka/0000-0002-8690-4507	NIA NIH HHS [AG11542, AG021494, AG19323] Funding Source: Medline; NIDA NIH HHS [DA02243] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG011542, R01AG021494, R01AG019323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abe Mayumi, 2001, Angiogenesis, V4, P289, DOI 10.1023/A:1016018617152; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; BENZING WC, 1993, BRAIN RES, V625, P125, DOI 10.1016/0006-8993(93)90145-D; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Califano A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P75; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dickey CA, 2003, J NEUROSCI, V23, P5219; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Ji Y, 2001, J ALZHEIMERS DIS, V3, P23, DOI 10.3233/JAD-2001-3105; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kramer AF, 2002, J MOL NEUROSCI, V19, P227, DOI 10.1007/s12031-002-0038-y; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lee EHY, 2003, EUR J NEUROSCI, V18, P2842, DOI 10.1111/j.1460-9568.2003.03032.x; LI CW, 1995, METHOD ENZYMOL, V248, P253; Marr RA, 2003, J NEUROSCI, V23, P1992; Mattson MP, 2001, MECH AGEING DEV, V122, P757, DOI 10.1016/S0047-6374(01)00226-3; Mattson MP, 2000, BRAIN RES, V886, P47, DOI 10.1016/S0006-8993(00)02790-6; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; NITSCH RM, 1993, P NATL ACAD SCI USA, V90, P5191, DOI 10.1073/pnas.90.11.5191; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Sapolsky RM., 1993, PRIMATE SOCIAL CONFL, P171; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Seo J, 2004, BIOINFORMATICS, V20, P2534, DOI 10.1093/bioinformatics/bth280; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Stein TD, 2002, J NEUROSCI, V22, P7380; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6	63	681	706	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					701	713		10.1016/j.cell.2005.01.015	http://dx.doi.org/10.1016/j.cell.2005.01.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766532	Bronze			2022-12-01	WOS:000227771400015
J	van Rossum, DB; Patterson, RL; Sharma, S; Barrow, RK; Kornberg, M; Gill, DL; Snyder, SH				van Rossum, DB; Patterson, RL; Sharma, S; Barrow, RK; Kornberg, M; Gill, DL; Snyder, SH			Phospholipase C gamma 1 controls surface expression of TRPC3 through an intermolecular PH domain	NATURE			English	Article							CHANNELS; RECEPTOR; DATABASE; FOLD	Many ion channels are regulated by lipids(1-3), but prominent motifs for lipid binding have not been identified in most ion channels. Recently, we reported that phospholipase Cgamma1 (PLC-gamma1) binds to and regulates TRPC3 channels(4), components of agonist-induced Ca2+ entry into cells. This interaction requires a domain in PLC-gamma1 that includes a partial pleckstrin homology (PH)domain - a consensus lipid-binding and protein-binding sequence(5,6). We have developed a gestalt algorithm to detect hitherto 'invisible' PH and PH-like domains, and now report that the partial PH domain of PLC-gamma1 interacts with a complementary partial PH-like domain in TRPC3 to elicit lipid binding and cell-surface expression of TRPC3. Our findings imply a far greater abundance of PH domains than previously appreciated, and suggest that intermolecular PH-like domains represent a widespread signalling mode.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland Baltimore	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Kornberg, Michael Davin/K-3329-2019	Kornberg, Michael Davin/0000-0003-2588-7325; van Rossum, Damian/0000-0003-1011-2586				Baranano DE, 2000, J BIOL CHEM, V275, P15166, DOI 10.1074/jbc.275.20.15166; DINITTO JP, 2003, SCI STKE; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gervais V, 2004, NAT STRUCT MOL BIOL, V11, P616, DOI 10.1038/nsmb782; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969	15	151	159	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					99	104		10.1038/nature03340	http://dx.doi.org/10.1038/nature03340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744307				2022-12-01	WOS:000227334600051
J	Lee, J; Croen, LA; Backstrand, KH; Yoshida, CK; Henning, LH; Lindan, C; Ferriero, DM; Fullerton, HJ; Barkovich, AJ; Wu, YW				Lee, J; Croen, LA; Backstrand, KH; Yoshida, CK; Henning, LH; Lindan, C; Ferriero, DM; Fullerton, HJ; Barkovich, AJ; Wu, YW			Maternal and infant characteristics associated with perinatal arterial stroke in the infant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL CEREBRAL INFARCTION; ISCHEMIC-STROKE; TERM INFANTS; CLINICAL PRESENTATION; RISK-FACTORS; CHILDREN; PALSY; NEWBORN; PREECLAMPSIA; WOMEN	Context Perinatal arterial ischemic stroke (PAS) is a common cause of hemiplegic cerebral palsy. Risk factors for this condition have not been clearly defined. Objective To determine maternal and infant characteristics associated with PAS. Design, Setting, and Patients Case-control study nested within the cohort of all 199176 infants born from 1997 through 2002 in the Kaiser Permanente Medical Care Program, a managed care organization providing care for more than 3 million residents of northern California. Case patients were confirmed by review of brain imaging and medical records (n=40). Three controls per case were randomly selected from the study population. Main Outcome Measure Association of maternal and infant complications with risk of PAS. Results The population prevalence of PAS was 20 per 100000 live births. The majority (85%) of infants with PAS were delivered at term. The following prepartum and intrapartum factors were more common among case than control infants: primiparity (73% vs 44%, P=.002), fetal heart rate abnormality (46% vs 14%, P<.001), emergency cesarean delivery (35% vs 13%, P=.002), chorioamnionitis (27% vs 11%, P=.03), prolonged rupture of membranes (26% vs 7%, P=.002), prolonged second stage of labor (25% vs 4%, P<.001), vacuum extraction (24% vs 11%, P=.04), cord abnormality (22% vs 6%, P=.01), preeclampsia (19% vs 5%, P=.01), and oligohydramnios (14% vs 3%, P=.01). Risk factors independently associated with PAS on multivariate analysis were history of infertility (odds ratio [OR], 7.5; 95% confidence interval [CI], 1.3-45.0), preeclampsia (OR, 5.3; 95% Cl, 1.3-22.0), prolonged rupture of membranes (OR, 3.8; 95% Cl, 1.1-12.8), and chorioamnionitis (OR, 3.4; 95% Cl, 1.1-10.5). The rate of PAS increased dramatically when multiple risk factors were present. Conclusions Perinatal arterial ischemic stroke in infants is associated with several independent maternal risk factors. How these complications, along with their potential effects on the placenta and fetus, may play a role in causing perinatal stroke deserves further study.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Kaiser Permanente, Dept Radiol, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente	Wu, YW (corresponding author), UCSF Dept Child Neurol, Box 0137,350 Parnassus Ave,Suite 609, San Francisco, CA 94117 USA.	wuy@neuropeds.ucsf.edu		Fullerton, Heather/0000-0002-4828-1687; Croen, Lisa/0000-0001-7849-9428	NINDS NIH HHS [NS35902] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMIT M, 1980, ARCH NEUROL-CHICAGO, V37, P109, DOI 10.1001/archneur.1980.00500510067013; Andrew M E, 2001, Hematology Am Soc Hematol Educ Program, P358; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Burke CJ, 1997, DEV MED CHILD NEUROL, V39, P726; deVeber GA, 2000, ANN NEUROL, V48, P514; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; deVries LS, 1997, NEUROPEDIATRICS, V28, P88, DOI 10.1055/s-2007-973679; Ericson A, 2002, HUM REPROD, V17, P929, DOI 10.1093/humrep/17.4.929; Estan J, 1997, ARCH DIS CHILD-FETAL, V76, pF88, DOI 10.1136/fn.76.2.F88; Fullerton HJ, 2003, NEUROLOGY, V61, P189, DOI 10.1212/01.WNL.0000078894.79866.95; Golomb MR, 2001, ANN NEUROL, V50, P163, DOI 10.1002/ana.1078; Govaert P, 2000, ARCH DIS CHILD-FETAL, V82, pF59, DOI 10.1136/fn.82.1.F59; Hagstrom JN, 1998, J PEDIATR-US, V133, P777, DOI 10.1016/S0022-3476(98)70150-7; HEIER LA, 1991, AM J NEURORADIOL, V12, P951; Hnat MD, 2002, AM J OBSTET GYNECOL, V186, P422, DOI 10.1067/mob.2002.120280; Hogeveen M, 2002, J PEDIATR-US, V141, P429, DOI 10.1067/mpd.2002.126598; Humphreys P, 2000, CAN J NEUROL SCI, V27, P210; Hunt RW, 2001, PEDIATR NEUROL, V25, P242, DOI 10.1016/S0887-8994(01)00291-0; Jan MMS, 1998, EUR J PEDIATR, V157, P846, DOI 10.1007/s004310050950; KOELFEN W, 1995, DEV MED CHILD NEUROL, V37, P204; Kraus FT, 1999, HUM PATHOL, V30, P759, DOI 10.1016/S0046-8177(99)90136-3; Kraus FT, 1997, HUM PATHOL, V28, P246, DOI 10.1016/S0046-8177(97)90114-3; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kupferminc MJ, 1999, NEW ENGL J MED, V341, P384; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; LIEN JM, 1995, OBSTET GYNECOL, V85, P163, DOI 10.1016/0029-7844(94)00375-N; Lynch JK, 2001, CURR OPIN PEDIATR, V13, P499, DOI 10.1097/00008480-200112000-00002; Lynch JK, 2001, NEUROLOGY, V56, pA10; MANNINO FL, 1983, J PEDIATR-US, V102, P605, DOI 10.1016/S0022-3476(83)80200-5; Ment L R, 1986, Pediatr Neurol, V2, P276, DOI 10.1016/0887-8994(86)90019-6; MENT LR, 1984, ANN NEUROL, V16, P559, DOI 10.1002/ana.410160506; Mercuri E, 1999, PEDIATRICS, V103, P39, DOI 10.1542/peds.103.1.39; Mercuri E, 2001, PEDIATRICS, V107, P1400, DOI 10.1542/peds.107.6.1400; Nelson KB, 2004, LANCET NEUROL, V3, P150, DOI 10.1016/S1474-4422(04)00679-9; Pabinger I, 2001, ARTERIOSCL THROM VAS, V21, P874, DOI 10.1161/01.ATV.21.5.874; PELLICER A, 1992, BRAIN DEV-JPN, V14, P381, DOI 10.1016/S0387-7604(12)80344-5; PERLMAN JM, 1994, PEDIATR NEUROL, V11, P281, DOI 10.1016/0887-8994(94)90002-7; Ramaswamy V, 2004, NEUROLOGY, V62, P2088, DOI 10.1212/01.WNL.0000129909.77753.C4; Redline RW, 2000, ARCH PATHOL LAB MED, V124, P1785; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Rogolino A, 2003, BLOOD COAGUL FIBRIN, V14, P277, DOI 10.1097/00001721-200304000-00009; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1097, DOI 10.1016/0002-9378(95)91333-5; Schneider AT, 2004, STROKE, V35, P1552, DOI 10.1161/01.STR.0000129335.28301.f5; Shah D M, 2001, Semin Pediatr Neurol, V8, P108, DOI 10.1053/spen.2001.25812; Sreenan C, 2000, J PEDIATR-US, V137, P351, DOI 10.1067/mpd.2000.107845; *STAT CAL DEP HLTH, 1976, INTR GROWTH NEON RIS; *STAT CORP, 2000, STATA 7 REF MAN; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; UVEBRANT P, 1988, ACTA PAEDIATR SCAND, P1; Wu YW, 2004, PEDIATRICS, V114, P612, DOI 10.1542/peds.2004-0385; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Wu YW, 2003, JAMA-J AM MED ASSOC, V290, P2677, DOI 10.1001/jama.290.20.2677; WULFECK BB, 1991, PEDIATR NEUROL, V7, P266, DOI 10.1016/0887-8994(91)90043-K; Yoshii F, 1999, NEUROLOGY, V53, P225, DOI 10.1212/WNL.53.1.225	54	210	218	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2005	293	6					723	729		10.1001/jama.293.6.723	http://dx.doi.org/10.1001/jama.293.6.723			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895DX	15701914	Bronze			2022-12-01	WOS:000226842200026
J	Gompel, N; Prud'homme, B; Wittkopp, PJ; Kassner, VA; Carroll, SB				Gompel, N; Prud'homme, B; Wittkopp, PJ; Kassner, VA; Carroll, SB			Chance caught on the wing: cis-regulatory evolution and the origin of pigment patterns in Drosophila	NATURE			English	Article							MELANOGASTER SPECIES-GROUP; GROUP DIPTERA; YELLOW LOCUS; PHYLOGENY; EXPRESSION; GENE; DIVERGENCE; MORPHOLOGY; ELEMENTS; LINEAGE	The gain, loss or modification of morphological traits is generally associated with changes in gene regulation during development. However, the molecular bases underlying these evolutionary changes have remained elusive. Here we identify one of the molecular mechanisms that contributes to the evolutionary gain of a male-specific wing pigmentation spot in Drosophila biarmipes, a species closely related to Drosophila melanogaster. We show that the evolution of this spot involved modifications of an ancestral cis-regulatory element of the yellow pigmentation gene. This element has gained multiple binding sites for transcription factors that are deeply conserved components of the regulatory landscape controlling wing development, including the selector protein Engrailed. The evolutionary stability of components of regulatory landscapes, which can be co-opted by chance mutations in cis-regulatory elements, might explain the repeated evolution of similar morphological patterns, such as wing pigmentation patterns in flies.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu		Gompel, Nicolas/0000-0003-3358-7963				Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Belting HG, 1998, P NATL ACAD SCI USA, V95, P2355, DOI 10.1073/pnas.95.5.2355; BLAIR SS, 1992, DEVELOPMENT, V115, P21; BLAIR SS, 1995, BIOESSAYS, V17, P299, DOI 10.1002/bies.950170406; BOCK IR, 1980, SYST ENTOMOL, V5, P341, DOI 10.1111/j.1365-3113.1980.tb00420.x; BOCK IR, 1972, STUDIES GENETICS, P1, DOI DOI 10.1590/S0085-56262014000400004; Carroll S. B., 2004, DNA DIVERSITY MOL GE; CELNIKER SE, 2002, GENOME BIOL, V0003; CHIA W, 1986, EMBO J, V5, P3597, DOI 10.1002/j.1460-2075.1986.tb04688.x; Davidson EH, 2001, GENOMIC REGULATORY S; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; Gompel N, 2003, NATURE, V424, P931, DOI 10.1038/nature01787; GONZALEZ P, 1995, MOL BIOL EVOL, V12, P773; HARDY DE, 1965, DIPTERA CYCLORRHAP 1, V2; *HUM GEN SEQ CTR, 2002, DROS GEN PROJ; Kauffman S, 1995, HOME UNIVERSE; Kopp A, 2002, EVOL DEV, V4, P278, DOI 10.1046/j.1525-142X.2002.02017.x; Kopp A, 2002, SYST BIOL, V51, P786, DOI 10.1080/10635150290102410; Llopart A, 2002, EVOLUTION, V56, P2262; Majerus M.E.N., 1998, MELANISM EVOLUTION A; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Miller DFB, 2002, BIOTECHNIQUES, V33, P366, DOI 10.2144/02332rr03; Monod J., 1970, HASARD N CESSIT ESSA; Powell J.R., 1997, PROGR PROSPECTS EVOL; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schawaroch V, 2002, BIOL J LINN SOC, V76, P21, DOI 10.1111/j.1095-8312.2002.tb01711.x; SCHENDEL PF, 1993, CURRENT PROTOCOLS MO; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; SINGH BN, 1987, ETHOLOGY, V75, P81; Solano PJ, 2003, DEVELOPMENT, V130, P1243, DOI 10.1242/dev.00348; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; True JR, 1999, CURR BIOL, V9, P1382, DOI 10.1016/S0960-9822(00)80083-4; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang XD, 2002, GENE DEV, V16, P2345, DOI 10.1101/gad.996302; Wheeler M.R., 1965, DROS INFORM SERV, V40, P98; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Yoon HS, 2004, P NATL ACAD SCI USA, V101, P6524, DOI 10.1073/pnas.0401824101	47	463	482	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					481	487		10.1038/nature03235	http://dx.doi.org/10.1038/nature03235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690032				2022-12-01	WOS:000226727200038
J	Laurberg, P				Laurberg, P			Global or Gaelic epidemic of hypothyroidism?	LANCET			English	Editorial Material							IODINE INTAKE; THYROID-DISEASE; POPULATION; HYPERTHYROIDISM; HEALTH		Aarhus Univ Hosp, Aalborg Hosp, Dept Endocrinol & Med, DK-9000 Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University	Laurberg, P (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Dept Endocrinol & Med, DK-9000 Aalborg, Denmark.	laurberg@aas.nja.dk						Flynn RWV, 2004, J CLIN ENDOCR METAB, V89, P3879, DOI 10.1210/jc.2003-032089; HALL R, 1987, BRIT MED J, V294, P721, DOI 10.1136/bmj.294.6574.721; Hetzel B.S., 2004, GLOBAL ELIMINATION B; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Laurberg P, 1999, THYROID, V9, P33, DOI 10.1089/thy.1999.9.33; Laurberg P, 2001, THYROID, V11, P457, DOI 10.1089/105072501300176417; LAURBERG P, 2003, IDD NEWSLETTER   NOV, P55; Pedersen IB, 2002, J CLIN ENDOCR METAB, V87, P4462, DOI 10.1210/jc.2002-020750; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; *UN CHILDREN FUND, 2001, ASS IOD DEF DIS MON; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wittig Holger, 2003, Leg Med (Tokyo), V5 Suppl 1, pS173, DOI 10.1016/S1344-6223(02)00103-7	12	18	18	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					738	740						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733704				2022-12-01	WOS:000227285300009
J	McGaha, TL; Sorrentino, B; Ravetch, JV				McGaha, TL; Sorrentino, B; Ravetch, JV			Restoration of tolerance in lupus by targeted inhibitory receptor expression	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; NEGATIVE SELECTION; CLONAL DELETION; DOWN-REGULATION; B-LYMPHOCYTES; MICE; ERYTHEMATOSUS; AUTOIMMUNITY; SUSCEPTIBILITY; REPERTOIRE	Lupus, a multigenic autoimmune condition in which a breakdown of tolerance results in the development of autoantibodies, leads to a variety of pathologic outcomes. Despite the heterogeneity of factors influencing disease susceptibility, we demonstrate that the partial restoration of inhibitory Fc receptor (FcgammaRIIB) levels on B cells in lupus-prone mouse strains is sufficient to restore tolerance and prevent autoimmunity. FcgammaRIIB regulates a common B cell checkpoint in genetically diverse lupus-prone mouse strains, and modest changes in its expression can result in either tolerance or autoimmunity. Therefore, increasing FcgammaRIIB levels on B cells may be an effective way to treat autoimmune diseases.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA	Rockefeller University; St Jude Children's Research Hospital	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; McGaha, Tracy/0000-0003-4721-9301				Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; CHALLITA PM, 1994, P NATL ACAD SCI USA, V91, P2567, DOI 10.1073/pnas.91.7.2567; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Jiang Y, 2000, IMMUNOGENETICS, V51, P429, DOI 10.1007/s002510050641; Jiang Y, 1999, INT IMMUNOL, V11, P1685, DOI 10.1093/intimm/11.10.1685; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; Klug CA, 2000, BLOOD, V96, P894, DOI 10.1182/blood.V96.3.894.015k35_894_901; Lange C, 1997, GENE THER, V4, P303, DOI 10.1038/sj.gt.3300395; Lund Anders H., 1996, Journal of Biomedical Science, V3, P365, DOI 10.1007/BF02258042; Marion Tony N, 2003, Curr Dir Autoimmun, V6, P123; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; Pritchard NR, 2003, IMMUNOLOGY, V108, P263, DOI 10.1046/j.1365-2567.2003.01592.x; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; SCHWARTZ RH, 1989, COLD SPRING HARB SYM, V54, P605; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340; Yan J, 2002, J IMMUNOL, V168, P3188, DOI 10.4049/jimmunol.168.7.3188	24	206	218	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2005	307	5709					590	593		10.1126/science.1105160	http://dx.doi.org/10.1126/science.1105160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681388				2022-12-01	WOS:000226694000050
J	Teeling, EC; Springer, MS; Madsen, O; Bates, P; O'Brien, SJ; Murphy, WJ				Teeling, EC; Springer, MS; Madsen, O; Bates, P; O'Brien, SJ; Murphy, WJ			A molecular phylogeny for bats illuminates biogeography and the fossil record	SCIENCE			English	Article							EOCENE BAT; CHIROPTERA; SEQUENCES	Bats make up more than 20% of extant mammals, yet their evolutionary history is largely unknown because of a limited fossil record and conflicting or incomplete phylogenies. Here, we present a highly resolved molecular phylogeny for all extant bat families. Our results support the hypothesis that megabats are nested among four major microbat lineages, which originated in the early Eocene [52 to 50 million years ago (Mya)], coincident with a significant global rise in temperature, increase in plant diversity and abundance, and the zenith of Tertiary insect diversity. Our data suggest that bats originated in Laurasia, possibly in North America, and that three of the major microbat lineages are Laurasian in origin, whereas the fourth is Gondwanan. Combining principles of ghost lineage analysis with molecular divergence dates, we estimate that the bat fossil record underestimates (unrepresented basal branch length, UBBL) first occurrences by, on average, 73% and that the sum of missing fossil history is 61%.	NCI, Lab Genom Divers, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA; Univ Coll Dublin, Dept Zool, Dublin 4, Ireland; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Radboud Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Harrison Inst, Ctr Systemat & Biodivers Res, Sevenoaks TN13 3AQ, Kent, England; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University College Dublin; University of California System; University of California Riverside; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Texas A&M University System; Texas A&M University College Station	Teeling, EC (corresponding author), NCI, Lab Genom Divers, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA.	emma.teeling@ucd.ie; mark.springer@ucr.edu; obrien@mail.ncifcrf.gov	Yousfi, Mohamed/A-5754-2012; Madsen, Ole/E-3730-2012; OBRIEN, STEPHEN/ABD-1346-2020; Rossiter, Stephen J/E-2111-2011; Raleva, Sofiya/A-3114-2011; Ho, Hilary/F-3029-2011	Yousfi, Mohamed/0000-0003-4831-8635; Madsen, Ole/0000-0001-8082-7881; OBRIEN, STEPHEN/0000-0001-7857-0757; Teeling, Emma/0000-0002-3309-1346	NATIONAL CANCER INSTITUTE [Z01BC005367] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker RJ, 1997, SYST BIOL, V46, P579, DOI 10.2307/2413496; Bates PJJ, 2001, ACTA CHIROPTEROL, V3, P33; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CZAPLEWSKI NJ, EVOLUTION TERTIARY M, V2; Flynn JJ, 1998, TRENDS ECOL EVOL, V13, P449, DOI 10.1016/S0169-5347(98)01457-8; HABERSETZER J, 1992, NATURWISSENSCHAFTEN, V79, P462, DOI 10.1007/BF01139198; HAND S, 1994, J VERTEBR PALEONTOL, V14, P375, DOI 10.1080/02724634.1994.10011565; Hand Suzanne J., 1998, P72; HILL J. E., 1977, B BRIT MUS NAT HIST, V32, P29; Hoofer SR, 2003, J MAMMAL, V84, P809, DOI 10.1644/BWG-034; Hutcheon JM, 1998, PHILOS T R SOC B, V353, P607, DOI 10.1098/rstb.1998.0229; JEPSEN GL, 1966, SCIENCE, V154, P1333, DOI 10.1126/science.154.3754.1333; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; MCKENNA MC, 1997, CLASSIFCATION MAMMAL; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Patterson BD, 2003, BAT ECOLOGY, P536; Simmons Nancy B., 1993, American Museum Novitates, V3077, P1; Simmons NB, 1998, B AM MUS NAT HIST, P1; SIMMONS NB, MAMMALIAN SPECIES WO; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Storch Gerhard, 2002, Palaeontologische Zeitschrift, V76, P189; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2003, MOL PHYLOGENET EVOL, V28, P308, DOI 10.1016/S1055-7903(03)00117-9; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Van den Bussche RA, 2004, J MAMMAL, V85, P321, DOI 10.1644/1545-1542(2004)085<0321:PRARCF>2.0.CO;2; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; WING SL, 1992, MESOZOIC EARLY CENOZ, P327; Woodburne Michael O., 1996, Journal of Mammalian Evolution, V3, P121, DOI 10.1007/BF01454359	29	766	816	3	384	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					580	584		10.1126/science.1105113	http://dx.doi.org/10.1126/science.1105113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681385				2022-12-01	WOS:000226694000047
J	Schwartz, MW; Porte, D				Schwartz, MW; Porte, D			Diabetes, obesity, and the brain	SCIENCE			English	Editorial Material							SEIP CONGENITAL LIPODYSTROPHY; INSULIN-RECEPTOR SUBSTRATE-2; ACTIVATED PROTEIN-KINASE; ACID SYNTHASE INHIBITOR; DIET-INDUCED OBESITY; REDUCES FOOD-INTAKE; GLUCOSE-PRODUCTION; ARCUATE NUCLEUS; BODY-WEIGHT; BETA-CELLS	Recent evidence suggests a key role for the brain in the control of both body fat content and glucose metabolism. Neuronal systems that regulate energy intake, energy expenditure, and endogenous glucose production sense and respond to input from hormonal and nutrient-related signals that convey information regarding both body energy stores and current energy availability. In response to this input, adaptive changes occur that promote energy homeostasis and the maintenance of blood glucose levels in the normal range. Defects in this control system are implicated in the link between obesity and type 2 diabetes.	Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98110 USA; Harborview Med Ctr, Seattle, WA 98110 USA; Univ Calif San Diego, Div Endocrinol Diabet & Metab, San Diego, CA 92161 USA; VA San Diego Hlth Care Syst, Div Endocrinol Diabet & Metab, San Diego, CA 92161 USA	University of Washington; University of Washington Seattle; Harborview Medical Center; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Schwartz, MW (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98110 USA.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032273, R01NS032273] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52989, DK683840] Funding Source: Medline; NINDS NIH HHS [NS32273] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adage T, 2001, J NEUROSCI, V21, P3639, DOI 10.1523/JNEUROSCI.21-10-03639.2001; Asilmaz E, 2004, J CLIN INVEST, V113, P414, DOI 10.1172/JCI200419511; Bates SH, 2004, J MOL MED, V82, P12, DOI 10.1007/s00109-003-0494-z; Bernard, 1854, LECONS PHYSL EXPT AP; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CLARK JT, 1985, ENDOCRINOLOGY, V117, P2435, DOI 10.1210/endo-117-6-2435; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Joffe BI, 2001, LANCET, V357, P1379, DOI 10.1016/S0140-6736(00)04616-X; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kotz CM, 1998, AM J PHYSIOL-REG I, V275, pR471, DOI 10.1152/ajpregu.1998.275.2.R471; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Marks JL, 1997, J NEUROENDOCRINOL, V9, P99, DOI 10.1046/j.1365-2826.1997.00554.x; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; POCAI A, IN PRESS CELL METAB; Porte D, 2001, DIABETES-METAB RES, V17, P181; Reitman ML, 2000, TRENDS ENDOCRIN MET, V11, P410, DOI 10.1016/S1043-2760(00)00309-X; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Schwartz MW, 2004, J CLIN ENDOCR METAB, V89, P5889, DOI 10.1210/jc.2004-0906; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Seaquist ER, 2001, DIABETES, V50, P2203, DOI 10.2337/diabetes.50.10.2203; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Takahashi KA, 2004, ENDOCRINOLOGY, V145, P184, DOI 10.1210/en.2003-0337; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; van den Hoek AM, 2004, DIABETES, V53, P2529, DOI 10.2337/diabetes.53.10.2529; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	54	610	635	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					375	379		10.1126/science.1104344	http://dx.doi.org/10.1126/science.1104344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662002				2022-12-01	WOS:000226492300032
J	Hanlon, RT; Naud, MJ; Shaw, PW; Havenhand, JN				Hanlon, RT; Naud, MJ; Shaw, PW; Havenhand, JN			Behavioural ecology - Transient sexual mimicry leads to fertilization	NATURE			English	Editorial Material							ALTERNATIVE REPRODUCTIVE STRATEGIES; SPAWNING AGGREGATION; CUTTLEFISH; SUCCESS; MOLLUSCA		Marine Biol Lab, Marine Resources Ctr, Woods Hole, MA 02543 USA; Univ London, Royal Holloway Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; Univ Gothenburg, Tjarno Marine Biol Lab, S-45296 Stromstad, Sweden	Marine Biological Laboratory - Woods Hole; University of London; Royal Holloway University London; Flinders University South Australia; University of Gothenburg	Hanlon, RT (corresponding author), Marine Biol Lab, Marine Resources Ctr, Woods Hole, MA 02543 USA.	rhanlon@mbl.edu	Hanlon, Roger T/Q-8687-2016; Havenhand, Jon N/F-5435-2013	Hanlon, Roger T/0000-0003-0004-5674; Havenhand, Jon N/0000-0003-0253-3428; Havenhand, Jonathan/0000-0001-6721-7763				Andersson Malte, 1994; Boal JG, 1996, ANIM BEHAV, V52, P529, DOI 10.1006/anbe.1996.0195; Fu P, 2001, P ROY SOC B-BIOL SCI, V268, P1105, DOI 10.1098/rspb.2001.1625; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hall KC, 2002, MAR BIOL, V140, P533; Naud MJ, 2004, ANIM BEHAV, V67, P1043, DOI 10.1016/j.anbehav.2003.10.005; NAUD MJ, IN PRESS P R SOC L B; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Saetre GP, 1996, AM NAT, V147, P981, DOI 10.1086/285889; SHUSTER SM, 1989, EVOLUTION, V43, P1683, DOI 10.1111/j.1558-5646.1989.tb02618.x	11	79	82	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					212	212		10.1038/433212a	http://dx.doi.org/10.1038/433212a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662403				2022-12-01	WOS:000226381300029
J	Wootton, JT				Wootton, JT			Field parameterization and experimental test of the neutral theory of biodiversity	NATURE			English	Article							CAPITA INTERACTION STRENGTH; COMPETITION; MODELS; COMMUNITIES; IMPACT; SPACE; TIME	Ecologists would like to explain general patterns observed across multi-species communities, such as species-area(1) and abundance-frequency relationships(1-4), in terms of the fundamental processes of birth, death and migration underlying the dynamics of all constituent species. The unified neutral theory of biodiversity(5,6) and related theories(7,8) based on these fundamental population processes have successfully recreated general species-abundance patterns without accounting for either the variation among species and individuals or resource-releasing processes such as predation and disturbance, long emphasized in ecological theory(9-14). If ecological communities can be described adequately without estimating variation in species and their interactions(15), our understanding of ecological community organization and the predicted consequences of reduced biodiversity and environmental change would shift markedly. Here, I introduce a strong method to test the neutral theory that combines field parameterization of the underlying population dynamics with a field experiment, and apply it to a rocky intertidal community. Although the observed abundance-frequency distribution of the system follows that predicted by the neutral theory, the neutral theory predicts poorly the field experimental results, indicating an essential role for variation in species interactions.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344				Adler PB, 2004, ECOLOGY, V85, P1265, DOI 10.1890/03-0602; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Brown J.H., 1995, MACROECOLOGY; CASWELL H, 1976, ECOL MONOGR, V46, P327, DOI 10.2307/1942257; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Drossel B, 2004, J THEOR BIOL, V229, P539, DOI 10.1016/j.jtbi.2004.04.033; Elton C., 1927, ANIMAL ECOLOGY; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gause G.F., 1934, STRUGGLE EXISTENCE; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Hubbell Stephen P., 2001, V32, pi; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kokkoris GD, 1999, ECOL LETT, V2, P70, DOI 10.1046/j.1461-0248.1999.22058.x; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.1890/0012-9658(1998)079[0461:TCAEAT]2.0.CO;2; MacArthur R.H., 1972, pvii; MacArthur R.H., 1969, THEORY ISLAND BIOGEO; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; MOORE JC, 1993, SCIENCE, V261, P906, DOI 10.1126/science.261.5123.906; PAINE RT, 1984, ECOLOGY, V65, P1339, DOI 10.2307/1939114; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; RAFAELLI DG, 1996, FOOD WEBS INTEGRATIO, P185; Wootton JT, 2004, ECOL LETT, V7, P653, DOI 10.1111/j.1461-0248.2004.00621.x; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881	27	110	116	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					309	312		10.1038/nature03211	http://dx.doi.org/10.1038/nature03211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662423				2022-12-01	WOS:000226381300054
J	Flores, G				Flores, G			Preventing hospitalisations for children	LANCET			English	Editorial Material							HOSPITALS; CARE		Med Coll Wisconsin, Ctr Advancement Undersaved Children, Dept Pediat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Ctr Advancement Undersaved Children, Dept Epidemiol, Milwaukee, WI 53226 USA; Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53201 USA	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin	Flores, G (corresponding author), Med Coll Wisconsin, Ctr Advancement Undersaved Children, Dept Pediat, Milwaukee, WI 53226 USA.	gflores@mail.mcw.edu						Billings J, 1989, USE SMALL AREA ANAL; CASANOVA C, 1995, INT J HEALTH SERV, V25, P283, DOI 10.2190/PCF7-ALX9-6CN3-7X9G; Flores G, 2003, PEDIATRICS, V112, P1021, DOI 10.1542/peds.112.5.1021; Johnston Grant, 2004, J Health Serv Res Policy, V9 Suppl 2, P23, DOI 10.1258/1355819042349907; Martinez-Mir I, 1999, BRIT J CLIN PHARMACO, V47, P681, DOI 10.1046/j.1365-2125.1999.00943.x; Miller MR, 2004, PEDIATRICS, V113, P1741, DOI 10.1542/peds.113.6.1741; OWENS P, 2003, AHRQ PUBLICATION; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Rennick JE, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00002	9	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2005	365	9455					201	202						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887MG	15652590				2022-12-01	WOS:000226309600008
J	Bradley, J; Dai, ZR; Erni, R; Browning, N; Graham, G; Weber, P; Smith, J; Hutcheon, I; Ishii, H; Bajt, S; Floss, C; Stadermann, F; Sandfords, S				Bradley, J; Dai, ZR; Erni, R; Browning, N; Graham, G; Weber, P; Smith, J; Hutcheon, I; Ishii, H; Bajt, S; Floss, C; Stadermann, F; Sandfords, S			An astronomical 2175 angstrom feature in interplanetary dust particles	SCIENCE			English	Article							ULTRAVIOLET EXTINCTION CURVES; MOLECULAR-CLOUD MATERIAL; IDENTIFICATION; CONSTRAINTS; GRAINS; SHAPES; CARBON	The 2175 angstrom extinction feature is the strongest (visible-ultraviolet) spectral signature of dust in the interstellar medium. Forty years after its discovery, the origin of the feature and the nature of the carrier(s) remain controversial. Using a transmission electron microscope, we detected a 5.7-electron volt (2175 angstrom) feature in interstellar grains embedded within interplanetary dust particles (IDPs). The carriers are organic carbon and amorphous silicates that are abundant in IDPs and in the interstellar medium. These multiple carriers may explain the enigmatic invariant central wavelength and variable bandwidth of the astronomical 2175 angstrom feature.	Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Bradley, J (corresponding author), Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA.	jbradley@igpp.ucllnl.org	Dai, Zurong/E-6732-2010; Erni, Rolf/P-7435-2014; Bajt, Sasa/O-4695-2019; Bajt, Sasa/G-2228-2010; Weber, Peter Kilian/AAP-9517-2020; 1.4, ALS Beamline/I-1886-2014	Erni, Rolf/0000-0003-2391-5943; Bajt, Sasa/0000-0002-7163-7602; Weber, Peter Kilian/0000-0001-6022-6050; Browning, Nigel/0000-0003-0491-251X; Dai, Zurong/0000-0002-4209-8718; Graham, Gerard/0000-0002-7801-204X; Ishii, Hope/0000-0002-7976-5078				Bernstein MP, 2003, ASTROPHYS J, V582, pL25, DOI 10.1086/345941; Bradley JP, 2005, TREATISE GEOCHEM, V1, P689; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; BRADLEY JP, 2004, LUNAR PLANET SCI, V35; BRION CE, 1982, AM I PHYS C P, V9, P429; BROWNLEE DE, 2000, LUNAR PLANET SCI, V31, P1921; CLEMETT SJ, 1993, SCIENCE, V262, P721, DOI 10.1126/science.262.5134.721; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; Draine B, 1989, INTERSTELLAR DUST, P313; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; FITZPATRICK EL, 1986, ASTROPHYS J, V307, P286, DOI 10.1086/164415; FITZPATRICK EL, 1990, ASTROPHYS J SUPPL S, V72, P163, DOI 10.1086/191413; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; Floss C., 2004, LUNAR PLANET SCI, VXXXV; Flynn GJ, 2004, ADV SPACE RES-SERIES, V33, P57, DOI 10.1016/j.asr.2003.09.036; Henning T, 1998, SCIENCE, V282, P2204, DOI 10.1126/science.282.5397.2204; Henning T., 2004, ASP C SER, V309, P603; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; KELLER LP, 1994, AIP C P, V310, P51; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Sandford SA, 1996, METEORIT PLANET SCI, V31, P449, DOI 10.1111/j.1945-5100.1996.tb02088.x; SANDFORD SA, 1991, ASTROPHYS J, V371, P607, DOI 10.1086/169925; SANDFORD SA, 1989, ICARUS, V82, P146, DOI 10.1016/0019-1035(89)90028-6; STECHER TP, 1969, ASTROPHYS J, V157, pL125, DOI 10.1086/180400; STEEL TM, 1987, ASTROPHYS J, V315, P337, DOI 10.1086/165138	26	61	61	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					244	247		10.1126/science.1106717	http://dx.doi.org/10.1126/science.1106717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653501				2022-12-01	WOS:000226361900039
J	Azevedo, RBR; Lohaus, R; Braun, V; Gumbel, M; Umamaheshwar, M; Agapow, PM; Houthoofd, W; Platzer, U; Borgonie, G; Meinzer, HP; Leroi, AM				Azevedo, RBR; Lohaus, R; Braun, V; Gumbel, M; Umamaheshwar, M; Agapow, PM; Houthoofd, W; Platzer, U; Borgonie, G; Meinzer, HP; Leroi, AM			The simplicity of metazoan cell lineages	NATURE			English	Article							MORPHOLOGICAL COMPLEXITY; EVOLUTION; NEMATODE; FRAMEWORK	Developmental processes are thought to be highly complex, but there have been few attempts to measure and compare such complexity across different groups of organisms(1-5). Here we introduce a measure of biological complexity based on the similarity between developmental and computer programs(6-9). We define the algorithmic complexity of a cell lineage as the length of the shortest description of the lineage based on its constituent sublineages(9-13). We then use this measure to estimate the complexity of the embryonic lineages of four metazoan species from two different phyla. We find that these cell lineages are significantly simpler than would be expected by chance. Furthermore, evolutionary simulations show that the complexity of the embryonic lineages surveyed is near that of the simplest lineages evolvable, assuming strong developmental constraints on the spatial positions of cells and stabilizing selection on cell number. We propose that selection for decreased complexity has played a major role in moulding metazoan cell lineages.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; German Canc Res Ctr, Div Med & Biol Informat, D-69120 Heidelberg, Germany; Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Univ Ghent, Dept Biol, B-9000 Ghent, Belgium	University of Houston System; University of Houston; Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; Ghent University	Azevedo, RBR (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	razevedo@uh.edu	Azevedo, Ricardo/AAV-3963-2021	Azevedo, Ricardo/0000-0001-5402-7071				APTER MJ, 1965, J THEOR BIOL, V8, P244, DOI 10.1016/0022-5193(65)90075-5; Arthur W, 2002, NATURE, V415, P757, DOI 10.1038/415757a; ATLAN H, 1990, B MATH BIOL, V52, P335, DOI 10.1007/BF02458575; Bennett, 1990, COMPLEXITY ENTROPY P, P137; Bonner JT., 1988, EVOLUTION COMPLEXITY; Borgonie G, 2000, NEMATOLOGY, V2, P65, DOI 10.1163/156854100508908; Braun V, 2003, BIOINFORMATICS, V19, P851, DOI 10.1093/bioinformatics/btg087; Brooks D.R., 1988, EVOLUTION ENTROPY UN; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; GEARD N, IN PRESS ARTIF LIFE; GOLDSTEIN B, 1992, NATURE, V357, P255, DOI 10.1038/357255a0; GOODWIN BC, 1993, J THEOR BIOL, V163, P135, DOI 10.1006/jtbi.1993.1112; Houthoofd W, 2003, DEV BIOL, V258, P57, DOI 10.1016/S0012-1606(03)00101-5; Kauffman S.A., 1993, ORIGINS ORDER; McShea DW, 1996, EVOLUTION, V50, P477, DOI 10.1111/j.1558-5646.1996.tb03861.x; Minelli A., 2003, DEV ANIMAL FORM ONTO; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; PAPENTIN F, 1980, J THEOR BIOL, V87, P421, DOI 10.1016/0022-5193(80)90230-1; Raff R. A., 1996, SHAPE LIFE; Richardson MK, 2003, J EXP ZOOL PART B, V296B, P8, DOI 10.1002/jez.b.00013; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; SOMMER RJ, 1994, DEVELOPMENT, P85; Stadler BMR, 2001, J THEOR BIOL, V213, P241, DOI 10.1006/jtbi.2001.2423; STERNBERG PW, 1982, DEV BIOL, V93, P181, DOI 10.1016/0012-1606(82)90251-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Szathmary E, 2001, SCIENCE, V292, P1315, DOI 10.1126/science.1060852; VALENTINE JW, 1994, PALEOBIOLOGY, V20, P131, DOI 10.1017/S0094837300012641; Wagner GP, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P338	30	28	29	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					152	156		10.1038/nature03178	http://dx.doi.org/10.1038/nature03178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650738				2022-12-01	WOS:000226252200036
J	Hopkinson, CS; Vallino, JJ				Hopkinson, CS; Vallino, JJ			Efficient export of carbon to the deep ocean through dissolved organic matter	NATURE			English	Article							PACIFIC SUBTROPICAL GYRE; EASTERN NORTH PACIFIC; TEMPORAL VARIABILITY; SARGASSO SEA; FLUX; RADIOCARBON; PHOSPHORUS; DYNAMICS; NITROGEN; CYCLE	Oceanic dissolved organic carbon (DOC) constitutes one of the largest pools of reduced carbon in the biosphere. Estimated DOC export from the surface ocean represents 20% of total organic carbon flux to the deep ocean(1-3), which constitutes a primary control on atmospheric carbon dioxide levels(4). DOC is the carbon component of dissolved organic matter (DOM) and an accurate quantification of DOM pools, fluxes and their controls is therefore critical to understanding oceanic carbon cycling. DOC export is directly coupled with dissolved organic nitrogen and phosphorus export. However, the C:N:P stoichiometry (by atoms) of DOM dynamics is poorly understood. Here we study the stoichiometry of the DOM pool and of DOM decomposition in continental shelf, continental slope and central ocean gyre environments. We find that DOM is remineralized and produced with a C:N:P stoichiometry of 199:20:1 that is substantially lower than for bulk pools (typically >775:54:1), but greater than for particulate organic matter (106:16:1-the Redfield ratio). Thus for a given mass of new N and P introduced into surface water, more DOC can be exported than would occur at the Redfield ratio. This may contribute to the excess respiration estimated to occur in the interior ocean(5). Our results place an explicit constraint on global carbon export and elemental balance via advective pathways.	Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole	Hopkinson, CS (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.	chopkins@mbl.edu	Vallino, Joseph/J-6177-2015	Vallino, Joseph/0000-0002-4184-4512; hopkinson, charles/0000-0002-7331-8322				Bauer JE, 1998, J GEOPHYS RES-OCEANS, V103, P2867, DOI 10.1029/97JC02545; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; Carlson C. A., 2002, BIOGEOCHEMISTRY MARI, V805, P91, DOI [10.1016/b978-012323841-2/50006-3, DOI 10.1016/B978-012323841-2/50006-3]; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; Church MJ, 2002, LIMNOL OCEANOGR, V47, P1, DOI 10.4319/lo.2002.47.1.0001; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; GARSIDE C, 1982, MAR CHEM, V11, P159, DOI 10.1016/0304-4203(82)90039-1; Hansell D.A., 2002, BIOGEOCHEMISTRY MARI, P685, DOI [10.1016/B978-012323841-2/50017-8, DOI 10.1016/B978-012323841-2/50017-8]; Hopkinson CS, 2002, DEEP-SEA RES PT II, V49, P4461, DOI 10.1016/S0967-0645(02)00125-X; Hopkinson CS, 1997, CONT SHELF RES, V17, P473, DOI 10.1016/S0278-4343(96)00046-5; JACKSON GA, 1985, DEEP-SEA RES, V32, P223, DOI 10.1016/0198-0149(85)90030-5; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; LE B, 1995, MAR CHEM, V51, P17; Loh AN, 2000, DEEP-SEA RES PT I, V47, P2287, DOI 10.1016/S0967-0637(00)00027-3; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Peltzer ET, 1996, DEEP-SEA RES PT II, V43, P1155, DOI 10.1016/0967-0645(95)00014-3; Press WH, 1992, COMPUT PHYS, V6, P274, DOI [10.1063/1.4823074, DOI 10.1063/1.4823074]; Qian JG, 1996, ANAL CHEM, V68, P3090, DOI 10.1021/ac960370z; SARMIENTO JL, 1992, ENVIR SCI R, V43, P317; Six KD, 1996, GLOBAL BIOGEOCHEM CY, V10, P559, DOI 10.1029/96GB02561; Sondergaard M, 2000, LIMNOL OCEANOGR, V45, P1097, DOI 10.4319/lo.2000.45.5.1097; TUPAS L, 1997, 977 SOEST U HAW; WALSH T, 1989, MAR CHEM, V26, P151; WILLIAMS PM, 1980, OCEANOL ACTA, V3, P471; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0	30	191	206	11	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					142	145		10.1038/nature03191	http://dx.doi.org/10.1038/nature03191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650735				2022-12-01	WOS:000226252200033
J	Haines, JL; Hauser, MA; Schmidt, S; Scott, WK; Olson, LM; Gallins, P; Spencer, KL; Kwan, SY; Noureddine, M; Gilbert, JR; Schnetz-Boutaud, N; Agarwal, A; Postel, EA; Pericak-Vance, MA				Haines, JL; Hauser, MA; Schmidt, S; Scott, WK; Olson, LM; Gallins, P; Spencer, KL; Kwan, SY; Noureddine, M; Gilbert, JR; Schnetz-Boutaud, N; Agarwal, A; Postel, EA; Pericak-Vance, MA			Complement factor H variant increases the risk of age-related macular degeneration	SCIENCE			English	Article							C-REACTIVE PROTEIN; SUSCEPTIBILITY LOCI; GENOMEWIDE-SCAN; MACULOPATHY; DISEASE; ASSOCIATION; ACTIVATION; MEMBRANE; PATHWAY; COMMON	Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in the elderly whose etiology remains largely unknown. Previous studies identified chromosome 1q32 as harboring a susceptibility locus for AMD. We used single-nucleotide polymorphisms to interrogate this region and identified a strongly associated haplotype in two independent data sets. DNA resequencing of the complement factor H gene within this haplotype revealed a common coding variant, Y402H, that significantly increases the risk for AMD with odds ratios between 2.45 and 5.57. This common variant likely explains similar to 43% of AMD in older adults.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37232 USA; Duke Univ, Med Ctr, Duke Univ Eye Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA	Duke University; Duke University; Vanderbilt University; Vanderbilt University; Duke University; Duke University	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, DUMC Box 3445,595 LaSalle St, Durham, NC 27710 USA.	mpv@chg.duhs.duke.edu	Mohammed, Imran/J-8271-2012; Scott, William/A-7593-2009; Haines, Jonathan/C-3374-2012	Mohammed, Imran/0000-0002-8412-0768; Haines, Jonathan/0000-0002-4351-4728; Scott, William/0000-0001-9336-6404	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R03EY015216, U10EY012118, R01EY012118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG011268] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00095] Funding Source: Medline; NEI NIH HHS [EY12118, EY015216] Funding Source: Medline; NIA NIH HHS [AG11268] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; CDC (Cent. Dis. Control Prev.), 2004, MMWR-MORBID MORTAL W, V53, P1069; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; GURNE DH, 1991, OPHTHALMOLOGY, V98, P602; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; MOLD C, 1984, J IMMUNOL, V133, P882; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Oksjoki R, 2003, ARTERIOSCL THROM VAS, V23, P630, DOI 10.1161/01.ATV.0000057808.91263.A4; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476	22	1862	2016	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					419	421		10.1126/science.1110359	http://dx.doi.org/10.1126/science.1110359			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761120				2022-12-01	WOS:000228492000055
J	Sharrock, NE; Finerty, E				Sharrock, NE; Finerty, E			Hip replacement, hip seeding, and epidural anaesthesia	LANCET			English	Editorial Material							BLADDER MANAGEMENT; ARTHROPLASTY; MORTALITY		Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA; Hosp Special Surg, Dept Nursing, Infect Control & Occupat Hlth Serv, New York, NY 10021 USA		Sharrock, NE (corresponding author), Hosp Special Surg, Dept Anesthesiol, 535 E 70th St, New York, NY 10021 USA.	sharrockn@hss.edu						Gedney JA, 1998, ANAESTHESIA, V53, P1148, DOI 10.1046/j.1365-2044.1998.00636.x; Knight RM, 1996, J ARTHROPLASTY, V11, P882, DOI 10.1016/S0883-5403(96)80127-6; Macdowell AD, 2004, J BONE JOINT SURG BR, V86B, P1115, DOI 10.1302/0301-620X.86B8.14240; MICHELSON JD, 1988, NEW ENGL J MED, V319, P321; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Salvati EA, 2000, J BONE JOINT SURG AM, V82A, P252; SHARROCK NE, 1995, ANESTH ANALG, V80, P242, DOI 10.1097/00000539-199502000-00008; Sharrock NE, 2005, REGION ANESTH PAIN M, V30, P123, DOI 10.1016/j.rapm.2004.12.005; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Williams A, 1995, J ROY SOC MED, V88, pP699; Wong ES., 1981, GUIDELINE PREVENTION; WROBLEWSKI BM, 1980, CLIN ORTHOP RELAT R, P209	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1011	1012						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781083				2022-12-01	WOS:000227731800008
J	Wang, PY; Weng, F; Anderson, RGW				Wang, PY; Weng, F; Anderson, RGW			OSBP is a cholesterol-regrulated scaffolding protein in control of ERK1/2 activation	SCIENCE			English	Article							OXYSTEROL-BINDING-PROTEIN; GOLGI LOCALIZATION; CELLS; PHOSPHORYLATION; EXPRESSION; MOTIF; VAP	Oxysterol-binding protein (OSBP) is the founding member of a family of sterol-binding proteins implicated in vesicle transport, lipid metabolism, and signal transduction. Here, OSBP was found to function as a cholesterol-binding scaffolding protein coordinating the activity of two phosphatases to control the extracellular signal-regulated kinase (ERK) signaling pathway. Cytosolic OSBP formed a similar to440-kilodalton oligomer with a member of the PTPPBS family of tyrosine phosphatases, the serine/threonine phosphatase PP2A, and cholesterol. This oligomer had dual specific phosphatase activity for phosphorylated ERK (pERK). When cell cholesterol was lowered, the oligomer disassembled and the level of pERK rose. The oligomer also disassembled when exposed to oxysterols. Increasing the amount of OSBP oligomer rendered cells resistant to the effects of cholesterol depletion and decreased the basal level of pERK. Thus, cholesterol functions through its interaction with OSBP outside of membranes to regulate the assembly of an oligomeric phosphatase that controls a key signaling pathway in the cell.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Anderson, RGW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	richard.anderson@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 20948] Funding Source: Medline; NIGMS NIH HHS [GM 52016] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ares MPS, 2000, ATHEROSCLEROSIS, V153, P23, DOI 10.1016/S0021-9150(00)00380-4; Augustine KA, 2000, ANAT REC, V258, P221, DOI 10.1002/(SICI)1097-0185(20000301)258:3<221::AID-AR1>3.0.CO;2-W; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mohammadi A, 2001, J LIPID RES, V42, P1062; Munro S, 2003, NATURE, V426, P775, DOI 10.1038/426775a; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yoon JH, 2004, HEPATOLOGY, V39, P732, DOI 10.1002/hep.20125	13	222	236	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1472	1476		10.1126/science.1107710	http://dx.doi.org/10.1126/science.1107710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746430				2022-12-01	WOS:000227503100049
J	Krimigis, SM; Mitchell, DG; Hamilton, DC; Krupp, N; Livi, S; Roelof, EC; Dandouras, J; Armstrong, TP; Mauk, BH; Paranicas, C; Brandt, PC; Bolton, S; Cheng, AF; Choo, T; Gloeckler, G; Hayes, J; Hsieh, KC; Ip, WH; Jaskulek, S; Keath, EP; Kirsch, E; Kusterer, M; Lagg, A; Lanzerotti, LJ; LaVallee, D; Manweiler, J; McEntire, RW; Rasmuss, W; Saur, J; Turner, FS; Williams, DJ; Woch, J				Krimigis, SM; Mitchell, DG; Hamilton, DC; Krupp, N; Livi, S; Roelof, EC; Dandouras, J; Armstrong, TP; Mauk, BH; Paranicas, C; Brandt, PC; Bolton, S; Cheng, AF; Choo, T; Gloeckler, G; Hayes, J; Hsieh, KC; Ip, WH; Jaskulek, S; Keath, EP; Kirsch, E; Kusterer, M; Lagg, A; Lanzerotti, LJ; LaVallee, D; Manweiler, J; McEntire, RW; Rasmuss, W; Saur, J; Turner, FS; Williams, DJ; Woch, J			Dynamics of Saturn's magnetosphere from MIMI during Cassini's orbital insertion	SCIENCE			English	Article							NITROGEN TORI; HOT PLASMA; PARTICLES; INNER; GAS	The Magnetospheric Imaging Instrument (MIMI) onboard the Cassini spacecraft observed the saturnian magnetosphere from January 2004 until Saturn orbit insertion (Sol) on 1 July 2004. The MIMI sensors observed frequent energetic particle activity in interplanetary space for several months before Sol. When the imaging sensor was switched to its energetic neutral atom (ENA) operating mode on 20 February 2004, at similar to10(3) times Saturn's radius R-s (0.43 astronomical units), a weak but persistent signal was observed from the magnetosphere. About 10 days before Sol, the magnetosphere exhibited a day-night asymmetry that varied with an similar to 11-hour periodicity. Once Cassini entered the magnetosphere, in situ measurements showed high concentrations of H+, H-2(+), O+, OH+, and H2O+ and low concentrations of N+. The radial dependence of ion intensity profiles implies neutral gas densities sufficient to produce high loss rates of trapped ions from the middle and inner magnetosphere. ENA imaging has revealed a radiation belt that resides inward of the D ring and is probably the result of double charge exchange between the main radiation belt and the upper layers of Saturn's exosphere.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Max Planck Inst Sonnensyst Forsch, D-37191 Lindau, Germany; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France; Fundamental Technol Inc, Lawrence, KS 66049 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; Natl Cent Univ, Grad Inst Astron, Jhongli City, Peoples R China; Bell Labs, Murray Hill, NJ 07974 USA; New Jersey Inst Technol, Newark, NJ 07102 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University System of Maryland; University of Maryland College Park; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; AT&T; New Jersey Institute of Technology	Krimigis, SM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	tom.krimigis@jhuapl.edu	Mauk, Barry H/E-8420-2017; Brandt, Pontus C/N-1218-2016; Kusterer, Martha/AAE-5505-2021; Krimigis, Stamatios/G-4591-2019; Dandouras, Iannis/V-2709-2017; Saur, Joachim/V-6780-2019; Korpi-Lagg, Andreas/W-8166-2019; Bolton, Scott/M-4392-2019; Paranicas, Christopher/B-1470-2016; Roelof, Edmond/G-6654-2019; Mitchell, Donald G/H-4601-2016	Mauk, Barry H/0000-0001-9789-3797; Brandt, Pontus C/0000-0002-4644-0306; Krimigis, Stamatios/0000-0003-2781-2386; Dandouras, Iannis/0000-0002-7121-1118; Saur, Joachim/0000-0003-1413-1231; Korpi-Lagg, Andreas/0000-0003-1459-7074; Paranicas, Christopher/0000-0002-4391-8255; Roelof, Edmond/0000-0002-2270-0652; Mitchell, Donald G/0000-0003-1960-2119; Kusterer, Martha/0000-0002-7943-1852; bolton, scott/0000-0002-9115-0789; Turner, Franklin/0000-0002-7935-7621; Hamilton, Douglas/0000-0001-6103-8019; Manweiler, Jerry/0000-0002-8800-2128				CHENG AF, 1989, OUTSTANDING PROBLEMS, P253; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; EVIATAR A, 1983, J GEOPHYS RES-SPACE, V88, P833, DOI 10.1029/JA088iA02p00833; FILLIUS W, 1980, SCIENCE, V207, P425, DOI 10.1126/science.207.4429.425; GLOECKLER G, 2001, S-P B ASTROPHYS, P287; IP WH, 1992, ADV SPACE RES-SERIES, V12, P73, DOI 10.1016/0273-1177(92)90379-C; KIRSCH E, 1981, NATURE, V292, P718, DOI 10.1038/292718a0; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; KRIMIGIS SM, 1982, SCIENCE, V215, P571, DOI 10.1126/science.215.4532.571; KRIMIGIS SM, 1981, SCIENCE, V212, P225, DOI 10.1126/science.212.4491.225; KRIMIGIS SM, 1983, J GEOPHYS RES-SPACE, V88, P8871, DOI 10.1029/JA088iA11p08871; KRIMIGIS SM, 2004, 36 DIV PLAN SCI M LO; Mauk BH, 1999, J GEOPHYS RES-SPACE, V104, P22759, DOI 10.1029/1999JA900097; Mitchell DG, 2001, GEOPHYS RES LETT, V28, P1151, DOI 10.1029/2000GL012395; Moritz J., 1972, Zeitschrift fur Geophysik, V38, P701; Richardson JD, 1998, REV GEOPHYS, V36, P501, DOI 10.1029/98RG01691; ROELOF EC, 1985, J GEOPHYS RES-SPACE, V90, P991, DOI 10.1029/JA090iA11p10991; Smith HT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020580; VANALLEN JA, 1980, SCIENCE, V207, P415, DOI 10.1126/science.207.4429.415	20	154	154	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1270	1273		10.1126/science.1105978	http://dx.doi.org/10.1126/science.1105978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731445				2022-12-01	WOS:000227313200047
J	Richardson, CJ; Reiss, P; Hussain, NA; Alwash, AJ; Pool, DJ				Richardson, CJ; Reiss, P; Hussain, NA; Alwash, AJ; Pool, DJ			The restoration potential of the Mesopotamian marshes of Iraq	SCIENCE			English	Article							SELENIUM; ENVIRONMENT; RIVER	Uncontrolled releases of Tigris and Euphrates River waters after the 2003 war have partially restored some former marsh areas in southern Iraq, but restoration is failing in others because of high soil and water salinities. Nearly 20% of the original 15,000-square-kilometer marsh area was reflooded by March 2004, but the extent of marsh restoration is unknown. High-quality water, nonsaline soils, and the densest native vegetation were found in the only remaining natural marsh, the Al-Hawizeh, located on the Iranian border. Although substantially reduced in area and under current threat of an Iranian dike, it has the potential to be a native repopulation center for the region. Rapid reestablishment, high productivity, and reproduction of native flora and fauna in reflooded former marsh areas indicate a high probability for successful restoration, provided the restored wetlands are hydraulically designed to allow sufficient flow of noncontaminated water and flushing of salts through the ecosystem.	Duke Univ, Nicholas Sch Environm & Earth sci, Duke Univ Wetland Ctr, Res Triangle Pk, NC 27709 USA; Dev Alternat, Bethesda, MD 20895 USA; Univ Basra, Coll Sci, Basra, Iraq; Iraq Fdn, Washington, DC 20005 USA; Int Resources Grp, Washington, DC 20036 USA	Duke University; University of Basrah	Richardson, CJ (corresponding author), Duke Univ, Nicholas Sch Environm & Earth sci, Duke Univ Wetland Ctr, Box 80333, Res Triangle Pk, NC 27709 USA.	curtr@duke.edu	Richardson, Curt/P-5905-2019; Richardson, Curtis J/A-8202-2009					Al-Mousawi AHA, 1983, ARAB GULF J SCI RES, V1, P237; ALHILLI MR, 1977, THESIS U CAIRO; BANAT KM, IN PRESS J ARID ENV; BRASINGTON J, 2002, IRAQI MARSHLANDS HUM, P151; Buringh P., 1960, SOILS SOIL CONDITION; DOUABUL AA, 1988, ARCH ENVIRON CON TOX, V17, P405, DOI 10.1007/BF01055178; ELDEMERDASH MA, 1994, VEGETATIO, V112, P141, DOI 10.1007/BF00044688; EVANS MI, 2002, IRAQI MARSHLANDS HUM, P201; Farber E, 2004, GEOCHIM COSMOCHIM AC, V68, P1989, DOI 10.1016/j.gca.2003.09.021; HUSSAIN NA, 1992, AHWAR IRAQ ENV APPRO; *IR FDN, 2003, ED AG INT TECHN ADV; Lemly AD, 1999, HUM ECOL RISK ASSESS, V5, P1139, DOI 10.1080/10807039.1999.10518883; LEMLY AD, 1993, ENVIRON MONIT ASSESS, V28, P83, DOI 10.1007/BF00547213; LEMLY AD, 1985, ECOTOX ENVIRON SAFE, V10, P314; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Maas E. V., 1999, Agricultural drainage., P55; Maltby E, 1994, DRAFT CONSULTIVE B; MAULOOD BK, 1981, HYDROBIOLOGIA, V80, P269, DOI 10.1007/BF00018367; Meyerson L. A., 2000, Wetlands Ecology and Management, V8, P89, DOI 10.1023/A:1008432200133; Nicholson E., 2003, IRAQI MARSHLANDS HUM; PARTOW H, 2001, UNEP PUBLICATION; RICHARDS LA, 1954, AGR HDB USDA, V60; Saeed T, 1999, WATER SCI TECHNOL, V40, P89, DOI 10.2166/wst.1999.0335; Salim S.M., 1962, MARSH DWELLERS EUPHR; Serag MS, 2001, ENVIRONMETRICS, V12, P219, DOI 10.1002/env.458; Thesinger W, 1964, MARSH ARABS; UNEP, 2003, ENV IR UNEP PROGR RE; YOUNG G, 1977, RETURN MARSHES LIFE	28	92	106	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1307	1311		10.1126/science.1105750	http://dx.doi.org/10.1126/science.1105750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731454				2022-12-01	WOS:000227313200058
J	Kuhl, M; Chen, M; Ralph, PJ; Schreiber, U; Larkum, AWD				Kuhl, M; Chen, M; Ralph, PJ; Schreiber, U; Larkum, AWD			A niche for cyanobacteria containing chlorophyll d	NATURE			English	Article							OXYGENIC PHOTOSYNTHETIC PROKARYOTE; ACARYOCHLORIS-MARINA; MAJOR PIGMENT		Univ Copenhagen, Marine Biol Lab, Inst Biol, DK-3000 Helsingor, Denmark; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Technol Sydney, Inst Water & Environm Resource Management, Gore Hill, NSW 2065, Australia; Univ Wurzburg, Julius von Sachs Inst Biowissensch, D-97082 Wurzburg, Germany	University of Copenhagen; University of Sydney; University of Technology Sydney; University of Wurzburg	Kuhl, M (corresponding author), Univ Copenhagen, Marine Biol Lab, Inst Biol, Strandpromenaden 5, DK-3000 Helsingor, Denmark.	mkuhl@bi.ku.dk	Ralph, Peter/L-1527-2019; Ralph, Peter J/C-5029-2009; Kühl, Michael/A-1977-2009	Ralph, Peter/0000-0002-3103-7346; Ralph, Peter J/0000-0002-3103-7346; Kühl, Michael/0000-0002-1792-4790; Chen, Min/0000-0001-8070-3248				Boichenko VA, 2000, PHOTOSYNTH RES, V65, P269, DOI 10.1023/A:1010637631417; Chen M, 2005, MOL BIOL EVOL, V22, P21, DOI 10.1093/molbev/msh250; Kuhl M, 2000, MICROBIAL ECOL, V40, P94; KUHL M, 2002, SYMBIOSIS MECH MODEL, P273; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Miyashita H, 2003, J PHYCOL, V39, P1247, DOI 10.1111/j.0022-3646.2003.03-158.x; Miyashita H, 1997, PLANT CELL PHYSIOL, V38, P274, DOI 10.1093/oxfordjournals.pcp.a029163; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Schiller H, 1997, FEBS LETT, V410, P433, DOI 10.1016/S0014-5793(97)00620-0	10	150	172	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					820	820		10.1038/433820a	http://dx.doi.org/10.1038/433820a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729331	Bronze			2022-12-01	WOS:000227174600031
J	Zerr, DM; Meier, AS; Selke, SS; Frenkel, LM; Huang, M; Wald, A; Rhoads, MP; Nguy, L; Bornemann, R; Morrow, RA; Corey, L				Zerr, DM; Meier, AS; Selke, SS; Frenkel, LM; Huang, M; Wald, A; Rhoads, MP; Nguy, L; Bornemann, R; Morrow, RA; Corey, L			A population-based study of primary human herpesvirus 6 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN HERPESVIRUS-6 INFECTION; CHILDREN; REACTIVATION; DNA	BACKGROUND: Serologic studies indicate that human herpesvirus 6 (HHV-6) infects 90 percent of children by two years of age. Little is known about the acquisition, virologic course, and clinical manifestations of HHV-6 infection. METHODS: We prospectively studied a cohort of 277 children from birth through the first two years of life to define the pattern of acquisition of HHV-6. The children's saliva was tested weekly for HHV-6 DNA with the use of the polymerase chain reaction. Parents maintained a daily log of signs and symptoms of illness in their children. RESULTS: Primary HHV-6 infection occurred in 130 children, with cumulative percentages of 40 percent by the age of 12 months and 77 percent by the age of 24 months. The peak age of acquisition was between 9 and 21 months. The acquisition of HHV-6 was associated with female sex (adjusted hazard ratio, 1.7; 95 percent confidence interval, 1.2 to 2.4) and having older siblings (adjusted hazard ratio, 2.1; 95 percent confidence interval, 1.4 to 2.9). Among 81 children with a well-defined time of acquisition of HHV-6, 93 percent had symptoms, and 38 percent were seen by a physician. None had seizures. As compared with children who had other illnesses, those with primary HHV-6 infection were more likely to have fever (P=0.003), fussiness (P=0.02), diarrhea (P=0.03), rash (P=0.003), and roseola (P=0.002) and were more likely to visit a physician (P=0.003). CONCLUSIONS: The acquisition of HHV-6 in infancy is usually symptomatic and often results in medical evaluation. Roseola occurs in a minority of patients, and febrile seizures are infrequently associated with primary HHV-6 infection. Older siblings appear to serve as a source of HHV-6 transmission.	Childrens Hosp, Seattle, WA 98105 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Zerr, DM (corresponding author), Childrens Hosp, 8G-1,4800 Sand Point Way NE, Seattle, WA 98105 USA.	zerr@u.washington.edu	Wald, Anna/B-6272-2012	Wald, Anna/0000-0003-3486-6438	NIAID NIH HHS [AI-30731, AI001679] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI001679, P01AI030731] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Black JB, 1996, CLIN DIAGN LAB IMMUN, V3, P79, DOI 10.1128/CDLI.3.1.79-83.1996; CHERRY JD, 1998, TXB PEDIAT INFECT DI, V1, P738; DALESSIO J, 1992, J CLIN MICROBIOL, V30, P1005, DOI 10.1128/JCM.30.4.1005-1007.1992; HALL CB, 1994, NEW ENGL J MED, V331, P432, DOI 10.1056/NEJM199408183310703; Ljungman P, 2000, BRIT J HAEMATOL, V111, P774, DOI 10.1046/j.1365-2141.2000.02422.x; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; PRUKSANANONDA P, 1992, NEW ENGL J MED, V326, P1445, DOI 10.1056/NEJM199205283262201; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; YAMAMOTO M, 1990, J CLIN MICROBIOL, V28, P1957, DOI 10.1128/JCM.28.9.1957-1962.1990; Zerr DM, 2000, J CLIN MICROBIOL, V38, P1981, DOI 10.1128/JCM.38.5.1981-1983.2000; Zerr DM, 2002, CLIN INFECT DIS, V34, P309, DOI 10.1086/338044; Zerr DM, 2001, CLIN INFECT DIS, V33, P763, DOI 10.1086/322642	13	283	299	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2005	352	8					768	776		10.1056/NEJMoa042207	http://dx.doi.org/10.1056/NEJMoa042207			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899MC	15728809				2022-12-01	WOS:000227147500006
J	Deahl, M				Deahl, M			Smoke, mirrors, and Gulf War illness	LANCET			English	Editorial Material							MORTALITY; VETERANS		256 City London Field Hosp V, London SE17 3RF, England		Deahl, M (corresponding author), 256 City London Field Hosp V, 71 Braganza St, London SE17 3RF, England.	martindeahl@fsmail.net						Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; DANDEKER C, IN PRESS ARMED FORCE; Davis LE, 2004, NEUROLOGY, V63, P1070, DOI 10.1212/01.WNL.0000138426.88460.CB; Haley RW, 2003, LANCET NEUROL, V2, P272, DOI 10.1016/S1474-4422(03)00376-4; INST. OF MED, 2000, GULF WAR HLTH; IVERSEN A, IN PRESS BR J PSYCHI; Kang HK, 2002, OCCUP ENVIRON MED, V59, P794, DOI 10.1136/oem.59.12.794; Macfarlane GJ, 2000, LANCET, V356, P17, DOI 10.1016/S0140-6736(00)02428-4; *RES ADV COMM GULF, 2004, 2004 REP REC; SHANE S, 2004, NY TIMES        1116, P6; TURNER MA, IN PRESS BR J PSYCHI; 2004, TIMES LOND      1207, P18	12	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2005	365	9460					635	638						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15721458				2022-12-01	WOS:000227096800006
J	Melyan, Z; Tarttelin, EE; Bellingham, J; Lucas, RJ; Hankins, MW				Melyan, Z; Tarttelin, EE; Bellingham, J; Lucas, RJ; Hankins, MW			Addition of human melanopsin renders mammalian cells photoresponsive	NATURE			English	Article							RETINAL GANGLION-CELLS; ACTION SPECTRUM; LIGHT; OPSIN; RESPONSES; PIGMENT; SYSTEM; SUPPRESSION; PROTEINS; EXPOSURE	A small number of mammalian retinal ganglion cells act as photoreceptors for regulating certain non-image forming photoresponses(1-10). These intrinsically photosensitive retinal ganglion cells express the putative photopigment melanopsin(11-13). Ablation of the melanopsin gene renders these cells insensitive to light(14); however, the precise role of melanopsin in supporting cellular photosensitivity is unconfirmed. Here we show that heterologous expression of human melanopsin in a mouse paraneuronal cell line (Neuro-2a) is sufficient to render these cells photoreceptive. Under such conditions, melanopsin acts as a sensory photopigment, coupled to a native ion channel via a G-protein signalling cascade, to drive physiological light detection. The melanopsin photoresponse relies on the presence of cis-isoforms of retinaldehyde and is selectively sensitive to short-wavelength light. We also present evidence to show that melanopsin functions as a bistable pigment in this system, having an intrinsic photoisomerase regeneration function that is chromatically shifted to longer wavelengths.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Psychol Med, Dept Visual Neurosci, London W6 8RF, England	University of Manchester; Imperial College London	Lucas, RJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	robert.lucas@manchester.ac.uk; m.hankins@imperial.ac.uk	谭, 德华 德/D-1910-2009; Bellingham, James/GVS-8955-2022	Bellingham, James/0000-0003-3368-5221; Lucas, Robert/0000-0002-1088-8029				ASANO T, 1986, MOL PHARMACOL, V29, P244; Beindl W, 1996, MOL PHARMACOL, V50, P415; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Leszkiewicz DN, 2000, J PHYSIOL-LONDON, V524, P365, DOI 10.1111/j.1469-7793.2000.t01-1-00365.x; LIU RSH, 1986, BIOCHEMISTRY-US, V25, P7026, DOI 10.1021/bi00370a040; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	31	303	351	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					741	745		10.1038/nature03344	http://dx.doi.org/10.1038/nature03344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15674244				2022-12-01	WOS:000227039200039
J	Fonarow, GC; Adams, KF; Abraham, WT; Yancy, CW; Boscardin, WJ				Fonarow, GC; Adams, KF; Abraham, WT; Yancy, CW; Boscardin, WJ		ADHERE Sci Advisory Comm Study Grp	Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; WORSENING RENAL-FUNCTION; NATRIURETIC PEPTIDE; EJECTION FRACTION; OLDER PATIENTS; TRIAL; SCORE; PROGNOSIS; SURVIVAL; PREDICTORS	Context Estimation of mortality risk in patients hospitalized with acute decompensated heart failure (ADHF) may help clinicians guide care. Objective To develop a practical user-friendly bedside tool for risk stratification for patients hospitalized with ADHF. Design, Setting, and Patients The Acute Decompensated Heart Failure National Registry (ADHERE) of patients hospitalized with a primary diagnosis of ADHF in 263 hospitals in the United States was queried with analysis of patient data to develop a risk stratification model. The first 33 046 hospitalizations (derivation cohort; October 2001-February 2003) were analyzed to develop the model and then the validity of the model was prospectively tested using data from 32 229 subsequent hospitalizations (validation cohort; March-July 2003). Patients had a mean age of 72.5 years and 52% were female. Main Outcome Measure Variables predicting mortality in ADHF. Results When the derivation and validation cohorts are combined, 37 772 (58%) of 65 275 patient-records had coronary artery disease. Of a combined cohort consisting of 52 164 patient-records, 23 910 (46%) had preserved left ventricular systolic function. In-hospital mortality was similar in the derivation (4.2%) and validation (4.0%) cohorts. Recursive partitioning of the derivation cohort for 39 variables indicated that the best single predictor for mortality was high admission levels of blood urea nitrogen (greater than or equal to43 mg/dL [15.35 mmol/L]) followed by low admission systolic blood pressure (<115 mm Hg) and then by high levels of serum creatinine (&GE;2.75 mg/dL [243.1 &mu;mol/L]). A simple risk tree identified patient groups with mortality ranging from 2.1% to 21.9%. The odds ratio for mortality between patients identified as high and low risk was 12.9 (95% confidence interval, 10.4-15.9) and similar results were seen when this risk stratification was applied prospectively to the validation cohort. Conclusions These results suggest that ADHF patients at low, intermediate, and high risk for in-hospital mortality can be easily identified using vital sign and laboratory data obtained on hospital admission. The ADHERE risk tree provides clinicians with a validated, practical bedside tool for mortality risk stratification.	Univ Calif Los Angeles, Div Cardiol, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; Univ N Carolina, Div Cardiol, Chapel Hill, NC USA; Ohio State Univ, Med Ctr, Dept Cardiol, Columbus, OH 43210 USA; Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Div Cardiol, Ahmanson UCLA Cardiomyopathy Ctr, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; *ACC AHA WRIT COMM, ACC AHA KEY DAT EL D; ADAMS KF, IN PRESS AM HEART J; [Anonymous], 2004, HEART DIS STROK STAT; Ansari M, 2003, AM HEART J, V146, P1, DOI 10.1016/S0002-8703(02)94801-5; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Blackledge HM, 2003, HEART, V89, P615, DOI 10.1136/heart.89.6.615; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Bongartz LG, 2004, HYPERTENSION, V43, pE14, DOI 10.1161/01.HYP.0000118521.06245.b8; Breimann L, 1984, CLASSIFICATION REGRE; Califf RM, 2000, CIRCULATION, V101, P2231, DOI 10.1161/01.CIR.101.19.2231; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; COHN JN, 1993, CIRCULATION, V87, P5; Cowie MR, 2003, EUR HEART J, V24, P1710, DOI 10.1016/S0195-668X(03)00476-7; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Ezekowitz JA, 2003, CIRCULATION, V107, P223, DOI 10.1161/01.CIR.0000052622.51963.FC; Felker GM, 2003, AM HEART J, V145, pS18, DOI 10.1067/mhj.2003.150; Felker GM, 2003, AM J CARDIOL, V92, P625, DOI 10.1016/S0002-9149(03)00740-9; Felker GM, 2003, J AM COLL CARDIOL, V41, P997, DOI 10.1016/S0735-1097(02)02968-6; Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 7, pS21; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; GARBE C, 1995, CANCER-AM CANCER SOC, V75, P2484, DOI 10.1002/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U; Gerald LB, 2002, AM J RESP CRIT CARE, V166, P1122, DOI 10.1164/rccm.200202-124OC; Havranek EP, 2002, AM HEART J, V143, P412, DOI 10.1067/mhj.2002.120773; HUNT SA, GUIDELINES EVALUATIO; Ishii J, 2003, CLIN CHEM, V49, P2020, DOI 10.1373/clinchem.2003.021311; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7; Kerzner R, 2003, AM HEART J, V146, P286, DOI 10.1016/S0002-8703(03)00151-0; Kosiborod M, 2003, AM J MED, V114, P112, DOI 10.1016/S0002-9343(02)01498-5; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; Krumholz HM, 2001, J AM COLL CARDIOL, V38, P453, DOI 10.1016/S0735-1097(01)01395-X; Kvasnicka HM, 2001, J CLIN ONCOL, V19, P2994, DOI 10.1200/JCO.2001.19.12.2994; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lehmann G, 2003, INT J CARDIOL, V89, P79, DOI 10.1016/S0167-5273(02)00408-4; Lewis RJ., INTRO CLASSIFICATION; Luthi J C, 2000, Eff Clin Pract, V3, P69; Morrow DA, 2001, LANCET, V358, P1571, DOI 10.1016/S0140-6736(01)06649-1; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7; Philbin EF, 1999, J AM COLL CARDIOL, V33, P1560, DOI 10.1016/S0735-1097(99)00059-5; Smith GL, 2003, J CARD FAIL, V9, P13, DOI 10.1054/jcaf.2003.3; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Teo K, 1996, ARCH INTERN MED, V156, P1669, DOI 10.1001/archinte.156.15.1669; Yohannes Y, CLASSIFICATION REGRE; Zugck C, 2001, EUR J HEART FAIL, V3, P577, DOI 10.1016/S1388-9842(01)00167-2	46	1124	1197	0	38	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2005	293	5					572	580		10.1001/jama.293.5.572	http://dx.doi.org/10.1001/jama.293.5.572			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893BL	15687312	Bronze			2022-12-01	WOS:000226694200020
J	Kim, YK; Furic, L; DesGroseillers, L; Maquat, LE				Kim, YK; Furic, L; DesGroseillers, L; Maquat, LE			Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay	CELL			English	Article							EXON JUNCTION COMPLEX; NONSENSE-MEDIATED DECAY; ROUGH ENDOPLASMIC-RETICULUM; BINDING PROTEIN STAUFEN; HUMAN TELOMERASE RNA; RAT-BRAIN; HIPPOCAMPAL-NEURONS; TERMINATION-CODON; LOCALIZATION; DROSOPHILA	Mammalian Staufen (Stau)1 is an RNA binding protein that is thought to function in mRNA transport and translational control. Nonsense-mediated mRNA decay(NMD) degrades abnormal and natural mRNAs that terminate translation sufficiently upstream of a splicing-generated exon-exon junction. Here we describe an mRNA decay mechanism that involves Stau1, the NMD factor Upf1, and a termination codon. Unlike NMD, this mechanism does not involve pre-mRNA splicing and occurs when Upf2 or Upf3X is downregulated. Stau1 binds directly to Upf1 and elicits mRNA decay when tethered downstream of a termination codon. Stau1 also interacts with the 3'-untranslated region of ADP-ribosylation factor (Arf)1 mRNA. Accordingly, downregulating either Stau1 or Upf1 increases Arf1 mRNA stability. These findings suggest that Arf1 mRNA is a natural target for Stau1-mediated decay, and data indicate that other mRNAs are also natural targets. We discuss this pathway as a means for cells to downregulate the expression of Stau1 binding transcripts.	Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA; Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	University of Rochester; Universite de Montreal	Maquat, LE (corresponding author), Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu	Furic, Luc/F-4886-2012	Furic, Luc/0000-0002-1893-9812; Maquat, Lynne/0000-0002-2789-2075; Kim, Yoon Ki/0000-0003-1303-072X				Bachand F, 2001, NUCLEIC ACIDS RES, V29, P3385, DOI 10.1093/nar/29.16.3385; Belanger G, 2003, J NEUROCHEM, V86, P669, DOI 10.1046/j.1471-4159.2003.01883.x; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Grentzmann G, 1998, RNA, V4, P479; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; IWAHANA H, 1995, BBA-GENE STRUCT EXPR, V1261, P369, DOI 10.1016/0167-4781(95)00036-G; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kielkopf CL, 2002, BIOCHEMISTRY-US, V41, P11711, DOI 10.1021/bi020393+; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Le SY, 2000, MOL BIOL CELL, V11, P999, DOI 10.1091/mbc.11.3.999; LEE CM, 1992, J BIOL CHEM, V267, P9028; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Luo M, 2002, BIOCHEM J, V365, P817, DOI 10.1042/BJ20020263; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Macchi P, 2003, J NEUROSCI, V23, P5778; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Maquat LE, 2004, CURR GENOMICS, V5, P175, DOI 10.2174/1389202043349453; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Matsuzaki F, 1998, DEVELOPMENT, V125, P4089; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mohr SE, 2001, GENE DEV, V15, P2886; Monshausen M, 2002, J NEUROCHEM, V81, P557, DOI 10.1046/j.1471-4159.2002.00887.x; Monshausen M, 2001, J NEUROCHEM, V76, P155, DOI 10.1046/j.1471-4159.2001.00061.x; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Wilusz CJ, 2001, GENE DEV, V15, P2781; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	74	374	389	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					195	208		10.1016/j.cell.2004.11.050	http://dx.doi.org/10.1016/j.cell.2004.11.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680326	Bronze			2022-12-01	WOS:000226740000009
J	Moles, AT; Ackerly, DD; Webb, CO; Tweddle, JC; Dickie, JB; Westoby, M				Moles, AT; Ackerly, DD; Webb, CO; Tweddle, JC; Dickie, JB; Westoby, M			A brief history of seed size	SCIENCE			English	Article							DISPERSAL; PLANTS; ANGIOSPERMS; MASS; DIVERSIFICATION; EVOLUTION; PATTERNS; TESTS	Improved phylogenies and the accumulation of broad comparative data sets have opened the way for phylogenetic analyses to trace trait evolution in major groups of organisms. We arrayed seed mass data for 12,987 species on the seed plant phylogeny and show the history of seed size from the emergence of the angiosperms through to the present day. The largest single contributor to the present-day spread of seed mass was the divergence between angiosperms and gymnosperms, whereas the widest divergence was between Celastraceae and Parnassiaceae. Wide divergences in seed size were more often associated with divergences in growth form than with divergences in dispersal syndrome or latitude. Cross-species studies and evolutionary theory are consistent with this evidence that growth form and seed size evolve in a coordinated manner.	Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Museum Nat Hist, London SW7 5BD, England; Royal Bot Gardens, Ardingly RH17 6TN, W Sussex, England	National Center for Ecological Analysis & Synthesis; Macquarie University; Stanford University; Yale University; Natural History Museum London; Royal Botanic Gardens, Kew	Moles, AT (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	amotes@bio.mq.edu.au	Moles, Angela T/C-3083-2008; Ackerly, David/A-1247-2009; Webb, Campbell/B-1488-2009	Moles, Angela T/0000-0003-2041-7762; Ackerly, David/0000-0002-1847-7398; Westoby, Mark/0000-0001-7690-4530; Webb, Campbell/0000-0003-1031-3249				Aarssen LW, 2001, ECOSCIENCE, V8, P471, DOI 10.1080/11956860.2001.11682677; Ackerly DD, 2004, EVOL ECOL, V18, P249, DOI 10.1023/B:EVEC.0000035031.50566.60; AXELROD DI, 1959, SCIENCE, V130, P203, DOI 10.1126/science.130.3369.203; Burleigh JG, 2004, AM J BOT, V91, P1599, DOI 10.3732/ajb.91.10.1599; Campbell, 2002, PLANT SYSTEMATICS PH; Charnov Eric L., 1993, P1; CRANE PR, 1989, SCIENCE, V246, P675, DOI 10.1126/science.246.4930.675; Donoghue MJ, 2000, CURR BIOL, V10, pR106, DOI 10.1016/S0960-9822(00)00304-3; Eriksson O, 2000, AM NAT, V156, P47, DOI 10.1086/303367; FOSTER SA, 1985, ECOLOGY, V66, P773, DOI 10.2307/1940538; HAIG D, 1991, EVOL ECOL, V5, P231, DOI 10.1007/BF02214230; HAMMOND DS, 1995, ECOLOGY, V76, P2544, DOI 10.2307/2265827; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; LEISHMAN MR, 1994, AM NAT, V143, P890, DOI 10.1086/285638; LEVIN DA, 1974, AM NAT, V108, P193, DOI 10.1086/282899; Lord J, 1997, J BIOGEOGR, V24, P205, DOI 10.1046/j.1365-2699.1997.00126.x; METCALFE DJ, 1995, CAN J BOT, V73, P817, DOI 10.1139/b95-090; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; MOLES AT, UNPUB; Raven JA, 1999, FUNCT ECOL, V13, P5, DOI 10.1046/j.1365-2435.1999.00293.x; SALISBURY E, 1974, PROC R SOC SER B-BIO, V186, P83, DOI 10.1098/rspb.1974.0039; Schmidt M, 2002, J MOL EVOL, V54, P715, DOI 10.1007/s00239-001-0042-9; Soltis DE, 2002, AM J BOT, V89, P1670, DOI 10.3732/ajb.89.10.1670; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; TIFFNEY BH, 1984, ANN MO BOT GARD, V71, P551, DOI 10.2307/2399037; Tiffney BH, 2004, ANNU REV ECOL EVOL S, V35, P1, DOI 10.1146/annurev.ecolsys.34.011802.132535; Wardle P., 1991, VEGETATION NZ; WEBB CO, IN PRESS MOL ECOL NO; WEBB CO, 2004, PHYLOCOM; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379	33	400	458	4	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					576	580		10.1126/science.1104863	http://dx.doi.org/10.1126/science.1104863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681384				2022-12-01	WOS:000226694000046
J	Eustace, K				Eustace, K			Colorectal cancer	LANCET			English	Article																			0	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 14	2005	365	9454					166	166		10.1016/S0140-6736(05)17707-1	http://dx.doi.org/10.1016/S0140-6736(05)17707-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639299				2022-12-01	WOS:000226170700032
J	Ikeda, M				Ikeda, M			Family bias by proxy	LANCET			English	Editorial Material									Pharmaceut & Med Devices Agcy, Chiyoda Ku, Tokyo 1000013, Japan		Ikeda, M (corresponding author), Pharmaceut & Med Devices Agcy, Chiyoda Ku, Tokyo 1000013, Japan.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 14	2005	365	9454					187	187		10.1016/S0140-6736(05)17710-1	http://dx.doi.org/10.1016/S0140-6736(05)17710-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639302				2022-12-01	WOS:000226170700035
J	Wang, GX; Poo, MM				Wang, GX; Poo, MM			Requirement of TRPC channels in netrin-1-induced chemotropic turning of nerve growth cones	NATURE			English	Article							CATION CHANNEL; CA2+ CHANNELS; CALCIUM; XENOPUS; BRAIN; CELLS; MODULATION; ACTIVATION; GUIDANCE; CURRENTS	Ion channels formed by the TRP ( transient receptor potential) superfamily of proteins act as sensors for temperature, osmolarity, mechanical stress and taste(1,2). The growth cones of developing axons are responsible for sensing extracellular guidance factors, many of which trigger Ca2+ influx at the growth cone(3,4); however, the identity of the ion channels involved remains to be clarified. Here, we report that TRP-like channel activity exists in the growth cones of cultured Xenopus neurons and can be modulated by exposure to netrin-1 and brain-derived neurotrophic factor, two chemoattractants for axon guidance. Whole-cell recording from growth cones showed that netrin-1 induced a membrane depolarization, part of which remained after all major voltage-dependent channels were blocked. Furthermore, the membrane depolarization was sensitive to blockers of TRP channels. Pharmacological blockade of putative TRP currents or downregulation of Xenopus TRP-1 (xTRPC1) expression with a specific morpholino oligonucleotide abolished the growth-cone turning and Ca2+ elevation induced by a netrin-1 gradient. Thus, TRPC currents reflect early events in the growth cone's detection of some extracellular guidance signals, resulting in membrane depolarization and cytoplasmic Ca2+ elevation that mediates the turning of growth cones.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu		Wang, Gordon/0000-0002-2707-7118				Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; GU X, 1993, J NEUROSCI, V13, P4936; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; SCHWARZ G, 1994, CELL CALCIUM, V15, P45, DOI 10.1016/0143-4160(94)90103-1; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	29	251	261	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					898	904		10.1038/nature03478	http://dx.doi.org/10.1038/nature03478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15758951				2022-12-01	WOS:000228327600041
J	Coyne, MJ; Reinap, B; Lee, MM; Comstock, LE				Coyne, MJ; Reinap, B; Lee, MM; Comstock, LE			Human symbionts use a host-like pathway for surface fucosylation	SCIENCE			English	Article							CAPSULAR POLYSACCHARIDES; EPITHELIAL-CELLS; SIALIC-ACID; BLOOD-GROUP; FUCOSE; COMMENSAL; BIOSYNTHESIS; ARABIDOPSIS; INTESTINE; ECOSYSTEM	The mammalian intestine harbors a beneficial microbiota numbering approximately 10(12) organisms per gram of colonic content. The host tolerates this tremendous bacterial. load while maintaining the ability to efficiently respond to pathogenic organisms. In this study, we show that the Bacteroides use a mammalian-like pathway to decorate numerous surface capsular polysaccharides and glycoproteins with L-fucose, an abundant surface molecule of intestinal epithelial cells, resulting in the coordinated expression of this surface molecule by host and symbiont. A Bacteroides mutant deficient in the ability to cover its surface with L-fucose is defective in colonizing the mammalian intestine under competitive conditions.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA.	lcomstock@channing.harvard.edu			NIAID NIH HHS [AI53694, R01 AI053694-03, R01 AI053694, AI44193, R01 AI044193, R01 AI044193-07] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044193, R01AI053694, R56AI044193] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrianopoulos K, 1998, J BACTERIOL, V180, P998, DOI 10.1128/JB.180.4.998-1001.1998; BAUMANN H, 1992, BIOCHEMISTRY-US, V31, P4081, DOI 10.1021/bi00131a026; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BERG RD, 1975, INFECT IMMUN, V11, P320, DOI 10.1128/IAI.11.2.320-329.1975; BJORK S, 1987, J BIOL CHEM, V262, P6758; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Coyne MJ, 2000, INFECT IMMUN, V68, P6176, DOI 10.1128/IAI.68.11.6176-6181.2000; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; FINNE J, 1989, J BIOL CHEM, V264, P5720; FOO MC, 1974, INFECT IMMUN, V9, P1066, DOI 10.1128/IAI.9.6.1066-1069.1974; Freshour G, 2003, PLANT PHYSIOL, V131, P1602, DOI 10.1104/pp.102.016444; Gaskins H. R., 1997, GASTROINTESTINAL MIC, V2, P537, DOI [10.1007/978-1-4757-0322-1_14, DOI 10.1007/978-1-4757-0322-1_14]; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9	17	203	227	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1778	1781		10.1126/science.1106469	http://dx.doi.org/10.1126/science.1106469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774760				2022-12-01	WOS:000227883900046
J	Olshansky, SJ; Passaro, DJ; Hershow, RC; Layden, J; Carnes, BA; Brody, J; Hayflick, L; Butler, RN; Allison, DB; Ludwig, DS				Olshansky, SJ; Passaro, DJ; Hershow, RC; Layden, J; Carnes, BA; Brody, J; Hayflick, L; Butler, RN; Allison, DB; Ludwig, DS			A potential decline in life expectancy in the United States in the 21st century	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; BODY-MASS INDEX; YOUNG ADULTHOOD; HUMAN LONGEVITY; US ADULTS; FOLLOW-UP; OBESITY; MORTALITY; OVERWEIGHT; DISEASE	Forecasts of life expectancy are an important component of public policy that influence age-based entitlement programs such as Social Security and Medicare. Although the Social Security Administration recently raised its estimates of how long Americans are going to live in the 21st century, current trends in obesity in the United States suggest that these estimates may not be accurate. From our analysis of the effect of obesity on longevity, we conclude that the steady rise in life expectancy during the past two centuries may soon come to an end.	Univ Illinois, Chicago, IL 60612 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Int Longev Ctr, New York, NY USA; Univ Alabama Birmingham, Birmingham, AL USA; Childrens Hosp, Boston, MA 02115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Harvard University; Boston Children's Hospital	Olshansky, SJ (corresponding author), Univ Illinois, 1603 W Taylor St,Rm 885, Chicago, IL 60612 USA.	sjayo@uic.edu	Hayflick, Leonard/AAW-2460-2020	Allison, David/0000-0003-3566-9399; Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG000785] Funding Source: NIH RePORTER; NIA NIH HHS [K02 AG00785-05, AG00979-05] Funding Source: Medline; NIDDK NIH HHS [1R01DK59240] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; ANDERSON RN, 1999, DHHS PUBLICATION; ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; ARIAS E, 2000, DHHS PUBLICATION; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; BAYO F, 1974, 72 SOC SEC ADM; BAYO F, 1966, 62 SOC SEC ADM; BELL FC, 2002, 116 SOC SEC ADM; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Centers for Disease Control and Prevention, 1999, JAMA-J AM MED ASSOC, V282, P724, DOI DOI 10.1001/JAMA.282.8.724; CHENG AW, 2004, SSA PUBLICATION; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P2743, DOI 10.1001/jama.292.22.2743; De Grey ADNJ, 2002, ANN NY ACAD SCI, V959, P452, DOI 10.1111/j.1749-6632.2002.tb02115.x; Dean H, 2002, DIABETES, V51, pA24; *DEP EC SOC AFF, 2004, STESASERA236 DEP EC; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; *EC SOC AFF POP DI, 2004, STESASERA229 POP DIV; FABER JF, 1982, SSA PUBLICATION; FABER JF, 1981, SSA PUBLICATION; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Koplan J.P., 2005, PREVENTING CHILDHOOD; Lakdawalla DN, 2004, HEALTH AFFAIR, V23, P168, DOI 10.1377/hlthaff.23.1.168; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; MacDonell WR, 1913, BIOMETRIKA, V9, P366, DOI 10.1093/biomet/9.3-4.366; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; McDonald LC, 1997, EMERG INFECT DIS, V3, P311, DOI 10.3201/eid0303.970307; McNeill W.H., 1976, PLAGUES PEOPLES; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; MYERS RJ, 1952, 33 SOC SEC ADM; NHLBI Obesity Education Initiative, 2000, NIH PUBL; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Olshansky S.J., 1996, HLTH MORTALITY ELDER, P39; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Olshansky SJ, 1997, POPUL BULL, V52, P2; Olshansky SJ, 2001, SCIENCE, V291, P1491, DOI 10.1126/science.291.5508.1491; Osmon S, 2003, CHEST, V124, P1021, DOI 10.1378/chest.124.3.1021; Peeters A, 2003, JAMA-J AM MED ASSOC, V289, P2941, DOI 10.1001/jama.289.22.2941-a; Pietrobelli A, 2002, J ENDOCRINOL INVEST, V25, P884, DOI 10.1007/BF03344052; *PRES COUNC BIOETH, 2004, THER BIOT PURS HAPP; *SOC SEC ADM, 2003 OASDI TRUST REP; *SOC SEC ADM, 1995, ANN REP BOARD TRUST; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; *TECHN PAN ASS MET, 2003, 2003 REP SOC SEC ADV; Todoriki H., 2004, OKINAWAN J AM STUDIE, V1, P55; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; *U AL SCH PUBL HLT, RES TABL; UTTLEY AHC, 1988, LANCET, V1, P57; WADE A, 1986, SSA PUBLICATION; WADE JF, 1984, SSA PUBLICATION; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; World Health Organization (WHO), 1999, INFL PAND PLAN ROL W	65	1726	1767	2	199	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1138	1145		10.1056/NEJMsr043743	http://dx.doi.org/10.1056/NEJMsr043743			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784668				2022-12-01	WOS:000227655000015
J	Fu, Y; Gu, Y; Zheng, ZL; Wasteneys, G; Yang, ZB				Fu, Y; Gu, Y; Zheng, ZL; Wasteneys, G; Yang, ZB			Arabidopsis interdigitating cell growth requires two antagonistic pathways with opposing action on cell morphogenesis	CELL			English	Article							F-ACTIN; MICROTUBULE; SHAPE; POLLEN; PROTEINS; DYNAMICS; GTPASES; ARP2/3; PLANTS; GENE	Coordinating growth and communication between adjacent cells is a critical yet poorly understood aspect of tissue development and organ morphogenesis. We report a Rho GTPase signaling network underlying the jigsaw puzzle appearance of Arabidopsis leaf pavement cells, in which localized outgrowth in one cell is coordinated with localized inhibition of outgrowth of the adjacent cell to form interdigitating lobes and indentations. Locally activated ROP2, a Rho-related GTPase from plants, activates RIC4 to promote the assembly of cortical actin microfilaments required for localized outgrowth. Meanwhile, ROP2 inactivates another target RIC1, whose activity promotes well-ordered cortical microtubules. RIC1-dependent microtubule organization not only locally inhibits outgrowth but in turn suppresses ROP2 activation in the indentation zones. Thus, outgrowth-promoting ROP2 and outgrowth-inhibiting RIC1 pathways antagonize each other. We propose that the counteractivity of these two pathways demarcates outgrowing and indenting cortical domains, coordinating a process that gives rise to interdigitations between adjacent pavement cells.	Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada	University of California System; University of California Riverside; University of California System; University of California Riverside; University of British Columbia	Yang, ZB (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	zhenbiao.yang@ucr.edu	Wasteneys, Geoffrey/AGQ-5388-2022	Wasteneys, Geoffrey/0000-0002-8746-7994; Gu, Ying/0000-0001-8415-4768				Cau J, 2001, J CELL BIOL, V155, P1029, DOI 10.1083/jcb.200104123; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deeks MJ, 2003, CURR OPIN PLANT BIOL, V6, P561, DOI 10.1016/j.pbi.2003.09.013; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank MJ, 2002, CURR BIOL, V12, P849, DOI 10.1016/S0960-9822(02)00819-9; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Le J, 2003, CURR BIOL, V13, P1341, DOI 10.1016/S0960-9822(03)00493-7; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Li H, 1998, PLANT PHYSIOL, V118, P407, DOI 10.1104/pp.118.2.407; Li SD, 2003, PLANT PHYSIOL, V132, P2034, DOI 10.1104/pp.103.028563; Lin YK, 1997, PLANT CELL, V9, P1647, DOI 10.1105/tpc.9.9.1647; Lloyd C, 2001, NAT REV MOL CELL BIO, V2, P40, DOI 10.1038/35048005; Mathur J, 2003, PLANT CELL, V15, P1632, DOI 10.1105/tpc.011676; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Smith LG, 2003, CURR OPIN PLANT BIOL, V6, P63, DOI 10.1016/S1369-5266(02)00012-2; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065	29	401	430	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					687	700		10.1016/j.cell.2004.12.026	http://dx.doi.org/10.1016/j.cell.2004.12.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766531	Bronze			2022-12-01	WOS:000227771400014
J	Kempf, S; Srama, R; Postberg, F; Burton, M; Green, SF; Helfert, S; Hillier, JK; McBride, N; McDonnell, JAM; Moragas-Klostermeyer, G; Roy, M; Grun, E				Kempf, S; Srama, R; Postberg, F; Burton, M; Green, SF; Helfert, S; Hillier, JK; McBride, N; McDonnell, JAM; Moragas-Klostermeyer, G; Roy, M; Grun, E			Composition of saturnian stream particles	SCIENCE			English	Article							DUST; JUPITER	During Cassini's approach to Saturn, the Cosmic Dust Analyser (CDA) discovered streams of tiny (less than 20 nanometers) high-velocity (similar to100 kilometers per second) dust particles escaping from the saturnian system. A fraction of these impactors originated from the outskirts of Saturn's dense A ring. The CDA time-of-flight mass spectrometer recorded 584 mass spectra from the stream particles. The particles consist predominantly of oxygen, silicon, and iron, with some evidence of water ice, ammonium, and perhaps carbon. The stream particles primarily consist, of silicate materials, and this implies that the particles are impurities from the icy ring material rather than the ice particles themselves.	Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Open University - UK; University of Hawaii System	Kempf, S (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.	Sascha.Kempf@mpi-hd.mpg.de	Green, Simon F/C-7408-2009; Postberg, Frank/AAE-6295-2019	Green, Simon F/0000-0002-9153-9786; Postberg, Frank/0000-0002-5862-4276; KEMPF, SASCHA/0000-0001-5236-3004				Ahrens TJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001912; [Anonymous], 1984, SATURN; Auer S, 2001, ASTR AST LI, P385; GUERNSEY C, COMMUNICATION; HAMILTON DP, 1993, NATURE, V364, P695, DOI 10.1038/364695a0; Horanyi M, 2000, PHYS PLASMAS, V7, P3847, DOI 10.1063/1.1288909; HORANYI M, 1993, J GEOPHYS RES-SPACE, V98, P21245, DOI 10.1029/93JA02588; JESSBERGER EK, 1991, ASTROPHYS SPACE SC L, V167, P1075, DOI 10.1017/S0252921100012823; Kempf S, 2005, NATURE, V433, P289, DOI 10.1038/nature03218; KNABE W, 1983, THESIS U HEIDELBERG; MOCKER A, UNPUB; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; STUBIG M, 2002, THESIS U HEIDELBERG; TIMMERMANN T, 1991, ORIGIN EVOLUTION INT, P387	14	67	67	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1274	1276		10.1126/science.1106218	http://dx.doi.org/10.1126/science.1106218			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731446				2022-12-01	WOS:000227313200048
J	Thompson, JR; Pacocha, S; Pharino, C; Klepac-Ceraj, V; Hunt, DE; Benoit, J; Sarma-Rupavtarm, R; Distel, DL; Polz, MF				Thompson, JR; Pacocha, S; Pharino, C; Klepac-Ceraj, V; Hunt, DE; Benoit, J; Sarma-Rupavtarm, R; Distel, DL; Polz, MF			Genotypic diversity within a natural coastal bacterioplankton population	SCIENCE			English	Article							LATERAL GENE-TRANSFER; SULFATE-REDUCING BACTERIA; ESCHERICHIA-COLI; EVOLUTION; SEQUENCE; GENOME; PATHOGENICITY; COMMUNITY; DYNAMICS	The genomic diversity and relative importance of distinct genotypes within natural bacterial populations have remained largely unknown. Here, we analyze the diversity and annual dynamics of a group of coastal bacterioplankton (greater than 99% 16S ribosomal RNA identity to Vibrio splendidus). We show that this group consists of at least a thousand distinct genotypes, each occurring at extremely low environmental concentrations (on average less than one cell per milliliter). Overall, the genomes show extensive allelic diversity and size variation. Individual genotypes rarely recurred in samples, and allelic distribution did not show spatial or temporal substructure. Ecological considerations suggest that much genotypic and possibly phenotypic variation within natural populations should be considered neutral.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; New England Biolabs Inc, Ocean Genome Legacy, Beverly, MA 01915 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mpolz@mit.edu	Polz, Martin/ABE-7199-2020; Thompson, Janelle/AAJ-8225-2020; Preheim, Sarah P/B-3432-2010; Distel, Daniel/A-8047-2017; Hunt, Dana/A-2051-2012	Thompson, Janelle/0000-0003-0445-3720; Preheim, Sarah P/0000-0001-7365-2382; Distel, Daniel/0000-0002-3860-194X; Hunt, Dana/0000-0002-8801-9624; /0000-0001-9296-3733; Klepac-Ceraj, Vanja/0000-0001-5387-5706; Polz, Martin/0000-0002-4975-2946				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Berg OG, 2002, MOL BIOL EVOL, V19, P2265, DOI 10.1093/oxfordjournals.molbev.a004050; Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847; Blackburn N, 1999, MAR ECOL PROG SER, V189, P1, DOI 10.3354/meps189001; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; DeLong EF, 2002, CURR OPIN MICROBIOL, V5, P520, DOI 10.1016/S1369-5274(02)00353-3; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; Klepac-Ceraj V, 2004, ENVIRON MICROBIOL, V6, P686, DOI 10.1111/j.1462-2920.2004.00600.x; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Sass H, 1998, ARCH MICROBIOL, V170, P243, DOI 10.1007/s002030050639; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Thompson J. O. F., UNPUB; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	30	289	297	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1311	1313		10.1126/science.1106028	http://dx.doi.org/10.1126/science.1106028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731455	Green Submitted			2022-12-01	WOS:000227313200059
J	Martinez, C; Rietbrock, S; Wise, L; Ashby, D; Chick, J; Moseley, J; Evans, S; Gunnell, D				Martinez, C; Rietbrock, S; Wise, L; Ashby, D; Chick, J; Moseley, J; Evans, S; Gunnell, D			Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study	BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; SUICIDE; PREVENTION; OXFORD	Objective To compare the risk of non-fatal self harm and suicide in patients taking selective serotonin reuptake inhibitors (SSRIs) with that of patients taking tricyclic antidepressants, as well as between different SSRIs and different tricyclic antidepressants. Design Nested case-control study. Setting Primary care in the United Kingdom. Participants 146 095 individuals with a first prescription of an antidepressant for depression. Main outcome measures Suicide and non-fatal self harm. Results 1968 cases of non-fatal self harm and 69 suicides occurred. The overall adjusted odds ratio of non-fatal self harm was 0.99 (95% confidence interval 0.86 to 1.14) and that of suicide 0.57 (0.26 to 1.25) in people prescribed SSRIs compared with those prescribed tricyclic antidepressants. We found little evidence that associations differed over time since starting or stopping treatment. We found some evidence that risks of non-fatal self harm in people prescribed SSRIs compared with those prescribed tricyclic antidepressants differed by age group (interaction P = 0.02). The adjusted odds ratio of non-fatal self harm for people prescribed SSRIs compared with users of tricylic antidepressants for those aged 18 or younger was 1.59 (1.01 to 2.50), but no association was apparent in other age groups. No suicides occur-red in those aged 18 or younger currently or recently prescribed tricyclic antidepressants or SSRIs. Conclusion We found no evidence that the risk of suicide or non-fatal self harm in adults prescribed SSRIs was greater than in those prescribed tricyclic antidepressants. We found some weak evidence of air increased risk of non-fatal self harm for current SSRI use among those aged 18 or younger. However, preferential prescribing of SSRIs to patients at higher risk of suicidal behaviour cannot be ruled out.	Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database Div, London SW8 5NQ, England; Med & Healthcare Prod Regulatory Agcy, Post Licensing Div, London SW8 5NQ, England; Univ London, Queen Mary, Wolfson Inst Prevent Med, London WC1E 7HU, England; Univ Edinburgh, Dept Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland; London Sch Hyg & Trop Med, Med Stat Unit, London, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	The Medicines & Healthcare Products Regulatory Agency; The Medicines & Healthcare Products Regulatory Agency; University of London; Queen Mary University London; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Martinez, C (corresponding author), Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database Div, London SW8 5NQ, England.	carlos.martinez@gprd.de	Gunnell, David/ABE-6653-2020; anand, amit/A-7222-2009	Gunnell, David/0000-0002-0829-6470; Martinez, Carlos/0000-0001-6498-6428; Evans, Stephen/0000-0002-1474-2596				Breslow NE, 1987, STAT METHODS CANC RE, VII; Brock A, 2003, HLTH STAT Q, V20, P7; Buckley NA, 2002, BRIT MED J, V325, P1332, DOI 10.1136/bmj.325.7376.1332; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; Healy D, 2003, PSYCHOTHER PSYCHOSOM, V72, P71, DOI 10.1159/000068691; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005, ICH HARM TRIP GUID C; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Medawar C, 1997, Int J Risk Saf Med, V10, P75, DOI 10.3233/JRS-1997-10203; Medawar C, 2002, INT J RISK SAFETY ME, V15, P161; *NAT STAT ONL, CENS 2001; *NAT STAT ONL, TRENDS SUIC METH ENG, P7; *NAT STAT ONL, TRENDS SUIC METH ENG; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004; Zahl DL, 2004, BRIT J PSYCHIAT, V185, P70, DOI 10.1192/bjp.185.1.70; 2003, CURR PROBL PHARMACOV, V29, P4	21	179	183	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2005	330	7488					389	393		10.1136/bmj.330.7488.389	http://dx.doi.org/10.1136/bmj.330.7488.389			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900NA	15718538	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000227220400017
J	Asher, RJ; Meng, J; Wible, JR; McKenna, MC; Rougier, GW; Dashzeveg, D; Novacek, MJ				Asher, RJ; Meng, J; Wible, JR; McKenna, MC; Rougier, GW; Dashzeveg, D; Novacek, MJ			Stem lagomorpha and the antiquity of Glires	SCIENCE			English	Article							RODENTS; SYSTEMATICS; TIMESCALE; RADIATION; RELATIVES; MAMMALIA; RABBITS	We describe several fossils referable to Gomphos elkema from deposits close to the Paleocene-Eocene boundary at Tsagan Khushu, Mongolia. Gomphos shares a suite of cranioskeletal characters with extant rabbits, hares, and pikas but retains a primitive dentition and jaw compared to its modern relatives. Phylogenetic analysis supports the position of Gomphos as a stem lagomorph and excludes Cretaceous taxa from the crown radiation of placental mammals. Our results support the hypothesis that rodents and lagomorphs radiated during the Cenozoic and diverged from other placental mammals close to the Cretaceous-Tertiary boundary.	Humboldt Univ, Museum Nat, D-10115 Berlin, Germany; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA 15206 USA; Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; Mongolian Acad Sci, Geol Ctr, Ulaanbaatar, Mongolia	Humboldt University of Berlin; American Museum of Natural History (AMNH); University of Wyoming; University of Louisville; Mongolian Academy of Sciences	Asher, RJ (corresponding author), Humboldt Univ, Museum Nat, Invalidenstr 43, D-10115 Berlin, Germany.	robert.asher@museum.hu-berlin.de						Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; Archibald JD, 2001, NATURE, V414, P62, DOI 10.1038/35102048; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; DASHZEVEG D, 1987, P K NED AKAD B PHYS, V90, P133; Douzery EJP, 2003, J MOL EVOL, V57, pS201, DOI 10.1007/s00239-003-0028-x; GOLOBOFF P, NONA VERS 1 9; Hartenberger JL, 1998, CR ACAD SCI II A, V326, P439, DOI 10.1016/S1251-8050(98)80068-2; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; KIELANJAWOROWSK.Z, 1978, PALAEONTOL POL, V37, P32; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lee MSY, 2000, SYST BIOL, V49, P829, DOI 10.1080/106351500750049879; Li C., 1985, EVOLUTIONARY RELATIO, P35; Luckett W.P., 1985, EVOLUTIONARY RELATIO; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; MCKENNA MC, 1994, NAT HIST, V103, P56; McKenna MC, 2001, J VERTEBR PALEONTOL, V21, P565, DOI 10.1671/0272-4634(2001)021[0565:APRORF]2.0.CO;2; McKenna MC, 1997, CLASSIFICATION MAMMA; Meng J, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)425<0001:GEGMFT>2.0.CO;2; Meng J, 2003, B AM MUS NAT HIST, P1; Montgelard C, 2002, MOL PHYLOGENET EVOL, V22, P220, DOI 10.1006/mpev.2001.1056; Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8; NIXON KC, WINCLADA BETA VER 0; Rohlf F.J., 1995, STAT TABLES; SHEVYREVA NS, 1975, B GEORGIAN ACAD SCI, V77, P225; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Swofford DL, 2002, PHYLOGENETIC ANAL US; VANVALEN L, 1964, EVOLUTION, V18, P484, DOI 10.1111/j.1558-5646.1964.tb01624.x; Wible JR, 2004, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2004)281<0001:NDOTSA>2.0.CO;2; Wyss AR, 1996, SYST BIOL, V45, P559, DOI 10.2307/2413531; ZHEGALLO VI, 1976, JT SOV MONG PALEONTO, V3, P269	31	141	156	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1091	1094		10.1126/science.1107808	http://dx.doi.org/10.1126/science.1107808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718468				2022-12-01	WOS:000227197300043
J	Malsam, J; Satoh, A; Pelletier, L; Warren, G				Malsam, J; Satoh, A; Pelletier, L; Warren, G			Goigin tethers define subpopulations of COPI vesicles	SCIENCE			English	Article							GOLGI; TRANSPORT; PROTEIN; ARCHITECTURE; RECRUITMENT; CONTAINS; REVEALS; COMPLEX; P115	Coiled-coil proteins of the golgin family have been implicated in intra-Golgi transport through tethering coat protein complex I (COPI) vesicles. The p115-golgin tether is the best studied, and here we characterize the golgin-84-CASP tether. The vesicles bound by this tether were strikingly different from those bound by the p115-golgin tether in that they lacked members of the p24 family of putative cargo receptors and contained enzymes instead of anterograde cargo. Microinjected golgin-84 or CASP also inhibited Golgi-enzyme transport to the endoplasmic reticulum, further implicating this tether in retrograde transport. These and other golgins may modulate the flow patterns within the Golgi stack.	Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, New Haven, CT 06520 USA	Ludwig Institute for Cancer Research; Yale University	Warren, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, 333 Cedar St, New Haven, CT 06520 USA.	graham.warren@yale.edu	Pelletier, Laurence/F-8858-2013; Satoh, Ayano/B-2423-2011	Satoh, Ayano/0000-0003-3736-1283				Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Malsam J, 1999, FEBS LETT, V462, P267, DOI 10.1016/S0014-5793(99)01543-4; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Nickel W, 2002, J CELL SCI, V115, P3235; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Whyte JRC, 2002, J CELL SCI, V115, P2627	28	150	161	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1095	1098		10.1126/science.1108061	http://dx.doi.org/10.1126/science.1108061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718469				2022-12-01	WOS:000227197300044
J	Broothaerts, W; Mitchell, HJ; Weir, B; Kaines, S; Smith, LMA; Yang, W; Mayer, JE; Roa-Rodriguez, C; Jefferson, RA				Broothaerts, W; Mitchell, HJ; Weir, B; Kaines, S; Smith, LMA; Yang, W; Mayer, JE; Roa-Rodriguez, C; Jefferson, RA			Gene transfer to plants by diverse species of bacteria	NATURE			English	Article							AGROBACTERIUM-TUMEFACIENS C58/; TI-PLASMID; RHIZOBIUM; GENOME; TRANSFORMATION; IDENTIFICATION; ARABIDOPSIS; VIRULENCE; MELILOTI; SEQUENCE	Agrobacterium is widely considered to be the only bacterial genus capable of transferring genes to plants. When suitably modified, Agrobacterium has become the most effective vector for gene transfer in plant biotechnology(1). However, the complexity of the patent landscape(2) has created both real and perceived obstacles to the effective use of this technology for agricultural improvements by many public and private organizations worldwide. Here we show that several species of bacteria outside the Agrobacterium genus can be modified to mediate gene transfer to a number of diverse plants. These plant-associated symbiotic bacteria were made competent for gene transfer by acquisition of both a disarmed Ti plasmid and a suitable binary vector. This alternative to Agrobacterium-mediated technology for crop improvement, in addition to affording a versatile 'open source' platform for plant biotechnology, may lead to new uses of natural bacteria-plant interactions to achieve plant transformation.	Charles Sturt Univ, Affiliated Res Ctr, CAMBIA, Canberra, ACT 2601, Australia	Charles Sturt University	Jefferson, RA (corresponding author), Charles Sturt Univ, Affiliated Res Ctr, CAMBIA, GPO Box 3200, Canberra, ACT 2601, Australia.	r.jefferson@cambia.org	broothaerts, wim/AAF-1287-2020	Jefferson, Richard/0000-0001-5352-4498; broothaerts, wim/0000-0003-3420-6368				Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cottage A, 2001, PLANT MOL BIOL REP, V19, P321, DOI 10.1007/BF02772830; Dennis C, 2004, NATURE, V431, P494, DOI 10.1038/431494a; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Goethals K, 2001, ANNU REV PHYTOPATHOL, V39, P27, DOI 10.1146/annurev.phyto.39.1.27; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; HOOYKAAS PJJ, 1977, J GEN MICROBIOL, V98, P477, DOI 10.1099/00221287-98-2-477; Jefferson R. A., 2003, US Patent, Patent No. [6, 391-547, 6391547]; KLEIN DT, 1953, J BACTERIOL, V66, P220, DOI 10.1128/JB.66.2.220-228.1953; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; LAMBERT B, 1990, APPL ENVIRON MICROB, V56, P1093, DOI 10.1128/AEM.56.4.1093-1102.1990; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Nair GR, 2003, PLANT PHYSIOL, V133, P989, DOI 10.1104/pp.103.030262; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; REIMMANN C, 1993, BACTERIAL CONJUGATIO, P137; ROARODRIGUEZ C, 2003, AGROBACTERIUM MEDIAT; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Suzuki K, 2002, PLANT J, V32, P775, DOI 10.1046/j.1365-313X.2002.01468.x; Svab Zora, 1995, P55; Van Montagu M, 2003, TRENDS PLANT SCI, V8, P353, DOI 10.1016/S1360-1385(03)00160-2; VANVEEN RJM, 1989, ARCH MICROBIOL, V153, P85, DOI 10.1007/BF00277546; Veen R. J. M. van, 1988, Molecular Plant-Microbe Interactions, V1, P231, DOI 10.1094/MPMI-1-231; Watts RA, 2001, P NATL ACAD SCI USA, V98, P10119, DOI 10.1073/pnas.191349198; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Young JM, 2003, INT J SYST EVOL MICR, V53, P1689, DOI 10.1099/ijs.0.02762-0	29	200	290	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					629	633		10.1038/nature03309	http://dx.doi.org/10.1038/nature03309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703747				2022-12-01	WOS:000226862000044
J	Ward, PD; Botha, J; Buick, R; De Kock, MO; Erwin, DH; Garrison, GH; Kirschvink, JL; Smith, R				Ward, PD; Botha, J; Buick, R; De Kock, MO; Erwin, DH; Garrison, GH; Kirschvink, JL; Smith, R			Abrupt and gradual extinction among Late Permian land vertebrates in the Karoo Basin, South Africa	SCIENCE			English	Article							TRIASSIC BOUNDARY; STRATIGRAPHIC RANGES; CONFIDENCE-INTERVALS; MASS EXTINCTION; SUPERGROUP; PATTERNS; MARINE	The Karoo basin of South Africa exposes a succession of Upper Permian. to Lower Triassic terrestrial strata containing abundant terrestrial vertebrate fossils. Paleomagnetic/magnetostratigraphic and carbon-isotope data allow sections to be correlated across the basin. With this stratigraphy, the vertebrate fossil data show a gradual extinction in the Upper Permian punctuated by an enhanced extinction pulse at the Permian-Triassic boundary interval, particularly among the dicynodont therapsids, coinciding with negative carbon-isotope anomalies.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; S African Museum, ZA-8000 Cape Town, South Africa; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Rand Afrikaans Univ, Dept Geol, Johannesburg, South Africa; MRC121 Smithsonian Inst, Dept Paleobiol, Washington, DC 20013 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; California Institute of Technology; University of Johannesburg; Smithsonian Institution; Smithsonian National Museum of Natural History	Ward, PD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	argo@u.washington.edu	Erwin, Douglas H/A-9668-2009; Botha-Brink, Jennifer/N-1893-2013	Botha-Brink, Jennifer/0000-0001-8824-9334; de Kock, Michiel/0000-0002-5036-3438; Erwin, Douglas/0000-0003-2518-5614; Buick, Roger/0000-0003-0139-1659				Arens NC, 2000, PALAIOS, V15, P314, DOI 10.2307/3515539; Basu AR, 2003, SCIENCE, V302, P1388, DOI 10.1126/science.1090852; Becker L, 2004, SCIENCE, V304, P1469, DOI 10.1126/science.1093925; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; BOTHA JM, UNPUB; Catuneanu O, 1998, BASIN RES, V10, P417; Cerling TE, 1992, GLOBAL BIOGEOCHEM CY, V6, P307, DOI 10.1029/92GB01102; CONEY L, 2004, LPSC, V35, P1488; De Kock MO, 2004, GONDWANA RES, V7, P175, DOI 10.1016/S1342-937X(05)70316-6; de Wit MJ, 2002, J GEOL, V110, P227, DOI 10.1086/338411; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; FOSTER C, 2002, 1 INT C PAL, P57; GROENWALD GH, 1995, GEOL SURV S AFR BIOS, V1, P35; HOLSER WT, 1992, GEOCHIM COSMOCHIM AC, V56, P3297, DOI 10.1016/0016-7037(92)90306-4; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; KING DA, 1990, CHEM PHYSICS SOLID A, V3, P1; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; MacLeod KG, 2000, GEOLOGY, V28, P227, DOI 10.1130/0091-7613(2000)28<227:TOMREA>2.0.CO;2; MARSHALL CR, 1994, PALEOBIOLOGY, V20, P459, DOI 10.1017/S0094837300012938; Nawrocki J, 2004, TERRA NOVA, V16, P139, DOI 10.1111/j.1365-3121.2004.00543.x; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Retallack GJ, 2003, GEOL SOC AM BULL, V115, P1133, DOI 10.1130/B25215.1; RUBIDGE B, 1995, GEOL SURV S AFR BIOS, V1; SHEEHAN PM, 1991, SCIENCE, V254, P835, DOI 10.1126/science.11536489; Signor P.W., 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; Solow AR, 2003, PALEOBIOLOGY, V29, P181, DOI 10.1666/0094-8373(2003)029<0181:EOSRWF>2.0.CO;2; SPRINGER MS, 1990, PALEOBIOLOGY, V16, P512, DOI 10.1017/S0094837300010228; STEINER M, 1989, J GEOPHYS RES-SOLID, V94, P7343, DOI 10.1029/JB094iB06p07343; Steiner MB, 2003, PALAEOGEOGR PALAEOCL, V194, P405, DOI 10.1016/S0031-0182(03)00230-X; Szurlies M, 2003, EARTH PLANET SC LETT, V212, P263, DOI 10.1016/S0012-821X(03)00288-7; Twitchett RJ, 2001, GEOLOGY, V29, P351, DOI 10.1130/0091-7613(2001)029<0351:RASCOM>2.0.CO;2; Wang SC, 2004, PALEOBIOLOGY, V30, P5, DOI 10.1666/0094-8373(2004)030<0005:ICIFET>2.0.CO;2; Ward PD, 2000, SCIENCE, V289, P1740, DOI 10.1126/science.289.5485.1740	34	257	282	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					709	714		10.1126/science.1107068	http://dx.doi.org/10.1126/science.1107068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15661973	Green Submitted			2022-12-01	WOS:000226814900039
J	Berndt, ER				Berndt, ER			To inform or persuade? Direct-to-consumer advetising of prescription drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Berndt, ER (corresponding author), MIT, Cambridge, MA 02139 USA.							AIKIN KJ, 2003, DIR TO CONS PROM PUB; *FOOD DRUG ADM, GUID IND BRIEF SUMM; WEISSMAN JS, 2004, PHYSICIANS REPORT PA; 2004, PINK SHEET      122, P16	4	37	37	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2005	352	4					325	328		10.1056/NEJMp048357	http://dx.doi.org/10.1056/NEJMp048357			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890UH	15673797				2022-12-01	WOS:000226535900002
J	Katanaev, VL; Ponzielli, R; Semeriva, M; Tomlinson, A				Katanaev, VL; Ponzielli, R; Semeriva, M; Tomlinson, A			Trimeric G protein-dependent frizzled signaling in Drosophila	CELL			English	Article							PLANAR CELL POLARITY; TISSUE POLARITY; NUCLEOTIDE-BINDING; WINGLESS; GENE; EXPRESSION; PATHWAYS; SUBUNIT; LOCALIZATION; TRANSDUCTION	Frizzled (Fz) proteins are serpentine receptors that transduce critical cellular signals during development. Serpentine receptors usually signal to downstream effectors through an associated trimeric G protein complex. However, clear evidence for the role of trimeric G protein complexes for the Fz family of receptors has hitherto been lacking. Here, we show roles for the Go, subunit (Go) in mediating the two distinct pathways transduced by Fz receptors in Drosophila: the Writ and planar polarity pathways. Go is required for transduction of both pathways, and epistasis experiments suggest that it is an immediate transducer of Fz. While overexpression effects of the wild-type form are receptor dependent, the activated form (Go-GTP) can signal when the receptor is removed. Thus, Go is likely part of a trimeric G protein complex that directly tranduces Fz signals from the membrane to downstream components.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Mediterranee, Lab Genet & Physiol Dev, CNRS, UMR 6545,IBDM,INSERM,Case 907, F-13288 Marseille 09, France	Columbia University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Tomlinson, A (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	at4l@columbia.edu	Katanaev, Vladimir/F-9480-2014	Katanaev, Vladimir/0000-0002-7909-5617	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057043] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; BURTON FH, 1991, NATURE, V350, P74, DOI 10.1038/350074a0; Chen CM, 1999, DEVELOPMENT, V126, P5441; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Ikeda SR, 1999, NEUROSCI LETT, V271, P163, DOI 10.1016/S0304-3940(99)00555-8; INOUE S, 1995, J BIOCHEM-TOKYO, V118, P650, DOI 10.1093/oxfordjournals.jbchem.a124959; Jones KH, 1996, GENETICS, V142, P205; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; PFEIFER M, 1994, DEVELOPMENT, V120, P369; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Strapps WR, 2001, DEVELOPMENT, V128, P4829; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Taylor J, 1998, GENETICS, V150, P199; Tomlinson A, 1997, DEVELOPMENT, V124, P4515; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VARMUS H, 1986, TAK S, V17, P31; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wieschaus E., 1986, P199; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	50	209	216	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					111	122		10.1016/j.cell.2004.11.014	http://dx.doi.org/10.1016/j.cell.2004.11.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652486	Bronze			2022-12-01	WOS:000226365400015
J	Sachs, JD				Sachs, JD			Achieving the millennium development goals - The case of malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BURDEN		Columbia Univ, Earth Inst, New York, NY 10027 USA; UN, Millennium Project, New York, NY USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.							Breman JG, 2004, AM J TROP MED HYG, V71, P1; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Narasimhan V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-8; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a	5	30	32	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2005	352	2					115	117		10.1056/NEJMp048319	http://dx.doi.org/10.1056/NEJMp048319			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886TG	15647571	Green Submitted			2022-12-01	WOS:000226251700001
J	Schanda, H				Schanda, H			Psychiatry reforms and illegal behaviour of the severely mentally ill	LANCET			English	Editorial Material							DISORDERS; DEINSTITUTIONALIZATION; SCHIZOPHRENIA; HOMICIDES; ILLNESS; 25-YEAR; CARE		Justizanstalt Gollersdorf, A-2013 Gollersdorf 17, Austria; Psychiat Univ Clin, Vienna, Austria		Schanda, H (corresponding author), Justizanstalt Gollersdorf, A-2013 Gollersdorf 17, Austria.	hans.schanda@meduniwien.ac.at						Erb Martin, 2001, Crim Behav Ment Health, V11, P6, DOI 10.1002/cbm.366; Eronen M, 1996, ARCH GEN PSYCHIAT, V53, P497; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; GOTTLIEB P, 1987, ACTA PSYCHIAT SCAND, V76, P285, DOI 10.1111/j.1600-0447.1987.tb02897.x; HODGINS S, 1996, ARCH GEN PSYCHIAT, V53, P486; Mullen PE, 2000, LANCET, V355, P614, DOI 10.1016/S0140-6736(99)05082-5; Munk-Jorgensen P, 1999, EUR ARCH PSY CLIN N, V249, P136, DOI 10.1007/s004060050078; Schanda H, 2000, INT J LAW PSYCHIAT, V23, P481, DOI 10.1016/S0160-2527(00)00045-5; Schanda H, 2004, EUR PSYCHIAT, V19, p30S; Schanda H, 2004, ACTA PSYCHIAT SCAND, V110, P98, DOI 10.1111/j.1600-0047.2004.00305.x; Simpson AIF, 2004, BRIT J PSYCHIAT, V185, P394, DOI 10.1192/bjp.185.5.394; Taylor PJ, 1999, BRIT J PSYCHIAT, V174, P9, DOI 10.1192/bjp.174.1.9; TAYLOR PJ, 1997, CRIMINAL BEHAV MENT, V7, P19; Wallace C, 2004, AM J PSYCHIAT, V161, P716, DOI 10.1176/appi.ajp.161.4.716	14	14	14	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					367	369						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891WE	15680440				2022-12-01	WOS:000226610900007
J	Venegas, JG; Winkler, T; Musch, G; Melo, MFV; Layfield, D; Tgavalekos, N; Fischman, AJ; Callahan, RJ; Bellani, G; Harris, RS				Venegas, JG; Winkler, T; Musch, G; Melo, MFV; Layfield, D; Tgavalekos, N; Fischman, AJ; Callahan, RJ; Bellani, G; Harris, RS			Self-organized patchiness in asthma as a prelude to catastrophic shifts	NATURE			English	Article							AIRWAY SMOOTH-MUSCLE; VENTILATION; LUNG; PET; HYPERRESPONSIVENESS; METHACHOLINE; PERFUSION; VOLUME; TREE	Asthma is a common disease affecting an increasing number of children throughout the world. In asthma, pulmonary airways narrow in response to contraction of surrounding smooth muscle. The precise nature of functional changes during an acute asthma attack is unclear. The tree structure of the pulmonary airways has been linked to complex behaviour in sudden airway narrowing(1,2) and avalanche-like reopening(3,4). Here we present experimental evidence that bronchoconstriction leads to patchiness in lung ventilation, as well as a computational model that provides interpretation of the experimental data. Using positron emission tomography, we observe that bronchoconstricted asthmatics develop regions of poorly ventilated lung. Using the computational model we show that, even for uniform smooth muscle activation of a symmetric bronchial tree, the presence of minimal heterogeneity breaks the symmetry and leads to large clusters of poorly ventilated lung units. These clusters are generated by interaction of short- and long-range feedback mechanisms, which lead to catastrophic shifts similar to those linked to self-organized patchiness in nature(5,6). This work might have implications for the treatment of asthma, and might provide a model for studying diseases of other distributed organs.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University	Venegas, JG (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, 55 Fruit St, Boston, MA 02114 USA.	jvenegas@vqpet.mgh.harvard.edu	Melo, Marcos Vidal/AAN-7219-2020; Bellani, Giacomo/D-2379-2010; Melo, Marcos F Vidal/C-3452-2013; Winkler, Tilo/B-5337-2009	Bellani, Giacomo/0000-0002-3089-205X; Winkler, Tilo/0000-0002-7276-5550				Alencar AM, 2002, NATURE, V417, P809, DOI 10.1038/417809b; Altemeier WA, 2000, J APPL PHYSIOL, V88, P1551, DOI 10.1152/jappl.2000.88.5.1551; Anafi RC, 2003, J APPL PHYSIOL, V94, P1003, DOI 10.1152/japplphysiol.00569.2002; Anafi RC, 2001, J APPL PHYSIOL, V91, P1185, DOI 10.1152/jappl.2001.91.3.1185; BATES JH, 1995, COMMENTS THEOR BIOL, V3, P397; Beigelman-Aubry C, 2002, RADIOLOGY, V223, P181, DOI 10.1148/radiol.2231010779; Cox PG, 2004, EUR RESPIR J, V24, P659, DOI 10.1183/09031936.04.00054604; Danek CJ, 2004, J APPL PHYSIOL, V97, P1946, DOI 10.1152/japplphysiol.01282.2003; Fredberg JJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-2; GUNST SJ, 1988, J APPL PHYSIOL, V64, P2522, DOI 10.1152/jappl.1988.64.6.2522; Judd SL, 2000, PHYSICA D, V136, P45, DOI 10.1016/S0167-2789(99)00154-2; Klarreich E, 2003, NATURE, V424, P873, DOI 10.1038/424873a; Latourelle J, 2002, J APPL PHYSIOL, V92, P771, DOI 10.1152/japplphysiol.01090.2000; Laurent F, 2000, EUR RADIOL, V10, P1404, DOI 10.1007/s003300000504; LAUWERIER H, 1991, FRACTALS ENDLESSLY R, P71; Lutchen KR, 2001, AM J RESP CRIT CARE, V164, P207, DOI 10.1164/ajrccm.164.2.2008119; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Melo MFV, 2003, J NUCL MED, V44, P1982; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Smith D, 2003, ANN EMERG MED, V41, P706, DOI 10.1067/mem.2003.144; SMITH JC, 1984, J APPL PHYSIOL, V57, P1422, DOI 10.1152/jappl.1984.57.5.1422; Suki B, 2003, J APPL PHYSIOL, V95, P2122, DOI 10.1152/japplphysiol.00636.2003; SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0; Venegas JG, 2000, J APPL PHYSIOL, V88, P1365, DOI 10.1152/jappl.2000.88.4.1365; Wagers S, 2003, J ALLERGY CLIN IMMUN, V111, P1201, DOI 10.1067/mai.2003.1545; Weibel ER, 1963, MORPHOMETRY HUMAN LU, P115	30	390	402	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					777	782		10.1038/nature03490	http://dx.doi.org/10.1038/nature03490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15772676				2022-12-01	WOS:000228160700044
J	Hao, SZ; Sharp, JW; Ross-Inta, CM; McDaniel, BJ; Anthony, TG; Wek, RC; Cavener, DR; McGrath, BC; Rudell, JB; Koehnle, TJ; Gietzen, DW				Hao, SZ; Sharp, JW; Ross-Inta, CM; McDaniel, BJ; Anthony, TG; Wek, RC; Cavener, DR; McGrath, BC; Rudell, JB; Koehnle, TJ; Gietzen, DW			Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex	SCIENCE			English	Article							EUKARYOTIC INITIATION FACTOR-2-ALPHA; FOOD-INTAKE; PREPYRIFORM CORTEX; PROTEIN-SYNTHESIS; DIETS DEFICIENT; KINASE GCN2; RATS; THREONINE; PHOSPHORYLATION; DEPRIVATION	Recognizing a deficiency of indispensable amino acids (IAAs) for protein synthesis is vital for dietary selection in metazoans, including humans. Celts in the brain's anterior piriform cortex (APC) are sensitive to IAA deficiency, Signaling diet rejection and foraging for complementary IAA sources, but the mechanism is unknown. Here we report that the mechanism for recognizing IAA-deficient foods follows the conserved general control (GC) system, wherein uncharged transfer RNA induces phosphorylation of eukaryotic initiation factor 2 (elF2) via the GC nonderepressing 2 (GCN2) kinase. Thus, a basic mechanism of nutritional stress management functions in mammalian brain to guide food selection for survival.	Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; Indiana Univ Sch Med, Dept Biochem & Mol Biol, Evansville, IN 47712 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	University of California System; University of California Davis; Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gietzen, DW (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	dwgietzen@ucdavis.edu	Cavener, Douglas R/E-3524-2010; Anthony, Tracy/K-7951-2017	Anthony, Tracy/0000-0002-8586-5884	NIGMS NIH HHS [GM49164] Funding Source: Medline; NINDS NIH HHS [NS043231, NS33347] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049164, R01GM049164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033347, R21NS043231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; BEVERLY JL, 1990, AM J PHYSIOL, V259, pR709, DOI 10.1152/ajpregu.1990.259.4.R709; Blevins JE, 2000, BRAIN RES, V879, P65, DOI 10.1016/S0006-8993(00)02734-7; Carpenter KJ, 2003, J NUTR, V133, P638, DOI 10.1093/jn/133.3.638; DELANEY K, 1986, J COMP PHYSIOL A, V159, P281, DOI 10.1007/BF00603975; FIRMAN JD, 1988, BRAIN RES BULL, V21, P637, DOI 10.1016/0361-9230(88)90203-1; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; GIETZEN DW, 1986, PHYSIOL BEHAV, V36, P1071, DOI 10.1016/0031-9384(86)90482-8; GIETZEN DW, 2000, NEURAL METABOLIC CON, pCH23; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Kimball SR, 2001, BIOCHEM BIOPH RES CO, V280, P293, DOI 10.1006/bbrc.2000.4103; KIMBALL SR, 1991, J BIOL CHEM, V266, P1969; Koehnle TJ, 2004, J NUTR, V134, P2365, DOI 10.1093/jn/134.9.2365; Koehnle TJ, 2003, J NUTR, V133, P2331, DOI 10.1093/jn/133.7.2331; LEUNG PMB, 1971, AM J PHYSIOL, V221, P929, DOI 10.1152/ajplegacy.1971.221.3.929; LEUNG PMB, 1972, PHYSIOL BEHAV, V9, P553, DOI 10.1016/0031-9384(72)90011-X; Markison S, 1999, J NUTR, V129, P1604, DOI 10.1093/jn/129.8.1604; Milton K, 2003, J NUTR, V133, p3886S, DOI 10.1093/jn/133.11.3886S; Monda M, 1997, AM J PHYSIOL-REG I, V273, pR554, DOI 10.1152/ajpregu.1997.273.2.R554; MURPHY ME, 1993, PHYSIOL BEHAV, V53, P689, DOI 10.1016/0031-9384(93)90175-F; PANKSEPP J, 1971, NATURE, V233, P341, DOI 10.1038/233341a0; Russell MC, 2003, NUTR NEUROSCI, V6, P247, DOI 10.1080/1028415031000151567; Sharp JW, 2004, NEUROSCIENCE, V126, P1053, DOI 10.1016/j.neuroscience.2004.03.066; Sharp JW, 2002, MOL BRAIN RES, V105, P11, DOI 10.1016/S0169-328X(02)00380-7; Sood R, 2000, GENETICS, V154, P787; WASHBURN BS, 1994, AM J PHYSIOL, V266, pR1922, DOI 10.1152/ajpregu.1994.266.6.R1922; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	29	252	268	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1776	1778		10.1126/science.1104882	http://dx.doi.org/10.1126/science.1104882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774759				2022-12-01	WOS:000227883900045
J	Langevin, Y; Poulet, F; Bibring, JP; Schmitt, B; Doute, S; Gondet, B				Langevin, Y; Poulet, F; Bibring, JP; Schmitt, B; Doute, S; Gondet, B			Summer evolution of the north polar cap of Mars as observed by OMEGA/Mars express	SCIENCE			English	Article							ORBITER CAMERA; WATER ICE; MODEL; SURFACES	The Observatoire pour la Mineralogie, l'Eau, les Gtaces, et l'Activite (OMEGA) visible-infrared imaging spectrometer extensively observed regions of Mars with latitudes above 70degreesN in late 2004 (heliocentric longitude from L-s 93degrees to L-s 127degrees). The extent of water ice at the surface and the size of ice grains were monitored as a function of time. Bright, small-grained frost, which initially covered a large fraction of the polar cap, waned in favor of large-grained ice. In outlying regions, dominated by large-grained ice, the albedo increased over the period. Evaluating the dust content was mode[ dependent. However, contamination of ice by dust was low.	Univ Paris 11, CNRS, Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Grenoble 1, CNRS, Lab Planetol Grenoble, F-38400 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Langevin, Y (corresponding author), Univ Paris 11, CNRS, Inst Astrophys Spatiale, F-91405 Orsay, France.	yves.langevin@ias.u-psud.fr	Schmitt, Bernard/A-1064-2009	Schmitt, Bernard/0000-0002-1230-6627				Bass DS, 2000, ICARUS, V144, P382, DOI 10.1006/icar.1999.6300; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; CALVIN WM, 2004, LUNAR PLANET SCI, V35, P1455; Doute S, 1998, J GEOPHYS RES-PLANET, V103, P31367, DOI 10.1029/98JE01894; Grundy WM, 1998, J GEOPHYS RES-PLANET, V103, P25809, DOI 10.1029/98JE00738; HALE AS, 2003, LUNAR PLANET SCI, V34, P1422; James PB, 2001, ICARUS, V154, P131, DOI 10.1006/icar.2001.6653; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; KIEFFER HH, 1990, J GEOPHYS RES-SOLID, V95, P1481, DOI 10.1029/JB095iB02p01481; Kieffer HH, 2001, ICARUS, V154, P162, DOI 10.1006/icar.2001.6670; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Nolin AW, 1998, J GEOPHYS RES-PLANET, V103, P25851, DOI 10.1029/98JE02082; Poulet F, 2002, ICARUS, V160, P313, DOI 10.1006/icar.2002.6970; Shkuratov Y, 1999, ICARUS, V137, P235, DOI 10.1006/icar.1998.6035	16	116	122	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1581	1584		10.1126/science.1109438	http://dx.doi.org/10.1126/science.1109438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718426				2022-12-01	WOS:000227622400035
J	Mustard, JF; Poulet, F; Gendrin, A; Bibring, JP; Langevin, Y; Gondet, B; Mangold, N; Bellucci, G; Altieri, F				Mustard, JF; Poulet, F; Gendrin, A; Bibring, JP; Langevin, Y; Gondet, B; Mangold, N; Bellucci, G; Altieri, F			Olivine and pyroxene, diversity in the crust of Mars	SCIENCE			English	Article							BASALTIC ROCKS; MGS-TES; SPECTRA; SPECTROSCOPY; REFLECTANCE; METEORITES	Data from the Observatoire pour la Mineralogie, l'Eau, les Glaces, et l'Activite (OMEGA) on the Mars Express spacecraft identify the distinct mafic, rock-forming minerals olivine, low-calcium pyroxene (LCP), and high-calcium pyroxene (HCP) on the surface of Mars. Olivine- and HCP-rich regions are found in deposits that span the age range of geologic units. However, LCP-rich regions are found only in the ancient Noachian-aged units, which suggests that melts for these deposits were derived from a mantle depleted in aluminum and calcium. Extended dark regions in the northern plains exhibit no evidence of strong mafic absorptions or absorptions due to hydrated materials.	Brown Univ, Providence, RI 02912 USA; Inst Astrophys Spatiale, F-91405 Orsay, France; IDES, F-91405 Orsay, France; IFSI INAF, Rome, Italy	Brown University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Istituto Nazionale Astrofisica (INAF)	Mustard, JF (corresponding author), Brown Univ, Providence, RI 02912 USA.	john_mustard@brown.edu	Bellucci, Giancarlo/ABA-9201-2020	Bellucci, Giancarlo/0000-0003-0867-8679; Altieri, Francesca/0000-0002-6338-8300				ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; BIBRING JP, 1989, NATURE, V341, P591, DOI 10.1038/341591a0; Burns R.G., 1970, MINERALOGIC APPL CRY; CLOUTIS EA, 1991, J GEOPHYS RES-PLANET, V96, P22809, DOI 10.1029/91JE02512; Hamilton VE, 2003, METEORIT PLANET SCI, V38, P871, DOI 10.1111/j.1945-5100.2003.tb00284.x; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; HESS PC, 2002, WORKSH UNM SNCS LUN; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; KING TVV, 1987, J GEOPHYS RES-SOLID, V92, P11457, DOI 10.1029/JB092iB11p11457; Kraft MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018848; McSween HY, 2002, METEORIT PLANET SCI, V37, P7, DOI 10.1111/j.1945-5100.2002.tb00793.x; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; MINITTI ME, 2002, J GEOPHYS RES, V107, pE5, DOI DOI 10.1029/2001JE001518; MITTLEFEHLDT D, 1994, METEORITICS, V29, P900, DOI 10.1111/j.1945-5100.1994.tb01106.x; MORRIS RV, 2003, 6 INT C MARS PAS CA; MUSTARD JF, 1995, SCIENCE, V267, P1623, DOI 10.1126/science.7886449; Mustard JF, 1997, J GEOPHYS RES-PLANET, V102, P25605, DOI 10.1029/97JE02354; SUNSHINE JM, 1993, J GEOPHYS RES-PLANET, V98, P9075, DOI 10.1029/93JE00677; SUNSHINE JM, 1990, J GEOPHYS RES-SOLID, V95, P6955, DOI 10.1029/JB095iB05p06955; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a	25	310	312	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1594	1597		10.1126/science.1109098	http://dx.doi.org/10.1126/science.1109098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718427				2022-12-01	WOS:000227622400039
J	Verhagen, E; Sauer, PJJ				Verhagen, E; Sauer, PJJ			The Groningen protocol - Euthanasia in severely ill newborn	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIFE		Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands	University of Groningen	Verhagen, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.		Verhagen, Eduard/F-9784-2013	Verhagen, Eduard/0000-0001-9555-6922				Sauer PJJ, 2001, EUR J PEDIATR, V160, P364, DOI 10.1007/s004310100735; vanderHeide A, 1997, LANCET, V350, P251, DOI 10.1016/S0140-6736(97)02315-5; Verhagen A A E, 2005, Ned Tijdschr Geneeskd, V149, P183	3	218	224	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					959	962		10.1056/NEJMp058026	http://dx.doi.org/10.1056/NEJMp058026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758003				2022-12-01	WOS:000227491200001
J	Kennedy, HJ; Crawford, AC; Fettiplace, R				Kennedy, HJ; Crawford, AC; Fettiplace, R			Force generation by mammalian hair bundles supports a role in cochlear amplification	NATURE			English	Article							GUINEA-PIG COCHLEA; MECHANOELECTRICAL TRANSDUCTION; MECHANICAL AMPLIFICATION; CELL MOTILITY; ADAPTATION; AMPLIFIER; STEREOCILIA; STIFFNESS; RESPONSES; CHANNELS	It is generally accepted that the acute sensitivity and frequency discrimination of mammalian hearing requires active mechanical amplification of the sound stimulus within the cochlea(1). The prevailing hypothesis is that this amplification stems from somatic electromotility of the outer hair cells attributable to the motor protein prestin(2,3). Thus outer hair cells contract and elongate in synchrony with the sound-evoked receptor potential(4,5). But problems arise with this mechanism at high frequencies, where the periodic component of the receptor potential will be attenuated by the membrane time constant. On the basis of work in non-mammalian vertebrates, force generation by the hair bundles has been proposed as an alternative means of boosting the mechanical stimulus(6,7). Here we show that hair bundles of mammalian outer hair cells can also produce force on a submillisecond timescale linked to adaptation of the mechano-transducer channels. Because the bundle motor may ultimately be limited by the deactivation rate of the channels, it could theoretically operate at high frequencies. Our results show the existence of another force generator in outer hair cells that may participate in cochlear amplification.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Bristol, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England	University of Wisconsin System; University of Wisconsin Madison; University of Bristol; University of Cambridge	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.	fettiplace@physiology.wisc.edu						ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; DALLOS P, 1992, J NEUROSCI, V12, P4575; DALLOS P, 1995, SCIENCE, V268, P1420, DOI 10.1126/science.268.5216.1420-a; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Langer MG, 2001, BIOPHYS J, V80, P2608, DOI 10.1016/S0006-3495(01)76231-5; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Preyer S, 1996, AUDIT NEUROSCI, V2, P145; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; RUSSELL IJ, 1992, P ROY SOC B-BIOL SCI, V250, P217, DOI 10.1098/rspb.1992.0152; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; STRELIOFF D, 1984, HEARING RES, V15, P19, DOI 10.1016/0378-5955(84)90221-1; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	30	228	239	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					880	883		10.1038/nature03367	http://dx.doi.org/10.1038/nature03367			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15696193				2022-12-01	WOS:000227174600046
J	Heikenwalder, M; Zeller, N; Seeger, H; Prinz, M; Klohn, PC; Schwarz, P; Ruddle, NH; Weissmann, C; Aguzzi, A				Heikenwalder, M; Zeller, N; Seeger, H; Prinz, M; Klohn, PC; Schwarz, P; Ruddle, NH; Weissmann, C; Aguzzi, A			Chronic lymphocytic inflammation specifies the organ tropism of prions	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; NONOBESE DIABETIC MICE; LYMPHOID NEOGENESIS; SCRAPIE; LYMPHOTOXIN; PROTEIN; PATHOGENESIS; REPLICATION; EXPRESSION	Prions typically accumulate in nervous and lymphoid tissues. Because proinflammatory cytokines and immune cells are required for lymphoid prion replication, we tested whether inflammatory conditions affect prion pathogenesis. We administered prions to mice with five inflammatory diseases of the kidney, pancreas, or liver. In all cases, chronic lymphocytic inflammation enabled prion accumulation in otherwise prion-free organs. Inflammatory foci consistently correlated with lymphotoxin up-regulation and ectopic induction of FDC-M1(+) cells expressing the normal cellular prion protein PrPc. By contrast, inflamed organs of mice lacking lymphotoxin-alpha or its receptor did not accumulate the abnormal isoform PrPsc, nor did they display infectivity upon prion inoculation. By expanding the tissue distribution of prions, chronic inflammatory conditions may act as modifiers of natural and iatrogenic prion transmission.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London WC1N 3BG, England; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	University of Zurich; University Zurich Hospital; University of London; University College London; Yale University; Yale University	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano@pathol.unizh.ch	Heikenwalder, Mathias/AAA-2269-2020; Kloehn, Peter/AAS-3719-2021; Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708	NCI NIH HHS [R01 CA 16885] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016885] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguzzi A, 2004, NAT CELL BIOL, V6, P290, DOI 10.1038/ncb0404-290; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Fan L, 2000, J IMMUNOL, V164, P3955, DOI 10.4049/jimmunol.164.8.3955; FAVEEUW C, 1994, J IMMUNOL, V152, P5969; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; HANNINEN A, 1993, J CLIN INVEST, V92, P2509, DOI 10.1172/JCI116859; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Kaiserling E, 2001, LYMPHOLOGY, V34, P22; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Mabbott NA, 2002, J VIROL, V76, P5131, DOI 10.1128/JVI.76.10.5131-5139.2002; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Vernau W, 1997, VET PATHOL, V34, P222, DOI 10.1177/030098589703400307; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103	33	158	161	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1107	1110		10.1126/science.1106460	http://dx.doi.org/10.1126/science.1106460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15661974				2022-12-01	WOS:000227197300048
J	Yanoviak, SP; Dudley, R; Kaspari, M				Yanoviak, SP; Dudley, R; Kaspari, M			Directed aerial descent in canopy ants	NATURE			English	Article							BEHAVIOR; RAIN	Numerous non- flying arboreal vertebrates use controlled descent ( either parachuting or gliding sensu stricto(1,2)) to avoid predation or to locate resources(3 - 7), and directional control during a jump or fall is thought to be an important stage in the evolution of flight(3,8,9). Here we show that workers of the neotropical ant Cephalotes atratus L. ( Hymenoptera: Formicidae) use directed aerial descent to return to their home tree trunk with > 80% success during a fall. Videotaped falls reveal that C. atratus workers descend abdomen- first through steep glide trajectories at relatively high velocities; a field experiment shows that falling ants use visual cues to locate tree trunks before they hit the forest floor. Smaller workers of C. atratus, and smaller species of Cephalotes more generally, regain contact with their associated tree trunk over shorter vertical distances than do larger workers. Surveys of common arboreal ants suggest that directed descent occurs in most species of the tribe Cephalotini and arboreal Pseudomyrmecinae, but not in arboreal ponerimorphs or Dolichoderinae. This is the first study to document the mechanics and ecological relevance of this form of locomotion in the Earth's most diverse lineage, the insects.	Smithsonian Trop Res Inst, Balboa, Panama; Univ Texas, Med Branch, Galveston, TX 77555 USA; Univ Florida, Florida Med Entomol Lab, Vero Beach, FL 32962 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida; University of California System; University of California Berkeley; University of Oklahoma System; University of Oklahoma - Norman	Kaspari, M (corresponding author), Smithsonian Trop Res Inst, POB 2072, Balboa, Panama.	mkaspari@ou.edu		Yanoviak, Stephen/0000-0001-6425-1413; Kaspari, Michael/0000-0002-9717-5768				COYLE FA, 1966, INSECT SOC, V13, P93, DOI 10.1007/BF02223565; de Andrade Maria L., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V271, P1; DUDLEY R, 2000, BIOMECHANICS INSECT, P275; ELLINGTON CP, 1991, ADV INSECT PHYSIOL, V23, P171, DOI 10.1016/S0065-2806(08)60094-6; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; Haemig PD, 1997, ANIM BEHAV, V54, P89, DOI 10.1006/anbe.1996.0428; HOLLDOBLER B, 1980, SCIENCE, V210, P86, DOI 10.1126/science.210.4465.86; Jackson SM, 2000, MAMMAL REV, V30, P9, DOI 10.1046/j.1365-2907.2000.00056.x; Kempf W. W., 1951, Revista de Entomologia Rio de Janeiro, V22, P1; KINGSOLVER JG, 1994, ANNU REV ENTOMOL, V39, P425, DOI 10.1146/annurev.en.39.010194.002233; Longino JT, 1997, ECOL APPL, V7, P1263, DOI 10.1890/1051-0761(1997)007[1263:BAUSIC]2.0.CO;2; McCay MG, 2001, J EXP BIOL, V204, P2817; Moffett MW, 2000, BIOTROPICA, V32, P569, DOI 10.1646/0006-3606(2000)032[0569:WSUACL]2.0.CO;2; MORI A, 1994, COPEIA, P124; OLIVER JA, 1951, AM NAT, V85, P171, DOI 10.1086/281666; Orivel J, 2001, ANN ENTOMOL SOC AM, V94, P449, DOI 10.1603/0013-8746(2001)094[0449:RBPMAA]2.0.CO;2; Saint-Paul U, 2000, ENVIRON BIOL FISH, V57, P235, DOI 10.1023/A:1007699130333; SMITH JM, 1952, EVOLUTION, V6, P127, DOI 10.1111/j.1558-5646.1952.tb02818.x; Socha JJ, 2002, NATURE, V418, P603, DOI 10.1038/418603a; Stork N.E., 1997, CANOPY ARTHROPODS; Walker JA, 1998, J EXP BIOL, V201, P981; WEBER NEAL A., 1957, PSYCHE, V64, P60, DOI 10.1155/1957/71981; WILSON EDWARD O., 1962, BULL MUS COMP ZOOL HARVARD UNIV, V127, P401; Wohlgemuth S, 2001, NATURE, V411, P795, DOI 10.1038/35081069; Yanoviak SP, 2000, OIKOS, V89, P259, DOI 10.1034/j.1600-0706.2000.890206.x	25	104	104	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					624	626		10.1038/nature03254	http://dx.doi.org/10.1038/nature03254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703745				2022-12-01	WOS:000226862000042
J	Couzin, ID; Krause, J; Franks, NR; Levin, SA				Couzin, ID; Krause, J; Franks, NR; Levin, SA			Effective leadership and decision-making in animal groups on the move	NATURE			English	Article							MIGRATORY BEHAVIOR; FISH	For animals that forage or travel in groups, making movement decisions often depends on social interactions among group members(1,2). However, in many cases, few individuals have pertinent information, such as knowledge about the location of a food source(3,4), or of a migration route(5-9). Using a simple model we show how information can be transferred within groups both without signalling and when group members do not know which individuals, if any, have information. We reveal that the larger the group the smaller the proportion of informed individuals needed to guide the group, and that only a very small proportion of informed individuals is required to achieve great accuracy. We also demonstrate how groups can make consensus decisions, even though informed individuals do not know whether they are in a majority or minority, how the quality of their information compares with that of others, or even whether there are any other informed individuals. Our model provides new insights into the mechanisms of effective leadership and decision-making in biological systems.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol BS8 1UG, Avon, England	Princeton University; University of Oxford; University of Leeds; University of Bristol	Couzin, ID (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	iain.couzin@zoo.ox.ac.uk	Couzin, Iain D./Q-6862-2018; Franks, Nigel/AAG-8207-2019; Krause, Jens/C-2750-2011; Levin, Simon A/J-1218-2014; Krause, Jens/J-4381-2013	Couzin, Iain D./0000-0001-8556-4558; Franks, Nigel/0000-0001-8139-9604; Levin, Simon A/0000-0002-8216-5639; Krause, Jens/0000-0002-1289-2857	Engineering and Physical Sciences Research Council [GR/T11241/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BATSCHELET E, 1981, CIRCULAR STAT BIOL, P34; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; BERTHOLD P, 1981, SCIENCE, V212, P77, DOI 10.1126/science.212.4490.77; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; KRAUSE J, 2002, LIVING GROUPS, P84; LINDAUER M, 1957, NATURE, V179, P63, DOI 10.1038/179063a0; NEILL WH, 1979, AM ZOOL, V19, P305; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; RUBENSTEIN DI, 1992, EVOL ECOL, V6, P254, DOI 10.1007/BF02214165; Seeley T. D., 1995, WISDOM HIVE, p[34, 85]; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V53, P417, DOI 10.1007/s00265-003-0598-z; SEELEY TD, 1985, HONEYBEE ECOLOGY STU, P71; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Swaney W, 2001, ANIM BEHAV, V62, P591, DOI 10.1006/anbe.2001.1788; VONFRISCH K, 1967, DANCE LANGUAGE ORIEN, P28	22	1682	1746	13	567	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					513	516		10.1038/nature03236	http://dx.doi.org/10.1038/nature03236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690039	Green Submitted			2022-12-01	WOS:000226727200046
J	Forterre, Y; Skotheim, JM; Dumais, J; Mahadevan, L				Forterre, Y; Skotheim, JM; Dumais, J; Mahadevan, L			How the Venus flytrap snaps	NATURE			English	Article							DIONAEA-MUSCIPULA ELLIS; MECHANISM; MOVEMENT; CLOSURE; GROWTH; PLANTS	The rapid closure of the Venus flytrap (Dionaea muscipula) leaf in about 100 ms is one of the fastest movements in the plant kingdom. This led Darwin to describe the plant as "one of the most wonderful in the world"(1). The trap closure is initiated by the mechanical stimulation of trigger hairs. Previous studies(2-7) have focused on the biochemical response of the trigger hairs to stimuli and quantified the propagation of action potentials in the leaves. Here we complement these studies by considering the post-stimulation mechanical aspects of Venus flytrap closure. Using high-speed video imaging, non-invasive microscopy techniques and a simple theoretical model, we show that the fast closure of the trap results from a snap-buckling instability, the onset of which is controlled actively by the plant. Our study identifies an ingenious solution to scaling up movements in nonletters muscular engines and provides a general framework for understanding nastic motion in plants.	Harvard Univ, Biol Labs, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Aix Marseille 1, CNRS, IUSTI, F-13453 Marseille 13, France; Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Cambridge; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Biol Labs, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	lm@deas.harvard.edu	Skotheim, Jan/C-3238-2015; Dumais, Jacques/H-7950-2013	Skotheim, Jan/0000-0001-8420-6820; Dumais, Jacques/0000-0003-2344-4766				ASHIDA JOJI, 1934, MEM COLL SCI KYOTO IMP UNIV SER B, V9, P141; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Brown WH, 1916, AM J BOT, V3, P68, DOI 10.2307/2435207; Burdon-Sanderson JS, 1882, PHILOS T R SOC LOND, V173, P1; Darwin C., 1875, INSECTIVOROUS PLANTS; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; FRENSCH J, 1989, PLANT PHYSIOL, V91, P719, DOI 10.1104/pp.91.2.719; GREEN PB, 1991, PLANTA, V185, P502, DOI 10.1007/BF00202959; HILL BS, 1981, Q REV BIOPHYS, V14, P173, DOI 10.1017/S0033583500002249; HODICK D, 1988, PLANTA, V174, P8, DOI 10.1007/BF00394867; HODICK D, 1989, PLANTA, V179, P32, DOI 10.1007/BF00395768; Juniper B.E., 1989, CARNIVOROUS PLANTS; Love A.E.H., 2013, TREATISE MATH THEORY; Mansfield E.H., 1989, BENDING STRETCHING P; Morillon R, 2001, PLANT PHYSIOL, V127, P720, DOI 10.1104/pp.010732; Sibaoka T., 1969, ANNU REV PLANT PHYS, V20, P165; Skotheim JM, 2004, P ROY SOC A-MATH PHY, V460, P1995, DOI 10.1098/rspa.2003.1270; STUHLMAN O, 1950, SCIENCE, V111, P491, DOI 10.1126/science.111.2888.491; STUHLMAN O, 1948, B TORREY BOT CLUB, V7, P22; WILLIAMS SE, 1982, SCIENCE, V218, P1120, DOI 10.1126/science.218.4577.1120	20	664	677	26	484	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					421	425		10.1038/nature03185	http://dx.doi.org/10.1038/nature03185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674293				2022-12-01	WOS:000226546200044
J	Nelson, WA; McCauley, E; Wrona, FJ				Nelson, WA; McCauley, E; Wrona, FJ			Stage-structured cycles promote genetic diversity in a predator-prey system of Daphnia and algae	NATURE			English	Article							LIFE-HISTORY EVOLUTION; CLONAL DIVERSITY; POPULATIONS; PULEX; PLANKTON; ECOLOGY; MODELS	Competition theory predicts that population fluctuations can promote genetic diversity when combined with density-dependent selection(1,2). However, this stabilizing mechanism has rarely been tested, and was recently rejected as an explanation for maintaining diversity in natural populations of the freshwater herbivore Daphnia pulex(3). The primary limitation of competition theory is its failure to account for the alternative types of population cycles that are caused by size- or stage-dependent population vital rates - even though such structure both explains the fluctuating dynamics of many species(4) and may alter the outcome of competition(5). Here we provide the first experimental test of whether alternative types of cycles affect natural selection in predator - prey systems. Using competing Daphnia genotypes, we show that internally generated, stage-structured cycles substantially reduce the magnitude of selection ( thereby contributing to the maintenance of genetic diversity), whereas externally forced cycles show rapid competitive exclusion. The change in selection is ecologically significant, spanning the observed range in natural populations(3). We argue that structured cycles reduce selection through a combination of stalled juvenile development and stage-specific mortality. This potentially general fitness-equalizing mechanism may reduce the need for strong stabilizing mechanisms to explain the maintenance of genetic diversity in natural systems.	Univ Calgary, Div Ecol, Calgary, AB T2N 1N4, Canada; Univ Victoria, Natl Water Res Inst, Water & Climate Impacts Res Ctr, Victoria, BC V8W 3P5, Canada	University of Calgary; Environment & Climate Change Canada; National Water Research Institute; University of Victoria	Nelson, WA (corresponding author), Univ Calgary, Div Ecol, Calgary, AB T2N 1N4, Canada.	wanelson@ucalgary.ca	Nelson, William A/D-1405-2013; Wrona, Frederick J/B-8258-2014	Wrona, Frederick J/0000-0003-1894-351X				ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; CARVALHO GR, 1987, J ANIM ECOL, V56, P469, DOI 10.2307/5061; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; DUFRESNE F, 1995, HEREDITY, V75, P45, DOI 10.1038/hdy.1995.102; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HEBERT PDN, 1980, SCIENCE, V207, P1363, DOI 10.1126/science.207.4437.1363; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; HEBERT PDN, 1977, J ANIM ECOL, V46, P399, DOI 10.2307/3819; Hebert PDN, 1993, METHODOLOGIES ALLOZY; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; LOARING JM, 1981, OECOLOGIA, V51, P162, DOI 10.1007/BF00540595; LYNCH M, 1984, EVOLUTION, V38, P465, DOI 10.1111/j.1558-5646.1984.tb00312.x; LYNCH M, 1987, GENETICS, V115, P657; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCCAULEY E, 1987, AM NAT, V129, P97, DOI 10.1086/284624; McCauley E, 1996, ECOL MONOGR, V66, P479, DOI 10.2307/2963491; Mitchell SE, 1998, ERGEB LIMNOL, V52, P185; MORT MA, 1991, TRENDS ECOL EVOL, V6, P41, DOI 10.1016/0169-5347(91)90120-M; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; NELSON WA, 2004, THESIS U CALGARY; Persson L, 1999, OIKOS, V87, P139, DOI 10.2307/3547005; SPITZE K, 1991, EVOLUTION, V45, P82, DOI 10.1111/j.1558-5646.1991.tb05268.x; WATSON S, 1992, CAN J FISH AQUAT SCI, V49, P2605, DOI 10.1139/f92-288; WEIDER LJ, 1985, J PLANKTON RES, V7, P101, DOI 10.1093/plankt/7.1.101; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481	28	36	37	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					413	417		10.1038/nature03212	http://dx.doi.org/10.1038/nature03212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674291				2022-12-01	WOS:000226546200042
J	Higuchi, T; Uhlmann, F				Higuchi, T; Uhlmann, F			Stabilization of microtubule dynamics at anaphase onset promotes chromosome segregation	NATURE			English	Article							BUDDING YEAST ANAPHASE; MITOTIC SPINDLE; SACCHAROMYCES-CEREVISIAE; PRECOCIOUS SEPARATION; METAPHASE; PROTEIN; COHESIN; KINASE; CDC14; DESTRUCTION	Microtubules of the mitotic spindle form the structural basis for chromosome segregation. In metaphase, microtubules show high dynamic instability, which is thought to aid the 'search and capture' of chromosomes for bipolar alignment on the spindle. Microtubules suddenly become more stable at the onset of anaphase, but how this change in microtubule behaviour is regulated and how important it is for the ensuing chromosome segregation are unknown(1-4). Here we show that in the budding yeast Saccharomyces cerevisiae, activation of the phosphatase Cdc14 at anaphase onset is both necessary and sufficient for silencing microtubule dynamics. Cdc14 is activated by separase, the protease that triggers sister chromatid separation, linking the onset of anaphase to microtubule stabilization(5,6). If sister chromatids separate in the absence of Cdc14 activity, microtubules maintain high dynamic instability; this correlates with defects in both the movement of chromosomes to the spindle poles (anaphase A) and the elongation of the anaphase spindle (anaphase B). Cdc14 promotes localization of microtubule-stabilizing proteins to the anaphase spindle, and dephosphorylation of the kinetochore component Ask1 contributes to both the silencing of microtubule turnover and successful anaphase A.	Canc Res UK London Res Inst, Chromosome Segregat Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk		Uhlmann, Frank/0000-0002-3527-6619	Cancer Research UK [A3592] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Li YM, 2003, CELL CYCLE, V2, P143, DOI 10.4161/cc.2.2.336; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Murray AW, 1996, P NATL ACAD SCI USA, V93, P12327, DOI 10.1073/pnas.93.22.12327; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Yin HW, 2002, MOL BIOL CELL, V13, P1881, DOI 10.1091/mbc.01-09-0458; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	30	146	151	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					171	176		10.1038/nature03240	http://dx.doi.org/10.1038/nature03240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650742	Green Accepted			2022-12-01	WOS:000226252200041
J	Jee, SH; Ohrr, H; Sull, JW; Yun, JE; Ji, M; Samet, JM				Jee, SH; Ohrr, H; Sull, JW; Yun, JE; Ji, M; Samet, JM			Fasting serum glucose level and cancer risk in Korean men and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIABETES-MELLITUS; PANCREATIC-CANCER; PROSTATE-CANCER; BREAST-CANCER; FOLLOW-UP; SMOKING; MORTALITY; DEATH; COHORT; TYPE-2	Context Diabetes is a serious and costly disease that is becoming increasingly common in many countries. The role of diabetes as a cancer risk factor remains unclear. Objective To examine the relationship between fasting serum glucose and diabetes and risk of all cancers and specific cancers in men and women in Korea. Design, Setting, and Participants Ten-year prospective cohort study of 1298 385 Koreans (829770 men and 468615 women) aged 30 to 95 years who received health insurance from the National Health Insurance Corp and had a biennial medical evaluation in 1992-1995 (with follow-up for up to 10 years). Main Outcome Measures Death from cancer and registry-documented incident cancer or hospital admission for cancer. Results During the 10 years of follow-up, there were 20566 cancer deaths in men and 5907 cancer deaths in women. Using Cox proportional hazards models and controlling for smoking and alcohol use, the stratum with the highest fasting serum glucose (greater than or equal to140 mg/dL [greater than or equal to7.8 mmol/L]) had higher death rates from all cancers combined (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.22-1.37 in men and HR, 1.23; 95% Cl, 1.09-1.39 in women) compared with the stratum with the lowest level (<90 mg/dL [<5.0 mmol/L]). By cancer site, the association was strongest for pancreatic cancer, comparing the highest and lowest strata in men (HR, 1.91; 95% Cl, 1.52-2.41) and in women (HR, 2.05; 95% Cl, 1.43-2.93). Significant associations were also found for cancers of the esophagus, liver, and colon/ rectum in men and of the liver and cervix in women, and there were significant trends with glucose level for cancers of the esophagus, colon/rectum, liver, pancreas, and bile duct in men and of the liver and pancreas in women. Of the 26473 total cancer deaths in men and women, 848 were estimated as attributable to having a fasting serum glucose level of less than 90 mg/dL. For cancer incidence, the general patterns reflected those found for mortality. For persons with a diagnosis of diabetes or a fasting serum glucose level greater than 125 mg/dL (6.9 mmol/L), risks for cancer incidence and mortality were generally elevated compared with those without diabetes. Conclusion In Korea, elevated fasting serum glucose levels and a diagnosis of diabetes are independent risk factors for several major cancers, and the risk tends to increase with an increased level of fasting serum glucose.	Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea; Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jee, SH (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea.	jsunha@yumc.yonsei.ac.kr			NCI NIH HHS [1R03 CA94771-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R03CA094771] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bjornholt JV, 1999, DIABETES CARE, V22, P45, DOI 10.2337/diacare.22.1.45; Cho N.H, 2001, DIABETES, V25, P1; COX DR, 1972, J R STAT SOC B, V34, P187; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Gavin JR, 1997, DIABETES CARE, V20, P1183; GRULICH AE, 1995, INT J CANCER, V63, P164, DOI 10.1002/ijc.2910630203; Hjalgrim H, 1997, J INTERN MED, V241, P471; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; International Agency for Research on Cancer (IARC), 2002, IARC SCI PUBL, V8; Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149; Jee SH, 2004, JNCI-J NATL CANCER I, V96, P1851, DOI 10.1093/jnci/djh334; Jee SH, 2004, CANCER CAUSE CONTROL, V15, P341, DOI 10.1023/B:CACO.0000027481.48153.97; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; KIM HS, 2000, KOREAN J NURS, V30, P1479; LaVecchia C, 1997, INT J CANCER, V73, P204, DOI 10.1002/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.3.CO;2-A; Lee SY, 2002, J HYPERTENS, V20, P617, DOI 10.1097/00004872-200204000-00017; Michels KB, 2003, DIABETES CARE, V26, P1752, DOI 10.2337/diacare.26.6.1752; National Institute of Diabetes and Digestive and Kidney Disorders, 2004, NAT DIAB INF CLEAR N; Rosenberg DJ, 2002, CANCER INVEST, V20, P157, DOI 10.1081/CNV-120001141; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; SMITH GD, 1992, AM J EPIDEMIOL, V136, P1110, DOI 10.1093/oxfordjournals.aje.a116576; Strickler H D, 2001, Diabetes Technol Ther, V3, P263, DOI 10.1089/152091501300209633; Szklo M., 2000, EPIDEMIOLOGY BASICS; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Weiderpass E, 1997, INT J CANCER, V71, P360, DOI 10.1002/(SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W; Weiderpass E, 2002, INT J CANCER, V102, P258, DOI 10.1002/ijc.10685; WHO, 2002, DIAB MELL, P138; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Will JC, 1999, EPIDEMIOLOGY, V10, P313, DOI 10.1097/00001648-199905000-00021	30	705	739	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					194	202		10.1001/jama.293.2.194	http://dx.doi.org/10.1001/jama.293.2.194			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644546	Bronze			2022-12-01	WOS:000226171000035
J	Di Fonzo, A; Rohe, CF; Ferreira, RJ; Chien, HF; Vacca, L; Stocchi, F; Guedes, L; Fabrizio, E; Manfredi, M; Vanacore, N; Goldwurm, S; Breedveld, G; Sampaio, C; Meco, G; Barbosa, E; Oostra, BA; Bonifati, V				Di Fonzo, A; Rohe, CF; Ferreira, RJ; Chien, HF; Vacca, L; Stocchi, F; Guedes, L; Fabrizio, E; Manfredi, M; Vanacore, N; Goldwurm, S; Breedveld, G; Sampaio, C; Meco, G; Barbosa, E; Oostra, BA; Bonifati, V		Italian Parkinson Genetics Network	A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease	LANCET			English	Article								Mutations in the LRRK2 gene have been identified in families with autosomal dominant parkinsonism. We amplified and sequenced the coding region of LRRK2 from genomic DNA by PCR, and identified a heterozygous mutation (Gly2019Ser) present in four of 61 (6.6%) unrelated families with Parkinson's disease and autosomal dominant inheritance. The families originated from Italy, Portugal, and Brazil, indicating the presence of the mutation in different populations. The associated phenotype was broad, including early and late disease onset. These findings confirm the association of LRRK2 with neurodegeneration, and identify a common mutation associated with dominantly inherited Parkinson's disease.	Erasmus MC Rotterdam, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Univ Milan, IRCCS Osped Maggiore Policlin, Ctr Dino Ferrari, Dept Neurol Sci, Milan, Italy; Inst Mol Med, Neurol Clin Res Unit, Lisbon, Portugal; Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil; Univ Roma La Sapienza, Dept Neurol Sci, Rome, Italy; Natl Inst Hlth, Natl Ctr Epidemiol, Rome, Italy; Ist Clin Perfezionamento, Parkinson Inst, Milan, Italy	Erasmus University Rotterdam; Erasmus MC; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universidade de Lisboa; Universidade de Sao Paulo; Sapienza University Rome; Istituto Superiore di Sanita (ISS)	Bonifati, V (corresponding author), Erasmus MC Rotterdam, Dept Clin Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	v.bonifati@erasmusmc.nl	Goldwurm, Stefano/Q-8978-2016; Ferreira, Joaquim/AAA-1837-2020; Barbosa, Egberto R/G-7763-2012; Vanacore, Nicola/ABC-7196-2021; Di Fonzo, Alessio/A-5702-2013; stocchi, fabrizio/K-5089-2016	Goldwurm, Stefano/0000-0002-1651-567X; Di Fonzo, Alessio/0000-0001-6478-026X; stocchi, fabrizio/0000-0002-5763-0033; Ferreira, Joaquim J/0000-0003-3950-5113; Vacca, Laura/0000-0002-6634-4119; Reis Barbosa, Egberto/0000-0002-6996-9130; Correia Guedes, Leonor/0000-0002-8422-0494				Bonifati V, 2004, CELL MOL LIFE SCI, V61, P1729, DOI 10.1007/s00018-004-4104-1; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	5	412	424	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2005	365	9457					412	415						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680456				2022-12-01	WOS:000226610900028
J	Koester, HJ; Johnston, D				Koester, HJ; Johnston, D			Target cell-dependent normalization of transmitter release at neocortical synapses	SCIENCE			English	Article							OPTICAL QUANTAL ANALYSIS; SYNAPTIC CONNECTIONS; PYRAMIDAL NEURONS; RAT NEOCORTEX; ACTION-POTENTIALS; CALCIUM DYNAMICS; NERVE-TERMINALS; NMDA RECEPTORS; DEPRESSION; HETEROGENEITY	The efficacy and short-term modification of neocortical synaptic connections vary with the type of target neuron. We investigated presynaptic Ca(2+) and release probability at single synaptic contacts between pairs of neurons in layer 2/3 of the rat neocortex. The amplitude of Ca(2+) signals in boutons of pyramids contacting bitufted or multipolar interneurons or other pyramids was dependent on the target cell type. Optical quantal analysis at single synaptic contacts suggested that release probabilities are also target cell-specific. Both the Ca(2+) signal and the release probability of different boutons of a pyramid contacting the same target cell varied little. We propose that the mechanisms that regulate the functional properties of boutons of a pyramid normalize the presynaptic Ca(2+) influx and release probability for all those boutons that innervate the same target cell.	Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Max Planck Society; Baylor College of Medicine	Koester, HJ (corresponding author), Univ Texas, Ctr Learning & Memory, Austin, TX 78712 USA.	HKoester@mail.utexas.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444] Funding Source: NIH RePORTER; NIMH NIH HHS [MH44754, MH48432] Funding Source: Medline; NINDS NIH HHS [NNS37444] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; KULLMANN DM, 1989, J NEUROSCI METH, V30, P231, DOI 10.1016/0165-0270(89)90134-9; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; STRICKER C, 1994, BIOPHYS J, V67, P532, DOI 10.1016/S0006-3495(94)80513-2; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yuste R, 1999, J NEUROSCI, V19, P1976; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	28	160	162	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					863	866		10.1126/science.1100815	http://dx.doi.org/10.1126/science.1100815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774725				2022-12-01	WOS:000228986500051
J	Vermot, J; Llamas, JG; Fraulob, V; Niederreither, K; Chambon, P; Dolle, P				Vermot, J; Llamas, JG; Fraulob, V; Niederreither, K; Chambon, P; Dolle, P			Retinoic acid controls the bilateral symmetry of somite formation in the mouse embryo	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; SEGMENTATION CLOCK; BOUNDARY FORMATION; NODAL EXPRESSION; GENE-EXPRESSION; SOMITOGENESIS; FGF	A striking characteristic of vertebrate embryos is their bilaterally symmetric body plan, which is particularly obvious at the level of the somites and their derivatives such as the vertebra[ column. Segmentation of the presomitic mesoderm must therefore be tightly coordinated along the left and right embryonic sides. We show that mutant mice defective for retinoic acid synthesis exhibit delayed somite formation on the right side. Asymmetric somite formation correlates with a left-right desynchronization of the segmentation clock oscillations. These data implicate retinoic acid as an endogenous signal that maintains the bilateral synchrony of mesoderm segmentation, and therefore controls bilateral symmetry, in vertebrate embryos.	Coll France, ULP, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Mol Biol, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine; Baylor College of Medicine	Vermot, J (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	julien@igbmc.u-strasbg.fr; dolle@igbmc.u-strasbg.fr	Vermot, Julien/I-6568-2016; Dolle, Pascal/A-8037-2010	Dolle, Pascal/0000-0002-9294-9090; , Julien/0000-0002-8924-732X				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; CERFONTAINE P, 2006, ARCH BIOL, P22; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Liu AM, 2003, DEVELOPMENT, V130, P6175, DOI 10.1242/dev.00845; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sawada A, 2001, DEVELOPMENT, V128, P4873; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062	22	167	175	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					563	566		10.1126/science.1108363	http://dx.doi.org/10.1126/science.1108363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15731404				2022-12-01	WOS:000228810500056
J	Zhang, SMM; Buring, JE; Lee, IM; Cook, NR; Ridker, PM				Zhang, SMM; Buring, JE; Lee, IM; Cook, NR; Ridker, PM			C-reactive protein levels are not associated with increased risk for colorectal cancer in women	ANNALS OF INTERNAL MEDICINE			English	Article							HORMONE REPLACEMENT THERAPY; INFLAMMATORY-BOWEL-DISEASE; PHASE REACTANT PROTEINS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SERUM CARCINOEMBRYONIC ANTIGEN; POSTMENOPAUSAL WOMEN; INTERLEUKIN-6 LEVELS; TUMOR RECURRENCE; SURVIVAL; HEALTH	Background: Observations that risk for colorectal cancer is elevated in patients with inflammatory bowel disease and that longterm use of anti-inflammatory drugs may reduce colorectal cancer risk have raised the possibility that inflammation may play a role in the development of colorectal cancer. While a recent prospective study observed a positive association between C-reactive protein (CRP), a marker of inflammation, and risk for colon cancer, data testing this hypothesis are sparse. Objective: To evaluate whether plasma CRP levels predict colorectal cancer risk in women. Design: Prospective cohort study, with 97% morbidity follow-up and 100% mortality follow-up within the past 2 years. Setting: women's Health Study. Participants: 27 913 apparently healthy women age 45 years or older who had CRP measured at entry into a trial of low-dose aspirin and vitamin E. Maximum length of intervention and follow-up was 10.8 years. Measurements: self-reported incident colorectal adenocarcinoma confirmed by medical record review. Results: 169 women developed colorectal adenocarcinomas during follow-up. Baseline CRP levels were not significantly associated with colorectal cancer risk. The multivariate hazard ratios according to cutoff points for CRP proposed in clinical guidelines were 0.79 (95% CI, 0.53 to 1.17) for the category of 1 to 3 mg/L and 0.66 (CI, 0.43 to 1.03) for the category of greater than 3 mg/L (P for trend = 0.09), as compared with the category of less than 1 mg/L. High CRP levels were also not associated with increased risk in analyses done according to tumor location and stage at diagnosis, according to alternative cutoff points for CRP, or in any of the subgroups evaluated. Limitations: Despite multivariate analysis, residual confounding might still be present. Although this study was prospective, we cannot completely exclude undetected cancer at baseline. Measurements for CRP were available for only 71% of women in the cohort; however, the women who did and those who did not provide blood were mostly similar. Conclusions: Plasma CRP levels do not appear to predict an increased risk for developing colorectal cancer in apparently healthy women. Low-grade inflammation may not play an important role in increasing the risk for colorectal cancer.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, SMM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02115 USA.	shumin.zhang@channing.harvard.edu	Lee, I-Min/ABD-5409-2021		NATIONAL CANCER INSTITUTE [K07CA096619] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA096619, CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Chung YC, 2003, EUR J GASTROEN HEPAT, V15, P369, DOI 10.1097/00042737-200304000-00006; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crespo CJ, 2002, DIABETES CARE, V25, P1675, DOI 10.2337/diacare.25.10.1675; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Demissie K, 2004, ANN EPIDEMIOL, V14, P215, DOI 10.1016/j.annepidem.2003.08.002; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; DURDEY P, 1984, BRIT J SURG, V71, P881, DOI 10.1002/bjs.1800711126; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Huls G, 2003, LANCET, V362, P230, DOI 10.1016/S0140-6736(03)13915-3; Kinoshita T, 1999, CANCER, V85, P2526, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2-3; Komoda H, 1998, WORLD J SURG, V22, P895, DOI 10.1007/s002689900489; MCMILLAN DC, 1995, AM J SURG, V170, P319, DOI 10.1016/S0002-9610(99)80296-7; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; MERCER DW, 1985, CLIN CHEM, V31, P1824; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Nielsen HJ, 2000, ANN SURG ONCOL, V7, P617, DOI 10.1007/BF02725342; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Ockene IS, 2001, CLIN CHEM, V47, P444; Panes J, 2001, ACTA PHYSIOL SCAND, V173, P159, DOI 10.1046/j.1365-201X.2001.00905.x; Pasche B, 2004, JAMA-J AM MED ASSOC, V291, P623, DOI 10.1001/jama.291.5.623; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ries L, 1975, SEER CANC STAT REV; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; STAMATIADIS AP, 1990, CANCER, V65, P2055, DOI 10.1002/1097-0142(19900501)65:9<2055::AID-CNCR2820650927>3.0.CO;2-6; STAMATIADIS AP, 1992, EUR J SURG ONCOL, V18, P41; van Baal WM, 1999, THROMB HAEMOSTASIS, V81, P925, DOI 10.1055/s-0037-1614600; Vatay A, 2003, IMMUNOGENETICS, V55, P247, DOI 10.1007/s00251-003-0575-8; Wigmore SJ, 2001, BRIT J SURG, V88, P255, DOI 10.1046/j.1365-2168.2001.01669.x; Yuceyar S, 1996, INT SURG, V81, P136; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	43	105	109	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					425	432		10.7326/0003-4819-142-6-200503150-00008	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767620				2022-12-01	WOS:000227621100004
J	Paige, DA				Paige, DA			Ancient mars: Wet in many places	SCIENCE			English	Editorial Material								New results from the Mars Express Orbiter mission reveal multiple deposits of minerals formed in the presence of liquid water. They reinforce the conclusion that ancient Mars was warmer and wetter than it is today, and increase the number of promising localities to search for evidence of past life.	Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Paige, DA (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	dap@mars.ucla.edu						Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Kirkland LE, 2001, APPL OPTICS, V40, P4852, DOI 10.1364/AO.40.004852; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Langevin Y, 2005, SCIENCE, V307, P1581, DOI 10.1126/science.1109438; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171	12	22	22	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1575	1576		10.1126/science.1110530	http://dx.doi.org/10.1126/science.1110530			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761146				2022-12-01	WOS:000227622400033
J	Schulz, O; Diebold, SS; Chen, M; Naslund, TI; Nolte, MA; Alexopoulou, L; Azuma, YT; Flavell, RA; Liljestrom, P; Sousa, CRE				Schulz, O; Diebold, SS; Chen, M; Naslund, TI; Nolte, MA; Alexopoulou, L; Azuma, YT; Flavell, RA; Liljestrom, P; Sousa, CRE			Toll-like receptor 3 promotes cross-priming to virus-infected cells	NATURE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; DOUBLE-STRANDED-RNA; CD8(+) T-CELLS; IN-VIVO; VIRAL-INFECTION; CUTTING EDGE; DYING CELLS; ANTIGENS; INTERFERON; IMMUNITY	Cross-presentation of cell-associated antigens plays an important role in regulating CD8(+) T cell responses to proteins that are not expressed by antigen-presenting cells (APCs)(1). Dendritic cells are the principal cross-presenting APCs in vivo and much progress has been made in elucidating the pathways that allow dendritic cells to capture and process cellular material(1). However, little is known about the signals that determine whether such presentation ultimately results in a cytotoxic T cell (CTL) response (cross-priming) or in CD8(+) T cell inactivation (cross-tolerance). Here we describe a mechanism that promotes cross-priming during viral infections. We show that murine CD8alpha(+) dendritic cells are activated by double-stranded (ds)RNA present in virally infected cells but absent from uninfected cells. Dendritic cell activation requires phagocytosis of infected material, followed by signalling through the dsRNA receptor, toll-like receptor 3 (TLR3). Immunization with virus-infected cells or cells containing synthetic dsRNA leads to a striking increase in CTL cross-priming against cell-associated antigens, which is largely dependent on TLR3 expression by antigen-presenting cells. Thus, TLR3 may have evolved to permit cross-priming of CTLs against viruses that do not directly infect dendritic cells.	Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England; Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, Dept Vaccine Res, S-17177 Stockholm, Sweden; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Cancer Research UK; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Yale University; Howard Hughes Medical Institute	Sousa, CRE (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Alexopoulou, Lena/A-5041-2017; Azuma, Yasu-Taka/C-7561-2009; chen, margaret/B-6757-2014; Nolte, Martijn A./AAC-8092-2022; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Alexopoulou, Lena/0000-0003-4619-697X; Nolte, Martijn A./0000-0002-5447-0839; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Schulz, Oliver/0000-0002-1493-3341; Azuma, Yasu-Taka/0000-0002-3515-171X; Liljestrom, Peter/0000-0002-2132-0981; Sallberg Chen, Margaret/0000-0002-3793-4064				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HELWIG FC, 1945, SCIENCE, V102, P31, DOI 10.1126/science.102.2637.31; Hoebe K, 2004, J ENDOTOXIN RES, V10, P130, DOI 10.1179/096805104225004031; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Melief CJM, 2003, EUR J IMMUNOL, V33, P2645, DOI 10.1002/eji.200324341; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898	30	678	715	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					887	892		10.1038/nature03326	http://dx.doi.org/10.1038/nature03326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15711573				2022-12-01	WOS:000227174600048
J	Deregnaucourt, S; Mitra, PP; Feher, O; Pytte, C; Tchernichovski, O				Deregnaucourt, S; Mitra, PP; Feher, O; Pytte, C; Tchernichovski, O			How sleep affects the developmental learning of bird song	NATURE			English	Article							ANTERIOR FOREBRAIN; VOCAL IMITATION; AGE; CONSOLIDATION; MEMORIES; DYNAMICS; NEURONS	Sleep affects learning and development in humans and other animals, but the role of sleep in developmental learning has never been examined. Here we show the effects of night-sleep on song development in the zebra finch by recording and analysing the entire song ontogeny. During periods of rapid learning we observed a pronounced deterioration in song structure after night-sleep. The song regained structure after intense morning singing. Daily improvement in similarity to the tutored song occurred during the late phase of this morning recovery; little further improvement occurred thereafter. Furthermore, birds that showed stronger post-sleep deterioration during development achieved a better final imitation. The effect diminished with age. Our experiments showed that these oscillations were not a result of sleep inertia or lack of practice, indicating the possible involvement of an active process, perhaps neural song-replay during sleep. We suggest that these oscillations correspond to competing demands of plasticity and consolidation during learning, creating repeated opportunities to reshape previously learned motor skills.	CUNY City Coll, Dept Biol, New York, NY 10031 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	City University of New York (CUNY) System; City College of New York (CUNY); Cold Spring Harbor Laboratory; Wesleyan University	Deregnaucourt, S (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	sderegna@sci.ccny.cuny.edu	Galantucci, Bruno/E-5770-2010; Tchernichovski, Ofer/AAC-5678-2019	Tchernichovski, Ofer/0000-0001-6788-614X; Mitra, Partha/0000-0001-8818-6804	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004722] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Brainard MS, 2001, J NEUROSCI, V21, P2501, DOI 10.1523/JNEUROSCI.21-07-02501.2001; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; GOLANI I, 1992, BEHAV BRAIN SCI, V15, P249, DOI 10.1017/S0140525X00068539; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Ho C, 1998, P JOINT S NEUR COMP, V5, P76; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Immelmann K., 1969, P61; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Keasar T, 1996, ANIM BEHAV, V52, P95, DOI 10.1006/anbe.1996.0155; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Loader Catherine, 2022, LOCFIT LOCAL REGRESS; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Margoliash D, 2002, J COMP PHYSIOL A, V188, P851, DOI 10.1007/s00359-002-0351-5; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; Nick TA, 2001, P NATL ACAD SCI USA, V98, P14012, DOI 10.1073/pnas.251525298; NORDEEN KW, 1988, NATURE, V334, P149, DOI 10.1038/334149a0; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; Rauske PL, 2003, J NEUROPHYSIOL, V89, P1688, DOI 10.1152/jn.00655.2002; SCHMIDT MF, 2001, NAT NEUROSCI, V1, P513; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Tchernichovski O, 2002, J COMP PHYSIOL A, V188, P867, DOI 10.1007/s00359-002-0352-4; Tchernichovski O, 1998, BIOL CYBERN, V78, P423, DOI 10.1007/s004220050446; Tchernichovski O, 2004, SOUND ANAL PRO USER; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wang NG, 2002, J NEUROSCI, V22, P10864; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; ZUCKERMAN B, 1987, PEDIATRICS, V80, P664	46	224	227	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					710	716		10.1038/nature03275	http://dx.doi.org/10.1038/nature03275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716944				2022-12-01	WOS:000227039200030
J	Doumbo, OK				Doumbo, OK			It takes a village: Medical research and ethics in Mali	SCIENCE			English	Editorial Material									Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Bamako, Mali	University of Bamako	Doumbo, OK (corresponding author), Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, BP 1805, Bamako, Mali.	okd@mrtcbko.org						DOUMBO O, 1999, MULTILATERAL INITIAT; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Toure YT, 1998, AM J TROP MED HYG, V59, P481, DOI 10.4269/ajtmh.1998.59.481	3	32	32	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					679	681		10.1126/science.1109773	http://dx.doi.org/10.1126/science.1109773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692036				2022-12-01	WOS:000226814900026
J	Riley, J; Ross, JR				Riley, J; Ross, JR			Research into care at the end of life	LANCET			English	Editorial Material							PALLIATIVE CARE		Royal Marsden Hosp Fdn Trust, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Riley, J (corresponding author), Royal Marsden Hosp Fdn Trust, London SW3 6JJ, England.	Julia.riley@rmh.nhs.uk						Acquaviva K, 2004, J PAIN SYMPTOM MANAG, V28, P488, DOI 10.1016/j.jpainsymman.2004.08.003; Casarett D, 2001, J Palliat Med, V4, P441, DOI 10.1089/109662101753381566; Casarett DJ, 2000, J PAIN SYMPTOM MANAG, V20, P130, DOI 10.1016/S0885-3924(00)00164-0; Grande GE, 2000, PALLIATIVE MED, V14, P69, DOI 10.1191/026921600677940614; *NIH, 2004, IN PRESS NIH STAT OF; PATRICK DL, 2004, J NATL CANC I MONOGR, V32, P9; Rees E, 2003, BRIT MED J, V327, P198, DOI 10.1136/bmj.327.7408.198	7	20	21	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					735	737						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733702				2022-12-01	WOS:000227285300007
J	Knorr, W; Prentice, IC; House, JI; Holland, EA				Knorr, W; Prentice, IC; House, JI; Holland, EA			Long-term sensitivity of soil carbon turnover to warming	NATURE			English	Article							ORGANIC-MATTER; TEMPERATURE-DEPENDENCE; CO2 EMISSIONS; DECOMPOSITION; RESPIRATION; CLIMATE; MINERALIZATION; CONSTRAINTS; RESPONSES; EXCHANGE	The sensitivity of soil carbon to warming is a major uncertainty in projections of carbon dioxide concentration and climate(1). Experimental studies overwhelmingly indicate increased soil organic carbon (SOC) decomposition(2-8) at higher temperatures, resulting in increased carbon dioxide emissions from soils. However, recent findings have been cited as evidence against increased soil carbon emissions in a warmer world(9,10). In soil warming experiments, the initially increased carbon dioxide efflux returns to pre-warming rates within one to three years(10-14), and apparent carbon pool turnover times are insensitive to temperature(15). It has already been suggested that the apparent lack of temperature dependence could be an artefact due to neglecting the extreme heterogeneity of soil carbon(16), but no explicit model has yet been presented that can reconcile all the above findings. Here we present a simple three-pool model that partitions SOC into components with different intrinsic turnover rates. Using this model, we show that the results of all the soil-warming experiments are compatible with long-term temperature sensitivity of SOC turnover: they can be explained by rapid depletion of labile SOC combined with the negligible response of non-labile SOC on experimental timescales. Furthermore, we present evidence that non-labile SOC is more sensitive to temperature than labile SOC, implying that the long-term positive feedback of soil decomposition in a warming world may be even stronger than predicted by global models(1,17-20).	Max Planck Inst Biogeochem, D-07701 Jena, Germany; Univ Bristol, Dept Earth Sci, QUEST, Bristol BS8 1RJ, Avon, England; Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Max Planck Society; University of Bristol; National Center Atmospheric Research (NCAR) - USA	Knorr, W (corresponding author), Max Planck Inst Biogeochem, POB 100164, D-07701 Jena, Germany.	wknorr@bgc-jena.mpg.de	House, Joanna I/B-6477-2016	House, Joanna I/0000-0003-4576-3960; Holland, Elisabeth Ann/0000-0002-3570-621X				Agren GI, 2002, SOIL BIOL BIOCHEM, V34, P129, DOI 10.1016/S0038-0717(01)00156-0; Agren GI, 2000, AMBIO, V29, P55, DOI 10.1639/0044-7447(2000)029[0055:TDOOSO]2.0.CO;2; Bird MI, 1996, NATURE, V381, P143, DOI 10.1038/381143a0; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dalias P, 2001, SOIL BIOL BIOCHEM, V33, P1049, DOI 10.1016/S0038-0717(01)00009-8; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Gu LH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002119; Holland EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1137, DOI 10.1029/2000GB001264; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; JENKINSON DS, 1977, SOIL SCI SOC AM J, V41, P912, DOI 10.2136/sssaj1977.03615995004100050020x; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Jenny H, 1929, SOIL SCI, V27, P169, DOI 10.1097/00010694-192903000-00001; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Liski J, 1999, AMBIO, V28, P171; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Sanderman J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001833; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393	30	870	969	26	652	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					298	301		10.1038/nature03226	http://dx.doi.org/10.1038/nature03226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662420				2022-12-01	WOS:000226381300051
J	Keegan, BR; Feldman, JL; Begemann, G; Ingham, PW; Yelon, D				Keegan, BR; Feldman, JL; Begemann, G; Ingham, PW; Yelon, D			Retinoic acid signaling restricts the cardiac progenitor pool	SCIENCE			English	Article							ANTEROPOSTERIOR POLARITY; ZEBRAFISH HINDBRAIN; HEART MORPHOGENESIS; DIFFERENTIATION; PROLIFERATION; SPECIFICATION; SEGMENTATION; PATTERN; EMBRYO; RALDH2	Organogenesis begins with specification of a progenitor cell population, the size of which provides a foundation for the organ's final dimensions. Here, we present a new mechanism for regulating the number of progenitor cells by limiting their density within a competent region. We demonstrate that retinoic acid signaling restricts cardiac specification in the zebrafish embryo. Reduction of retinoic acid signaling causes formation of an excess of cardiomyocytes, via fate transformations that increase cardiac progenitor density within a multipotential zone. Thus, retinoic acid signaling creates a balance between cardiac and noncardiac identities, thereby refining the dimensions of the cardiac progenitor pool.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Univ Konstanz, Lehrstuhl Zool Evolutionary Biol, D-78457 Constance, Germany; Univ Sheffield, Sch Med, Dept Biomed Sci, Ctr Dev Genet, Sheffield S10 2TN, S Yorkshire, England	New York University; New York University; University of Konstanz; University of Sheffield	Yelon, D (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.	yelon@saturn.med.nyu.edu	Ingham, Philip W/E-6710-2010; Ingham, Philip W/G-9903-2011; Begemann, Gerrit/C-6223-2011; Ingham, Philip William/AAH-5884-2020	Ingham, Philip W/0000-0001-8224-9958; Begemann, Gerrit/0000-0001-7822-7617; Ingham, Philip William/0000-0001-8224-9958				Begemann G, 2001, DEVELOPMENT, V128, P3081; Begemann G, 2004, DEV BIOL, V271, P119, DOI 10.1016/j.ydbio.2004.03.033; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Chazaud C, 1999, DEVELOPMENT, V126, P2589; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Drysdale TA, 1997, DEV BIOL, V188, P205, DOI 10.1006/dbio.1997.8623; Goldstein AM, 1998, DEV BIOL, V201, P247, DOI 10.1006/dbio.1998.8976; Grandel H, 2002, DEVELOPMENT, V129, P2851; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; Linville A, 2004, DEV BIOL, V270, P186, DOI 10.1016/j.ydbio.2004.02.022; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Rones MS, 2000, DEVELOPMENT, V127, P3865; Schulze GE, 2001, TOXICOL SCI, V59, P297, DOI 10.1093/toxsci/59.2.297; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; STAINIER DYR, 1992, DEV BIOL, V153, P91, DOI 10.1016/0012-1606(92)90094-W; Stuckmann I, 2003, DEV BIOL, V255, P334, DOI 10.1016/S0012-1606(02)00078-7; YUTZEY KE, 1994, DEVELOPMENT, V120, P871	18	161	170	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2005	307	5707					247	249		10.1126/science.1101573	http://dx.doi.org/10.1126/science.1101573			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888GJ	15653502				2022-12-01	WOS:000226361900040
J	Jackson, R; Lawes, CMM; Bennett, DA; Milne, RJ; Rodgers, A				Jackson, R; Lawes, CMM; Bennett, DA; Milne, RJ; Rodgers, A			Treating Individuals 5 - Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk	LANCET			English	Article							CORONARY-HEART-DISEASE; PROSPECTIVELY-DESIGNED OVERVIEWS; SERUM-CHOLESTEROL; PRIMARY PREVENTION; NEW-ZEALAND; OPTIMAL AGE; HEALTH; PREDICTION; MANAGEMENT; EVENTS	In this review, we outline the rationale for targeting blood pressure and blood cholesterol lowering drug treatments to patients at high absolute cardiovascular risk, irrespective of their blood pressure or blood cholesterol levels. Because the specific levels of blood pressure and cholesterol are of little clinical relevance when considered in isolation from other risk factors, terms such as hypertension or hypercholesterolaemia have limited value. Separate management guidelines for raised blood pressure and blood cholesterol need to be replaced by integrated cardiovascular risk management guidelines, and absolute cardiovascular risk prediction scores should be used routinely. Since cardiovascular risk factors interact with each other, moderate reductions in several risk factors can be more effective than major reductions in one. An affordable daily pill combining low doses of various drugs could be useful for the many individuals with slightly abnormal cardiovascular risk factors.	Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Dept Med, Clin Trials Res Unit, Auckland 1, New Zealand	University of Auckland; University of Auckland	Jackson, R (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Epidemiol & Biostat Sect, POB 92019, Auckland 1, New Zealand.	rt.jackson@auckland.ac.nz	Bennett, Derrick/AAH-1220-2022; Bennett, Derrick/AFL-9254-2022; , Bennett/O-7998-2019	Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Jackson, Rod/0000-0001-5914-6934; Rodgers, Anthony/0000-0003-1282-1896				ALDERMAN MH, 1993, ANN INTERN MED, V119, P329, DOI 10.7326/0003-4819-119-4-199308150-00013; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], WORLD HLTH REP 2002; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Black N, 2003, BRIT MED J, V326, P2, DOI 10.1136/bmj.326.7379.2; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cruickshank J, 2001, LANCET, V358, P1994, DOI 10.1016/S0140-6736(01)06981-1; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Friedmann PD, 1996, ANN INTERN MED, V124, P414, DOI 10.7326/0003-4819-124-4-199602150-00005; Gold MR., 1996, COST EFFECTIVENESS H; Hall LML, 2003, BRIT MED J, V326, P251, DOI 10.1136/bmj.326.7383.251; Hawthorne V, 2002, HEART, V88, P222; IRWIG L, 1991, JAMA-J AM MED ASSOC, V266, P1678, DOI 10.1001/jama.266.12.1678; Isles CG, 2000, BMJ-BRIT MED J, V320, P690, DOI 10.1136/bmj.320.7236.690; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Jones DW, 2003, JAMA-J AM MED ASSOC, V289, P1027, DOI 10.1001/jama.289.8.1027; Kannel W B, 2000, J Atheroscler Thromb, V6, P60; KANNEL WB, 1976, AM J CARDIOL, V37, P269, DOI 10.1016/0002-9149(76)90323-4; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawes Carlene M M, 2002, Semin Vasc Med, V2, P355, DOI 10.1055/s-2002-36765; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lawes CMM, 2004, STROKE, V35, P776, DOI 10.1161/01.STR.0000116869.64771.5A; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lowensteyn I, 1998, PREV MED, V27, P730, DOI 10.1006/pmed.1998.0351; Lundin J, 2003, BRIT MED J, V326, P29, DOI 10.1136/bmj.326.7379.29; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Marshall T, 2000, BMJ-BRIT MED J, V321, P637; Milne Richard, 2003, N Z Med J, V116, pU662; Montgomery AA, 2000, BRIT MED J, V320, P686, DOI 10.1136/bmj.320.7236.686; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; Neal B, 2000, LANCET, V356, P1955; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Norris RM, 1998, BMJ-BRIT MED J, V316, P1065; *NZ GUID GROUP, MAN MILDL RAIS BLOOD; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pocock SJ, 2001, BMJ-BRIT MED J, V323, P75, DOI 10.1136/bmj.323.7304.75; Qizilbash N, 1995, LANCET, V346, P1647; Rodgers A, 1998, LANCET, V352, P1801; RODGERS A, 1997, NEUROL REV INT, V2, P12; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Shepherd J, 1996, LANCET, V348, P1339; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Trewby PN, 2002, CLIN MED, V2, P527, DOI 10.7861/clinmedicine.2-6-527; Turnbull F, 2003, LANCET, V362, P1527; Ulrich S, 2000, BMJ-BRIT MED J, V320, P1134, DOI 10.1136/bmj.320.7242.1134; Voss R, 2002, INT J EPIDEMIOL, V31, P1253, DOI 10.1093/ije/31.6.1253; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wood D, 2000, BRIT MED J, V320, P705, DOI 10.1136/bmj.320.7236.705; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	63	377	387	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2005	365	9457					434	441						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680460				2022-12-01	WOS:000226610900032
J	Shawcross, D; Jalan, R				Shawcross, D; Jalan, R			Dispelling myths in the treatment of hepatic encephalopathy	LANCET			English	Review							PORTAL-SYSTEMIC ENCEPHALOPATHY; BLIND CLINICAL-TRIAL; CEREBRAL-BLOOD-FLOW; ACUTE LIVER-FAILURE; INDUCED HYPERAMMONEMIA; INTERORGAN AMMONIA; BRAIN EDEMA; CIRRHOSIS; LACTULOSE; METABOLISM	Context Guidelines for the treatment of hepatic encephalopathy suggest ammonia reduction as the main focus, based on strategies to reduce ammonia's generation and absorption in the colon by using lactulose and a reduced protein diet. Starting point Two studies provide compelling and provocative data questioning the relevance of these interventions. Bodils Als-Nielsen and colleagues, in a systematic review of randomised trials, found insufficient evidence about whether non-absorbable disaccharides; are beneficial (BMJ 2004; 328: 1046-50). In a small randomised study, Juan Cordoba and colleagues showed that diets with normal protein content can be administered safely during episodic hepatic encephalopathy due to cirrhosis and that protein restriction does not have any beneficial effect during such episodes (J Hepatol 2004; 41: 38-43). Where next Two approaches to new therapies for hepatic encephalopathy are needed. First, it is important to focus on the interorgan metabolism of ammonia. The small intestine and kidneys might be important producers of ammonia, and muscle is an important organ that can remove ammonia. Novel therapies targeting these organs reduce ammonia. Second, research is needed to explore factors other than ammonia that might be important in hepatic encephalopathy, including the synergistic role of inflammation. The lack of conclusive data about the efficacy of any treatment supports the view that placebo-controlled trials of newer agents are needed and ethical. The emphasis should shift to aggressive management of the precipitating event.	UCL, Inst Hepatol, London WC1E 6HX, England	University of London; University College London	Jalan, R (corresponding author), UCL, Inst Hepatol, London WC1E 6HX, England.	r.jalan@ucLac.uk	Shawcross, Debbie Lindsay/H-9669-2012	Shawcross, Debbie Lindsay/0000-0001-6133-4619				Ahl B, 2004, HEPATOLOGY, V40, P73, DOI 10.1002/hep.20290; Als-Nielsen B, 2004, BMJ-BRIT MED J, V328, P1046, DOI 10.1136/bmj.38048.506134.EE; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Balata S, 2003, HEPATOLOGY, V37, P931, DOI 10.1053/jhep.2003.50156; BIRCHER J, 1966, LANCET, V1, P890; CONN HO, 1977, GASTROENTEROLOGY, V72, P573; Cordoba J, 2004, J HEPATOL, V41, P38, DOI 10.1016/j.jhep.2004.03.023; Cordoba J, 2001, J HEPATOL, V35, P598, DOI 10.1016/S0168-8278(01)00181-7; Damink SWMO, 2003, HEPATOLOGY, V37, P1277, DOI 10.1053/jhep.2003.50221; Damink SWMO, 2002, NEUROCHEM INT, V41, P177, DOI 10.1016/S0197-0186(02)00040-2; Damink SWMO, 2002, HEPATOLOGY, V36, P1163, DOI 10.1053/jhep.2002.36497; DEJONG CHC, 1993, J CLIN INVEST, V92, P2834, DOI 10.1172/JCI116903; Delcker AM, 2000, HEPATOLOGY, V32, p310A; ELKINGTON SG, 1969, NEW ENGL J MED, V281, P408, DOI 10.1056/NEJM196908212810803; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; GERMAIN L, 1973, ARCH FR MAL APP DIG, V62, P293; Jalan R, 2004, CLIN SCI, V106, P467, DOI 10.1042/CS20030357; Jalan R, 2003, METAB BRAIN DIS, V18, P37, DOI 10.1023/A:1021978618745; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Kircheis G, 1997, HEPATOLOGY, V25, P1351, DOI 10.1002/hep.510250609; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Master S, 1999, HEPATOLOGY, V30, P876, DOI 10.1002/hep.510300428; MULLEN KD, 1991, SEMIN LIVER DIS, V11, P292, DOI 10.1055/s-2008-1040447; NANCE FC, 1974, GASTROENTEROLOGY, V66, P108; RODGERS JB, 1973, AM J GASTROENTEROL, V60, P459; Romero-Gomez M, 2004, J HEPATOL, V41, P49, DOI 10.1016/j.jhep.2004.03.021; Rose C, 1999, HEPATOLOGY, V30, P636, DOI 10.1002/hep.510300311; Sen S, 2004, LIVER TRANSPLANT, V10, P1109, DOI 10.1002/lt.20236; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; SIMMONS F, 1970, GASTROENTEROLOGY, V59, P827; WEBER FL, 1979, GASTROENTEROLOGY, V77, P235; WOLPERT E, 1970, NEW ENGL J MED, V283, P159, DOI 10.1056/NEJM197007232830401	32	75	85	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					431	433						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680459	Green Submitted			2022-12-01	WOS:000226610900031
J	Spiliotis, ET; Kinoshita, M; Nelson, WJ				Spiliotis, ET; Kinoshita, M; Nelson, WJ			A mitotic septin scaffold required for mammalian chromosome congression and segregation	SCIENCE			English	Article							CENP-E; MICROTUBULE CAPTURE; BUDDING YEAST; PROTEIN-E; CHECKPOINT; CYTOKINESIS; COMPONENT; ACTIN; KINETOCHORES; ORGANIZATION	Coordination of cytokinesis with chromosome congression and segregation is critical for proper cell division, but the mechanism is unknown. Here, septins, a conserved family of polymerizing guanosine triphosphate-binding proteins, localized to the metaphase plate during mitosis. Septin depletion resulted in chromosome loss from the metaphase plate, lack of chromosome segregation and spindle elongation, and incomplete cytokinesis upon delayed mitotic exit. These defects correlated with loss of the mitotic motor and the checkpoint regulator centromere-associated protein E (CENP-E) from the kinetochores of congressing chromosomes. Mammalian septins may thus form a mitotic scaffold for CENP-E and other effectors to coordinate cytokinesis with chromosome congression and segregation.	Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Kyoto Univ, Grad Sch Med, Biochem & Cell Biol Unit, Horizontal Med Res Org, Kyoto 6068501, Japan	Stanford University; Kyoto University	Nelson, WJ (corresponding author), Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	wjnelson@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM035527, GM35527, R37 GM035527] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	27	188	197	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1781	1785		10.1126/science.1106823	http://dx.doi.org/10.1126/science.1106823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774761	Green Accepted			2022-12-01	WOS:000227883900047
J	Nakagawa, T; Sakurai, T; Nishioka, T; Touhara, K				Nakagawa, T; Sakurai, T; Nishioka, T; Touhara, K			Insect sex-pheromone signals mediated by specific combinations of olfactory receptors	SCIENCE			English	Article							MOTH HELIOTHIS-VIRESCENS; BOMBYX-MORI; FLY BRAIN; DROSOPHILA; ACTIVATION; MECHANISMS; RESPONSES; ANTHERAEA; SILKMOTH; NEURONS	We describe two mate-specific olfactory receptors (ORs) in the silk moth, Bombyx mori, that are mutually exclusively expressed in a pair of adjacent pheromone-sensitive neurons of mate antennae: One is specifically tuned to bombykol, the sex pheromone, and the other to bombykal, its oxidized form. Both pheromone ORs are coexpressed with an OR from the highly conserved insect OR subfamily. This coexpression promotes the functional expression of pheromone receptors and confers ligand-stimulated nonselective cation channel activity. The same effects were also observed for general ORs. Both odorant and pheromone signaling pathways are mediated by means of a common mechanism in insects.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan	University of Tokyo; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Nishioka, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan.	nishioka@scl.kyoto-u.ac.jp; touhara@k.u-tokyo.ac.jp						Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mori K, 1998, CHIRALITY, V10, P578, DOI 10.1002/(SICI)1520-636X(1998)10:7<578::AID-CHIR5>3.0.CO;2-Z; NAKAGAWA T, UNPUB; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; TOPAZZINI A, 1990, J INSECT PHYSIOL, V36, P619, DOI 10.1016/0022-1910(90)90065-N; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7	24	391	435	9	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1638	1642		10.1126/science.1106267	http://dx.doi.org/10.1126/science.1106267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15692016				2022-12-01	WOS:000227622400051
J	Snow, RW; Guerra, CA; Noor, AM; Myint, HY; Hay, SI				Snow, RW; Guerra, CA; Noor, AM; Myint, HY; Hay, SI			The global distribution of clinical episodes of Plasmodium falciparum malaria	NATURE			English	Article							MORTALITY; AFRICA; BURDEN; TRANSMISSION; POPULATION; MORBIDITY; CHILDREN; ABSENCE; DISEASE; WORLD	Interest in mapping the global distribution of malaria is motivated by a need to define populations at risk for appropriate resource allocation(1,2) and to provide a robust framework for evaluating its global economic impact(3,4). Comparison of older(5-7) and more recent(1,4) malaria maps shows how the disease has been geographically restricted, but it remains entrenched in poor areas of the world with climates suitable for transmission. Here we provide an empirical approach to estimating the number of clinical events caused by Plasmodium falciparum worldwide, by using a combination of epidemiological, geographical and demographic data. We estimate that there were 515 ( range 300 - 660) million episodes of clinical P. falciparum malaria in 2002. These global estimates are up to 50% higher than those reported by the World Health Organization ( WHO) and 200% higher for areas outside Africa, reflecting the WHO's reliance upon passive national reporting for these countries. Without an informed understanding of the cartography of malaria risk, the global extent of clinical disease caused by P. falciparum will continue to be underestimated.	KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, Nairobi 00100, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DS, England; Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	University of Oxford; University of Oxford; Mahidol University	Snow, RW (corresponding author), KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, POB 43640, Nairobi 00100, Kenya.	rsnow@wtnairobi.mimcom.net	Snow, Robert William/AFR-1436-2022; Hay, Simon I/F-8967-2015	Snow, Robert William/0000-0003-3725-6088; Hay, Simon I/0000-0002-0611-7272	Wellcome Trust [058992, 069045, 081829] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alles HK, 1998, PARASITOL TODAY, V14, P369, DOI 10.1016/S0169-4758(98)01296-4; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; *INT ASS MED ASS T, 2004, WORLD MAL RISK CHART; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; Lysenko AJ, 1968, ITOGI NAUKI MEDICINS, P25; Maitland K, 1997, T ROY SOC TROP MED H, V91, P562, DOI 10.1016/S0035-9203(97)90026-2; MAYFONG M, 2004, TRENDS PARASITOL, V20, P233; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Murray C. J. L., 1996, GLOBAL HLTH STAT COM; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Prusty SKR, 2001, ANN TROP MED PARASIT, V95, P133, DOI 10.1080/00034980120041080; RUSSELL PF, 1956, AM J TROP MED HYG, V5, P937, DOI 10.4269/ajtmh.1956.5.937; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; United Nations Development Program, 2003, HUM DEV REP 2003 MIL; *WHO, 2003, INT TRAV HLTH SIT 1; *WO, 1999, WORLD HLTH REP 1999	23	1988	2067	5	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2005	434	7030					214	217		10.1038/nature03342	http://dx.doi.org/10.1038/nature03342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759000	Green Accepted			2022-12-01	WOS:000227494500045
J	McMahon, BJ; Bruden, DL; Petersen, KM; Bulkow, LR; Parkinson, AJ; Nainan, O; Khristova, M; Zanis, C; Peters, H; Margolis, HS				McMahon, BJ; Bruden, DL; Petersen, KM; Bulkow, LR; Parkinson, AJ; Nainan, O; Khristova, M; Zanis, C; Peters, H; Margolis, HS			Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up	ANNALS OF INTERNAL MEDICINE			English	Article							YUPIK ESKIMO POPULATION; HEALTH-CARE WORKERS; LONG-TERM EFFICACY; VIRUS-INFECTION; SURFACE-ANTIGEN; CHILDHOOD VACCINATION; ALASKA NATIVES; CHILDREN; IMMUNOGENICITY; INFANTS	Background: The duration of protection afforded by hepatitis B vaccination is unknown. Objective: To determine antibody persistence and protection from hepatitis B virus (HBV) infection. Design: Prospective cohort study. Setting: 15 villages in southwest Alaska. Participants: 1578 Alaska Natives vaccinated at age 6 months or older. Intervention: During 1981-1982, participants received 3 doses of plasma-derived hepatitis 8 vaccine. This cohort was followed annually over the first 11 years, and 841 (53%) persons were tested at 15 years. Measurements: Antibody to hepatitis B surface antigen (anti-HBs), markers of HBV infection, and testing to identify HBV variants. Results: Levels of anti-HBs in the cohort decreased from a geometric mean concentration of 822 mIU/mL after vaccination to 27 mIU/mL at 15 years. Initial anti-HBs level, older age at vaccination, and male sex were associated with persistence of higher anti-HBs levels at 15 years when analyzed by a longitudinal linear mixed model. After adjustment for initial anti-HBs level and sex, those vaccinated at age 6 months to 4 years had the lowest anti-HBs level at 15 years. Asymptomatic breakthrough infections were detected in 16 participants and occurred more frequently in persons who did not respond to vaccination than those who responded (P = 0.01). Among infected persons with viremia, 2 were infected with wild-type HBV and 4 had HBV surface glycoprotein variants, generally accompanied by wild-type HBV. Limitations: The loss of participants to follow-up at 15 years was 47%. However, characteristics of persons tested were similar to those of persons lost to follow-up. Conclusions: Hepatitis B vaccination strongly protected against infection for at least 15 years in all age groups. Antibody levels decreased the most among persons immunized at 4 years of age or younger.	Ctr Dis Control & Prevent, Arct Invest Program, Natl Ctr Infect Dis, Anchorage, AK 99508 USA; Alaska Native Med Ctr, Anchorage, AK USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Alaska Native Medical Center; Centers for Disease Control & Prevention - USA	McMahon, BJ (corresponding author), Ctr Dis Control & Prevent, Arct Invest Program, Natl Ctr Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	bdm9@cdc.gov			ODCDC CDC HHS [U50/CCU022279] Funding Source: Medline	ODCDC CDC HHS		Barash C, 1999, ARCH INTERN MED, V159, P1481, DOI 10.1001/archinte.159.13.1481; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Bulkow LR, 1998, CLIN INFECT DIS, V26, P933, DOI 10.1086/513939; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DING LM, 1993, CLIN INFECT DIS, V17, P475; FORTUIN M, 1994, J INFECT DIS, V169, P1374, DOI 10.1093/infdis/169.6.1374; GOH KT, 1992, B WORLD HEALTH ORGAN, V70, P233; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; HADLER SC, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P766; Harpaz R, 2000, J INFECT DIS, V181, P413, DOI 10.1086/315259; HEYWARD WL, 1985, AM J EPIDEMIOL, V121, P914, DOI 10.1093/oxfordjournals.aje.a114061; Hino K, 1999, HEPATOLOGY, V30, p300A; Hsu HY, 1997, HEPATOLOGY, V26, P786, DOI 10.1053/jhep.1997.v26.pm0009303514; Huang LM, 1999, HEPATOLOGY, V29, P954, DOI 10.1002/hep.510290349; LAI CL, 1993, HEPATOLOGY, V18, P763, DOI 10.1002/hep.1840180403; Littell R.C., 2006, SAS SYSTEM MIXED MOD, DOI 10.1017/CBO9781107415324.004; MCMAHON BJ, 1993, AM J EPIDEMIOL, V138, P544; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; MCMAHON BJ, 2000, VIRAL HEPATITIS REV, V6, P229; MILNE A, 1994, J MED VIROL, V44, P113, DOI 10.1002/jmv.1890440202; Nainan OV, 1996, J VIROL METHODS, V61, P127, DOI 10.1016/0166-0934(96)02077-0; Nainan OV, 2002, J MED VIROL, V68, P319, DOI 10.1002/jmv.10206; Ni YH, 2001, ANN INTERN MED, V135, P796, DOI 10.7326/0003-4819-135-9-200111060-00009; Ogata N, 1999, HEPATOLOGY, V30, P779, DOI 10.1002/hep.510300309; PASKO MT, 1990, AM J PUBLIC HEALTH, V80, P590, DOI 10.2105/AJPH.80.5.590; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; STEVENS CE, 1992, PEDIATRICS, V90, P170; TABOR E, 1993, J MED VIROL, V40, P204, DOI 10.1002/jmv.1890400307; WAINWRIGHT RB, 1989, JAMA-J AM MED ASSOC, V261, P2362, DOI 10.1001/jama.261.16.2362; Wainwright RB, 1997, J INFECT DIS, V175, P674, DOI 10.1093/infdis/175.3.674; WAINWRIGHT RB, 1991, ARCH INTERN MED, V151, P1634, DOI 10.1001/archinte.151.8.1634; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; Williams JL, 2001, VACCINE, V19, P4081, DOI 10.1016/S0264-410X(01)00112-8; Wu JS, 1999, J INFECT DIS, V179, P1319, DOI 10.1086/314768; XU ZY, 1995, J INFECT DIS, V171, P54, DOI 10.1093/infdis/171.1.54; Yotsuyanagi H, 1998, HEPATOLOGY, V27, P1377, DOI 10.1002/hep.510270526; YVONNET B, 1987, J MED VIROL, V22, P315, DOI 10.1002/jmv.1890220404	38	215	227	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					333	341		10.7326/0003-4819-142-5-200503010-00008	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738452				2022-12-01	WOS:000227325100003
J	Machens, CK; Romo, R; Brody, CD				Machens, CK; Romo, R; Brody, CD			Flexible control of mutual inhibition: A neural model of two-interval discrimination	SCIENCE			English	Article							PARAMETRIC WORKING-MEMORY; PREFRONTAL CORTEX; DECISION-MAKING; PERSISTENT ACTIVITY; RECURRENT NETWORK; PREMOTOR CORTEX; REVERBERATION; MECHANISMS; DYNAMICS; STIMULI	Networks adapt to environmental demands by switching between distinct dynamical behaviors. The activity of frontal-lobe neurons during two-interval discrimination tasks is an example of these adaptable dynamics. Subjects first perceive a stimulus, then hold it in working memory, and finally make a decision by comparing it with a second stimulus. We present a simple mutual-inhibition network model that captures all three task phases within a single framework. The model integrates both working memory and decision making because its dynamical properties are easily controlled without changing its connectivity. Mutual inhibition between nonlinear units is a useful design motif for networks that must display multiple behaviors.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Cold Spring Harbor Laboratory; Universidad Nacional Autonoma de Mexico	Brody, CD (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	brody@cshl.edu		romo, ranulfo/0000-0003-3529-3635; Machens, Christian/0000-0003-1717-1562	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067991] Funding Source: NIH RePORTER; NIMH NIH HHS [1R01MH067991-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abarbanel HD, 2001, CURR OPIN NEUROBIOL, V11, P423, DOI 10.1016/S0959-4388(00)00229-4; BRODY C, UNPUB; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; BROWN E, IN PRESS INT J BIFUR; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Cowan N., 1999, MODELS WORKING MEMOR; Dayan P., 2001, THEORETICAL NEUROSCI; Green DG., 1966, SIGNAL DETECTION THE, DOI 10.1901/jeab.1969.12-475; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; HOPPENSTEADT FC, 1997, INTRO MATH NEURONS, P155; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Link SW, 1992, WAVE THEORY DIFFEREN; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Luce R.D., 1991, RESPONSE TIMES THEIR; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Moody SL, 1998, J NEUROSCI, V18, P399; MORISHITA I, 1972, KYBERNETIK, V11, P154, DOI 10.1007/BF00270672; RATCLIFF R, 1981, PSYCHOL REV, V88, P552, DOI 10.1037/0033-295X.88.6.552; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; Salinas E, 2003, NEURAL COMPUT, V15, P1439, DOI 10.1162/089976603321891756; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Seung HS., 2003, HDB BRAIN THEORY NEU, V2, P94; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WILSON HR, 1999, SPIKES DECISIONS ACT; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	39	337	339	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1121	1124		10.1126/science.1104171	http://dx.doi.org/10.1126/science.1104171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718474				2022-12-01	WOS:000227197300052
J	Morgan, JF; Murphy, H; Lacey, JH; Conway, G				Morgan, JF; Murphy, H; Lacey, JH; Conway, G			Long term psychological outcome for women with congenital adrenal hyperplasia: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							INTERSEX		Univ London St Georges Hosp, Sch Med, Dept Mental Hlth, London SW17 0RE, England; Middlesex Hosp, Dept Endocrinol, London W1T 3AA, England	St Georges University London; University of London; University College London	Morgan, JF (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Mental Hlth, London SW17 0RE, England.	jmorgan@sghms.ac.uk						COOPER P, 1982, BRIT J PSYCHIAT, V141, P68, DOI 10.1192/bjp.141.1.68; Creighton S, 2001, BMJ-BRIT MED J, V323, P1264, DOI 10.1136/bmj.323.7324.1264; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Meyer-Bahlburg HFL, 2001, ENDOCRIN METAB CLIN, V30, P155, DOI 10.1016/S0889-8529(08)70024-0; Slijper FME, 1998, ARCH SEX BEHAV, V27, P125, DOI 10.1023/A:1018670129611	5	27	27	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 12	2005	330	7487					340	341		10.1136/bmj.38334.427361.D3	http://dx.doi.org/10.1136/bmj.38334.427361.D3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897OZ	15677365	Bronze, Green Published			2022-12-01	WOS:000227015800018
J	Bitton, A; Neuman, MD; Barnoya, J; Glantz, SA				Bitton, A; Neuman, MD; Barnoya, J; Glantz, SA			The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest	LANCET			English	Article							TP53 MUTATION SPECTRUM; LUNG-CANCER; MUTAGENIC SIGNATURE; SMOKE; SCIENCE; COMPONENTS; HOTSPOTS; POLICIES; LESSONS	Mutations in the p53 tumour suppressor gene lead to uncontrolled cell division and are found in over 50% of all human tumours, including 60% of lung cancers. Research published in 1996 by Denissenko and colleagues demonstrated patterned in-vitro mutagenic effects on p53 of benzo[a]pyrene, a carcinogen present in tobacco smoke. We investigated the tobacco industry's response to p53 research linking smoking to cancer. We searched online tobacco document archives, including the Legacy Tobacco Documents Library and Tobacco Documents Online, and archives maintained by tobacco companies such as Philip Morris and R J Reynolds. Documents were also obtained from the British American Tobacco Company depository in Guildford, UK. Informal correspondence was carried out with scientists, lawyers, and tobacco control experts in the USA and Europe. We found that executives and scientists at the highest levels of the tobacco industry anticipated and carefully monitored p53 research. The tobacco industry's own scientists conducted research which appeared to cast doubt on the link between smoking and p53 mutations. Researchers and a journal editor with tobacco industry ties participated in the publication of this research in a peer-reviewed journal without clear disclosure of their tobacco industry links. Tobacco industry responses to research linking smoking to carcinogenic p53 mutations mirror prior industry efforts to challenge the science linking smoking and lung cancer. The extent of tobacco industry involvement in p53 research and the potential conflict of interest discussed here demonstrate the need for consistent standards for the disclosure and evaluation of such potential conflicts in biomedical research.	Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu		Barnoya, Joaquin/0000-0002-1731-479X	NATIONAL CANCER INSTITUTE [R01CA087472] Funding Source: NIH RePORTER; NCI NIH HHS [CA-87472] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM ASS CANC RES, 2000, AM ASS CANC RES 91 A; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Barnoya J, 2002, TOB CONTROL, V11, P305, DOI 10.1136/tc.11.4.305; BARNOYA J, IN PRESS EUR J PUB H; BINNS RM, 1988, COMMUNICATION   0506; BORELLI T, 1993, WALL STREET J   0728; BOULLIN J, 2004, COMMUNICATION; BOULLIN JM, 2003, COMMUNICATION; BOULLIN JM, 2001, COMMUNICATION   0404; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; Clever LH, 1997, ANN INTERN MED, V126, P36, DOI 10.7326/0003-4819-126-1-199701010-00006; COGGINS C, 2000, VERBANDT PAPER KEIN; DEMPSEY R, 1996, COMMUNICATION   1219; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DIETHELM PA, WHOLE TRUTH NOTHING; Drope J, 2001, J EPIDEMIOL COMMUN H, V55, P588, DOI 10.1136/jech.55.8.588; *ED BOARD, 2003, MUTAGENESIS; Francey N, 2000, BRIT MED J, V321, P371, DOI 10.1136/bmj.321.7257.371; Friedman LS, 2004, J GEN INTERN MED, V19, P51, DOI 10.1111/j.1525-1497.2004.30617.x; GERNTENBACH R, 1988, 135R1 COUNC TOB RES; GERTENBACH R, 1988, 135R2 COUNC TOB RES; Glantz SA., 1996, CIGARETTE PAPERS; GORI G, 1993, INVOICE CONSULTING; GORI G, 1992, INVOICE CONSULTATION; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hainaut P, 2001, MUTAGENESIS, V16, P551, DOI 10.1093/mutage/16.6.551; HAINAUT P, 2001, COMMUNICATION   0112; HELLER WD, 1999, AD HOC ARBEITSGRUPPE; Hernandez-Boussard TM, 1998, ENVIRON HEALTH PERSP, V106, P385, DOI 10.2307/3434065; Hirschhorn N, 2000, TOB CONTROL, V9, P242, DOI 10.1136/tc.9.2.242; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Hong MK, 2002, BRIT MED J, V325, P1413, DOI 10.1136/bmj.325.7377.1413; Horton R, 2003, BRIT MED J, V327, P503, DOI 10.1136/bmj.327.7413.503-a; *INBIFO, 1997, P53 ADD; *INT COMM MED J ED, 2001, UN REQ MAN SUBM BIOM; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; Krawczak M, 1998, MUTAGENESIS, V13, P319, DOI 10.1093/mutage/13.4.319; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; LAEK R, 2000, ANAL MISSENSE POINT; MASSEY ED, 1998, COMMUNICATION   0427; MASSEY ED, 1988, COMMUNICATION   0603; ME R, 1998, P53 MUTATIONS LUNG C; MUELLER T, 1996, TECHNICAL REV SCI PA; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; Muggli ME, 2001, AM J PUBLIC HEALTH, V91, P1419, DOI 10.2105/AJPH.91.9.1419; *NAT PUBL GROUP, ONC; Ong E, 2000, B WORLD HEALTH ORGAN, V78, P938; Ong EK, 2000, LANCET, V355, P1253, DOI 10.1016/S0140-6736(00)02098-5; Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749; PARRY JM, 2001, COMMUNICATION   0212; Paschke T, 2001, MUTAGENESIS, V16, P555, DOI 10.1093/mutage/16.6.555; Paschke T, 2000, MUTAGENESIS, V15, P457, DOI 10.1093/mutage/15.6.457; *PHIL MORR US, 2003, HLTH ISS; Rampton S, 2002, PUBLIC HEALTH REP, V117, P331, DOI 10.1016/S0033-3549(04)50169-3; RENNIE D, 1993, JAMA-J AM MED ASSOC, V270, P1742, DOI 10.1001/jama.270.14.1742; ROE F, 1993, FUTURE DIRECTIONS HL; Samet JM, 2001, AM J PUBLIC HEALTH, V91, P1742, DOI 10.2105/AJPH.91.11.1742; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13; SOLANA R, 1996, PM US SAYS NEW STUDY; THORNTON R, 1993, SMOKE CLUE CANC MUTA; THORNTON R, 1991, VISIT M CURIE RES I; THORNTON RE, 1991, VISIT US CANADA; THORNTON RE, 1993, SRG CONSULTANTS; THORNTON RE, 1993, NOTE TOBACCO STRATEG; TRICKER A, 1998, LIST ACCOUNTABILITIE; TRICKER A, 1998, TRIP REPORT; WYNDER EL, 1994, CANCER RES, V54, P5284; Yach D, 2001, AM J PUBLIC HEALTH, V91, P1745, DOI 10.2105/AJPH.91.11.1745; 1995, SCI RES REV COMMITTE; 2000, SCI RES REV COMMITTE; 1993, SMOKING HLTH REGULAT; 1999, POTENTIAL AREAS CONS; 1996, REV PREFERENTIAL FOR; 1996, BENZO ALPHA PYRENE P	77	19	19	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2005	365	9458					531	540						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894SS	15705463				2022-12-01	WOS:000226812500031
J	Frankino, WA; Zwaan, BJ; Stern, DL; Brakefield, PM				Frankino, WA; Zwaan, BJ; Stern, DL; Brakefield, PM			Natural selection and developmental constraints in the evolution of allometries	SCIENCE			English	Article							QUANTITATIVE VARIATION; SEXUAL SELECTION; BODY-SIZE; FLIGHT; BUTTERFLIES; SURVIVAL; CANALIZATION; DIOPSIDAE; INSECTS; DIPTERA	In animals, scaling relationships between appendages and body size exhibit high interspecific variation but low intraspecific variation. This pattern could result from natural selection for specific allometries or from developmental constraints on patterns of differential growth. We performed artificial selection on the allometry between forewing area and body size in a butterfly to test for developmental constraints, and then used the resultant increased range of phenotypic variation to quantify natural selection on the scaling relationship. Our results show that the short-term evolution of allometries is not limited by developmental constraints. Instead, scaling relationships are shaped by strong natural selection.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Leiden Univ, Inst Biol, Sect Evolutionary Biol, NL-2300 RA Leiden, Netherlands	Princeton University; Leiden University; Leiden University - Excl LUMC	Frankino, WA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	frankino@alumni.indiana.edu	Zwaan, Bas J/D-8721-2015	Zwaan, Bas J/0000-0002-8221-4998; Stern, David/0000-0002-1847-6483	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063622] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063622, R01 GM063622-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2003, COMP BIOMECHANICS; BURKHARDT D, 1987, ENTOMOL GEN, V12, P221; Dudley R., 2000, BIOMECHANICS INSECT; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.2307/2409478; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 1996, EVOLUTION, V50, P1219, DOI [10.2307/2410662, 10.1111/j.1558-5646.1996.tb02362.x]; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Falconer D. S., 1997, INTRO QUANTITATIVE G; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Huxley J.S., 1932, BIOMETRICS, V50, P893; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Kingsolver JG, 1999, EVOLUTION, V53, P1479, DOI 10.1111/j.1558-5646.1999.tb05412.x; Kingsolver JG, 2000, EVOL ECOL RES, V2, P593; Kooi RE, 1996, ENTOMOL EXP APPL, V80, P149, DOI 10.1007/BF00194745; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Srygley RB, 2000, BIOL J LINN SOC, V70, P707, DOI 10.1111/j.1095-8312.2000.tb00225.x; Stern DL, 1999, DEVELOPMENT, V126, P1091; STRAUSS RE, 1990, EVOLUTION, V44, P86, DOI 10.1111/j.1558-5646.1990.tb04281.x; Strauss Richard E., 1992, P157; Thompson DW., 1917, GROWTH FORM, DOI [10.5962/bhl.title.11332, DOI 10.5962/BHL.TITLE.11332]; Van Dyck H, 1999, TRENDS ECOL EVOL, V14, P172, DOI 10.1016/S0169-5347(99)01610-9; Wagner GP, 1997, EVOLUTION, V51, P329, DOI 10.1111/j.1558-5646.1997.tb02420.x; Wagner GP, 1996, AM ZOOL, V36, P36; WEBER KE, 1990, GENETICS, V126, P975; WICKMAN PO, 1992, EVOLUTION, V46, P1525, DOI 10.1111/j.1558-5646.1992.tb01142.x; WILKINSON GS, 1993, GENET RES, V62, P213, DOI 10.1017/S001667230003192X; Wolf JB, 2001, EVOLUTION, V55, P232	29	173	177	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					718	720		10.1126/science.1105409	http://dx.doi.org/10.1126/science.1105409			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692049	Green Accepted			2022-12-01	WOS:000226814900041
J	Kaufman, FR				Kaufman, FR			Intensive management of type 1 diabetes in young children	LANCET			English	Editorial Material							MELLITUS		Univ So Calif, Childrens Hosp, Keck Sch Med, Ctr Diabet Endocrinol & Metab, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California	Kaufman, FR (corresponding author), Univ So Calif, Childrens Hosp, Keck Sch Med, Ctr Diabet Endocrinol & Metab, Los Angeles, CA 90027 USA.	fkaufman@chla.usc.edu						Dahlquist G, 2000, ACTA PAEDIATR, V89, P1231, DOI 10.1080/080352500750027628; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Kaufman FR, 1999, DIABETES-METAB RES, V15, P338, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<338::AID-DMRR57>3.0.CO;2-Y; Kaufman FR, 2003, PEDIATR REV, V24, P291, DOI 10.1542/pir.24-9-291; Kaufman FR, 1999, J DIABETES COMPLICAT, V13, P31, DOI 10.1016/S1056-8727(98)00029-4; Kaufman Francine Ratner, 2002, Pediatr Diabetes, V3, P179, DOI 10.1034/j.1399-5448.2002.30402.x; Ryan CM, 1999, ENDOCRIN METAB CLIN, V28, P883, DOI 10.1016/S0889-8529(05)70107-9; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Weinzimer SA, 2004, PEDIATRICS, V114, P1601, DOI 10.1542/peds.2004-0092	9	8	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					737	738						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733703				2022-12-01	WOS:000227285300008
J	Grassly, NC; Fraser, C; Garnett, GP				Grassly, NC; Fraser, C; Garnett, GP			Host immunity and synchronized epidemics of syphilis across the United States	NATURE			English	Article							TRANSMISSION DYNAMICS; MODELS; GONORRHEA; MORTALITY; REGIONS; AIDS; MEN; SEX	A central question in population ecology is the role of 'exogenous' environmental factors versus density-dependent 'endogenous' biological factors in driving changes in population numbers(1). This question is also central to infectious disease epidemiology, where changes in disease incidence due to behavioural or environmental change must be distinguished from the nonlinear dynamics of the parasite population(2). Repeated epidemics of primary and secondary syphilis infection in the United States over the past 50 yr have previously been attributed to social and behavioural changes(3). Here, we show that these epidemics represent a rare example of unforced, endogenous oscillations in disease incidence, with an 8-11-yr period that is predicted by the natural dynamics of syphilis infection, to which there is partially protective immunity(4). This conclusion is supported by the absence of oscillations in gonorrhoea cases, where a protective immune response is absent(5,6). We further demonstrate increased synchrony of syphilis oscillations across cities over time, providing empirical evidence for an increasingly connected sexual network in the United States.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Grassly, NC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	n.grassly@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Grassly, Nicholas C/C-6381-2008; Garnett, Geoffrey P/A-9312-2008	Fraser, Christophe/0000-0003-2399-9657; Grassly, Nicholas C/0000-0001-6067-4507; 				Aral SO, 1996, SEX TRANSM DIS, V23, P9, DOI 10.1097/00007435-199601000-00005; Bailey N. T., 1975, MATH THEORY INFECT D; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Chatfield C., 2003, ANAL TIME SERIES INT, V6th, DOI 10.4324/9780203491683; Chesson HW, 2003, SEX TRANSM DIS, V30, P419, DOI 10.1097/00007435-200305000-00008; Cliff A, 1998, DECIPHERING GLOBAL E; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Garnett GP, 1999, PHILOS T R SOC B, V354, P787, DOI 10.1098/rstb.1999.0431; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Gibson Campbell, 1998, 27 US CENS BUR POP D; Greenberg Judith B, 2002, J Public Health Manag Pract, V8, P59; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HAMERS FF, 1995, AM J PUBLIC HEALTH, V85, P1104, DOI 10.2105/AJPH.85.8_Pt_1.1104; Hethcote H.W., 1984, LECT NOTES BIOMATH, V56; Hook EW, 1997, SEX TRANSM DIS, V24, P443, DOI 10.1097/00007435-199709000-00001; Kahn RH, 2002, SEX TRANSM DIS, V29, P285, DOI 10.1097/00007435-200205000-00006; Keeling MJ, 2002, ECOL LETT, V5, P20, DOI 10.1046/j.1461-0248.2002.00268.x; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Morgan CA, 2003, INFECT IMMUN, V71, P5605, DOI 10.1128/IAI.71.10.5605-5612.2003; Nakashima AK, 1996, SEX TRANSM DIS, V23, P16, DOI 10.1097/00007435-199601000-00006; Nasell I, 2002, MATH BIOSCI, V179, P1, DOI 10.1016/S0025-5564(02)00098-6; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Schmidt KA, 2001, SEX TRANSM DIS, V28, P555, DOI 10.1097/00007435-200110000-00001; *US DEP TRANSP BUR, 2003, NAT TRANSP STAT 2003; Wallace R, 1997, SOC SCI MED, V44, P935, DOI 10.1016/S0277-9536(96)00197-9; Wasserheit J.N., 1996, J INFECT DIS S2, V174, P201; Wolitski RJ, 2001, AM J PUBLIC HEALTH, V91, P883, DOI 10.2105/AJPH.91.6.883	30	154	159	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2005	433	7024					417	421		10.1038/nature03072	http://dx.doi.org/10.1038/nature03072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674292				2022-12-01	WOS:000226546200043
J	Lowell, BB; Shulmanz, GI				Lowell, BB; Shulmanz, GI			Mitochondrial dysfunction and type 2 diabetes	SCIENCE			English	Editorial Material							BETA-CELL LIPOTOXICITY; FREE FATTY-ACIDS; STIMULATED INSULIN-SECRETION; UNCOUPLING PROTEIN-2; RESISTANCE; OBESITY; FAILURE; MUSCLE; PATHOGENESIS; MECHANISMS	Maintenance of normal blood glucose levels depends on a complex interplay between the insulin responsiveness of skeletal muscle and liver and glucose-stimutated insulin secretion by pancreatic beta cells. Defects in the former are responsible for insulin resistance, and defects in the latter are responsible for progression to hyperglycemia. Emerging evidence supports the potentially unifying hypothesis that both of these prominent features of type 2 diabetes are caused by mitochondrial dysfunction.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Yale Univ, Sch Med, Dept Internal Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Yale University; Yale University	Lowell, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, 99 Brookline Ave, Boston, MA 02215 USA.	blowell@bidmc.harvard.edu; gerald.shulman@yale.edu	Northe, Hilda/I-1916-2012; Shulman, Gerald I./P-7176-2019	Northe, Hilda/0000-0002-8873-5014; Shulman, Gerald I./0000-0003-1529-5668	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK040936] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azen SP, 1998, CONTROL CLIN TRIALS, V19, P217, DOI 10.1016/S0197-2456(97)00151-7; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Brown JEP, 2002, FEBS LETT, V513, P189, DOI 10.1016/S0014-5793(02)02296-2; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Dufour E, 2004, BBA-BIOENERGETICS, V1658, P122, DOI 10.1016/j.bbabio.2004.04.020; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Gerich JE, 2003, MAYO CLIN PROC, V78, P447, DOI 10.4065/78.4.447; Hui HX, 2004, J CELL PHYSIOL, V200, P177, DOI 10.1002/jcp.20021; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Krempler F, 2002, DIABETES, V51, P3331, DOI 10.2337/diabetes.51.11.3331; Langin D, 2001, NEW ENGL J MED, V345, P1772, DOI 10.1056/NEJM200112133452412; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; LILLIOJA S, 1988, NEW ENGL J MED, V318, P1217, DOI 10.1056/NEJM198805123181901; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI200215001, 10.1172/JCI0215001]; Petersen M, 2003, DIABETES CARE, V26, P917; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Poitout V, 2004, ENDOCRINOLOGY, V145, P3563, DOI 10.1210/en.2004-0479; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; RANDLE PJ, 1963, LANCET, V1, P785; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Sasahara M, 2004, DIABETES, V53, P482, DOI 10.2337/diabetes.53.2.482; Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; VONDRA K, 1977, DIABETOLOGIA, V13, P527, DOI 10.1007/BF01234508; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Winzell MS, 2003, DIABETES, V52, P2057; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamashita T, 2004, ENDOCRINOLOGY, V145, P3566, DOI 10.1210/en.2003-1602; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	58	1497	1589	7	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					384	387		10.1126/science.1104343	http://dx.doi.org/10.1126/science.1104343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662004				2022-12-01	WOS:000226492300034
J	Kublin, JG; Patnaik, P; Jere, CS; Miller, WC; Hoffman, IF; Chimbiya, N; Pendame, R; Taylor, TE; Molyneux, ME				Kublin, JG; Patnaik, P; Jere, CS; Miller, WC; Hoffman, IF; Chimbiya, N; Pendame, R; Taylor, TE; Molyneux, ME			Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-HISTORY; VIRAL LOAD; IMMUNE ACTIVATION; HIV-INFECTION; TRANSMISSION; TUBERCULOSIS; REPLICATION; PARASITEMIA; INDUCTION	Background Raised HIV viral load in blood has been associated with accelerated disease progression and increased transmission of infection. To assess the effect of Plasmodium falciparum malaria on concentrations of HIV in blood, we did a prospective cohort study in Malawi. Methods We recruited 367 HIV-1-infected adults. Among 334 people aparasitaemic at baseline, 148 had at least one malaria episode during follow-up and received antimalarial treatment. Of these, 77 had HIV-1-RNA measurements at baseline, during malaria, and post-malaria. We used linear regression with generalised estimating equations to assess effect of four definitions of malaria (any parasitaemia, parasite density greater than or equal to2000/muL, febrile parasitaemia, and febrile parasitaemia with parasite density greater than or equal to2000/mul) on changes in log HIV-1 RNA, overall and by baseline CD4 count. Findings With malaria defined as any parasitaemia, HIV-1-RNA concentration almost doubled between baseline (median 96 215 copies per mL) and malaria (168 901 copies per mL), a 0.25 (95% CI 0.11-0.39) log increase in mean RNA concentration. HIV-1-RNA concentration fell to median 82 058 copies per mL by about 8-9 weeks postmalaria. Increases in HIV-1-RNA were greatest for people with fever, parasite density 2000/muL or greater, and CD4 count more than 300 cells per p,L, in whom concentrations rose from median 38 483 copies per mL at baseline to 196 098 copies per mL during malaria, a mean log increase of 0.82 (95% CI 0.55-1.10, p<0.0001), and fell to median 75 331 copies per mL post-malaria. People who remained aparasitaemic showed no changes in HIV-1-RNA concentration. Interpretation HIV-infected individuals with malaria have a significantly increased viral load, which might enhance HIV transmission and accelerate disease progression.	Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; Minist Hlth & Populat, Llongwe, Malawi; Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	University of Malawi; University of Malawi; University of Malawi; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Malawi	Kublin, JG (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,EL-500, Seattle, WA 98109 USA.	jkublin@fhcrc.com	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827; Kublin, James/0000-0003-1279-3741	FIC NIH HHS [D43 TWO1039-05 S1] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Artzrouni M, 2002, AIDS, V16, pW1; BATE CAW, 1988, IMMUNOLOGY, V64, P227; Chandramohan D, 1998, INT J EPIDEMIOL, V27, P296, DOI 10.1093/ije/27.2.296; Delley V, 2000, TROP MED INT HEALTH, V5, P404, DOI 10.1046/j.1365-3156.2000.00566.x; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Jaffar S, 2004, B WORLD HEALTH ORGAN, V82, P462; Lawn SD, 1999, AIDS, V13, P2231, DOI 10.1097/00002030-199911120-00005; Lyles CM, 1999, EUR J EPIDEMIOL, V15, P99, DOI 10.1023/A:1007556327269; Lyles RH, 1999, AIDS, V13, P341, DOI 10.1097/00002030-199902250-00006; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; Morgan D, 2001, NAT MED, V7, P143, DOI 10.1038/84564; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pisell TL, 2002, AIDS, V16, P1503, DOI 10.1097/00002030-200207260-00007; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rowland-Jones SL, 2002, MICROBES INFECT, V4, P1265, DOI 10.1016/S1286-4579(02)01655-6; Steketee RW, 1996, AM J TROP MED HYG, V55, P17, DOI 10.4269/ajtmh.1996.55.17; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Whitty CJM, 2002, LANCET, V359, P80, DOI 10.1016/S0140-6736(02)07300-2; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	29	179	191	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2005	365	9455					233	240		10.1016/S0140-6736(05)17743-5	http://dx.doi.org/10.1016/S0140-6736(05)17743-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887MG	15652606				2022-12-01	WOS:000226309600029
J	Hijri, M; Sanders, IR				Hijri, M; Sanders, IR			Low gene copy number shows that arbuscular mycorrhizal fungi inherit genetically different nuclei	NATURE			English	Article							GLOMUS-INTRARADICES; DNA CONTENT; DIVERSITY; GLOMALES	Arbuscular mycorrhizal fungi (AMF) are ancient asexually reproducing organisms that form symbioses with the majority of plant species, improving plant nutrition and promoting plant diversity(1,2). Little is known about the evolution or organization of the genomes of any eukaryotic symbiont or ancient asexual organism. Direct evidence shows that one AMF species is heterokaryotic; that is, containing populations of genetically different nuclei(3). It has been suggested, however, that the genetic variation passed from generation to generation in AMF is simply due to multiple chromosome sets (that is, high ploidy)(4). Here we show that previously documented genetic variation in Pol-like sequences, which are passed from generation to generation, cannot be due to either high ploidy or repeated gene duplications. Our results provide the clearest evidence so far for substantial genetic differences among nuclei in AMF. We also show that even AMF with a very large nuclear DNA content are haploid. An underlying principle of evolutionary theory is that an individual passes on one or half of its genome to each of its progeny. The coexistence of a population of many genomes in AMF and their transfer to subsequent generations, therefore, has far-reaching consequences for understanding genome evolution.	Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Lausanne	Sanders, IR (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	ian.sanders@unil.ch	Hijri, Mohamed/AAL-5737-2021; Sanders, Ian R/T-9988-2017; Hijri, Mohamed/ABC-5969-2021	Sanders, Ian R/0000-0002-9591-8214; Hijri, Mohamed/0000-0001-6112-8372				BIANCIOTTO V, 1992, MYCOL RES, V96, P1071, DOI 10.1016/S0953-7562(09)80118-4; Corradi N, 2004, FUNGAL GENET BIOL, V41, P262, DOI 10.1016/j.fgb.2003.11.001; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; GRAUT D, 2000, FUNDAMENTALS MOL EVO; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; Hijri M, 2004, FUNGAL GENET BIOL, V41, P253, DOI 10.1016/j.fgb.2003.10.011; Hosny M, 1998, GENOME, V41, P422, DOI 10.1139/gen-41-3-422; HOSNY M, 1997, GENOME SIZE GLOMALES; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; Pawlowska TE, 2004, NATURE, V427, P733, DOI 10.1038/nature02290; Rosendahl S, 1997, MOL ECOL, V6, P821, DOI 10.1046/j.1365-294X.1997.d01-213.x; Schussler A, 1999, NEW PHYTOL, V144, P205, DOI 10.1046/j.1469-8137.1999.00526.x; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932	14	130	144	3	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					160	163		10.1038/nature03069	http://dx.doi.org/10.1038/nature03069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650740				2022-12-01	WOS:000226252200038
J	Lindorff-Larsen, K; Best, RB; DePristo, MA; Dobson, CM; Vendruscolo, M				Lindorff-Larsen, K; Best, RB; DePristo, MA; Dobson, CM; Vendruscolo, M			Simultaneous determination of protein structure and dynamics	NATURE			English	Article							X-RAY; COUPLING-CONSTANTS; ORDER PARAMETERS; BACKBONE MOTION; NATIVE PROTEINS; NMR RELAXATION; UBIQUITIN; TRANSITION; SIMULATIONS; STATE	We present a protocol for the experimental determination of ensembles of protein conformations that represent simultaneously the native structure and its associated dynamics. The procedure combines the strengths of nuclear magnetic resonance spectroscopy-for obtaining experimental information at the atomic level about the structural and dynamical features of proteins-with the ability of molecular dynamics simulations to explore a wide range of protein conformations. We illustrate the method for human ubiquitin in solution and find that there is considerable conformational heterogeneity throughout the protein structure. The interior atoms of the protein are tightly packed in each individual conformation that contributes to the ensemble but their overall behaviour can be described as having a significant degree of liquid-like character. The protocol is completely general and should lead to significant advances in our ability to understand and utilize the structures of native proteins.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge	Vendruscolo, M (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk; mv245@cam.ac.uk	Best, Robert/H-7588-2016; Vendruscolo, Michele/F-5901-2012; Lindorff-Larsen, Kresten/K-6469-2014	Best, Robert/0000-0002-7893-3543; Vendruscolo, Michele/0000-0002-3616-1610; Lindorff-Larsen, Kresten/0000-0002-4750-6039				Benitez-Cardoza CG, 2004, BIOCHEMISTRY-US, V43, P5195, DOI 10.1021/bi0361620; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Best RB, 2004, J AM CHEM SOC, V126, P8090, DOI 10.1021/ja0396955; Best RB, 2004, J AM CHEM SOC, V126, P7734, DOI 10.1021/ja049078w; BONVIN AMJJ, 1993, PROTEINS, V15, P385, DOI 10.1002/prot.340150406; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 1999, J AM CHEM SOC, V121, P9645, DOI 10.1021/ja991309p; Chou JJ, 2003, J AM CHEM SOC, V125, P8959, DOI 10.1021/ja029972s; Choy WY, 2001, J MOL BIOL, V308, P1011, DOI 10.1006/jmbi.2001.4750; Clore GM, 2004, J AM CHEM SOC, V126, P2923, DOI 10.1021/ja0386804; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DePristo MA, 2004, STRUCTURE, V12, P831, DOI 10.1016/j.str.2004.02.031; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Fox T, 1996, PROTEINS, V25, P315, DOI 10.1002/(SICI)1097-0134(199607)25:3<315::AID-PROT4>3.0.CO;2-E; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; HOCH JC, 1985, BIOCHEMISTRY-US, V24, P3831, DOI 10.1021/bi00336a003; Johnson EC, 1999, STRUCTURE, V7, P967, DOI 10.1016/S0969-2126(99)80123-3; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kitao A, 2000, P NATL ACAD SCI USA, V97, P2064, DOI 10.1073/pnas.030540397; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Lee AL, 1999, J AM CHEM SOC, V121, P2891, DOI 10.1021/ja983758f; Lee AL, 2001, NATURE, V411, P501, DOI 10.1038/35078119; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Lindorff-Larsen K, 2004, J AM CHEM SOC, V126, P3291, DOI 10.1021/ja039250g; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; MIERKE DF, 1994, BIOPOLYMERS, V34, P559, DOI 10.1002/bip.360340411; Ottiger M, 1999, J AM CHEM SOC, V121, P4690, DOI 10.1021/ja984484z; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Peti W, 2002, J AM CHEM SOC, V124, P5822, DOI 10.1021/ja011883c; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; SCHEEK RM, 1991, NATO ADV SCI I A-LIF, V225, P209; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; STILLINGER FH, 1990, J CHEM PHYS, V93, P6013, DOI 10.1063/1.459488; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Vendruscolo M, 2003, J AM CHEM SOC, V125, P15686, DOI 10.1021/ja036523z; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wong CF, 2003, ANNU REV PHARMACOL, V43, P31, DOI 10.1146/annurev.pharmtox.43.100901.140216; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Zhou YQ, 1999, J MOL BIOL, V285, P1371, DOI 10.1006/jmbi.1998.2374	46	547	556	6	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2005	433	7022					128	132		10.1038/nature03199	http://dx.doi.org/10.1038/nature03199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	886TH	15650731				2022-12-01	WOS:000226252200029
J	Gilks, WP; Abou-Sleiman, PM; Gandhi, S; Jain, S; Singleton, A; Lees, AJ; Shaw, K; Bhatia, KP; Bonifati, V; Quinn, NP; Lynch, J; Healy, DG; Holton, JL; Revesz, T; Wood, NW				Gilks, WP; Abou-Sleiman, PM; Gandhi, S; Jain, S; Singleton, A; Lees, AJ; Shaw, K; Bhatia, KP; Bonifati, V; Quinn, NP; Lynch, J; Healy, DG; Holton, JL; Revesz, T; Wood, NW			Common LRRK2 mutation in idiopathic Parkinson's disease	LANCET			English	Article								Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant Parkinson's disease. Few mutations in this gene have been identified. We investigated the frequency of a common heterozygous mutation, 2877510G-->A, which produces a glycine to serine aminoacid substitution at codon 2019 (Gly2019Ser), in idiopathic Parkinson's disease. We assessed 482 patients with the disorder, of whom 263 had pathologically confirmed disease, by direct sequencing for mutations in exon 41 of LRRK2. The mutation was present in eight (1.6%) patients. We have shown that a common single Mendelian mutation is implicated in sporadic Parkinson's disease. We suggest that testing for this mutation will be important in the management and genetic counselling of patients with Parkinson's disease.	Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; Inst Neurol, Dept Motor Neurosci, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Reta Lila Weston Inst Neurol Studies, London, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; University of London; University College London	Wood, NW (corresponding author), Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	n.wood@ion.ucLac.uk	Singleton, Andrew B/C-3010-2009; Holton, Janice L/F-6831-2011; Gilks, William/P-9137-2015; Revesz, Tamas/A-8732-2010; Wood, Nicholas W/C-2505-2009; Lees, Andrew J/A-6605-2009	Holton, Janice L/0000-0002-3882-5249; Gilks, William/0000-0001-7814-3173; Revesz, Tamas/0000-0003-2501-0259; Wood, Nicholas W/0000-0002-9500-3348; Lees, Andrew J/0000-0002-2476-4385	NATIONAL INSTITUTE ON AGING [Z01AG000957, Z01AG000958, ZIAAG000958, ZIAAG000957] Funding Source: NIH RePORTER; Parkinson&apos;s UK [G-4062, G-4029] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Parkinson&apos;s UK(Parkinson&apos;s UK)		Healy DG, 2004, LANCET NEUROL, V3, P652, DOI 10.1016/S1474-4422(04)00905-6; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	5	581	610	1	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					415	416		10.1016/S0140-6736(05)17830-1	http://dx.doi.org/10.1016/S0140-6736(05)17830-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680457				2022-12-01	WOS:000226610900029
J	Giraldez, AJ; Cinalli, RM; Glasner, ME; Enright, AJ; Thomson, JM; Baskerville, S; Hammond, SM; Bartel, DP; Schier, AF				Giraldez, AJ; Cinalli, RM; Glasner, ME; Enright, AJ; Thomson, JM; Baskerville, S; Hammond, SM; Bartel, DP; Schier, AF			MicroRNAs regulate brain morphogenesis in zebrafish	SCIENCE			English	Article							RNA-INTERFERENCE; GENE-EXPRESSION; MESSENGER-RNAS; DICER; DROSOPHILA; CELLS; INITIATION; TARGETS; DIFFERENTIATION; MECHANISMS	MicroRNAs (miRNAs) are small RNAs that regulate gene expression posttranscriptionally. To block all miRNA formation in zebrafish, we generated maternal-zygotic dicer (MZdicer) mutants that disrupt the Dicer ribonuclease III and double-stranded RNA-binding domains. Mutant embryos do not process precursor miRNAs into mature miRNAs, but injection of preprocessed miRNAs restores gene silencing, indicating that the disrupted domains are dispensable for later steps in silencing. MZdicer mutants undergo axis formation and differentiate multiple cell types but display abnormal morphogenesis during gastrulation, brain formation, somitogenesis, and heart development. Injection of miR-430 miRNAs rescues the brain defects in MZdicer mutants, revealing essential roles for miRNAs during morphogenesis.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	New York University; New York University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Wellcome Trust Sanger Institute; University of North Carolina; University of North Carolina Chapel Hill	Giraldez, AJ (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.	giraldez@saturn.med.nyu.edu; schier@saturn.med.nyu.edu	Enright, Anton/F-3094-2011	Enright, Anton/0000-0002-6090-3100; Giraldez, Antonio/0000-0002-6823-137X; Schier, Alexander Franz/0000-0001-7645-5325; Glasner, Margaret/0000-0003-1818-1965				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; GLASNER ME, UNPUB; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	40	996	1144	6	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					833	838		10.1126/science.1109020	http://dx.doi.org/10.1126/science.1109020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774722				2022-12-01	WOS:000228986500042
J	Klein, RJ; Zeiss, C; Chew, EY; Tsai, JY; Sackler, RS; Haynes, C; Henning, AK; SanGiovanni, JP; Mane, SM; Mayne, ST; Bracken, MB; Ferris, FL; Ott, J; Barnstable, C; Hoh, J				Klein, RJ; Zeiss, C; Chew, EY; Tsai, JY; Sackler, RS; Haynes, C; Henning, AK; SanGiovanni, JP; Mane, SM; Mayne, ST; Bracken, MB; Ferris, FL; Ott, J; Barnstable, C; Hoh, J			Complement factor H polymorphism in age-related macular degeneration	SCIENCE			English	Article							GENOMEWIDE-SCAN; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; DISEASE; DRUSEN; ASSOCIATIONS; ACTIVATION; REGIONS; PROJECT; PROTEIN	Age-related macular degeneration (AMD) is a major cause of blindness in the elderly. We report a genome-wide screen of 96 cases and 50 controls for polymorphisms associated with AMD. Among 116,204 single-nucleotide polymorphisms genotyped, an intronic and common variant in the complement factor H gene (CFH) is strongly associated with AMD (nominal P value <10(-7)). in individuals homozygous for the risk allele, the likelihood of AMD is increased by a factor of 7.4 (95% confidence interval 2.9 to 19). Resequencing revealed a polymorphism in linkage disequilibrium with the Ask allele representing a tyrosine-histidine change at amino acid 402. This polymorphism is in a region of CFH that binds heparin and C-reactive protein. The CFH gene is located on chromosome 1 in a region repeatedly linked to AMD in family-based studies.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; NEI, Bethesda, MD 20892 USA; EMMES Corp, Rockville, MD 20850 USA; Yale Univ, WM Keck Facil, New Haven, CT 06511 USA	Yale University; Rockefeller University; Yale University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Emmes Corporation; Yale University	Hoh, J (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	josephine.hoh@yale.edu	SanGiovanni, John Paul/A-7605-2008; Mohammed, Imran/J-8271-2012; Klein, Robert/K-1888-2013; Barnstable, Colin/ABB-4822-2021; Barnstable, Colin/GLU-9219-2022; SanGiovanni, John Paul/AAU-3895-2020	Mohammed, Imran/0000-0002-8412-0768; Klein, Robert/0000-0003-3539-5391; Ferris, Frederick/0000-0002-4933-0639; SanGiovanni, John Paul/0000-0001-7199-7053; Barnstable, Colin/0000-0002-7011-4068	NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR016090] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015771, Z01EY000394] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K25HG000060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hayashi M, 2004, Ophthalmic Genet, V25, P111; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; McKay GJ, 2004, MOL VIS, V10, P682; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; TEMPLETON AR, 1987, GENETICS, V117, P343; Tuo JS, 2004, PROG RETIN EYE RES, V23, P229, DOI 10.1016/j.preteyeres.2004.02.001; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wistow G, 2002, MOL VIS, V8, P205	30	3152	3464	5	341	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					385	389		10.1126/science.1109557	http://dx.doi.org/10.1126/science.1109557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761122	Green Accepted			2022-12-01	WOS:000228492000044
J	Jamrozik, K				Jamrozik, K			Estimate of deaths attributable to passive smoking among UK adults: database analysis	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; LUNG-CANCER; OCCUPATIONAL-EXPOSURE; CIGARETTE-SMOKING; ISCHEMIC-STROKE; HEART-DISEASE; RISK	Objective To estimate deaths from passive smoking in employees of the hospitality industry as well as in the general workforce and general population of the United Kingdom. Design Calculation, using the formula for population attributable proportion, of deaths likely to have been caused by passive smoking at home and at work in the UK according to occupation. Sensitivity analyses to examine impact of varying assumptions regarding prevalence and risks of exposure. Setting National UK databases of causes of death, employment, structure of households, and prevalences of active and passive smoking. Main outcome measures Estimates of deaths due to passive smoking according to age group (< 65 or >= 65) and site of exposure (domestic or workplace). Results Across the United Kingdom as a whole, passive smoking at work is likely to be responsible for the deaths of more than two employed people per working day (617 deaths per year), including 54 deaths in the hospitality industry each year. Each year passive smoking at home might account for another 2700 deaths in persons aged 20-64 years and 8000 deaths among people aged >= 65. Conclusion Exposure at work might contribute up to one fifth of all deaths from passive smoking in the general population aged 20-64 years, and up to half of such deaths among employees of the hospitality industry. Adoption of smoke free policies in all workplaces and reductions in the general prevalence of active smoking would lead to substantial reductions in these avoidable deaths.	Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Queensland	Jamrozik, K (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia.	k.jamrozik@sph.uq.edu.au						*BMRB INT, 2002, COMP UK LAB FORC STA; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; DONNAN GA, 1989, LANCET, V2, P643; Glantz SA, 2000, TOB CONTROL, V9, P111; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; JARVIS MJ, 2001, QUANTITATIVE SURVEY; Johnsson T, 2003, AM J IND MED, V43, P523, DOI 10.1002/ajim.10207; KAWACHI I, 1989, NEW ZEAL MED J, V102, P337; Kurukulaaratchy RJ, 2004, PEDIATRICS, V113, P345, DOI 10.1542/peds.113.2.345; Law MR, 1996, BRIT MED BULL, V52, P22, DOI 10.1093/oxfordjournals.bmb.a011528; LEE PN, 1986, BRIT J CANCER, V54, P97, DOI 10.1038/bjc.1986.157; MCDONNELL S, 1991, AUSTRALIAN      0613, P3; MOLGAARD C A, 1986, Neuroepidemiology, V5, P88, DOI 10.1159/000110818; *NAT HLTH MED RES, 1997, HLTH EFF PASS SMOK S; Nurminen MM, 2001, J OCCUP ENVIRON MED, V43, P687, DOI 10.1097/00043764-200108000-00006; *OFF NAT STAT, EMPL WORKF JOBS IND; *OFF NAT STAT, GEN HOUS SURV LIV BR; *OFF NAT STAT, 2004, MID 2002 POP EST UK; *OFF NAT STAT, EMPL WORKF JOS IND; *OFF NAT STAT, MID 2002 POP EST UK; *OFF NAT STAT, DEATHS AG SEX UND CA; *SECT SKILLS DEV A, 2002, MARK ASS HOSP LEIS T; Stead LF, 2006, REP SCI COMM TOB HLT, DOI 10.1002/14651858.CD002850.pub2; The Office of Environmental Health Hazard Assessment, 1997, HLTH EFF EXP ENV TOB; TRICHOPOULOS D, 1981, INT J CANCER, V27, P1, DOI 10.1002/ijc.2910270102; Wakefield M, 2002, AUST NZ J PUBL HEAL, V26, P375, DOI 10.1111/j.1467-842X.2002.tb00190.x; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; White V, 2003, TOB CONTROL, V12, P67, DOI 10.1136/tc.12.suppl_2.ii67; WOODWARD A, 2000, DEATHS NZ ATTRIBUTAB; You RX, 1999, AM J PUBLIC HEALTH, V89, P572, DOI 10.2105/AJPH.89.4.572	32	81	83	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 9	2005	330	7495					812	+		10.1136/bmj.38370.496632.8F	http://dx.doi.org/10.1136/bmj.38370.496632.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915BZ	15741188	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000228273900014
J	Lawlor, DA; Ben-Shlomo, Y; Ebrahim, S; Smith, GD; Stansfeld, SA; Yarnell, JWG; Gallacher, JEJ				Lawlor, DA; Ben-Shlomo, Y; Ebrahim, S; Smith, GD; Stansfeld, SA; Yarnell, JWG; Gallacher, JEJ			Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEART		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Barts & London Queen Mary Univ London, Ctr Psychiat, London WC1E 7HU, England; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; Cardiff Univ, Dept Epidemiol Stat & Publ Hlth, Cardiff CF4 4XN, S Glam, Wales	University of Bristol; University of London; Queen Mary University London; Queens University Belfast; Cardiff University	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	d.a.lawlor@bristol.ac.uk	Davey Smith, George/A-7407-2013; Ben-Shlomo, Yoav/ABD-2004-2021	Davey Smith, George/0000-0002-1407-8314; Ben-Shlomo, Yoav/0000-0001-6648-3007; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lawlor, Debbie A/0000-0002-6793-2262				Golomb BA, 2002, J CLIN EPIDEMIOL, V55, P767, DOI 10.1016/S0895-4356(02)00407-9; Lawlor DA, 2003, BRIT MED J, V327, P1383, DOI 10.1136/bmj.327.7428.1383; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; STANSFELD SA, 1991, PSYCHOL MED, V21, P157, DOI 10.1017/S0033291700014744; Timonen M, 2005, BMJ-BRIT MED J, V330, P17, DOI 10.1136/bmj.38313.513310.F71	5	41	42	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 26	2005	330	7493					705	706		10.1136/bmj.38377.616921.F7	http://dx.doi.org/10.1136/bmj.38377.616921.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912IT	15684022	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000228071900017
J	Macq, J				Macq, J			Commentary: Trials should inform structures and processes needed for tailoring interventions	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; DESIGN		Free Univ Brussels, Sch Publ Hlth, Dept Hlth Syst & Policies, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Macq, J (corresponding author), Free Univ Brussels, Sch Publ Hlth, Dept Hlth Syst & Policies, CP 597,808 Route Lennik, B-1070 Brussels, Belgium.	jmacq@ulb.ac.be						Battersby MW, 2005, BRIT MED J, V330, P662, DOI 10.1136/bmj.330.7492.662; Cretin S, 2004, EVALUATION REV, V28, P28, DOI 10.1177/0193841X03256298; Kumpers S, 2002, PUBLIC ADMIN, V80, P339, DOI 10.1111/1467-9299.00307; Segal L, 2004, HEALTH POLICY, V69, P215, DOI 10.1016/j.healthpol.2004.02.001; Singh D, 2005, TRANSFORMING CHRONIC	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					665	666		10.1136/bmj.330.7492.665	http://dx.doi.org/10.1136/bmj.330.7492.665			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15775002	Green Published			2022-12-01	WOS:000227861700035
J	MacFadden, BJ				MacFadden, BJ			Fossil horses - Evidence for evolution	SCIENCE			English	Editorial Material									Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	MacFadden, BJ (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	bmacfadd@flmnh.uft.edu						Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Froehlich DJ, 2002, ZOOL J LINN SOC-LOND, V134, P141, DOI 10.1046/j.1096-3642.2002.00005.x; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Kelly Thomas S., 1995, Contributions in Science (Los Angeles), V455, P1; MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824; MACFADDEN BJ, 1992, FOSSIL HORSES SYSTEM; Nowak R. M., 1997, WALKERS MAMMALS WORL; Oakenfull E. Ann, 2000, Conservation Genetics, V1, P341, DOI 10.1023/A:1011559200897; SCHUCHERT C, 1940, MARSH PIONEER PALEON; Simpson G.G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764	10	86	91	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1728	1730		10.1126/science.1105458	http://dx.doi.org/10.1126/science.1105458			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774746				2022-12-01	WOS:000227883900030
J	Johnson, SM; Grosshans, H; Shingara, J; Byrom, M; Jarvis, R; Cheng, A; Labourier, E; Reinert, KL; Brown, D; Slack, FJ				Johnson, SM; Grosshans, H; Shingara, J; Byrom, M; Jarvis, R; Cheng, A; Labourier, E; Reinert, KL; Brown, D; Slack, FJ			RAS is regulated by the let-7 MicroRNA family	CELL			English	Article							C-ELEGANS; PATTERN-FORMATION; CELL FATES; SMALL RNAS; GENE; ENCODES; VULVAR; IDENTIFICATION; ACTIVATION; INHIBITION	MicroRNAs (miRNAs) are regulatory RNAs found in multicellular eukaryotes, including humans, where they are implicated in cancer. The let-7 miRNA times seam cell terminal differentiation in C. elegans. Here we show that the let-7 family negatively regulates let-60/RAS. Loss of let-60/RAS suppresses let-7, and the let-60/RAS 3'UTR contains multiple let-7 complementary sites (LCSs), restricting reporter gene expression in a let-7-dependent manner. mir-84, a let-7 family member, is largely absent in vulval precursor cell P6.p at the time that let-60/RAS specifies the 1 degrees vulval fate in that cell, and mir-84 overexpression suppresses the multivulva phenotype of activating let-60/ RAS mutations. The 3'UTRs of the human RAS genes contain multiple LCSs, allowing let-7 to regulate RAS expression. let-7 expression is lower in lung tumors than in normal lung tissue, while RAS protein is significantly higher in lung tumors, providing a possible mechanism for let-7 in cancer.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Ambion Inc, Austin, TX 78744 USA	Yale University	Slack, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	frank.slack@yale.edu	Vickers, Michael M/E-4095-2010; Grosshans, Helge/W-8931-2019; Johnson, Steven M/B-3940-2013; Ferrua, Camila/F-5439-2015; Jackson, Benjamin L/C-4297-2012	Grosshans, Helge/0000-0002-8169-6905; Ferrua, Camila/0000-0001-8071-377X; Labourier, Emmanuel/0000-0001-8010-0674; Johnson, Steven/0000-0002-7399-8153; Slack, Frank/0000-0001-8263-0409	NIGMS NIH HHS [GM62594, R01 GM062594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Ambros V, 1999, DEVELOPMENT, V126, P1947; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dent JA, 1998, MECH DEVELOP, V72, P179, DOI 10.1016/S0925-4773(98)00026-4; Eisenmann DM, 1997, GENETICS, V146, P553; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; HAN M, 1990, GENETICS, V126, P899; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE JH, 1994, GENE DEV, V8, P60, DOI 10.1101/gad.8.1.60; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MCKAY IA, 1986, EMBO J, V5, P2617, DOI 10.1002/j.1460-2075.1986.tb04542.x; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Michael MZ, 2003, MOL CANCER RES, V1, P882; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang MQ, 2001, CURR TOP DEV BIOL, V51, P189, DOI 10.1016/S0070-2153(01)51006-6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	56	2816	3144	4	293	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					635	647		10.1016/j.cell.2005.01.014	http://dx.doi.org/10.1016/j.cell.2005.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766527	Bronze			2022-12-01	WOS:000227771400010
J	Vergani, P; Lockless, SW; Nairn, AC; Gadsby, DC				Vergani, P; Lockless, SW; Nairn, AC; Gadsby, DC			CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MULTIDRUG-RESISTANCE PROTEIN; ABC TRANSPORTER; HYDROLYSIS; SUBUNIT; CYCLE; DIMER	ABC (ATP-binding cassette) proteins constitute a large family of membrane proteins that actively transport a broad range of substrates. Cystic fibrosis transmembrane conductance regulator ( CFTR), the protein dysfunctional in cystic fibrosis, is unique among ABC proteins in that its transmembrane domains comprise an ion channel. Opening and closing of the pore have been linked to ATP binding and hydrolysis at CFTR's two nucleotide-binding domains, NBD1 and NBD2 (see, for example, refs 1, 2). Isolated NBDs of prokaryotic ABC proteins dimerize upon binding ATP, and hydrolysis of the ATP causes dimer dissociation(3-5). Here, using single-channel recording methods on intact CFTR molecules, we directly follow opening and closing of the channel gates, and relate these occurrences to ATP-mediated events in the NBDs. We find that energetic coupling(6) between two CFTR residues, expected to lie on opposite sides of its predicted NBD1-NBD2 dimer interface, changes in concert with channel gating status. The two monitored side chains are independent of each other in closed channels but become coupled as the channels open. The results directly link ATP-driven tight dimerization of CFTR's cytoplasmic nucleotide-binding domains to opening of the ion channel in the transmembrane domains. This establishes a molecular mechanism, involving dynamic restructuring of the NBD dimer interface, that is probably common to all members of the ABC protein superfamily.	Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Yale Univ, Dept Psychiat, New Haven, CT 06519 USA	Rockefeller University; Rockefeller University; Rockefeller University; Yale University	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.	paola.vergani@rockefeller.edu; gadsby@rockefeller.edu	Vergani, Paola/C-2019-2008	Vergani, Paola/0000-0002-5422-4662; Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051767] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK051767, R01 DK051767-09] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Bakos E, 1997, BIOCHEM J, V323, P777, DOI 10.1042/bj3230777; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Fersht A, 1999, STRUCTURE MECH PROTE; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Horn C, 2003, J MOL BIOL, V334, P403, DOI 10.1016/j.jmb.2003.09.079; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Qian YM, 2001, J BIOL CHEM, V276, P38636, DOI 10.1074/jbc.M107025200; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673	28	326	332	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					876	880		10.1038/nature03313	http://dx.doi.org/10.1038/nature03313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729345	Green Accepted, Green Published			2022-12-01	WOS:000227174600045
J	Duster, T				Duster, T			Medicine - Race and reification in science	SCIENCE			English	Article							DNA; BLACKS		NYU, Inst Hist Prod Knowledge, New York, NY 10003 USA	New York University	Duster, T (corresponding author), NYU, Inst Hist Prod Knowledge, 269 Mercer St, New York, NY 10003 USA.	troy.duster@nyu.edu						Cooper RS, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-2; Cooper RS, 1998, HYPERTENSION, V32, P813, DOI 10.1161/01.HYP.32.5.813; Donohue JJ, 2001, J LAW ECON, V44, P367, DOI 10.1086/322810; Duster T., 2004, DNA CRIMINAL JUSTICE, P315; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GRIFFITH V, 2001, FINANCIAL TIMES 0309, P13; HACKER A, 1992, 2 NATIONS BLACK WHIT, P197; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Kahn J., COMMUNICATION; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; KLAG MJ, 1991, JAMA-J AM MED ASSOC, V265, P599, DOI 10.1001/jama.265.5.599; Knowles J, 2001, J POLIT ECON, V109, P203, DOI 10.1086/318603; LAZER D, 2004, DNA CRIMINAL JUSTICE, P1; Lowe AL, 2001, FORENSIC SCI INT, V119, P17, DOI 10.1016/S0379-0738(00)00387-X; Mauer M, 1999, RACE INCARCERATE; *NITROMED INC, 2005, PR NEWSWIRE US  0111; Shriver MD, 1997, AM J HUM GENET, V60, P957; Simonov VI, 2003, NATO SCI SER II-MATH, V126, P1; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Whitehead AN., 1929, PROCESS REALITY, P11	21	233	237	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1050	1051		10.1126/science.1110303	http://dx.doi.org/10.1126/science.1110303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718453				2022-12-01	WOS:000227197300028
J	Dacey, DM; Liao, HW; Peterson, BB; Robinson, FR; Smith, VC; Pokorny, J; Yau, KW; Gamlin, PD				Dacey, DM; Liao, HW; Peterson, BB; Robinson, FR; Smith, VC; Pokorny, J; Yau, KW; Gamlin, PD			Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN	NATURE			English	Article							ACTION SPECTRUM; S-CONE; BRIGHTNESS; RESPONSES; ADAPTATION; PATHWAY; HUMANS; SYSTEM; MIDGET	Human vision starts with the activation of rod photoreceptors in dim light and short (S)-, medium (M)-, and long (L)-wavelength-sensitive cone photoreceptors in daylight. Recently a parallel, non-rod, non-cone photoreceptive pathway, arising from a population of retinal ganglion cells, was discovered in nocturnal rodents(1). These ganglion cells express the putative photopigment melanopsin and by signalling gross changes in light intensity serve the subconscious, 'non-image-forming' functions of circadian photoentrainment and pupil constriction(1-7). Here we show an anatomically distinct population of 'giant', melanopsin-expressing ganglion cells in the primate retina that, in addition to being intrinsically photosensitive, are strongly activated by rods and cones, and display a rare, S-Off, ( L + M)-On type of colour-opponent receptive field. The intrinsic, rod and (L + M) cone-derived light responses combine in these giant cells to signal irradiance over the full dynamic range of human vision. In accordance with cone-based colour opponency, the giant cells project to the lateral geniculate nucleus, the thalamic relay to primary visual cortex. Thus, in the diurnal trichromatic primate, 'non-image-forming' and conventional 'image-forming' retinal pathways are merged, and the melanopsin-based signal might contribute to conscious visual perception.	Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Univ Chicago, Vis Sci Labs, Chicago, IL 60637 USA; Univ Alabama Birmingham, Vis Sci Res Ctr, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; University of Chicago; University of Alabama System; University of Alabama Birmingham	Dacey, DM (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	dmd@u.washington.edu	Gamlin, Paul/W-2169-2019	Gamlin, Paul/0000-0002-2966-4762; Robinson, Farrel/0000-0002-3903-8327; Dacey, Dennis/0000-0001-8476-5585	NATIONAL EYE INSTITUTE [R01EY006837, R37EY006837, R01EY014596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-15, R01 EY006837, R01 EY006837-18, R01 EY006837-16A1, R37 EY006837, R01 EY006837-17, R01 EY014596-01, R37 EY006837-15S1, R01 EY014596] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-01, R01 DC006904] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; BARLOW RB, 1976, VISION RES, V16, P1291, DOI 10.1016/0042-6989(76)90056-0; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hannibal J, 2004, INVEST OPHTH VIS SCI, V45, P4202, DOI 10.1167/iovs.04-0313; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Kaufman L, 1986, HDB PERCEPTION HUMAN, Vfirst, P1; KAYAMA Y, 1979, J NEUROPHYSIOL, V42, P1495, DOI 10.1152/jn.1979.42.6.1495; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Klug K, 2003, J NEUROSCI, V23, P9881; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MARROCCO RT, 1975, BRAIN RES, V86, P128, DOI 10.1016/0006-8993(75)90644-7; MOLLON JD, 1989, DIE FARBE, V35, P139; Packer O, 2001, VISION RES, V41, P427, DOI 10.1016/S0042-6989(00)00271-6; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; VALBERG A, 1986, VISION RES, V26, P1061, DOI 10.1016/0042-6989(86)90040-4	30	899	929	4	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					749	754		10.1038/nature03387	http://dx.doi.org/10.1038/nature03387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716953				2022-12-01	WOS:000227039200041
J	Qiu, XD; Kumbalasiri, T; Carlson, SM; Wong, KY; Krishna, V; Provencio, I; Berson, DM				Qiu, XD; Kumbalasiri, T; Carlson, SM; Wong, KY; Krishna, V; Provencio, I; Berson, DM			Induction of photosensitivity by heterologous expression of melanopsin	NATURE			English	Article							RETINAL GANGLION-CELLS; TRP CHANNELS; RESPONSES; PHOTOTRANSDUCTION; MELANOPHORES; CURRENTS; OPSIN	Melanopsin(1-8) has been proposed to be the photopigment of the intrinsically photosensitive retinal ganglion cells (ipRGCs)(7-15); these photoreceptors of the mammalian eye drive circadian and pupillary adjustments through direct projections to the brain(5,6,8 - 14,16 - 18). Their action spectrum (lambda(max) approximate to 480 nm) implicates an opsin(10) and melanopsin is the only opsin known to exist in these cells. Melanopsin is required for ipRGC photosensitivity(13) and for behavioural photoresponses that survive disrupted rod and cone function(14,17). Heterologously expressed melanopsin apparently binds retinaldehyde and mediates photic activation of G proteins(19). However, its amino- acid sequence differs from vertebrate photosensory opsins(1,20) and some have suggested that melanopsin may be a photoisomerase, providing retinoid chromophore to an unidentified opsin(3,20). To determine whether melanopsin is a functional sensory photopigment, here we transiently expressed it in HEK293 cells that stably expressed TRPC3 channels. Light triggered a membrane depolarization in these cells and increased intracellular calcium. The light response resembled that of ipRGCs, with almost identical spectral sensitivity (lambda(max) approximate to 479 nm). The phototransduction pathway included Gq or a related G protein, phospholipase C and TRPC3 channels. We conclude that mammalian melanopsin is a functional sensory photopigment, that it is the photopigment of ganglion-cell photoreceptors, and that these photoreceptors may use an invertebrate-like phototransduction cascade.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA	Brown University; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Box 1953, Providence, RI 02912 USA.	David_Berson@brown.edu		Wong, Kwoon/0000-0001-9279-7827; Provencio, Ignacio/0000-0003-1175-920X				Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Bellingham J, 2002, CELL TISSUE RES, V309, P57, DOI 10.1007/s00441-002-0573-4; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, ANN MED, V34, P401, DOI 10.1080/078538902320772151; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Oh EJ, 2003, J NEUROPHYSIOL, V90, P2069, DOI 10.1152/jn.00026.2003; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rollag MD, 2000, METHOD ENZYMOL, V316, P291; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	32	320	368	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					745	749		10.1038/nature03345	http://dx.doi.org/10.1038/nature03345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15674243				2022-12-01	WOS:000227039200040
J	Kazakova, SV; Hageman, JC; Matava, M; Srinivasan, A; Phelan, L; Garfinkel, B; Boo, T; McAllister, S; Anderson, J; Jensen, B; Dodson, D; Lonsway, D; McDougal, LK; Arduino, M; Fraser, VJ; Killgore, G; Tenover, FC; Cody, S; Jernigan, DB				Kazakova, SV; Hageman, JC; Matava, M; Srinivasan, A; Phelan, L; Garfinkel, B; Boo, T; McAllister, S; Anderson, J; Jensen, B; Dodson, D; Lonsway, D; McDougal, LK; Arduino, M; Fraser, VJ; Killgore, G; Tenover, FC; Cody, S; Jernigan, DB			A clone of methicillin-resistant Staphylococcus aureus among professional football players	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCIBLE CLINDAMYCIN RESISTANCE; PANTON-VALENTINE LEUKOCIDIN; COMMUNITY; INFECTIONS; DISEASES	BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging cause of infections outside of health care settings. We investigated an outbreak of abscesses due to MRSA among members of a professional football team and examined the transmission and microbiologic characteristics of the outbreak strain. METHODS: We conducted a retrospective cohort study and nasal-swab survey of 84 St. Louis Rams football players and staff members. S. aureus recovered from wound, nasal, and environmental cultures was analyzed by means of pulsed-field gel electrophoresis (PFGE) and typing for resistance and toxin genes. MRSA from the team was compared with other community isolates and hospital isolates. RESULTS: During the 2003 football season, eight MRSA infections occurred among 5 of the 58 Rams players (9 percent); all of the infections developed at turf-abrasion sites. MRSA infection was significantly associated with the lineman or linebacker position and a higher body-mass index. No MRSA was found in nasal or environmental samples; however, methicillin-susceptible S. aureus was recovered from whirlpools and taping gel and from 35 of the 84 nasal swabs from players and staff members (42 percent). MRSA from a competing football team and from other community clusters and sporadic cases had PFGE patterns that were indistinguishable from those of the Rams' MRSA; all carried the gene for Panton-Valentine leukocidin and the gene complex for staphylococcal-cassette-chromosome mec type IVa resistance (clone USA300-0114). CONCLUSIONS: We describe a highly conserved, community-associated MRSA clone that caused abscesses among professional football players and that was indistinguishable from isolates from various other regions of the United States.	CDCP, Epidem Intelligence Serv, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; Missouri Dept Hlth & Senior Serv, St Louis, MO USA; BJC Med Grp, St Louis, MO USA; St Louis Rams Profess Football Team, St Louis, MO USA; Santa Clara Cty Hlth Dept, Off Dis Control, San Jose, CA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Washington University (WUSTL); Washington University (WUSTL)	Kazakova, SV (corresponding author), CDCP, Epidem Intelligence Serv, Div Healthcare Qual Promot, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A35, Atlanta, GA 30333 USA.	srk7@cdc.gov	Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X; Fraser, Victoria/0000-0001-6251-0733				Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P919; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Dorman JM, 2000, J AM COLL HEALTH, V49, P105, DOI 10.1080/07448480009596291; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; GOODMAN RA, 1994, JAMA-J AM MED ASSOC, V271, P862, DOI 10.1001/jama.271.11.862; HAGEMAN J, 2004, INT C EM INF DIS ATL; Jorgensen JH, 2004, J CLIN MICROBIOL, V42, P1800, DOI 10.1128/JCM.42.4.1800-1802.2004; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Letertre C, 2003, MOL CELL PROBE, V17, P227, DOI 10.1016/S0890-8508(03)00058-6; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Luby S, 2002, AM J TROP MED HYG, V67, P430, DOI 10.4269/ajtmh.2002.67.430; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; Maslow Joel N., 1993, P563; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; *NAT COMM CLIN LAB, 2004, M100S14 NAT COMM S14, V24; *NAT CTR HLTH STAT, 2004, 2002 NAT AMB MED CAR; *NAT CTR HLTH STAT, 2004, 2002 NAT HOSP AMB ME; Schreckenberger PC, 2004, J CLIN MICROBIOL, V42, P2777, DOI 10.1128/JCM.42.6.2777-2779.2004; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; 2003, MMWR MORB MORTAL WKL, V52, P793; 2003, MMWR MORB MORTAL WKL, V52, P992	25	552	585	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2005	352	5					468	475		10.1056/NEJMoa042859	http://dx.doi.org/10.1056/NEJMoa042859			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893NE	15689585				2022-12-01	WOS:000226725400007
J	Garne, D; Watson, M; Chapman, S; Byrne, F				Garne, D; Watson, M; Chapman, S; Byrne, F			Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry	LANCET			English	Article							SECONDHAND SMOKE; 2ND-HAND SMOKE; DOCUMENTS; RISK	In the late 1980s, the international tobacco industry assisted in the establishment of the International Society of the Built Environment, which published the journal Indoor and Built Environment. Using evidence from tobacco industry documents, we examine the industry associations of the Society's executive, the journal's editor and board, and the extent to which the journal publishes papers on environmental tobacco smoke that would be deemed favourable by the tobacco industry. The society's executive has been dominated by paid consultants to the tobacco industry: all six members in 1992 and seven of eight members in 2002 had financial associations through industry lawyers. 67% of the editorial board in 1992 and 66% in 2002 had histories of financial associations with the tobacco industry. 61% (40/66) of papers related to environmental tobacco smoke published in Indoor and Built Environment in the study period reached conclusions that could be judged to be industry-positive. Of these, 90% (36/40) had at least one author with a history of association with the tobacco industry. The executive of the International Society of the Built Environment and the editorial board of Indoor and Built Environment are in large part consisted of people with histories of consultancies to the tobacco industry. On the basis of the evidence presented in this paper, there is a serious concern the tobacco industry may have been unduly influential on the content of the journal.	Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	simonchapman@health.usyd.edu.au	Chapman, Simon/D-4114-2009		NCI NIH HHS [R01 CA87110-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087110] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguinaga Bialous S., 2002, PROFITS PEOPLE TOBAC; Assunta M, 2004, Tob Control, V13 Suppl 2, pii4, DOI 10.1136/tc.2003.005199; Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Barnoya J, 2002, TOB CONTROL, V11, P305, DOI 10.1136/tc.11.4.305; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P241, DOI 10.1001/jama.274.3.241; BRIGGS D, 1987, TI M WASH MARCH 18 1; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P769; Drope J, 2004, TOB CONTROL, V13, P41, DOI 10.1136/tc.2003.004101; Drope J, 2001, J EPIDEMIOL COMMUN H, V55, P588, DOI 10.1136/jech.55.8.588; Glantz SA., 1996, CIGARETTE PAPERS; GREEN C, 1987, JOINT TAC VDC JTI TI; GREEN C, COMMUNICATION   0406; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; Hirschhorn N, 2001, TOB CONTROL, V10, P375, DOI 10.1136/tc.10.4.375; Hong MK, 2002, BRIT MED J, V325, P1413, DOI 10.1136/bmj.325.7377.1413; International Committee of Medical Journal Editors, UN REQ MAN SUBM BIOM; Lee K, 2004, ADDICTION, V99, P394, DOI 10.1111/j.1360-0443.2004.00718.x; Liberman J, 2002, TOB CONTROL, V11, P271, DOI 10.1136/tc.11.3.271; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; Ong EK, 2000, LANCET, V355, P1253, DOI 10.1016/S0140-6736(00)02098-5; *SAG PUBL, IND BUILT ENV	23	28	29	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					804	809		10.1016/S0140-6736(05)17990-2	http://dx.doi.org/10.1016/S0140-6736(05)17990-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733724				2022-12-01	WOS:000227285300030
J	Fabra, M; Raldua, D; Power, DM; Deen, PMT; Cerda, J				Fabra, M; Raldua, D; Power, DM; Deen, PMT; Cerda, J			Marine fish egg hydration is aquaporin-mediated	SCIENCE			English	Article							WATER CHANNELS; BUOYANCY; OOCYTES		Ctr Aquaculture, Inst Recerca & Tecnol Agroalimentaries, Tarragona, Spain; Reference Ctr Aquaculture, Barcelona, Spain; Univ Algarve, Ctr Marine Sci, Faro, Portugal; Radboud Univ Nijmegen Med Ctr, Dept Physiol, Nijmegen, Netherlands	IRTA; Universidade do Algarve; Radboud University Nijmegen	Cerda, J (corresponding author), Ctr Aquaculture, Inst Recerca & Tecnol Agroalimentaries, Tarragona, Spain.	jcerda@icm.csic.es	Deen, P.M.T./H-8023-2014; Raldúa, Demetrio/K-6661-2014; Deen, Peter MT/B-9854-2013; Power, Deborah M/D-3333-2011; Raldua, Demetrio/N-9910-2019; Cerdà, Joan/M-1099-2016	Deen, P.M.T./0000-0002-7868-4655; Raldúa, Demetrio/0000-0001-5256-1641; Deen, Peter MT/0000-0002-7868-4655; Power, Deborah M/0000-0003-1366-0246; Raldua, Demetrio/0000-0001-5256-1641; Cerdà, Joan/0000-0003-2568-6398				Adlandsvik B, 2001, FISH RES, V50, P59, DOI 10.1016/S0165-7836(00)00242-3; Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; MELLINGER J, 1994, ANN BIOL-PARIS, V33, P117; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Selman K, 2001, J EXP ZOOL, V290, P265, DOI 10.1002/jez.1057	5	106	113	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					545	545		10.1126/science.1106305	http://dx.doi.org/10.1126/science.1106305			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681377	Green Submitted			2022-12-01	WOS:000226694000037
J	Gerber, LR; Hyrenbach, KD; Zacharias, MA				Gerber, LR; Hyrenbach, KD; Zacharias, MA			Ecology - Do the largest protected areas conserve whales or whalers?	SCIENCE			English	Editorial Material							MANAGEMENT; RESERVES; OCEAN		Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA; Duke Univ, Marine Lab, Beaufort, NC 28516 USA; Univ Victoria, Dept Geog, Victoria, BC V8W 3P5, Canada	Arizona State University; Arizona State University-Tempe; Duke University; University of Victoria	Gerber, LR (corresponding author), Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA.	Leah.Gerber@asu.edu; khyrenba@duke.edu; Mark.Zacharias@uvic.ca		Gerber, Leah/0000-0002-6763-6842				Ainley D. G., 2002, Marine Ornithology, V30, P55; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Bannister J.D., 2002, ENCY MARINE MAMMALS, P62; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Clapham PJ, 2003, BIOSCIENCE, V53, P210, DOI 10.1641/0006-3568(2003)053[0210:WAS]2.0.CO;2; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; DAVIS CR, 2004, SC56SOS2 IWC; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; *IWC, 1999, ANN REP INT WHAL COM, P42; Mills CE, 1998, CONSERV BIOL, V12, P244, DOI 10.1046/j.1523-1739.1998.96475.x; Murray SN, 1999, FISHERIES, V24, P11, DOI 10.1577/1548-8446(1999)024&lt;0011:NRN&gt;2.0.CO;2; Reilly S.B., 1984, REP INT WHAL COMM SP, V6, P389; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Stafford KM, 2004, DEEP-SEA RES PT I, V51, P1337, DOI 10.1016/j.dsr.2004.05.007; YOUNG NM, 2002, UNDERSTANDING REVISE; ZACHARIAS MA, 2004, SC56SOS5 IWC	18	12	15	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					525	526		10.1126/science.1106120	http://dx.doi.org/10.1126/science.1106120			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681370				2022-12-01	WOS:000226694000030
J	Park, BJ; Kang, JW; Lee, SW; Choi, SJ; Shin, YK; Ahn, YH; Choi, YH; Choi, DH; Lee, KS; Kim, S				Park, BJ; Kang, JW; Lee, SW; Choi, SJ; Shin, YK; Ahn, YH; Choi, YH; Choi, DH; Lee, KS; Kim, S			The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR	CELL			English	Article							TRANSFER-RNA SYNTHETASE; CELL-CYCLE; DNA-DAMAGE; CHECKPOINT PATHWAY; CANCER CELLS; ATM; GENE; COMPLEX; MICE; PHOSPHORYLATION	p18 was first identified as a factor associated with a macromolecular tRNA synthetase complex. Here we describe the mouse p18 loss-of-function phenotype and a role for p18 in the DNA damage response. Inactivation of both p18 alleles caused embryonic lethality, while heterozygous mice showed high susceptibility to spontaneous tumors. p18 was induced and translocated to the nucleus in response to DNA damage. Expression of p18 resulted in elevated p53 levels, while p18 depletion blocked p53 induction. p18 directly interacted with ATM/ATR in response to DNA damage. The activity of ATM was dependent on the level of p18, suggesting the requirement of p18 for the activation of ATM. Low p18 expression was frequently observed in different human cancer cell lines and tissues. These results suggest that p18 is a haploinsufficient tumor suppressor and a key factor for ATM/ATR-mediated p53 activation.	Seoul Natl Univ, Natl Creat Res Initiat Ctr ARS Network, Coll Pharm, Seoul 151742, South Korea; Soonchunhyang Univ, Dept Surg, Coll Med, Seoul 140743, South Korea; Hanyang Univ, Dept Surg, Coll Med, Seoul 133791, South Korea; Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon, South Korea	Seoul National University (SNU); Soonchunhyang University; Hanyang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, S (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr ARS Network, Coll Pharm, Seoul 151742, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020; Shin, Young Kee/C-8929-2011	Shin, Young Kee/0000-0003-0896-718X; Ahn, Young Ha/0000-0002-6843-5444				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Baumgartner AK, 2003, LAB INVEST, V83, P1509, DOI 10.1097/01.LAB.0000090157.13040.58; BHATIA K, 1993, FASEB J, V7, P951, DOI 10.1096/fasebj.7.10.8344493; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; French JE, 2001, CARCINOGENESIS, V22, P99, DOI 10.1093/carcin/22.1.99; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Ide F, 2003, AM J PATHOL, V163, P1729, DOI 10.1016/S0002-9440(10)63531-6; ISAACS WB, 1991, CANCER RES, V51, P4716; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Ko YG, 2002, PROTEOMICS, V2, P1304, DOI 10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lin WC, 2001, GENE DEV, V15, P1833; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Quevillon S, 1996, FEBS LETT, V395, P63, DOI 10.1016/0014-5793(96)01005-8; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Takai H, 2000, GENE DEV, V14, P1439; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wang VW, 2001, CANCER RES, V61, P4169; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	38	106	115	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					209	221		10.1016/j.cell.2004.11.054	http://dx.doi.org/10.1016/j.cell.2004.11.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680327	Bronze			2022-12-01	WOS:000226740000010
J	Mendelson, TC; Shaw, KL				Mendelson, TC; Shaw, KL			Sexual behaviour: Rapid speciation in an arthropod	NATURE			English	Editorial Material							SELECTION; DIVERSITY		Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Mendelson, TC (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	tamram@lehigh.edu	Mendelson, Tamra/GSN-8151-2022					Carson Hampton L., 1995, P14; Coyne J.A., 2004, SPECIATION; Knight ME, 2004, P ROY SOC B-BIOL SCI, V271, P675, DOI 10.1098/rspb.2003.2639; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; McCune Amy R., 1997, P585; Mendelson TC, 2004, MOL ECOL, V13, P3787, DOI 10.1111/j.1365-294X.2004.02375.x; Mendelson TC, 2002, GENETICA, V116, P301, DOI 10.1023/A:1021244812270; Otte D., 1994, SITY HAWAII; Parsons YM, 2001, MOL ECOL, V10, P1765, DOI 10.1046/j.1365-294X.2001.01318.x; Pomiankowski A, 1998, P NATL ACAD SCI USA, V95, P5106, DOI 10.1073/pnas.95.9.5106; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Shaw Kerry L., 1995, P39; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	13	313	317	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					375	376		10.1038/433375a	http://dx.doi.org/10.1038/433375a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674280				2022-12-01	WOS:000226546200031
J	Holt, NE; Zigmantas, D; Valkunas, L; Li, XP; Niyogi, KK; Fleming, GR				Holt, NE; Zigmantas, D; Valkunas, L; Li, XP; Niyogi, KK; Fleming, GR			Carotenoid cation formation and the regulation of photosynthetic light harvesting	SCIENCE			English	Article							PHOTOSYSTEM-II; ARABIDOPSIS MUTANTS; XANTHOPHYLL CYCLE; PURPLE BACTERIA; PSBS PROTEIN; ENERGY; PLANTS; PHOTOPROTECTION; COMPLEXES; STATE	Photosynthetic light harvesting in excess light is regulated by a process known as feedback deexcitation. Femtosecond transient absorption measurements on thylakoid membranes show selective formation of a carotenoid radical cation upon excitation of chlorophyll under conditions of maximum, steady-state feedback deexcitation. Studies on transgenic Arabidopsis thaliana plants confirmed that this carotenoid radical cation formation is correlated with feedback deexcitation and requires the presence of zeaxanthin, the specific carotenoid synthesized during high light exposure. These results indicate that energy transfer from chlorophyll molecules to a chlorophyll-zeaxanthin heterodimer, which then undergoes charge separation, is the mechanism for excess energy dissipation during feedback deexcitation.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	grfleming@lbl.gov	Zigmantas, Donatas/E-5541-2014	Zigmantas, Donatas/0000-0003-2007-5256				BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Dreuw A, 2003, PHYS CHEM CHEM PHYS, V5, P3247, DOI 10.1039/b304944b; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jeevarajan JA, 1996, J PHYS CHEM-US, V100, P5637, DOI 10.1021/jp9530663; Kodis G, 2004, J PHYS CHEM B, V108, P414, DOI 10.1021/jp036139o; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nield J, 2000, PHILOS T R SOC B, V355, P1337, DOI 10.1098/rstb.2000.0695; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pan JX, 2004, J AM CHEM SOC, V126, P3066, DOI 10.1021/ja031775l; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Polivka T, 2004, J PHYS CHEM B, V108, P15398, DOI 10.1021/jp0483019; Polivka T, 2002, J PHYS CHEM B, V106, P11016, DOI 10.1021/jp025752p; Tracewell CA, 2003, BIOCHEMISTRY-US, V42, P9127, DOI 10.1021/bi0345844; Zigmantas D, 2002, P NATL ACAD SCI USA, V99, P16760, DOI 10.1073/pnas.262537599	25	618	637	8	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					433	436		10.1126/science.1105833	http://dx.doi.org/10.1126/science.1105833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662017				2022-12-01	WOS:000226492300050
J	Packer, C; Hilborn, R; Mosser, A; Kissui, B; Borner, M; Hopcraft, G; Wilmshurst, J; Mduma, S; Sinclair, ARE				Packer, C; Hilborn, R; Mosser, A; Kissui, B; Borner, M; Hopcraft, G; Wilmshurst, J; Mduma, S; Sinclair, ARE			Ecological change, group territoriality, and population dynamics in Serengeti lions	SCIENCE			English	Article							AFRICAN LIONS; PANTHERA-LEO	Territorial behavior is expected to buffer populations against short-term environmental perturbations, but we have found that group living in African lions causes a complex response to long-term ecological change. Despite numerous gradual changes in prey availability and vegetative cover, regional populations of Serengeti lions remained stable for 10- to 20-year periods and only shifted to new equilibria in sudden leaps. Although gradually improving environmental conditions provided sufficient resources to permit the subdivision of preexisting territories, regional lion populations did not expand until short-term conditions supplied enough prey to generate large cohorts of surviving young. The results of a simulation model show that the observed pattern of "saltatory equilibria" results from the lions' grouping behavior.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98105 USA; Frankfurt Zool Soc, Arusha, Tanzania; Pk Canada, Ecosyst Serv, Winnipeg, MB R3B 0R9, Canada; Univ British Columbia, Ctr Biodivers Res, Vancouver, BC VLT 1Z4, Canada; Tanzanian Wildlife Res Inst, Arusha, Tanzania	University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of British Columbia	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	packer@cbs.umn.edu	Hilborn, Ray W/D-6332-2013					Hanby J. P., 1995, SERENGETI, P315; Hanby JP, 1979, SERENGETI DYNAMICS E, P249; HAWKINS D. M., 1998, CUMULATIVE SUM CONTR; Hawkins DM, 2002, STAT MED, V21, P1913, DOI 10.1002/sim.1013; Heinsohn R, 1996, P ROY SOC B-BIOL SCI, V263, P475, DOI 10.1098/rspb.1996.0071; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; HOPCRAFT JGC, IN PRESS J ANIM ECOL; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; KREBS CJ, 1972, ECOLOGY EXPT ANAL DI; KREBS J R, 1971, Ecology (Washington D C), V52, P2, DOI 10.2307/1934734; Kruuk H., 1985, P521; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; Packer C., 1988, P363; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Sinclair A. R. E., 1979, SERENGETI DYNAMICS E, P82; VANORSDOL KG, 1985, J ZOOL, V206, P97; Wynne-Edwards V. C., 1962, pUnpaginated	20	178	181	3	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					390	393		10.1126/science.1105122	http://dx.doi.org/10.1126/science.1105122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662005				2022-12-01	WOS:000226492300036
J	Dickinson, M; Farman, G; Frye, M; Bekyarova, T; Gore, D; Maughan, D; Irving, T				Dickinson, M; Farman, G; Frye, M; Bekyarova, T; Gore, D; Maughan, D; Irving, T			Molecular dynamics of cyclically contracting insect flight muscle in vivo	NATURE			English	Article							X-RAY-DIFFRACTION; DROSOPHILA-MELANOGASTER; MYOSIN-FILAMENTS; CROSS-BRIDGES; TARGET ZONES; ACTIN; REFLECTIONS; ACTIVATION; EFFICIENCY; STRETCH	Flight in insects-which constitute the largest group of species in the animal kingdom-is powered by specialized muscles located within the thorax. In most insects each contraction is triggered not by a motor neuron spike but by mechanical stretch imposed by antagonistic muscles(1). Whereas 'stretch activation' and its reciprocal phenomenon 'shortening deactivation' are observed to varying extents in all striated muscles, both are particularly prominent in the indirect flight muscles of insects(1). Here we show changes in thick-filament structure and actin-myosin interactions in living, flying Drosophila with the use of synchrotron small-angle X-ray diffraction. To elicit stable flight behaviour and permit the capture of images at specific phases within the 5-ms wingbeat cycle, we tethered flies within a visual flight simulator(2). We recorded images of 340 mus duration every 625 mus to create an eight-frame diffraction movie, with each frame reflecting the instantaneous structure of the contractile apparatus. These time-resolved measurements of molecular-level structure provide new insight into the unique ability of insect flight muscle to generate elevated power at high frequency.	IIT, Dept BCPS, BioCAT, Chicago, IL 60616 USA; CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; IIT, Dept BCPS, CSRRI, Chicago, IL 60616 USA; Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	Illinois Institute of Technology; California Institute of Technology; Illinois Institute of Technology; University of Vermont	Irving, T (corresponding author), IIT, Dept BCPS, BioCAT, Chicago, IL 60616 USA.	irving@iit.edu		Frye, Mark/0000-0003-3277-3094				Agianian B, 2004, EMBO J, V23, P772, DOI 10.1038/sj.emboj.7600097; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; ALKHAYAT HA, 1995, J MOL BIOL, V252, P611, DOI 10.1006/jmbi.1995.0524; Chan WP, 1996, J EXP BIOL, V199, P2767; DICKINSON MH, 1995, SCIENCE, V268, P87, DOI 10.1126/science.7701346; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Huxley HE, 1998, ADV EXP MED BIOL, V453, P281; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; Huxley HE, 2003, BIOPHYS J, V84, p139A; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0; Irving TC, 2000, NUCL INSTRUM METH A, V448, P250, DOI 10.1016/S0168-9002(99)00732-9; Irving TC, 2000, BIOPHYS J, V78, P2511, DOI 10.1016/S0006-3495(00)76796-8; Josephson RK, 2000, J EXP BIOL, V203, P2713; Juanhuix J, 2001, BIOPHYS J, V80, P1429, DOI 10.1016/S0006-3495(01)76115-2; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; Littlefield KP, 2003, AM J PHYSIOL-CELL PH, V284, pC1031, DOI 10.1152/ajpcell.00474.2002; MENETRET JF, 1990, J MUSCLE RES CELL M, V11, P1, DOI 10.1007/BF01833321; MILLER A, 1970, NATURE, V226, P1060, DOI 10.1038/2261060a0; Reedy MC, 2000, J CELL SCI, V113, P3551; REEDY MK, 1965, NATURE, V207, P1276, DOI 10.1038/2071276a0; REEDY MK, 1985, J MOL BIOL, V185, P145, DOI 10.1016/0022-2836(85)90188-3; SPARROW J, 1991, J CELL SCI, P73; Squire J, 1981, STRUCTURAL BASIS MUS; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; Tregear RT, 2004, BIOPHYS J, V86, P3009, DOI 10.1016/S0006-3495(04)74350-7; Tregear RT, 1998, BIOPHYS J, V74, P1439, DOI 10.1016/S0006-3495(98)77856-7; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; WEISFOGH T, 1965, 12TH P INT C ENT, P186	30	64	67	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					330	333		10.1038/nature03230	http://dx.doi.org/10.1038/nature03230			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662427				2022-12-01	WOS:000226381300059
J	Kotera, E; Tasaka, M; Shikanai, T				Kotera, E; Tasaka, M; Shikanai, T			A pentatricopeptide repeat protein is essential for RNA editing in chloroplasts	NATURE			English	Article							NUCLEUS-ENCODED FACTOR; CYCLIC ELECTRON FLOW; MESSENGER-RNA; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; RESTORES FERTILITY; PHOTOSYSTEM-I; SITE; PLANTS	RNA editing is a process of RNA maturation involved in the insertion, deletion or modification of nucleotides(1). In organellar transcripts of higher plants, specific cytidine residues are converted into uridine residues. In many cases, editing results in the restoration of conserved amino acid residues, a process that is essential for protein function in plastids(2,3). Despite the technical breakthrough in establishing systems in vivo(4) and in vitro(5) for analysing RNA editing, its machinery still remains to be identified in higher plants. Here we introduce a genetic approach and report the discovery of a gene responsible for the specific RNA editing event in the chloroplast.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kyushu Univ, Grad Sch Agr, Fukuoka 8128581, Japan	Nara Institute of Science & Technology; Kyushu University	Shikanai, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	shikanai@agr.kyushu-u.ac.jp	Shikanai, Toshiharu/AAK-9112-2020					Aubourg S, 2000, PLANT MOL BIOL, V42, P603, DOI 10.1023/A:1006352315928; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; BOCK R, 1994, EMBO J, V13, P4623, DOI 10.1002/j.1460-2075.1994.tb06784.x; Chateigner-Boutin AL, 2003, NUCLEIC ACIDS RES, V31, P2586, DOI 10.1093/nar/gkg354; CHAUDHURI S, 1995, EMBO J, V14, P2951, DOI 10.1002/j.1460-2075.1995.tb07295.x; Coffin JW, 1997, CURR GENET, V32, P273, DOI 10.1007/s002940050277; del Campo EM, 2002, J BIOL CHEM, V277, P36457, DOI 10.1074/jbc.M204500200; Fisk DG, 1999, EMBO J, V18, P2621, DOI 10.1093/emboj/18.9.2621; GLEGE P, 1999, P NATL ACAD SCI USA, V96, P15324; Guera A, 2000, PLANT CELL PHYSIOL, V41, P49, DOI 10.1093/pcp/41.1.49; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Hirose T, 1997, EMBO J, V16, P6804, DOI 10.1093/emboj/16.22.6804; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Koizuka N, 2003, PLANT J, V34, P407, DOI 10.1046/j.1365-313X.2003.01735.x; LURIN C, PLANT CELL, V16, P2089; Lutz KA, 2001, CURR GENET, V40, P214, DOI 10.1007/s002940100242; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Miyamoto T, 2004, P NATL ACAD SCI USA, V101, P48, DOI 10.1073/pnas.0307163101; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; Sasaki Y, 2001, J BIOL CHEM, V276, P3937, DOI 10.1074/jbc.M008166200; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 1999, PLANT CELL PHYSIOL, V40, P1134, DOI 10.1093/oxfordjournals.pcp.a029498; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith HC, 1997, RNA, V3, P1105; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Yamazaki H, 2004, PLANT J, V38, P152, DOI 10.1111/j.1365-313X.2004.02035.x	30	418	450	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					326	330		10.1038/nature03229	http://dx.doi.org/10.1038/nature03229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662426				2022-12-01	WOS:000226381300058
J	Xu, XD; Yang, DM; Ding, JH; Wang, W; Chu, PH; Dalton, ND; Wang, HY; Bermingham, JR; Ye, Z; Liu, F; Rosenfeld, MG; Manley, JL; Ross, J; Chen, J; Xiao, RP; Cheng, HP; Fu, XD				Xu, XD; Yang, DM; Ding, JH; Wang, W; Chu, PH; Dalton, ND; Wang, HY; Bermingham, JR; Ye, Z; Liu, F; Rosenfeld, MG; Manley, JL; Ross, J; Chen, J; Xiao, RP; Cheng, HP; Fu, XD			ASF/SF2-Regulated CaMKII delta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle	CELL			English	Article							PROTEIN-KINASE-II; MESSENGER-RNA; DILATED CARDIOMYOPATHY; ISOFORM; ASF/SF2; GENE; SC35; HYPERTROPHY; DISRUPTION; MECHANISMS	The transition from juvenile to adult life is accompanied by programmed remodeling in many tissues and organs, which is key for organisms to adapt to the demand of the environment. Here we report a novel regulated alternative splicing program that is crucial for postnatnal heart remodeling in the mouse. We identify the essential splicing factor ASF/SF2 as a key component of the program, regulating a restricted set of tissue-specific alternative splicing events during heart remodeling. Cardiomyocytes deficient in ASF/SF2 display an unexpected hypercontraction phenotype due to a defect in postnatal splicing switch of the Ca2+/calmodulin-dependent kinase IIdelta (CaMKIIdelta) transcript. This failure results in mistargeting of the kinase to sarcolemmal membranes, causing severe excitation-contraction coupling defects. Our results validate ASF/SF2 as a fundamental splicing regulator in the reprogramming pathway and reveal the central contribution of ASF/SF2-regulated CaMKIIdelta alternative splicing to functional remodeling in developing heart.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Columbia University	Fu, XD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	xdfu@ucsd.edu	Xiao, Rui-Ping/AAE-2629-2019; Chu, Pao-Hsien/G-3685-2010; cheng, heping/A-7299-2011; Heping, Cheng/AAE-2680-2019; Chen, Ju/E-5579-2011; Yimei, Wang/AAE-4083-2019; wang, wang/GWQ-7272-2022; Chu, Pao-Hsien/P-5249-2019	Heping, Cheng/0000-0002-9604-6702; Chu, Pao-Hsien/0000-0003-0361-6348; Wang, Wang/0000-0001-9093-412X; Xu, Xiangdong/0000-0003-2220-0890; Manley, James/0000-0002-8341-1459	NHLBI NIH HHS [R01 HL066100, R01 HL66100] Funding Source: Medline; NIGMS NIH HHS [R01 GM49369, R37 GM48259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048259, R01GM049369] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson ME, 2004, TRENDS CARDIOVAS MED, V14, P152, DOI 10.1016/j.tcm.2004.02.005; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Chen J, 1998, DEVELOPMENT, V125, P1943; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Haddock PS, 1999, CIRC RES, V85, P415, DOI 10.1161/01.RES.85.5.415; HAJLHOSSEINI MK, 2001, P NATL ACAD SCI USA, V98, P3855; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; HODGES D, 1994, ADV GENET, V31, P207, DOI 10.1016/S0065-2660(08)60399-5; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Huang XP, 1999, CIRC RES, V84, P1; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Kim S, 2003, NUCLEIC ACIDS RES, V31, P1955, DOI 10.1093/nar/gkg286; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li L, 1997, J PHYSIOL-LONDON, V501, P17, DOI 10.1111/j.1469-7793.1997.017bo.x; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Lynch KW, 1996, GENE DEV, V10, P2089, DOI 10.1101/gad.10.16.2089; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; REISER PJ, 1994, AM J PHYSIOL-HEART C, V267, pH1589; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; SIMMERMAN HK, 1998, PHYSIOL REV, V78, P9231; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; XIAO RP, 2001, SCI STKE RE15, DOI DOI 10.1126/STKA.2001.104.RE15; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou YY, 1997, AM J PHYSIOL-HEART C, V273, pH1611, DOI 10.1152/ajpheart.1997.273.3.H1611; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	54	410	430	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					59	72		10.1016/j.cell.2004.11.036	http://dx.doi.org/10.1016/j.cell.2004.11.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652482	Bronze			2022-12-01	WOS:000226365400011
J	Lam, RTS; Belenguer, A; Roberts, SL; Naumann, C; Jarrosson, T; Otto, S; Sanders, JKM				Lam, RTS; Belenguer, A; Roberts, SL; Naumann, C; Jarrosson, T; Otto, S; Sanders, JKM			Amplification of acetylcholine-binding catenanes from dynamic combinatorial libraries	SCIENCE			English	Article							SELECTION; CHEMISTRY; RECEPTORS; HOSTS	Directed chemical synthesis can produce a vast range of molecular structures, but the intended product must be known at the outset. In contrast, evolution in nature can lead to efficient receptors and catalysts whose structures defy prediction. To access such unpredictable structures, we prepared dynamic combinatorial libraries in which reversibly binding building blocks assemble around a receptor target. We selected for an acetylcholine receptor by adding the neurotransmitter to solutions of dipeptide hydrazones [proline-phenylalanine or proline-(cyclohexyl)alanine], which reversibly combine through hydrazone linkages. At thermodynamic equilibrium, the dominant receptor structure was an elaborate [2]-catenane consisting of two interlocked macrocyclic trimers. This complex receptor with a 100 nM affinity for acetylcholine could be isolated on a preparative scale in 67% yield.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Sanders, JKM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	jkms@cam.ac.uk	Jarrosson, Thibaut/K-8730-2018; Otto, Sijbren/E-9568-2014; Naumann, Christoph/A-4552-2010	Jarrosson, Thibaut/0000-0002-2673-4198; Sanders, Jeremy Keith Morris/0000-0002-5143-5210; Otto, Sijbren/0000-0003-0259-5637	Engineering and Physical Sciences Research Council [GR/S76892/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BRADY PA, 1996, CHEM COMMUN, V35, P2143; Brisig B, 2003, ANGEW CHEM INT EDIT, V42, P1270, DOI 10.1002/anie.200390326; Corbett PT, 2004, CHEM-EUR J, V10, P3139, DOI 10.1002/chem.200400300; Cousins GRL, 2001, ANGEW CHEM INT EDIT, V40, P423, DOI 10.1002/1521-3773(20010119)40:2<423::AID-ANIE423>3.0.CO;2-6; Dietrich-Buchecker C, 1999, CHEM COMMUN, P615, DOI 10.1039/a809885i; Godt A, 2004, EUR J ORG CHEM, V2004, P1639, DOI 10.1002/ejoc.200300503; HUNTER CA, 1992, J AM CHEM SOC, V114, P5303, DOI 10.1021/ja00039a047; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Otto S, 2002, SCIENCE, V297, P590, DOI 10.1126/science.1072361; Otto S, 2003, J AM CHEM SOC, V125, P7804, DOI 10.1021/ja0351589; Otto S, 2003, CURR OPIN DRUG DISC, V6, P509; Raehm L, 2002, SYNLETT, P1743; Ramstrom O, 2002, NAT REV DRUG DISCOV, V1, P26, DOI 10.1038/nrd704; Roberts SL, 2003, ORG BIOMOL CHEM, V1, P1625, DOI 10.1039/b300956d; Rowan SJ, 2002, ANGEW CHEM INT EDIT, V41, P898, DOI 10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E; Sarri P, 2004, J ORG CHEM, V69, P3654, DOI 10.1021/jo049899j; Vignon SA, 2004, ORG LETT, V6, P1095, DOI 10.1021/ol0364881	17	240	240	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					667	669		10.1126/science.1109999	http://dx.doi.org/10.1126/science.1109999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15761119				2022-12-01	WOS:000228810900041
J	Lolle, SJ; Victor, JL; Young, JM; Pruitt, RE				Lolle, SJ; Victor, JL; Young, JM; Pruitt, RE			Genome-wide non-mendelian inheritance of extra-genomic information in Arabidopsis	NATURE			English	Article							CHIMERIC RNA/DNA OLIGONUCLEOTIDES; DEPENDENT RNA-POLYMERASE; DOUBLE-STRANDED-RNA; ORGAN FUSION; GENE; METHYLATION; MUTATION; TRANSGENE; NEUROSPORA; EVOLUTION	A fundamental tenet of classical mendelian genetics is that allelic information is stably inherited from one generation to the next, resulting in predictable segregation patterns of differing alleles(1). Although several exceptions to this principle are known, all represent specialized cases that are mechanistically restricted to either a limited set of specific genes ( for example mating type conversion in yeast(2)) or specific types of alleles ( for example alleles containing transposons(3) or repeated sequences(4)). Here we show that Arabidopsis plants homozygous for recessive mutant alleles of the organ fusion gene HOTHEAD(5) (HTH) can inherit allele-specific DNA sequence information that was not present in the chromosomal genome of their parents but was present in previous generations. This previously undescribed process is shown to occur at all DNA sequence polymorphisms examined and therefore seems to be a general mechanism for extragenomic inheritance of DNA sequence information. We postulate that these genetic restoration events are the result of a template-directed process that makes use of an ancestral RNA-sequence cache.	Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pruitt, RE (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, 915 W State St, W Lafayette, IN 47907 USA.	pruittr@purdue.edu		Pruitt, Robert E/0000-0003-4817-5806				AUERBACH C, 1971, ANNU REV GENET, V5, P163, DOI 10.1146/annurev.ge.05.120171.001115; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FOSTER PL, 1992, GENETICS, V131, P783; Galitski T, 1996, GENETICS, V143, P645; GONDO Y, 1993, P NATL ACAD SCI USA, V90, P297, DOI 10.1073/pnas.90.1.297; HALL BG, 1990, GENETICS, V126, P5; KLAR AJS, 1979, GENETICS, V92, P777; Kovalchuk I, 2003, NATURE, V423, P760, DOI 10.1038/nature01683; Krolikowski KA, 2003, PLANT J, V35, P501, DOI 10.1046/j.1365-313X.2003.01824.x; Lolle SJ, 1998, GENETICS, V149, P607; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ries G, 2000, NATURE, V406, P98, DOI 10.1038/35017595; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Taller J, 1998, THEOR APPL GENET, V97, P705, DOI 10.1007/s001220050946; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Zhu T, 1999, P NATL ACAD SCI USA, V96, P8768, DOI 10.1073/pnas.96.15.8768	30	142	152	0	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					505	509		10.1038/nature03380	http://dx.doi.org/10.1038/nature03380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15785770				2022-12-01	WOS:000227836000042
J	Paltiel, AD; Weinstein, MC; Kimmel, AD; Seage, GR; Losina, E; Zhang, H; Freedberg, KA; Walensky, RP				Paltiel, AD; Weinstein, MC; Kimmel, AD; Seage, GR; Losina, E; Zhang, H; Freedberg, KA; Walensky, RP			Expanded screening for HIV in the United States - An analysis of cost-effectiveness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLUS INDINAVIR; CELL COUNTS; INFECTION; VACCINE; TRIALS; CARE; SEX	BACKGROUND: Although the Centers for Disease Control and Prevention (CDC) recommend routine HIV counseling, testing, and referral (HIVCTR) in settings with at least a 1 percent prevalence of HIV, roughly 280,000 Americans are unaware of their human immunodeficiency virus (HIV) infection. The effect of expanded screening for HIV is unknown in the era of effective antiretroviral therapy. METHODS: We developed a computer simulation model of HIV screening and treatment to compare routine, voluntary HIVCTR with current practice in three target populations: ``high-risk'' (3.0 percent prevalence of undiagnosed HIV infection; 1.2 percent annual incidence); ``CDC threshold'' (1.0 percent and 0.12 percent, respectively); and ``U.S. general'' (0.1 percent and 0.01 percent). Input data were derived from clinical trials and observational cohorts. Outcomes included quality-adjusted survival, cost, and cost-effectiveness. RESULTS: In the high-risk population, the addition of one-time screening for HIV antibodies with an enzyme-linked immunosorbent assay (ELISA) to current practice was associated with earlier diagnosis of HIV (mean CD4 cell count at diagnosis, 210 vs. 154 per cubic millimeter). One-time screening also improved average survival time among HIV-infected patients (quality-adjusted survival, 220.7 months vs. 219.8 months). The incremental cost-effectiveness was $36,000 per quality-adjusted life-year gained. Testing every five years cost $50,000 per quality-adjusted life-year gained, and testing every three years cost $63,000 per quality-adjusted life-year gained. In the CDC threshold population, the cost-effectiveness ratio for one-time screening with ELISA was $38,000 per quality-adjusted life-year gained, whereas testing every five years cost $71,000 per quality-adjusted life-year gained, and testing every three years cost $85,000 per quality-adjusted life-year gained. In the U.S. general population, one-time screening cost $113,000 per quality-adjusted life-year gained. CONCLUSIONS: In all but the lowest-risk populations, routine, voluntary screening for HIV once every three to five years is justified on both clinical and cost-effectiveness grounds. One-time screening in the general population may also be cost-effective.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Risk Anal, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr,Dept Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Boston University; Harvard University; Brigham & Women's Hospital	Paltiel, AD (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	david.paltiel@yale.edu		Losina, ELENA/0000-0002-3424-0892; Paltiel, A. David/0000-0002-4861-3290; Walensky, Rochelle P./0000-0002-8795-379X	NIAID NIH HHS [K24AI062476, K25AI50436, R01AI42006, K24 AI062476, K23AI01794, K25 AI050436, P30 AI042851, K23 AI001794, R01 AI042006, P30AI42851] Funding Source: Medline; NIDA NIH HHS [R01 DA015612, R01DA015612] Funding Source: Medline; NIMH NIH HHS [R01 MH065869] Funding Source: Medline; PHS HHS [S1396-20/21] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042851, K23AI001794, K25AI050436, K24AI062476, R01AI042006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bos JM, 2002, AIDS, V16, P1185, DOI 10.1097/00002030-200205240-00015; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; CAMPSMITH M, 2001, 2001 NAT HIV PREV C; *CDCP, HIV AIDS UPD GLANC H; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; *DEP HLTH HUM SERV, GUID US ANT AG HIV I; DIGUISEPPI C, 1996, GUIDE CLIN PREVENTIV; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44; Fleming PL, 2000, AM J PUBLIC HEALTH, V90, P1037, DOI 10.2105/AJPH.90.7.1037; Freedberg KA, 1999, ARCH INTERN MED, V159, P1994, DOI 10.1001/archinte.159.17.1994; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gold MR., 1996, COST EFFECTIVENESS H; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; *HARV CTR RISK AN, COST UT AN PUBL 1976; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; *MACS, 1995, MACS PUBL DAT REL PO; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; *NAT TECHN INF SER, 1992, AIDS COST SERV UT SU; *NIH HLTH RES SERV, 2004, MMWR RECOMM REP, V53, P744; *NIH HLTH RES SERV, 2003, MMWR RECOMM REP, V52, P1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Sheon AR, 1998, J ACQ IMMUN DEF SYND, V19, P519, DOI 10.1097/00042560-199812150-00012; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; U.S. Census Bureau, 2002, STAT ABSTR US; Walensky RP, 2005, AM J PUBLIC HEALTH, V95, P71, DOI 10.2105/AJPH.2003.031310; Webster RD, 2003, JAIDS-J ACQ IMM DEF, V33, P223, DOI 10.1097/00126334-200306010-00018; Zaric GS, 2000, J ACQ IMMUN DEF SYND, V25, P403, DOI 10.1097/00126334-200012150-00004; 1998, MMWR MORB MORTAL WKL, V47, P211	36	429	437	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2005	352	6					586	595		10.1056/NEJMsa042088	http://dx.doi.org/10.1056/NEJMsa042088			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	895KY	15703423				2022-12-01	WOS:000226862100008
J	Butland, G; Peregrin-Alvarez, JM; Li, J; Yang, WH; Yang, XC; Canadien, V; Starostine, A; Richards, D; Beattie, B; Krogan, N; Davey, M; Parkinson, J; Greenblatt, J; Emili, A				Butland, G; Peregrin-Alvarez, JM; Li, J; Yang, WH; Yang, XC; Canadien, V; Starostine, A; Richards, D; Beattie, B; Krogan, N; Davey, M; Parkinson, J; Greenblatt, J; Emili, A			Interaction network containing conserved and essential protein complexes in Escherichia coli	NATURE			English	Article							PHYLOGENETIC PROFILES; FUNCTIONAL LINKAGES; SIMPLE DEPENDENCE; EVOLUTION RATE; DATABASE; DNA; IDENTIFICATION; DISCOVERY; SYSTEM; NUMBER	Proteins often function as components of multi-subunit complexes. Despite its long history as a model organism(1), no large-scale analysis of protein complexes in Escherichia coli has yet been reported. To this end, we have targeted DNA cassettes into the E. coli chromosome to create carboxy-terminal, affinity-tagged alleles of 1,000 open reading frames (similar to23% of the genome). A total of 857 proteins, including 198 of the most highly conserved, soluble non-ribosomal proteins essential in at least one bacterial species, were tagged successfully, whereas 648 could be purified to homogeneity and their interacting protein partners identified by mass spectrometry. An interaction network of protein complexes involved in diverse biological processes was uncovered and validated by sequential rounds of tagging and purification. This network includes many new interactions as well as interactions predicted based solely on genomic inference or limited phenotypic data(2). This study provides insight into the function of previously uncharacterized bacterial proteins and the overall topology of a microbial interaction network, the core components of which are broadly conserved across Prokaryota.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Hosp Sick Children, Toronto, ON M4K 1X8, Canada; Affinium Pharmaceut, Toronto, ON M5J 1V6, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Greenblatt, J (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	jack.greenblatte@utoronto.ca; andrew.emili@utoronto.ca	Parkinson, John/A-4424-2008	Parkinson, John/0000-0001-9815-1189; Alvarez, Jose/0000-0002-7184-832X; Davey, Michael/0000-0002-1172-5934				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; Haselbeck R, 2002, CURR PHARM DESIGN, V8, P1155, DOI 10.2174/1381612023394818; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Nakayama H, 2002, ONCOGENE, V21, P9008, DOI 10.1038/sj.onc.1205959; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; SERRES MH, 2001, GENOME BIOL, V2, P7; STUKENBERG PT, 1995, J BIOL CHEM, V270, P13384, DOI 10.1074/jbc.270.22.13384; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; [No title captured]	30	887	921	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					531	537		10.1038/nature03239	http://dx.doi.org/10.1038/nature03239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690043				2022-12-01	WOS:000226727200051
J	Tesfaye, S; Chaturvedi, N; Eaton, SEM; Ward, JD; Manes, C; Ionescu-Tirgoviste, C; Witte, DR; Fuller, JH				Tesfaye, S; Chaturvedi, N; Eaton, SEM; Ward, JD; Manes, C; Ionescu-Tirgoviste, C; Witte, DR; Fuller, JH		EURODIAB Prospective Complications	Vascular risk factors and diabetic neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-RESISTANCE; PERIPHERAL NEUROPATHY; SENSORY NEUROPATHY; BLOOD-FLOW; CHOLESTEROL; PHOTOGRAPHY; RETINOPATHY; PREVALENCE; MORTALITY; SMOKING	BACKGROUND: Other than glycemic control, there are no treatments for diabetic neuropathy. Thus, identifying potentially modifiable risk factors for neuropathy is crucial. We studied risk factors for the development of distal symmetric neuropathy in 1172 patients with type 1 diabetes mellitus from 31 centers participating in the European Diabetes (EURODIAB) Prospective Complications Study. METHODS: Neuropathy was assessed at baseline (1989 to 1991) and at follow-up (1997 to 1999), with a mean (+/-SD) follow-up of 7.3+/-0.6 years. A standardized protocol included clinical evaluation, quantitative sensory testing, and autonomic-function tests. Serum lipids and lipoproteins, glycosylated hemoglobin, and the urinary albumin excretion rate were measured in a central laboratory. RESULTS: At follow-up, neuropathy had developed in 276 of 1172 patients without neuropathy at baseline (23.5 percent). The cumulative incidence of neuropathy was related to the glycosylated hemoglobin value and the duration of diabetes. After adjustment for these factors, we found that higher levels of total and low-density lipoprotein cholesterol and triglycerides, a higher body-mass index, higher von Willebrand factor levels and urinary albumin excretion rate, hypertension, and smoking were all significantly associated with the cumulative incidence of neuropathy. After adjustment for other risk factors and diabetic complications, we found that duration of diabetes, current glycosylated hemoglobin value, change in glycosylated hemoglobin value during the follow-up period, body-mass index, and smoking remained independently associated with the incidence of neuropathy. Cardiovascular disease at baseline was associated with double the risk of neuropathy, independent of cardiovascular risk factors. CONCLUSIONS: This prospective study indicates that, apart from glycemic control, the incidence of neuropathy is associated with potentially modifiable cardiovascular risk factors, including a raised triglyceride level, body-mass index, smoking, and hypertension.	Royal Hallamshire Hosp, Diabet Res Unit, Sheffield S10 2JF, S Yorkshire, England; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Fac Med, London, England; Papageorgiou Gen Teaching Hosp, Dept Internal Med, Thessaloniki, Greece; Papageorgiou Gen Teaching Hosp, Ctr Diabet, Thessaloniki, Greece; Inst Diabet Nutr & Metab Dis, Bucharest, Romania; UCL Royal Free & Univ Coll Med Sch, Dept Epidemiol & Publ Hlth, EURODIAB, London, England	University of Sheffield; Imperial College London; Papageorgiou Hospital; Papageorgiou Hospital; University of London; University College London; UCL Medical School	Tesfaye, S (corresponding author), Royal Hallamshire Hosp, Diabet Res Unit, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	solomon.tesfaye@sth.nhs.uk	Witte, Daniel R/C-1722-2008; Witte, Daniel/AAF-9535-2019	Witte, Daniel R/0000-0002-0769-2922; Witte, Daniel/0000-0002-0769-2922; Tesfaye, Solomon/0000-0003-1190-1472				ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281; [Anonymous], 1995, ANN INTERN MED, V122, P561, DOI 10.7326/0003-4819-122-8-199504150-00001; BUCOLO G, 1973, CLIN CHEM, V19, P476; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; Chaturvedi N, 2001, KIDNEY INT, V60, P219, DOI 10.1046/j.1523-1755.2001.00789.x; Chaturvedi N, 2001, DIABETES CARE, V24, P284, DOI 10.2337/diacare.24.2.284; Coppini DV, 2000, J CLIN EPIDEMIOL, V53, P519, DOI 10.1016/S0895-4356(99)00170-5; DEFRONZO RA, 1982, DIABETES, V31, P795, DOI 10.2337/diab.31.9.795; Dyck PJ, 1999, DIABETES CARE, V22, P1479, DOI 10.2337/diacare.22.9.1479; Eaton SEM, 2003, DIABETOLOGIA, V46, P934, DOI 10.1007/s00125-003-1127-3; Erbey JR, 1999, METABOLISM, V48, P1337; Erbey JR, 1999, METABOLISM, V48, P531, DOI 10.1016/S0026-0495(99)90116-6; FORD I, 1992, THROMB HAEMOSTASIS, V68, P628; Forrest KYZ, 1997, DIABETES, V46, P665, DOI 10.2337/diabetes.46.4.665; Forsblom CM, 1998, DIABETOLOGIA, V41, P1253, DOI 10.1007/s001250051062; FRANKLIN GM, 1990, AM J EPIDEMIOL, V131, P633, DOI 10.1093/oxfordjournals.aje.a115547; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GADIA MT, 1987, DIABETES CARE, V10, P613, DOI 10.2337/diacare.10.5.613; HARRIS M, 1993, DIABETES CARE, V16, P1446, DOI 10.2337/diacare.16.11.1446; JOHN WG, 1993, CLIN CHEM, V39, P663; KEARNEY EM, 1987, J CLIN PATHOL, V40, P465, DOI 10.1136/jcp.40.4.465; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; MITCHELL BD, 1990, DIABETES CARE, V13, P434, DOI 10.2337/diacare.13.4.434; Rose G.A., 1982, CARDIOVASCULAR SURVE; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Soedamah-Muthu SS, 2004, DIABETES CARE, V27, P530, DOI 10.2337/diacare.27.2.530; TESFAYE S, 1993, DIABETOLOGIA, V36, P1266, DOI 10.1007/BF00400804; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; *URODIAB IDDM COMP, 1994, DIABETOLOGIA, V37, P278; Vinik AI, 2000, DIABETOLOGIA, V43, P957, DOI 10.1007/s001250051477; WARNICK GR, 1978, J LIPID RES, V19, P65; WILES PG, 1991, DIABETIC MED, V8, P157, DOI 10.1111/j.1464-5491.1991.tb01563.x; Williams KV, 2000, DIABETES, V49, P626, DOI 10.2337/diabetes.49.4.626; WITTE DR, IN PRESS DIABETOLOGI; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; ZENERE BM, 1995, DIABETES CARE, V18, P975, DOI 10.2337/diacare.18.7.975	37	839	903	2	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2005	352	4					341	350		10.1056/NEJMoa032782	http://dx.doi.org/10.1056/NEJMoa032782			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890UH	15673800	Green Published			2022-12-01	WOS:000226535900006
J	Hwang, ES; Szabo, SJ; Schwartzberg, PL; Glimcher, LH				Hwang, ES; Szabo, SJ; Schwartzberg, PL; Glimcher, LH			T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3	SCIENCE			English	Article							TEC FAMILY KINASES; TYROSINE PHOSPHORYLATION; LINEAGE COMMITMENT; SIGNALING PATHWAYS; MICE LACKING; DNA-BINDING; ITK; DIFFERENTIATION; ASTHMA	Cell Lineage specification depends on both gene activation and gene silencing, and in the differentiation of T helper progenitors to Th1 or Th2 effector cells, this requires the action of two opposing transcription factors, T-bet and GATA-3. T-bet is essential for the development of Th1 cells, and GATA-3 performs an equivalent role in Th2 development. We report that T-bet represses Th2 lineage commitment through tyrosine kinase-mediated interaction between the two transcription factors that interferes with the binding of GATA-3 to its target DNA. These results provide a novel function for tyrosine phosphorylation of a transcription factor in specifying alternate fates of a common progenitor cell.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; NHGRI, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu			NIAID NIH HHS [AI56296, AI48126] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048126, P01AI056296] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; HWANG ES, UNPUB; KTISTAKI E, 1995, P NATL ACAD SCI USA, V92, P9876, DOI 10.1073/pnas.92.21.9876; Lucas JA, 2003, IMMUNOL REV, V191, P119, DOI 10.1034/j.1600-065X.2003.00029.x; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Novina CD, 1998, J BIOL CHEM, V273, P33443, DOI 10.1074/jbc.273.50.33443; Pulichino AM, 2003, GENE DEV, V17, P738, DOI 10.1101/gad.1065703; REIFELMILLER AE, 1994, J BIOL CHEM, V269, P23861; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takesono A, 2002, J CELL SCI, V115, P3039; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737	22	385	432	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					430	433		10.1126/science.1103336	http://dx.doi.org/10.1126/science.1103336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662016				2022-12-01	WOS:000226492300049
J	Barratt, A; Howard, K; Irwig, L; Salkeld, G; Houssami, N				Barratt, A; Howard, K; Irwig, L; Salkeld, G; Houssami, N			Model of outcomes of screening mammography: information to support informed choices	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA IN-SITU; BREAST-CANCER; WOMEN; METAANALYSIS	Objective To provide easy to use estimates of the benefits and harms of biennial screening mammography for women aged 40, 50, 60, and 70 years. Design Markov process model, with data from BreastScreen Australia, the Australian Institute of Health and Welfare, and the Australian Bureau of Statistics. Main outcome measure Age specific outcomes expressed per 1000 women over 10 years. Results For every 1000 women screened over 10 years, 167-251 (depending on age) receive an abnormal result; 56-64 of these women undergo at least one biopsy, 9-26 have an invasive cancer detected by screening, and 3-6 have ductal carcinoma in situ (DCIS) detected by screening. More breast cancers (both invasive and DCIS) are diagnosed among screened than unscreened women. For example, among 1000 women aged 50 who have five biennial screens, 33 breast cancers are diagnosed: 28 invasive cancers (18 detected at screening and 10 interval cancers) and five DCTS (all detected at screening). By comparison, among 1000 women aged 50 who decline screening, 20 cancers are diagnosed over 10 years. There are about 0.5, 2, 3, and 2 fewer deaths from breast cancer over 10 years per 1000 women aged 40, 50, 60, and 70, respectively, who choose to be screened compared with women who decline screening at times determined by relevant policy. Conclusion Benefits and harms of screening mammography are relatively finely balanced. Quantitative estimates such as these can be used to support individual informed choices about screening.	Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia	University of Sydney	Barratt, A (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.	alexb@usyd.edu.au	Houssami, Nehmat/ABC-1103-2020; Barratt, Alexandra/A-7349-2011	Houssami, Nehmat/0000-0002-3641-952X; Barratt, Alexandra/0000-0002-2561-3319; Howard, Kirsten/0000-0002-0918-7540				Anttila A, 2002, J MED SCREEN, V9, P153, DOI 10.1136/jms.9.4.153; *AUSTR I HLH WELF, 2000, CANC SER AUSTR I HLT, V13; *AUSTR I HLTH WELF, 2003, BREASTSCREEN AUSTR M; *AUSTR I HLTH WELF, 2000, CANC SER AUSTR I HLT, V13; Barratt A, 2004, BMJ-BRIT MED J, V329, P507, DOI 10.1136/bmj.329.7464.507; *BREASTSCREEN AUST, WHO SHOULD HAV MAMM; *BREASTSCREEN SA, 2003, BREASTSCREEN SA STAT; *BREASTSCREEN VICT, 2002, BREASTSCREEN VICT 20; Chen H H, 1995, J Med Screen, V2, P10; Drossaert CHC, 2001, J MED SCREEN, V8, P204, DOI 10.1136/jms.8.4.204; Ernster VL, 2002, J NATL CANCER I, V94, P1546; *GEN MED COUNC, SEEK PAT CONS ETH CO; GLASZIOU PP, 1992, J CLIN EPIDEMIOL, V45, P1251, DOI 10.1016/0895-4356(92)90166-K; IRWIG I, 1997, REV EVIDENCE VALUE M; Irwig L., 1997, REV EVIDENCE VALUE M; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Paci E, 2004, J MED SCREEN, V11, P23, DOI 10.1258/096914104772950718; *QUEENSL HLTH, 2001, BREASTSCREEN QUEENSL; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Taylor R, 2001, J MED SCREEN, V8, P73, DOI 10.1136/jms.8.2.73; Thornton H, 2003, BMJ-BRIT MED J, V327, P101, DOI 10.1136/bmj.327.7406.101; U.S. Preventive Services Task Force, SCREEN BREAST CANC; *UK NAT SCREEN COM, 2 UK NAT SCREEN COMM; Van Zee KJ, 1999, CANCER-AM CANCER SOC, V86, P1757, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1757::AID-CNCR18>3.0.CO;2-V; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	26	92	93	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2005	330	7497					936	938		10.1136/bmj.38398.469479.8F	http://dx.doi.org/10.1136/bmj.38398.469479.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15755755	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000228715900019
J	Baxter, EJ; Scott, LM; Campbell, PJ; East, C; Fourouclas, N; Swanton, S; Vassiliou, GS; Bench, AJ; Boyd, EM; Curtin, N; Scott, MA; Erber, WN; Green, AR				Baxter, EJ; Scott, LM; Campbell, PJ; East, C; Fourouclas, N; Swanton, S; Vassiliou, GS; Bench, AJ; Boyd, EM; Curtin, N; Scott, MA; Erber, WN; Green, AR		Canc Genome Project	Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders	LANCET			English	Article							POLYCYTHEMIA-VERA; DIAGNOSTIC-CRITERIA; ESSENTIAL THROMBOCYTHEMIA; PROGENITOR CELLS; STEM-CELL; BCL-X; EXPRESSION; RECEPTOR; HYPERSENSITIVITY; MYELOFIBROSIS	Background Human myeloproliferative disorders form a range of clonal haematological malignant diseases, the main members of which are polycythaemia vera, essential thrombocythaemia, and idiopathic myelofibrosis. The molecular pathogenesis of these disorders is unknown, but tyrosine kinases have been implicated in several related disorders. We investigated the role of the cytoplasmic tyrosine kinase JAK2 in patients with a myeloproliferative disorder. Methods We obtained DNA samples from patients with polycythaemia vera, essential thrombocythaemia, or idiopathic myelofibrosis. The coding exons of JAK2 were bidirectionally sequenced from peripheral-blood granulocytes, T cells, or both. Allele-specific PCR, molecular cytogenetic studies, microsatellite PCR, Affymetrix single nucleotide polymorphism array analyses, and colony assays were undertaken on subgroups of patients. Findings A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis. The mutation is acquired, is present in a variable proportion of granulocytes, alters a highly conserved valine present in the negative regulatory JH2 domain, and is predicted to dysregulate kinase activity. It was heterozygous in most patients, homozygous in a subset as a result of mitotic recombination, and arose in a multipotent progenitor capable of giving rise to erythroid and myeloid cells. The mutation was present in all erythropoietin-independent erythroid colonies. Interpretation A single acquired mutation of JAK2 was noted in more than half of patients with a myeloproliferative disorder. Its presence in all erythropoietin-independent erythroid colonies demonstrates a link with growth factor hypersensitivity, a key biological feature of these disorders. Relevance to practice Identification of the Val617Phe JAK2 mutation lays the foundation for new approaches to the diagnosis, classification, and treatment of myeloproliferative disorders.	Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England; Addenbrookes NHS Trust, Dept Haematol, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Green, AR (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	arg1000@cam.ac.uk	Erber, Wendy/A-1955-2012; Scott, Linda/D-9777-2012	Scott, Linda/0000-0003-0334-1479; Vassiliou, George/0000-0003-4337-8022; Erber, Wendy/0000-0002-1028-9376; Raine, Keiran/0000-0002-5634-1539; Green, Anthony/0000-0002-9795-0218; Baxter, Elizabeth Joanna/0000-0002-5946-5238	Wellcome Trust [088340] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Axelrad AA, 2000, BLOOD, V96, P3310; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; DAI CH, 1992, BLOOD, V80, P891; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; FIALKOW PJ, 1981, BLOOD, V58, P916; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Green AR, 2004, HEMATOL J, V5, pS126, DOI 10.1038/sj.thj.6200438; Griesshammer M, 2004, ANN HEMATOL, V83, P364, DOI 10.1007/s00277-004-0864-9; Harrison CN, 2003, HEMATOL ONCOL CLIN N, V17, P1175, DOI 10.1016/S0889-8588(03)00082-0; Hinshelwood S, 1997, BLOOD REV, V11, P224, DOI 10.1016/S0268-960X(97)90021-7; Klippel S, 2003, BLOOD, V102, P3569, DOI 10.1182/blood-2003-03-0919; KOBAYASHI S, 1993, BRIT J HAEMATOL, V83, P539, DOI 10.1111/j.1365-2141.1993.tb04688.x; Komura E, 2003, EXP HEMATOL, V31, P622, DOI 10.1016/S0301-472X(03)00085-7; Kralovics R, 2005, BLOOD REV, V19, P1, DOI 10.1016/j.blre.2004.02.002; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; LI Y, 1994, BRIT J HAEMATOL, V87, P471, DOI 10.1111/j.1365-2141.1994.tb08300.x; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Reilly JT, 2003, BLOOD REV, V17, P241, DOI 10.1016/S0268-960X(03)00024-9; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Skoda RC, 2004, HEMATOL J, V5, pS122, DOI 10.1038/sj.thj.6200437; Spivak Jerry L, 2003, Hematology Am Soc Hematol Educ Program, P200; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Wadleigh M, 2005, BLOOD, V105, P22, DOI 10.1182/blood-2003-11-3896	36	2635	2891	1	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1054	1061		10.1016/S0140-6736(05)71142-9	http://dx.doi.org/10.1016/S0140-6736(05)71142-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781101				2022-12-01	WOS:000227731800030
J	Holland, ND; Clague, DA; Gordon, DP; Gebruk, A; Pawson, DL; Vecchione, M				Holland, ND; Clague, DA; Gordon, DP; Gebruk, A; Pawson, DL; Vecchione, M			Lophenteropneust' hypothesis refuted by collection and photos of new deep-sea hemichordates	NATURE			English	Article							PACIFIC	The deep ocean is home to a group of broad-collared hemichordates - the so-called 'lophenteropneusts' - that have been photographed gliding on the sea floor(1-8) but have not previously been collected. It has been claimed that these worms have collar tentacles and blend morphological features of the two main hemichordate body plans, namely the tentacle-less enteropneusts and the tentacle-bearing pterobranchs. Consequently, lophenteropneusts have been invoked as missing links to suggest that the former evolved into the latter(5). The most significant aspect of the lophenteropneust hypothesis is its prediction that the fundamental body plan within a basal phylum of deuterostomes was enteropneust-like. The assumption of such an ancestral state influences ideas about the evolution of the vertebrates from the invertebrates(9-14). Here we report on the first collected specimen of a broad-collared, deep-sea enteropneust and describe it as a new family, genus and species. The collar, although disproportionately broad, lacks tentacles. In addition, we find no evidence of tentacles in the available deep-sea photographs ( published and unpublished) of broad-collared enteropneusts, including those formerly designated as lophenteropneusts. Thus, the lophenteropneust hypothesis was based on misinterpretation of deep-sea photographs of low quality and should no longer be used to support the idea that the enteropneust body plan is basal within the phylum Hemichordata.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Natl Inst Water & Atmospher Res, Wellington, New Zealand; Russian Acad Sci, PP Shirshov Oceanol Inst, Moscow 117851, Russia; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; Natl Museum Nat Hist, NOAA, Natl Systemat Lab, Washington, DC 20013 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Monterey Bay Aquarium Research Institute; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Russian Academy of Sciences; Shirshov Institute of Oceanology; Smithsonian Institution; Smithsonian National Museum of Natural History; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Holland, ND (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	nholland@ucsd.edu	Gebruk, Andrey/A-9041-2016					BATESON W, 1886, Q J MICROSC SCI, V26, P535; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; BOURNE DW, 1965, SCIENCE, V150, P60, DOI 10.1126/science.150.3692.60; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Dilly P.N., 1975, Symposia Zool Soc Lond, VNo. 36, P1; Ewing M., 1967, DEEP SEA PHOTOGRAPHY, P259; FOELL EJ, 1986, OHIO J SCI, V86, P61; Gage J.D., 1991, DEEP SEA BIOL NATURA, DOI 10.1017/CBO9781139163637; GAILLARD C, 1991, Palaios, V6, P302, DOI 10.2307/3514910; Heezen B.C., 1971, FACE DEEP; JACOBS SS, 1970, HYDROGRAPHIC STATION, P32; Jefferies RPS, 2001, SYST ASSOC SPEC VOL, V61, P40; JOLLIE M, 1973, ACTA ZOOLOGICA, V54, P81; LEMCHE H, 1976, VINDENSK MEDDR DANSK, V139, P262; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; PAWSON D, 2003, DEEP SEA NEWSL, V32, P6; SPENGEL JW, 1893, MONOGRAPH, V18; Tendal Ole Secher, 1998, Deep-Sea Newsletter, V27, P21; TENDAL OS, 1999, DEEP SEA NEWSL, V28, P8; Thiel H., 1979, Ambio Special Report, P25; THORNDIKE EM, 1982, OCEAN FLOOR, P255; WOODWICK KH, 1985, P BIOL SOC WASH, V98, P351; WOODWICK KH, 1993, TAXONOMIC ATLAS BENT, V14, P251; Young CM, 2003, ECOSY WORLD, V28, P381	25	39	42	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					374	376		10.1038/nature03382	http://dx.doi.org/10.1038/nature03382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772659				2022-12-01	WOS:000227715100049
J	Ozdamar, B; Bose, R; Barrios-Rodiles, M; Wang, HR; Zhang, Y; Wrana, JL				Ozdamar, B; Bose, R; Barrios-Rodiles, M; Wang, HR; Zhang, Y; Wrana, JL			Regulation of the polarity protein Par6 by TGF beta receptors controls epithelial cell plasticity	SCIENCE			English	Article							MESENCHYMAL TRANSITION; TIGHT JUNCTIONS; KINASE-C; TRANSDIFFERENTIATION; MECHANISMS; PATHWAYS; COMPLEX; GROWTH; SIGNAL; RHO	The transition of cells from an epithelia[ to a mesenchymal phenotype is a critical event during morphogenesis in multicellular organisms and underlies the pathology of many diseases, including the invasive phenotype associated with metastatic carcinomas. Transforming growth factor beta (TGFbeta) is a key regulator of epithetial-to-mesenchymal transition (EMT). However, the molecular mechanisms that control the dissolution of tight junctions, an early event in EMT, remain elusive. We demonstrate that Par6, a regulator of epithelia[ cell polarity and tight-junction assembly, interacts with TGFbeta receptors and is a substrate of the type II receptor, TbetaRII Phosphorylation of Par6 is required for TGFbeta-dependent EMT in mammary gland epithelia[ cells and controls the interaction of Par6 with the E3 ubiquitin ligase Smurf1. Smurf1, in turn, targets the guanosine triphosphatase RhoA for degradation, thereby leading to a loss of tight junctions. These studies define how an extracellular cue signals to the polarity machinery to control epithelia[ cell morphology.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Wrana, JL (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada.	wrana@mshri.on.ca	Bose, Rohit/O-9825-2018; Wrana, Jeffrey/F-8857-2013	Bose, Rohit/0000-0002-6785-0697; Wang, Hong-Rui/0000-0002-2916-8849				Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen ML, 2002, J BIOL CHEM, V277, P4247, DOI 10.1074/jbc.M109254200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ehrlich M, 2001, J CELL SCI, V114, P1777; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Fujita H, 2000, BIOCHEM J, V346, P617, DOI 10.1042/0264-6021:3460617; Gao C, 2002, MOL CANCER RES, V1, P12; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kaartinen V, 2002, INT J MOL MED, V9, P563; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moustakas A, 2001, J CELL SCI, V114, P4359; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; OZDAMAR B, UNPUB; Pagan R, 1996, EXP CELL RES, V222, P333, DOI 10.1006/excr.1996.0043; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tian YC, 2003, AM J PHYSIOL-RENAL, V285, pF130, DOI 10.1152/ajprenal.00408.2002; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watts JL, 1996, DEVELOPMENT, V122, P3133; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	48	680	722	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1603	1609		10.1126/science.1105718	http://dx.doi.org/10.1126/science.1105718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761148				2022-12-01	WOS:000227622400042
J	Paradise, J; Andrews, L; Holbrook, T				Paradise, J; Andrews, L; Holbrook, T			Patents on human genes: An analysis of scope and claims	SCIENCE			English	Editorial Material							INTELLECTUAL PROPERTY-RIGHTS; POLICY		Chicago Kent Coll Law, IIT, Chicago, IL 60661 USA	Illinois Institute of Technology	Paradise, J (corresponding author), Chicago Kent Coll Law, IIT, 565 W Adams, Chicago, IL 60661 USA.	jparadise@kent-law.edu						Andrews LB, 2002, NAT REV GENET, V3, P803, DOI 10.1038/nrg909; Barton JH, 2000, SCIENCE, V287, P1933, DOI 10.1126/science.287.5460.1933; BLANTON K, 2002, BOSTON GLOBE    0224, P10; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Cho M. K., 1998, PREPARING MILLENNIUM, P47; Gad S, 2001, J MED GENET, V38, P388, DOI 10.1136/jmg.38.6.388; Lemley MA, 2001, NORTHWEST U LAW REV, V95, P1495; MERGES RP, 1999, BERKELEY TECH L J, V14, P577; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a	9	41	43	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1566	1567		10.1126/science.1105162	http://dx.doi.org/10.1126/science.1105162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761140	Green Submitted			2022-12-01	WOS:000227622400027
J	El-Khamisy, SF; Saifi, GM; Weinfeld, M; Johansson, F; Helleday, T; Lupski, JR; Caldecott, KW				El-Khamisy, SF; Saifi, GM; Weinfeld, M; Johansson, F; Helleday, T; Lupski, JR; Caldecott, KW			Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1	NATURE			English	Article							I COVALENT COMPLEXES; TOPOISOMERASE-I; BASE DAMAGES; PHOSPHODIESTERASE; XRCC1; MUTATION; TDP1; ELONGATION; PATHWAYS; ABSENCE	Spinocerebellar ataxia with axonal neuropathy- 1 (SCAN1) is a neurodegenerative disease that results from mutation of tyrosyl phosphodiesterase 1 (TDP1)(1). In lower eukaryotes, Tdp1 removes topoisomerase 1 (top1) peptide from DNA termini during the repair of double-strand breaks created by collision of replication forks with top1 cleavage complexes in proliferating cells(2-4). Although TDP1 most probably fulfils a similar function in human cells, this role is unlikely to account for the clinical phenotype of SCAN1, which is associated with progressive degeneration of post-mitotic neurons. In addition, this role is redundant in lower eukaryotes, and Tdp1 mutations alone confer little phenotype(4-7). Moreover, defects in processing or preventing double-strand breaks during DNA replication are most probably associated with increased genetic instability and cancer, phenotypes not observed in SCAN1 ( ref. 8). Here we show that in human cells TDP1 is required for repair of chromosomal singlestrand breaks arising independently of DNA replication from abortive top1 activity or oxidative stress. We report that TDP1 is sequestered into multi-protein single-strand break repair (SSBR) complexes by direct interaction with DNA ligase IIIalpha and that these complexes are catalytically inactive in SCAN1 cells. These data identify a defect in SSBR in a neurodegenerative disease, and implicate this process in the maintenance of genetic integrity in post-mitotic neurons.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Univ Stockholm, Arrhenius Lab, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England	University of Sussex; Baylor College of Medicine; University of Alberta; Stockholm University; University of Sheffield	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England.	k.w.caldecott@sussex.ac.uk	Helleday, Thomas/D-5224-2013; Caldecott, Keith/S-4245-2019	Caldecott, Keith/0000-0003-4255-9016; Helleday, Thomas/0000-0002-7384-092X; , Sherif/0000-0003-2721-7763	Medical Research Council [G0001259] Funding Source: Medline; MRC [G0001259] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BENDIXEN C, 1990, BIOCHEMISTRY-US, V29, P5613, DOI 10.1021/bi00475a028; BRADLEY MO, 1979, NUCLEIC ACIDS RES, V7, P793, DOI 10.1093/nar/7.3.793; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Lambert S, 2001, ONCOGENE, V20, P6627, DOI 10.1038/sj.onc.1204813; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Liu JK, 2004, CHEM BIODIVERS, V1, P601, DOI 10.1002/cbdv.200490050; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Rasouli-Nia A, 2004, P NATL ACAD SCI USA, V101, P6905, DOI 10.1073/pnas.0400099101; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; ZHOU W, 1994, BIOCHEMISTRY-US, V33, P14926, DOI 10.1021/bi00253a032	30	335	338	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					108	113		10.1038/nature03314	http://dx.doi.org/10.1038/nature03314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744309				2022-12-01	WOS:000227334600053
J	Guimera, R; Amaral, LAN				Guimera, R; Amaral, LAN			Functional cartography of complex metabolic networks	NATURE			English	Article							SMALL-WORLD; ORGANIZATION; MODULARITY	High-throughput techniques are leading to an explosive growth in the size of biological databases and creating the opportunity to revolutionize our understanding of life and disease. Interpretation of these data remains, however, a major scientific challenge. Here, we propose a methodology that enables us to extract and display information contained in complex networks(1-3). Specifically, we demonstrate that we can find functional modules(4,5) in complex networks, and classify nodes into universal roles according to their pattern of intra- and inter-module connections. The method thus yields a 'cartographic representation' of complex networks. Metabolic networks(6-8) are among the most challenging biological networks and, arguably, the ones with most potential for immediate applicability(9). We use our method to analyse the metabolic networks of twelve organisms from three different superkingdoms. We find that, typically, 80% of the nodes are only connected to other nodes within their respective modules, and that nodes with different roles are affected by different evolutionary constraints and pressures. Remarkably, we find that metabolites that participate in only a few reactions but that connect different modules are more conserved than hubs whose links are mostly within a single module.	Northwestern Univ, NICO, Evanston, IL 60208 USA; Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Amaral, LAN (corresponding author), Northwestern Univ, NICO, Evanston, IL 60208 USA.	amaral@northwestern.edu	Guimera, Roger/C-1727-2008; Amaral, LAN/A-4980-2008; Amaral, Luis N./C-5485-2009; Guimera, Roger/M-9808-2019	Guimera, Roger/0000-0002-3597-4310; Amaral, LAN/0000-0002-3762-789X; Guimera, Roger/0000-0002-3597-4310	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K25GM069546] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Arenas A, 2004, EUR PHYS J B, V38, P373, DOI 10.1140/epjb/e2004-00130-1; Donetti L, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10012; Eriksen KA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.148701; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hatzimanikatis V, 2004, CURR OPIN STRUC BIOL, V14, P300, DOI 10.1016/j.sbi.2004.04.004; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; WASSERMAN S, 1994, SOCIAL NETWORK ANAL, pCH12	29	2220	2367	38	430	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					895	900		10.1038/nature03288	http://dx.doi.org/10.1038/nature03288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729348	Green Accepted, Green Submitted			2022-12-01	WOS:000227174600050
J	Jenkins, V; Fallowfield, L; Solis-Trapala, I; Langridge, C; Farewell, V				Jenkins, V; Fallowfield, L; Solis-Trapala, I; Langridge, C; Farewell, V			Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research LTK training programme	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNICATION-SKILLS; KEY	Objective To evaluate a training intervention aimed at improving healthcare professionals' communication with cancer patients about randomised clinical trials. Design Before and after evaluation of training programme. Setting Members of the National Cancer Research Network, Scottish Trials Network, and the Welsh Cancer Trials Network Participants 101 healthcare professionals (33 clinicians and 68 research nurses). Intervention Four modules delivered by a trained facilitator using videotapes and interactive exercises to cover general issues about discussing randomised clinical trials with patients, problems specific to adjuvant trials, trials with palliation as the goal, and trials where patients had a strong preference for one treatment arm. Main outcome measures Before and after the intervention, participants were videotaped discussing a trial with an actor portraying a patient. These consultations were assessed for presence of information required by good clinical practice guidelines. The actor patients gave an assessment after each interview Participants reported their self confidence about key aspects of trial discussion. Results Analysis of the videotaped consultations showed that, after intervention, significantly more participants displayed key communication behaviours such as explaining randomisation (69 v 8 1, odds ratio 2.33, P = 0.033), checking patients' understanding (I I v 3 1, odds ratio 3.22, P = 0.002), and discussing standard treatment (73 v 88, odds ratio 4.75, P = 0.005) and side effects (69 v 85, odds ratio 3.29, P = 0.006). Participants' self confidence increased significantly (P < 0.001) across all areas. Actor patients' ratings of participants' communication showed significant improvements for 12/15 key items. Conclusion This intensive 8 hour intervention significantly improved participants' confidence and competence when communicating about randomised clinical trials.	Univ Sussex, Brighton & Sussex Med Sch, Sussex Psychosocial Oncol Grp, Brighton BN1 9QG, E Sussex, England; Ctr Invest Matemat, Guanajuato, Mexico; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Brighton; University of Sussex; CIMAT - Centro de Investigacion en Matematicas; MRC Biostatistics Unit; University of Cambridge	Jenkins, V (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Sussex Psychosocial Oncol Grp, Brighton BN1 9QG, E Sussex, England.	val@sussex.ac.uk	Solis-Trapala, Ivonne/D-8144-2011; Solis-Trapala, Ivonne/AAZ-2105-2021	Solis-Trapala, Ivonne/0000-0002-1264-1396; Solis-Trapala, Ivonne/0000-0002-1264-1396; Fallowfield, Lesley/0000-0003-0577-4518; Farewell, Vernon/0000-0001-6704-5295				Albrecht TL, 1999, J CLIN ONCOL, V17, P3324, DOI 10.1200/JCO.1999.17.10.3324; *DEP HLTH, 2000, 6 DEP HLTH; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Fallowfield L, 2003, BRIT J CANCER, V89, P1445, DOI 10.1038/sj.bjc.6601309; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; Fallowfield L, 2001, CANCER NURS, V24, P185, DOI 10.1097/00002820-200106000-00004; Jenkins V, 2002, BRIT J CANCER, V87, P854, DOI 10.1038/sj.bjc.6600527; Jenkins VA, 1999, EUR J CANCER, V35, P1187, DOI 10.1016/S0959-8049(99)00116-1; Maguire P, 2002, BRIT MED J, V325, P697, DOI 10.1136/bmj.325.7366.697; *MED RES COUNC, 1998, MRC GUID GOOD CLIN P; Pope JE, 2003, J RHEUMATOL, V30, P815; Razavi D, 2003, J CLIN ONCOL, V21, P3141, DOI 10.1200/JCO.2003.08.031	14	67	68	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2005	330	7488					400	403		10.1136/bmj.38366.562685.8F	http://dx.doi.org/10.1136/bmj.38366.562685.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900NA	15705666	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000227220400021
J	Raimondo, G; Pollicino, T; Squadrito, G				Raimondo, G; Pollicino, T; Squadrito, G			What is the clinical impact of occult hepatitis B virus infection?	LANCET			English	Editorial Material							ANTIGEN		Univ Messina, Dept Internal Med, Unit Clin & Mol Hepatol, I-98124 Messina, Italy	University of Messina	Raimondo, G (corresponding author), Univ Messina, Dept Internal Med, Unit Clin & Mol Hepatol, I-98124 Messina, Italy.	raimondo@unime.it	Pollicino, Teresa/K-5790-2016; Pollicino, Teresa/HDN-3708-2022	Pollicino, Teresa/0000-0001-6602-3035; 				Allain JP, 2004, VOX SANG, V86, P83, DOI 10.1111/j.0042-9007.2004.00406.x; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; CARMAN W, 1993, LANCET, V341, P349, DOI 10.1016/0140-6736(93)90146-8; CHAZOUILLERES O, 1994, LANCET, V343, P142, DOI 10.1016/S0140-6736(94)90934-2; Chemin I, 2001, J HEPATOL, V34, P447, DOI 10.1016/S0168-8278(00)00100-8; GRUMAYER ER, 1989, J HEPATOL, V8, P232, DOI 10.1016/0168-8278(89)90012-3; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Minuk GY, 2004, HEPATOLOGY, V40, P1072, DOI 10.1002/hep.20435; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; Raimondo C, 2001, J HEPATOL, V34, P471, DOI 10.1016/S0168-8278(01)00016-2; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; WAITE J, 1988, AIDS, V2, P443, DOI 10.1097/00002030-198812000-00006; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100	16	45	52	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2005	365	9460					638	640						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15721459				2022-12-01	WOS:000227096800007
J	Snir, Y; Kamien, RD				Snir, Y; Kamien, RD			Entropically driven helix formation	SCIENCE			English	Article							SHAPES		Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania	Kamien, RD (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	kamien@physics.upenn.edu						ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Banavar JR, 2003, REV MOD PHYS, V75, P23, DOI 10.1103/RevModPhys.75.23; BELLO J, 1993, BIOPOLYMERS, V33, P491, DOI 10.1002/bip.360330315; DELATOUR EB, 1988, CELL, V55, P937, DOI 10.1016/0092-8674(88)90239-5; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Gonzalez O, 1999, P NATL ACAD SCI USA, V96, P4769, DOI 10.1073/pnas.96.9.4769; LAU KF, 1989, MACROMOLECULES, V22, P3986, DOI 10.1021/ma00200a030; Maritan A, 2000, NATURE, V406, P287, DOI 10.1038/35018538; Pickett GT, 2000, PHYS REV LETT, V85, P3652, DOI 10.1103/PhysRevLett.85.3652	9	216	222	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1067	1067		10.1126/science.1106243	http://dx.doi.org/10.1126/science.1106243			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718461	Green Submitted			2022-12-01	WOS:000227197300036
J	Zhang, ZX; Roman, GC; Hong, Z; Wu, CB; Qu, QM; Huang, JB; Zhou, B; Geng, ZP; Wu, JX; Wen, HB; Zhao, H; Zahner, GEP				Zhang, ZX; Roman, GC; Hong, Z; Wu, CB; Qu, QM; Huang, JB; Zhou, B; Geng, ZP; Wu, JX; Wen, HB; Zhao, H; Zahner, GEP			Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai	LANCET			English	Article								A cross-sectional prevalence study of Parkinson's disease in China was undertaken in 1997-98. We assessed 29 454 residents aged greater than or equal to55 years from 79 rural and 58 urban communities in Beijing, Xian, and Shanghai, who were selected through stratified, multistage, cluster sampling. With a standardised diagnostic protocol, we identified 277 people with the disease. Prevalence of Parkinson's disease for those aged greater than or equal to65 years was 1.7% (95% CI 1.5-1.9). We estimate that 1.7 million people in China have the disease (aged greater than or equal to55 years). Our findings suggest that prevalence of Parkinson's disease in China is similar to that in developed countries.	Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Epidemiol, Beijing 100037, Peoples R China; Univ Texas, Hlth Sci Ctr, Dept Med & Neurol, San Antonio, TX USA; Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; Xian Transportat Univ, First Hosp, Dept Neurol, Xian, Peoples R China; Tongren Hosp, Dept Neurol, Beijing, Peoples R China; Beijing Sixth Hosp, Dept Neurol, Beijing, Peoples R China; Natl Res Inst Family Planning, Dept Stat, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Texas System; University of Texas Health San Antonio; Fudan University; National Research Institute for Family Planning - China	Zhang, ZX (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China.	zhangzx@pumch.ac.cn						CALNE DB, 1992, ANN NEUROL S, V32, P125; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; SAS Institute, 2000, SAS STAT VERS 8; Tanner C. M., 2004, MOVEMENT DISORDERS N, P177; ZHANG ZX, 1993, NEUROEPIDEMIOLOGY, V12, P195, DOI 10.1159/000110318; Zhang ZX, 2003, MOVEMENT DISORD, V18, P764, DOI 10.1002/mds.10445	6	277	439	4	114	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 12	2005	365	9459					595	597						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708103				2022-12-01	WOS:000226984300032
J	Gital, Z; Dye, NA; Reisenauer, A; Wachi, M; Shapiro, L				Gital, Z; Dye, NA; Reisenauer, A; Wachi, M; Shapiro, L			MreB actin-mediated segregation of a specific region of a bacterial chromosome	CELL			English	Article							CELL-CYCLE PROGRESSION; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; BACILLUS-SUBTILIS; DNA-REPLICATION; POLAR LOCALIZATION; CONTROLLED PROTEOLYSIS; PROTEINS; DIVISION; ORIGIN	Faithful chromosome segregation is an essential component of cell division in all organisms. The eukaryotic mitotic machinery uses the cytoskeleton to move specific chromosomal regions. To investigate the potential role of the actin-like MreB protein in bacterial chromosome segregation, we first demonstrate that MreB is the direct target of the small molecule A22. We then demonstrate that A22 completely blocks the movement of newly replicated loci near the origin of replication but has no qualitative or quantitative effect on the segregation of other loci if added after origin segregation. MreB selectively interacts, directly or indirectly, with origin-proximal regions of the chromosome, arguing that the origin-proximal region segregates via an MreB-dependent mechanism not used by the rest of the chromosome.	Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Beckman Ctr, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Stanford University; Stanford University; Princeton University; Tokyo Institute of Technology	Gital, Z (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	zgitai@stanford.edu; shapiro@cmgm.stanford.edu	Dye, Natalie/X-4910-2019; Wachi, Masaaki/D-1220-2015	Dye, Natalie/0000-0002-4859-6670; Wachi, Masaaki/0000-0002-3655-4035	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051426] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM51426] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alley MRK, 2001, MOL MICROBIOL, V40, P1335, DOI 10.1046/j.1365-2958.2001.02476.x; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gordon GS, 2002, MOL MICROBIOL, V44, P501, DOI 10.1046/j.1365-2958.2002.02901.x; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Iwai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2658, DOI 10.1271/bbb.66.2658; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Jaffe A, 1997, J BACTERIOL, V179, P3494, DOI 10.1128/jb.179.11.3494-3499.1997; Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Jensen RB, 2001, EMBO J, V20, P4952, DOI 10.1093/emboj/20.17.4952; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; MARCZYNSKI GT, 1990, J MOL BIOL, V212, P709, DOI 10.1016/0022-2836(90)90232-B; MARCZYNSKI GT, 1992, J MOL BIOL, V226, P959, DOI 10.1016/0022-2836(92)91045-Q; Marczynski GT, 2002, ANNU REV MICROBIOL, V56, P625, DOI 10.1146/annurev.micro.56.012302.161103; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Niki H, 2000, GENE DEV, V14, P212; Quardokus E, 1996, P NATL ACAD SCI USA, V93, P6314, DOI 10.1073/pnas.93.13.6314; Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Webb CD, 1998, MOL MICROBIOL, V28, P883, DOI 10.1046/j.1365-2958.1998.00808.x; WINZELER E, 1995, J MOL BIOL, V251, P346, DOI 10.1006/jmbi.1995.0439; Yamaichi Y, 2004, EMBO J, V23, P221, DOI 10.1038/sj.emboj.7600028	51	323	328	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					329	341		10.1016/j.cell.2005.01.007	http://dx.doi.org/10.1016/j.cell.2005.01.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707892	Bronze			2022-12-01	WOS:000227028900009
J	Laugwitz, KL; Moretti, A; Lam, J; Gruber, P; Chen, YH; Woodard, S; Lin, LZ; Cai, CL; Lu, MM; Reth, M; Platoshyn, O; Yuan, JXJ; Evans, S; Chien, KR				Laugwitz, KL; Moretti, A; Lam, J; Gruber, P; Chen, YH; Woodard, S; Lin, LZ; Cai, CL; Lu, MM; Reth, M; Platoshyn, O; Yuan, JXJ; Evans, S; Chien, KR			Postnatal isl1+cardioblasts enter fully differentiated cardiomyocyte lineages	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; TAMOXIFEN-INDUCIBLE FORM; CARDIAC MYOCYTES; CRE; EXPRESSION; PATHWAYS; DISEASE; FUSION	The purification, renewal and differentiation of native cardiac progenitors would form a mechanistic underpinning for unravelling steps for cardiac cell lineage formation, and their links to forms of congenital and adult cardiac diseases(1 - 3). Until now there has been little evidence for native cardiac precursor cells in the postnatal heart(4). Herein, we report the identification of isl1(+) cardiac progenitors in postnatal rat, mouse and human myocardium. A cardiac mesenchymal feeder layer allows renewal of the isolated progenitor cells with maintenance of their capability to adopt a fully differentiated cardiomyocyte phenotype. Tamoxifen- inducible Cre/ lox technology enables selective marking of this progenitor cell population including its progeny, at a defined time, and purification to relative homogeneity. Coculture studies with neonatal myocytes indicate that isl1(+) cells represent authentic, endogenous cardiac progenitors ( cardioblasts) that display highly efficient conversion to a mature cardiac phenotype with stable expression of myocytic markers ( 25%) in the absence of cell fusion, intact Ca2+- cycling, and the generation of action potentials. The discovery of native cardioblasts represents a genetically based system to identify steps in cardiac cell lineage formation and maturation in development and disease.	Univ Calif San Diego, Sch Med, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Childrens Hosp Philadelphia, Cardiac Ctr, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA; Univ Freiburg, Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Max Planck Society; University of Freiburg	Chien, KR (corresponding author), Univ Calif San Diego, Sch Med, Inst Mol Med, La Jolla, CA 92093 USA.	syevans@ucsd.edu; kchien@partners.org	Moretti, Alessandra/O-9271-2015; Evans, Sylvia/G-1980-2015	Moretti, Alessandra/0000-0001-5782-7832; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL117649, R01HL070867] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006428] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070867, DP1 HL117649] Funding Source: Medline; NIH HHS [DP1 OD006428] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; D'Amour KA, 2002, NAT MED, V8, P213, DOI 10.1038/nm0302-213; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Epstein J. A., 2001, TRENDS GENET, V17, pS13; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Maltsev VA, 1999, CIRC RES, V84, P136, DOI 10.1161/01.RES.84.2.136; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Rosenthal N, 2003, NEW ENGL J MED, V349, P267, DOI 10.1056/NEJMra020849; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Verrou C, 1999, BIOL CHEM, V380, P1435, DOI 10.1515/BC.1999.184; Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604	25	980	1071	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					647	653		10.1038/nature03215	http://dx.doi.org/10.1038/nature03215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703750	Green Accepted			2022-12-01	WOS:000226862000048
J	Maeda, S; Hsu, LC; Liu, HJ; Bankston, LA; Iimura, M; Kagnoff, MF; Eckmann, L; Karin, M				Maeda, S; Hsu, LC; Liu, HJ; Bankston, LA; Iimura, M; Kagnoff, MF; Eckmann, L; Karin, M			Nod2 mutation in Crohn's disease potentiates NF-kappa B activity and IL-10 processing	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; RECOGNITION; SUSCEPTIBILITY; MACROPHAGES; COLITIS; IKK	Variants of NOD2, an intracellular sensor of bacteria-derived muramyl dipeptide (MDP), increase susceptibility to Crohn's disease (CD). These variants are thought to be defective in activation of nuclear factor kappaB (NF-kappaB) and antibacterial defenses, but CD clinical specimens display elevated NF-kappaB activity. To illuminate the pathophysiological function of NOD2, we introduced such a variant to the mouse Nod2 locus. Mutant mice exhibited elevated NF-kappaB activation in response to MDP and more efficient processing and secretion of the cytokine interleukin-1beta (IL-1beta). These effects are linked to increased susceptibility to bacterial-induced intestinal inflammation and identify NOD2 as a positive regulator of NF-kappaB activation and IL-1beta secretion.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Lab Mucosal Immunol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pediat, Lab Mucosal Immunol, La Jolla, CA 92093 USA; Burnham Inst, Program Cell Adhes, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu		Hsu, Li-Chung/0000-0001-7206-5231	NIAID NIH HHS [AI56075, AI43477] Funding Source: Medline; NIDDK NIH HHS [DK07202, DK35108] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI056075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108, T32DK007202] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, TRENDS IMMUNOL, V24, P652, DOI 10.1016/j.it.2003.10.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; MAEDA S, UNPUB; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155	24	626	655	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					734	738		10.1126/science.1103685	http://dx.doi.org/10.1126/science.1103685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692052				2022-12-01	WOS:000226814900046
J	Catania, KC; Remple, FE				Catania, KC; Remple, FE			Asymptotic prey profitability drives star-nosed moles to the foraging speed limit	NATURE			English	Article							FOOD	Foraging theory provides models for predicting predator diet choices assuming natural selection has favoured predators that maximize their rate of energy intake during foraging(1-6). Prey profitability ( energy gained divided by prey handling time) is an essential variable for estimating the optimal diet. Time constraints of capturing and consuming prey generally result in handling times ranging from minutes to seconds, yet profitability increases dramatically as handling time approaches zero, providing the potential for strong directional selection for increasing predator speed at high encounter rates ( tiny increments in speed increase profitability markedly, allowing expanded diets of smaller prey). We provide evidence that the unusual anatomical and behavioural specializations characterizing star-nosed moles resulted from progressively stronger selection for speed, allowing the progressive addition of small prey to their diet. Here we report handling times as short as 120 ms (mean 227 ms) for moles identifying and eating prey. 'Double takes' during prey identification suggest that star-nosed moles have reached the speed limit for processing tactile information. The exceptional speed of star-nosed moles, coupled with unusual specializations for finding and eating tiny prey, provide new support for optimal foraging theory.	Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B, Box 351634, Nashville, TN 37235 USA.	ken.catania@Vanderbilt.edu						Anderson JT, 2000, ECOL APPL, V10, P550, DOI 10.1890/1051-0761(2000)010[0550:IRTMSM]2.0.CO;2; Carpenter RHS, 1977, MOVEMENTS EYES; Catania KC, 2004, BRAIN BEHAV EVOLUT, V63, P1, DOI 10.1159/000073755; Catania KC, 1997, J COMP NEUROL, V387, P215; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; CUMMINS KW, 1971, INT ASS THEOR APPL L, V18, P2; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; HAMILTON WILLIAM JOHN, 1931, JOUR MAMMAL, V12, P345, DOI 10.2307/1373758; Kamil A. C., 1981, FORAGING BEHAV ECOLO; MAIOROV V I, 1980, Neuroscience and Behavioral Physiology, V10, P374, DOI 10.1007/BF01184053; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P2602, DOI 10.1152/jn.2002.87.5.2602; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Stephens D.W., 1986, pi; SUGA N, 1976, SCIENCE, V194, P542, DOI 10.1126/science.973140; WITZ BW, 1993, COMP BIOCHEM PHYS A, V105, P151, DOI 10.1016/0300-9629(93)90188-A; WONGRILEY MTT, 1984, J COMP NEUROL, V222, P18, DOI 10.1002/cne.902220103	20	55	57	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					519	522		10.1038/nature03250	http://dx.doi.org/10.1038/nature03250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690041				2022-12-01	WOS:000226727200048
J	Yamamoto, A; Nagano, T; Takehara, S; Hibi, M; Aizawa, S				Yamamoto, A; Nagano, T; Takehara, S; Hibi, M; Aizawa, S			Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, Wnt and FGF	CELL			English	Article							ENDOPLASMIC-RETICULUM; MESODERM INDUCTION; QUALITY-CONTROL; HOMEOBOX GENE; XENOPUS; SPECIFICATION; ANTAGONIST; EXPRESSION; ORGANIZER; WINGLESS	Head formation requires simultaneous inhibition of multiple caudalizing signals during early vertebrate embryogenesis. We identified a novel antagonist against Wnt and FGF signaling for head formation, Shisa, which functions cell autonomously in the endoplasmic reticulum (ER). Shisa is specifically expressed in the prospective head ectoderm and the Spemann organizer of Xenopus gastrulae. Overexpression of Shisa inhibited both Wnt and FGF signaling in Xenopus embryos and in a cell line. Loss of Shisa function sensitized the neuroectoderm to Wnt signaling and suppressed head formation during gastrulation. Shisa physically interacted with immature forms of the Wnt receptor Frizzled and the FGF receptor within the ER and inhibited their posttranslational maturation and trafficking to the cell surface. Taken together, these findings indicate that Shisa is a novel molecule that controls head formation by regulating the establishment of the receptors for caudalizing factors.	RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Chuou Ku, Kobe, Hyogo 6500047, Japan; RIKEN, Ctr Dev Biol, Lab Vertebrate Axis Format, Chuou Ku, Kobe, Hyogo 6500047, Japan	RIKEN; RIKEN	Yamamoto, A (corresponding author), RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Chuou Ku, 2-2-3 Minatojima Minami, Kobe, Hyogo 6500047, Japan.	akihito@cdb.riken.jp; saizawa@cdb.riken.jp	Hibi, Masahiko/I-6215-2014	Hibi, Masahiko/0000-0002-9142-4444				AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BLITZ IL, 1995, DEVELOPMENT, V121, P993; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CORNELL RA, 1994, DEVELOPMENT, V120, P453; Cox WG, 1995, DEVELOPMENT, V121, P4349; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hunter T, 1998, Harvey Lect, V94, P81; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kazanskaya O, 2000, DEVELOPMENT, V127, P4981; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kudoh T, 2002, DEVELOPMENT, V129, P4335; LABONNE C, 1994, DEVELOPMENT, V120, P463; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; PANNESE M, 1995, DEVELOPMENT, V121, P707; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pownall ME, 1996, DEVELOPMENT, V122, P3881; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sive H. L., 2000, EARLY DEV XENOPUS LA; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Thisse C, 1999, DEVELOPMENT, V126, P229; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8	48	122	128	5	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					223	235		10.1016/j.cell.2004.11.051	http://dx.doi.org/10.1016/j.cell.2004.11.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680328	Bronze			2022-12-01	WOS:000226740000011
J	Moore, JP				Moore, JP			Topical microbicides become topical	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEXUAL TRANSMISSION; PREVENTION; INFECTION; HIV		Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.							Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833	5	25	25	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2005	352	3					298	300		10.1056/NEJMcibr043727	http://dx.doi.org/10.1056/NEJMcibr043727			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888JP	15659734				2022-12-01	WOS:000226370500015
J	Domergue, R; Castano, I; De las Penas, A; Zupancic, M; Lockatell, V; Hebel, JR; Johnson, D; Cormack, BP				Domergue, R; Castano, I; De las Penas, A; Zupancic, M; Lockatell, V; Hebel, JR; Johnson, D; Cormack, BP			Nicotinic acid limitation regulates silecing of Candida adhesins during UTI	SCIENCE			English	Article							ESCHERICHIA-COLI; GENE FAMILY; GLABRATA; DEACETYLASE; METABOLISM; EVOLUTION; CHROMATIN	The adherence of Candida glabrata to host cells is mediated, at least in part, by the EPA genes, a family of adhesins encoded at subtelomeric loci, where they are subject to transcriptional silencing. We show that normally silent EPA genes are expressed during murine urinary tract infection (UTI) and that the inducing signal is the limitation of nicotinic acid (NA), a precursor of nicotinamide adenine dinucleotide (NAD(+)). C. glabrata is an NA auxotroph, and NA-induced EPA expression is likely the result of a reduction in NAD(+) availability for the NAD(+)-dependent histone deacetylase Sir2p. The adaptation of C. glabrata to the host, therefore, involves a loss of metabolic capacity and exploitation of the resulting auxotrophy to signal a particular host environment.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Dept Vet Affairs, Res Serv, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Cormack, BP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	bcormack@jhmi.edu	De Las Penas, Alejandro/M-7719-2013	Castano, Irene/0000-0002-5968-2101; De Las Penas, Alejandro/0000-0002-2933-2856	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049720] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI46223] Funding Source: Medline; NIDDK NIH HHS [2PO1DK49720] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Castano I, 2005, MOL MICROBIOL, V55, P1246, DOI 10.1111/j.1365-2958.2004.04465.x; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; DAI J, UNPUB; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fukuwatari T, 2004, BIOSCI BIOTECH BIOCH, V68, P44, DOI 10.1271/bbb.68.44; Guarente L, 2000, GENE DEV, V14, P1021; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x; KUNIN CM, 1993, J CLIN MICROBIOL, V31, P47, DOI 10.1128/JCM.31.1.47-49.1993; LIDIA Do CARMO-SOUSA, 1969, The yeasts. Vol. I. Biology of yeasts., P79; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Lundstrom T, 2001, CLIN INFECT DIS, V32, P1602, DOI 10.1086/320531; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; ROBESON JP, 1980, NATURE, V283, P104, DOI 10.1038/283104a0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sandmeier JJ, 2002, GENETICS, V160, P877; Staib P, 1999, MOL MICROBIOL, V32, P533, DOI 10.1046/j.1365-2958.1999.01367.x; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; VANPILSUN J, 1974, BIOL DATA BOOK, P1496; Vazquez JA, 1999, CLIN INFECT DIS, V28, P1025, DOI 10.1086/514746	27	204	219	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					866	870		10.1126/science.1108640	http://dx.doi.org/10.1126/science.1108640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774723				2022-12-01	WOS:000228986500052
J	Grandesso, F; Sanderson, F; Kruijt, J; Koene, T; Brown, V				Grandesso, F; Sanderson, F; Kruijt, J; Koene, T; Brown, V			Mortality and malnutrition among populations living in South Darfur, Sudan - Results of 3 surveys, September 2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Mass violence against civilians in the west of Sudan has resulted in the displacement of more than 1.5 million people (25% of the population of the Darfur region). Most of these people are camped in 142 settlements. There has been increasing international concern about the health status of the displaced population. Objective To perform rapid epidemiological assessments of mortality and nutritional status at 3 sites in South Darfur for relief efforts. Design, Setting, and Participants In August and September 2004, mortality surveys were conducted among 137000 internally displaced persons (IDPs) in 3 sites in South Darfur (Kass [n = 900 households], Kalma [n = 893 households], and Muhajiria [n = 900 households]). A nutritional survey was performed concomitantly among children aged 6 to 59 months using weight for height as an index of acute malnutrition (Kass [n = 894], Kalma [n = 8881, and Muhajiria [n = 8961). A questionnaire detailing access to food and basic services was administered to a subset of households (n = 210 in each site). Main Outcome Measures Crude and under 5-year mortality rates and nutritional status of IDPs in Kass, Kalma, and Muhajiria, South Darfur. Results Crude mortality rates, expressed as deaths per 10000 per day, were 3.2 (95% confidence interval [CI], 2.2-4.1) in Kass, 2.0 (95% Cl, 1.3-2.7) in Kalma, and 2.3 (95% Cl, 1.2-3.4) in Muhajiria. Under 5-year mortality rates were 5.9 (95% Cl, 3.8-8.0) in Kass, 3.5 (95% Cl, 1.5-5.7) in Kalma, and 1.0 (95% Cl, 0.03-1.9) in Muhajiria. During the period of displacement covered by our survey in Muhajiria, violence was reported to be responsible for 72% of deaths, mainly among young men. Diarrheal disease was reported to cause between 25% and 47% of deaths in camp residents and mainly affected the youngest and oldest age groups. Acute malnutrition was common, affecting 14.1% of the target population in Kass, 23.6% in Kalma, and 10.7% in Muhajiria. Conclusion This study provides epidemiological evidence of the high rates of mortality and malnutrition among the displaced population in South Darfur and reinforces the need to mount appropriate and timely humanitarian responses.	Charing Cross Hosp, Dept Infect, London W6 8RF, England; Epictr, Paris, France; Med Sans Frontieres, Amsterdam, Netherlands	Imperial College London; Doctors Without Borders	Sanderson, F (corresponding author), Charing Cross Hosp, Dept Infect, London W6 8RF, England.	frances.sanderson@imperial.ac.uk						*CEDAT BRIEF DARF, 2004, AN MORT NUTR SURV N; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; *MED FRONT, 1995, NUTR GUID; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; The Sphere Project, 1998, HUM CHART MIN STAND; UN. High Commission for Refugees, 1999, HDB EM; WOODRUFF BA, 2002, FIELD EXCHANGE, V17, P16; *WORLD MED ASS, DECL HELS 2004	9	33	33	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1490	1494		10.1001/jama.293.12.1490	http://dx.doi.org/10.1001/jama.293.12.1490			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784873				2022-12-01	WOS:000227784700029
J	Berenbrink, M; Koldkjaer, P; Kepp, O; Cossins, AR				Berenbrink, M; Koldkjaer, P; Kepp, O; Cossins, AR			Evolution of oxygen secretion in fishes and the emergence of a complex physiological system	SCIENCE			English	Article							STRUCTURAL BASIS; MEMBRANE-TRANSPORT; HEMOGLOBIN; ERYTHROCYTES; AFFINITY; MECHANISM; TELEOST; BLOOD; EYE	We have reconstructed the events that led to the evolution of a key physiological innovation underpinning the large adaptive radiation of fishes, namely their unique ability to secrete molecular oxygen (O-2). We show that O-2 secretion into the swimbladder evolved some 100 million years after another O-2-secreting system in the eye. We unravel the likely sequence in which the functional components of both systems evolved. These components include ocular and swimbladder countercurrent exchangers, the Bohr and Root effects, the buffering power and surface histidine content of hemoglobins, and red blood cell Na+/H+ exchange activity. Our synthesis reveals the dynamics of gains and losses of these multiple traits over time, accounting for part of the huge diversity of form and function in living fishes.	Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Humboldt Univ, Dept Anim Physiol, D-10115 Berlin, Germany	University of Liverpool; Humboldt University of Berlin	Berenbrink, M (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St, Liverpool L69 7ZB, Merseyside, England.	michaelb@liv.ac.uk	Kepp, Oliver/GPX-8627-2022; Berenbrink, Michael/W-7519-2019; Kepp, Oliver/N-2763-2017	Kepp, Oliver/0000-0002-6081-9558; Cossins, Andrew/0000-0002-0813-5212				ALEXANDER RM, 1966, BIOL REV, V41, P141, DOI 10.1111/j.1469-185X.1966.tb01542.x; Berenbrink M, 2000, J PHYSIOL-LONDON, V526, P69, DOI 10.1111/j.1469-7793.2000.t01-1-00069.x; Bohr C, 1894, J Physiol, V15, P494; BORGESE F, 1992, P NATL ACAD SCI USA, V89, P6765, DOI 10.1073/pnas.89.15.6765; FAIRBANKS MB, 1974, J GEN PHYSIOL, V64, P263, DOI 10.1085/jgp.64.3.263; Fang TY, 1999, BIOCHEMISTRY-US, V38, P13423, DOI 10.1021/bi9911379; FARMER M, 1979, COMP BIOCHEM PHYS A, V62, P109, DOI 10.1016/S0300-9629(79)80004-3; FONNER DB, 1973, COMP BIOCHEM PHYSIOL, V46, P559, DOI 10.1016/0300-9629(73)90107-2; GILLEN RG, 1977, ARCH BIOCHEM BIOPHYS, V183, P678, DOI 10.1016/0003-9861(77)90401-5; Heaslet HA, 1999, STRUCT FOLD DES, V7, P517, DOI 10.1016/S0969-2126(99)80068-9; Heisler N., 1986, P397; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; ITO N, 1995, J MOL BIOL, V250, P648, DOI 10.1006/jmbi.1995.0405; JENSEN FB, 1989, J EXP BIOL, V143, P225; KILLMARTIN JV, 1976, BR MED B, V32, P209; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; MOTAIS R, 1987, J GEN PHYSIOL, V90, P197, DOI 10.1085/jgp.90.2.197; Nikinmaa M, 1997, J EXP BIOL, V200, P369; NIKINMAA M, 1992, PHYSIOL REV, V72, P301, DOI 10.1152/physrev.1992.72.2.301; Pelster B, 1998, FISH RESP, P113; Perutz MF, 1996, NAT STRUCT BIOL, V3, P211, DOI 10.1038/nsb0396-211; PERUTZ MF, 1982, NATURE, V299, P421, DOI 10.1038/299421a0; Qiu Y, 2000, J BIOL CHEM, V275, P13517, DOI 10.1074/jbc.275.18.13517; Root RW, 1931, BIOL BULL-US, V61, P427, DOI 10.2307/1536959; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; WITTENBERG JB, 1974, BIOL BULL-US, V146, P116, DOI 10.2307/1540402; WITTENBERG JB, 1962, NATURE, V194, P106, DOI 10.1038/194106a0; Yokoyama T, 2004, J BIOL CHEM, V279, P28632, DOI 10.1074/jbc.M401740200	28	170	176	2	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1752	1757		10.1126/science.1107793	http://dx.doi.org/10.1126/science.1107793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774753				2022-12-01	WOS:000227883900038
J	Srinivasan, A; Burton, EC; Kuehnert, MJ; Rupprecht, C; Sutker, WL; Ksiazek, TG; Paddock, CD; Guarner, J; Shieh, WJ; Goldsmith, C; Hanlon, CA; Zoretic, J; Fischbach, B; Niezgoda, M; El-Feky, WH; Orciari, L; Sanchez, EQ; Likos, A; Klintmalm, GB; Cardo, D; LeDuc, J; Chamberland, ME; Jernigan, DB; Zaki, SR				Srinivasan, A; Burton, EC; Kuehnert, MJ; Rupprecht, C; Sutker, WL; Ksiazek, TG; Paddock, CD; Guarner, J; Shieh, WJ; Goldsmith, C; Hanlon, CA; Zoretic, J; Fischbach, B; Niezgoda, M; El-Feky, WH; Orciari, L; Sanchez, EQ; Likos, A; Klintmalm, GB; Cardo, D; LeDuc, J; Chamberland, ME; Jernigan, DB; Zaki, SR		Rabies Transplant Recipients Inves	Transmission of rabies virus from an organ donor to four transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORTHOTOPIC LIVER-TRANSPLANTATION; ARTERIAL REVASCULARIZATION; UNITED-STATES; EPIDEMIOLOGY; PREVENTION; CONDUITS; DEATHS; GRAFTS	BACKGROUND: In 2004, four recipients of kidneys, a liver, and an arterial segment from a common organ donor died of encephalitis of an unknown cause. METHODS: We reviewed the medical records of the organ donor and the recipients. Blood, cerebrospinal fluid, and tissues from the recipients were tested with a variety of assays and pathological stains for numerous causes of encephalitis. Samples from the recipients were also inoculated into mice. RESULTS: The organ donor had been healthy before having a subarachnoid hemorrhage that led to his death. Encephalitis developed in all four recipients within 30 days after transplantation and was accompanied by rapid neurologic deterioration characterized by agitated delirium, seizures, respiratory failure, and coma. They died an average of 13 days after the onset of neurologic symptoms. Mice inoculated with samples from the affected patients became ill seven to eight days later, and electron microscopy of central nervous system (CNS) tissue demonstrated rhabdovirus particles. Rabies-specific immunohistochemical and direct fluorescence antibody staining demonstrated rabies virus in multiple tissues from all recipients. Cytoplasmic inclusions consistent with Negri bodies were seen in CNS tissue from all recipients. Antibodies against rabies virus were present in three of the four recipients and the donor. The donor had told others of being bitten by a bat. CONCLUSIONS: This report documenting the transmission of rabies virus from an organ donor to multiple recipients underscores the challenges of preventing and detecting transmission of unusual pathogens through transplantation.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv Branch, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA USA; Baylor Univ, Med Ctr, Dallas, TX USA; Texas Dept State Hlth Serv, Austin, TX USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Baylor University; Baylor University Medical Center; Texas Department of State Health Services	Srinivasan, A (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.		Rupprecht, Charles/AAI-1544-2020; Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541				ANDERSON LJ, 1984, ANN INTERN MED, V100, P728, DOI 10.7326/0003-4819-100-5-728; Awasthi M, 2001, AM J NEURORADIOL, V22, P677; BLECK TP, 2000, PRINCIPLES PRACTICE, P1811; DOE J, 2000, MMWR RECOMM REP, V49, P737; DOE J, 1999, MMWR RECOMM REP, V48, P16; DOE J, 1999, MMWR RECOMM REP, V48, P1; ESIRI MM, 1992, GREENFIELDS NEUROPAT, P335; GODE GR, 1988, LANCET, V2, P791; GOLDSTEIN RM, 1990, SURGERY, V107, P540; HOUFF SA, 1979, NEW ENGL J MED, V300, P603, DOI 10.1056/NEJM197903153001105; Human death associated with bat rabies-California, 2003, MMWR MORB MORTAL WKL, V53, P33; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; *JOINT COMM ACCR H, PROP TISS STOR ISS S; Mani J, 2003, POSTGRAD MED J, V79, P352, DOI 10.1136/pmj.79.932.352; Muiesan P, 1998, LIVER TRANSPLANT SUR, V4, P232, DOI 10.1002/lt.500040314; Muralidharan V, 2004, TRANSPL INT, V17, P163, DOI 10.1007/s00147-004-0701-z; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; *ORG PROC TRANSPL, MIN PROC STAND ORG P; Organ Procurement and Transplantation Network, ORG PROC TRANSPL NET; Pinna AD, 1996, TRANSPLANTATION, V62, P1584, DOI 10.1097/00007890-199612150-00010; Sellers MT, 2002, AM J TRANSPLANT, V2, P471, DOI 10.1034/j.1600-6143.2002.20513.x; Shames BD, 2003, ANN SURG, V237, P116, DOI 10.1097/00000658-200301000-00016; SUREAU P, 1981, CR ACAD SCI III-VIE, V293, P689; ZAKI SR, 1995, AM J PATHOL, V146, P552; Zamboni F, 2002, DIGEST LIVER DIS, V34, P122, DOI 10.1016/S1590-8658(02)80241-9; 2004, MMWR MORB MORTAL WKL, V53, P1171; 1981, MMWR MORB MORTAL WKL, V30, P473; PROTOCOL POSTMORTEM; 2003, MMWR MORB MORTAL WKL, V52, P1102; 1980, MMWR MORB MORTAL WKL, V29, P25; CASES RABIES HUMAN B	32	278	303	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1103	1111		10.1056/NEJMoa043018	http://dx.doi.org/10.1056/NEJMoa043018			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784663				2022-12-01	WOS:000227655000007
J	Wang, YC; Ferguson, EL				Wang, YC; Ferguson, EL			Spatial bistability of Dpp-receptor interactions during Drosophila dorsal-ventral patterning	NATURE			English	Article							TWISTED GASTRULATION; SIGNAL-TRANSDUCTION; ACTIVITY GRADIENT; BMP ACTIVITY; I RECEPTORS; EMBRYO; GENE; SOG; IDENTIFICATION; ACTIVATION	In many developmental contexts, a locally produced morphogen specifies positional information by forming a concentration gradient over a field of cells(1). However, during embryonic dorsal - ventral patterning in Drosophila, two members of the bone morphogenetic protein (BMP) family, Decapentaplegic (Dpp) and Screw (Scw), are broadly transcribed but promote receptor-mediated signalling in a restricted subset of expressing cells(2-4). Here we use a novel immunostaining protocol to visualize receptor-bound BMPs and show that both proteins become localized to a sharp stripe of dorsal cells. We demonstrate that proper BMP localization involves two distinct processes. First, Dpp undergoes directed, long-range extracellular transport. Scw also undergoes long-range movement, but can do so independently of Dpp transport. Second, an intracellular positive feedback circuit promotes future ligand binding as a function of previous signalling strength. These data elicit a model in which extracellular Dpp transport initially creates a shallow gradient of BMP binding that is acted on by positive intracellular feedback to produce two stable states of BMP - receptor interactions, a spatial bistability in which BMP binding and signalling capabilities are high in dorsal-most cells and low in lateral cells.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ferguson, EL (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	elfergus@midway.uchicago.edu	; Wang, Yu-Chiun/N-6541-2015	Ferguson, Edwin/0000-0003-4125-4253; Wang, Yu-Chiun/0000-0002-3797-4138				ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Decotto E, 2001, DEVELOPMENT, V128, P3831; Dorfman R, 2001, DEVELOPMENT, V128, P965; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Kosman D, 1997, DEVELOPMENT, V124, P1343; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; RUSHLOW C, 1987, GENE DEV, V1, P1268, DOI 10.1101/gad.1.10.1268; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; SHIMMI O, IN PRESS CELL; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577	31	164	168	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					229	234		10.1038/nature03318	http://dx.doi.org/10.1038/nature03318			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759004				2022-12-01	WOS:000227494500049
J	Hayward, R				Hayward, R			Historical keywords - Development	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London, England	University of London; University College London	Hayward, R (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London, England.	Rhodri.Hayward@ucl.ac.uk							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					839	839		10.1016/S0140-6736(05)71028-X	http://dx.doi.org/10.1016/S0140-6736(05)71028-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752517				2022-12-01	WOS:000227444600012
J	Du, C; Falini, G; Fermani, S; Abbott, C; Moradian-Oldak, J				Du, C; Falini, G; Fermani, S; Abbott, C; Moradian-Oldak, J			Supramolecular assembly of amelogenin nanospheres into birefringent microribbons	SCIENCE			English	Article							EMBRYONIC BOVINE ENAMEL; NEUTRAL-SOLUBLE PROTEINS; DYNAMIC LIGHT-SCATTERING; TOOTH ENAMEL; ORGANIC MATRIX; RAT; MATURATION; CRYSTALS; APATITE; GROWTH	Although both tooth enamel and bone are composed of organized assemblies of carbonated apatite crystals, enamel is unusual in that it does not contain collagen nor does it remodel. Self-assembly of amelogenin protein into nanospheres has been recognized. as a key factor in controlling the oriented and elongated growth of carbonated apatite crystals during dental enamel biomineralization. We report the in vitro formation of birefringent microribbon structures that were generated through the supramolecular assembly of amelogenin nanospheres. These microribbons have diffraction patterns that indicate a periodic structure of crystalline units along the long axis. The growth of apatite crystals orientated along the c axis and parallel to the long axes of the microribbons was observed in vitro. The linear arrays (chains) of nanospheres observed as intermediate states before the microribbon formation give an important indication as to the function of amelogenin in controlling the oriented growth of apatite crystals during enamel mineralization.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy	University of Southern California; University of Bologna	Moradian-Oldak, J (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	joldak@usc.edu	Du, Chang/H-4200-2012	Du, Chang/0000-0002-6460-0764	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015332] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE013414, R01-DE-13414, R21-DE-15332] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BETKE U, 1995, DISCRETE COMPUT GEOM, V13, P297, DOI 10.1007/BF02574046; BONAR LC, 1965, J ULTRA MOL STRUCT R, V13, P308, DOI 10.1016/S0022-5320(65)80079-X; Bouropoulos N, 2004, J DENT RES, V83, P278, DOI 10.1177/154405910408300402; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; EASTOE JE, 1960, NATURE, V187, P411, DOI 10.1038/187411b0; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Iijima M, 2004, J MATER CHEM, V14, P2189, DOI 10.1039/b401961j; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; MECHANIC GL, 1967, BIOCHIM BIOPHYS ACTA, V133, P97, DOI 10.1016/0005-2795(67)90042-6; Moradian-Oldak J, 1998, J STRUCT BIOL, V122, P320, DOI 10.1006/jsbi.1998.4008; MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006; NIKIFORUK G, 1965, J DENT RES, V44, P1119, DOI 10.1177/00220345650440061101; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; REITH EJ, 1961, J BIOPHYS BIOCHEM CY, V9, P825, DOI 10.1083/jcb.9.4.825; RENUGOPALAKRISHNAN V, 1989, BIOPOLYMERS, V28, P297, DOI 10.1002/bip.360280130; RENUGOPALAKRISHNAN V, 1986, BIOCHEMISTRY-US, V25, P4879, DOI 10.1021/bi00365a023; ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2; ROBINSON C, 1981, CALCIFIED TISSUE INT, V33, P513, DOI 10.1007/BF02409483; ROBINSON C, 1978, CARIES RES, V12, P1, DOI 10.1159/000260309; Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200; SMALES FC, 1975, NATURE, V258, P772, DOI 10.1038/258772a0; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Toyosawa S, 1998, P NATL ACAD SCI USA, V95, P13056, DOI 10.1073/pnas.95.22.13056; TRAVIS DF, 1964, J CELL BIOL, V23, P447, DOI 10.1083/jcb.23.3.447; WATSON ML, 1960, J BIOPHYS BIOCHEM CY, V7, P489, DOI 10.1083/jcb.7.3.489; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; WEINER S, 1986, CALCIFIED TISSUE INT, V39, P365, DOI 10.1007/BF02555173; ZHENG SD, 1987, BIOPOLYMERS, V26, P1809, DOI 10.1002/bip.360261012	29	278	291	13	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1450	1454		10.1126/science.1105675	http://dx.doi.org/10.1126/science.1105675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746422				2022-12-01	WOS:000227503100041
J	Cuthill, IC; Stevens, M; Sheppard, J; Maddocks, T; Parraga, CA; Troscianko, TS				Cuthill, IC; Stevens, M; Sheppard, J; Maddocks, T; Parraga, CA; Troscianko, TS			Disruptive coloration and background pattern matching	NATURE			English	Article								Effective camouflage renders a target indistinguishable from irrelevant background objects. Two interrelated but logically distinct mechanisms for this are background pattern matching (crypsis(1,2)) and disruptive coloration: in the former, the animal's colours are a random sample of the background(1,2); in the latter, bold contrasting colours on the animal's periphery break up its outline. The latter has long been proposed as an explanation for some apparently conspicuous coloration in animals(3,4), and is standard textbook material. Surprisingly, only one quantitative test(5) of the theory exists, and one experimental test of its effectiveness against non-human predators(6). Here we test two key predictions: that patterns on the body's outline should be particularly effective in promoting concealment and that highly contrasting colours should enhance this disruptive effect. Artificial moth-like targets were exposed to bird predation in the field, with the experimental colour patterns on the 'wings' and a dead mealworm as the edible 'body'. Survival analysis supported the predictions, indicating that disruptive coloration is an effective means of camouflage, above and beyond background pattern matching.	Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England	University of Bristol; University of Bristol	Cuthill, IC (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	i.cuthill@bristol.ac.uk	; Parraga, C. Alejandro/D-2329-2011	Stevens, Martin/0000-0001-7768-3426; Parraga, C. Alejandro/0000-0002-3809-241X	Biotechnology and Biological Sciences Research Council [S18903] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 1940, ADAPTIVE COLORATION; Behrens R., 2002, FALSE COLOURS ART DE; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; COX DR, 1972, J R STAT SOC B, V34, P187; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Cuthill Innes C., 2000, Acta Ethologica, V3, P29, DOI 10.1007/s102110000027; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; KILTIE RA, 1988, TRENDS ECOL EVOL, V3, P21, DOI 10.1016/0169-5347(88)90079-1; Maddocks SA, 2001, J EXP BIOL, V204, P2509; Majerus MEN, 2000, J EVOLUTION BIOL, V13, P155, DOI 10.1046/j.1420-9101.2000.00170.x; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; RASBAND W, 2003, IMAGEJ; Ruxton GD, 2004, ANIM BEHAV, V68, P445, DOI 10.1016/j.anbehav.2003.12.009; SILBERGLIED RE, 1980, SCIENCE, V209, P617, DOI 10.1126/science.209.4456.617; *SPSS INC, 2003, SPSS WIND REL 9 0; THAYER AH, 1896, AUK, V13, P124; Thayer G.H., 1909, CONCEALING COLORATIO; WALDBAUER GP, 1983, EVOLUTION, V37, P1085, DOI 10.1111/j.1558-5646.1983.tb05635.x	24	379	386	23	375	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					72	74		10.1038/nature03312	http://dx.doi.org/10.1038/nature03312			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744301				2022-12-01	WOS:000227334600045
J	Roosild, TP; Greenwald, J; Vega, M; Castronovo, S; Riek, R; Choe, S				Roosild, TP; Greenwald, J; Vega, M; Castronovo, S; Riek, R; Choe, S			NMR structure of Mistic, a membrane-integrating protein for membrane protein expression	SCIENCE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RESONANCE; CHANNEL; SPECTROSCOPY; SENSITIVITY	Although structure determination of soluble proteins has become routine, our understanding of membrane proteins has been limited by experimental bottlenecks in obtaining both sufficient yields of protein and ordered crystals. Mistic is an unusual Bacillus subtilis integral membrane protein that folds autonomously into the membrane, bypassing the cellular translocon machinery. Using paramagnetic probes, we determined by nuclear magnetic resonance (NMR) spectroscopy that the protein forms a helical bundle with a surprisingly polar lipid-facing surface. Additional experiments suggest that Mistic can be used for high-level production of other membrane proteins in their native conformations, including many eukaryotic proteins that have previously been intractable to bacterial. expression.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Riek, R (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA.	riek@salk.edu; choe@salk.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056653] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM056653] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; Fernandez C, 2004, J MOL BIOL, V336, P1211, DOI 10.1016/j.jmb.2003.09.014; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kiefer H, 2000, RECEPTOR CHANNEL, V7, P109; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Laage R, 2001, TRAFFIC, V2, P99, DOI 10.1034/j.1600-0854.2001.020204.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Ritter C, 2004, J BIOMOL NMR, V28, P289, DOI 10.1023/B:JNMR.0000013698.89582.dc; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Wimley WC, 2000, BIOCHEMISTRY-US, V39, P4432, DOI 10.1021/bi992746j; Wuthrich K, 1998, NAT STRUCT BIOL, V5, P492, DOI 10.1038/728; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	25	214	229	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1317	1321		10.1126/science.1106392	http://dx.doi.org/10.1126/science.1106392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731457				2022-12-01	WOS:000227313200061
J	Rondelez, Y; Tresset, G; Nakashima, T; Kato-Yamada, Y; Fujita, H; Takeuchi, S; Noji, H				Rondelez, Y; Tresset, G; Nakashima, T; Kato-Yamada, Y; Fujita, H; Takeuchi, S; Noji, H			Highly coupled ATP synthesis by F-1-ATPase single molecules	NATURE			English	Article							EPSILON-SUBUNIT; ESCHERICHIA-COLI; THERMOPHILIC F1-ATPASE; F0F1-ATP SYNTHASE; ROTATION; RESOLUTION; CATALYSIS; ENZYME; MOTOR	F-1-ATPase is the smallest known rotary motor, and it rotates in an anticlockwise direction as it hydrolyses ATP(1-5). Single-molecule experiments(6-9) point towards three catalytic events per turn, in agreement with the molecular structure of the complex(10). The physiological function of F-1 is ATP synthesis. In the ubiquitous F0F1 complex, this energetically uphill reaction is driven by F-0, the partner motor of F-1, which forces the backward ( clockwise) rotation of F-1, leading to ATP synthesis(11-13). Here, we have devised an experiment combining single- molecule manipulation and microfabrication techniques to measure the yield of this mechanochemical transformation. Single F-1 molecules were enclosed in femtolitre-sized hermetic chambers and rotated in a clockwise direction using magnetic tweezers. When the magnetic field was switched off, the F-1 molecule underwent anticlockwise rotation at a speed proportional to the amount of synthesized ATP. At 10 Hz, the mechanochemical coupling efficiency was low for the alpha(3)beta(3)gamma subcomplex (F-1(-epsilon)), but reached up to 77% after reconstitution with the epsilon-subunit (F-1(+epsilon)). We provide here direct evidence that F-1 is designed to tightly couple its catalytic reactions with the mechanical rotation. Our results suggest that the epsilon-subunit has an essential function during ATP synthesis.	Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; Univ Tokyo, CNRS IIS, LIMMS, Tokyo 1538505, Japan; Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Tokyo 1718501, Japan; Univ Tokyo, Inst Ind Sci, CIRMM, Tokyo 1538505, Japan	University of Tokyo; University of Tokyo; Rikkyo University; University of Tokyo	Noji, H (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan.	hnoji@iis.u-tokyo.ac.jp	Takeuchi, Shoji/J-5349-2019; Tresset, Guillaume/B-9009-2008; Rondelez, Yannick/F-3315-2014	Rondelez, Yannick/0000-0002-2565-476X; Takeuchi, Shoji/0000-0001-6946-0409				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2003, METHOD ENZYMOL, V361, P211; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bulygin VV, 2004, J BIOL CHEM, V279, P35616, DOI 10.1074/jbc.M405012200; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HIRONOHARA Y, IN PRESS P NATL ACAD; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Kinosita K Jr, 2000, Essays Biochem, V35, P3; LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V197, P83, DOI 10.1016/0003-9861(79)90222-4; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Nowak KF, 2002, BIOCHEMISTRY-US, V41, P15130, DOI 10.1021/bi026594v; RONDELEZ Y, IN PRESS NATURE BIOT; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P10583, DOI 10.1073/pnas.94.20.10583	30	264	281	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					773	777		10.1038/nature03277	http://dx.doi.org/10.1038/nature03277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716957	Bronze			2022-12-01	WOS:000227039200046
J	Valadkhan, S				Valadkhan, S			Construction of a minimal, protein-free spliceosome	SCIENCE			English	Editorial Material							TERTIARY INTERACTION; SNRNAS; U6		Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University	Valadkhan, S (corresponding author), Case Western Reserve Univ, 2109 Adelbert Rd,Wood RT 100-8, Cleveland, OH 44106 USA.	saba.valadkhan@case.edu	Valadkhan, Saba/G-5561-2010; Valadkhan, Saba/G-7271-2012					Collins CA, 2000, NAT STRUCT BIOL, V7, P850; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Valadkhan S, 2000, RNA, V6, P206, DOI 10.1017/S1355838200992197; Valadkhan S, 2003, RNA, V9, P892, DOI 10.1261/rna.5440303; Valadkhan S, 2002, NAT STRUCT BIOL, V9, P498, DOI 10.1038/nsb0702-498; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; YU YT, 1993, CELL, V75, P1049, DOI 10.1016/0092-8674(93)90315-H	8	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2005	307	5711					863	864		10.1126/science.1110022	http://dx.doi.org/10.1126/science.1110022			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705832				2022-12-01	WOS:000226985100034
J	Jordan, IK; Kondrashov, FA; Adzhubei, IA; Wolf, YI; Koonin, EV; Kondrashov, AS; Sunyaev, S				Jordan, IK; Kondrashov, FA; Adzhubei, IA; Wolf, YI; Koonin, EV; Kondrashov, AS; Sunyaev, S			A universal trend of amino acid gain and loss in protein evolution	NATURE			English	Article							FREQUENCIES; SEQUENCES; ALIGNMENT; GENE	Amino acid composition of proteins varies substantially between taxa and, thus, can evolve. For example, proteins from organisms with ( G+C)- rich ( or ( A+T)- rich) genomes contain more ( or fewer) amino acids encoded by ( G+C)- rich codons(1 - 4). However, no universal trends in ongoing changes of amino acid frequencies have been reported. We compared sets of orthologous proteins encoded by triplets of closely related genomes from 15 taxa representing all three domains of life ( Bacteria, Archaea and Eukaryota), and used phylogenies to polarize amino acid substitutions. Cys, Met, His, Ser and Phe accrue in at least 14 taxa, whereas Pro, Ala, Glu and Gly are consistently lost. The same nine amino acids are currently accrued or lost in human proteins, as shown by analysis of non- synonymous single-nucleotide polymorphisms. All amino acids with declining frequencies are thought to be among the first incorporated into the genetic code; conversely, all amino acids with increasing frequencies, except Ser, were probably recruited late(5 - 7). Thus, expansion of initially under- represented amino acids, which began over 3,400 million years ago(8,9), apparently continues to this day.	Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kondrashov, AS (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	kondrashov@ncbi.nlm.nih.gov; ssunyaev@rics.bwh.harvard.edu	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Wolf, Yuri/0000-0002-0247-8708; Adzhubey, Ivan/0000-0002-1483-9259	NATIONAL LIBRARY OF MEDICINE [Z01LM000095] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Brooks DJ, 2002, MOL CELL PROTEOMICS, V1, P125, DOI 10.1074/mcp.M100001-MCP200; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Cronin J R, 1983, Adv Space Res, V3, P5, DOI 10.1016/0273-1177(83)90036-4; Eyre-Walker A, 1998, J MOL EVOL, V47, P686, DOI 10.1007/PL00006427; Feng DF, 1996, METHOD ENZYMOL, V266, P368; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goldman N, 2002, MOL BIOL EVOL, V19, P1821, DOI 10.1093/oxfordjournals.molbev.a004007; Gu X, 1998, GENETICA, V102-3, P383, DOI 10.1023/A:1017028102013; Henikoff S, 2000, ADV PROTEIN CHEM, V54, P73, DOI 10.1016/S0065-3233(00)54003-0; HOLM S, 1979, SCAND J STAT, V6, P65; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KNIGHT RD, 2001, GENOME BIOL, V4; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; MILLER SL, 1987, COLD SPRING HARB SYM, V52, P17, DOI 10.1101/SQB.1987.052.01.005; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Sorhannus U, 1999, J MOL EVOL, V48, P209, DOI 10.1007/PL00006459; SUEOKA N, 1961, P NATL ACAD SCI USA, V47, P1141, DOI 10.1073/pnas.47.8.1141; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; Wang HC, 2004, MOL BIOL EVOL, V21, P90, DOI [10.1093/molbev/msh003, 10.1093/molbev/msg003]; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	30	195	199	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					633	638		10.1038/nature03306	http://dx.doi.org/10.1038/nature03306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15660107				2022-12-01	WOS:000226862000045
J	Todo, Y; Kitazato, H; Hashimoto, J; Gooday, AJ				Todo, Y; Kitazato, H; Hashimoto, J; Gooday, AJ			Simple foraminifera flourish at the ocean's deepest point	SCIENCE			English	Article							CHALLENGER DEEP; MARIANA TRENCH		Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; Shizuoka Univ, Sch Sci, Dept Life & Earth Sci, Shizuoka, Japan; U Dom Corp, Tokyo, Japan; Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; Southampton Oceanog Ctr, DEEPSEAS Benth Biol Grp, Southampton SO143 ZH, Hants, England	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Shizuoka University; Nagasaki University; NERC National Oceanography Centre	Kitazato, H (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Natsushimacho 2-15, Yokosuka, Kanagawa 2370061, Japan.	kitazatoh@jamstec.go.jp; ang@soton.soc.ac.jp	Gooday, Andrew/ABB-4267-2020; Gooday, Andrew/AAH-8991-2021	Gooday, Andrew/0000-0002-5661-7371; 				Akimoto K, 2001, MAR MICROPALEONTOL, V42, P95, DOI 10.1016/S0377-8398(01)00012-3; Fujioka K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013595; Gooday AJ, 2002, J FORAMIN RES, V32, P384, DOI 10.2113/0320384; HASHIMOTO J, 2002, KR0213 JAMSTEC; Meisterfeld R, 2001, PROTIST, V152, P185, DOI 10.1078/1434-4610-00058; Pawlowski J, 2003, P NATL ACAD SCI USA, V100, P11494, DOI 10.1073/pnas.2035132100; Sabbatini A, 2002, J MICROPALAEONTOL, V21, P131, DOI 10.1144/jm.21.2.131	7	61	66	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					689	689		10.1126/science.1105407	http://dx.doi.org/10.1126/science.1105407			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692042				2022-12-01	WOS:000226814900032
J	Pray-Grant, MG; Daniel, JA; Schieltz, D; Yates, JR; Grant, PA				Pray-Grant, MG; Daniel, JA; Schieltz, D; Yates, JR; Grant, PA			Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ELONGATION-FACTORS; ACTIVE GENES; CHROMATIN; YEAST; H3; TRANSCRIPTION; COMPLEXES; DOMAIN; ASSOCIATION	The specific post-translational modifications to histones influence many nuclear processes including gene regulation, DNA repair and replication(1). Recent studies have identified effector proteins that recognize patterns of histone modification and transduce their function in downstream processes(2). For example, histone acetyltransferases (HATs) have been shown to participate in many essential cellular processes, particularly those associated with activation of transcription(3). Yeast SAGA (Spt-Ada-Gcn5 acetyltransferase) and SLIK (SAGA-like) are two highly homologous and conserved multi-subunit HAT complexes, which preferentially acetylate histones H3 and H2B and deubiquitinate histone H2B. Here we identify the chromatin remodelling protein Chd1 (chromo-ATPase/helicase-DNAbinding domain 1) as a component of SAGA and SLIK. Our findings indicate that one of the two chromodomains of Chd1 specifically interacts with the methylated lysine 4 mark on histone H3 that is associated with transcriptional activity. Furthermore, the SLIK complex shows enhanced acetylation of a methylated substrate and this activity is dependent upon a functional methyl-binding chromodomain, both in vitro and in vivo. Our study identifies the first chromodomain that recognizes methylated histone H3 (Lys 4) and possibly identifies a larger subfamily of chromodomain proteins with similar recognition properties.	Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Diversa Corp, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Virginia; Scripps Research Institute	Grant, PA (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	pag9n@virginia.edu	Daniel, Jeremy/S-4729-2016	Daniel, Jeremy/0000-0002-1981-5571				Bernstein NA, 1999, MOTOR CONTROL, V3, P4; Bottomley MJ, 2004, EMBO REP, V5, P464, DOI 10.1038/sj.embor.7400146; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kelley DE, 1999, CHROMOSOMA, V108, P10, DOI 10.1007/s004120050347; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Torok MS, 2004, ADV PROTEIN CHEM, V67, P181; Tran HG, 2000, EMBO J, V19, P2323, DOI 10.1093/emboj/19.10.2323; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472	30	371	400	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					434	438		10.1038/nature03242	http://dx.doi.org/10.1038/nature03242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15647753				2022-12-01	WOS:000226546200047
J	Lazar, MA				Lazar, MA			How obesity causes diabetes: Not a tall tale	SCIENCE			English	Editorial Material							INDUCED INSULIN-RESISTANCE; FREE FATTY-ACIDS; METABOLIC SYNDROME; STRESS-RESPONSE; ADIPOSE-TISSUE; LINKS OBESITY; PPAR-GAMMA; MELLITUS; INFLAMMATION; LEPTIN	The epidemic of obesity-associated diabetes is a major crisis in modern societies, in which food is plentiful and exercise is optional. The biological basis of this problem has been explored from evolutionary and mechanistic perspectives. Evolutionary theories, focusing on the potential survival advantages of "thrifty" genes that are now maladaptive, are of great interest but are inherently speculative and difficult to prove. Mechanistic studies have revealed numerous fat-derived molecules and a link to inflammation that, together, are hypothesized to underlie the obesity-diabetes connection and thereby represent prospective targets for therapeutic intervention.	Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Diabet Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mait.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019					Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Damcott CM, 2003, ENDOCRIN METAB CLIN, V32, P761, DOI 10.1016/S0889-8529(03)00076-8; Das M, 2004, Obes Rev, V5, P13, DOI 10.1111/j.1467-789X.2004.00115.x; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Fernandez-Real JM, 1999, DIABETOLOGIA, V42, P1367, DOI 10.1007/s001250051451; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GOULD SJ, 1996, NAT HIST, V5, P18; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Haluzik M, 2004, PHYSIOL RES, V53, P123; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Ottaviani E, 1998, DOMEST ANIM ENDOCRIN, V15, P291, DOI 10.1016/S0739-7240(98)00021-6; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Petersen M, 2003, DIABETES CARE, V26, P917; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Weyer C, 2001, MOL GENET METAB, V72, P231, DOI 10.1006/mgme.2001.3147; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zimmet P, 2003, J INTERN MED, V254, P114, DOI 10.1046/j.1365-2796.2003.01170.x	51	425	460	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2005	307	5708					373	375		10.1126/science.1104342	http://dx.doi.org/10.1126/science.1104342			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662001				2022-12-01	WOS:000226492300031
J	de Garidel-Thoron, T; Rosenthal, Y; Bassinot, F; Beaufort, L				de Garidel-Thoron, T; Rosenthal, Y; Bassinot, F; Beaufort, L			Stable sea surface temperatures in the western Pacific warm pool over the past 1.75 million years	NATURE			English	Article							LAST GLACIAL MAXIMUM; CLIMATE; FORAMINIFERA; MAGNITUDE; PATTERNS; ATLANTIC; RATIOS; SST	About 850,000 years ago, the period of the glacial cycles changed from 41,000 to 100,000 years. This mid-Pleistocene climate transition has been attributed to global cooling, possibly caused by a decrease in atmospheric carbon dioxide concentrations(1,2). However, evidence for such cooling is currently restricted to the cool upwelling regions in the eastern equatorial oceans(3,4), although the tropical warm pools on the western side of the ocean basins are particularly sensitive to changes in radiative forcing(5,6). Here we present high-resolution records of sea surface temperatures spanning the past 1.75 million years, obtained from oxygen isotopes and Mg/Ca ratios in planktonic foraminifera from the western Pacific warm pool. In contrast with the eastern equatorial regions, sea surface temperatures in the western Pacific warm pool are relatively stable throughout the Pleistocene epoch, implying little long-term change in the tropical net radiation budget. Our results challenge the hypothesis of a gradual decrease in atmospheric carbon dioxide concentrations as a dominant trigger of the longer glacial cycles since 850,000 years ago. Instead, we infer that the temperature contrast across the equatorial Pacific Ocean increased, which might have had a significant influence on the mid-Pleistocene climate transition.	Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; CEA, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Univ Aix Marseille 3, CNRS, CEREGE, F-135345 Aix En Provence 4, France	Rutgers State University New Brunswick; Rutgers State University New Brunswick; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	de Garidel-Thoron, T (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	garidel@marine.rutgers.edu	Beaufort, Luc/ABG-2289-2021; Beaufort, Luc/AAH-5305-2021; de Garidel-Thoron, Thibault/B-1204-2008	Beaufort, Luc/0000-0001-6055-9373; de Garidel-Thoron, Thibault/0000-0001-8983-9571				Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Berger A, 1999, QUATERNARY SCI REV, V18, P1, DOI 10.1016/S0277-3791(98)00033-X; BOYLE EA, 1985, EARTH PLANET SC LETT, V76, P135, DOI 10.1016/0012-821X(85)90154-2; Broccoli AJ, 2000, J CLIMATE, V13, P951, DOI 10.1175/1520-0442(2000)013<0951:TCATLG>2.0.CO;2; Carcaillet JT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017550; CONKRIGHT M, 1998, 16 NODC; Delcroix T, 1998, J GEOPHYS RES-OCEANS, V103, P18611, DOI 10.1029/98JC00814; DELCROIX T, 2002, J GEOPHYS RES-OCEANS, V107, P22135; HALPERT MS, 1992, J CLIMATE, V5, P577, DOI 10.1175/1520-0442(1992)005<0577:STPAWT>2.0.CO;2; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Kawahata H, 2002, DEEP-SEA RES PT II, V49, P2783, DOI 10.1016/S0967-0645(02)00058-9; KIEFER T, IN PRESS QUAT SCI RE; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; Liu ZH, 2004, NATURE, V427, P720, DOI 10.1038/nature02338; Marlow JR, 2000, SCIENCE, V290, P2288; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P839, DOI 10.2973/odp.proc.sr.138.160.1995; Nurnberg D, 2000, PALEOCEANOGRAPHY, V15, P124, DOI 10.1029/1999PA000370; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Rosenthal Y, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000749; Rosenthal Y, 1999, ANAL CHEM, V71, P3248, DOI 10.1021/ac981410x; Schefuss E, 2003, NATURE, V422, P418, DOI 10.1038/nature01500; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Sun DZ, 2003, J CLIMATE, V16, P185, DOI 10.1175/1520-0442(2003)016<0185:APEOAI>2.0.CO;2; Tziperman E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000627; Visser K, 2003, NATURE, V421, P152, DOI 10.1038/nature01297; Yin JH, 2001, J CLIMATE, V14, P565, DOI 10.1175/1520-0442(2001)014<0565:TIOTSS>2.0.CO;2	30	188	194	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					294	298		10.1038/nature03189	http://dx.doi.org/10.1038/nature03189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662419				2022-12-01	WOS:000226381300050
J	Bloom, S; Rguig, A; Berraho, A; Zniber, L; Bouazzaoui, N; Zaghloul, K; Reef, S; Zidouh, A; Papania, M; Seward, J				Bloom, S; Rguig, A; Berraho, A; Zniber, L; Bouazzaoui, N; Zaghloul, K; Reef, S; Zidouh, A; Papania, M; Seward, J			Congenital rubella syndrome burden in Morocco: a rapid retrospective assessment	LANCET			English	Article							DEVELOPING-COUNTRIES; SYNDROME CRS; CHILDREN; ABNORMALITIES; DISEASE; SCHOOL; DEAF	Background WHO recommends that countries considering introduction of rubella vaccine into their immunisation programme assess their burden of congenital rubella syndrome, to determine whether vaccination is warranted. However, few guidelines exist for such assessments in developing countries. We retrospectively estimated the burden of congenital rubella syndrome in Morocco, and assessed our methods of rapid case finding. Methods We undertook case finding in the two cities with Morocco's main tertiary care referral centres, using medical records from births between Jan 1, 1990, and May 31, 2002, disability records from 1965 to 1997, and retinal examinations from deaf students born between 1985 and 1994, applying the WHO definition for a clinically confirmed case of congenital rubella syndrome. We also reviewed disability data for evidence of epidemic periodicity and estimated yearly incidence of the syndrome from congenital cataract data for births between 1990 and 2001. Findings We identified 62 clinically confirmed cases of congenital rubella syndrome from medical records, 148 from disability records, and 15 in deaf students. We noted no epidemic periodicity in disability data, and estimated a yearly incidence of the syndrome in Morocco of 8.1-12.7 cases per 100 000 livebirths. Interpretation We show evidence of congenital rubella syndrome in Morocco and support the addition of rubella vaccination to the national programme. Various data sources can be explored to rapidly assess burden of the syndrome; ophthalmology departments and outpatient cardiology clinics could offer the most potential for such case finding, dependent on documentation practices.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Minist Hlth, Dept Epidemiol & Dis Prevent, Rabat, Morocco; Ibn Sina Univ Hosp, Dept Ophthalmol, Rabat, Morocco; Ctr Cardiol, Rabat, Morocco; Ibn Sina Univ Hosp, Childrens Hosp, Dept Neonatol, Rabat, Morocco; Ibn Rochd Univ Hosp, Dept Paediat Ophthalmol, Casablanca, Morocco	Centers for Disease Control & Prevention - USA; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca	Bloom, S (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, MS E-61, Atlanta, GA 30333 USA.	SBloom@cdc.gov						[Anonymous], 2003, B WORLD HEAL ORGAN; AZELMAT M, 1999, NATL SURVEY MOTHER C; BLICHTEINWINICK.D, 2002, ANALES FACULTAD MED, V63, P1; BLITCHTEINWINIC.D, 2002, ANALES FACULTAD MED, V63, P93; BOUAZZAOUI NL, 1994, B ACAD NAT MED PARIS, V178, P1013; Cooper L Z, 1969, Dis Mon, P3; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; Cutts FT, 1997, B WORLD HEALTH ORGAN, V75, P55; CUTTS FT, 1999, WHOVB9922; DUDGEON JA, 1972, POSTGRAD MED J, V48, P7; Durkin MS, 2000, AM J EPIDEMIOL, V152, P1024, DOI 10.1093/aje/152.11.1024; Eckstein M, 1996, BRIT J OPHTHALMOL, V80, P628, DOI 10.1136/bjo.80.7.628; ELANGO S, 1994, ANN TROP PAEDIATR, V14, P149, DOI 10.1080/02724936.1994.11747708; GUESSOUSIDRISSI N, 1984, PATHOL BIOL, V32, P761; Hanioglu-Kargi S, 2003, TURKISH J PEDIATR, V45, P39; ISACSOHN M, 1979, ISRAEL J MED SCI, V15, P17; Nejmi S, 1972, Maroc Med, V52, P420; NEJMI S, 2000, P 5 NAT C NEON OCT 2, P77; ORENSTEIN WA, 1985, REV INFECT DIS, V7, pS22; PECKHAM CS, 1972, ARCH DIS CHILD, V47, P571, DOI 10.1136/adc.47.254.571; Preblud S R, 1980, Epidemiol Rev, V2, P171; Rahman M. M., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P811; Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928; ROBERTSON SE, 2004, REV PANAM SALUD PUBL, V14, P306; RUDOLPH A J, 1972, International Ophthalmology Clinics, V12, P3, DOI 10.1097/00004397-197201220-00003; SHIFF GM, 1970, PERINATAL INFECT, P31; SIEGEL M, 1968, JAMA-J AM MED ASSOC, V203, P116; Wolf SM, 1973, J PEDIATR OPHTHALMOL, V10, P101; World Health Organization, 2000, WKLY EPIDEMIOL REC, V75, P161	30	21	27	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2005	365	9454					135	141		10.1016/S0140-6736(05)17703-4	http://dx.doi.org/10.1016/S0140-6736(05)17703-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639295				2022-12-01	WOS:000226170700028
J	Hart, DNJ				Hart, DNJ			Dendritic cell biology evolves into clinical application	LANCET			English	Editorial Material							LANGERHANS CELLS; IN-VIVO; RECEPTORS; MATURATION; ANTIGENS; SKIN		Mater Med Res Inst, Dendrit Cell Lab, Brisbane, Qld 4101, Australia	Mater Research	Hart, DNJ (corresponding author), Mater Med Res Inst, Dendrit Cell Lab, Raymond Terrace, Brisbane, Qld 4101, Australia.	dhart@mmri.mater.org.au	Hart, Derek NJ/B-9505-2014					Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; COLLIN M, IN PRESS TRANSPLANTA; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; Jocham D, 2004, LANCET, V363, P594, DOI 10.1016/S0140-6736(04)15590-6; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Munster DJ, 2004, INT IMMUNOL, V16, P33, DOI 10.1093/intimm/dxh004; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Soumelis V, 2004, SPRINGER SEMIN IMMUN, V25, P325, DOI 10.1007/s00281-003-0152-0; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Xu MQ, 2004, WORLD J GASTROENTERO, V10, P2361	19	4	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 14	2005	365	9454					102	104		10.1016/S0140-6736(05)17717-4	http://dx.doi.org/10.1016/S0140-6736(05)17717-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885PZ	15639277				2022-12-01	WOS:000226170700006
J	Maruyama, K; Kawahara, N; Shin, M; Tago, M; Kishimoto, J; Kurita, H; Kawamoto, S; Morita, A; Kirino, T				Maruyama, K; Kawahara, N; Shin, M; Tago, M; Kishimoto, J; Kurita, H; Kawamoto, S; Morita, A; Kirino, T			The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA-KNIFE RADIOSURGERY; LINEAR-ACCELERATOR RADIOSURGERY; FOLLOW-UP DATA; NATURAL-HISTORY; STEREOTACTIC RADIOSURGERY; NIDUS OBLITERATION; BRAIN; SURGERY; EXPERIENCE	Background: Angiography shows that stereotactic radiosurgery obliterates most cerebral arteriovenous malformations after a latency period of a few years. However, the effect of this procedure on the risk of hemorrhage is poorly understood. Methods: We performed a retrospective observational study of 500 patients with malformations who were treated with radiosurgery with use of a gamma knife. The rates of hemorrhage were assessed during three periods: before radiosurgery, between radiosurgery and the angiographic documentation of obliteration of the malformation (latency period), and after angiographic obliteration. Results: Forty-two hemorrhages were documented before radiosurgery (median follow-up, 0.4 year), 23 during the latency period (median follow-up, 2.0 years), and 6 after obliteration (median follow-up, 5.4 years). As compared with the period between diagnosis and radiosurgery, the risk of hemorrhage decreased by 54 percent during the latency period (hazard ratio, 0.46; 95 percent confidence interval, 0.26 to 0.80; P=0.006) and by 88 percent after obliteration (hazard ratio, 0.12; 95 percent confidence interval, 0.05 to 0.29; P<0.001). The risk was significantly reduced during the period after obliteration, as compared with the latency period (hazard ratio, 0.26; 95 percent confidence interval, 0.10 to 0.68; P=0.006). The reduction was greater among patients who presented with hemorrhage than among those without hemorrhage at presentation and similar in analyses that took into account the delay in confirming obliteration by means of angiography and analyses that excluded data obtained during the first year after diagnosis. Conclusions: Radiosurgery significantly decreases the risk of hemorrhage in patients with cerebral arteriovenous malformations, even before there is angiographic evidence of obliteration. The risk of hemorrhage is further reduced, although not eliminated, after obliteration.	Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Univ Hosp, Dept Radiol, Tokyo 1138655, Japan; Tokyo Univ Hosp, Dept Clin Bioinformat, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Maruyama, K (corresponding author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kskmaru-tky@umin.ac.jp	Kawamoto, Shunsuke/E-9947-2013	Kawamoto, Shunsuke/0000-0002-1388-1287; Morita, Akio/0000-0002-2497-5772				Chang SD, 1997, CLIN NEUROPATHOL, V16, P111; COLOMBO F, 1994, NEUROSURGERY, V34, P14; COX DR, 1972, J R STAT SOC B, V34, P187; CRAWFORD PM, 1986, J NEUROL NEUROSUR PS, V49, P1, DOI 10.1136/jnnp.49.1.1; CROWLEY J, 1977, J AM STAT ASSOC, V72, P27, DOI 10.2307/2286902; Duong DH, 1999, NEW ENGL J MED, V340, P1812; Fabrikant J I, 1992, Neurosurg Clin N Am, V3, P99; Fleetwood IG, 2002, LANCET, V359, P863, DOI 10.1016/S0140-6736(02)07946-1; Friedman WA, 1996, J NEUROSURG, V84, P912, DOI 10.3171/jns.1996.84.6.0912; FRIEDMAN WA, 1995, J NEUROSURG, V82, P180, DOI 10.3171/jns.1995.82.2.0180; FULTS D, 1984, NEUROSURGERY, V15, P658, DOI 10.1227/00006123-198411000-00003; GRAF CJ, 1983, J NEUROSURG, V58, P331, DOI 10.3171/jns.1983.58.3.0331; ITOYAMA Y, 1989, J NEUROSURG, V71, P805, DOI 10.3171/jns.1989.71.6.0805; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karlsson B, 1997, NEUROSURGERY, V40, P425, DOI 10.1097/00006123-199703000-00001; Karlsson B, 1996, MINIM INVAS NEUROSUR, V39, P21, DOI 10.1055/s-2008-1052210; Karlsson B, 2001, INT J RADIAT ONCOL, V49, P1045, DOI 10.1016/S0360-3016(00)01432-2; LEVY RP, 1989, NEUROSURGERY, V24, P841, DOI 10.1227/00006123-198906000-00009; Lindquist C, 1988, MODERN STEREOTACTIC, P491; Lindqvist M, 2000, NEUROSURGERY, V46, P803, DOI 10.1097/00006123-200004000-00006; LUNSFORD LD, 1991, J NEUROSURG, V75, P512, DOI 10.3171/jns.1991.75.4.0512; Maruyama K, 2004, J NEUROSURG, V100, P407, DOI 10.3171/jns.2004.100.3.0407; Mast H, 1997, LANCET, V350, P1065, DOI 10.1016/S0140-6736(97)05390-7; Ogilvy CS, 2001, STROKE, V32, P1458, DOI 10.1161/01.STR.32.6.1458; ONDRA SL, 1990, J NEUROSURG, V73, P387, DOI 10.3171/jns.1990.73.3.0387; PHILLIPS TL, 1991, RAD INJURY NERVOUS S, P37; Pollock BE, 1996, NEUROSURGERY, V38, P652, DOI 10.1227/00006123-199604000-00004; Schneider BF, 1997, J NEUROSURG, V87, P352, DOI 10.3171/jns.1997.87.3.0352; Shin M, 2004, J NEUROSURG, V101, P18, DOI 10.3171/jns.2004.101.1.0018; Shin M, 2002, J NEUROSURG, V97, P779, DOI 10.3171/jns.2002.97.4.0779; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; STEINBERG GK, 1990, NEW ENGL J MED, V323, P96, DOI 10.1056/NEJM199007123230205; STEINER L, 1992, J NEUROSURG, V77, P1, DOI 10.3171/jns.1992.77.1.0001; Szeifert GT, 2003, NEUROL RES, V25, P718, DOI 10.1179/016164103101202228; YAMAMOTO M, 1992, SURG NEUROL, V37, P219, DOI 10.1016/0090-3019(92)90235-F	35	229	237	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2005	352	2					146	153		10.1056/NEJMoa040907	http://dx.doi.org/10.1056/NEJMoa040907			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	886TG	15647577				2022-12-01	WOS:000226251700007
J	Li, Y; Jia, YC; Cui, K; Li, N; Zheng, ZY; Wang, YZ; Yuan, XB				Li, Y; Jia, YC; Cui, K; Li, N; Zheng, ZY; Wang, YZ; Yuan, XB			Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor	NATURE			English	Article							PHOSPHOLIPASE-C; CATION CHANNELS; AXON GUIDANCE; CELLS; RECEPTORS; ACTIVATION; INHIBITOR; CURRENTS; FAMILY; BDNF	Brain-derived neurotrophic factor ( BDNF) is known to promote neuronal survival and differentiation(1) and to guide axon extension both in vitro(2,3) and in vivo(4). The BDNF-induced chemoattraction of axonal growth cones requires Ca2+ signalling(3), but how Ca2+ is regulated by BDNF at the growth cone remains largely unclear. Extracellular application of BDNF triggers membrane currents resembling those through TRPC ( transient receptor potential canonical) channels in rat pontine neurons(5) and in Xenopus spinal neurons(6). Here, we report that in cultured cerebellar granule cells, TRPC channels contribute to the BDNF-induced elevation of Ca2+ at the growth cone and are required for BDNF-induced chemo-attractive turning. Several members of the TRPC family are highly expressed in these neurons, and both Ca2+ elevation and growth-cone turning induced by BDNF are abolished by pharmacological inhibition of TRPC channels, overexpression of a dominant-negative form of TRPC3 or TRPC6, or downregulation of TRPC3 expression via short interfering RNA. Thus, TRPC channel activity is essential for nerve-growth-cone guidance by BDNF.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Yuan, XB (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn; yuanxb@ion.ac.cn		Jia, Yichang/0000-0002-7767-5714; Yuan, Xiaobing/0000-0002-1632-8460				Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TAPLEY P, 1992, ONCOGENE, V7, P371; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yamada H, 2000, NEUROSCI LETT, V285, P111, DOI 10.1016/S0304-3940(00)01033-8; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	29	352	379	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					894	898		10.1038/nature03477	http://dx.doi.org/10.1038/nature03477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15758952				2022-12-01	WOS:000228327600040
J	Dong, XH; Li, H; Derdowski, A; Ding, LM; Burnett, A; Chen, XM; Peters, TR; Dermody, TS; Woodruff, E; Wang, JJ; Spearman, P				Dong, XH; Li, H; Derdowski, A; Ding, LM; Burnett, A; Chen, XM; Peters, TR; Dermody, TS; Woodruff, E; Wang, JJ; Spearman, P			AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HERMANSKY-PUDLAK-SYNDROME; ENVELOPE GLYCOPROTEIN; PATHWAY REQUIRES; PLASMA-MEMBRANE; PROTEIN COMPLEX; DOMAIN; TRANSPORT; BINDING; TSG101	Gag proteins direct the process of retroviral particle assembly and form the major protein constituents of the viral core. The matrix region of the HIV-1 Gag polyprotein plays a critical role in the transport of Gag to the plasma membrane assembly site. Recent evidence indicates that Gag trafficking to late endosomal compartments, including multivesicular bodies, occurs prior to viral particle budding from the plasma membrane. Here we demonstrate that the matrix region of HIV-1 Gag interacts directly with the 6 subunit of the AP-3 complex, and that this interaction plays an important functional role in particle assembly. Disruption of this interaction eliminated Gag trafficking to multivesicular bodies and diminished HIV particle formation. These studies illuminate an early step in retroviral particle assembly and provide evidence that the trafficking of Gag to late endosomes is part of a productive particle assembly pathway.	Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Fu Jen Catholic Univ, Dept Cell Biol, Taipei, Taiwan	Vanderbilt University; Vanderbilt University; Fu Jen Catholic University	Spearman, P (corresponding author), Vanderbilt Univ, Dept Pediat, 221 Kirkland Hall, Nashville, TN 37232 USA.	paul.spearman@vanderbilt.edu		Burnett, Atuhani/0000-0003-3276-3697	NCI NIH HHS [CA68485] Funding Source: Medline; NIAID NIH HHS [R01 AI32539, R21 AI055441, R01 AI40338, P30 AI054999] Funding Source: Medline; NICHD NIH HHS [HD15052] Funding Source: Medline; NIDDK NIH HHS [DK58404, DK20593] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032539, R21AI055441, P30AI054999, R01AI040338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK058404] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; FACKE M, 1993, J VIROL, V67, P4972; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Freedman BI, 1998, AM J HYPERTENS, V11, P251, DOI 10.1016/S0895-7061(97)00481-0; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lindwasser OW, 2004, J VIROL, V78, P6013, DOI 10.1128/JVI.78.11.6013-6023.2004; Luban J, 2001, NAT MED, V7, P1278, DOI 10.1038/nm1201-1278; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; PEVSNER J, 1994, GENE, V146, P279, DOI 10.1016/0378-1119(94)90306-9; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Sandefur S, 2000, J VIROL, V74, P7238, DOI 10.1128/JVI.74.16.7238-7249.2000; Schneider S, 1996, BIOTECHNIQUES, V20, P960; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Starcevic M, 2002, SEMIN CELL DEV BIOL, V13, P271, DOI 10.1016/S1084952102000563; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang JJ, 2001, APPL IMMUNOHISTO M M, V9, P371, DOI 10.1097/00022744-200112000-00014; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992	52	187	201	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					663	674		10.1016/j.cell.2004.12.023	http://dx.doi.org/10.1016/j.cell.2004.12.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766529	Bronze			2022-12-01	WOS:000227771400012
J	Hegi, ME; Diserens, A; Gorlia, T; Hamou, M; de Tribolet, N; Weller, M; Kros, JM; Hainfellner, JA; Mason, W; Mariani, L; Bromberg, JEC; Hau, P; Mirimanoff, RO; Cairncross, JG; Janzer, RC; Stupp, R				Hegi, ME; Diserens, A; Gorlia, T; Hamou, M; de Tribolet, N; Weller, M; Kros, JM; Hainfellner, JA; Mason, W; Mariani, L; Bromberg, JEC; Hau, P; Mirimanoff, RO; Cairncross, JG; Janzer, RC; Stupp, R			MGMT gene silencing and benefit from temozolomide in glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER HYPERMETHYLATION; MALIGNANT GLIOMA; MISMATCH REPAIR; ALKYLTRANSFERASE; METHYLATION; SURVIVAL; CANCER; PROGRESSION; CARMUSTINE	BACKGROUND: Epigenetic silencing of the MGMT (O(sup 6)-methylguanine-DNA methyltransferase) DNA-repair gene by promoter methylation compromises DNA repair and has been associated with longer survival in patients with glioblastoma who receive alkylating agents. METHODS: We tested the relationship between MGMT silencing in the tumor and the survival of patients who were enrolled in a randomized trial comparing radiotherapy alone with radiotherapy combined with concomitant and adjuvant treatment with temozolomide. The methylation status of the MGMT promoter was determined by methylation-specific polymerase-chain-reaction analysis. RESULTS: The MGMT promoter was methylated in 45 percent of 206 assessable cases. Irrespective of treatment, MGMT promoter methylation was an independent favorable prognostic factor (P<0.001 by the log-rank test; hazard ratio, 0.45; 95 percent confidence interval, 0.32 to 0.61). Among patients whose tumor contained a methylated MGMT promoter, a survival benefit was observed in patients treated with temozolomide and radiotherapy; their median survival was 21.7 months (95 percent confidence interval, 17.4 to 30.4), as compared with 15.3 months (95 percent confidence interval, 13.0 to 20.9) among those who were assigned to only radiotherapy (P=0.007 by the log-rank test). In the absence of methylation of the MGMT promoter, there was a smaller and statistically insignificant difference in survival between the treatment groups. CONCLUSIONS: Patients with glioblastoma containing a methylated MGMT promoter benefited from temozolomide, whereas those who did not have a methylated MGMT promoter did not have such a benefit.	Univ Lausanne Hosp, Dept Neurosurg, Lab Tumor Biol & Genet, Lausanne, Switzerland; Univ Lausanne Hosp, Dept Radiotherapy, Lausanne, Switzerland; Univ Lausanne Hosp, Dept Neuropathol, Lausanne, Switzerland; Univ Lausanne Hosp, Multidisciplinary Oncol Ctr, Lausanne, Switzerland; Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland; Swiss Inst Expt Canc Res, Natl Ctr Competence Res Mol Oncol, CH-1066 Epalinges, Switzerland; Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; European Org Res Treatment Canc, Ctr Data, Brussels, Belgium; Univ Tubingen, Dept Neurol, D-7400 Tubingen, Germany; Univ Regensburg, Dept Neurol, D-8400 Regensburg, Germany; Univ Rotterdam Hosp, Div Neuropathol, Rotterdam, Netherlands; Univ Med Ctr, Utrecht, Netherlands; Med Univ Vienna, Inst Neurol, Vienna, Austria; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Univ Calgary, Calgary, AB, Canada	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Swiss Institute Experimental Cancer Research; University of Bern; University Hospital of Bern; European Organisation for Research & Treatment of Cancer; Eberhard Karls University of Tubingen; University of Regensburg; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Medical University of Vienna; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Calgary	Hegi, ME (corresponding author), CHU Vaudois, Dept Neurosurg, Lab Tumor Biol & Genet, BH19-110, CH-1011 Lausanne, Switzerland.	monika.hegi@chuv.hospvd.ch	Hegi, Monika/O-4796-2015; Stupp, Roger/L-3303-2019; Mariani, Luigi/AAB-9464-2019	Hegi, Monika/0000-0003-0855-6495; Weller, Michael/0000-0002-1748-174X				Belanich M, 1996, CANCER RES, V56, P783; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 1999, CANCER RES, V59, P793; Friedman HS, 2000, J CLIN ONCOL, V18, P3522, DOI 10.1200/JCO.2000.18.20.3522; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Gorlia T, 2004, J CLIN ONCOL, V22, p859S; Grombacher T, 1996, CARCINOGENESIS, V17, P2329, DOI 10.1093/carcin/17.11.2329; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HOTTA T, 1994, J NEURO-ONCOL, V21, P135, DOI 10.1007/BF01052897; Jaeckle KA, 1998, J CLIN ONCOL, V16, P3310, DOI 10.1200/JCO.1998.16.10.3310; Komine C, 2003, BRAIN PATHOL, V13, P176; Liu LL, 1996, CANCER RES, V56, P5375; Ochs K, 2000, CANCER RES, V60, P5815; Palmisano WA, 2000, CANCER RES, V60, P5954; Qian XLC, 1997, CANCER RES, V57, P3672; QUINN J, 2003, P AN M AM SOC CLIN, V22, P103; Silber JR, 1999, CLIN CANCER RES, V5, P807; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Watts GS, 1997, MOL CELL BIOL, V17, P5612, DOI 10.1128/MCB.17.9.5612	22	4799	5002	8	397	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					997	1003		10.1056/NEJMoa043331	http://dx.doi.org/10.1056/NEJMoa043331			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758010	Green Published			2022-12-01	WOS:000227491200008
J	Moqrich, A; Hwang, SW; Earley, TJ; Petrus, MJ; Murray, AN; Spencer, KSR; Andahazy, M; Story, GM; Patapoutian, A				Moqrich, A; Hwang, SW; Earley, TJ; Petrus, MJ; Murray, AN; Spencer, KSR; Andahazy, M; Story, GM; Patapoutian, A			Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin	SCIENCE			English	Article							ION-CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; THERMAL HYPERALGESIA; NERVE-FIBERS; RECEPTOR; KERATINOCYTES; ACTIVATION; SENSATION; EPIDERMIS	Environmental temperature is thought to be directly sensed by neurons through their projections in the skin. A subset of the mammalian transient receptor potential (TRP) family of ion channels has been implicated in this process. These "thermoTRPs" are activated at distinct temperature thresholds and are typically expressed in sensory neurons. TRPV3 is activated by heat (>33degreesC) and, unlike most thermoTRPs, is expressed in mouse keratinocytes. We found that TRPV3 null mice have strong deficits in responses to innocuous and noxious heat but not in other sensory modalities; hence, TRPV3 has a specific role in thermosensation. The natural compound camphor, which modulates sensations of warmth in humans, proved to be a specific activator of TRPV3. Camphor activated cultured primary keratinocytes but not sensory neurons, and this activity was abolished in TRPV3 null mice. Therefore, heat-activated receptors in keratinocytes are important for mammalian thermosensation.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Hwang, Sun Wook/0000-0001-8460-7480; moqrich, aziz/0000-0002-1937-1675				Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CAUNA N, 1973, J ANAT, V115, P277; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; GREEN BG, 1990, J INVEST DERMATOL, V94, P662, DOI 10.1111/1523-1747.ep12876242; Guler AD, 2002, J NEUROSCI, V22, P6408; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HILLIGES M, 1995, J INVEST DERMATOL, V104, P134, DOI 10.1111/1523-1747.ep12613631; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	23	505	546	7	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1468	1472		10.1126/science.1108609	http://dx.doi.org/10.1126/science.1108609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746429				2022-12-01	WOS:000227503100048
J	Scholes, RJ; Biggs, R				Scholes, RJ; Biggs, R			A biodiversity intactness index	NATURE			English	Article							PINUS-RADIATA; ASSEMBLAGES; AFFORESTATION; SAVANNA; LOWVELD	The nations of the world have set themselves a target of reducing the rate of biodiversity loss by 2010. Here, we propose a biodiversity intactness index (BII) for assessing progress towards this target that is simple and practical - but sensitive to important factors that influence biodiversity status - and which satisfies the criteria for policy relevance set by the Convention on Biological Diversity. Application of the BII is demonstrated on a large region ( 4 3 10 6 km 2) of southern Africa. The BII score in the year 2000 is about 84%: in other words, averaged across all plant and vertebrate species in the region, populations have declined to 84% of their presumed pre-modern levels. The taxonomic group with the greatest loss is mammals, at 71% of pre-modern levels, and the ecosystem type with the greatest loss is grassland, with 74% of its former populations remaining. During the 1990s, a population decline of 0.8% is estimated to have occurred.	CSIR Environmentek, ZA-0001 Pretoria, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa	Scholes, RJ (corresponding author), CSIR Environmentek, POB 395, ZA-0001 Pretoria, South Africa.	bscholes@csir.co.za	Biggs, Reinette/A-5155-2010	Biggs, Reinette/0000-0003-0300-4149; Scholes, Robert/0000-0001-5537-6935				ANDERSON JA, 2001, GONDWANA ALIVE PROMO; ARMSTRONG AJ, 1994, S AFR J WILDL RES, V24, P48; *CBD, 2003, MON IND DES NAT LEV; *CBD, 2003, PROP BIOD IND REL 20; *CIESIN IFPRI CIAT, 2004, GLOB RUR URB MAPP PR; *CSIR, 2002, SADC LANDC DAT; *CSIR, 2003, PROT AR S AFR; *CSIR, 1996, NAT LAND COV S AFR; Dean WRJ, 2002, J ARID ENVIRON, V51, P1, DOI 10.1006/jare.2001.0910; *EC, 2003, GLOB LAND COV 2000 G; Fabricius C, 2003, J APPL ECOL, V40, P392, DOI 10.1046/j.1365-2664.2003.00793.x; *FAO, 2004, FAOSTAT AGR DAT; FAO, 2001, GLOB FOR RES ASS 200; Friedmann Y, 2004, RED DATA BOOK MAMMAL; Herremans M, 1998, BIOL CONSERV, V86, P139, DOI 10.1016/S0006-3207(98)00016-0; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Houghton J.T., 1997, CH4 EMISSIONS COAL M; *IUCN UNEP, 2003, WORLD DAT PROT AR; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson R, 2002, J MAMMAL, V83, P290, DOI 10.1644/1545-1542(2002)083&lt;0290:DROSMA&gt;2.0.CO;2; Joubert DF, 1999, J ARID ENVIRON, V43, P287, DOI 10.1006/jare.1999.0553; Le Roux J, 2002, BIODIVERSITY S AFRIC; LOH J, 2002, LIVING PLANET REPORT; Magurran A.E., 2004, MEASURING BIOLOGICAL; Meik JM, 2002, BIOL CONSERV, V106, P29, DOI 10.1016/S0006-3207(01)00226-9; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parsons DAB, 1997, J ARID ENVIRON, V37, P319, DOI 10.1006/jare.1997.0283; Reid WV, 1993, BIODIVERSITY INDICAT; RICHARDSON DM, 1986, S AFR J BOT, V52, P309, DOI 10.1016/S0254-6299(16)31526-5; *ROYAL SOC, 2003, MEAS BIOD CONS; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Shackleton CM, 2000, BIOL CONSERV, V94, P273, DOI 10.1016/S0006-3207(00)00001-X; Smart R, 2005, BIOL CONSERV, V122, P23, DOI 10.1016/j.biocon.2004.06.016; TENBRINK BJE, 2002, TECHNISCH ONTWERP NA, V2; United Nations, 2002, WORLD SUMMIT SUSTAIN; World Conservation Monitoring Centre (WCMC), 2000, GLOB BIOD EARTHS LIV; *WWF US, 2003, SPEC DAT AFR EC	38	278	298	3	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					45	49		10.1038/nature03289	http://dx.doi.org/10.1038/nature03289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744293				2022-12-01	WOS:000227334600037
J	Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, PC; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R				Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, PC; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R			Cassini Imaging Science: Initial results on Phoebe and Iapetus	SCIENCE			English	Article							DARK SIDE; IRREGULAR SATELLITES; EVOLUTION; ASTEROIDS; LAPETUS; ORIGIN	The Cassini Imaging Science Subsystem acquired high-resolution imaging data on the outer Saturnian moon, Phoebe, during Cassini's close flyby on 11 June 2004 and on lapetus during a flyby on 31 December 2004. Phoebe has a heavily cratered and ancient surface, shows evidence of ice near the surface, has distinct layering of different materials, and has a mean density that is indicative of an ice-rock mixture. lapetus's dark leading side (Cassini Regio) is ancient, heavily cratered terrain bisected by an equatorial ridge system that reaches 20 kilometers relief. Local albedo variations within and bordering Cassini Regio suggest mass wasting of ballistically deposited material, the origin of which remains unknown.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris 07, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; SW Res Inst, Dept Space Sci, Boulder, CO 80302 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Cornell University; University of Arizona; Free University of Berlin; California Institute of Technology; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carotyn@ciclops.org	Evans, Michael W/AAG-4117-2020; Tiscareno, Matthew/D-6963-2011; Turtle, Elizabeth/K-8673-2012; Del Genio, Anthony/D-4663-2012	Turtle, Elizabeth/0000-0003-1423-5751; Del Genio, Anthony/0000-0001-7450-1359; Barbara, John/0000-0002-2190-4290				Bauer JM, 2004, ASTROPHYS J, V610, pL57, DOI 10.1086/423131; BELL JF, 1985, ICARUS, V61, P192, DOI 10.1016/0019-1035(85)90101-0; Brown ME, 2000, ASTRON J, V119, P977, DOI 10.1086/301202; BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; BURNS JA, 1986, SATELLITES, P117; CLARK RN, 2005, IN PRESS NATURE; COLVIN TR, 1989, N2934NASA NASA STI; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; Denk T., 2000, LUN PLAN SCI C, V31, P1596; DENK T, 2000, LUNAR PLANET SCI C, V31, P1660; Gladman B, 2001, NATURE, V412, P163, DOI 10.1038/35084032; Hahn JM, 1999, ASTRON J, V117, P3041, DOI 10.1086/300891; JACOBSON RA, 2004, B AM AST SOC, V35; Lee P, 1996, ICARUS, V120, P87, DOI 10.1006/icar.1996.0039; MCKINNON WB, 1996, NEPTUNE TRITON, P807; Melosh H.J., 1989, IMPACT CRATERING GEO; MORRISON D, 1975, ICARUS, V24, P17; Nesvorny D, 2003, ASTRON J, V126, P398, DOI 10.1086/375461; NEUKUM BA, 1994, HAZARDS DUE COMETS A, P359; Neukum G, 1997, THREE GALILEOS: THE MAN, THE SPACECRAFT, THE TELESCOPE, P201; NEUKUM G, 1971, EARTH PLANET SC LETT, V12, P59, DOI 10.1016/0012-821X(71)90055-0; NEUKUM G, 2001, CHRONOLOGY EVOLUTION, P53; NEUKUM G, 1998, LUNAR PLANET SCI, V29, P1742; Owen TC, 1999, ICARUS, V139, P379, DOI 10.1006/icar.1999.6116; Owen TC, 2001, ICARUS, V149, P160, DOI 10.1006/icar.2000.6521; Peale S.J, 1977, IAU C 28 PLANETARY S, P87; PECHMANN JB, 1979, ICARUS, V38, P243, DOI 10.1016/0019-1035(79)90181-7; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Schubert G., 1986, SATELLITES, P224; Simonelli DP, 1999, ICARUS, V138, P249, DOI 10.1006/icar.1999.6077; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; TABAK RG, 1989, EARTH MOON PLANETS, V44, P251, DOI 10.1007/BF00054241; Wilson PD, 1996, ICARUS, V122, P92, DOI 10.1006/icar.1996.0111	34	141	141	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1237	1242		10.1126/science.1107981	http://dx.doi.org/10.1126/science.1107981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731440				2022-12-01	WOS:000227313200039
J	Loftus, B; Anderson, I; Davies, R; Alsmark, UCM; Samuelson, J; Amedeo, P; Roncaglia, P; Berriman, M; Hirt, RP; Mann, BJ; Nozaki, T; Suh, B; Pop, M; Duchene, M; Ackers, J; Tannich, E; Leippe, M; Hofer, M; Bruchhaus, I; Willhoeft, U; Bhattacharya, A; Chillingworth, T; Churcher, C; Hance, Z; Harris, B; Harris, D; Jagels, K; Moule, S; Mungall, K; Ormond, D; Squares, R; Whitehead, S; Quail, MA; Rabbinowitsch, E; Norbertczak, H; Price, C; Wang, Z; Guillen, N; Gilchrist, C; Stroup, SE; Bhattacharya, S; Lohia, A; Foster, PG; Sicheritz-Ponten, T; Weber, C; Singh, U; Mukherjee, C; El-Sayed, NM; Petri, WA; Clark, CG; Embley, TM; Barrell, B; Fraser, CM; Hall, N				Loftus, B; Anderson, I; Davies, R; Alsmark, UCM; Samuelson, J; Amedeo, P; Roncaglia, P; Berriman, M; Hirt, RP; Mann, BJ; Nozaki, T; Suh, B; Pop, M; Duchene, M; Ackers, J; Tannich, E; Leippe, M; Hofer, M; Bruchhaus, I; Willhoeft, U; Bhattacharya, A; Chillingworth, T; Churcher, C; Hance, Z; Harris, B; Harris, D; Jagels, K; Moule, S; Mungall, K; Ormond, D; Squares, R; Whitehead, S; Quail, MA; Rabbinowitsch, E; Norbertczak, H; Price, C; Wang, Z; Guillen, N; Gilchrist, C; Stroup, SE; Bhattacharya, S; Lohia, A; Foster, PG; Sicheritz-Ponten, T; Weber, C; Singh, U; Mukherjee, C; El-Sayed, NM; Petri, WA; Clark, CG; Embley, TM; Barrell, B; Fraser, CM; Hall, N			The genome of the protist parasite Entamoeba histolytica	NATURE			English	Article							GENE; EVOLUTION; INFERENCE; PROGRAM	Entamoeba histolytica is an intestinal parasite and the causative agent of amoebiasis, which is a significant source of morbidity and mortality in developing countries(1). Here we present the genome of E. histolytica, which reveals a variety of metabolic adaptations shared with two other amitochondrial protist pathogens: Giardia lamblia and Trichomonas vaginalis. These adaptations include reduction or elimination of most mitochondrial metabolic pathways and the use of oxidative stress enzymes generally associated with anaerobic prokaryotes. Phylogenomic analysis identifies evidence for lateral gene transfer of bacterial genes into the E. histolytica genome, the effects of which centre on expanding aspects of E. histolytica's metabolic repertoire. The presence of these genes and the potential for novel metabolic pathways in E. histolytica may allow for the development of new chemotherapeutic agents. The genome encodes a large number of novel receptor kinases and contains expansions of a variety of gene families, including those associated with virulence. Additional genome features include an abundance of tandemly repeated transfer-RNA-containing arrays, which may have a structural function in the genome. Analysis of the genome provides new insights into the workings and genome evolution of a major human pathogen.	TIGR, Rockville, MD 20850 USA; Sanger Inst, Cambridge CB10 1SA, England; Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; Univ Virginia, Dept Internal Med, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; Med Univ Vienna, Ctr Physiol & Pathophysiol, Div Specif Prophylaxis & Trop Med, A-1095 Vienna, Austria; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, D-20359 Hamburg, Germany; Univ Kiel, Inst Zool, D-24098 Kiel, Germany; Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; Inst Pasteur, INSERM, U389, Unite Biol Cellulaire Parasitisme, F-75724 Paris 15, France; Bose Inst, Dept Biochem, Kolkata 700054, India; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; Stanford Univ, Sch Med, Dept Internal Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA	J. Craig Venter Institute; Wellcome Trust Sanger Institute; Newcastle University - UK; Boston University; University of Virginia; University of Virginia; National Institute of Infectious Diseases (NIID); Medical University of Vienna; University of London; London School of Hygiene & Tropical Medicine; Bernhard Nocht Institut fur Tropenmedizin; University of Kiel; Jawaharlal Nehru University, New Delhi; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Department of Science & Technology (India); Bose Institute; Natural History Museum London; Technical University of Denmark; Stanford University; Stanford University; Stanford University	Loftus, B (corresponding author), TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	bjloftus@tigr.org	Willhoeft, Ute H/K-5970-2015; Leippe, Matthias/AAP-1677-2020; Puigbò, Pere/A-2214-2008; Hirt, Robert/R-5429-2017; Alsmark, Cecilia/AAO-1330-2021; Hall, Neil/A-8717-2013; Duchêne, Michael/G-6659-2019; El-Sayed, Najib M.A./K-7266-2015; Petri, William/AAL-3642-2020; MIRELMAN, DAVID/K-1596-2012; Quail, michael/ABE-6131-2020; Pop, Mihai/A-7987-2013; Clark, C Graham/H-3683-2011; Petri, William A./D-3639-2019; Sicheritz-Ponten, Thomas/A-4325-2017	Willhoeft, Ute H/0000-0003-3313-2125; Hirt, Robert/0000-0002-3760-9958; Hall, Neil/0000-0002-7995-3810; Duchêne, Michael/0000-0003-1232-3600; El-Sayed, Najib M.A./0000-0001-7970-3312; Petri, William/0000-0002-7268-1218; Pop, Mihai/0000-0001-9617-5304; Clark, C Graham/0000-0002-0521-0977; loftus, brendan/0000-0001-8871-8356; Singh, Upinder/0000-0003-0630-0306; Samuelson, John/0000-0001-9533-3040; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Foster, Peter/0000-0003-0194-9237; Embley, Thomas Martin/0000-0002-1484-340X; Hall, Neil/0000-0003-2808-0009; Lohia, Anuradha/0000-0003-3686-5738; Roncaglia, Paola/0000-0002-2825-0621; Fraser, Claire/0000-0003-1462-2428				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Allen JE, 2004, GENOME RES, V14, P142, DOI 10.1101/gr.1562804; Azachi M, 2002, PLANT PHYSIOL, V129, P1320, DOI 10.1104/pp.001909; BAUM KF, 1989, J BIOL CHEM, V264, P21087; Cawley SE, 2001, MOL BIOCHEM PARASIT, V118, P167, DOI 10.1016/S0166-6851(01)00363-2; Coppi A, 2002, J BIOL CHEM, V277, P8083, DOI 10.1074/jbc.M111895200; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Desper R, 2004, MOL BIOL EVOL, V21, P587, DOI 10.1093/molbev.msh049; Duhon D, 2002, J MUSCLE RES CELL M, V23, P803, DOI 10.1023/A:1024435913949; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; Huston CD, 2004, TRENDS PARASITOL, V20, P23, DOI 10.1016/j.pt.2003.10.013; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; Jordan IK, 2003, J MOL MICROB BIOTECH, V5, P172, DOI 10.1159/000070268; Lawrence JG, 2003, MOL MICROBIOL, V50, P739, DOI 10.1046/j.1365-2958.2003.03778.x; Leon-Avila G, 2004, MICROBIOL-SGM, V150, P1245, DOI 10.1099/mic.0.26923-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mazzuco A, 1997, MICRON, V28, P241, DOI 10.1016/S0968-4328(97)00024-3; Melville SE, 1999, CHROMOSOME RES, V7, P191, DOI 10.1023/A:1009247315947; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; PATARAPOTIKUL J, 1988, NUCLEIC ACIDS RES, V16, P4331, DOI 10.1093/nar/16.10.4331; Sicheritz-Ponten T, 2001, NUCLEIC ACIDS RES, V29, P545, DOI 10.1093/nar/29.2.545; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Voigt H, 1999, CELL MICROBIOL, V1, P195, DOI 10.1046/j.1462-5822.1999.00021.x; Welter BH, 2004, MOL BIOCHEM PARASIT, V135, P183, DOI 10.1016/j.molbiopara.2004.02.002	30	630	683	5	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					865	868		10.1038/nature03291	http://dx.doi.org/10.1038/nature03291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729342	Green Accepted, hybrid			2022-12-01	WOS:000227174600042
J	Tard, C; Liu, XM; Ibrahim, SK; Bruschi, M; De Gioia, L; Davies, SC; Yang, X; Wang, LS; Sawers, G; Pickett, CJ				Tard, C; Liu, XM; Ibrahim, SK; Bruschi, M; De Gioia, L; Davies, SC; Yang, X; Wang, LS; Sawers, G; Pickett, CJ			Synthesis of the H-cluster framework of iron-only hydrogenase	NATURE			English	Article							DENSITY-FUNCTIONAL THEORY; ELECTRONIC-STRUCTURE; DIIRON SUBSITE; ACTIVE-SITE; STRUCTURAL ELEMENTS; MODEL COMPLEXES; APPROXIMATION; MECHANISM; EVOLUTION; LIGANDS	The metal- sulphur active sites of hydrogenases catalyse hydrogen evolution or uptake at rapid rates. Understanding the structure and function of these active sites - through mechanistic studies of hydrogenases(1 - 4), synthetic assemblies(5 - 12) and in silico models(13 - 15) - will help guide the design of new materials for hydrogen production or uptake(16). Here we report the assembly of the iron- sulphur framework of the active site of iron- only hydrogenase ( the H- cluster), and show that it functions as an electrocatalyst for proton reduction. Through linking of a di- iron subsite to a {4Fe4S} cluster, we achieve the first synthesis of a metallosulphur cluster core involved in small- molecule catalysis. In addition to advancing our understanding of the natural biological system, the availability of an active, free- standing analogue of the H- cluster may enable us to develop useful electrocatalytic materials for application in, for example, reversible hydrogen fuel cells. ( Platinum is currently the preferred electrocatalyst for such applications, but is expensive, limited in availability and, in the long term, unsustainable(17).)	John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; Washington State Univ, Dept Phys, Richland, WA USA; Pacific NW Natl Lab, WR Wiley Environm Sci Lab, Richland, WA 99352 USA; Pacific NW Natl Lab, Div Chem Sci, Richland, WA 99352 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Milano-Bicocca; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Pickett, CJ (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	chris.pickett@bbsrc.ac.uk	Liu, Xiaoming/C-4030-2008; Tard, Cédric/A-9318-2008; De Gioia, Luca/K-6439-2016; PICKETT, CHRISTOPHER J/F-3896-2010	Liu, Xiaoming/0000-0003-0038-6292; Tard, Cédric/0000-0002-1515-1915; PICKETT, CHRISTOPHER J/0000-0003-3142-0780; BRUSCHI, MAURIZIO/0000-0002-5709-818X; Yang, Xin/0000-0002-9173-1188				Armstrong FA, 2004, CURR OPIN CHEM BIOL, V8, P133, DOI 10.1016/j.cbpa.2004.02.004; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bruschi M, 2004, INORG CHEM, V43, P3733, DOI 10.1021/ic035326y; Cao ZX, 2001, J AM CHEM SOC, V123, P3734, DOI 10.1021/ja000116v; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; George SJ, 2002, CHEM-EUR J, V8, P4037, DOI 10.1002/1521-3765(20020902)8:17<4037::AID-CHEM4037>3.0.CO;2-O; Gloaguen F, 2002, INORG CHEM, V41, P6573, DOI 10.1021/ic025838x; Le Cloirec A, 1999, CHEM COMMUN, P2285; Liu ZP, 2002, J AM CHEM SOC, V124, P5175, DOI 10.1021/ja0118690; Lyon EJ, 1999, ANGEW CHEM INT EDIT, V38, P3178, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3178::AID-ANIE3178>3.0.CO;2-4; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Ott S, 2004, ANGEW CHEM INT EDIT, V43, P1006, DOI 10.1002/anie.200353190; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; PICKETT CJ, 1994, J CHEM SOC DALTON, P2181, DOI 10.1039/dt9940002181; Popescu CV, 1999, J AM CHEM SOC, V121, P7877, DOI 10.1021/ja991243y; Razavet M, 2003, DALTON T, P586, DOI 10.1039/b209690k; Razavet M, 2002, CHEM COMMUN, P700, DOI 10.1039/b111613b; Reihlen H, 1929, LIEBIGS ANN CHEM, V472, P268; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Schmidt M, 1999, J AM CHEM SOC, V121, P9736, DOI 10.1021/ja9924187; STACK TDP, 1987, J AM CHEM SOC, V109, P2546, DOI 10.1021/ja00242a067; Tard C, 2005, CHEM COMMUN, P133, DOI 10.1039/b411559g; *UK DEP TRANSP, 2003, PLAT HYDR FUEL CELL; *US DEP EN OFF SCI, 2003, BAS EN SCI WORKSH HY; Wang LS, 1999, REV SCI INSTRUM, V70, P1957, DOI 10.1063/1.1149694; Wang XB, 2003, J AM CHEM SOC, V125, P14072, DOI 10.1021/ja036831x; Yang X, 2003, J PHYS CHEM A, V107, P4612, DOI 10.1021/jp034432i; Zhao X, 2002, INORG CHEM, V41, P3917, DOI 10.1021/ic020237r	30	445	448	1	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					610	613		10.1038/nature03298	http://dx.doi.org/10.1038/nature03298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703741				2022-12-01	WOS:000226862000038
J	Li, ZH; Kosorok, MR; Farrell, PM; Laxova, A; West, SEH; Green, CG; Collins, J; Rock, MJ; Splaingard, ML				Li, ZH; Kosorok, MR; Farrell, PM; Laxova, A; West, SEH; Green, CG; Collins, J; Rock, MJ; Splaingard, ML			Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRONCHOPULMONARY DISEASE; ANTIBIOTIC-TREATMENT; CROSS-INFECTION; YOUNG-CHILDREN; COLONIZATION; TOBRAMYCIN; INHIBITION; RESISTANCE; CONVERSION	Context Although Pseudomonas aeruginosa is the most common virulent respiratory pathogen in cystic fibrosis (CF), the longitudinal development of P aeruginosa infection and its effect on antibody responses and lung disease progression in children with CF remain unclear. Objective To prospectively examine the epidemiology of Paeruginosa infection and its impact on CF pulmonary morbidity. Design, Setting, and Patients We prospectively evaluated 56 CF patients at 2 CF centers in Madison and Milwaukee, Wis, from birth up to age 16 years between April 15, 1985, and April 15, 2004, with diagnoses made through the Wisconsin CF Neonatal Screening Project. Main Outcome Measures Timing of nonmucoid P aeruginosa and mucoid P aeruginosa acquisition was assessed by first positive result. Longitudinal development from no P aeruginosa to nonmucoid P aeruginosa and from nonmucoid Paerugginosa to mucoid Paeruginosa was examined. Outcome measurements included antibody titers, respiratory symptoms, quantitative chest radiography, and pulmonary function tests. Results Sixteen patients (29%) acquired nonmucoid Paeruginosa in the first 6 months of life. The age-specific prevalence of mucoid Paeruginosa increased markedly from age 4 to 16 years. Nonmucoid and mucoid P aeruginosa were acquired at median ages of 1.0 and 13.0 years, respectively. In contrast with the short transition time from no Paeruginosa to nonmucoid P aeruginosa, the transition time from nonmucoid to mucoid P aeruginosa was relatively long (median, 10.9 years) and could be slightly extended by brief/low anti-Paeruginosa antibiotic treatment. Antibody titers increased with both transitions, but the deterioration in cough scores, chest radiograph scores, and pulmonary function correlated best with transition from nonmucoid to mucoid P aeruginosa. Conclusions Early prevention and detection of nonmucoid and mucoid P aeruginosa are critical because of early acquisition and prevalence. There is a Window of opportunity for suppression and possible eradication (by aggressive anti-P aeruginosa treatment) of initial nonmucoid Paeruginosa. Mucoid Paeruginosa plays a much greater role in CF lung disease progression than nonmucoid Paeruginosa. Antibody titers, cough scores, and chest radiographs are early signs of nonmucoid P aeruginosa and especially mucoid P aeruginosa stages.	Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53705 USA; Univ Wisconsin, Dept Biostat Med Informat, Madison, WI 53705 USA; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA; Univ Wisconsin, Dept Radiol, Madison, WI 53705 USA; Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Farrell, PM (corresponding author), Univ Wisconsin, Sch Med, Dept Pediat, Room 4129 HSLC,750 Highland Ave, Madison, WI 53705 USA.	pmfarrel@facstaff.wics.edu	Splaingard, Mark/D-9206-2012; Kosorok, Michael/ABB-7427-2021; Splaingard, Mark/AAL-7356-2021	Splaingard, Mark/0000-0002-1361-4947; 	NCRR NIH HHS [M01 RR03186] Funding Source: Medline; NIDDK NIH HHS [DK 34108] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK034108, R01DK034108] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANWAR H, 1989, J ANTIMICROB CHEMOTH, V24, P647, DOI 10.1093/jac/24.5.647; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Ballmann M, 1998, THORAX, V53, P732, DOI 10.1136/thx.53.9.732; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; CABRAL DA, 1987, PEDIATR RES, V22, P429, DOI 10.1203/00006450-198710000-00013; DORING G, 1988, CHEST, V94, pS109, DOI 10.1378/chest.94.2.109S; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell P M, 2000, Adv Pediatr, V47, P79; Farrell PM, 2003, AM J RESP CRIT CARE, V168, P1100, DOI 10.1164/rccm.200303-434OC; Farrell PM, 2003, PEDIATR PULM, V36, P230, DOI 10.1002/ppul.10336; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; FEGAN M, 1990, J CLIN MICROBIOL, V28, P1143, DOI 10.1128/JCM.28.6.1143-1146.1990; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Griese M, 2002, EUR J MED RES, V7, P79; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Heinzl B, 2002, PEDIATR PULM, V33, P32, DOI 10.1002/ppul.10019; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; HODGES NA, 1991, ANTIMICROB AGENTS CH, V35, P2450, DOI 10.1128/AAC.35.11.2450; Hoiby N, 2000, Paediatr Drugs, V2, P451; Koch C, 2002, PEDIATR PULM, V34, P232, DOI 10.1002/ppul.10135; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Li ZH, 2004, PEDIATR PULM, V38, P277, DOI 10.1002/ppul.20092; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MARTIN DW, 1993, MOL MICROBIOL, V9, P497, DOI 10.1111/j.1365-2958.1993.tb01711.x; NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518; Nixon GM, 2001, J PEDIATR-US, V138, P699, DOI 10.1067/mpd.2001.112897; Ojeniyi B, 2000, PEDIATR PULM, V29, P177, DOI 10.1002/(SICI)1099-0496(200003)29:3<177::AID-PPUL4>3.0.CO;2-U; Parad RB, 1999, INFECT IMMUN, V67, P4744, DOI 10.1128/IAI.67.9.4744-4750.1999; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Ratjen F, 2001, LANCET, V358, P983, DOI 10.1016/S0140-6736(01)06124-4; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; SOKOL PA, 1994, J BACTERIOL, V176, P553, DOI 10.1128/jb.176.3.553-562.1994; STIVER HG, 1988, CLIN INVEST MED, V11, P247; Tubbs D, 2001, RESP MED, V95, P147, DOI 10.1053/rmed.2000.1009; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; West SEH, 2002, JAMA-J AM MED ASSOC, V287, P2958, DOI 10.1001/jama.287.22.2958; Yu HW, 2002, FRONT BIOSCI-LANDMRK, V7, pD442	40	395	400	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2005	293	5					581	588		10.1001/jama.293.5.581	http://dx.doi.org/10.1001/jama.293.5.581			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	893BL	15687313	Bronze			2022-12-01	WOS:000226694200021
J	Jain, A; Atreja, A; Harris, M; Lehmann, M; Burns, J; Young, J				Jain, A; Atreja, A; Harris, M; Lehmann, M; Burns, J; Young, J			Responding to the rofecoxib withdrawal crisis: A new model for notifying patients at risk and their health care providers	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN ORDER ENTRY; SAFETY; MEDICATION; RECALL; INFORMATION; MEDICINES; ARTHRITIS; MERCK; FDA	Background: We decided to inform our patients of the withdrawal of rofecoxib, one of the largest drug withdrawals in United States history, and instruct them to contact their providers for guidance. Objective: To identify and inform patients and providers affected by the rofecoxib withdrawal. Design: Descriptive observational study. Setting: Tertiary care center with an electronic medical record (EMR) system. Patients: Patients with an active rofecoxib prescription within the EMR. Intervention: Existing information technology and traditional communication resources were used to automate the identifying and notifying of patients and providers and to deactivate rofecoxib prescriptions in the EMR. Measurements: characteristics of patients receiving rofecoxib at our institution, details of their prescription and provider, number of EMR alerts, and medication discontinuations. Results: The 11699 patients with a rofecoxib prescription in our practice were sent notifications within 24 hours of the withdrawal. Limitations: we did not directly measure the effect of our notification on patients or providers. Conclusions: information technology enabled our institution to rapidly identify and notify individual patients and their providers about an important drug withdrawal. The methods modeled a feasible way for health care organizations with EMRs to participate in notification processes that may be applicable in a variety of situations.	Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Jain, A (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave,A91, Cleveland, OH 44195 USA.			Atreja, Ashish/0000-0002-0628-4417				Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; *CAMH, 2004, OFF HDB CAMH; Delorio NM, 2004, J EMERG MED, V26, P305, DOI 10.1016/j.jemermed.2003.09.009; DICK S, 1997, COMPUTER BASED PATIE; Folz-Murphy N, 1998, J AM MED INFORM ASSN, P260; Foster Erica, 2003, J AHIMA, V74, P34; Friedman MA, 1999, JAMA-J AM MED ASSOC, V281, P1728, DOI 10.1001/jama.281.18.1728; Greene H L, 2000, Health News, V6, P4; Harris C Martin, 2003, J Healthc Inf Manag, V17, P37; Houston TK, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e7; JOHNSON LJ, 2001, MED ECON, V78, P118; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kleinke JD, 1998, BRIT MED J, V317, P899; LIMA HA, 1995, AM J HEALTH-SYST PH, V52, P1010, DOI 10.1093/ajhp/52.9.1010; *MERCK CO INC, 2004, NEWS REL, P1; Murphy GF, 1999, ELECT HLTH RECORDS C; Poland GA, 1997, JAMA-J AM MED ASSOC, V278, P1022, DOI 10.1001/jama.278.12.1022; Rich D S, 1995, Hosp Pharm, V30, P165; Schiff GD, 2002, PHARMACOEPIDEM DR S, V11, P643, DOI 10.1002/pds.778; Singh D, 2004, BRIT MED J, V329, P816, DOI 10.1136/bmj.329.7470.816-a; SMITHELLS RW, 1963, LANCET, V1, P1095; SPOONER T, 2003, INTERNET USE REGION, P2; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; *US DEP HLTH HUM S, 2001, STAND PRIV IND ID HL; US Food and Drug Administration, 2004, FDA ISS PUBL HLTH AD; Wolfe SM, 2002, PHARMACOEPIDEM DR S, V11, P641, DOI 10.1002/pds.776; Wood AJJ, 1999, JAMA-J AM MED ASSOC, V281, P1753, DOI 10.1001/jama.281.18.1753; Zaidi STR, 2002, AM J HEALTH-SYST PH, V59, P1569, DOI 10.1093/ajhp/59.16.1569a; *ZIX CORP E PRESCR, 2004, FORB BUS WIRE; 2004, FAMILYMEDS USES NEW, P1	31	17	17	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2005	142	3					182	186		10.7326/0003-4819-142-3-200502010-00008	http://dx.doi.org/10.7326/0003-4819-142-3-200502010-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900UH	15684206				2022-12-01	WOS:000227239300004
J	Alvarez-Vasquez, F; Sims, KJ; Cowart, LA; Okamoto, Y; Voit, EO; Hannun, YA				Alvarez-Vasquez, F; Sims, KJ; Cowart, LA; Okamoto, Y; Voit, EO; Hannun, YA			Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae	NATURE			English	Article							BINDING-PROTEIN; STRESS; SPHINGOSINE-1-PHOSPHATE; INHIBITION; CERAMIDE; SYSTEMS; GENE	Mathematical models have become a necessary tool for organizing the rapidly increasing amounts of large-scale data on biochemical pathways and for advanced evaluation of their structure and regulation. Most of these models have addressed specific pathways using either stoichiometric(1) or flux-balance analysis(2), or fully kinetic Michaelis - Menten representations(3), metabolic control analysis(4), or biochemical systems theory(5-7). So far, the predictions of kinetic models have rarely been tested using direct experimentation. Here, we validate experimentally a biochemical systems theoretical model of sphingolipid metabolism in yeast(8). Simulations of metabolic fluxes, enzyme deletion and the effects of inositol ( a key regulator of phospholipid metabolism) led to predictions that show significant concordance with experimental results generated post hoc. The model also allowed the simulation of the effects of acute perturbations in fatty-acid precursors of sphingolipids, a situation that is not amenable to direct experimentation. The results demonstrate that modelling now allows testable predictions as well as the design and evaluation of hypothetical 'thought experiments' that may generate new metabolomic approaches.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA; Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Med Sch, Atlanta, GA 30332 USA	Medical University of South Carolina; Medical University of South Carolina; University System of Georgia; Georgia Institute of Technology	Voit, EO (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	eberhard.voit@bme.gatech.edu; hannun@musc.edu	OKAMOTO, Yasuo/J-8438-2015	Alvarez-Vasquez, Fernando/0000-0003-4008-9858				Alvarez-Vasquez F, 2004, J THEOR BIOL, V226, P265, DOI 10.1016/j.jtbi.2003.08.010; BIELAWSKA J, IN PRESS SIMULTANEOU; Fell D., 1997, UNDERSTANDING CONTRO; FERREIRA AEN, 1995, PLAS WINDOWS; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Heinrich R., 1996, REGULATION CELLULAR; JENKINS GM, 1999, APOPTOSIS PRACTICAL; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MANDALA SM, 1994, J ANTIBIOT, V47, P376, DOI 10.7164/antibiotics.47.376; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Mulquiney P. J., 2003, MODELING METABOLISM; RASMUSSEN JT, 1993, BIOCHEM J, V292, P907, DOI 10.1042/bj2920907; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Voit EO, 2004, MATH BIOSCI, V191, P83, DOI 10.1016/j.mbs.2004.04.004; Voit EO, 2000, COMPUTATIONAL ANAL B; Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6	26	125	126	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					425	430		10.1038/nature03232	http://dx.doi.org/10.1038/nature03232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674294				2022-12-01	WOS:000226546200045
J	Schulz, HN; Schulz, HD				Schulz, HN; Schulz, HD			Large sulfur bacteria and the formation of phosphorite	SCIENCE			English	Article							WASTE-WATER; SEDIMENTS; OXYGEN; PHOSPHOGENESIS; POLYPHOSPHATE; REMOVAL	Phosphorite deposits in marine sediments are a long-term sink for an essential nutrient, phosphorus. Here we show that apatite abundance in sediments on the Namibian shelf correlates with the abundance and activity of the giant sulfur bacterium Thiomargarita namibiensis, which suggests that sulfur bacteria drive phosphogenesis. Sediments populated by Thiomargarita showed sharp peaks of pore water phosphate (less than or equal to300 micromolar) and massive phosphorite accumulations (greater than or equal to50 grams of phosphorus per kilogram). Laboratory experiments revealed that under anoxic conditions, Thiomargarita released enough phosphate to account for the precipitation of hydroxyapatite observed in the environment.	Univ Hannover, Inst Microbiol, D-30167 Hannover, Germany; Univ Bremen, Dept Geosci, D-28359 Bremen, Germany	Leibniz University Hannover; University of Bremen	Schulz, HN (corresponding author), Univ Hannover, Inst Microbiol, Schneiderberg 50, D-30167 Hannover, Germany.	schulz@ifmb.uni-hannover.de	Schulz-Vogt, Heide/I-1397-2012	Schulz-Vogt, Heide/0000-0003-1445-0291				Follmi KB, 1996, EARTH-SCI REV, V40, P55, DOI 10.1016/0012-8252(95)00049-6; GALLARDO VA, 1977, NATURE, V268, P331, DOI 10.1038/268331a0; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; KRAJEWSKI KP, 1994, ECLOGAE GEOL HELV, V87, P701; Larkin JM, 1996, MICROSC RES TECHNIQ, V33, P23; MAIER S, 1990, CAN J MICROBIOL, V36, P438, DOI 10.1139/m90-077; Mino T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P341; NATHAN Y, 1993, GEOMICROBIOL J, V11, P69, DOI 10.1080/01490459309377935; Parkhurst D.L, 1999, USERS GUIDE PHREEQC; Reimers CE, 1996, GEOCHIM COSMOCHIM AC, V60, P4037, DOI 10.1016/S0016-7037(96)00231-1; REIMERS CE, 1990, PHOSPHATE DEPOSITS W, V3, P300; Schenau S, 2000, MAR GEOL, V169, P1, DOI 10.1016/S0025-3227(00)00083-9; Schmaljohann R, 2001, MAR ECOL PROG SER, V220, P295; SCHULZ HD, 2000, MARINE GEOCHEMISTRY, P417; Schulz HN, 2002, APPL ENVIRON MICROB, V68, P5746, DOI 10.1128/AEM.68.11.5746-5749.2002; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; Thiede J., 1983, COASTAL UPWELLING, VB, P11; vanLoosdrecht MCM, 1997, ANTON LEEUW INT J G, V71, P109, DOI 10.1023/A:1000150523030; WILLIAMS LA, 1983, GEOLOGY, V11, P267, DOI 10.1130/0091-7613(1983)11<267:ROBMIO>2.0.CO;2	19	289	299	4	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2005	307	5708					416	418		10.1126/science.1103096	http://dx.doi.org/10.1126/science.1103096			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890DQ	15662012				2022-12-01	WOS:000226492300044
J	Bilukha, OO; Brennan, M				Bilukha, OO; Brennan, M			Injuries and deaths caused by unexploded ordnance in Afganistan: review of surveillance data, 1997-2002	BMJ-BRITISH MEDICAL JOURNAL			English	Article								In 2000-2, Afghanistan had the highest number of casualties due to landmines and unexploded ordnance in the world.(1) Increasing international awareness of the public health threat posed by landmines is the legacy of the International Campaign to Ban Landmines. More attention must be paid to, the growing and equally deadly threat posed by unexploded ordnance.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Bilukha, OO (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop C-09, Atlanta, GA 30341 USA.	obilukha@cdc.gov	Bilukha, Oleg/ABC-5095-2020					Gall C, 2002, NY TIMES, pA15; *HUM RIGHTS WATCH, 2001, LANDM US AFGH; *INT CAMP BAN LAND, 2002, LANDM MON REP 2003; *INT COMM RED CROS, 2002, SEM REP JAN JUN 2002	4	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2005	330	7483					127	128		10.1136/bmj.38337.361782.82	http://dx.doi.org/10.1136/bmj.38337.361782.82			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889PM	15640249	Green Published, Bronze			2022-12-01	WOS:000226454900019
J	PELLI, DG; CHAMBERLAIN, SC				PELLI, DG; CHAMBERLAIN, SC			THE VISIBILITY OF 350-DEGREES-C BLACK-BODY RADIATION BY THE SHRIMP RIMICARIS-EXOCULATA AND MAN	NATURE			English	Article									SYRACUSE UNIV,DEPT BIOENGN,SYRACUSE,NY 13244	Syracuse University	PELLI, DG (corresponding author), SYRACUSE UNIV,INST SENSORY RES,SYRACUSE,NY 13244, USA.							BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BROWNE MW, 1988, NY TIMES        0809, pB5; DRTNALL HJA, 1972, HDB SENSORY PHYSL 2, V7; Pirenne M. H., 1962, EYE, V2; STILES WS, 1974, VISION RES, V14, P195, DOI 10.1016/0042-6989(74)90101-1; THOMPSON G, 1988, CAN MINERAL, V26, P697; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; VANDOVER CL, 1989, NATURE, V337; Wyszecki Gunter, 1982, COLOR SCI, V8	9	45	45	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	FEB 2	1989	337	6206					460	461		10.1038/337460a0	http://dx.doi.org/10.1038/337460a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T0720	15726721				2022-12-01	WOS:A1989T072000066
J	McCoy, CB; Rodriguez, F				McCoy, CB; Rodriguez, F			Global overview of injecting drug use and HIV infection	LANCET			English	Editorial Material									Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33176 USA; Univ Costa Rica, Inst Hlth Res, San Jose, Costa Rica	University of Miami; Universidad Costa Rica	McCoy, CB (corresponding author), Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33176 USA.	cmccoy@med.miami.edu						Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; Ball A L, 1998, Public Health Rep, V113 Suppl 1, P170; DESJARLAIS DC, 1992, AIDS, V6, P1053, DOI 10.1097/00002030-199210000-00001; Mann J. M., 1992, AIDS WORLD; McCoy CB, 2004, ANN EPIDEMIOL, V14, P535, DOI 10.1016/j.annepidem.2003.10.001; Pisani E., 2003, ESTIMATING SIZE POPU; Stimson G. V., 1993, Bulletin on Narcotics, V45, P3; *UNAIDS, 2003, FOLL UP 2001 UN GEN	8	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1008	1009						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781081				2022-12-01	WOS:000227731800006
J	Carrel, L; Willard, HF				Carrel, L; Willard, HF			X-inactivation profile reveals extensive variability in X-linked gene expression in females	NATURE			English	Article							CHROMOSOME INACTIVATION; MAMMALIAN X; FACULTATIVE HETEROCHROMATIN; REPEAT HYPOTHESIS; METHYLATION; REGION	In female mammals, most genes on one X chromosome are silenced as a result of X-chromosome inactivation(1,2). However, some genes escape X-inactivation and are expressed from both the active and inactive X chromosome. Such genes are potential contributors to sexually dimorphic traits, to phenotypic variability among females heterozygous for X-linked conditions, and to clinical abnormalities in patients with abnormal X chromosomes(3). Here, we present a comprehensive X-inactivation profile of the human X chromosome, representing an estimated 95% of assayable genes in fibroblast-based test systems(4,5). In total, about 15% of X-linked genes escape inactivation to some degree, and the proportion of genes escaping inactivation differs dramatically between different regions of the X chromosome, reflecting the evolutionary history of the sex chromosomes. An additional 10% of X-linked genes show variable patterns of inactivation and are expressed to different extents from some inactive X chromosomes. This suggests a remarkable and previously unsuspected degree of expression heterogeneity among females.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Duke University	Carrel, L (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	lcarrel@psu.edu						Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Brown CJ, 2003, TRENDS GENET, V19, P432, DOI 10.1016/S0168-9525(03)00177-X; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carrel L, 1999, P NATL ACAD SCI USA, V96, P7364, DOI 10.1073/pnas.96.13.7364; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chadwick BP, 2003, SEMIN CELL DEV BIOL, V14, P359, DOI 10.1016/j.semcdb.2003.09.016; Esposito T, 1997, GENOMICS, V43, P183, DOI 10.1006/geno.1997.4797; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LYON MF, 1962, AM J HUM GENET, V14, P135; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Miller AP, 1998, P NATL ACAD SCI USA, V95, P8709, DOI 10.1073/pnas.95.15.8709; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Ohno S., 1967, SEX CHROMOSOMES SEX; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Willard HF, 2000, METABOLIC MOL BASES, P1191; Wizemann TM, 2001, EXPLORING BIOL CONTR	28	1420	1464	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					400	404		10.1038/nature03479	http://dx.doi.org/10.1038/nature03479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772666				2022-12-01	WOS:000227715100056
J	High, K				High, K			Anemia and gene therapy - A matter of control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	High, K (corresponding author), Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Kirn D, 2002, TRENDS MOL MED, V8, pS68, DOI 10.1016/S1471-4914(02)02318-3; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Takacs K, 2004, P NATL ACAD SCI USA, V101, P16298, DOI 10.1073/pnas.0405271101	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1146	1147		10.1056/NEJMcibr044437	http://dx.doi.org/10.1056/NEJMcibr044437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784669				2022-12-01	WOS:000227655000016
J	Zatorre, R; McGill, J				Zatorre, R; McGill, J			Music, the food of neuroscience?	NATURE			English	Article							ABSOLUTE PITCH; LANGUAGE; BRAIN		Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Zatorre, R (corresponding author), Montreal Neurol Inst, Montreal, PQ, Canada.							Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Juslin P.N., 2001, MUSIC EMOTION THEORY; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; Meyer LB, 1956, EMOTION MEANING MUSI; PANTEV C, 2003, COGNITIVE NEUROSCIEN, P382; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Saffran J.R., 2003, COGNITIVE NEUROSCIEN, P32; SCHLAUG G, 2003, COGNITIVE NEUROSCIEN, P366; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	16	182	188	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					312	315		10.1038/434312a	http://dx.doi.org/10.1038/434312a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	907KG	15772648				2022-12-01	WOS:000227715100037
J	Busby, A; Abramsky, L; Dolk, H; Armstrong, B				Busby, A; Abramsky, L; Dolk, H; Armstrong, B		Eurocat Folic Acid Working Grp	Preventing neural tube defects in Europe: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Northwick Pk Hosp & Clin Res Ctr, N Thames W Congenital Malformat Register, Harrow HA1 3UJ, Middx, England; Univ Ulster, EUROCAT Cent Registry, Newtownabbey BT37 0QB, Antrim, North Ireland	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Ulster University	Busby, A (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	araceli.busby@lshtm.ac.uk		armstrong, benedict/0000-0003-4407-0409; Relton, Caroline/0000-0003-2052-4840				[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; BUSBY A, 2005, EUROCAT SPECIAL REPO; CLARK NAC, 1994, BRIT J OBSTET GYNAEC, V101, P709, DOI 10.1111/j.1471-0528.1994.tb13190.x; DOLK H, 1991, J EPIDEMIOL COMMUN H, V45, P52, DOI 10.1136/jech.45.1.52; *EUR FOL AC WORK G, 2003, EUR SPEC REP PREV NE; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Persad VL, 2002, CAN MED ASSOC J, V167, P241	7	86	98	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2005	330	7491					574	575		10.1136/bmj.330.7491.574	http://dx.doi.org/10.1136/bmj.330.7491.574			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15760997	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000227622300018
J	Lee, TT; Agarwalla, S; Stroud, RM				Lee, TT; Agarwalla, S; Stroud, RM			A unique RNA fold in the RumA-RNA-Cofactor ternary complex contributes to substrate selectivity and enzymatic function	CELL			English	Article							IRON-SULFUR CLUSTER; CRYSTAL-STRUCTURE; PSEUDOURIDINE SYNTHASE; ESCHERICHIA-COLI; METHYLTRANSFERASE; MECHANISM; RECOGNITION; BASE; NUCLEOSIDES; M(5)U1939	A single base (U1939) within E. coli 23S ribosomal RNA is methylated by its dedicated enzyme, RumA. The structure of RumA/RNA/S-adenosylhomocysteine uncovers the mechanism for achieving unique selectivity. The single-stranded substrate is "refolded" on the enzyme into a compact conformation with six key intra-RNA interactions. The RNA substrate contributes directly to catalysis. In addition to the target base, a second base is "flipped out" from the core loop to stack against the adenine of the cofactor S-adenosylhomocysteine. Nucleotides in permuted sequence order are stacked into the site vacated by the everted target U1939 and compensate for the energetic penalty of base eversion. The 3' hairpin segment of the RNA binds distal to the active site and provides binding energy that contributes to enhanced catalytic efficiency. Active collaboration of RNA in catalysis leads us to conclude that RumA and its substrate RNA may reflect features from the earliest RNA-protein era.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu	Stroud, Rhonda/GQZ-0151-2022	Stroud, Rhonda/0000-0001-5242-8015	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051232] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; Agarwalla S, 2002, J BIOL CHEM, V277, P8835, DOI 10.1074/jbc.M111825200; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cheng XD, 2002, STRUCTURE, V10, P127, DOI 10.1016/S0969-2126(02)00710-4; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Fersht A, 1999, STRUCTURE MECH PROTE; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Gimenez JAM, 1998, J THEOR BIOL, V194, P485, DOI 10.1006/jtbi.1998.0770; GU XG, 1992, BIOCHEMISTRY-US, V31, P10295, DOI 10.1021/bi00157a017; HARTLEY BS, 1954, BIOCHEM J, V56, P288, DOI 10.1042/bj0560288; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KEALEY JT, 1994, BIOCHIMIE, V76, P1133, DOI 10.1016/0300-9084(94)90042-6; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TT, 2004, STRUCTURE, V12, P397, DOI 10.1016/j.str.2004.02.009; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; LIU L, 1992, BIOCHEMISTRY-US, V31, P5100, DOI 10.1021/bi00137a002; Madsen CT, 2003, NUCLEIC ACIDS RES, V31, P4738, DOI 10.1093/nar/gkg657; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PERRY KM, 1990, PROTEINS, V8, P315, DOI 10.1002/prot.340080406; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SOLIE TN, 1968, J MOL BIOL, V33, P61, DOI 10.1016/0022-2836(68)90281-7; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu J C, 1985, Prog Clin Biol Res, V198, P119; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	49	91	93	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					599	611		10.1016/j.cell.2004.12.037	http://dx.doi.org/10.1016/j.cell.2004.12.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766524	Bronze			2022-12-01	WOS:000227771400007
J	Le Gal, G; Testuz, A; Righini, M; Bounameaux, H; Perrier, A				Le Gal, G; Testuz, A; Righini, M; Bounameaux, H; Perrier, A			Reproduction of chest pain by palpation: diagnostic accuracy in suspected pulmonary embolism	BRITISH MEDICAL JOURNAL			English	Article									Brest Univ Hosp, Equipe Accueil GETBO 3878, F-29609 Brest, France; Univ Hosp Geneva, Geneva Fac Med, Dept Internal Med, Div Gen Internal Med, CH-1211 Geneva, Switzerland	CHU Brest; University of Geneva	Le Gal, G (corresponding author), Brest Univ Hosp, Equipe Accueil GETBO 3878, F-29609 Brest, France.	gregoire.legal@chu-brest.fr	Righini, Marc/AAX-8731-2020; LE GAL, Gregoire/K-1077-2012; Perrier, Arnaud/M-2263-2014	LE GAL, Gregoire/0000-0002-9253-248X				DREYFUSS AI, 1984, ARCH INTERN MED, V144, P2057, DOI 10.1001/archinte.144.10.2057; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Stein PD, 1997, CHEST, V112, P974, DOI 10.1378/chest.112.4.974; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92	5	17	17	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2005	330	7489					452	453		10.1136/bmj.38331.602384.8F	http://dx.doi.org/10.1136/bmj.38331.602384.8F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901XK	15684025	Green Published, Bronze			2022-12-01	WOS:000227315400018
J	Bradshaw, GA; Schore, AN; Brown, JL; Poole, JH; Moss, CJ				Bradshaw, GA; Schore, AN; Brown, JL; Poole, JH; Moss, CJ			Elephant breakdown	NATURE			English	Article									Oregon State Univ, Environm Sci Grad Programme, Corvallis, OR 97331 USA; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; Smithsonian Natl Zool Pk, Washington, DC USA; Amboseli Elephant Res Project, Nairobi, Kenya	Oregon State University; Oregon State University; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Bradshaw, GA (corresponding author), Oregon State Univ, Environm Sci Grad Programme, Corvallis, OR 97331 USA.							CLUBB R, 2002, REV WELFARE ELEPHANT; Schore AN., 2003, AFFECT DYSREGULATION; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191	3	106	108	3	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					807	807		10.1038/433807a	http://dx.doi.org/10.1038/433807a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729320	Bronze			2022-12-01	WOS:000227174600022
J	Krentz, AJ; Wheeler, DC				Krentz, AJ; Wheeler, DC			New-onset diabetes after transplantation: a threat to graft and patient survival	LANCET			English	Editorial Material							IMMUNOSUPPRESSIVE AGENTS; CALCINEURIN INHIBITORS; KIDNEY-TRANSPLANTATION; MELLITUS; DISEASE; OBESITY		Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA; UCL Royal Free & Univ Coll Med Sch, Ctr Nephrol, London, England	University of California System; University of California San Diego; University of London; University College London; UCL Medical School	Krentz, AJ (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA.	akrentz@ucsd.edu	Krentz, Andrew/AAD-2493-2019					Beckebaum S, 2004, TRANSPL P, V36, p574S, DOI 10.1016/j.transproceed.2004.01.044; Boots JMM, 2004, DRUGS, V64, P2047, DOI 10.2165/00003495-200464180-00004; Bostom AD, 2002, AM J TRANSPLANT, V2, P491, DOI 10.1034/j.1600-6143.2002.20602.x; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Jindal RM, 2000, TRANSPLANTATION, V70, pSS58; John PR, 2002, LIVER TRANSPLANT, V8, P708, DOI 10.1053/jlts.2002.34638; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; KRENTZ AJ, 1995, CLIN IMMUNOTHER, V4, P103, DOI 10.1007/BF03259076; Markell M, 2004, AM J KIDNEY DIS, V43, P953, DOI 10.1053/j.ajkd.2004.03.020; Montori VM, 2002, DIABETES CARE, V25, P583, DOI 10.2337/diacare.25.3.583; Morris PJ, 2004, NEW ENGL J MED, V351, P2678, DOI 10.1056/NEJMp048256; Pischon T, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.1.14; Schulak JA, 2004, J SURG RES, V117, P154, DOI 10.1016/j.jss.2003.11.005; Sims RJA, 2003, BRIT MED J, V327, P463, DOI 10.1136/bmj.327.7413.463; Tanabe K, 2003, DRUGS, V63, P1535, DOI 10.2165/00003495-200363150-00002; Valantine H, 2004, J HEART LUNG TRANSPL, V23, pS187, DOI 10.1016/j.healun.2004.03.009; Wilkinson A, 2003, TRANSPLANTATION, V75, pSS1, DOI 10.1097/00007890-200305271-00001; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x	20	32	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2005	365	9460					640	642						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15721460				2022-12-01	WOS:000227096800008
J	Fatouros, NE; Huigens, ME; van Loon, JJA; Dicke, M; Hilker, M				Fatouros, NE; Huigens, ME; van Loon, JJA; Dicke, M; Hilker, M			Chemical communication - Butterfly anti-aphrodisiac lures parasitic wasps	NATURE			English	Editorial Material							SCELIONIDAE; HYMENOPTERA		Free Univ Berlin, Inst Biol, D-12163 Berlin, Germany; Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands	Free University of Berlin; Wageningen University & Research	Fatouros, NE (corresponding author), Free Univ Berlin, Inst Biol, D-12163 Berlin, Germany.	hilker@zedat.fu-berlin.de	Dicke, Marcel/B-2300-2010; van Loon, Joop J.A./B-3744-2009; Fatouros, Nina/AAO-9698-2020	Dicke, Marcel/0000-0001-8565-8896; van Loon, Joop J.A./0000-0002-4260-0501; Fatouros, Nina/0000-0003-0841-3144				Andersson J, 2000, P ROY SOC B-BIOL SCI, V267, P1271, DOI 10.1098/rspb.2000.1138; Andersson J, 2003, J CHEM ECOL, V29, P1489, DOI 10.1023/A:1024277823101; Arakaki N, 1996, J CHEM ECOL, V22, P1079, DOI 10.1007/BF02027946; Bruni R, 2000, J INSECT BEHAV, V13, P165, DOI 10.1023/A:1007728012482; CLAUSEN CP, 1976, ANNU REV ENTOMOL, V21, P343, DOI 10.1146/annurev.en.21.010176.002015; GILBERT LE, 1976, SCIENCE, V193, P419, DOI 10.1126/science.935877; Hilker M., 2002, CHEMOECOLOGY INSECT; ORR DB, 1986, CAN ENTOMOL, V118, P1063, DOI 10.4039/Ent1181063-10; STOWE MK, 1995, P NATL ACAD SCI USA, V92, P23, DOI 10.1073/pnas.92.1.23; Tabata S, 1940, REV APPL ENTOMOL A; Vinson S.B., 1984, Symposia of the Royal Entomological Society of London, V12, P325	11	82	87	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					704	704		10.1038/433704a	http://dx.doi.org/10.1038/433704a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716942				2022-12-01	WOS:000227039200028
J	Tomson, T; Forsgren, L				Tomson, T; Forsgren, L			Life expectancy in epilepsy	LANCET			English	Editorial Material							LONG-TERM; MORTALITY; SEIZURE; COHORT; PEOPLE		Karolinska Inst, Sect Neurol, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; Umea Univ, Dept Pharmacol & Clin Neurosci, Neurol Sect, S-90187 Umea, Sweden	Karolinska Institutet; Umea University	Tomson, T (corresponding author), Karolinska Inst, Sect Neurol, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	torbjorn.tomson@karolinska.se						COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Forsgren L, 1996, EPILEPSIA, V37, P956, DOI 10.1111/j.1528-1157.1996.tb00533.x; Gaitatzis A, 2004, BRAIN, V127, P2427, DOI 10.1093/brain/awh267; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; HAUSER WA, 1967, EPILEPSIA, V16, P1; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Lindsten H, 2000, EPILEPSIA, V41, P1469, DOI 10.1111/j.1528-1157.2000.tb00124.x; Loiseau J, 1999, EPILEPSIA, V40, P1388, DOI 10.1111/j.1528-1157.1999.tb02010.x; Olafsson E, 1998, EPILEPSIA, V39, P89, DOI 10.1111/j.1528-1157.1998.tb01279.x; ZIELINSKI JJ, 1974, EPILEPSIA, V15, P191, DOI 10.1111/j.1528-1157.1974.tb04941.x	10	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 12	2005	365	9459					557	558						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708087				2022-12-01	WOS:000226984300010
J	Ryu, JS; Kim, JI; Kunkel, T; Kim, BC; Cho, DS; Hong, SH; Kim, SH; Fernandez, AP; Kim, Y; Alonso, JM; Ecker, JR; Nagy, F; Lim, PO; Song, PS; Schafer, E; Nam, HG				Ryu, JS; Kim, JI; Kunkel, T; Kim, BC; Cho, DS; Hong, SH; Kim, SH; Fernandez, AP; Kim, Y; Alonso, JM; Ecker, JR; Nagy, F; Lim, PO; Song, PS; Schafer, E; Nam, HG			Phytochrome-specific type 5 phosphatase controls light signal flux by enhancing phytochrome stability and affinity for a signal transducer	CELL			English	Article							INTERACTING FACTOR-3; HYPOCOTYL ELONGATION; OAT PHYTOCHROME; IN-VITRO; ARABIDOPSIS; PROTEIN; PHOTORECEPTOR; PLANTS; PHOTOMORPHOGENESIS; PHOSPHORYLATION	Environmental light information such as quality, intensity, and duration in red (similar to660 nm) and far-red (similar to730 nm) wavelengths is perceived by phytochrome photoreceptors in plants, critically influencing almost all developmental strategies from germination to flowering. Phytochromes interconvert between red light-absorbing Pr and biologically functional far-red light-absorbing Pfr forms. To ensure optimal photoresponses in plants, the flux of light signal from Pfr-phytochromes should be tightly controlled. Phytochromes are phosphorylated at specific serine residues. We found that a type 5 protein phosphatase (PAPP5) specifically dephosphorylates biologically active Pfr-phytochromes and enhances phytochrome-mediated photoresponses. Depending on the specific serine residues dephosphorylated by PAPP5, phytochrome stability and affinity for a downstream signal transducer, NDPK2, were enhanced. Thus, phytochrome photoreceptors have developed an elaborate biochemical tuning mechanism for modulating the flux of light signal, employing variable phosphorylation states controlled by phosphorylation and PAPP5-mediated dephosphorylation as a mean to control phytochrome stability and affinity for downstream transducers.	Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; Pohang Univ Sci & Technol, Syst Biodynam Res Ctr, Pohang 790784, Kyungbuk, South Korea; Kumho Life & Environm Sci Lab, Kwangju 500712, South Korea; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea; Univ Freiburg, Inst Bot, D-79104 Freiburg, Germany; Salk Inst Biol Studies, La Jolla, CA 92037 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Gyeongsang National University; University of Freiburg; Salk Institute	Nam, HG (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea.	nam@postech.ac.kr	Kim, Yumi/AAA-9398-2021; Nagy, Ferenc/D-3532-2015; Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014	Kim, Yumi/0000-0001-6369-5055; Nagy, Ferenc/0000-0002-6157-9269; Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571				Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; BOYLAN MT, 1991, P NATL ACAD SCI USA, V88, P10806, DOI 10.1073/pnas.88.23.10806; Casal JJ, 2002, PLANT PHYSIOL, V129, P1127, DOI 10.1104/pp.010977; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Colon-Carmona A, 2000, PLANT PHYSIOL, V124, P1728, DOI 10.1104/pp.124.4.1728; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Gyula N, 2003, CURR OPIN PLANT BIOL, V6, P446, DOI 10.1016/S1369-5266(03)00082-7; Hennig L, 1999, PLANTA, V208, P257, DOI 10.1007/s004250050557; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Jordan ET, 1997, PLANT PHYSIOL, V115, P693, DOI 10.1104/pp.115.2.693; Kim J, 2004, PLANT CELL, V16, P2629, DOI 10.1105/tpc.104.023879; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Lagarias DM, 1997, PLANT CELL, V9, P675, DOI 10.1105/tpc.9.5.675; Lapko VN, 1999, PROTEIN SCI, V8, P1032, DOI 10.1110/ps.8.5.1032; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Okamoto H, 2001, PLANT CELL, V13, P1639, DOI 10.1105/tpc.13.7.1639; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	29	121	137	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					395	406		10.1016/j.cell.2004.12.019	http://dx.doi.org/10.1016/j.cell.2004.12.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707897	Bronze			2022-12-01	WOS:000227028900014
J	Yu, B; Yang, ZY; Li, JJ; Minakhina, S; Yang, MC; Padgett, RW; Steward, R; Chen, XM				Yu, B; Yang, ZY; Li, JJ; Minakhina, S; Yang, MC; Padgett, RW; Steward, R; Chen, XM			Methylation as a crucial step in plant microRNA biogenesis	SCIENCE			English	Article							VIRUS-RESISTANCE; PAZ DOMAIN; RNA; ARABIDOPSIS; GENE; RECOGNITION; METABOLISM; TRANSGENE; GENOMICS; PROTEIN	Methylation on the base or the ribose is prevalent in eukaryotic ribosomal RNAs (rRNAs) and is thought to be crucial for ribosome biogenesis and function. Artificially introduced 2'-O-methyl groups in small interfering RNAs (siRNAs) can stabilize siRNAs in serum without affecting their activities in RNA interference in mammalian cells. Here, we show that plant microRNAs (miRNAs) have a naturally occurring methyl group on the ribose of the last nucleotide. Whereas methylation of rRNAs depends on guide RNAs, the methyltransferase protein HEN1 is sufficient to methylate miRNA/miRNA* duplexes. Our studies uncover a new and crucial step in plant miRNA biogenesis and have profound implications in the function of miRNAs.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Chen, XM (corresponding author), Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA.	xuemei@waksman.rutgers.edu	Yu, Bin/A-7714-2010	Chen, Xuemei/0000-0002-5209-1157	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM061146, GM61146] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alefelder S, 1998, NUCLEIC ACIDS RES, V26, P4983, DOI 10.1093/nar/26.21.4983; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mallory AC, 2004, CURR OPIN PLANT BIOL, V7, P120, DOI 10.1016/j.pbi.2004.01.006; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; YANG ZB, UNPUB	16	752	821	4	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					932	935		10.1126/science.1107130	http://dx.doi.org/10.1126/science.1107130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705854	Green Accepted			2022-12-01	WOS:000226985100056
J	Klironomos, JN; Allen, MF; Rillig, MC; Piotrowski, J; Makvandi-Nejad, S; Wolfe, BE; Powell, JR				Klironomos, JN; Allen, MF; Rillig, MC; Piotrowski, J; Makvandi-Nejad, S; Wolfe, BE; Powell, JR			Abrupt rise in atmospheric CO2 overestimates community response in a model plant-soil system	NATURE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ELEVATED CO2; COLONIZATION	Attempts to understand the ecological effect of increasing atmospheric CO2 concentration, [CO2], usually involve exposing today's ecosystems to expected future [CO2] levels(1,2). However, a major assumption of these approaches has not been tested that exposing ecosystems to a single- step increase in [ CO2] will yield similar responses to those of a gradual increase over several decades(3). We tested this assumption on a mycorrhizal fungal community over a period of six years. [ CO2] was either increased abruptly, as is typical of most [ CO2] experiments, or more gradually over 21 generations. The two approaches resulted in different structural and functional community responses to increased [ CO2]. Some fungi were sensitive to the carbon pulse of the abrupt [ CO2] treatment. This resulted in an immediate decline in fungal species richness and a significant change in mycorrhizal functioning. The magnitude of changes in fungal diversity and functioning in response to gradually increasing [ CO2] was smaller, and not significantly different to those with ambient [ CO2]. Our results suggest that studies may overestimate some community responses to increasing [ CO2] because biota may be sensitive to ecosystem changes that occur as a result of abrupt increases.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Guelph; University of California System; University of California Riverside; University of Montana System; University of Montana	Klironomos, JN (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	jklirono@uoguelph.ca	Rillig, Matthias C./B-3675-2009; Powell, Jeff R/A-5076-2010; Rillig, Matthias C./AAE-6980-2019	Rillig, Matthias C./0000-0003-3541-7853; Powell, Jeff R/0000-0003-1091-2452; Rillig, Matthias C./0000-0003-3541-7853				Allen M. F., 1991, ECOLOGY MYCORRHIZAE; BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; BRUNDRETT MC, 1984, CAN J BOT, V62, P2128, DOI 10.1139/b84-290; Gange AC, 2003, ECOL LETT, V6, P1051, DOI 10.1046/j.1461-0248.2003.00540.x; Goverde M, 2000, OECOLOGIA, V125, P362, DOI 10.1007/s004420000465; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; *IPCC, 2001, CLIM CHANG 2001 SYNT; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Klironomos J., 2000, MICROB BIOSYS, V1, P845; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Klironomos JN, 1998, NEW PHYTOL, V138, P599, DOI 10.1046/j.1469-8137.1998.00141.x; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Luo Y, 1999, CARBON DIOXIDE ENV S; Luo YQ, 1999, ECOLOGY, V80, P1568, DOI 10.1890/0012-9658(1999)080[1568:VOEFCE]2.0.CO;2; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Piotrowski JS, 2004, NEW PHYTOL, V164, P365, DOI 10.1111/j.1469-8137.2004.01181.x; Rillig MC, 1999, NATURE, V400, P628, DOI 10.1038/23168; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, ECOL STU AN, V157, P135; SINEAD C, NATURE, V431, P566; Smith SE, 1997, MYCORRHIZAL SYMBIOSE; Staddon PL, 1998, TRENDS ECOL EVOL, V13, P455, DOI 10.1016/S0169-5347(98)01493-1; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2003, ECOSYSTEMS, V6, P786, DOI 10.1007/s10021-003-0182-4; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Ward JK, 2004, ECOL LETT, V7, P427, DOI 10.1111/j.1461-0248.2004.00589.x; Wolf J, 2003, NEW PHYTOL, V157, P579, DOI 10.1046/j.1469-8137.2003.00696.x	28	132	151	4	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					621	624		10.1038/nature03268	http://dx.doi.org/10.1038/nature03268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703744				2022-12-01	WOS:000226862000041
J	McCormick, C; Ganem, D				McCormick, C; Ganem, D			The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs	SCIENCE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; AU-RICH ELEMENTS; MAPKAP KINASE-2; NUCLEAR EXPORT; CELL-LINES; C-FOS; DEGRADATION; PHOSPHORYLATION; IDENTIFICATION; COMPLEX	Cytokine production plays a critical role in diseases caused by Kaposi's sarcoma-associated herpesvirus (KSHV). Here we show that a latent KSHV gene product, kaposin B, increases the expression of cytokines by blocking the degradation of their messenger RNAs (mRNAs). Cytokine transcripts are normally unstable because they contain AU-rich elements (AREs) in their 3' noncoding regions that target them for degradation. Kaposin B reverses this instability by binding to and activating the kinase MK2, a target of the p38 mitogen-activated protein kinase signaling pathway and a known inhibitor of ARE-mRNA decay. These findings define an important mechanism linking latent KSHV infection to cytokine production, and also illustrate a distinctive mode by which viruses can selectively modulate mRNA turnover.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ganem, D (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722				Asou H, 1998, BLOOD, V91, P2475, DOI 10.1182/blood.V91.7.2475.2475_2475_2481; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Drexler HG, 1999, LEUKEMIA, V13, P634, DOI 10.1038/sj.leu.2401371; Drexler HG, 1998, LEUKEMIA, V12, P1507, DOI 10.1038/sj.leu.2401160; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; ENSOLI B, 1992, IMMUNOL REV, V127, P147, DOI 10.1111/j.1600-065X.1992.tb01412.x; Ensoli B, 1998, CYTOKINE GROWTH F R, V9, P63, DOI 10.1016/S1359-6101(97)00037-3; ENSOLI B, 1989, SCIENCE, V243, P223, DOI 10.1126/science.2643161; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Komanduri KV, 1996, J ACQ IMMUN DEF SYND, V13, P215, DOI 10.1097/00042560-199611010-00003; Meng WY, 2002, J BIOL CHEM, V277, P37401, DOI 10.1074/jbc.C200418200; MILES SA, 1990, P NATL ACAD SCI USA, V87, P4068, DOI 10.1073/pnas.87.11.4068; Nishimoto N, 2000, BLOOD, V95, P56, DOI 10.1182/blood.V95.1.56; Sadler R, 1999, J VIROL, V73, P5722, DOI 10.1128/JVI.73.7.5722-5730.1999; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Underwood KW, 2003, STRUCTURE, V11, P627, DOI 10.1016/S0969-2126(03)00092-3; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969	22	169	186	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					739	741		10.1126/science.1105779	http://dx.doi.org/10.1126/science.1105779			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692053				2022-12-01	WOS:000226814900047
J	Reid, PC; Mukri, F				Reid, PC; Mukri, F			Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIAL; OUTCOMES; AUDIT		Luton & Dunstable Hosp NHS Trust, Directorate Obstet & Gynaecol, Luton LU4 0DZ, Beds, England		Reid, PC (corresponding author), Luton & Dunstable Hosp NHS Trust, Directorate Obstet & Gynaecol, Luton LU4 0DZ, Beds, England.	Peter.Reid@ldh-tr.anglox.nhs.uk						COULTER A, 1991, BRIT J OBSTET GYNAEC, V98, P789, DOI 10.1111/j.1471-0528.1991.tb13484.x; Fender GRK, 2001, BRIT MED J, V322, P523, DOI 10.1136/bmj.322.7285.523; Grant A, 1999, BRIT J OBSTET GYNAEC, V106, P360; Hurskainen R, 2004, JAMA-J AM MED ASSOC, V291, P1456, DOI 10.1001/jama.291.12.1456; Kennedy A D M, 2003, Health Technol Assess, V7, P1	5	67	68	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					938	939		10.1136/bmj.38376.505382.AE	http://dx.doi.org/10.1136/bmj.38376.505382.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15695496	Green Published, Bronze			2022-12-01	WOS:000228715900020
J	Sakatani, T; Kaneda, A; Iacobuzio-Donahue, CA; Carter, MG; Witzel, SD; Okano, H; Ko, MSH; Ohlsson, R; Longo, DL; Feinberg, AP				Sakatani, T; Kaneda, A; Iacobuzio-Donahue, CA; Carter, MG; Witzel, SD; Okano, H; Ko, MSH; Ohlsson, R; Longo, DL; Feinberg, AP			Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice	SCIENCE			English	Article							COLORECTAL-CANCER; CELL-DIFFERENTIATION; STEM-CELL; GROWTH; GENE; MARKER; MOUSE; EXPRESSION; NEOPLASIA; DELETION	Loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) is an epigenetic alteration that results in a modest increase in IGF2 expression, and it is present in the normal colonic mucosa of about 30% of patients with colorectal cancer. To investigate its role in intestinal tumorigenesis, we created a mouse model of lgf2 LOI by crossing female H19(+/-) mice with mate Apc(+/min) mice. Mice with LOI developed twice as many intestinal tumors as did control littermates. Notably, these mice also showed a shift toward a less differentiated normal intestinal epithelium, reflected by an increase in crypt length and increased staining with progenitor,cell markers. A similar shift in differentiation was seen in the normal colonic mucosa of humans with LOI. Thus, altered maturation of nonneoplastic tissue may be one mechanism. by which epigenetic changes affect cancer risk.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Uppsala Univ, Dept Genet & Dev, S-75236 Uppsala, Sweden	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Keio University; Uppsala University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Longo, Dan L./F-6022-2011; Okano, Hideyuki/I-7584-2019; Ko, Minoru S. H./B-7969-2009; Carter, Mark/B-5089-2010; Feinberg, Andrew/AAY-7666-2020	Ko, Minoru S. H./0000-0002-3530-3015; Kaneda, Atsushi/0000-0002-6980-5515; Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [K08CA106610, R01CA065145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000662, Z01AG000656] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA65145, K08CA106610] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; CHRISTOFORI G, 1995, NAT GENET, V10, P196, DOI 10.1038/ng0695-196; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hassan AB, 2000, CANCER RES, V60, P1070; Howe LR, 2003, CANCER RES, V63, P1906; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; LIPKIN M, 1976, CANCER RES, V36, P2665; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; SEGAL GH, 1997, HISTOLOGY PATHOLOGIS, P495; SELL S, 1994, LAB INVEST, V70, P6; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Thiery JP, 2004, NAT MED, V10, P777, DOI 10.1038/nm0804-777; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; WEST AB, 1988, GASTROENTEROLOGY, V94, P343, DOI 10.1016/0016-5085(88)90421-0; Woodson K, 2004, JNCI-J NATL CANCER I, V96, P407, DOI 10.1093/jnci/djh042; Yang WC, 2003, CANCER RES, V63, P4990	28	252	268	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1976	1978		10.1126/science.1108080	http://dx.doi.org/10.1126/science.1108080			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15731405				2022-12-01	WOS:000227957300061
J	De Smet, PAGM				De Smet, PAGM			Herbal medicine in Europe - Relaxing regulatory standards	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Sci Inst Dutch Pharmacists, The Hague, Netherlands; Univ Med Ctr St Radboud, Dept Clin Pharm, Nijmegen, Netherlands	Radboud University Nijmegen	De Smet, PAGM (corresponding author), Sci Inst Dutch Pharmacists, The Hague, Netherlands.		Smet, P.A.G.M./L-4654-2015						0	74	74	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2005	352	12					1176	1178		10.1056/NEJMp048083	http://dx.doi.org/10.1056/NEJMp048083			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909AW	15788494				2022-12-01	WOS:000227832300003
J	Gendrin, A; Mangold, N; Bibring, JP; Langevin, Y; Gondet, B; Poulet, F; Bonello, G; Quantin, C; Mustard, J; Arvidson, R; LeMouelic, S				Gendrin, A; Mangold, N; Bibring, JP; Langevin, Y; Gondet, B; Poulet, F; Bonello, G; Quantin, C; Mustard, J; Arvidson, R; LeMouelic, S			Suffates in martian layered terrains: the OMEGA/Mars Express view	SCIENCE			English	Article							EARLY MARS; VALLES-MARINERIS; MERIDIANI; EVOLUTION; SULFATE; HISTORY; SOIL	The OMEGA/Mars Express hyperspectral imager identified hydrated sulfates on light-toned layered terrains on Mars. Outcrops in Valles Marineris, Margaritifer Sinus, and Terra Meridiani show evidence for kieserite, gypsum, and polyhydrated sulfates. This identification has its basis in vibrational absorptions between 1.3 and 2.5 micrometers. These minerals constitute direct records of the past aqueous activity on Mars.	Inst Astrophys Spatiale, F-91405 Orsay, France; Interact & Dynam Environm Surface, F-91405 Orsay, France; Lab Sci Terre, F-69100 Villeurbanne, France; Brown Univ, Providence, RI 02912 USA; Washington Univ, St Louis, MO 63130 USA; Univ Nantes, F-44322 Nantes, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Brown University; Washington University (WUSTL); Nantes Universite	Gendrin, A (corresponding author), Inst Astrophys Spatiale, Batiment 121, F-91405 Orsay, France.	Aline_Gendrin@brown.edu	Quantin, Cathy/H-1516-2014	Le Mouelic, Stephane/0000-0001-5260-1367				Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; ARVIDSON RE, 2003, J GEOPHYS RES, V108; Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; BISHOP J, IN PRESS AM MINER; Bullock MA, 2004, ICARUS, V170, P404, DOI 10.1016/j.icarus.2004.03.016; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Chapman MG, 2002, ICARUS, V155, P324, DOI 10.1006/icar.2001.6735; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; Crowley J.K., 2003, GEOCHEM-EXPLOR ENV A, V3, P219, DOI DOI 10.1144/1467-7873/03-001; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; GREEN, 1993, IEEE T GEOSC REM SEN, V26, P65; Hunten D. M., 1971, Comments on Astrophysics and Space Physics, V3, P1; Huston DL, 2004, EARTH PLANET SC LETT, V220, P41, DOI 10.1016/S0012-821X(04)00034-2; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Lane MD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021231; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; LUCCHITTA BK, 1994, J GEOPHYS RES-PLANET, V99, P3783, DOI 10.1029/93JE03095; LUCCHITTA BK, 1982, 85127 NASA, P233; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; MCCAULEY JF, 1972, ICARUS, V17, P289, DOI 10.1016/0019-1035(72)90003-6; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; NEDELL SS, 1987, ICARUS, V70, P409, DOI 10.1016/0019-1035(87)90086-8; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Vaniman DT, 2004, NATURE, V431, P663, DOI 10.1038/nature02973; WARREN J, 1999, EVAPORITES THEIR EVO	27	763	776	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1587	1591		10.1126/science.1109087	http://dx.doi.org/10.1126/science.1109087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718429				2022-12-01	WOS:000227622400037
J	Zhao, RM; Davey, M; Hsu, YC; Kaplanek, P; Tong, A; Parsons, AB; Krogan, N; Cagney, G; Mai, D; Greenblatt, J; Boone, C; Emili, A; Houry, WA				Zhao, RM; Davey, M; Hsu, YC; Kaplanek, P; Tong, A; Parsons, AB; Krogan, N; Cagney, G; Mai, D; Greenblatt, J; Boone, C; Emili, A; Houry, WA			Navigating the chaperone network: An integrative map of physical and genetic interactions mediated by the Hsp90 chaperone	CELL			English	Article							ATPASE ACTIVITY; CRYSTAL-STRUCTURE; MOLECULAR CLAMP; GLOBAL ANALYSIS; PROTEIN; YEAST; COMPLEX; ACTIVATION; DOMAIN; CO	Physical, genetic, and chemical-genetic interactions centered on the conserved chaperone Hsp90 were mapped at high resolution in yeast using systematic proteomic and genomic methods. Physical interactions were identified using genome-wide two hybrid screens combined with large-scale affinity purification of Hsp90-containing protein complexes. Genetic interactions were uncovered using synthetic genetic array technology and by a microarray-based chemical-genetic screen of a set of about 4700 viable yeast gene deletion mutants for hypersensitivity to the Hsp90 inhibitor geldanamycin. An extended network, consisting of 198 putative physical interactions and 451 putative genetic and chemical-genetic interactions, was found to connect Hsp90 to cofactors; and substrates involved in a wide range of cellular functions. Two novel Hsp90 cofactors, Tah1 (YCR060W) and Pih1 (YHR034C), were also identified. These cofactors interact physically and functionally with the conserved AAA(+)-type DNA helicases Rvb1/Rvb2, which are key components of several chromatin remodeling factors, thereby linking Hsp90 to epigenetic gene regulation.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Emili, A (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5S 1A8, Canada.	andrew.emili@utoronto.ca; walid.houry@utoronto.ca	Cagney, Gerard/A-4648-2009	Cagney, Gerard/0000-0001-7189-9496; Davey, Michael/0000-0002-1172-5934; Zhao, Rongmin/0000-0003-1300-5882				BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; CSERMELY P, 1994, BIOCHEM BIOPH RES CO, V202, P1657, DOI 10.1006/bbrc.1994.2124; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; GUARENTE L, 1992, TRENDS GENET, V8, P27, DOI 10.1016/0168-9525(92)90021-U; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lan CG, 2004, J BIOL CHEM, V279, P27607, DOI 10.1074/jbc.M402777200; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1998, MOL BIOL CELL, V9, P3071, DOI 10.1091/mbc.9.11.3071; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	56	615	640	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					715	727		10.1016/j.cell.2004.12.024	http://dx.doi.org/10.1016/j.cell.2004.12.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766533	Bronze			2022-12-01	WOS:000227771400016
J	Mueller, KL; Hoon, MA; Erlenbach, I; Chandrashekar, J; Zuker, CS; Ryba, NJP				Mueller, KL; Hoon, MA; Erlenbach, I; Chandrashekar, J; Zuker, CS; Ryba, NJP			The receptors and coding logic for bitter taste	NATURE			English	Article							MAMMALIAN SWEET; MICE; SACCHARIN; RESPONSES; PATHWAYS; STIMULI; FAMILY; MOUSE; CELLS	The sense of taste provides animals with valuable information about the nature and quality of food. Bitter taste detection functions as an important sensory input to warn against the ingestion of toxic and noxious substances. T2Rs are a family of approximately 30 highly divergent G-protein-coupled receptors (GPCRs)(1,2) that are selectively expressed in the tongue and palate epithelium(1) and are implicated in bitter taste sensing(1-8). Here we demonstrate, using a combination of genetic, behavioural and physiological studies, that T2R receptors are necessary and sufficient for the detection and perception of bitter compounds, and show that differences in T2Rs between species ( human and mouse) can determine the selectivity of bitter taste responses. In addition, we show that mice engineered to express a bitter taste receptor in 'sweet cells'(9) become strongly attracted to its cognate bitter tastants, whereas expression of the same receptor ( or even a novel GPCR) in T2R-expressing cells resulted in mice that are averse to the respective compounds. Together these results illustrate the fundamental principle of bitter taste coding at the periphery: dedicated cells act as broadly tuned bitter sensors that are wired to mediate behavioural aversion.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu; nick.ryba@nih.gov		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; FARBMAN AI, 1965, DEV BIOL, V11, P110, DOI 10.1016/0012-1606(65)90040-0; Franchini LF, 2003, NEUROSCIENCE, V121, P875, DOI 10.1016/S0306-4522(03)00485-8; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; Nakashima K, 1999, CELL PHYSIOL BIOCHEM, V9, P90, DOI 10.1159/000016305; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	21	354	384	3	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					225	229		10.1038/nature03352	http://dx.doi.org/10.1038/nature03352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759003				2022-12-01	WOS:000227494500048
J	Jones, RH; Flynn, KJ				Jones, RH; Flynn, KJ			Nutritional status and diet composition affect the value of diatoms as copepod prey	SCIENCE			English	Article							MARINE PLANKTONIC COPEPOD; EGG-PRODUCTION; ACARTIA-TONSA; FOOD QUALITY; REPRODUCTIVE SUCCESS; CALANUS-FINMARCHICUS; HATCHING SUCCESS; GROWTH; PHYTOPLANKTON; RECRUITMENT	The role of diatoms as key food for copepods at the base of pelagic food chains has been questioned recently on the grounds of toxicity. We show, using unialgal versus mixed algal diets of different nutritional status (i.e., nitrogen:carbon ratio) fed to Acartia tonsa, that diatoms per se are not toxic but that single-diatom diets are inadequate. Additionally, the nutritional state of the phytoplankton has a profound effect on copepod growth and growth efficiency. The ecological significance of laboratory demonstrations of diatom toxicity needs to be reconsidered.	Univ Coll Swansea, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales	Swansea University	Flynn, KJ (corresponding author), Univ Coll Swansea, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales.	k.j.flynn@swansea.ac.uk	Flynn, Kevin/AAA-3253-2021; Jones, Ruth/R-5773-2016	Flynn, Kevin/0000-0001-6913-5884; Jones, Ruth/0000-0001-5811-8827				Alonzo F, 2001, MAR ECOL PROG SER, V209, P231, DOI 10.3354/meps209231; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Ban SH, 1997, MAR ECOL PROG SER, V157, P287, DOI 10.3354/meps157287; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Carotenuto Y, 2002, J EXP MAR BIOL ECOL, V276, P49, DOI 10.1016/S0022-0981(02)00237-X; CHECKLEY DM, 1980, LIMNOL OCEANOGR, V25, P430, DOI 10.4319/lo.1980.25.3.0430; Colin SP, 2002, LIMNOL OCEANOGR, V47, P1430, DOI 10.4319/lo.2002.47.5.1430; Ianora A, 1996, MAR BIOL, V125, P279, DOI 10.1007/BF00346308; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; Irigoien X, 2000, LIMNOL OCEANOGR, V45, P44, DOI 10.4319/lo.2000.45.1.0044; JONASDOTTIR SH, 1994, MAR BIOL, V121, P67, DOI 10.1007/BF00349475; Jonasdottir SH, 1996, MAR BIOL, V125, P743, DOI 10.1007/BF00349257; Jonasdottir SH, 1998, MAR ECOL PROG SER, V172, P305, DOI 10.3354/meps172305; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; KIORBOE T, 1989, MAR ECOL PROG SER, V55, P229, DOI 10.3354/meps055229; Kuijper LDJ, 2004, J PLANKTON RES, V26, P213, DOI 10.1093/plankt/fbh020; Marshall S. M., 1955, BIOL MARINE COPEPOD; Meyer-Harms B, 1999, LIMNOL OCEANOGR, V44, P154, DOI 10.4319/lo.1999.44.1.0154; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; POULET SA, 1994, MAR ECOL PROG SER, V111, P79, DOI 10.3354/meps111079; REEVE MR, 1977, J EXP MAR BIOL ECOL, V29, P211, DOI 10.1016/0022-0981(77)90066-1; Roman MR, 1997, LIMNOL OCEANOGR, V42, P623, DOI 10.4319/lo.1997.42.4.0623; Shin K, 2003, PROG OCEANOGR, V57, P265, DOI 10.1016/S0079-6611(03)00101-0; Starr M, 1999, SARSIA, V84, P379, DOI 10.1080/00364827.1999.10807345	26	161	163	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1457	1459		10.1126/science.1107767	http://dx.doi.org/10.1126/science.1107767			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746424				2022-12-01	WOS:000227503100043
J	Stokin, GB; Lillo, C; Falzone, TL; Brusch, RG; Rockenstein, E; Mount, SL; Raman, R; Davies, P; Masliah, E; Williams, DS; Goldstein, LSB				Stokin, GB; Lillo, C; Falzone, TL; Brusch, RG; Rockenstein, E; Mount, SL; Raman, R; Davies, P; Masliah, E; Williams, DS; Goldstein, LSB			Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease	SCIENCE			English	Article							AMYLOID-PRECURSOR-PROTEIN; AXONAL-TRANSPORT; TRANSGENIC MICE; PLAQUE-FORMATION; NERVE-TERMINALS; BASAL FOREBRAIN; BETA-SECRETASE; PRESENILIN-1; BRAIN; ACCUMULATION	We identified axonal defects in mouse models of Alzheimer's disease that preceded known disease-related pathology by more than a year; we observed similar axonal defects in the early stages of Alzheimer's disease in humans. Axonal defects consisted of swellings that accumulated abnormal amounts of microtubule-associated and molecular motor proteins, organelles, and vesicles. Impairing axonal transport by reducing the dosage of a kinesin molecular motor protein enhanced the frequency of axonal defects and increased amyloid-beta peptide levels and amyloid deposition. Reductions in microtubule-dependent transport may stimulate proteolytic processing of beta-amyloid precursor protein, resulting in the development of senile plaques and Alzheimer's disease.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu	Lillo, Concepcion/A-6321-2009; Stokin, Gorazd Bernard/D-9480-2015; Falzone, Tomás/W-2528-2019	Lillo, Concepcion/0000-0001-5814-9826; Stokin, Gorazd Bernard/0000-0001-8430-8755; Falzone, Tomas/0000-0002-7984-1149	NATIONAL EYE INSTITUTE [P30EY012598, R01EY007042, R01EY013408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER; NEI NIH HHS [EY13408, R01 EY013408-02, R01 EY013408, R01 EY007042-19, R01 EY007042, EY12598] Funding Source: Medline; NIA NIH HHS [P50 AG05131] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; DAVIES P, 1976, LANCET, V2, P1403; Dhaenens CM, 2004, NEUROSCI LETT, V368, P290, DOI 10.1016/j.neulet.2004.07.040; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hernandez D, 2001, NEUROREPORT, V12, P1377, DOI 10.1097/00001756-200105250-00018; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KAWARABAYASHI T, 1993, NEUROSCI LETT, V153, P73, DOI 10.1016/0304-3940(93)90080-5; KITT CA, 1984, SCIENCE, V226, P1443, DOI 10.1126/science.6505701; MASLIAH E, 1993, AM J PATHOL, V142, P871; MASLIAH E, 1993, J NEUROPATH EXP NEUR, V52, P619, DOI 10.1097/00005072-199311000-00009; MORIN PJ, 1993, J NEUROCHEM, V61, P464; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Papp H, 2002, NEUROCHEM INT, V41, P429, DOI 10.1016/S0197-0186(02)00014-1; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Redwine JM, 2003, P NATL ACAD SCI USA, V100, P1381, DOI 10.1073/pnas.242746599; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; TERRY RD, 1964, AM J PATHOL, V44, P269; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; UCHIHARA T, 1995, ACTA NEUROPATHOL, V90, P51; WEBSTER HDF, 1962, J CELL BIOL, V12, P361; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; Wong TP, 1999, J NEUROSCI, V19, P2706; YAGISHITA S, 1978, VIRCHOWS ARCH A, V378, P181, DOI 10.1007/BF00427359	36	902	952	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1282	1288		10.1126/science.1105681	http://dx.doi.org/10.1126/science.1105681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731448				2022-12-01	WOS:000227313200051
J	Young, DT; Berthelier, JJ; Blanc, M; Burch, JL; Bolton, S; Coates, AJ; Crary, FJ; Goldstein, R; Grande, M; Hill, TW; Johnson, RE; Baragiola, RA; Kelha, V; McComas, DJ; Mursula, K; Sittler, EC; Svenes, KR; Szego, K; Tanskanen, P; Thomsen, MF; Bakshi, S; Barraclough, BL; Bebesi, Z; Delapp, D; Dunlop, MW; Gosling, JT; Furman, JD; Gilbert, LK; Glenn, D; Holmlund, C; Illiano, JM; Lewis, GR; Linder, DR; Maurice, S; McAndrews, HJ; Narheim, BT; Pallier, E; Reisenfeld, D; Rymer, AM; Smith, HT; Tokar, RL; Vilppola, J; Zinsmeyer, C				Young, DT; Berthelier, JJ; Blanc, M; Burch, JL; Bolton, S; Coates, AJ; Crary, FJ; Goldstein, R; Grande, M; Hill, TW; Johnson, RE; Baragiola, RA; Kelha, V; McComas, DJ; Mursula, K; Sittler, EC; Svenes, KR; Szego, K; Tanskanen, P; Thomsen, MF; Bakshi, S; Barraclough, BL; Bebesi, Z; Delapp, D; Dunlop, MW; Gosling, JT; Furman, JD; Gilbert, LK; Glenn, D; Holmlund, C; Illiano, JM; Lewis, GR; Linder, DR; Maurice, S; McAndrews, HJ; Narheim, BT; Pallier, E; Reisenfeld, D; Rymer, AM; Smith, HT; Tokar, RL; Vilppola, J; Zinsmeyer, C			Composition and dynamics of plasma in Saturn's magnetosphere	SCIENCE			English	Article							WATER ICE; MODEL; INJECTIONS; TRANSPORT	During Cassini's initial orbit, we observed a dynamic magnetosphere composed primarily of a complex mixture of water-derived atomic and molecular ions. We have identified four distinct regions characterized by differences in both bulk plasma properties and ion composition. Protons are the dominant species outside about 9 R-s (where R-s is the radial distance from the center of Saturn), whereas inside, the plasma consists primarily of a corotating comet-like mix of water-derived ions with similar to3% N+. Over the A and B rings, we found an ionosphere in which O-2(+) and O+ are dominant, which suggests the possible existence of a layer of O-2. gas similar to the atmospheres of Europa and Ganymede.	SW Res Inst, San Antonio, TX 78238 USA; Observ St Maur, Ctr Etud Environm Terr & Planetaires, F-94107 St Maur, France; Observ Midi Pyrenees, F-31400 Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; Univ Virginia, Charlottesville, VA USA; Univ Oulu, Dept Phys Sci, Oulu 90014, Finland; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Norwegian Def Res Estab, Div Elect, N-2027 Kjeller, Norway; KFKI Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Los Alamos Natl Lab, Space & Atmospher Sci Grp, Los Alamos, NM 87545 USA; Univ Montana, Dept Phys & Astron, Missoula, MT 59812 USA	Southwest Research Institute; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Rice University; University of Virginia; University of Oulu; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Norwegian Defence Research Establishment; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Montana System; University of Montana	Young, DT (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.	dyoung@swri.edu	dunlop, malcolm w/F-1347-2010; Mursula, Kalevi/L-8952-2014; Reisenfeld, Daniel/F-7614-2015; McComas, David J/H-6202-2011; Bolton, Scott/M-4392-2019; Smith, Howard/H-4662-2016; Grande, Manuel/C-2242-2013; Coates, Andrew/C-2396-2008	dunlop, malcolm w/0000-0002-8195-5137; Mursula, Kalevi/0000-0003-4892-5056; McComas, David J/0000-0001-6160-1158; Smith, Howard/0000-0003-3537-3360; Grande, Manuel/0000-0002-2233-2618; Coates, Andrew/0000-0002-6185-3125; bolton, scott/0000-0002-9115-0789; Holmlund, Christer/0000-0002-6116-6632				[Anonymous], 1984, SATURN; BALSIGER H, 1986, NATURE, V321, P330, DOI 10.1038/321330a0; BRIDGE HS, 1982, SCIENCE, V215, P563, DOI 10.1126/science.215.4532.563; BRIDGE HS, 1981, SCIENCE, V212, P217, DOI 10.1126/science.212.4491.217; CUMMINGS WD, 1967, J GEOPHYS RES, V72, P1007, DOI 10.1029/JZ072i003p01007; Delitsky ML, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001855; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; EVIATAR A, 1984, J GEOPHYS RES-SPACE, V89, P3821, DOI 10.1029/JA089iA06p03821; FRANK LA, 1980, J GEOPHYS RES-SPACE, V85, P5695, DOI 10.1029/JA085iA11p05695; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; HASEGAWA A, 1978, J GEOPHYS RES-SPACE, V83, P1117, DOI 10.1029/JA083iA03p01117; Hill TW, 1974, GEOPHYS RES LETT, V1, DOI 10.1029/GL001i001p00003; IP WH, 1995, ICARUS, V115, P295, DOI 10.1006/icar.1995.1098; Johnson RE, 1997, J GEOPHYS RES-PLANET, V102, P10985, DOI 10.1029/97JE00068; Johnson RE, 2003, ASTROBIOLOGY, V3, P823, DOI 10.1089/153110703322736123; Johnson RE, 2004, CAMB PLANET, P485; JOHNSON RE, 1989, ICARUS, V77, P311, DOI 10.1016/0019-1035(89)90092-4; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Jurac S, 2001, PLANET SPACE SCI, V49, P319, DOI 10.1016/S0032-0633(00)00153-7; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; KNUDSEN DJ, 1992, J GEOPHYS RES-SPACE, V97, P77, DOI 10.1029/91JA02300; LAZARUS AJ, 1983, J GEOPHYS RES-SPACE, V88, P8831, DOI 10.1029/JA088iA11p08831; MAUK BH, 1983, J GEOPHYS RES-SPACE, V88, P11, DOI 10.1029/JA088iA12p10011; Mauk BH, 1997, GEOPHYS RES LETT, V24, P2949, DOI 10.1029/97GL03026; Maurice S, 1996, J GEOPHYS RES-SPACE, V101, P15211, DOI 10.1029/96JA00765; NISHIDA A, 1966, J GEOPHYS RES, V71, P5669, DOI 10.1029/JZ071i023p05669; PONTIUS DH, 1986, GEOPHYS RES LETT, V13, P1097, DOI 10.1029/GL013i011p01097; Richardson JD, 1998, REV GEOPHYS, V36, P501, DOI 10.1029/98RG01691; Richardson JD, 1998, J GEOPHYS RES-PLANET, V103, P20245, DOI 10.1029/98JE01127; RICHARDSON JD, 1995, GEOPHYS RES LETT, V22, P1177, DOI 10.1029/95GL01018; RICHARDSON JD, 1990, J GEOPHYS RES-SPACE, V95, P12019, DOI 10.1029/JA095iA08p12019; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; Shi M, 1995, J GEOPHYS RES-PLANET, V100, P26387, DOI 10.1029/95JE03099; SITTLER EC, 1983, J GEOPHYS RES-SPACE, V88, P8847, DOI 10.1029/JA088iA11p08847; Smith HT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020580; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	36	264	264	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1262	1266		10.1126/science.1106151	http://dx.doi.org/10.1126/science.1106151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731443				2022-12-01	WOS:000227313200045
J	Chen, B; Vogan, EM; Gong, HY; Skehel, JJ; Wiley, DC; Harrison, SC				Chen, B; Vogan, EM; Gong, HY; Skehel, JJ; Wiley, DC; Harrison, SC			Structure of an unliganded simian immunodeficiency virus gp120 core	NATURE			English	Article							ENVELOPE GLYCOPROTEIN; TYPE-1 GP120; NEUTRALIZATION SENSITIVITY; CD4 INDEPENDENCE; HIV-1 ENVELOPE; SOLUBLE CD4; RECEPTOR; PROTEIN; ANTIBODY; GP41	Envelope glycoproteins of human and simian immunodeficiency virus (HIV and SIV) undergo a series of conformational changes when they interact with receptor (CD4) and co-receptor on the surface of a potential host cell, leading ultimately to fusion of viral and cellular membranes. Structures of fragments of gp120 and gp41 from the envelope protein are known, in conformations corresponding to their post-attachment and postfusion states, respectively. We report the crystal structure, at 4 A resolution, of a fully glycosylated SIV gp120 core, in a conformation representing its prefusion state, before interaction with CD4. Parts of the protein have a markedly different organization than they do in the CD4-bound state. Comparison of the unliganded and CD4-bound structures leads to a model for events that accompany receptor engagement of an envelope glycoprotein trimer. The two conformations of gp120 also present distinct antigenic surfaces. We identify the binding site for a compound that inhibits viral entry.	Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Natl Inst Med Res, Ridgeway, London NW7 1AA, England	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Harrison, SC (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu		Vogan, Erik/0000-0002-2939-8070	Medical Research Council [MC_U117512711] Funding Source: Medline; MRC [MC_U117512711] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Center RJ, 2002, J VIROL, V76, P7863, DOI 10.1128/JVI.76.15.7863-7867.2002; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chen B, 2004, J VIROL, V78, P4508, DOI 10.1128/JVI.78.9.4508-4516.2004; CHEN B, IN PRESS STRUCTURE C; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Etemad-Moghadam B, 1998, J VIROL, V72, P8437, DOI 10.1128/JVI.72.10.8437-8445.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999; Guo Q, 2003, J VIROL, V77, P10528, DOI 10.1128/JVI.77.19.10528-10536.2003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Madani N, 2004, J VIROL, V78, P3742, DOI 10.1128/JVI.78.7.3742-3752.2004; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; POLLARD SR, 1991, P NATL ACAD SCI USA, V88, P11320, DOI 10.1073/pnas.88.24.11320; Puffer BA, 2004, VIROLOGY, V327, P16, DOI 10.1016/j.virol.2004.03.016; Puffer BA, 2002, J VIROL, V76, P2595, DOI 10.1128/JVI.76.6.2595-2605.2002; Pugach P, 2004, VIROLOGY, V321, P8, DOI 10.1016/j.virol.2003.12.012; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RUD EW, 1992, VACCINE, V92, P229; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; TURNER S, 1992, P NATL ACAD SCI USA, V89, P1335, DOI 10.1073/pnas.89.4.1335; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zwick MB, 2003, J VIROL, V77, P6965, DOI 10.1128/JVI.77.12.6965-6978.2003	50	439	462	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					834	841		10.1038/nature03327	http://dx.doi.org/10.1038/nature03327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729334				2022-12-01	WOS:000227174600034
J	Basso, O; Olsen, J				Basso, O; Olsen, J			Subfecundity and neonatal mortality: longitudinal study within the Danish national birth cohort	BRITISH MEDICAL JOURNAL			English	Article							PRETERM DELIVERY		Aarhus Univ, Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, DK-8000 Aarhus, Denmark	Aarhus University	Basso, O (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, DK-8000 Aarhus, Denmark.	bassoo2@niehs.nih.gov	Basso, Olga/E-5384-2010	Basso, Olga/0000-0001-9298-4921				Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Henriksen TB, 1997, OBSTET GYNECOL, V89, P594; OLIVENNES F, 1993, HUM REPROD, V8, P1297, DOI 10.1093/oxfordjournals.humrep.a138245; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201	5	40	42	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2005	330	7488					393	394		10.1136/bmj.38336.616806.8F	http://dx.doi.org/10.1136/bmj.38336.616806.8F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900NA	15695499	Bronze, Green Published			2022-12-01	WOS:000227220400018
J	Ruxin, J; Paluzzi, JE; Wilson, PA; Tozan, Y; Kruk, M; Teklehaimanot, A				Ruxin, J; Paluzzi, JE; Wilson, PA; Tozan, Y; Kruk, M; Teklehaimanot, A			Emerging consensus in HIV/AIDS, malaria, tuberculosis, and access to essential medicines	LANCET			English	Article									Columbia Univ, Mailman Sch Publ Hlth, Ctr Global Hlth & Econ Dev, New York, NY 10027 USA; Columbia Univ, Earth Inst, New York, NY 10027 USA; Partners Hlth, Boston, MA USA; UN Millennium Project Secretariat, New York, NY USA	Columbia University; Columbia University; Partners Healthcare System	Ruxin, J (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Global Hlth & Econ Dev, 215 W 125th St, New York, NY 10027 USA.	jnr4@columbia.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432				[Anonymous], 2004, HUM RES HLTH OV CRIS; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Chen XY, 2004, LANCET, V364, P417; *GFATM, GFATM PROGR REP; *GLOB HIV PREV WOR, HIV PREV ER EXP TREA; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; STOP TB, 2004, PARTNERSHIP PROGR RE; *UN MILL PROJ, 2005, COMB AIDS DEV WORLD; *UN MILL PROJ, 2005, COM GRIPS MAL NEW MI; UN Millennium Project, 2005, PRESCR HLTH DEV INCR; UN Millennium Project 2005, 2005, INV STRAT REV GLOB I; *UNAIDS, 2004, 2004 REP GLOB HIV AI; WHO, WORLD MED SIT; *WHO, 2000, TECHN REP SER WHO, V892; *WHO, 2004, 3 WHO; World Health Organization, 2004, Wkly Epidemiol Rec, V79, P6	17	28	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2005	365	9459					618	621						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897DN	15708108				2022-12-01	WOS:000226984300037
J	Dorgan, KM; Jumars, PA; Johnson, B; Boudreau, BP; Landis, E				Dorgan, KM; Jumars, PA; Johnson, B; Boudreau, BP; Landis, E			Burrow extension by crack propagation	NATURE			English	Editorial Material							GROWTH		Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; Univ Maine, Dept Civil & Environm Engn, Orono, ME 04469 USA	University of Maine System; University of Maine Orono; Dalhousie University; University of Maine System; University of Maine Orono	Dorgan, KM (corresponding author), Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA.	kelly.dorgan@umit.maine.edu		Boudreau, Bernard/0000-0002-7748-1151				ABDALLA AM, 1969, J AGR ENG RES, V14, P236, DOI 10.1016/0021-8634(69)90126-7; BOUDREAU BP, IN PRESS GEOLOGY; Broek D., 1978, ELEMENTARY ENG FRACT; ELDER HY, 1980, ASPECTS ANIMAL MOVEM, P71; FULL RJ, 1995, J EXP BIOL, V198, P2441; HAMILTON EL, 1980, J ACOUST SOC AM, V68, P1313, DOI 10.1121/1.385100; HUNTER RD, 1989, J ZOOL, V218, P209, DOI 10.1111/j.1469-7998.1989.tb02533.x; Johnson BD, 2002, MAR GEOL, V187, P347, DOI 10.1016/S0025-3227(02)00383-3; KANAZAWA K, 1992, PALAEONTOLOGY, V35, P733; Menand T, 2001, NATURE, V411, P678, DOI 10.1038/35079552; Meysman FJR, 2003, J MAR RES, V61, P391, DOI 10.1357/002224003322201241	11	120	121	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2005	433	7025					475	475		10.1038/433475a	http://dx.doi.org/10.1038/433475a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690029				2022-12-01	WOS:000226727200032
J	Fraser, L				Fraser, L			Pre-eclampsia: a first hand account	LANCET			English	Editorial Material									Insurance Australia Grp, Sydney, NSW, Australia		Fraser, L (corresponding author), Insurance Australia Grp, Sydney, NSW, Australia.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					800	800						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733722				2022-12-01	WOS:000227285300028
J	Bertaux, JL; Leblanc, F; Perrier, SV; Quemerais, E; Korablev, O; Dimarellis, E; Reberac, A; Forget, F; Simon, PC; Stern, SA; Sandel, B				Bertaux, JL; Leblanc, F; Perrier, SV; Quemerais, E; Korablev, O; Dimarellis, E; Reberac, A; Forget, F; Simon, PC; Stern, SA; Sandel, B		SPICAM Team	Nightglow in the upper atmosphere of Mars and implications for atmospheric transport	SCIENCE			English	Article							MARTIAN ATMOSPHERE; ODD NITROGEN; VENUS; AIRGLOW; MODEL	We detected light emissions in the nightside martian atmosphere with the SPICAM (spectroscopy for the investigation of the characteristics of the atmosphere of Mars) ultraviolet (UV) spectrometer on board the Mars Express. The UV spectrum of this nightglow is composed of hydrogen Lyman a emission (121.6 nanometers) and the gamma and delta bands of nitric oxide (NO) (190 to 270 nanometers) produced when N and O atoms combine to produce the NO molecule. N and O atoms are produced by extreme UV photodissociation of O-2, CO2, and N-2 in the dayside upper atmosphere and transported to the night side. The NO emission is brightest in the winter south polar night because of continuous downward transport of air in this region at night during winter and because of freezing at ground level.	CNRS, Serv Aeron, Inst Pierre Simon Laplace, F-91371 Verrieres Le Buisson, France; Moscow Space Res Inst, Moscow 117810, Russia; Univ Paris 06, Meteorol Dynam Lab, IPSL, F-75252 Paris, France; Inst Aeron Spatiale Belgique, B-1180 Brussels, Belgium; SW Res Inst, Boulder, CO 80302 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Arizona	Bertaux, JL (corresponding author), CNRS, Serv Aeron, Inst Pierre Simon Laplace, BP 3, F-91371 Verrieres Le Buisson, France.	bertaux@aerov.jussieu.fr	Korablev, Oleg I/K-6770-2017; Korablev, Oleg/L-5083-2013	Korablev, Oleg I/0000-0003-1115-0656; Korablev, Oleg/0000-0003-1115-0656				BARTH CA, 1971, J GEOPHYS RES, V76, P2213, DOI 10.1029/JA076i010p02213; BARTH CA, 1967, SCIENCE, V158, P1675, DOI 10.1126/science.158.3809.1675; BARTH CA, 1992, MARS, P1054; Bertaux JL, 2000, PLANET SPACE SCI, V48, P1303, DOI 10.1016/S0032-0633(00)00111-2; BERTAUX JL, 2004, EUROPEAN SPACE AGENC, P95; BERTAUX JL, IN PRESS ADV SPACE R; BOUGHER SW, 1990, J GEOPHYS RES-SPACE, V95, P6271, DOI 10.1029/JA095iA05p06271; Bougher SW, 1997, SPACE SCI S, P259; FELDMAN PD, 1979, NATURE, V279, P221, DOI 10.1038/279221a0; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; Fox J. L., 1992, VENUS MARS ATMOSPHER, V66, P191, DOI [10.1029/GM066p0191, DOI 10.1029/GM066P0191]; GERARD JC, 1981, GEOPHYS RES LETT, V8, P633, DOI 10.1029/GL008i006p00633; GERARD JC, 1988, ICARUS, V75, P171, DOI 10.1016/0019-1035(88)90135-2; HEDIN AE, 1983, J GEOPHYS RES-SPACE, V88, P73, DOI 10.1029/JA088iA01p00073; KEATING GM, 2003, P MARS ATM MOD OBS W; MCCOY RP, 1983, J GEOPHYS RES-SPACE, V88, P3197, DOI 10.1029/JA088iA04p03197; QUEMERAIS X, UNPUB; STEWART A. M., 1961, AUSTRALIAN JOUR EXPTL AGRIC AND ANIMAL HUSBANDRY, V1, P85; STEWART AI, 1979, SCIENCE, V203, P777, DOI 10.1126/science.203.4382.777; STEWART AI, 1979, SCIENCE, V205, P59, DOI 10.1126/science.205.4401.59	20	79	80	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2005	307	5709					566	569		10.1126/science.1106957	http://dx.doi.org/10.1126/science.1106957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893BJ	15681381				2022-12-01	WOS:000226694000043
J	Esnault, C; Heidmann, O; Delebecque, F; Dewannieux, M; Ribet, D; Hance, AJ; Heidmann, T; Schwartz, O				Esnault, C; Heidmann, O; Delebecque, F; Dewannieux, M; Ribet, D; Hance, AJ; Heidmann, T; Schwartz, O			APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses	NATURE			English	Article							EDITING ENZYME APOBEC3G; MAMMALIAN-CELLS; VIF PROTEIN; ANTIRETROVIRAL FACTOR; INDICATOR GENE; HIV-1; DNA; RETROELEMENTS; GENOME; MOBILE	Endogenous retroviruses are multicopy retroelements accounting for nearly 10% of murine or human genomes(1,2). These retroelements spread into our ancestral genome millions of years ago and have acted as a driving force for genome evolution(2-4). Endogenous retroviruses may also be deleterious for their host, and have been implicated in cancers and autoimmune diseases(5). Most retroelements have lost replication competence because of the accumulation of inactivating mutations, but several, including some murine intracisternal A-particle (IAP) and MusD sequences, are still mobile(6,7). These elements encode a reverse transcriptase activity and move by retrotransposition, an intracellular copy-and-paste process involving an RNA intermediate. The host has developed mechanisms to silence their expression, mainly cosuppression and gene methylation(4,8). Here we identify another level of antiviral control, mediated by APOBEC3G, a member of the cytidine deaminase family that was previously shown to block HIV replication(9-12). We show that APOBEC3G markedly inhibits retrotransposition of IAP and MusD elements, and induces G-to-A hypermutations in their DNA copies. APOBEC3G, by editing viral genetic material, provides an ancestral wide cellular defence against endogenous and exogenous invaders.	Inst Gustave Roussy, CNRS, UMR8122, Unite Retrovirus Endogenes & Elements Retroides E, F-94805 Villejuif, France; Inst Pasteur, Dept Virol, CNRS, URA 1930,Virus & Immun Grp, F-75015 Paris, France; Hop Bichat Claude Bernard, INSERM, U552, F-75018 Paris, France	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Heidmann, T (corresponding author), Inst Gustave Roussy, CNRS, UMR8122, Unite Retrovirus Endogenes & Elements Retroides E, Rue Camille Desmoulins, F-94805 Villejuif, France.	heidmann@igr.fr; schwartz@pasteur.fr	Schwartz, Olivier/AAZ-3765-2021; Ribet, David/AAA-6659-2020	Schwartz, Olivier/0000-0002-0729-1475; Ribet, David/0000-0003-1175-6471; Dewannieux, Marie/0000-0003-3918-2414				Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Baust C, 2003, J VIROL, V77, P11448, DOI 10.1128/JVI.77.21.11448-11458.2003; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Boeke J. D., 1997, P343; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; Esnault C, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e49; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lower R, 1999, TRENDS MICROBIOL, V7, P350, DOI 10.1016/S0966-842X(99)01565-6; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Ribet D, 2004, GENOME RES, V14, P2261, DOI 10.1101/gr.2924904; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Turelli P, 2004, J BIOL CHEM, V279, P43371, DOI 10.1074/jbc.C400334200; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	30	260	270	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2005	433	7024					430	433		10.1038/nature03238	http://dx.doi.org/10.1038/nature03238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674295				2022-12-01	WOS:000226546200046
J	Hollinghurst, S; Kessler, D; Peters, TJ; Gunnell, D				Hollinghurst, S; Kessler, D; Peters, TJ; Gunnell, D			Opportunity cost of antidepressant prescribing in England: analysis of routine data	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol; University of Bristol	Hollinghurst, S (corresponding author), Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England.	s.p.hollinghurst@bristol.ac.uk	Gunnell, David/ABE-6653-2020; Kessler, david/ABB-6489-2021	Gunnell, David/0000-0002-0829-6470; Peters, Tim/0000-0003-2881-4180				[Anonymous], 2004, MAN DEPR PRIM SEC CA; Curtis, 2003, UNIT COSTS HLTH SOCI; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; Lawrenson RA, 2000, J AFFECT DISORDERS, V59, P149, DOI 10.1016/S0165-0327(99)00147-0; *OFF NAT STAT, 2001, PSYCH MORT AD LIV PR	5	27	27	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 30	2005	330	7498					999	1000		10.1136/bmj.38377.715799.F7	http://dx.doi.org/10.1136/bmj.38377.715799.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923UP	15778232	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000228935100020
J	Cavanagh, P				Cavanagh, P			The artist as neuroscientist	NATURE			English	Article							PERCEPTION; FACES; RECOGNITION		Harvard Univ, Dept Psychol, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University	Cavanagh, P (corresponding author), Harvard Univ, Dept Psychol, Vis Sci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.							Bovet D, 2000, BEHAV BRAIN RES, V109, P143, DOI 10.1016/S0166-4328(00)00146-7; Bruno VJ, 1977, FORM COLOUR GREEK PA; BUSEY TA, 1990, PERCEPT PSYCHOPHYS, V48, P1, DOI 10.3758/BF03205006; CASATI R, 2004, SHADOW CLUB; Cavanagh P, 2004, 2ND INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P35, DOI 10.1109/TDPVT.2004.1335139; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; Croucher CJ, 2002, J EXP PSYCHOL HUMAN, V28, P546, DOI 10.1037//0096-1523.28.3.546; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; GOMBRICH EH, 1995, SHADOWS; Hills Paul, 1987, LIGHT EARLY ITALIAN; ITAKURA S, 1994, J GEN PSYCHOL, V121, P189, DOI 10.1080/00221309.1994.9921195; KENNEDY JM, 1974, PERCEPTION, V3, P313, DOI 10.1068/p030313; KENNEDY JM, 1975, PERCEPTION, V4, P391, DOI 10.1068/p040391; Koenderink JJ, 2003, LOOKING INTO PICTURES, P239; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; MILLER J, 1998, REFLECTION; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; OSTROVSKY Y, IN PRESS PERCEPTION; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; SAVARESE S., 2004, P 1 S APPL PERC GRAP, P115, DOI DOI 10.1145/1012551.1012571; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WASSERSTEIN J, 1987, BRAIN COGNITION, V6, P1, DOI 10.1016/0278-2626(87)90042-X; YONAS A, 1978, SCIENCE, V200, P77, DOI 10.1126/science.635576; YONAS A, 1994, PERCEPTION, V23, P1427, DOI 10.1068/p231427	24	145	147	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					301	307		10.1038/434301a	http://dx.doi.org/10.1038/434301a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772645				2022-12-01	WOS:000227715100034
J	Langevin, Y; Poulet, F; Bibring, JP; Gondet, B				Langevin, Y; Poulet, F; Bibring, JP; Gondet, B			Sulfates in the north polar region of Mars detected by OMEGA/Mars express	SCIENCE			English	Article							EVOLUTION; DEPOSITS	The Observatoire pour la Mineralogie, l'Eau, les Glaces, et l'Activite (OMEGA) imaging spectrometer observed the northern circumpolar regions of Mars at a resolution of a few kilometers. An extended region at 240degreesE, 85degreesN, with an area of 60 kilometers by 200 kilometers, exhibits absorptions at wavelengths of 1.45, 1.75, 1.94, 2.22, 2.26, and 2.48 micrometers. These signatures can be unambiguously attributed to calcium-rich sulfates, most likely gypsum. This region corresponds to the dark longitudinal dunes of Olympia Planitia. These observations reveal that Water alteration played a major role in the formation of the constituting minerals of northern circumpolar terrains.	Inst Astrophys Spatiale, F-91405 Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Langevin, Y (corresponding author), Inst Astrophys Spatiale, Batiment 121, F-91405 Orsay, France.	yves.langevin@ias.u-psud.fr						Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; BISHOP JL, IN PRESS INT J ASTRO; BURNS RG, 1990, J GEOPHYS RES-SOLID, V95, P14415, DOI 10.1029/JB095iB09p14415; Byrne S, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001615; Clifford SM, 2000, ICARUS, V144, P210, DOI 10.1006/icar.1999.6290; CLIFFORD SM, 1999, LUNAR PLANET SCI, V30, P1619; Fishbaugh KE, 2000, J GEOPHYS RES-PLANET, V105, P22455, DOI 10.1029/1999JE001230; FISHBAUGH KE, 2004, LUN PLAN SCI C, V25, P1156; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Herkenhoff KE, 1999, J GEOPHYS RES-PLANET, V104, P16487, DOI 10.1029/1998JE000589; IVANOV S, 2003, 6 INT C MARS PAS CA; Langevin Y, 2005, SCIENCE, V307, P1581, DOI 10.1126/science.1109438; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PATHARE AV, 1998, 1 INT C MARS POL SCI; Wyatt M. B., 2003, 3 INT C MARS POL SCI	19	385	396	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1584	1586		10.1126/science.1109091	http://dx.doi.org/10.1126/science.1109091			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718428				2022-12-01	WOS:000227622400036
J	Krogsgaard, M; Li, QJ; Sumen, C; Huppa, JB; Huse, M; Davis, MM				Krogsgaard, M; Li, QJ; Sumen, C; Huppa, JB; Huse, M; Davis, MM			Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity	NATURE			English	Article							IMMUNOLOGICAL SYNAPSE FORMATION; HLA-DR MOLECULES; CLASS-II; LIGAND RECOGNITION; FOREIGN ANTIGEN; BINDING-SITE; CD8; PROLIFERATION; EXPRESSION; CONTRIBUTE	alphabeta T lymphocytes are able to detect even a single peptide - major histocompatibility complex (MHC) on the surface of an antigen-presenting cell(1,2). This is despite clear evidence, at least with CD4(+) T cells, that monomeric ligands are not stimulatory(3,4). In an effort to understand how this remarkable sensitivity is achieved, we constructed soluble peptide - MHC heterodimers in which one peptide is an agonist and the other is one of the large number of endogenous peptide - MHCs displayed by presenting cells. We found that some specific combinations of these heterodimers can stimulate specific T cells in a CD4-dependent manner. This activation is severely impaired if the CD4-binding site on the agonist ligand is ablated, but the same mutation on an endogenous ligand has no effect. These data correlate well with analyses of lipid bilayers and cells presenting these ligands, and indicate that the basic unit of helper T cell activation is a heterodimer of agonist peptide - and endogenous peptide MHC complexes, stabilized by CD4.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Huppa, Johannes/0000-0003-2634-8198; Davis, Mark/0000-0001-6868-657X				Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Ge Q, 2002, P NATL ACAD SCI USA, V99, P13729, DOI 10.1073/pnas.212515299; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lee SJE, 2002, TRENDS IMMUNOL, V23, P492, DOI 10.1016/S1471-4906(02)02285-8; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Schild H, 1995, INT IMMUNOL, V7, P1957, DOI 10.1093/intimm/7.12.1957; Sporri R, 2002, EUR J IMMUNOL, V32, P3161, DOI 10.1002/1521-4141(200211)32:11<3161::AID-IMMU3161>3.0.CO;2-6; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741	30	266	271	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					238	243		10.1038/nature03391	http://dx.doi.org/10.1038/nature03391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15724150				2022-12-01	WOS:000227494500051
J	Kumarevel, T; Mizuno, H; Kumar, PKR				Kumarevel, T; Mizuno, H; Kumar, PKR			Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand	NATURE			English	Article							RNA-BINDING PROTEIN; X-RAY-DIFFRACTION; BACILLUS-SUBTILIS; TRANSCRIPTIONAL ANTITERMINATION; GENOME SEQUENCE; MESSENGER-RNA; ATTENUATION PROTEIN; CRYSTAL-STRUCTURE; IN-VITRO; OPERON	HutP regulates the expression of the hut structural genes of Bacillus subtilis by an anti-termination mechanism and requires two components, Mg2+ ions and L-histidine. HutP recognizes three UAG triplet units, separated by four non-conserved nucleotides on the terminator region. Here we report the 1.60-Angstrom resolution crystal structure of the quaternary complex ( HutP - L- histidine - Mg2+ 21-base single-stranded RNA). In the complex, the RNA adopts a novel triangular fold on the hexameric surface of HutP, without any base-pairing, and binds to the protein mostly by specific protein - base interactions. The structure explains how the HutP and RNA interactions are regulated critically by the L- histidine and Mg2+ ion through the structural rearrangement. To gain insights into these structural rearrangements, we solved two additional crystal structures ( uncomplexed HutP and HutP - L- histidine - Mg2+) that revealed the intermediate structures of HutP ( before forming an active structure) and the importance of the Mg2+ ion interactions in the complexes.	Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Funct Nucl Acids Grp, Tsukuba, Ibaraki 3058566, Japan; Natl Inst Agrobiol Sci, Dept Biochem, Tsukuba, Ibaraki 3058602, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Agrobiological Sciences - Japan	Kumar, PKR (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Funct Nucl Acids Grp, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	pkr-kumar@aist.go.jp	Penmetcha, Kumar/K-8834-2017; Kumarevel, Thirumananseri/C-6275-2012	Penmetcha, Kumar/0000-0002-3512-704X; Kumarevel, Thirumananseri/0000-0001-9326-6585				Alpert CA, 1997, J BACTERIOL, V179, P1555, DOI 10.1128/jb.179.5.1555-1562.1997; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Arnaud M, 1996, J BIOL CHEM, V271, P18966, DOI 10.1074/jbc.271.31.18966; AYMERICH S, 1992, P NATL ACAD SCI USA, V89, P10410, DOI 10.1073/pnas.89.21.10410; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Glatz E, 1996, MOL MICROBIOL, V19, P319, DOI 10.1046/j.1365-2958.1996.376903.x; Gollnick P, 2002, BBA-GENE STRUCT EXPR, V1577, P240, DOI 10.1016/S0167-4781(02)00455-4; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HOUMAN F, 1990, CELL, V62, P1153, DOI 10.1016/0092-8674(90)90392-R; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kimmhi Y., 1970, J BIOL CHEM, V245, P3545; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumarevel T, 2004, STRUCTURE, V12, P1269, DOI 10.1016/j.str.2004.05.005; Kumarevel TS, 2004, NUCLEIC ACIDS RES, V32, P3904, DOI 10.1093/nar/gkh725; Kumarevel TS, 2002, J STRUCT BIOL, V138, P237, DOI 10.1016/S1047-8477(02)00024-2; KUMAREVEL TS, 2003, NUCL ACIDS RES S, V3, P199; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lu Y, 1996, P NATL ACAD SCI USA, V93, P14462, DOI 10.1073/pnas.93.25.14462; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODA M, 1988, J BACTERIOL, V170, P3199, DOI 10.1128/jb.170.7.3199-3205.1988; Oda M, 2000, MOL MICROBIOL, V35, P1244, DOI 10.1046/j.1365-2958.2000.01795.x; Oldfield TJ, 2001, ACTA CRYSTALLOGR D, V57, P82, DOI 10.1107/S0907444900014098; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Stulke J, 2002, ARCH MICROBIOL, V177, P433, DOI 10.1007/s00203-002-0407-5; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WRAY LV, 1994, J BACTERIOL, V176, P5466, DOI 10.1128/JB.176.17.5466-5473.1994; Yang YS, 2002, EMBO J, V21, P1987, DOI 10.1093/emboj/21.8.1987; Yanofsky C, 2001, ANNU REV BIOCHEM, V70, P1, DOI 10.1146/annurev.biochem.70.1.1	39	38	39	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					183	191		10.1038/nature03355	http://dx.doi.org/10.1038/nature03355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758992				2022-12-01	WOS:000227494500037
J	Neijssen, J; Herberts, C; Drijfhout, JW; Reits, E; Janssen, L; Neefjes, J				Neijssen, J; Herberts, C; Drijfhout, JW; Reits, E; Janssen, L; Neefjes, J			Cross-presentation by intercellular peptide transfer through gap junctions	NATURE			English	Article							MHC CLASS-I; CD8(+) T-CELLS; ANTIGEN PRESENTATION; COMMUNICATION; PROTEIN; DEGRADATION; GROWTH; VITRO	Major histocompatibility complex (MHC) class I molecules present peptides that are derived from endogenous proteins1. These antigens can also be transferred to professional antigen-presenting cells in a process called cross-presentation, which precedes initiation of a proper T-cell response(2,3); but exactly how they do this is unclear. We tested whether peptides can be transferred directly from the cytoplasm of one cell into the cytoplasm of its neighbour through gap junctions. Here we show that peptides with a relative molecular mass of up to,1,800 diffuse intercellularly through gap junctions unless a three-dimensional structure is imposed. This intercellular peptide transfer causes cytotoxic T-cell recognition of adjacent, innocent bystander cells as well as activated monocytes. Gap-junction-mediated peptide transfer is restricted to a few coupling cells owing to the high cytosolic peptidase activity. We present a mechanism of antigen acquisition for cross-presentation that couples the antigen presentation system of two adjacent cells and is lost in most tumours: gap-junction-mediated intercellular peptide coupling for presentation by bystander MHC class I molecules and transfer to professional antigen presenting cells for cross-priming.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Univ Med Ctr, Dept Immunohematol & Blood Transfus Leiden, NL-2333 RC Leiden, Netherlands	Netherlands Cancer Institute	Neijssen, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	J.Neefjes@nki.nl	Drijfhout, Jan Wouter/ABA-6318-2021; Neefjes, Jacques J.C./H-8780-2017	Drijfhout, Jan Wouter/0000-0003-4808-5296; Neefjes, Jacques J.C./0000-0001-6763-2211; Neijssen, Joost/0000-0001-6697-4324; Janssen, Lennert/0000-0001-9705-0204				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; ESINDUY CB, 1995, CARCINOGENESIS, V16, P915, DOI 10.1093/carcin/16.4.915; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Fischer NO, 2001, J VIROL METHODS, V91, P157, DOI 10.1016/S0166-0934(00)00260-3; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; GOLDBERG GS, 1993, BIOCHEM J, V295, P735, DOI 10.1042/bj2950735; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Harks EGA, 2003, FASEB J, V17, P941, DOI 10.1096/fj.02-0786fje; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Kurts C, 1998, CIBA F SYMP, V215, P172; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; Mesnil M, 2000, CANCER RES, V60, P3989; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; OELZE L, 1995, J VIROL, V69, P4489; Oviedo-Orta E, 2004, BBA-BIOMEMBRANES, V1662, P102, DOI 10.1016/j.bbamem.2003.10.021; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Savinov AY, 2003, J EXP MED, V197, P643, DOI 10.1084/jem.20021378; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Serna A, 2003, J IMMUNOL, V171, P5668, DOI 10.4049/jimmunol.171.11.5668; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Verra NCV, 2004, CANCER RES, V64, P2153, DOI 10.1158/0008-5472.CAN-03-1339; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	30	327	340	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					83	88		10.1038/nature03290	http://dx.doi.org/10.1038/nature03290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744304				2022-12-01	WOS:000227334600048
J	Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thornas, P; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R				Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thornas, P; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R			Cassini Imaging Science: Initial results on Saturn's atmosphere	SCIENCE			English	Article							ZONAL WINDS; ELECTROSTATIC DISCHARGES; JUPITERS ATMOSPHERE; CLOUD LEVEL; MORPHOLOGY; MOTIONS	The Cassini Imaging Science Subsystem (ISS) began observing Saturn in early February 2004. From analysis of cloud motions through early October 2004, we report vertical wind shear in Saturn's equatorial jet and a maximum wind speed of similar to375 meters per second, a value that differs from both Hubble Space Telescope and Voyager values. We also report a particularly active narrow southern mid-latitude region in which dark ovals are observed both to merge with each other and to arise from the eruptions of large, bright storms. Bright storm eruptions are correlated with Saturn's electrostatic discharges, which are thought to originate from lightning.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris 07, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; SW Res Inst, Dept Space Sci, Boulder, CO 80302 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Cornell University; University of Arizona; Free University of Berlin; California Institute of Technology; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carolyn@ciclops.org	Turtle, Elizabeth/K-8673-2012; Tiscareno, Matthew/D-6963-2011; Del Genio, Anthony/D-4663-2012; Evans, Michael W/AAG-4117-2020	Turtle, Elizabeth/0000-0003-1423-5751; Del Genio, Anthony/0000-0001-7450-1359; Barbara, John/0000-0002-2190-4290				BARNET CD, 1992, ICARUS, V100, P499, DOI 10.1016/0019-1035(92)90113-L; BEZARD B, 1984, ICARUS, V60, P274, DOI 10.1016/0019-1035(84)90189-1; BURNS JA, 1983, ICARUS, V54, P280, DOI 10.1016/0019-1035(83)90198-7; Desch M. D., 1984, SATURN, P378; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Galopeau PHM, 2000, J GEOPHYS RES-SPACE, V105, P13089, DOI 10.1029/1999JA005089; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Ingersoll AP, 2000, NATURE, V403, P630, DOI 10.1038/35001021; INGERSOLL AP, 1984, SATURN, P195; KAISER ML, 1983, NATURE, V303, P50, DOI 10.1038/303050a0; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; Sanchez-Lavega A, 2000, ICARUS, V147, P405, DOI 10.1006/icar.2000.6449; Sanchez-Lavega A, 2004, ICARUS, V170, P519, DOI 10.1016/j.icarus.2004.05.002; Sanchez-Lavega A, 2003, NATURE, V423, P623, DOI 10.1038/nature01653; SanchezLavega A, 1996, SCIENCE, V271, P631, DOI 10.1126/science.271.5249.631; SANCHEZLAVEGA A, 1991, NATURE, V353, P397, DOI 10.1038/353397a0; SROMOVSKY LA, 1983, J GEOPHYS RES-SPACE, V88, P8650, DOI 10.1029/JA088iA11p08650; TEMMA T, IN PRESS ICARUS; WEST RA, 1982, ICARUS, V51, P51, DOI 10.1016/0019-1035(82)90029-X	20	93	93	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1243	1247		10.1126/science.1107691	http://dx.doi.org/10.1126/science.1107691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731441				2022-12-01	WOS:000227313200040
J	Yoshimura, Y; Dantzker, JLM; Callaway, EM				Yoshimura, Y; Dantzker, JLM; Callaway, EM			Excitatory cortical neurons form fine-scale functional networks	NATURE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; INHIBITORY NEURONS; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; RAT; CONNECTIONS; CIRCUITS; LAYERS; INTERNEURONS	The specificity of cortical neuron connections creates columns of functionally similar neurons spanning from the pia to the white matter(1-6). Here we investigate whether there is an additional, finer level of specificity that creates subnetworks of excitatory neurons within functional columns. We tested for fine-scale specificity of connections to cortical layer 2/3 pyramidal neurons in rat visual cortex by using cross-correlation analyses of synaptic currents evoked by photostimulation. Recording simultaneously from adjacent layer 2/3 pyramidal cells, we find that when they are connected to each other (20% of all recorded pairs) they share common input from layer 4 and within layer 2/3. When adjacent layer 2/3 neurons are not connected to each other, they share very little ( if any) common excitatory input from layers 4 and 2/3. In contrast, all layer 2/3 neurons share common excitatory input from layer 5 and inhibitory input from layers 2/3 and 4, regardless of whether they are connected to each other. Thus, excitatory connections from layer 4 to layer 2/3 and within layer 2/3 form fine-scale assemblies of selectively interconnected neurons; inhibitory connections and excitatory connections from layer 5 link neurons across these fine-scale subnetworks. Relatively independent subnetworks of excitatory neurons are therefore embedded within the larger-scale functional architecture; this allows neighbouring neurons to convey information more independently than suggested by previous descriptions of cortical circuitry.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Yoshimura, Yumiko/0000-0002-7526-4153	NIMH NIH HHS [R01 MH063912] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AGMON A, 1992, J NEUROSCI, V12, P319; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1991, ANATOMY CORTEX; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Hebb D.O., 2002, CLIN PSYCHOL; HELLWIG B, 1994, BIOL CYBERN, V71, P1, DOI 10.1007/BF00198906; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Meskenaite V, 1997, J COMP NEUROL, V379, P113; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Mountcastle VB, 2003, CEREB CORTEX, V13, P2, DOI 10.1093/cercor/13.1.2; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Schubert D, 2003, J NEUROSCI, V23, P2961; Staiger JF, 2002, EUR J NEUROSCI, V16, P11, DOI 10.1046/j.1460-9568.2002.02048.x; Sur M, 2002, CURR BIOL, V12, pR168, DOI 10.1016/S0960-9822(02)00733-9; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Yoshimura Y, 2003, J NEUROSCI, V23, P6557	30	425	465	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					868	873		10.1038/nature03252	http://dx.doi.org/10.1038/nature03252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729343				2022-12-01	WOS:000227174600043
J	Lim, LP; Lau, NC; Garrett-Engele, P; Grimson, A; Schelter, JM; Castle, J; Bartel, DP; Linsley, PS; Johnson, JM				Lim, LP; Lau, NC; Garrett-Engele, P; Grimson, A; Schelter, JM; Castle, J; Bartel, DP; Linsley, PS; Johnson, JM			Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs	NATURE			English	Article							EXPRESSION; PREDICTION; SIRNAS; PLANT	MicroRNAs ( miRNAs) are a class of noncoding RNAs that post-transcriptionally regulate gene expression in plants and animals(1,2). To investigate the influence of miRNAs on transcript levels, we transfected miRNAs into human cells and used microarrays to examine changes in the messenger RNA profile. Here we show that delivering miR-124 causes the expression profile to shift towards that of brain, the organ in which miR-124 is preferentially expressed, whereas delivering miR-1 shifts the profile towards that of muscle, where miR-1 is preferentially expressed. In each case, about 100 messages were downregulated after 12 h. The 30 untranslated regions of these messages had a significant propensity to pair to the 50 region of the miRNA, as expected if many of these messages are the direct targets of the miRNAs(3). Our results suggest that metazoan miRNAs can reduce the levels of many of their target transcripts, not just the amount of protein deriving from these transcripts. Moreover, miR-1 and miR-124, and presumably other tissue-specific miRNAs, seem to downregulate a far greater number of targets than previously appreciated, thereby helping to define tissue-specific gene expression in humans.	Rosetta Inpharmat, Seattle, WA 98109 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Merck & Company; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lim, LP (corresponding author), Rosetta Inpharmat, 401 Terry Ave N, Seattle, WA 98109 USA.	lee_lim@merck.com	Huang, H/E-9490-2010	Lau, Nelson/0000-0001-9907-1404				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey T.L., 1994, P 2 INT C INT SYST M, V2, P28; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	30	3828	4132	5	348	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					769	773		10.1038/nature03315	http://dx.doi.org/10.1038/nature03315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15685193				2022-12-01	WOS:000227039200045
J	Sword, GA; Lorch, PD; Gwynne, DT				Sword, GA; Lorch, PD; Gwynne, DT			Migratory bands give crickets protection	NATURE			English	Editorial Material									ARS, USDA, No Plains Agr Res Lab, Sidney, MT 59270 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Toronto, Mississauga, ON L5L 1C6, Canada	United States Department of Agriculture (USDA); University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Mississauga	Sword, GA (corresponding author), ARS, USDA, No Plains Agr Res Lab, Sidney, MT 59270 USA.	gsword@sidney.ars.usda.gov		Sword, Gregory/0000-0003-2094-2436				Dingle H., 1996, MIGRATION BIOL LIFE; GWYNNE DT, 1993, ECOLOGY, V74, P1406, DOI 10.2307/1940070; Gwynne DT, 2001, CORNELL S ARTHR BIOL; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; KARBAN R, 1982, ECOLOGY, V63, P321, DOI 10.2307/1938949; Krause J., 2002, LIVING GROUPS; Lorch PD, 2000, NATURWISSENSCHAFTEN, V87, P370, DOI 10.1007/s001140050743; MacVean C.M., 1987, P116; Sword GA, 2005, ANIM BEHAV, V69, P437, DOI 10.1016/j.anbehav.2004.04.016; Uvarov B., 1977, BEHAVIOUR ECOLOGY BI, V2; WILLIAMS KS, 1993, ECOLOGY, V74, P1143, DOI 10.2307/1940484	11	65	69	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					703	703		10.1038/433703a	http://dx.doi.org/10.1038/433703a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716941	Bronze			2022-12-01	WOS:000227039200027
J	Maiorano, D; Cuvier, O; Danis, E; Mechali, M				Maiorano, D; Cuvier, O; Danis, E; Mechali, M			MCM8 is an MCM2-7-related protein that functions as a DNA helicase during replication elongation and not initiation	CELL			English	Article							XENOPUS EGG EXTRACTS; CELL-CYCLE REGULATION; S-PHASE; POLYMERASE-ALPHA; SCHIZOSACCHAROMYCES-POMBE; ATP HYDROLYSIS; IN-VITRO; CHROMATIN; COMPLEX; FAMILY	MCM2-7 proteins are replication factors required to initiate DNA synthesis and are currently the best candidates for replicative helicases. We show that the MCM2-7-related protein MCM8 is required to efficiently replicate chromosomal DNA in Xenopus egg extracts. MCM8 does not associate with the soluble MCM2-7 complex and binds chromatin upon initiation of DNA synthesis. MCM8 depletion does not affect replication licensing or MCM3 loading but slows down DNA synthesis and reduces chromatin recruitment of RPA34 and DNA polymerase-alpha. Recombinant MCM8 displays both DNA helicase and ATPase activities in vitro. Reconstitution experiments show that ATP binding in MCM8 is required to rescue DNA synthesis in MCM8-depleted extracts. MCM8 colocalizes with replication foci and RPA34 on chromatin. We suggest that MCM8 functions in the elongation step of DNA replication as a helicase that facilitates the recruitment of RPA34 and stimulates the processivity of DNA polymerases at replication foci.	CNRS, Inst Human Genet, F-34396 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier 05, France.	mechali@igh.cnrs.fr	Cuvier, Olivier/ADO-0657-2022; CUVIER, Olivier/AAC-4693-2019; Maiorano, Domenico/N-5755-2017	CUVIER, Olivier/0000-0003-0644-2734; Maiorano, Domenico/0000-0003-4229-5903				ADACHI Y, 1992, J CELL BIOL, V119, P1, DOI 10.1083/jcb.119.1.1; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; ALMOUZNI G, 1988, EMBO J, V7, P665, DOI 10.1002/j.1460-2075.1988.tb02861.x; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; Francon P, 2004, J CELL SCI, V117, P4909, DOI 10.1242/jcs.01361; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Gozuacik D, 2001, ONCOGENE, V20, P6233, DOI 10.1038/sj.onc.1204835; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Johnson EM, 2003, NUCLEIC ACIDS RES, V31, P2915, DOI 10.1093/nar/gkg395; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Krude T, 1996, J CELL SCI, V109, P309; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Kubota Y, 1997, EMBO J, V16, P3320, DOI 10.1093/emboj/16.11.3320; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; LEIBOVICI M, 1992, J CELL SCI, V102, P63; Liang DT, 1999, J CELL SCI, V112, P559; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Maiorano D, 2000, J BIOL CHEM, V275, P8426, DOI 10.1074/jbc.275.12.8426; Maiorano D, 2004, EXP CELL RES, V295, P138, DOI 10.1016/j.yexcr.2003.11.018; Maiorano D, 1996, EMBO J, V15, P861, DOI 10.1002/j.1460-2075.1996.tb00421.x; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; MENUT S, 1988, ADV MOL BIOL COMP ME, P196; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rowles A, 1999, J CELL SCI, V112, P2011; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Shechter D, 2004, J BIOL CHEM, V279, P45586, DOI 10.1074/jbc.M407772200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Vuillard L, 1998, EUR J BIOCHEM, V256, P128, DOI 10.1046/j.1432-1327.1998.2560128.x; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; You ZY, 1999, MOL CELL BIOL, V19, P8003	63	95	102	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2005	120	3					315	328		10.1016/j.cell.2004.12.010	http://dx.doi.org/10.1016/j.cell.2004.12.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897TS	15707891	Bronze			2022-12-01	WOS:000227028900008
J	Borchert, R; Renner, SS; Calle, Z; Navarrete, D; Tye, A; Gautier, L; Spichiger, R; von Hildebrand, P				Borchert, R; Renner, SS; Calle, Z; Navarrete, D; Tye, A; Gautier, L; Spichiger, R; von Hildebrand, P			Photoperiodic induction of synchronous flowering near the Equator	NATURE			English	Article							LENGTH; TREES	In tropical rainforests, 30 - 65% of tree species grow at densities of less than one individual per hectare(1). At these low population densities, successful cross- pollination relies on synchronous flowering. In rainforests with low climatic seasonality, photoperiodic control is the only reliable mechanism for inducing synchronous flowering(2,3). This poses a problem because there is no variation in day length at the Equator. Here we propose a new mechanism of photoperiodic timekeeping based on the perception of variation in sunrise or sunset time, which explains and predicts the annually repeated, staggered, synchronous and bimodal flowering of many tree species in Amazonian rainforests near the Equator.	Univ Kansas, Div Biol, Lawrence, KS 66045 USA; Univ Munich, Dept Biol, D-80638 Munich, Germany; CIPAV, Ctr Res Sustainable Agr, Cali AA 20591, Colombia; Fdn Puerto Rastrojo, Bogota AA 241438, Colombia; Charles Darwin Res Stn, Dept Bot, Quito, Ecuador; Conservatoire & Jardin Bot Ville Geneve, CH-1292 Chambesy, GE, Switzerland	University of Kansas; University of Munich	Borchert, R (corresponding author), Univ Kansas, Div Biol, Lawrence, KS 66045 USA.	borchert@ku.edu						Borchert R, 2004, GLOBAL ECOL BIOGEOGR, V13, P409, DOI 10.1111/j.1466-822X.2004.00111.x; Borchert R, 2001, TREE PHYSIOL, V21, P213, DOI 10.1093/treephys/21.4.213; BORCHERT R, 2004, ENV CONTROL TROPICAL; CALLE Z, 2002, BIOTROPICA, V34, P621; CONDIT R, IN PRESS BIOL SKR DA; DORE J, 1959, NATURE, V183, P413, DOI 10.1038/183413a0; GAUTIER L, 1986, Candollea, V41, P193; GAUTIER L, 1985, THESIS U GENEVE; Holttum R. E., 1940, Gardens' Bulletin, V11, P119; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Justiniano MJ, 2000, BIOTROPICA, V32, P276, DOI 10.1111/j.1744-7429.2000.tb00470.x; *NAT MAR MUS, TIM EQ TIM; Rivera G, 2002, TREES-STRUCT FUNCT, V16, P445, DOI 10.1007/s00468-002-0185-3; Rivera G, 2001, TREE PHYSIOL, V21, P201, DOI 10.1093/treephys/21.4.201; SNOW DW, 1966, OIKOS, V15, P274, DOI 10.2307/3565124; Thomas B., 1996, PHOTOPERIODISM PLANT; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761	17	151	168	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					627	629		10.1038/nature03259	http://dx.doi.org/10.1038/nature03259			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703746				2022-12-01	WOS:000226862000043
J	Ohki, K; Chung, S; Ch'ng, YH; Kara, P; Reid, RC				Ohki, K; Chung, S; Ch'ng, YH; Kara, P; Reid, RC			Functional imaging with cellular resolution reveals precise micro-architecture in visual cortex	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; RECEPTIVE-FIELD PROPERTIES; IN-VIVO; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; PINWHEEL CENTERS; STRIATE CORTEX; SINGLE NEURONS; CAT AREA-18; CA2+ INFLUX	Neurons in the cerebral cortex are organized into anatomical columns, with ensembles of cells arranged from the surface to the white matter. Within a column, neurons often share functional properties, such as selectivity for stimulus orientation; columns with distinct properties, such as different preferred orientations, tile the cortical surface in orderly patterns. This functional architecture was discovered with the relatively sparse sampling of microelectrode recordings. Optical imaging of membrane voltage or metabolic activity elucidated the overall geometry of functional maps, but is averaged over many cells ( resolution > 100 mum). Consequently, the purity of functional domains and the precision of the borders between them could not be resolved. Here, we labelled thousands of neurons of the visual cortex with a calcium- sensitive indicator in vivo. We then imaged the activity of neuronal populations at single- cell resolution with two- photon microscopy up to a depth of 400 mum. In rat primary visual cortex, neurons had robust orientation selectivity but there was no discernible local structure; neighbouring neurons often responded to different orientations. In area 18 of cat visual cortex, functional maps were organized at a fine scale. Neurons with opposite preferences for stimulus direction were segregated with extraordinary spatial precision in three dimensions, with columnar borders one to two cells wide. These results indicate that cortical maps can be built with single- cell precision.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu						Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; BERMAN NEJ, 1987, J NEUROPHYSIOL, V58, P676, DOI 10.1152/jn.1987.58.4.676; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Braitenberg V, 1991, ANATOMY CORTEX STAT; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kara P, 2003, J NEUROSCI, V23, P8547; Kim DS, 1999, NEUROREPORT, V10, P2515, DOI 10.1097/00001756-199908200-00015; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Martinez-Diaz JJ, 2002, TECTONOPHYSICS, V356, P291, DOI 10.1016/S0040-1951(02)00400-6; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MOUNTCASTLE VB, 1988, PERCEPTUAL NEUROSCIE; Ohki K, 2000, CEREB CORTEX, V10, P593, DOI 10.1093/cercor/10.6.593; PARNAVELAS JG, 1981, NEUROSCI LETT, V27, P291, DOI 10.1016/0304-3940(81)90445-6; PAYNE BR, 1981, BRAIN RES, V211, P445, DOI 10.1016/0006-8993(81)90971-9; PETERS A, 1993, CEREB CORTEX, V3, P49, DOI 10.1093/cercor/3.1.49; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; ROSE D, 1974, EXP BRAIN RES, V20, P1; Shmuel A, 1996, J NEUROSCI, V16, P6945; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; TSIEN RY, 1988, TRENDS NEUROSCI, V11, P419, DOI 10.1016/0166-2236(88)90192-0; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Waters J, 2003, J NEUROSCI, V23, P8558; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; WIESENFELD Z, 1975, BRAIN RES, V94, P401, DOI 10.1016/0006-8993(75)90225-5; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	37	796	811	5	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					597	603		10.1038/nature03274	http://dx.doi.org/10.1038/nature03274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15660108				2022-12-01	WOS:000226862000035
J	Grossman, DC; Mueller, BA; Riedy, C; Dowd, MD; Villaveces, A; Prodzinski, J; Nakagawara, J; Howard, J; Thiersch, N; Harruff, R				Grossman, DC; Mueller, BA; Riedy, C; Dowd, MD; Villaveces, A; Prodzinski, J; Nakagawara, J; Howard, J; Thiersch, N; Harruff, R			Gun storage practices and risk of youth suicide and unintentional firearm injuries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADOLESCENT SUICIDE; US HOMES; CHILDREN; PATTERNS; DEATHS; LAWS	Context Household firearms are associated with an elevated risk of firearm death to occupants in the home. Many organizations and health authorities advocate locking firearms and ammunition to prevent access to guns by children and adolescents. The association of these firearm storage practices with the reduction of firearm injury risk is unclear. Objective To measure the association of specific household firearm storage practices (locking guns, locking ammunition, keeping guns unloaded) and the risk of unintentional and self-inflicted firearm injuries. Design and Setting Case-control study of firearms in events identified by medical examiner and coroner offices from 37 counties in Washington, Oregon, and Missouri, and 5 trauma centers in Seattle, Spokane, and Tacoma, Wash, and Kansas City, Mo. Cases and Controls Case firearms were identified by involvement in an incident in which a child or adolescent younger than 20 years gained access to a firearm and shot himself/herself intentionally or unintentionally or shot another individual unintentionally. Firearm assaults and homicides were excluded. We used records from hospitals and medical examiners to ascertain these incidents. Using random-digit dial telephone sampling, control firearms were identified by identification of eligible households with at least 1 firearm and children living or visiting in the home. Controls were frequency matched by age group and county. Main Exposure Measures The key exposures of interest in this study were: (1) whether the subject firearm was stored in a locked location or with an extrinsic lock; (2) whether the firearm was stored unloaded; (3) whether the firearm was stored both unloaded in a locked location; (4) whether the ammunition for the firearm was stored separately; and (5) whether the ammunition was stored in a locked location. Data regarding the storage status of case and control guns were collected by interview with respondents from the households of case and control firearms. Results We interviewed 106 respondents with case firearms and 480 with control firearms. Of the shootings associated with the case firearms, 82 were suicide attempts (95% fatal) and 24 were unintentional injuries (52% fatal). After adjustment for potentially confounding variables, guns from case households were less likely to be stored unloaded than control guns (odds ratio [OR], 0.30; 95% confidence interval [Cl], 0.16-0.56). Similarly, case guns were less likely to be stored locked (OR, 0.27; 95 % Cl, 0.17-0.45), stored separately from ammunition (OR, 0.45; 95% Cl, 0.34-0.93), or to have ammunition that was locked (OR, 0.39; 95% Cl, 0.23-0.66) than were control guns. These findings were consistent for both handguns and long guns and were also similar for both suicide attempts and unintentional injuries. Conclusions The 4 practices of keeping a gun locked, unloaded, storing ammunition locked, and in a separate location are each associated with a protective effect and suggest a feasible strategy to reduce these types of injuries in homes with children and teenagers where guns are stored.	Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; Med Examiner Off King Cty, Washington, DC USA; Med Examiner Off Pierce Cty, Washington, DC USA; Med Examiner Off Snohomish Cty, Washington, DC USA; Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Mercy Hospital	Grossman, DC (corresponding author), Grp Hlth Cooperat Puget Sound, Dept Prevent Care, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	grossman.d@ghc.org		Villaveces, Andres/0000-0002-3725-2741	ODCDC CDC HHS [R49/CCR015592] Funding Source: Medline	ODCDC CDC HHS		Azrael D, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e31; Biener L, 2004, AM J PREV MED, V27, P254, DOI 10.1016/j.amepre.2004.05.006; BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; BRENT DA, 1991, JAMA-J AM MED ASSOC, V266, P2989, DOI 10.1001/jama.266.21.2989; BRENT DA, 1993, AM J DIS CHILD, V147, P1066, DOI 10.1001/archpedi.1993.02160340052013; BUKSTEIN OG, 1993, ACTA PSYCHIAT SCAND, V88, P403, DOI 10.1111/j.1600-0447.1993.tb03481.x; *CDCP, 2002, BEH RISK FACT SURV S; Coyne-Beasley T, 2001, ARCH PEDIAT ADOL MED, V155, P659, DOI 10.1001/archpedi.155.6.659; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; CUMMINGS P, 1987, AM J PUBLIC HEALTH, V87, P899; Grossman DC, 1999, ARCH PEDIAT ADOL MED, V153, P875, DOI 10.1001/archpedi.153.8.875; Grossman DC, 2000, PEDIATRICS, V106, P22, DOI 10.1542/peds.106.1.22; HEMENWAY D, 1995, JAMA-J AM MED ASSOC, V273, P46, DOI 10.1001/jama.273.1.46; Horn A, 2003, INJURY PREV, V9, P231, DOI 10.1136/ip.9.3.231; Johnson RM, 2004, AM J PREV MED, V27, P173, DOI 10.1016/j.amepre.2004.04.015; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Schuster MA, 2000, AM J PUBLIC HEALTH, V90, P588, DOI 10.2105/AJPH.90.4.588; Senturia YD, 1996, ARCH PEDIAT ADOL MED, V150, P265, DOI 10.1001/archpedi.1996.02170280035006; Stennies G, 1999, ARCH PEDIAT ADOL MED, V153, P586; Vernick JS, 2003, INJURY PREV, V9, P307, DOI 10.1136/ip.9.4.307; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594; WEIL DS, 1992, JAMA-J AM MED ASSOC, V267, P3033, DOI 10.1001/jama.267.22.3033; WINTEMUTE GJ, 1987, JAMA-J AM MED ASSOC, V257, P3107, DOI 10.1001/jama.257.22.3107	23	344	347	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2005	293	6					707	714		10.1001/jama.293.6.707	http://dx.doi.org/10.1001/jama.293.6.707			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895DX	15701912	Bronze			2022-12-01	WOS:000226842200024
J	de Lichtenberg, U; Jensen, LJ; Brunak, S; Bork, P				de Lichtenberg, U; Jensen, LJ; Brunak, S; Bork, P			Dynamic complex formation during the yeast cell cycle	SCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ORGANIZATION; BUDDING YEAST; IDENTIFICATION; DATABASE; BIOLOGY	To analyze the dynamics of protein complexes during the yeast cell cycle, we integrated data on protein interactions and gene expression. The resulting time-dependent interaction network places both periodically and constitutively expressed proteins in a temporal cell cycle context, thereby revealing previously unknown components and modules. We discovered that most complexes consist of both periodically and constitutively expressed subunits, which suggests that the former control complex activity by a mechanism of just-in-time assembly. Consistent with this, we show that additional regulation through targeted degradation and phosphorylation by Cdc28p (Cdk1) specifically affects the periodically expressed proteins.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Technical University of Denmark; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	bork@embl.de	de Lichtenberg, Ulrik/AAY-7279-2020; Jensen, Lars Juhl/C-6492-2008; Bork, Peer/F-1813-2013; Brunak, Soren/O-6621-2016	Jensen, Lars Juhl/0000-0001-7885-715X; Bork, Peer/0000-0002-2627-833X; de Lichtenberg, Ulrik/0000-0002-0985-9343; Brunak, Soren/0000-0003-0316-5866				Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; DELICHTENBERG U, 2004, BIOINFORMATICS; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; JENSEN LJ, 2004, DRUG DISCOV TODAY, V3, P51; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Measday V, 2000, MOL MICROBIOL, V35, P825, DOI 10.1046/j.1365-2958.2000.01754.x; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034	21	316	321	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2005	307	5710					724	727		10.1126/science.1105103	http://dx.doi.org/10.1126/science.1105103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	894TQ	15692050				2022-12-01	WOS:000226814900043
J	Lin, JD; Yang, RJ; Tarr, PT; Wu, PH; Handschin, C; Li, SM; Yang, WL; Pei, LM; Uldry, M; Tontonoz, P; Newgard, CB; Spiegelman, BM				Lin, JD; Yang, RJ; Tarr, PT; Wu, PH; Handschin, C; Li, SM; Yang, WL; Pei, LM; Uldry, M; Tontonoz, P; Newgard, CB; Spiegelman, BM			Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 beta cactivation of SREBP	CELL			English	Article							STEROL REGULATORY ELEMENT; LEUCINE ZIPPER PROTEIN; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; TRANSGENIC MICE; CARDIOVASCULAR-DISEASE; DIABETIC DYSLIPIDEMIA; ENERGY-METABOLISM; BINDING PROTEINS	The PGC-1 family of coactivators stimulates the activity of certain transcription factors and nuclear receptors. Transcription factors in the sterol responsive element binding protein (SREBP) family are key regulators of the lipogenic genes in the liver. We show here that high-fat feeding, which induces hyperlipidemia and atherogenesis, stimulates the expression of both PGC-1beta and SREBP1c and 1a in liver. PGC-1beta0 coactivates the SREBP transcription factor family and stimulates lipogenic gene expression. Further, PGC-1beta is required for SREBP-mediated lipogenic gene expression. However, unlike SREBP itself, PGC-1beta reduces fat accumulation in the liver while greatly increasing circulating triglycerides and cholesterol in VLDL particles. The stimulation of lipoprotein transport upon PGC-1beta expression is likely due to the simultaneous coactivation of the liver X receptor, LXRalpha, a nuclear hormone receptor with known roles in hepatic lipid transport. These data suggest a mechanism through which dietary saturated fats can stimulate hyperlipidemia and atherogenesis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Handschin, Christoph/E-6886-2015; Wu, Pei-Hsuan/AAL-1704-2020	Handschin, Christoph/0000-0003-0603-1097; Wu, Pei-Hsuan/0000-0002-6690-0744	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, K01DK065584, R01DK061562, R01DK054477] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL66088] Funding Source: Medline; NIDDK NIH HHS [K01DK065584, P01DK58398, R01DK61562, R01DK54477] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Betteridge DJ, 1999, EUR J CLIN INVEST, V29, P12; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Goldberg IJ, 2001, J CLIN ENDOCR METAB, V86, P965, DOI 10.1210/jc.86.3.965; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	48	473	499	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2005	120	2					261	273		10.1016/j.cell.2004.11.043	http://dx.doi.org/10.1016/j.cell.2004.11.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	893SR	15680331	Bronze, Green Published			2022-12-01	WOS:000226740000014
J	Arad, M; Maron, BJ; Gorham, JM; Johnson, WH; Saul, JP; Perez-Atayde, AR; Spirito, P; Wright, GB; Kanter, RJ; Seidman, CE; Seidman, JG				Arad, M; Maron, BJ; Gorham, JM; Johnson, WH; Saul, JP; Perez-Atayde, AR; Spirito, P; Wright, GB; Kanter, RJ; Seidman, CE; Seidman, JG			Glycogen storage diseases presenting as hypertrophic cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUDDEN-DEATH; MUTATIONS; GENE; IDENTIFICATION; DEFICIENCY	BACKGROUND: Unexplained left ventricular hypertrophy often prompts the diagnosis of hypertrophic cardiomyopathy, a sarcomere-protein gene disorder. Because mutations in the gene for AMP-activated protein kinase gamma(2) (PRKAG2) cause an accumulation of cardiac glycogen and left ventricular hypertrophy that mimics hypertrophic cardiomyopathy, we hypothesized that hypertrophic cardiomyopathy might also be clinically misdiagnosed in patients with other mutations in genes regulating glycogen metabolism. METHODS: Genetic analyses performed in 75 consecutive unrelated patients with hypertrophic cardiomyopathy detected 40 sarcomere-protein mutations. In the remaining 35 patients, PRKAG2, lysosome-associated membrane protein 2 (LAMP2), alpha-galactosidase (GLA), and acid alpha-1,4-glucosidase (GAA) genes were studied. RESULTS: Gene defects causing Fabry's disease (GLA) and Pompe's disease (GAA) were not found, but two LAMP2 and one PRKAG2 mutations were identified in probands with prominent hypertrophy and electrophysiological abnormalities. These results prompted the study of two additional, independent series of patients. Genetic analyses of 20 subjects with massive hypertrophy (left ventricular wall thickness, greater than or equal to 30 mm) but without electrophysiological abnormalities revealed mutations in neither LAMP2 nor PRKAG2. Genetic analyses of 24 subjects with increased left ventricular wall thickness and electrocardiograms suggesting ventricular preexcitation revealed four LAMP2 and seven PRKAG2 mutations. Clinical features associated with defects in LAMP2 included male sex, severe hypertrophy, early onset (at 8 to 17 years of age), ventricular preexcitation, and asymptomatic elevations of two serum proteins. CONCLUSIONS: LAMP2 mutations typically cause multisystem glycogen-storage disease (Danon's disease) but can also present as a primary cardiomyopathy. The glycogen-storage cardiomyopathy produced by LAMP2 or PRKAG2 mutations resembles hypertrophic cardiomyopathy but is distinguished by electrophysiological abnormalities, particularly ventricular preexcitation.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Minneapolis Heart Ind Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA; Univ Alabama Birmingham, Dept Pediat, Div Pediat Cardiol, Birmingham, AL USA; Med Univ S Carolina, Childrens Heart Program S Carolina, Charleston, SC 29425 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Galleria Genova, Dept Cardiol, Genoa, Italy; Childrens Heart Clin, Minneapolis, MN USA; Duke Univ, Med Ctr, Div Pediat Cardiol, Durham, NC USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Medical University of South Carolina; Harvard University; Boston Children's Hospital; Duke University	Seidman, JG (corresponding author), Harvard Univ, Sch Med, Dept Genet, NRB Rm 256,77 Ave Louis Pasteur, Boston, MA 02115 USA.	seidman@genetics.med.harvard.edu						Amato AA, 2000, NEUROL CLIN, V18, P151, DOI 10.1016/S0733-8619(05)70182-1; Arad M, 2003, CIRCULATION, V107, P2850, DOI 10.1161/01.CIR.0000075270.13497.2B; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI14571; AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V10; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; CHOU TC, 1996, LEFT VENTRICULAR HYP, P37; DANON MJ, 1981, NEUROLOGY, V31, P51, DOI 10.1212/WNL.31.1.51; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; GOLLOB MH, 2002, NEW ENGL J MED, V346, P300; GOLLOB MH, 2001, NEW ENGL J MED, V345, P552; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P2748, DOI 10.1161/01.CIR.92.9.2748; Morita H, 2002, COLD SPRING HARB SYM, V67, P383, DOI 10.1101/sqb.2002.67.383; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Patel VV, 2003, J AM COLL CARDIOL, V42, P942, DOI 10.1016/S0735-1097(03)00850-7; Roberts R, 2001, CIRCULATION, V104, P2249, DOI 10.1161/hc4301.097430; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Sugie K, 2002, NEUROLOGY, V58, P1773, DOI 10.1212/WNL.58.12.1773; Van den Hout H, 2000, LANCET, V356, P397, DOI 10.1016/S0140-6736(00)02533-2	29	395	432	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2005	352	4					362	372		10.1056/NEJMoa033349	http://dx.doi.org/10.1056/NEJMoa033349			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	890UH	15673802				2022-12-01	WOS:000226535900008
J	Basile-Doelsch, I; Meunier, JD; Parron, C				Basile-Doelsch, I; Meunier, JD; Parron, C			Another continental pool in the terrestrial silicon cycle	NATURE			English	Article							ISOTOPIC COMPOSITION; STABLE-ISOTOPES; SILCRETE; FRACTIONATION; DIAGENESIS; CALCRETE; DIATOMS; OCEAN	Silicon is the second most abundant element on Earth. It is an important nutrient for phytoplankton(1) and is readily absorbed by terrestrial vegetation(2); it also assists the removal of carbon dioxide from the atmosphere through the weathering of silicates(3). But the continental cycle of silicon is not well known, and only a few studies have attempted to use silicon stable isotopes (Si-28, Si-29 and Si-30)(4-13) to quantify the continental silicon reservoirs. Dissolved silicon in sea and river waters forms a reservoir of mean isotopic value 11.1parts per thousand (refs 7, 10). It is enriched in Si-30 with respect to the igneous rocks reservoir, which has a mean isotopic value of -0.3parts per thousand (refs 4, 9). This enrichment can only be produced by a major fractionation during weathering, and should result in the formation of a continental Si-30-depleted reservoir. Such a reservoir, however, has not been identified to date. Here we analyse silicon isotopes of in situ quartz from a sandstone series in France, using a new-generation secondary ion mass spectrometry apparatus. We show that quartz that precipitates as siliceous cements forms a strongly Si-30-depleted reservoir with isotopic values down to -5.7parts per thousand, a more negative value than any previously published for terrestrial samples. Our findings suggest that quartz re-precipitation plays an important role in the biogeochemical cycle of silicon.	IRD Reunion, LSTUR, F-97492 St Denis, France; Univ Paul Cezanne, IRD, Europole Arbois, CEREGE UMR CNRS, F-13545 Aix En Provence 4, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Basile-Doelsch, I (corresponding author), IRD Reunion, LSTUR, UR037,BP 172, F-97492 St Denis, France.	basile@cerege.fr	Shrestha, Yesha/N-8890-2014; Basile, Isabelle IBD/B-4173-2010					Abdel-Wahab A, 1998, J AFR EARTH SCI, V27, P277, DOI 10.1016/S0899-5362(98)00061-X; Alexandre A, 1997, GEOCHIM COSMOCHIM AC, V61, P677, DOI 10.1016/S0016-7037(97)00001-X; [Anonymous], 1996, SILICON ISOTOPE GEOC; ARAKEL AV, 1989, AUST J EARTH SCI, V36, P73, DOI 10.1080/14400958908527952; Berner RA, 1997, SCIENCE, V276, P544, DOI 10.1126/science.276.5312.544; CHADWICK OA, 1989, SOIL SCI SOC AM J, V53, P158, DOI 10.2136/sssaj1989.03615995005300010030x; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; De La Rocha CL, 2003, GEOLOGY, V31, P423, DOI 10.1130/0091-7613(2003)031<0423:SIFBMS>2.0.CO;2; De la Rocha CL, 2000, GEOCHIM COSMOCHIM AC, V64, P2467, DOI 10.1016/S0016-7037(00)00373-2; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; De La Rocha CL, 1997, GEOCHIM COSMOCHIM AC, V61, P5051, DOI 10.1016/S0016-7037(97)00300-1; Ding T, 2004, GEOCHIM COSMOCHIM AC, V68, P205, DOI 10.1016/S0016-7037(03)00264-3; DOUTHITT CB, 1982, GEOCHIM COSMOCHIM AC, V46, P1449, DOI 10.1016/0016-7037(82)90278-2; DOVE PM, 1996, CHEM WEATHERING RATE, P235; Elsass F, 2000, CLAY MINER, V35, P477, DOI 10.1180/000985500546954; Girard JP, 2000, GEOCHIM COSMOCHIM AC, V64, P409, DOI 10.1016/S0016-7037(99)00299-9; KHALAF FI, 1988, J SEDIMENT PETROL, V58, P1014; MCKEEGAN KD, 1985, GEOCHIM COSMOCHIM AC, V49, P1971, DOI 10.1016/0016-7037(85)90091-2; MOLINIVELSKO C, 1986, GEOCHIM COSMOCHIM AC, V50, P2719, DOI 10.1016/0016-7037(86)90221-8; Nash DJ, 1998, J AFR EARTH SCI, V27, P11, DOI 10.1016/S0899-5362(98)00043-8; PARRON C, 1985, GEOL FR, V2, P137; Parron C., 1976, SCI GEOL B, V29, P273; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; Thiry M, 1996, CATENA, V26, P1, DOI 10.1016/0341-8162(95)00044-5; Thiry M, 1997, SOILS AND SEDIMENTS, P191; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; ZIEGLER K, 2002, GEOCHIM COSMOCHIM AC, V66; ZIEGLER K, 2002, 6 INT S GEOCH EARTHS, P103; ZIEGLER K, 2000, GOLDSCHM C, P1135; ZINNER E, 1989, NEW FRONTIERS STABLE, P145	30	157	173	3	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2005	433	7024					399	402		10.1038/nature03217	http://dx.doi.org/10.1038/nature03217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	890XZ	15674287				2022-12-01	WOS:000226546200038
J	Taylor, EN; Stampfer, MJ; Curhan, GC				Taylor, EN; Stampfer, MJ; Curhan, GC			Obesity, weight gain, and the risk of kidney stones	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	10th International Symposium on Urolithiasis	MAY 25-28, 2004	Hong Kong, PEOPLES R CHINA				CALCIUM-OXALATE; DIETARY CALCIUM; URIC-ACID; PHOSPHATE-METABOLISM; DIABETES-MELLITUS; PHYSICAL-ACTIVITY; BODY-WEIGHT; FREQUENCY; HYPERINSULINEMIA; REPRODUCIBILITY	Context Larger body size may result in increased urinary excretion of calcium. oxalate, and uric acid, thereby increasing the risk for calcium-containing kidney stones. It is unclear if obesity increases the risk of stone formation, and it is not known if weight gain influences risk. Objective To determine if weight, weight gain, body mass index (BMI), and waist circumference are associated with kidney stone formation. Design, Setting, and Participants A prospective study of 3 large cohorts: the Heath Professionals Follow-up Study (N=45988 men; age range at baseline, 40-75 years). the Nurses' Health Study I (N =93 758 older women; age range at baseline, 34-59 years), and the Nurses' Health Study 11 (N=101 877 younger women; age range at bas-elin-e b 0 0 27-44 years). Main Outcome Measures Incidence of symptomatic kidney stones. Results We documented 4827 incident kidney stones over a combined 46 years of follow-up. After adjusting for age, dietary factors, fluid intake, and thiazide use, the relative risk (RR) for stone formation in men weighing more than 220 lb (100.0 kg) vs men less than 150 lb (68.2 kg) was 1.44 (95% confidence interval [CI], 1.11-1.86; P=.002 for trend). in older and younger women, RRs for these weight categories were 1.89 (95% Cl, 1.52-2.36; P<.001 for trend) and 1.92 (95% Cl, 1.59-2.31; P<.001 for trend), respectively. The RR in men who gained more than 35 lb (15.9 kg) since age 21 years vs men whose weight did not change was 1.39 (95% Cl. 1.14-1.70; P=.001 for trend). Corresponding RRs for the same categories of weight gain since age 18 years in older and younger women were 1.70 (95% Cl, 1.40-2.05; P<.001 for trend) and 1.82 (95% Cl, 1.50-2.21; P<.001 for trend). Body mass index was associated with the risk of kidney stone formation: the RR for men with a BMI of 30 or greater vs those with a BMI of 21 to 22.9 was 1.33 (95% CI, 1.08-1.63; P<.001 for trend). Corresponding RRs for the same categories of BMI in older and younger women were 1.90 (95% Cl, 1.61-2.25; P<.001 for trend) and 2.09 (95% Cl, 1.77-2.48; P<.001 for trend). Waist circumference was also positively associated with risk in men (P=.002 for trend) and in older and younger women (P<.001 for trend for both). Conclusions Obesity and weight gain increase the risk of kidney stone formation. The magnitude of the increased risk may be greater in women than in men.	Harvard Univ, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Taylor, EN (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Channing Lab, 3rd Floor,181 Longwood Ave, Boston, MA 02115 USA.	entaylor@partners.org			NATIONAL CANCER INSTITUTE [P01CA087969, R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007791, R01DK059583] Funding Source: NIH RePORTER; NCI NIH HHS [CA 50385, CA 55075, CA 87969] Funding Source: Medline; NIDDK NIH HHS [DK 07791, DK 59583] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; COE FL, 1980, KIDNEY INT, V17, P662, DOI 10.1038/ki.1980.205; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; COE FL, 1974, NEW ENGL J MED, V291, P1344; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.00746.x; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Curhan GC, 1998, J AM SOC NEPHROL, V9, P1645; Elia M, 2001, OBES RES, V9, p244S, DOI 10.1038/oby.2001.126; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Heller HJ, 2002, J UROLOGY, V168, P1923, DOI 10.1016/S0022-5347(05)64264-4; HIATT RA, 1982, AM J EPIDEMIOL, V115, P255, DOI 10.1093/oxfordjournals.aje.a113297; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; KERSTETTER J, 1991, METABOLISM, V40, P707, DOI 10.1016/0026-0495(91)90088-E; Kramer HJM, 2003, J AM SOC NEPHROL, V14, P1272, DOI 10.1097/01.ASN.0000060682.25472.C3; Krivosikova Z, 1998, PHYSIOL RES, V47, P177; Lemann J, 1996, KIDNEY INT, V49, P200, DOI 10.1038/ki.1996.27; LEMANN J, 1969, NEW ENGL J MED, V280, P232, DOI 10.1056/NEJM196901302800502; LEMANN J, 1970, J LAB CLIN MED, V75, P578; LEVY FL, 1995, AM J MED, V98, P50, DOI 10.1016/S0002-9343(99)80080-1; LINGEMAN JE, 1986, MED CARE, V24, P1151, DOI 10.1097/00005650-198612000-00007; Maalouf NM, 2004, KIDNEY INT, V65, P1422, DOI 10.1111/j.1523-1755.2004.00522.x; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Nowicki M, 1998, NEPHROL DIAL TRANSPL, V13, P2566, DOI 10.1093/ndt/13.10.2566; PAK CYC, 1975, P SOC EXP BIOL MED, V149, P930; Pearle M, 2004, UROLOGIC DIS AM, P34; Powell CR, 2000, UROLOGY, V55, P825, DOI 10.1016/S0090-4295(99)00617-2; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RUMENAPF G, 1990, CALCIFIED TISSUE INT, V46, P73, DOI 10.1007/BF02556090; Shimamoto K, 1995, TOHOKU J EXP MED, V177, P271, DOI 10.1620/tjem.177.271; Siener R, 2004, OBES RES, V12, P106, DOI 10.1038/oby.2004.14; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; Willett W., 1990, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOOD RJ, 1983, J NUTR, V113, P1561, DOI 10.1093/jn/113.8.1561; YAMASHITA S, 1986, INT J OBESITY, V10, P255	42	728	779	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2005	293	4					455	462		10.1001/jama.293.4.455	http://dx.doi.org/10.1001/jama.293.4.455			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	890DW	15671430	Bronze			2022-12-01	WOS:000226492900024
J	Leimane, V; Riekstina, V; Holtz, TH; Zarovska, E; Skripconoka, V; Thorpe, LE; Laserson, KF; Wells, CD				Leimane, V; Riekstina, V; Holtz, TH; Zarovska, E; Skripconoka, V; Thorpe, LE; Laserson, KF; Wells, CD			Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study	LANCET			English	Article							DOTS-PLUS; MYCOBACTERIUM-TUBERCULOSIS; MDR-TB; CHEMOTHERAPY; EXPERIENCE; RIFAMPIN; THERAPY; PERU	Background Latvia has one of the highest rates of multidrug-resistant tuberculosis (MDRTB). Our aim was to assess treatment outcomes for the first full cohort of MDRTB patients treated under Latvia's DOTS-Plus strategy following WHO guidelines. Methods We retrospectively reviewed all civilian patients who began treatment with individualised treatment regimens for pulmonary MDRTB in Latvia between Jan 1, and Dec 31, 2000. We applied treatment outcome definitions for MDRTB, developed by an international. expert consensus group, and assessed treatment effectiveness and risk factors associated with poor outcome. Findings Of the 204 patients assessed, 55 (27%) had been newly diagnosed with MDRTB, and 149 (73%) had earlier been treated with first-line or second-line drugs for this disease. Assessment of treatment outcomes showed that 135 (66%) patients were cured or completed therapy, 14 (7%) died, 26 (13%) defaulted, and treatment failed in 29 (14%). Of the 178 adherent patients, 135 (76%) achieved cure or treatment completion. In a multivariate Cox proportional-hazards model of these patients, independent predictors of poor outcome (death and treatment failure) included having previously received treatment for MDRTB (hazard ratio 5.7, 95% CI 1.9-16.6), the use of five or fewer drugs for 3 months or more (3.2, 1.1-9.6), resistance to ofloxacin (2.6, 1.2-5.4), and body-mass index less than 18.5 at start of treatment (2.3, 1.1-4.9). Interpretation The DOTS-Plus strategy of identifying and treating patients with MDRTB can be effectively implemented on a nationwide scale in a setting of limited resources.	State Ctr TB & Lung Dis, Riga, Latvia; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA	Riga East University Hospital; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Leimane, V (corresponding author), Latvia State Ctr TB & Lung Dis, PO Cekule, Stopinup, Riga Region, Latvia.	vaira@tuberculosis.lv						ALLISON P, 1995, SURVIVAL ANAL USIN S; [Anonymous], 1983, Stat Bull Metrop Life Found, V64, P3; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P661; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Davies GR, 1999, INT J TUBERC LUNG D, V3, P799; Dean AG, 1997, EPI INFO VERSION 6 0; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; Farmer P, 1998, BRIT MED J, V317, P671, DOI 10.1136/bmj.317.7159.671; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Hadiarto M, 1996, CHEMOTHERAPY, V42, P24, DOI 10.1159/000239511; Iseman MD, 1998, INT J TUBERC LUNG D, V2, P867; Johansen IS, 2003, INT J TUBERC LUNG D, V7, P899; Kim HJ, 2001, INT J TUBERC LUNG D, V5, P1129; Kruuner A, 1998, INT J TUBERC LUNG D, V2, P130; LASERSON KF, IN PRESS INT J TB LU; Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Narita M, 2001, CHEST, V120, P343, DOI 10.1378/chest.120.2.343; Organization WH, 1997, WHOTB97229; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; Riekstina V, 2003, INT J TUBERC LUNG D, V7, P903; *SAS I INC, 1999, STAT AN SYST WIND RE; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Suo J, 1996, CHEMOTHERAPY, V42, P20, DOI 10.1159/000239510; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; *WHO, 2000, WHOCDSTB2000278; WHO, 2000, WHOCDSTB2000279; World Health Organisation (WHO), 1995, WHO TECHN REP SER, V854; World Health Organization, 2003, TREATM TUB GUID NAT; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744; Zalesky R, 1997, Monaldi Arch Chest Dis, V52, P142	36	224	241	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2005	365	9456					318	326						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889NL	15664227				2022-12-01	WOS:000226449600035
J	Abella, BS; Alvarado, JP; Myklebust, H; Edelson, DP; Barry, A; O'Hearn, N; Vanden Hoek, TL; Becker, LB				Abella, BS; Alvarado, JP; Myklebust, H; Edelson, DP; Barry, A; O'Hearn, N; Vanden Hoek, TL; Becker, LB			Quality of cardiopulmonary resuscitation during in-hospital cardiac arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BASIC LIFE-SUPPORT; CHEST COMPRESSIONS; VENTRICULAR-FIBRILLATION; PRECORDIAL COMPRESSION; CPR PERFORMANCE; BYSTANDER CPR; DEFIBRILLATION; SURVIVAL; SYSTEM	Context The survival benefit of well-performed cardiopulmonary resuscitation (CPR) is well-documented, but little objective data exist regarding actual CPR quality during cardiac arrest. Recent studies have challenged the notion that CPR is uniformly performed according to established international guidelines. Objectives To measure multiple parameters of in-hospital CPR quality and to determine compliance with published American Heart Association and international guidelines. Design and Setting A prospective observational study of 67 patients who experienced in-hospital cardiac arrest at the University of Chicago Hospitals, Chicago, III, between December 11, 2002, and April 5, 2004. Using a monitor/defibrillator with novel additional sensing capabilities, the parameters of CPR quality including chest compression rate, compression depth, ventilation rate, and the fraction of arrest time without chest compressions (no-flow fraction) were recorded. Main Outcome Measure Adherence to American Heart Association and international CPR guidelines. Results Analysis of the first 5 minutes of each resuscitation by 30-second segments revealed that chest compression rates were less than 90/min in 28.1% of segments. Compression depth was too shallow (defined as <38 mm) for 37.4% of compressions. Ventilation rates were high, with 60.9% of segments containing a rate of more than 20/min. Additionally, the mean (SD) no-flow fraction was 0.24 (0.18). A 10-second pause each minute of arrest would yield a no-flow fraction of 0.17. A total of 27 patients (40.3%) achieved return of spontaneous circulation and 7 (10.4%) were discharged from the hospital. Conclusions In this study of in-hospital cardiac arrest, the quality of multiple parameters of CPR was inconsistent and often did not meet published guideline recommendations, even when performed by well-trained hospital staff. The importance of high-quality CPR suggests the need for rescuer feedback and monitoring of CPR quality during resuscitation efforts.	Univ Chicago Hosp, Sect Emergency Med, Chicago, IL 60637 USA; Univ Chicago Hosp, Sect Crit Care, Chicago, IL 60637 USA; Laerdal Med Corp, Stavanger, Norway	University of Chicago; University of Illinois System; University of Chicago; University of Illinois System	Becker, LB (corresponding author), Univ Chicago Hosp, Sect Emergency Med, 5841 S Maryland Ave,MC 5068, Chicago, IL 60637 USA.	lbecker@medicine.bsd.uchicago.edu	Abella, Benjamin/G-3579-2010	Abella, Benjamin/0000-0003-2521-0891				Aase SO, 2000, IEEE T BIO-MED ENG, V47, P1440, DOI 10.1109/10.880095; Aase SO, 2002, IEEE T BIO-MED ENG, V49, P263, DOI 10.1109/10.983461; ABELLA BS, IN PRESS CIRCULATION; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Becker L, 1996, CARDIAC ARREST SCI P, P28; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Donnelly P, 2000, RESUSCITATION, V45, P195, DOI 10.1016/S0300-9572(00)00186-6; Dowie R, 2003, RESUSCITATION, V56, P173, DOI 10.1016/S0300-9572(02)00343-X; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; FENELEY MP, 1988, CIRCULATION, V77, P240, DOI 10.1161/01.CIR.77.1.240; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; Handley AJ, 2003, RESUSCITATION, V57, P57, DOI 10.1016/S0300-9572(02)00400-8; HIGHTOWER D, 1995, ANN EMERG MED, V26, P300, DOI 10.1016/S0196-0644(95)70076-5; *INT CONS SCI, 2000, CIRCULATION S1, V102, P1; KAYE W, 1986, CRIT CARE MED, V14, P620, DOI 10.1097/00003246-198607000-00007; Keim SM, 2001, RESUSCITATION, V51, P269, DOI 10.1016/S0300-9572(01)00418-X; Kern KB, 2003, RESUSCITATION, V58, P273, DOI 10.1016/S0300-9572(03)00269-7; Koster RW, 2003, RESUSCITATION, V58, P275, DOI 10.1016/S0300-9572(03)00270-3; Marsch SCU, 2004, RESUSCITATION, V60, P51, DOI 10.1016/j.resuscitation.2003.08.004; MILANDER MM, 1995, ACAD EMERG MED, V2, P708, DOI 10.1111/j.1553-2712.1995.tb03622.x; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Pellis T, 2002, CRIT CARE MED, V30, pS176, DOI 10.1097/00003246-200204001-00012; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Sato Y, 1997, CRIT CARE MED, V25, P733, DOI 10.1097/00003246-199705000-00005; Steen S, 2003, RESUSCITATION, V58, P249, DOI 10.1016/S0300-9572(03)00265-X; Sunde K, 1997, RESUSCITATION, V34, P235, DOI 10.1016/S0300-9572(96)01087-8; Timerman S, 2004, RESUSCITATION, V61, P273, DOI 10.1016/j.resuscitation.2004.01.025; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; WHITE RD, 1994, ANN EMERG MED, V23, P25, DOI 10.1016/S0196-0644(94)70003-6; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Wik L, 2001, RESUSCITATION, V50, P167, DOI 10.1016/S0300-9572(01)00331-8; Wik L, 2000, RESUSCITATION, V47, P7, DOI 10.1016/S0300-9572(00)00190-8; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E	36	890	957	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2005	293	3					305	310		10.1001/jama.293.3.305	http://dx.doi.org/10.1001/jama.293.3.305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888FA	15657323	Bronze			2022-12-01	WOS:000226358400024
J	Holowiecki, J				Holowiecki, J			NOTCH1 pathway: a molecular target in T-cell cancers?	LANCET			English	Editorial Material							GAMMA-SECRETASE; EXPRESSION; SURVIVAL; LEUKEMIA		Silesian Med Univ, Dept Haematol & BMT, PL-40023 Katowice, Poland	Medical University Silesia	Holowiecki, J (corresponding author), Silesian Med Univ, Dept Haematol & BMT, PL-40023 Katowice, Poland.	holow@slam.katowice.pl	Holowiecki, Jerzy/AAW-7928-2021					Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; HOUDE C, 2004, BLOOD           0803; Iwata M, 2004, BLOOD, V103, P4496, DOI 10.1182/blood-2004-01-0256; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kantarjian HM, 2004, BLOOD, V104, P1979, DOI 10.1182/blood-2004-02-0711; Laws AM, 2004, EUR J IMMUNOL, V34, P726, DOI 10.1002/eji.200324772; Lleo A, 2003, J BIOL CHEM, V278, P47370, DOI 10.1074/jbc.M308480200; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	14	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2005	365	9455					197	199						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887MG	15652588				2022-12-01	WOS:000226309600006
J	Jiang, H; Guo, W; Liang, XH; Rao, Y				Jiang, H; Guo, W; Liang, XH; Rao, Y			Both the establishment and the maintenance of neuronal polarity require active mechanisms: Critical roles of GSK-3 beta and its upstream regulators	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3; HIPPOCAMPAL-NEURONS; PROTEIN-KINASE; TUMOR-SUPPRESSOR; AXON; PHOSPHORYLATION; INHIBITION; GROWTH; TAU; FAMILY	Axon-dendrite polarity is a cardinal feature of neuronal morphology essential for information flow. Here we report a differential distribution of GSK-3beta activity in the axon versus the dendrites. A constitutively active GSK-3beta mutant inhibited axon formation, whereas multiple axons formed from a single neuron when GSK-3beta activity was reduced by pharmacological inhibitors, a peptide inhibitor, or siRNAs. An active mechanism for maintaining neuronal polarity was revealed by the conversion of preexisting dendrites into axons upon GSK-3 inhibition. Biochemical and functional data show that the Akt kinase and the PTEN phosphatase are upstream of GSK-3beta in determining neuronal polarity. Our results demonstrate that there are active mechanisms for maintaining as well as establishing neuronal polarity, indicate that GSK-3beta relays signaling from Akt and PTEN to play critical roles in neuronal polarity, and suggest that application of GSK-3beta inhibitors can be a novel approach to promote generation of new axons after neural injuries.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Grad Sch, Shanghai 200031, Peoples R China; Natl Inst Biol Sci, Beijing 102206, Peoples R China; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institute of Biological Sciences, Beijing; Northwestern University; Feinberg School of Medicine	Rao, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	y-rao@northwestem.edu		Jiang, Hui/0000-0002-0277-9711; Rao, Yi/0000-0002-0405-5426; Guo, Wei/0000-0002-9937-7152				AHMAD FJ, 1994, NEURON, V12, P271, DOI 10.1016/0896-6273(94)90270-4; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Esch T, 1999, J NEUROSCI, V19, P6417; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goold RG, 1999, J CELL SCI, V112, P3373; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174; LEIN PJ, 1992, DEV BRAIN RES, V69, P191, DOI 10.1016/0165-3806(92)90159-T; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lucas FR, 1998, J CELL SCI, V111, P1351; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mandell JW, 1996, J NEUROSCI, V16, P5727; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Rolls MM, 2004, NAT NEUROSCI, V7, P1293, DOI 10.1038/nn1346; Ruthel G, 2000, J NEUROSCI, V20, P2266; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Steward O, 2002, NEURON, V36, P338, DOI 10.1016/S0896-6273(02)01006-1; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; WANG QM, 1994, J BIOL CHEM, V269, P14566; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yu JY, 2003, MOL THER, V7, P228, DOI 10.1016/S1525-0016(02)00037-0; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	55	441	461	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2005	120	1					123	135		10.1016/j.cell.2004.12.033	http://dx.doi.org/10.1016/j.cell.2004.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652487	Bronze			2022-12-01	WOS:000226365400016
J	Puig, S; Askeland, E; Thiele, DJ				Puig, S; Askeland, E; Thiele, DJ			Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation	CELL			English	Article							ZINC-FINGER PROTEINS; GENOME-WIDE ANALYSIS; AU-RICH ELEMENTS; SACCHAROMYCES-CEREVISIAE; TRISTETRAPROLIN BINDS; ESCHERICHIA-COLI; GENE-EXPRESSION; CDNA ARRAYS; YEAST; TRANSCRIPTION	Iron (Fe) is an essential micronutrient for virtually all organisms and serves as a cofactor for a wide variety of vital cellular processes. Although Fe deficiency is the primary nutritional disorder in the world, cellular responses to Fe deprivation are poorly understood. We have discovered a posttranscriptional regulatory process controlled by Fe deficiency, which coordinately drives widespread metabolic reprogramming. We demonstrate that, in response to Fe deficiency, the Saccharomyces cerevisiae Cth2 protein specifically downregulates mRNAs encoding proteins that participate in many Fe-dependent processes. mRNA turnover requires the binding of Cth2, an RNA binding protein conserved in plants and mammals, to specific AU-rich elements in the 3' untranslated region of mRNAs targeted for degradation. These studies elucidate coordinated global metabolic reprogramming in response to Fe deficiency and identify a mechanism for achieving this by targeting specific mRNA molecules for degradation, thereby facilitating the utilization of limited cellular Fe levels.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Duke University	Thiele, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Res Dr LSRC-C351, Durham, NC 27710 USA.	dennis.thiele@duke.edu	Puig, Sergi/E-4788-2010	Puig, Sergi/0000-0002-1856-490X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41840] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nu.10.070190.001025, 10.1146/annurev.nutr.10.1.133]; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Khodursky AB, 2003, TRENDS GENET, V19, P113, DOI 10.1016/S0168-9525(02)00047-1; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Nittis T, 2002, SEMIN HEMATOL, V39, P282, DOI 10.1053/shem.2002.35633; Puig S, 2004, J BIOL CHEM, V279, P30298, DOI 10.1074/jbc.M313463200; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Putz U, 1996, NUCLEIC ACIDS RES, V24, P4838, DOI 10.1093/nar/24.23.4838; Roy CN, 2001, HUM MOL GENET, V10, P2181, DOI 10.1093/hmg/10.20.2181; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Stoecklin G, 2001, RNA, V7, P1578; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Theil EC, 2000, BIOCHEM PHARMACOL, V59, P87, DOI 10.1016/S0006-2952(99)00300-7; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Van Ho A, 2002, ANNU REV MICROBIOL, V56, P237, DOI 10.1146/annurev.micro.56.012302.160847; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x	38	307	317	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 14	2005	120	1					99	110		10.1016/j.cell.2004.11.032	http://dx.doi.org/10.1016/j.cell.2004.11.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	888HS	15652485	Bronze			2022-12-01	WOS:000226365400014
J	Cosgrove, SE; Fishman, NO; Talbot, TR; Woeltje, KF; Schaffner, W; Fraser, VJ; McMillan, JA; Perl, TM				Cosgrove, SE; Fishman, NO; Talbot, TR; Woeltje, KF; Schaffner, W; Fraser, VJ; McMillan, JA; Perl, TM			Strategies for use of a limited influenza vaccine supply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERUM ANTIBODY-RESPONSES; VIRUS VACCINE; LIVE; TRIVALENT; SAFETY; IMMUNOGENICITY; EFFICACY		Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA; Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; University of Pennsylvania; Vanderbilt University; Washington University (WUSTL); Johns Hopkins University	Cosgrove, SE (corresponding author), Johns Hopkins Univ Hosp, Osler 425,600 N Wolfe St, Baltimore, MD 21287 USA.	scosgro1@jhmi.edu		Fraser, Victoria/0000-0001-6251-0733; Talbot, Thomas/0000-0002-6139-212X; Woeltje, Keith/0000-0002-6385-3970				Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1; Belshe RB, 2004, CLIN INFECT DIS, V39, P920, DOI 10.1086/423001; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Cha TA, 2000, J CLIN MICROBIOL, V38, P839, DOI 10.1128/JCM.38.2.839-845.2000; *DEP HLTH HUM SERV, RESP HYG COUGH ET HE; *DEP HLTH HUM SERV, CDCP ADV COMM IMM PR; Hayden Frederick G., 1997, American Journal of Medicine, V102, P55, DOI 10.1016/S0002-9343(97)80013-7; Jackson LA, 1999, VACCINE, V17, P1905, DOI 10.1016/S0264-410X(98)00471-X; KEITEL WA, 1993, J INFECT DIS, V167, P305, DOI 10.1093/infdis/167.2.305; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; King JC, 2000, J INFECT DIS, V181, P725, DOI 10.1086/315246; King JC, 2001, PEDIATR INFECT DIS J, V20, P1124, DOI 10.1097/00006454-200112000-00006; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Sartor C, 2002, INFECT CONT HOSP EP, V23, P615, DOI 10.1086/501981; TALBOT TR, 2004, SOC HEALTHC EP AM 14; Treanor J, 2002, VACCINE, V20, P1099, DOI 10.1016/S0264-410X(01)00440-6; VESIKARI T, 2001, 41 INT C ANT AG CHEM; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908	20	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					229	232		10.1001/jama.293.2.229	http://dx.doi.org/10.1001/jama.293.2.229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644550				2022-12-01	WOS:000226171000039
J	Annas, GJ				Annas, GJ			"Culture of life'' politics at the bedside - The case of Terri Schiavo	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1991, NEW ENGL J MED, V324, P1210, DOI 10.1056/NEJM199104253241711; ANNAS GJ, 1975, RIGHTS HOSP PATIENTS, P81; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; EISENBERG D, 2005, TIME            0404, P23; GOODNOUGH A, 2005, NY TIMES        0427, pA1; Kirkpatrick David D, 2005, N Y Times Web, pA18; *MULT TASK FORC PV, 1995, NEW ENGL J MED, V333, P130; Shannon TA, 2004, HASTINGS CENT REP, V34, P18, DOI 10.2307/3528689	8	95	97	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1710	1715		10.1056/NEJMlim050643	http://dx.doi.org/10.1056/NEJMlim050643			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15784657	Green Published			2022-12-01	WOS:000228515200015
J	Berry, RJ; Kihlberg, R; Devine, O				Berry, RJ; Kihlberg, R; Devine, O			Impact of misclassification of in vitro fertilisation in studies of folic acid and twinning: modelling using population based Swedish vital records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUPPLEMENTATION; FORTIFICATION; RATES; BORN; RISK	Objective To determine whether failure to adequately adjust for a reported 40% misclassification of use of in vitro fertilisation (IVF) as reported in a Swedish study could have led to a false finding that folic acid increases dizygotic twinning. Design Modelling with population based data. Setting Swedish vital records for 1995-9. Main outcome measures Rates of twinning calculated according to whether women used AT to become pregnant. Estimated unadjusted and adjusted odds ratios of the association between use of folic acid and twinning by use of IVF. Results In 1995-9, Swedish women who used IVF had almost 20 times the chance of having twins than women who did not use IVF (rate ratio 19.7, 95% confidence interval 18.7 to 20.6). In the absence of true effect of folic acid, the use of a 40% misclassified surrogate variable to adjust for use of IVF would have resulted in a false finding that folic acid was associated with a more than twofold increase in twinning. Conclusion Use of IVF is a strong confounder because it is associated with both use of folic acid and twinning. Even when misclassification of IVF was reduced to 5%, this bias persisted in the adjusted model. Using a 40% misclassified surrogate to adjust for IVF, as reported in the Swedish study, probably led to a false finding that folic acid increased dizygotic twinning.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Dept Hlth & Human Serv, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Berry, RJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Dept Hlth & Human Serv, 1600 Clifton Rd,MS E-86, Atlanta, GA 30333 USA.	RJBerry@cdc.gov		Berry, Robert/0000-0002-7162-5046				Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Cornel MC, 1997, TERATOLOGY, V55, P134; Czeizel A. E., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P175; Czeizel AE, 2004, AM J OBSTET GYNECOL, V191, P790, DOI 10.1016/j.ajog.2004.02.018; Ericson A, 2002, HUM REPROD, V17, P929, DOI 10.1093/humrep/17.4.929; Ericson A, 2001, Twin Res, V4, P63, DOI 10.1375/twin.4.2.63; George L, 2002, JAMA-J AM MED ASSOC, V288, P1867, DOI 10.1001/jama.288.15.1867; Kallen B, 2002, OBSTET GYNECOL, V100, P414, DOI 10.1016/S0029-7844(02)02069-0; Kallen B, 2004, EARLY HUM DEV, V80, P143, DOI 10.1016/j.earlhumdev.2004.06.002; KIHLBERG R, 2002, DAGENS MED, V41, P38; Kinzler WL, 2000, J SOC GYNECOL INVEST, V7, P321, DOI 10.1016/S1071-5576(00)00084-8; Kucik J, 2004, J REPROD MED, V49, P707; Li Z, 2003, LANCET, V361, P380, DOI 10.1016/S0140-6736(03)12390-2; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; Marshall JR, 2003, J NUTR, V133, p881S, DOI 10.1093/jn/133.3.881S; *NAT BOARD HLTH WE, 2004, ASS BEFR 2001; *NAT BOARD HLTH WE, 2000, BARN FODD SVER PROV; National Board of Health and Welfare Centre for Epidemiology, 2003, SWED MED BIRTH REG S; National Board of Health and Welfare Centre for Epidemiology, 2002, FAKT MAMM FORL NYF B; Shaw GM, 2003, AM J MED GENET A, V119A, P137, DOI 10.1002/ajmg.a.20145; Waller DK, 2003, PAEDIATR PERINAT EP, V17, P378, DOI 10.1046/j.1365-3016.2003.00511.x	21	16	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2005	330	7495					815	818		10.1136/bmj.38369.437789.82	http://dx.doi.org/10.1136/bmj.38369.437789.82			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915BZ	15722370	Bronze, Green Published			2022-12-01	WOS:000228273900015
J	Akiyama, T; Maeda, S; Yamane, S; Ogino, K; Kasai, M; Kajiura, F; Matsumoto, M; Inoue, J				Akiyama, T; Maeda, S; Yamane, S; Ogino, K; Kasai, M; Kajiura, F; Matsumoto, M; Inoue, J			Dependence of self-tolerance on TRAF6-directed development of thymic stroma	SCIENCE			English	Article							NF-KAPPA-B; PROMISCUOUS GENE-EXPRESSION; NEGATIVE SELECTION; AIRE EXPRESSION; RECEPTOR; CELLS; RELB; MICE; PROTEIN; KINASE	The microenvironments of the thymus are generated by thymic epithelial cells (TECs) and are essential for inducing immune self-toterance or developing T cells. However, the molecular mechanisms that underlie the differentiation of TECs and thymic compartmentalization are not fully understood. Here we show that deficiency in the tumor necrosis factor receptor-associated factor (TRAF) 6 results in disorganized distribution of medullary TECs (mTECs) and the absence of mature mTECs. Engraftment of thymic stroma of TRAF6(-/-)embryos into athymic nude mice induced autoimmunity. Thus, TRAF6 directs the development of thymic stroma and represents a critical point of regulation for self-tolerance and autoimmunity.	Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo 1088639, Japan; Natl Inst Infect Dis, Div Bacterial & Blood Prod, Musashimurayama, Tokyo 2080011, Japan; Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 7708503, Japan	University of Tokyo; National Institute of Infectious Diseases (NIID); Tokushima University	Inoue, J (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo 1088639, Japan.	jun-i@ims.u-tokyo.ac.jp						Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Chiffoleau E, 2003, J IMMUNOL, V171, P5751, DOI 10.4049/jimmunol.171.11.5751; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; KASAI M, 1991, CELL IMMUNOL, V132, P377, DOI 10.1016/0008-8749(91)90035-A; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; SCHENINKING J, 1993, MOLT SALT FORUM, V1&2, P13; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	28	225	233	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					248	251		10.1126/science.1105677	http://dx.doi.org/10.1126/science.1105677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15705807				2022-12-01	WOS:000228273700052
J	Condon, D; Zhu, MY; Bowring, S; Wang, W; Yang, AH; Jin, YG				Condon, D; Zhu, MY; Bowring, S; Wang, W; Yang, AH; Jin, YG			U-Pb ages from the neoproterozoic Doushantuo Formation, China	SCIENCE			English	Article							SNOWBALL EARTH HYPOTHESIS; SOUTH CHINA; MARINOAN GLACIATION; METAZOAN EVOLUTION; CONSTRAINTS; FOSSILS; NAMIBIA; OMAN; CARBONATES; AUSTRALIA	U-Pb zircon dates from volcanic ash beds within the Doushantuo Formation (China) indicate that its deposition occurred between 635 and 551 million years ago. The base records termination of the global-scale Marinoan glaciation and is coeval with similar dated rocks from Namibia, indicating synchronous deglaciation. Carbon isotopic and sequence-stratigraphic data imply that the spectacular animal fossils of the Doushantuo Formation are for the most part younger than 580 million years old. The uppermost Doushantuo Formation contains a pronounced negative carbonate carbon isotopic excursion, which we interpret as a global event at circa 551 million years ago.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Chinese Acad Sci, Nanjing Inst Geol & Paleontol, Nanjing 210008, Peoples R China	Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS	Condon, D (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	dcondon@mit.edu	Condon, Daniel/A-4249-2008; Zhu, Maoyan/K-1124-2014	Condon, Daniel/0000-0002-9082-3283; Zhu, Maoyan/0000-0001-7327-9856				Allen P.A., 2002, 16 INT SED C VOL JOA, P7; Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Bowring SA, 2003, GEOPH RES ABSTR, V5, P13219; BURNS SJ, 1993, ECLOGAE GEOL HELV, V86, P595; Calver CR, 2000, PRECAMBRIAN RES, V100, P121, DOI 10.1016/S0301-9268(99)00072-8; Chen DF, 2004, PRECAMBRIAN RES, V132, P123, DOI 10.1016/j.precamres.2004.02.005; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Corsetti FA, 2003, GEOL SOC AM BULL, V115, P916, DOI 10.1130/B25066.1; Cozzi A, 2004, GEOL SOC AM BULL, V116, P1367, DOI 10.1130/B25387.1; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Grazhdankin D, 2004, PALEOBIOLOGY, V30, P203, DOI 10.1666/0094-8373(2004)030<0203:PODITE>2.0.CO;2; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; HALVERSON GP, IN PRESS GEOL SOC AM; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hoffmann KH, 2004, GEOLOGY, V32, P817, DOI 10.1130/G20519.1; Jenkins RJF, 2002, J GEOL SOC LONDON, V159, P645, DOI 10.1144/0016-764901-127; Jiang GQ, 2003, GEOLOGY, V31, P917, DOI 10.1130/G19790.1; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Macouin M, 2004, EARTH PLANET SC LETT, V224, P387, DOI 10.1016/j.epsl.2004.05.015; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Myrow PM, 1999, J SEDIMENT RES, V69, P784, DOI 10.2110/jsr.69.784; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Saylor BZ, 1998, J SEDIMENT RES, V68, P1223, DOI 10.2110/jsr.68.1223; [王伟 Wang Wei], 2002, [微体古生物学报, Acta Micropalaeontologica Sinica], V19, P382; Wood RA, 2002, SCIENCE, V296, P2383, DOI 10.1126/science.1071599; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2004, PRECAMBRIAN RES, V130, P1, DOI 10.1016/j.precamres.2003.10.013; Xiao SH, 2002, J PALEONTOL, V76, P347, DOI 10.1666/0022-3360(2002)076<0347:MCCIAT>2.0.CO;2; Yang JD, 1999, PRECAMBRIAN RES, V93, P215; Zhou CM, 2004, GEOLOGY, V32, P437, DOI 10.1130/G20286.1; Zhu MY, 2003, PROG NAT SCI-MATER, V13, P951, DOI 10.1080/10020070312331344710	35	969	1152	12	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					95	98		10.1126/science.1107765	http://dx.doi.org/10.1126/science.1107765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15731406				2022-12-01	WOS:000228221500040
J	Stanulla, M; Schaeffeler, E; Flohr, T; Cario, G; Schrauder, A; Zimmermann, M; Welte, K; Ludwig, WD; Bartram, CR; Zanger, UM; Eichelbaum, M; Schrappe, M; Schwab, M				Stanulla, M; Schaeffeler, E; Flohr, T; Cario, G; Schrauder, A; Zimmermann, M; Welte, K; Ludwig, WD; Bartram, CR; Zanger, UM; Eichelbaum, M; Schrappe, M; Schwab, M			Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMAL RESIDUAL DISEASE; S-METHYLTRANSFERASE; PROGNOSTIC VALUE; POPULATION; 6-MERCAPTOPURINE; QUANTIFICATION; IDENTIFICATION; POLYMORPHISM; PHENOTYPE; ALLELES	Context Early response to multiagent chemotherapy, including mercaptopurine, as measured by minimal residual disease is an important prognostic factor for children with acute lymphoblastic leukemia (ALL). Thiopurine m ethyltransfe rase (TPMT) is involved in the metabolism of mercaptopurine and subject to genetic polymorphism, with heterozygous individuals having intermediate and homozygous mutant individuals having very low TPMT activity. Objective To assess the association of TPMT genotype with minimal residual disease load before and after treatment with mercaptopurine in the early treatment course of childhood ALL. Design, Setting, and Patients TPMT genotyping of childhood ALL patients (n=814) in Germany consecutively enrolled in the ALL-BFM (Berlin-Frankfurt-MOnster) 2000 study from October 1999 to September 2002. Minimal residual disease was analyzed on treatment days 33 and 78 for risk-adapted treatment stratification. A 4-week cycle of mercaptopurine was administered between these 2 minimal residual disease measurements. Patients (n =4) homozygous for a mutant TPMT allele, and consequently deficient in TPMT activity, were treated with reduced doses of mercaptopurine and, therefore, not included in the analyses. Main Outcome Measures Minimal residual disease load before (day 33) and after (day 78) mercaptopurine treatment. Loads smaller than 10(-4) were defined as negative. Results Patients (n =55) heterozygous for allelic variants of TPMT conferring lower enzyme activity had a significantly lower rate of minimal residual disease positivity (9.1%) compared with patients (n=755) with homozygous wild-type alleles (22.8%) on day 78 (P=.02). This translated into a 2.9-fold reduction in risk for patients with wild-type heterozygous alleles (relative risk, 0.34; 95% confidence interval, 0.13-0.86). Conclusions TPMT genotype has a substantial impact on minimal residual disease after administration of mercaptopurine in the early course of childhood ALL, most likely through modulation of mercaptopurine dose intensity. Our findings support a role for minimal residual disease analyses in the assessment of genotype-phenotype associations in multiagent chemotherapeutic trials.	Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany; Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; HELIOS Clin Berlin, Dept Hematol Oncol & Tumor Immunol, Robert Rossle Clin, Berlin, Germany; Univ Childrens Hosp, Kiel, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital	Stanulla, M (corresponding author), Hannover Med Sch, Dept Pediat Hematol & Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Stanulla.Martin@MH-Hannover.de	Zanger, Ulrich M./A-9364-2012; Stanulla, Martin/N-4674-2017; Stanulla, Martin/D-2528-2010; Schwab, Matthias/ABH-7449-2020; Schrappe, Martin/ABA-6144-2020; Schrappe, Martin/A-8109-2010; Cario, Gunnar/D-2535-2010	Zanger, Ulrich M./0000-0002-5276-2002; Stanulla, Martin/0000-0002-3834-0727; 				BRISCO MJ, 1994, LANCET, V343, P196, DOI 10.1016/S0140-6736(94)90988-1; BURCHENAL JH, 1953, BLOOD, V8, P965, DOI 10.1182/blood.V8.11.965.965; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Ciudad J, 1998, J CLIN ONCOL, V16, P3774, DOI 10.1200/JCO.1998.16.12.3774; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Dworzak MN, 2002, BLOOD, V99, P1952, DOI 10.1182/blood.V99.6.1952; ELION GB, 1952, J AM CHEM SOC, V74, P411, DOI 10.1021/ja01122a037; Ganiere-Monteil C, 2004, EUR J CLIN PHARMACOL, V60, P89, DOI 10.1007/s00228-004-0732-5; Indjova D, 2003, THER DRUG MONIT, V25, P631, DOI 10.1097/00007691-200310000-00013; Kurzawski M, 2004, THER DRUG MONIT, V26, P541, DOI 10.1097/00007691-200410000-00013; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; McLeod HL, 1999, BRIT J HAEMATOL, V105, P696, DOI 10.1046/j.1365-2141.1999.01416.x; *NAT CANC I, 1999, COMM TOX CRIT MAN VE; Nyvold C, 2002, BLOOD, V99, P1253, DOI 10.1182/blood.V99.4.1253; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Relling MV, 1999, BLOOD, V93, P2817; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db; Schaeffeler E, 2001, CLIN CHEM, V47, P548; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; Silverman LB, 2003, CURR OPIN HEMATOL, V10, P290, DOI 10.1097/00062752-200307000-00007; van der Velden VHJ, 2003, LEUKEMIA, V17, P1013, DOI 10.1038/sj.leu.2402922; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6	24	214	237	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1485	1489		10.1001/jama.293.12.1485	http://dx.doi.org/10.1001/jama.293.12.1485			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784872				2022-12-01	WOS:000227784700028
J	Battersby, MW				Battersby, MW		SA HlthPlus Team	Health reform through coordinated care: SA HealthPlus	BRITISH MEDICAL JOURNAL			English	Article								How can care for chronic illness best be coordinated? An Australian study sought to move towards collaborative and patient centred planned care.	Flinders Univ S Australia, Flinders Human Behav & Hlth Res Unit, Adelaide, SA 5001, Australia	Flinders University South Australia	Battersby, MW (corresponding author), Flinders Univ S Australia, Flinders Human Behav & Hlth Res Unit, GPO Box 2100, Adelaide, SA 5001, Australia.	malcolm.battersby@flinders.edu.au		Battersby, Malcolm/0000-0001-7306-5591				Australian Government Department of Health and Ageing, AUSTR PRIM CAR COLL; Badamgarav E, 2003, AM J PSYCHIAT, V160, P2080, DOI 10.1176/appi.ajp.160.12.2080; Battersby M, 2002, AUSTR COORDINATED CA, P201; Battersby MW., 2003, AUSTR J PRIMARY HLTH, V9, P41, DOI [DOI 10.1071/PY03022, 10.1071/PY03022]; Chen A, 2000, BEST PRACTICES COORD; *COMM DEP HLTH AG, 2004, LOOK OUR PEOPL INF H; *COMM DEP HLTH AG, 2001, 2911 COMM DEP HLTH A; *COMM DEP HLTH AG, 1999, EXPR INT PRIM CAR I; Commonwealth Department of Health and Aged Care, 1999, AUSTR COORD CAR TRIA; GAMBLE C, 2000, WORKING SERIOUS MENT; Harvey P, 2000, AUST NZ J PUBL HEAL, V24, P217, DOI 10.1111/j.1467-842X.2000.tb00149.x; HARVEY PW, 2001, AUST J RURAL HEALTH, V9, P70, DOI DOI 10.1046/J.1440-1584.2001.00319.X; HARVEY PW, 2001, THESIS U W AUSTR PER; HEARD A, 2002, AUST J PRIM HEALTH, V8, P52; Henning JH, 2002, BRIT MED J, V325, P1; Marks I, 1986, BEHAV PSYCHOTHERAPY; Marks IM, 1977, NURSING BEHAV PSYCHO; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; *S AUSTR DEP HUM S, 2003, FIN REP GEN HLTH REV; Smith BJ, 2002, MED J AUSTRALIA, V177, P481, DOI 10.5694/j.1326-5377.2002.tb04915.x; Wagner E H, 1999, Manag Care Q, V7, P56; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	23	69	71	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					662	665		10.1136/bmj.330.7492.662	http://dx.doi.org/10.1136/bmj.330.7492.662			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	909LP	15775001	Green Published, Green Submitted			2022-12-01	WOS:000227861700034
J	Fialova, D; Topinkova, E; Gambassi, G; Finne-Soveri, H; Jonsson, PV; Carpenter, I; Schroll, M; Onder, G; Sorbye, LW; Wagner, C; Reissigova, J; Bernabei, R				Fialova, D; Topinkova, E; Gambassi, G; Finne-Soveri, H; Jonsson, PV; Carpenter, I; Schroll, M; Onder, G; Sorbye, LW; Wagner, C; Reissigova, J; Bernabei, R		AdHOC Project Res Grp	Potentially inappropriate among elderly home medication use care patients in Europe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMUM DATA SET; OLDER-ADULTS; EXPLICIT CRITERIA; CONSENSUS PANEL; COMMUNITY; POPULATION; RESIDENTS; POLYPHARMACY; INPATIENTS; PEOPLE	Context Criteria for potentially inappropriate medication use among elderly patients have been used in the past decade in large US epidemiological surveys to identify populations at risk and specifically target risk-management strategies. In contrast, in Europe little information is available about potentially inappropriate medication use and is based on small studies with uncertain generalizability. Objective To estimate the prevalence and associated factors of potentially inappropriate medication use among elderly home care patients in European countries. Design, Setting, and Participants Retrospective cross-sectional study of 2707 elderly patients receiving home care (mean [SDI age, 82.2 [7.2] years) representatively enrolled in metropolitan areas of the Czech Republic, Denmark, Finland, Iceland, Italy, the Netherlands, Norway, and the United Kingdom. Patients were prospectively assessed between September 2001 and January 2002 using the Minimum Data Set in Home Care instrument. Main Outcome Measures Prevalence of potentially inappropriate medication use was documented using all expert panels criteria for community-living elderly persons (Beers and McLeod). Patient-related characteristics independently associated with inappropriate medication use were identified with a multiple logistic regression model. Results Combining all 3 sets of criteria, we found that 19.8% of patients in the total sample used at least 1 inappropriate medication; using older 1997 criteria it was 9.8% to 10.9%. Substantial differences were documented between Eastern Europe (41.1% in the Czech Republic) and Western Europe (mean 15.8%, ranging from 5.8% in Denmark to 26.5% in Italy). Potentially inappropriate medication use was associated with patient's poor economic situation (adjusted relative risk [RR], 1.96; 95% confidence interval [CI], 1.58-2.36), polypharmacy (RR, 1.91; 95% Cl, 1.62-2.22), anxiolytic drug use (RR, 1.82; 95% Cl, 1.51-2.15), and depression (RR, 1.29; 95% Cl, 1.06-1.55). Negatively associated factors were age 85 years and older (RR, 0.78; 95% Cl, 0.65-0.92) and living alone (RR, 0.76; 95% Cl, 0.64-0.89). The odds of potentially inappropriate medication use significantly increased with the number of associated factors (P<.001). Conclusions Substantial differences in potentially inappropriate medication use exist between European countries and might be a consequence of different regulatory measures, clinical practices, or inequalities in socioeconomic background. Since financial resources and selected patient-related characteristics are associated with such prescribing, specific educational strategies and regulations should reflect these factors to improve prescribing quality in elderly individuals in Europe.	Charles Univ Prague, Dept Geriatr & Gerontol, Fac Med 1, Prague 12000 2, Czech Republic; Charles Univ Prague, Fac Pharm, Dept Social & Clin Pharm, CS-50165 Hradec Kralove, Czech Republic; Univ Cattolica Sacro Cuore, Ctr Med Invecchiamento, Rome, Italy; Natl Res & Dev Ctr Social Welf & Hlth, STATES CHESS, Helsinki, Finland; Univ Iceland, Landspitali Univ Hosp, Dept Geriatr, Reykjavik, Iceland; Univ Kent, Ctr Hlth Serv Studies, Canterbury, Kent, England; E Kent Hosp NHS Trust, Canterbury, Kent, England; Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; Decon Coll, Oslo, Norway; Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; AS CR, Inst Comp Sci, EuroMISE Ctr, Prague, Czech Republic	Charles University Prague; Charles University Prague; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Landspitali National University Hospital; University of Iceland; University of Kent; University of Copenhagen; Bispebjerg Hospital; Netherlands Institute for Health Services Research; Czech Academy of Sciences; Institute of Computer Science of the Czech Academy of Sciences	Fialova, D (corresponding author), Charles Univ Prague, Dept Geriatr & Gerontol, Fac Med 1, Londynska 15, Prague 12000 2, Czech Republic.	fickova@faf.cuni.cz	Reissigova, Jindra/B-3201-2014; Bernabei, Roberto/AAB-2704-2019; Topinkova, Eva/A-5076-2019	Bernabei, Roberto/0000-0002-9197-004X; Topinkova, Eva/0000-0002-6786-4116				ADAMS SR, 2002, 48325 HCFAOBRA MEDPA; Balogun SA, 2003, J AM GERIATR SOC, V51, pS103; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; *BRIT MED ASS ROYA, 2004, BRIT NAT FORM; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Chutka DS, 2004, MAYO CLIN PROC, V79, P122, DOI 10.4065/79.1.122; Cohen JS, 2000, GERIATRICS-US, V55, P54; Curtis LH, 2004, ARCH INTERN MED, V164, P1621, DOI 10.1001/archinte.164.15.1621; *CZECH NAT FORM, 2003, PHARM BREV; Fick D, 2001, J MANAGE CARE PHARM, V7, P407, DOI [10.18553/jmcp.2001.7.5.407, DOI 10.18553/JMCP.2001.7.5.407]; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Giron MST, 2001, J AM GERIATR SOC, V49, P277, DOI 10.1046/j.1532-5415.2001.4930277.x; Goulding MR, 2004, ARCH INTERN MED, V164, P305, DOI 10.1001/archinte.164.3.305; Gray SL, 2003, ANN PHARMACOTHER, V37, P988, DOI 10.1345/aph.1C365; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hanlon JT, 2004, ANN PHARMACOTHER, V38, P9, DOI 10.1345/aph.1D313; *IC NAT FORM, 2003, SERL 2002 2003; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; Lane CJ, 2004, J AM GERIATR SOC, V52, P861, DOI 10.1111/j.1532-5415.2004.52250.x; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Linjakumpu T, 2002, INT J GERIATR PSYCH, V17, P874, DOI 10.1002/gps.712; Malik AB, 2003, J AM GERIATR SOC, V51, pS123; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; MCNUTT LA, 1994, J CLIN EPIDEMIOL, V47, P613, DOI 10.1016/0895-4356(94)90209-7; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; *NORW MED AG, NORW PHARM PROD COMP; Onder G, 2003, EUR J CLIN PHARMACOL, V59, P157, DOI 10.1007/s00228-003-0600-8; ONDER G, IN PRESS EUR J CLIN; Pitkala KH, 2002, ARCH INTERN MED, V162, P1707, DOI 10.1001/archinte.162.15.1707; Schmader KE, 2004, AM J MED, V116, P394, DOI 10.1016/j.amjmed.2003.10.031; STEWART RB, 1994, DRUG AGING, V4, P449, DOI 10.2165/00002512-199404060-00002; STUCK AE, 1994, ARCH INTERN MED, V154, P2195; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Thirstrup S, 2001, LANCET, V358, P1734, DOI 10.1016/S0140-6736(01)06760-5; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	41	480	501	5	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1348	1358		10.1001/jama.293.11.1348	http://dx.doi.org/10.1001/jama.293.11.1348			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	907EP	15769968	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000227698600023
J	Arvidson, RE; Poulet, F; Bibring, JP; Wolff, M; Gendrin, A; Morris, RV; Freeman, JJ; Langevin, Y; Mangold, N; Bellucci, G				Arvidson, RE; Poulet, F; Bibring, JP; Wolff, M; Gendrin, A; Morris, RV; Freeman, JJ; Langevin, Y; Mangold, N; Bellucci, G			Spectral reflectance and morphologic correlations in eastern Terra Meridiani, Mars	SCIENCE			English	Article							OPPORTUNITY ROVER; PLANUM; SPECTROMETER; WATER	The Mars Express Observatoire pour la Mineralogie, l'Eau, les Glaces, et l'Activite (OMEGA) hyperspectral image data covering eastern Terra Meridiani indicate the ubiquitous presence of molecular water in etched terrain materials that disconformabty overlie heavily cratered terrains and underlie the hematite-bearing plains explored by the Opportunity rover. Identification of crystalline water in kieserite (MgSO4.H2O) is linked to materials exposed in a valley and plateau to the north of hematite-bearing plains. The mineralogical similarities between the etched terrain deposits examined with OMEGA data and the layered rocks examined by Opportunity imply that the ancient aqueous environments inferred from analyses of the rover data extend over regional scales.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Inst Astrophys Spatiale, F-91405 Orsay, France; Space Sci Inst, Boulder, CO 80301 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Ist Fis Spazio Interplanetario, Ist Nazl Astrofis, I-00133 Rome, Italy	Washington University (WUSTL); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Istituto Nazionale Astrofisica (INAF)	Arvidson, RE (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	arvidson@wunder.wustl.edu	Bellucci, Giancarlo/ABA-9201-2020	Bellucci, Giancarlo/0000-0003-0867-8679				Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Baldridge AM, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002066; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; BISHOP JL, UNPUB; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Crowley J.K., 2003, GEOCHEM-EXPLOR ENV A, V3, P219, DOI DOI 10.1144/1467-7873/03-001; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; Herzberg G, 1945, MOL SPECTRA MOL STRU; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; MORRIS RV, 1985, J GEOPHYS RES-SOLID, V90, P3126, DOI 10.1029/JB090iB04p03126; Murchie S, 2000, ICARUS, V147, P444, DOI 10.1006/icar.2000.6446; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; MUSTARD JF, 1994, GEOPHYS RES LETT, V21, P353, DOI 10.1029/94GL00198; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; STAMNES K, 1988, APPL OPTICS, V27, P2502, DOI 10.1364/AO.27.002502; Yen AS, 1998, J GEOPHYS RES-PLANET, V103, P11125, DOI 10.1029/98JE00739	24	150	154	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1591	1594		10.1126/science.1109509	http://dx.doi.org/10.1126/science.1109509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718425				2022-12-01	WOS:000227622400038
J	Froemke, RC; Poo, MM; Dan, Y				Froemke, RC; Poo, MM; Dan, Y			Spike-timing-dependent synaptic plasticity depends on dendritic location	NATURE			English	Article							ACTION-POTENTIALS; NMDA RECEPTORS; CALCIUM; MECHANISM; INPUTS; COINCIDENCE; SUMMATION; CHANNELS; NEURONS; CELLS	In the neocortex, each neuron receives thousands of synaptic inputs distributed across an extensive dendritic tree. Although postsynaptic processing of each input is known to depend on its dendritic location(1-8), it is unclear whether activity-dependent synaptic modification is also location-dependent. Here we report that both the magnitude and the temporal specificity of spike-timing-dependent synaptic modification(9-17) vary along the apical dendrite of rat cortical layer 2/3 pyramidal neurons. At the distal dendrite, the magnitude of long-termpotentiation is smaller, and the window of pre-/postsynaptic spike interval for long-term depression (LTD) is broader. The spike-timing window for LTD correlates with the window of action potential-induced suppression of NMDA (N-methyl-D-aspartate) receptors; this correlation applies to both their dendritic location-dependence and pharmacological properties. Presynaptic stimulation with partial blockade of NMDA receptors induced LTD and occluded further induction of spike-timing-dependent LTD, suggesting that NMDA receptor suppression underlies LTD induction. Computer simulation studies showed that the dendritic inhomogeneity of spike-timing-dependent synaptic modification leads to differential input selection at distal and proximal dendrites according to the temporal characteristics of presynaptic spike trains. Such location-dependent tuning of inputs, together with the dendritic heterogeneity of postsynaptic processing, could enhance the computational capacity of cortical pyramidal neurons.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X; Froemke, Robert/0000-0002-1230-6811				Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hausser M, 2001, SCIENCE, V291, P138, DOI 10.1126/science.291.5501.138; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422; Stuart G, 1998, J NEUROSCI, V18, P3501; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Waters J, 2003, J NEUROSCI, V23, P8558; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	30	265	269	4	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					221	225		10.1038/nature03366	http://dx.doi.org/10.1038/nature03366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759002				2022-12-01	WOS:000227494500047
J	Buddha, S				Buddha, S			Complication of urethral catheterisation	LANCET			English	Editorial Material									Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales		Buddha, S (corresponding author), Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales.								0	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					909	909		10.1016/S0140-6736(05)71051-5	http://dx.doi.org/10.1016/S0140-6736(05)71051-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752537				2022-12-01	WOS:000227444600035
J	Avery, AA; Prakash, CS; McHughen, A; Trewavas, AR; DeGregori, TR				Avery, AA; Prakash, CS; McHughen, A; Trewavas, AR; DeGregori, TR			What kind of farming works best?	SCIENCE			English	Letter									Ctr Global Food Issues, Hudson Inst, Churchville, VA 24421 USA; Tuskegee Univ, Ctr Plant Biotechnol Res, Tuskegee, AL 36088 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Houston, Dept Econ, Houston, TX 77204 USA	Tuskegee University; University of California System; University of California Riverside; University of Edinburgh; University of Houston System; University of Houston	Avery, AA (corresponding author), Ctr Global Food Issues, Hudson Inst, POB 202, Churchville, VA 24421 USA.	aavery@cgfi.org	McHughen, Alan/AAM-9215-2021					Dobbs TL, 1996, J SUSTAIN AGR, V9, P63, DOI 10.1300/J064v09n01_06; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; SHEPARD M, 2003, ASSESSMENT ENV IMPAC; SMIL V, COMMUNICATION; *SOIL WAT CONS SOC, 1995, FARM BETT ENV	5	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1410	1410						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15751124				2022-12-01	WOS:000227503100022
J	Loftus, BJ; Fung, E; Roncaglia, P; Rowley, D; Amedeo, P; Bruno, D; Vamathevan, J; Miranda, M; Anderson, IJ; Fraser, JA; Allen, JE; Bosdet, IE; Brent, MR; Chiu, R; Doering, TL; Dontin, MJ; D'Souza, CA; Fox, DS; Grinberg, V; Fu, JM; Fukushima, M; Haas, BJ; Huang, JC; Janbon, G; Jones, SJM; Koo, HL; Krzywinski, MI; Kwon-Chung, JK; Lengeler, KB; Maiti, R; Marra, MA; Marra, RE; Mathewson, CA; Mitchell, TG; Pertea, M; Riggs, FR; Salzberg, SL; Schein, JE; Shvartsbeyn, A; Shin, H; Shumway, M; Specht, CA; Suh, BB; Tenney, A; Utterback, TR; Wickes, BL; Wortman, JR; Wye, NH; Kronstad, JW; Lodge, JK; Heitman, J; Davis, RW; Fraser, CM; Hyman, RW				Loftus, BJ; Fung, E; Roncaglia, P; Rowley, D; Amedeo, P; Bruno, D; Vamathevan, J; Miranda, M; Anderson, IJ; Fraser, JA; Allen, JE; Bosdet, IE; Brent, MR; Chiu, R; Doering, TL; Dontin, MJ; D'Souza, CA; Fox, DS; Grinberg, V; Fu, JM; Fukushima, M; Haas, BJ; Huang, JC; Janbon, G; Jones, SJM; Koo, HL; Krzywinski, MI; Kwon-Chung, JK; Lengeler, KB; Maiti, R; Marra, MA; Marra, RE; Mathewson, CA; Mitchell, TG; Pertea, M; Riggs, FR; Salzberg, SL; Schein, JE; Shvartsbeyn, A; Shin, H; Shumway, M; Specht, CA; Suh, BB; Tenney, A; Utterback, TR; Wickes, BL; Wortman, JR; Wye, NH; Kronstad, JW; Lodge, JK; Heitman, J; Davis, RW; Fraser, CM; Hyman, RW			The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EVOLUTION; SEQUENCE	Cryptococcus neoformans is a basidionnycetous yeast ubiquitous in the environment, a model for fungal pathogenesis, and an opportunistic human pathogen of global importance. We have sequenced its similar to20-megabase genome, which contains similar to6500 intron-rich gene structures and encodes a transcriptome abundant in alternatively spliced and antisense messages. The genome is rich in transposons, many of which cluster at candidate centromeric regions. The presence of these transposons may drive karyotype instability and phenotypic variation. C. neoformans encodes unique genes that may contribute to its unusual virulence properties, and comparison of two phenotypically distinct strains reveals variation in gene content in addition to sequence polymorphisms between the genomes.	Inst Genom Res, Rockville, MD 20850 USA; Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Scuola Int Super Studi Avanzati, SISSA, I-34014 Trieste, Italy; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; Washington Univ, Lab Computat Genom, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Childrens Hosp, Louisiana State Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70118 USA; Childrens Hosp, Louisiana State Hlth Sci Ctr, Res Inst Children, New Orleans, LA 70118 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA; Inst Pasteur, Unite Mycol Mol, Paris 15, France; NIAID, Mol Microbiol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; Univ Dusseldorf, Inst Mikrobiol, D-4000 Dusseldorf, Germany; Connecticut Agr Expt Stn, New Haven, CT 06511 USA; Boston Univ, Dept Med, Boston, MA 02118 USA; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; J Craig Venter Fdn, Joint Technol Ctr, Rockville, MD 20850 USA	J. Craig Venter Institute; Stanford University; International School for Advanced Studies (SISSA); Duke University; Washington University (WUSTL); Washington University (WUSTL); Saint Louis University; University of British Columbia; Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Health San Antonio; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Heinrich Heine University Dusseldorf; Connecticut Agricultural Experiment Station; Boston University; University of California System; University of California Santa Cruz; J. Craig Venter Institute	Loftus, BJ (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	bjloftus@tigr.org	Fraser, James A/B-4918-2012; Mitchell, Thomas G./A-2356-2008; Salzberg, Steven L/F-6162-2011; Pertea, Mihaela/AAT-2705-2021; Marra, Marco A/B-5987-2008; Schein, Jacquie E/G-3674-2015; Heitman, Joseph/ABC-6006-2021; Janbon, Guilhem/AAW-7398-2021; Jones, Steven J/C-3621-2009; Marra, Robert E/G-4220-2011; Salzberg, Steven/Q-6514-2019; Brent, Michael/AAK-3702-2020; Janbon, Guilhem/AAL-6607-2021	Fraser, James A/0000-0001-5724-5285; Salzberg, Steven L/0000-0002-8859-7432; Pertea, Mihaela/0000-0003-0762-8637; Marra, Marco A/0000-0001-7146-7175; Janbon, Guilhem/0000-0002-4788-1154; Jones, Steven J/0000-0003-3394-2208; Salzberg, Steven/0000-0002-8859-7432; Brent, Michael/0000-0002-8689-0299; Wortman, Jennifer/0000-0002-8713-1227; Donlin, Maureen/0000-0001-7312-079X; Lodge, Jennifer/0000-0002-2526-1210; Vamathevan, Jessica/0000-0003-2016-9754; Allen, Jonathan/0000-0002-4359-8263; Roncaglia, Paola/0000-0002-2825-0621; Wickes, Brian/0000-0001-5909-5815; Fraser, Claire/0000-0003-1462-2428; loftus, brendan/0000-0001-8871-8356	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050184, U01AI047087, Z01AI000057, U01AI048594] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL088905-04A2, R01 HL088905] Funding Source: Medline; NIAID NIH HHS [AI47087, R01 AI050184-05, AI48594, R01 AI050184] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bose I, 2003, EUKARYOT CELL, V2, P655, DOI 10.1128/EC.2.4.655-663.2003; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; Casadevall A, 2000, CURR OPIN MICROBIOL, V3, P354, DOI 10.1016/S1369-5274(00)00103-X; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; FRASER JD, UNPUB; Gorlach JM, 2002, MICROBIOL-SGM, V148, P213, DOI 10.1099/00221287-148-1-213; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x	13	542	1296	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2005	307	5713					1321	1324		10.1126/science.1103773	http://dx.doi.org/10.1126/science.1103773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15653466	Green Accepted, Green Submitted			2022-12-01	WOS:000227313200062
J	Mota, LJ; Journet, L; Sorg, I; Agrain, C; Cornelis, GR				Mota, LJ; Journet, L; Sorg, I; Agrain, C; Cornelis, GR			Bacterial injectisomes: Needle length does matter	SCIENCE			English	Article									Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	guy.cornelis@unibas.ch	Mota, Luis/B-9497-2008	Mota, Luis/0000-0002-5592-8397; Journet, Laure/0000-0002-5847-2962				Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610	6	111	117	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1278	1278		10.1126/science.1107679	http://dx.doi.org/10.1126/science.1107679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731447				2022-12-01	WOS:000227313200049
J	West, NP; Sansonetti, P; Mounier, J; Exley, RM; Parsot, C; Guadagnini, S; Prevost, MC; Prochnicka-Chalufour, A; Delepierre, M; Tanguy, M; Tang, CM				West, NP; Sansonetti, P; Mounier, J; Exley, RM; Parsot, C; Guadagnini, S; Prevost, MC; Prochnicka-Chalufour, A; Delepierre, M; Tanguy, M; Tang, CM			Optimization of virulence functions through glucosylation of Shigella LPS	SCIENCE			English	Article							O-ANTIGEN MODIFICATION; IPAB PROTEIN; PLASMID; INVASION; GENES	Shigella, the leading cause of bacillary dysentery, uses a type III secretion system (TTSS) to inject proteins into human cells, leading to bacterial invasion and a vigorous inflammatory response. The bacterium is protected against the response by the O antigen of lipopolysaccha ride (LPS) on its surface. We show that bacteriophage-encoded glucosylation of Shigella O antigen, the basis of different serotypes, shortens the LPS molecule by around half. This enhances TTSS function without compromising the protective properties of the LPS. Thus, LPS glucosylation promotes bacterial invasion and evasion of innate immunity, which may have contributed to the emergence of serotype diversity in Shigella.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne, F-75724 Paris 15, France; Inst Pasteur, Plate Forme Microscopie Elect, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, F-75724 Paris 15, France	Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Tang, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, Ctr Mol Microbiol & Infect, Flowers Bldg, London SW7 2AZ, England.	c.tang@imperial.ac.uk	West, Nicholas P/C-3119-2008	West, Nicholas P/0000-0003-0955-9890				Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; BOCK K, 1982, J CHEM SOC PERK T 2, P59, DOI 10.1039/p29820000059; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Clement MJ, 2003, J BIOL CHEM, V278, P47928, DOI 10.1074/jbc.M308259200; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Huan PT, 1997, GENE, V195, P217, DOI 10.1016/S0378-1119(97)00143-1; ITO K, 1991, MICROBIOL IMMUNOL, V35, P335, DOI 10.1111/j.1348-0421.1991.tb01563.x; KENNE L, 1978, EUR J BIOCHEM, V91, P279, DOI 10.1111/j.1432-1033.1978.tb20963.x; MAURELLI AT, 1985, INFECT IMMUN, V49, P164, DOI 10.1128/IAI.49.1.164-171.1985; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; SANSONETTI PJ, 1995, J CLIN INVEST, V96, P884, DOI 10.1172/JCI118135; SIMMONS DAR, 1990, BIOCHEM SOC T, V18, P1271, DOI 10.1042/bst0181271; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; VENKATESAN MM, 1992, J BACTERIOL, V174, P1990, DOI 10.1128/jb.174.6.1990-2001.1992; WEST NP, UNPUB	20	231	249	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1313	1317		10.1126/science.1108472	http://dx.doi.org/10.1126/science.1108472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731456				2022-12-01	WOS:000227313200060
J	Sage, C; Huang, MQ; Karimi, K; Gutierrez, G; Vollrath, MA; Zhang, DS; Garcia-Anoveros, J; Hinds, PW; Corwin, JT; Corey, DP; Chen, ZY				Sage, C; Huang, MQ; Karimi, K; Gutierrez, G; Vollrath, MA; Zhang, DS; Garcia-Anoveros, J; Hinds, PW; Corwin, JT; Corey, DP; Chen, ZY			Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein	SCIENCE			English	Article							INNER-EAR; FATE DETERMINATION; ACOUSTIC TRAUMA; RB; MOUSE; GENE; MUTATION; REGENERATION; SURVIVAL; NEUROGENESIS	In mammals, hair cell loss causes irreversible hearing and balance impairment because hair cells are terminally differentiated and do not regenerate spontaneously. By profiling gene expression in developing mouse vestibular organs, we identified the retinoblastorna protein (pRb) as a candidate regulator of cell cycle exit in hair cells. Differentiated and functional mouse hair cells with a targeted deletion of Rb1 undergo mitosis, divide, and cycle, yet continue to become highly differentiated and functional. Moreover, acute loss of Rb1 in postnatal hair cells caused cell cycle reentry. Manipulation of the pRb pathway may ultimately lead to mammalian hair cell regeneration.	Massachusetts Gen Hosp, MGH HMS Ctr Nervous Syst Repair, Neurol Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Tufts New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Northwestern Univ, Inst Neurosci, Dept Anesthesiol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Dept Neurol, Chicago, IL 60611 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Virginia; Tufts Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Northwestern University; Northwestern University; Northwestern University	Chen, ZY (corresponding author), Massachusetts Gen Hosp, MGH HMS Ctr Nervous Syst Repair, Neurol Serv, Boston, MA 02114 USA.	zhengyi@helix.mgh.harvard.edu		Gutierrez, Gabriel/0000-0001-8487-0414; Corey, David/0000-0003-4497-6016; Garcia-Anoveros, Jaime/0000-0001-6561-9048	NIDCD NIH HHS [DC-00200, DC-04546, DC-AG20208] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004546] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen P, 2002, DEVELOPMENT, V129, P2495; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Ferguson KL, 2001, NEUROREPORT, V12, pA55, DOI 10.1097/00001756-200107030-00001; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Holt JR, 1999, J NEUROPHYSIOL, V81, P1881, DOI 10.1152/jn.1999.81.4.1881; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; Marino S, 2003, DEVELOPMENT, V130, P3359, DOI 10.1242/dev.00553; Meyers JR, 2003, J NEUROSCI, V23, P4054; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Vooijs M, 2002, ONCOGENE, V21, P4635, DOI 10.1038/sj.onc.1205575; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; WOODS AL, 1991, HISTOPATHOLOGY, V19, P21, DOI 10.1111/j.1365-2559.1991.tb00890.x; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	30	193	230	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1114	1118		10.1126/science.1106642	http://dx.doi.org/10.1126/science.1106642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15653467				2022-12-01	WOS:000227197300050
J	Kidwell, SM				Kidwell, SM			Shell composition has no net impact on large-scale evolutionary patterns in mollusks	SCIENCE			English	Article							FOSSIL RECORD; MISSING MOLLUSKS; DISSOLUTION; ARAGONITE; DIVERSITY; CARBONATE; SEAWATER	A major suspected bias in the fossil record of sketetonized groups is variation in preservability owing to differences in shell composition. However, despite extensive changes in shell composition over the 500-million-year history of marine bivalves, genus duration and shell composition show few significant relationships, and of those, virtually all are contrary to bias from preferential loss of highly reactive shell types. Distortion of large-scale temporal patterns in marine bivalves owing to preservability is thus apparently weak or randomly distributed, which increases the likelihood that observed patterns in this and other shelled groups carry a strong biological signal.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Kidwell, SM (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	skidwell@uchicago.edu						[Anonymous], 1969, B BRIT MUS NATL HIST; BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; Bush AM, 2004, J GEOL, V112, P625, DOI 10.1086/424576; Cherns L, 2000, GEOLOGY, V28, P791, DOI 10.1130/0091-7613(2000)028<0791:MMAEOL>2.3.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; GLOVER CP, 1993, J GEOL, V101, P729, DOI 10.1086/648271; Harper EM, 2000, J ZOOL, V251, P179, DOI 10.1017/S095283690000604X; Harper EM, 1998, ADEQUACY OF THE FOSSIL RECORD, P243; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; KOCH CF, 1983, PALEOBIOLOGY, V9, P26, DOI 10.1017/S0094837300007351; Kowalewski M, 1996, GEOLOGY, V24, P977, DOI 10.1130/0091-7613(1996)024<0977:IWATFR>2.3.CO;2; KOWALEWSKI M, 2002, 8 PAL SOC; MALIVA RG, 1988, J GEOL, V96, P387, DOI 10.1086/629235; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; MORSE JW, 1980, GEOCHIM COSMOCHIM AC, V44, P85, DOI 10.1016/0016-7037(80)90178-7; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Paul CRC, 1998, ADEQUACY OF THE FOSSIL RECORD, P111; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; RAUP D M, 1979, Bulletin of Carnegie Museum of Natural History, P85; Sanders D, 2003, J AFR EARTH SCI, V36, P99, DOI 10.1016/S0899-5362(03)00027-7; Schubert JK, 1997, GEOLOGY, V25, P1031, DOI 10.1130/0091-7613(1997)025<1031:SRFTTP>2.3.CO;2; Sepkoski, 2002, B AM PALEONTOL, V363, P1; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; SMITH AB, 2001, PALAEOBIOLOGY, V2, P504; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; WAINWRIG.SA, 1969, NATURE, V224, P777, DOI 10.1038/224777a0; WALTER LM, 1985, SEPM SPECIAL PUBLICA, V36, P3; Wright P, 2003, GEOLOGY, V31, P211, DOI 10.1130/0091-7613(2003)031<0211:MMFTTL>2.0.CO;2	29	76	77	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2005	307	5711					914	917		10.1126/science.1106654	http://dx.doi.org/10.1126/science.1106654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897DV	15705849				2022-12-01	WOS:000226985100050
J	Sumbre, G; Fiorito, G; Flash, T; Hochner, B				Sumbre, G; Fiorito, G; Flash, T; Hochner, B			Motor control of flexible octopus arms	NATURE			English	Editorial Material							REACHING MOVEMENTS; NERVOUS-SYSTEM; MODEL		Hebrew Univ Jerusalem, Inst Life Sci, Interdisciplinary Ctr Neuronal Computat, IL-91904 Jerusalem, Israel; Staz Zool Anton Dohrn, Neurobiol Lab, I-80121 Naples, Italy; Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Stazione Zoologica Anton Dohrn di Napoli; Weizmann Institute of Science; Hebrew University of Jerusalem	Sumbre, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	bennyh@lobsterls.huji.ac.il	Sumbre, German/K-7538-2017	Sumbre, German/0000-0003-4436-6840				BIZZI E, 1992, BEHAV BRAIN SCI, V15, P603, DOI 10.1017/S0140525X00072538; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P766; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Flash T, 2001, CURR OPIN NEUROBIOL, V11, P655, DOI 10.1016/S0959-4388(01)00265-3; Gutfreund Y, 1998, J NEUROSCI, V18, P5976; Gutfreund Y, 1996, J NEUROSCI, V16, P7297; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; SOECHTING JF, 1995, J NEUROSCI, V15, P6271; Sumbre G, 2001, SCIENCE, V293, P1845, DOI 10.1126/science.1060976; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	12	115	117	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2005	433	7026					595	596		10.1038/433595a	http://dx.doi.org/10.1038/433595a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	895KX	15703737				2022-12-01	WOS:000226862000031
J	Wittstein, IS; Thiemann, DR; Lima, JAC; Baughman, KL; Schulman, SP; Gerstenblith, G; Wu, KC; Rade, JJ; Bivalacqua, TJ; Champion, HC				Wittstein, IS; Thiemann, DR; Lima, JAC; Baughman, KL; Schulman, SP; Gerstenblith, G; Wu, KC; Rade, JJ; Bivalacqua, TJ; Champion, HC			Neurohumoral features of myocardial stunning due to sudden emotional stress	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; GENDER-DIFFERENCES; SUBARACHNOID HEMORRHAGE; NEUROPEPTIDE-Y; CARDIOMYOPATHY; PLASMA; ABNORMALITIES; LESIONS	BACKGROUND: Reversible left ventricular dysfunction precipitated by emotional stress has been reported, but the mechanism remains unknown. METHODS: We evaluated 19 patients who presented with left ventricular dysfunction after sudden emotional stress. All patients underwent coronary angiography and serial echocardiography; five underwent endomyocardial biopsy. Plasma catecholamine levels in 13 patients with stress-related myocardial dysfunction were compared with those in 7 patients with Killip class III myocardial infarction. RESULTS: The median age of patients with stress-induced cardiomyopathy was 63 years, and 95 percent were women. Clinical presentations included chest pain, pulmonary edema, and cardiogenic shock. Diffuse T-wave inversion and a prolonged QT interval occurred in most patients. Seventeen patients had mildly elevated serum troponin I levels, but only 1 of 19 had angiographic evidence of clinically significant coronary disease. Severe left ventricular dysfunction was present on admission (median ejection fraction, 0.20; interquartile range, 0.15 to 0.30) and rapidly resolved in all patients (ejection fraction at two to four weeks, 0.60; interquartile range, 0.55 to 0.65; P<0.001). Endomyocardial biopsy showed mononuclear infiltrates and contraction-band necrosis. Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction (median epinephrine level, 1264 pg per milliliter [interquartile range, 916 to 1374] vs. 376 pg per milliliter [interquartile range, 275 to 476]; norepinephrine level, 2284 pg per milliliter [interquartile range, 1709 to 2910] vs. 1100 pg per milliliter [interquartile range, 914 to 1320]; and dopamine level, 111 pg per milliliter [interquartile range, 106 to 146] vs. 61 pg per milliliter [interquartile range, 46 to 77]; P<0.005 for all comparisons). CONCLUSIONS: Emotional stress can precipitate severe, reversible left ventricular dysfunction in patients without coronary disease. Exaggerated sympathetic stimulation is probably central to the cause of this syndrome.	Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital	Wittstein, IS (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, Carnegie 568,600 N Wolfe St, Baltimore, MD 21287 USA.	iwittste@jhmi.edu	Wu, Katherine C/A-9760-2008					Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Brandspiegel HZ, 1998, CIRCULATION, V98, P1349, DOI 10.1161/01.CIR.98.13.1349; Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; CEBELIN MS, 1980, HUM PATHOL, V11, P123, DOI 10.1016/S0046-8177(80)80129-8; Desmet WJR, 2003, HEART, V89, P1027, DOI 10.1136/heart.89.9.1027; DRISLANE FW, 1987, AM REV RESPIR DIS, V135, P498; FRANKENHAEUSER M, 1976, PSYCHOPHARMACOLOGY, V47, P1, DOI 10.1007/BF00428693; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Grouzmann E, 2001, CLIN CHEM, V47, P1748; Grouzmann E, 2001, CLIN CHEM, V47, P1075; Hernandez-Pampaloni M, 2001, CIRCULATION, V104, P527, DOI 10.1161/hc3001.093503; Hinojosa-Laborde CM, 1999, CLIN EXP PHARMACOL P, V26, P122, DOI 10.1046/j.1440-1681.1999.02995.x; Jonsson BH, 2000, INTEGR PHYS BEH SCI, V35, P256, DOI 10.1007/BF02688788; Kawai S, 2000, JPN CIRC J, V64, P237; Kawai S, 2000, JPN CIRC J, V64, P156, DOI 10.1253/jcj.64.156; Kawano H, 2003, HEART VESSELS, V18, P32, DOI 10.1007/s003800300005; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; LACY CR, 1995, AM J CARDIOL, V75, P503, DOI 10.1016/S0002-9149(99)80590-6; Lambert G, 2002, BRAIN RES BULL, V58, P77, DOI 10.1016/S0361-9230(02)00762-1; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Mayer SA, 1999, STROKE, V30, P780, DOI 10.1161/01.STR.30.4.780; MORI H, 1993, CARDIOVASC RES, V27, P192, DOI 10.1093/cvr/27.2.192; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; Onuoha GN, 2000, EUR J CLIN INVEST, V30, P570; Pavin D, 1997, HEART, V78, P509, DOI 10.1136/hrt.78.5.509; PIERPONT GL, 1984, AM J PHYSIOL, V246, pH824, DOI 10.1152/ajpheart.1984.246.6.H824; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Sadamatsu K, 2000, JPN CIRC J, V64, P789, DOI 10.1253/jcj.64.789; Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Sharkey SW, 1998, CHEST, V114, P98, DOI 10.1378/chest.114.1.98; SINGAL PK, 1982, CAN J PHYSIOL PHARM, V60, P1390, DOI 10.1139/y82-207; Spreux-Varoquaux O, 2001, LIFE SCI, V69, P647, DOI 10.1016/S0024-3205(01)01158-4; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Villareal RP, 2001, MAYO CLIN PROC, V76, P79, DOI 10.4065/76.1.79; Wang TD, 1997, INT J CARDIOL, V58, P308, DOI 10.1016/S0167-5273(96)02879-3; WILKENFELD C, 1992, J HEART LUNG TRANSPL, V11, P363	39	2059	2164	1	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2005	352	6					539	548		10.1056/NEJMoa043046	http://dx.doi.org/10.1056/NEJMoa043046			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	895KY	15703419				2022-12-01	WOS:000226862100004
J	Pedersen, TR; Gerken, EA				Pedersen, TR; Gerken, EA			Creation of visible artificial optical emissions in the aurora by high-power radio waves	NATURE			English	Article								Generation of artificial light in the sky by means of high-power radio waves interacting with the ionospheric plasma has been envisaged since the early days of radio exploration of the upper atmosphere, with proposed applications ranging from regional night-time street lighting to atmospheric measurements(1). Weak optical emissions have been produced for decades in such ionospheric 'heating' experiments, where they serve as key indicators of electron acceleration, thermal heating, and other effects of incompletely understood wave - particle interactions in the plasma under conditions difficult to replicate in the laboratory(2). The extremely low intensities produced previously have, however, required sensitive instrumentation for detection, preventing applications beyond scientific research. Here we report observations of radio-induced optical emissions bright enough to be seen by the naked eye, and produced not in the quiet midlatitude ionosphere, but in the midst of a pulsating natural aurora. This may open the door to visual applications of ionospheric heating technology or provide a way to probe the dynamics of the natural aurora and magnetosphere.	USAF, Space Vehicles Directorate, Res Lab, Hanscom AFB, MA 01731 USA; Cornell Univ, Dept Elect & Comp Engn, Ithaca, NY 14853 USA	United States Department of Defense; United States Air Force; Cornell University	Pedersen, TR (corresponding author), USAF, Space Vehicles Directorate, Res Lab, Hanscom AFB, MA 01731 USA.	todd.pedersen@hanscom.af.mil		Pedersen, Todd/0000-0002-6940-0112				Bailey VA, 1938, PHILOS MAG, V26, P425; BAUER SJ, 1973, PHYS CHEM SPACE, V6, P82; BERNHARDT PA, 1988, SCIENCE, V242, P1022, DOI 10.1126/science.242.4881.1022; Blagoveshchenskaya NF, 2001, J GEOPHYS RES-SPACE, V106, P29071, DOI 10.1029/2001JA900002; CARLSON HC, 1995, INTRO SPACE PHYS, P459; CHAMBERLAIN JW, 1961, INT GEOPHYS SERIES, V2; DAVIS N, 1992, AURORA WATCHERS HDB, V58; Djuth FT, 1999, GEOPHYS RES LETT, V26, P1557, DOI 10.1029/1999GL900296; OMHOLT A, 1971, PHYS CHEM SPACE, V4; Rishbeth H., 1969, INTRO IONOSPHERIC PH, VVolume 14; Sergienko T, 1997, J ATMOS SOL-TERR PHY, V59, P2401, DOI 10.1016/S1364-6826(97)88118-7	11	27	28	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2005	433	7025					498	500		10.1038/nature03243	http://dx.doi.org/10.1038/nature03243			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893NT	15690034				2022-12-01	WOS:000226727200041
J	Lasmezas, CI; Comoy, E; Hawkins, S; Herzog, C; Mouthon, F; Konold, T; Auvre, F; Correia, E; Lescoutra-Etchegaray, N; Sales, N; Wells, G; Brown, P; Deslys, JP				Lasmezas, CI; Comoy, E; Hawkins, S; Herzog, C; Mouthon, F; Konold, T; Auvre, F; Correia, E; Lescoutra-Etchegaray, N; Sales, N; Wells, G; Brown, P; Deslys, JP			Risk of oral infection with bovine spongiform encephalopathy agent in primates	LANCET			English	Article							BSE; TRANSMISSION; HEALTH; TISSUE; CATTLE	The uncertain extent of human exposure to bovine spongiform encephalopathy (BSE)-which can lead to variant Creutzfeldt-jakob disease (vCJD)-is compounded by incomplete knowledge about the efficiency of oral infection and the magnitude of any bovine-to-human biological barrier to transmission. We therefore investigated oral transmission of BSE to non-human primates. We gave two macaques a 5 g oral dose of brain homogenate from a BSE-infected cow. One macaque developed vCjD-Iike neurological disease 60 months after exposure, whereas the other remained free of disease at 76 months. On the basis of these findings and data from other studies, we made a preliminary estimate of the food exposure risk for man, which provides additional assurance that existing public health measures can prevent transmission of BSE to man.	Commissariat Energie Atom, Direct Sci Vivant, Dept Rech Med, F-92265 Fontenay Aux Roses, France; Vet Labs Agcy, Addlestone, Surrey, England	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Veterinary Laboratories Agency	Deslys, JP (corresponding author), Commissariat Energie Atom, Direct Sci Vivant, Dept Rech Med, 18 Route Panorama, F-92265 Fontenay Aux Roses, France.	jpdeslys@cea.fr	Konold, Timm/C-6498-2011; Hawkins, Stephen/F-1136-2011					Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; *EUR COMM, OP SCI STEER COMM HU; Grassi J, 2001, VET REC, V149, P577, DOI 10.1136/vr.149.19.577; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; KLITZMAN R L, 1984, Neuroepidemiology, V3, P3, DOI 10.1159/000110837; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981	9	72	73	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					781	783		10.1016/S0140-6736(05)17985-9	http://dx.doi.org/10.1016/S0140-6736(05)17985-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733719				2022-12-01	WOS:000227285300025
J	Sawai, S; Thomason, PA; Cox, EC				Sawai, S; Thomason, PA; Cox, EC			An autoregulatory circuit for long-range self-organization in Dictyostelium cell populations	NATURE			English	Article							SPIRAL WAVES; ADENYLYL-CYCLASE; CAMP; AGGREGATION; PROPAGATION; FEEDBACK; KINASE	Nutrient-deprived Dictyostelium amoebae aggregate to form a multicellular structure by chemotaxis, moving towards propagating waves of cyclic AMP that are relayed from cell to cell. Organizing centres are not formed by founder cells, but are dynamic entities consisting of cores of outwardly rotating spiral waves(1-4) that self-organize in a homogeneous cell population. Spiral waves are ubiquitously observed in chemical reactions as well as in biological systems(5-8). Although feedback control of spiral waves in spatially extended chemical reactions has been demonstrated in recent years(9,10), the mechanism by which control is achieved in living systems is unknown. Here we show that mutants of the cyclic AMP/protein kinase A pathway show periodic signalling, but fail to organize coherent long-range wave territories, owing to the appearance of numerous spiral cores. A theoretical model suggests that autoregulation of cell excitability mediated by protein kinase A acts to optimize the number of signalling centres.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Sawai, S (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ssawai@molbio.princeton.edu; ecox@princeton.edu	Sawai, Satoshi/AAX-8536-2020	Thomason, Peter/0000-0003-3104-8392; Sawai, Satoshi/0000-0003-3764-219X				DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; FEY P, 1995, GENE, V165, P127, DOI 10.1016/0378-1119(95)00430-E; FOERSTER P, 1990, DEVELOPMENT, V109, P11; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; GROSS JD, 1976, J CELL SCI, V22, P645; HARWOOD AJ, 1992, CELL, V69, P615, DOI 10.1016/0092-8674(92)90225-2; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Kim M, 2001, SCIENCE, V292, P1357, DOI 10.1126/science.1059478; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; Lauzeral J, 1997, P NATL ACAD SCI USA, V94, P9153, DOI 10.1073/pnas.94.17.9153; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; LEE KJ, 2001, PHYS REV LETT, V87; Levine H, 1996, P NATL ACAD SCI USA, V93, P6382, DOI 10.1073/pnas.93.13.6382; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; Palsson E, 1997, P NATL ACAD SCI USA, V94, P13719, DOI 10.1073/pnas.94.25.13719; Patel H, 2000, EMBO J, V19, P2247, DOI 10.1093/emboj/19.10.2247; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; SEGALL JE, 1995, J CELL BIOL, V128, P405, DOI 10.1083/jcb.128.3.405; SIEGERT F, 1989, J CELL SCI, V93, P325; SIMON MN, 1992, NATURE, V356, P171, DOI 10.1038/356171a0; Sucgang R, 1997, DEV BIOL, V192, P181, DOI 10.1006/dbio.1997.8720; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tung CK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248302; Wessels DJ, 2000, MOL BIOL CELL, V11, P2803, DOI 10.1091/mbc.11.8.2803	28	128	130	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2005	433	7023					323	326		10.1038/nature03228	http://dx.doi.org/10.1038/nature03228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888NK	15662425				2022-12-01	WOS:000226381300057
J	Chao, A; Thun, MJ; Connell, CJ; McCullough, ML; Jacobs, EJ; Flanders, WD; Rodriguez, C; Sinha, R; Calle, EE				Chao, A; Thun, MJ; Connell, CJ; McCullough, ML; Jacobs, EJ; Flanders, WD; Rodriguez, C; Sinha, R; Calle, EE			Meat consumption and risk of colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							II NUTRITION COHORT; COLO-RECTAL CANCER; LARGE-BOWEL-CANCER; HETEROCYCLIC AMINES; UNITED-STATES; RED MEAT; FOOD GROUPS; N-NITROSATION; GASTROINTESTINAL CANCERS; GENETIC SUSCEPTIBILITY	Context Consumption of red and processed meat has been associated with colorectal cancer in many but not all epidemiological studies; few studies have examined risk in relation to long-term meat intake or the association of meat with rectal cancer. Objective To examine the relationship between recent and long-term meat consumption and the risk of incident colon and rectal cancer. Design, Setting, and Participants A cohort of 148610 adults aged 50 to 74 years (median, 63 years), residing in 21 states with population-based cancer registries, who provided information on meat consumption in 1982 and again in 1992/1993 when enrolled in the Cancer Prevention Study II (CPS II) Nutrition Cohort. Follow-up from time of enrollment in 1992/1993 through August 31, 2001, identified 1667 incident colorectal cancers. Participants contributed person-years at risk until death or a diagnosis of colon or rectal cancer. Main Outcome Measure Incidence rate ratio (RR) of colon and rectal cancer. Results High intake of red and processed meat reported in 1992/1993 was associated with higher risk of colon cancer after adjusting for age and energy intake but not after further adjustment for body mass index, cigarette smoking, and other covariates. When long-term consumption was considered, persons in the highest tertile of consumption in both 1982 and 1992/1993 had higher risk of distal colon cancer associated with processed meat (RR, 1.50; 95% confidence interval [CI], 1.04-2.17), and ratio of red meat to poultry and fish (RR, 1.53; 95% Cl, 1.08-2.18) relative to those persons in the lowest tertile at both time points. Long-term consumption of poultry and fish was inversely associated with risk of both proximal and distal colon cancer. High consumption of red meat reported in 1992/1993 was associated with higher risk of rectal cancer (RR, 1.71; 95% Cl, 1.15-2.52; P=.007 for trend), as was high consumption reported in both 1982 and 1992/1993 (RR, 1.43; 95% Cl, 1.00-2.05). Conclusions Our results demonstrate the potential value of examining long-term meat consumption in assessing cancer risk and strengthen the evidence that prolonged high consumption of red and processed meat may increase the risk of cancer in the distal portion of the large intestine.	Amer Canc Soc, Atlanta, GA 30329 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; NCI, Div Canc Epidemiol & Genet, Rockville, MD USA	American Cancer Society; Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Thun, MJ (corresponding author), Amer Canc Soc, 1599 Clifton Rd NE, Atlanta, GA 30329 USA.	mthun@cancer.org	Sinha, Rashmi/G-7446-2015	Sinha, Rashmi/0000-0002-2466-7462; McCullough, Marjorie/0000-0003-3025-6341	NCI NIH HHS [K07CA75062] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIACP010127, K07CA075062, Z01CP010127] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Taie OH, 2003, NUTR CANCER, V46, P125, DOI 10.1207/S15327914NC4602_04; [Anonymous], 1992, INT CLASS DIS 10 REV; Augustsson K, 1999, LANCET, V353, P703, DOI 10.1016/S0140-6736(98)06099-1; BENITO E, 1990, INT J CANCER, V45, P69, DOI 10.1002/ijc.2910450114; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P556; BIDOLI E, 1992, INT J CANCER, V50, P223, DOI 10.1002/ijc.2910500211; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; BLOCK G, 1989, HLTH HABITS HIST QUE; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Boutron-Ruault MC, 1999, EUR J CANCER PREV, V8, P229, DOI 10.1097/00008469-199906000-00011; Butler LM, 2003, AM J EPIDEMIOL, V157, P434, DOI 10.1093/aje/kwf221; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970.abs; Chen J, 1998, CANCER RES, V58, P3307; Cross AJ, 2003, CANCER RES, V63, P2358; DEVERDIER MG, 1991, INT J CANCER, V49, P520, DOI 10.1002/ijc.2910490408; English DR, 2004, CANCER EPIDEM BIOMAR, V13, P1509; Fernandez-Banares F, 2002, AM J GASTROENTEROL, V97, P2103, DOI 10.1111/j.1572-0241.2002.05930.x; Flagg EW, 2000, EPIDEMIOLOGY, V11, P462, DOI 10.1097/00001648-200007000-00017; Flood A, 2003, AM J EPIDEMIOL, V158, P59, DOI 10.1093/aje/kwg099; Gaard M, 1996, EUR J CANCER PREV, V5, P445; GIOVANNUCCI E, 1992, JNCI-J NATL CANCER I, V84, P91, DOI 10.1093/jnci/84.2.91; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GOLDBOHM RA, 1994, CANCER RES, V54, P718; GRAHAM S, 1978, JNCI-J NATL CANCER I, V61, P709; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; GROSS GA, 1992, J CHROMATOGR, V592, P271, DOI 10.1016/0021-9673(92)85095-B; HAENSZEL W, 1980, JNCI-J NATL CANCER I, V64, P17; HAENSZEL W, 1973, J NATL CANCER I, V51, P1765, DOI 10.1093/jnci/51.6.1765; Hsing AW, 1998, INT J CANCER, V77, P549, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;549::AID-IJC13&gt;3.0.CO;2-1; HU JF, 1991, INT J EPIDEMIOL, V20, P362, DOI 10.1093/ije/20.2.362; Hughes R, 2002, NUTR CANCER, V42, P70, DOI 10.1207/S15327914NC421_10; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; Jarvinen R, 2001, BRIT J CANCER, V85, P357, DOI 10.1054/bjoc.2001.1906; Kampman E, 1999, CANCER EPIDEM BIOMAR, V8, P15; KAMPMAN E, 1995, CANCER CAUSE CONTROL, V6, P225, DOI 10.1007/BF00051794; Kato I, 1997, NUTR CANCER, V28, P276, DOI 10.1080/01635589709514588; Kato T, 2002, CANCER LETT, V187, P169, DOI 10.1016/S0304-3835(02)00432-9; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; Kune S, 1987, Nutr Cancer, V9, P21; LAVECCHIA C, 1988, INT J CANCER, V41, P492, DOI 10.1002/ijc.2910410404; LaVecchia C, 1996, INT J CANCER, V66, P60, DOI 10.1002/(SICI)1097-0215(19960328)66:1&lt;60::AID-IJC11&gt;3.0.CO;2-F; LAYTON DW, 1995, CARCINOGENESIS, V16, P39, DOI 10.1093/carcin/16.1.39; LEE HP, 1989, INT J CANCER, V43, P1007, DOI 10.1002/ijc.2910430609; LeMarchand L, 1997, CANCER CAUSE CONTROL, V8, P637, DOI 10.1023/A:1018406716115; Levi F, 1999, BRIT J CANCER, V79, P1283, DOI 10.1038/sj.bjc.6690206; MACQUARTMOULIN G, 1986, INT J CANCER, V38, P183, DOI 10.1002/ijc.2910380207; McCullough ML, 2003, CANCER CAUSE CONTROL, V14, P1, DOI 10.1023/A:1022591007673; MILLER AB, 1983, INT J CANCER, V32, P155, DOI 10.1002/ijc.2910320204; Murata M, 1999, JPN J CANCER RES, V90, P711, DOI 10.1111/j.1349-7006.1999.tb00805.x; Murtaugh MA, 2004, J NUTR, V134, P776, DOI 10.1093/jn/134.4.776; Narayanan BA, 2003, CANCER RES, V63, P972; National Cattlemen's Beef Association, 2001, US BEEF IND DEM SPEN; Njoroge F G, 1989, Prog Clin Biol Res, V304, P85; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; PETERS RK, 1992, CANCER CAUSE CONTROL, V3, P457, DOI 10.1007/BF00051359; PHILLIPS RL, 1985, JNCI-J NATL CANCER I, V74, P307; PICKLE LW, 1984, CANCER RES, V44, P363; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; ProbstHensch NM, 1997, CANCER CAUSE CONTROL, V8, P175, DOI 10.1023/A:1018416128894; RobertsThomson IC, 1996, LANCET, V347, P1372, DOI 10.1016/S0140-6736(96)91012-0; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Seow A, 2002, CANCER-AM CANCER SOC, V95, P2390, DOI 10.1002/cncr.10971; Sesink ALA, 1999, CANCER RES, V59, P5704; Shannon J, 1996, CANCER EPIDEM BIOMAR, V5, P495; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; Sinha R, 1997, MUTAT RES-FUND MOL M, V376, P195, DOI 10.1016/S0027-5107(97)00043-2; Sinha R, 1999, CANCER RES, V59, P4320; SINHA R, 1995, CANCER RES, V55, P4516; TAJIMA K, 1985, JPN J CANCER RES, V76, P705; *TEX CATTL FEED AS, CAP MEAT CONS POUNDS; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; Tiemersma EW, 2002, CANCER CAUSE CONTROL, V13, P383, DOI 10.1023/A:1015236701054; TUYNS AJ, 1988, NUTR CANCER, V11, P189, DOI 10.1080/01635588809513986; VLAJINAC H, 1987, Archiv fuer Geschwulstforschung, V57, P493; Weisburger JH, 2002, MUTAT RES-FUND MOL M, V506, P9, DOI 10.1016/S0027-5107(02)00147-1; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; WOHLLEB JC, 1990, INT J CANCER, V46, P22, DOI 10.1002/ijc.2910460107; World Health Organisation, 1977, INT CLASS DIS 9 REV; Yang CX, 2003, EUR J CANCER PREV, V12, P109, DOI 10.1097/00008469-200304000-00004	83	385	407	0	79	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2005	293	2					172	182		10.1001/jama.293.2.172	http://dx.doi.org/10.1001/jama.293.2.172			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885QC	15644544	Bronze			2022-12-01	WOS:000226171000033
J	Foglia, A				Foglia, A			An unforgivable delay	LANCET			English	Editorial Material									FMH Psichiatria & Psicoterapia, CH-6900 Lugano, Switzerland		Foglia, A (corresponding author), FMH Psichiatria & Psicoterapia, CH-6900 Lugano, Switzerland.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2005	365	9457					445	445						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891WE	15680462				2022-12-01	WOS:000226610900034
